data_2lpd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lpd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 56' ' ' PRO . 9.1 mp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.782 0.801 . . . . 63.11 111.193 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.57 151.13 49.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.366 -1.288 . . . . 73.33 109.306 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.626 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -116.46 157.68 24.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 74.33 109.397 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -85.86 134.83 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.16 -1.422 . . . . 71.3 107.16 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.73 159.32 37.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.954 0.407 . . . . 74.31 111.379 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 38.0 ptt180 -169.21 170.23 8.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.192 -0.913 . . . . 74.21 110.509 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.65 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.77 140.38 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.653 -0.249 . . . . 44.45 111.061 170.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 49.11 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.883 1.068 . . . . 73.12 113.883 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.09 -32.0 6.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.747 -0.596 . . . . 70.25 111.464 -174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.71 -22.81 6.19 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.262 -0.426 . . . . 21.2 113.014 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.03 174.04 10.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.749 -0.464 . . . . 74.31 109.749 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.21 143.3 45.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.901 0.704 . . . . 73.1 112.901 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -136.83 -179.91 5.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.987 -1.006 . . . . 73.51 109.694 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.9 m -125.67 155.34 34.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.807 0.337 . . . . 71.43 110.803 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -148.48 149.1 31.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 74.31 109.306 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.8 ttt -81.61 121.51 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.647 0.26 . . . . 73.3 110.326 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.56 148.89 44.64 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.231 -0.441 . . . . 70.44 111.014 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.97 -23.03 36.26 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.741 -0.544 . . . . 43.5 111.741 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -92.98 118.83 31.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.004 -0.369 . . . . 74.1 110.004 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.3 m -60.24 137.33 58.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.04 0.448 . . . . 72.32 111.391 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.4 mt -93.31 142.43 25.26 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.425 -0.807 . . . . 65.25 110.882 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.13 140.44 70.93 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.863 2.375 . . . . 72.34 111.714 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.67 124.89 11.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 71.5 110.386 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.2 -29.42 7.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.296 -0.478 . . . . 71.01 112.669 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.65 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.1 m95 -76.95 149.88 35.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.335 0.568 . . . . 74.55 111.46 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 18.8 pt-20 -129.62 151.23 50.45 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.977 -0.556 . . . . 74.23 110.245 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -107.99 160.59 15.66 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.214 0.946 . . . . 63.35 111.255 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.17 158.51 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 123.408 0.683 . . . . 74.21 110.608 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.461 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 89.61 -166.85 33.23 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.833 -0.621 . . . . 72.2 112.259 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.55 142.25 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.745 -0.835 . . . . 72.41 108.745 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.626 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.4 Cg_endo -72.57 108.74 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 120.816 1.01 . . . . 72.4 110.575 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.57 172.99 17.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.416 -0.811 . . . . 55.44 110.361 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -55.77 155.33 6.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.898 0.38 . . . . 72.34 111.503 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -49.55 -36.49 23.81 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.619 -0.719 . . . . 75.31 110.923 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -55.71 -55.67 29.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.516 -0.765 . . . . 73.42 110.302 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -52.0 64.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.776 -0.647 . . . . 72.45 111.003 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.562 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.0 t -55.86 -52.46 63.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.197 -0.91 . . . . 63.15 111.071 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.2 pp -68.26 -44.92 74.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.916 -0.313 . . . . 54.21 110.445 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.465 ' N ' HD13 ' A' ' 63' ' ' LEU . 22.0 tt0 -54.8 -36.51 65.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.968 0.413 . . . . 74.01 110.394 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.452 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 48.5 ttt85 -64.21 -53.53 47.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.774 -0.648 . . . . 74.43 111.046 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.07 -34.05 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 111.679 0.251 . . . . 74.43 111.679 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 39.7 mm-40 -65.97 -32.77 74.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.487 -0.324 . . . . 71.01 110.385 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.75 4.95 42.32 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.295 -0.411 . . . . 75.11 111.266 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 48.0 mt -103.73 -66.97 0.91 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.92 0.39 . . . . 70.13 111.195 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -86.32 -54.84 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.272 0.558 . . . . 73.15 111.417 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -78.19 -10.92 59.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.187 -0.915 . . . . 55.35 111.399 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 113.977 1.103 . . . . 73.31 113.977 -171.168 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.236 0.367 0 CA-C-O 121.784 0.802 . . . . 63.11 111.455 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -127.31 148.7 50.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.502 -1.226 . . . . 73.33 109.156 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -114.1 162.39 16.54 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.61 0.569 . . . . 74.33 109.543 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -88.42 140.65 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.247 -1.02 . . . . 71.3 108.247 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 40' ' ' TRP . 23.4 m -144.99 158.23 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 122.195 -0.316 . . . . 74.31 110.85 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 19.9 ptt85 -169.36 170.1 8.63 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.335 -0.393 . . . . 74.21 111.542 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -157.89 139.82 14.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.342 -0.39 . . . . 44.45 111.063 171.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 35.12 21.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.137 1.375 . . . . 73.12 114.294 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ASN . 10.7 pt-20 -112.4 -32.11 6.6 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.616 -0.677 . . . . 70.25 111.385 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.86 -22.79 5.52 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.972 -0.558 . . . . 21.2 112.078 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -84.35 161.56 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.14 -0.689 . . . . 74.31 109.14 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -106.32 137.48 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.086 0.469 . . . . 73.1 111.711 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -124.13 -179.21 4.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.046 -0.979 . . . . 73.51 109.726 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -132.31 157.3 43.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.879 0.371 . . . . 71.43 110.877 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 30' ' ' VAL . 73.4 t-105 -155.75 149.41 25.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.823 -0.806 . . . . 74.31 108.823 -171.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.86 130.35 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 73.3 110.539 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.58 144.12 27.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.993 -0.548 . . . . 70.44 111.621 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -20.69 12.09 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.13 -0.486 . . . . 43.5 113.254 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -79.91 131.1 35.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.762 0.281 . . . . 74.1 110.274 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -65.92 148.76 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.314 0.578 . . . . 72.32 111.821 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 29.1 mt -111.35 147.71 37.25 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.094 -0.957 . . . . 65.25 111.204 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -81.07 176.1 9.2 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.913 2.409 . . . . 72.34 113.029 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 125.44 10.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.907 -1.042 . . . . 71.5 111.94 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.57 -32.32 7.52 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.634 -0.712 . . . . 71.01 112.847 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.3 m95 -76.91 133.54 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.034 0.417 . . . . 74.55 111.689 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 9.8 pt-20 -127.62 152.78 47.23 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.746 -0.661 . . . . 74.23 110.393 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' VAL . 39.5 p -102.13 159.66 15.19 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.289 0.993 . . . . 63.35 111.42 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -173.6 175.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.743 0.817 . . . . 74.21 110.285 -173.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 82.75 -161.2 40.05 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.723 -0.671 . . . . 72.2 112.882 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.5 138.62 20.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 123.366 0.666 . . . . 72.41 109.588 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.7 Cg_endo -71.59 113.38 3.62 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.673 1.582 . . . . 72.4 111.078 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.37 167.11 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.726 -0.67 . . . . 55.44 109.938 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -61.69 161.36 10.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.679 0.276 . . . . 72.34 110.961 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -46.89 -48.52 21.19 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.869 -0.605 . . . . 75.31 111.633 -176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.37 -45.09 84.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.978 -0.555 . . . . 73.42 111.406 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.75 -38.78 64.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 72.45 110.708 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.2 t -59.02 -49.26 78.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.73 -0.668 . . . . 63.15 110.202 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.6 pp -68.05 -37.22 81.06 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.43 -0.35 . . . . 54.21 110.508 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.472 ' N ' HD13 ' A' ' 63' ' ' LEU . 33.9 tt0 -60.31 -32.74 71.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.089 0.471 . . . . 74.01 110.411 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -76.57 -44.02 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.982 -0.554 . . . . 74.43 110.548 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 63' ' ' LEU . 44.4 pt -67.61 -34.55 68.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 121.153 -0.219 . . . . 74.43 110.675 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.586 ' HA ' ' HB ' ' A' ' 71' ' ' THR . 34.3 mt-10 -54.03 -56.04 21.67 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.25 -0.432 . . . . 71.01 110.112 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -65.76 -10.18 34.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 75.11 112.384 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.02 -67.79 0.88 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.329 0.492 . . . . 70.13 112.329 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -87.01 -55.44 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.965 0.888 . . . . 73.15 111.168 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 5.5 m -74.09 -11.52 60.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.027 -1.442 . . . . 55.35 111.609 -170.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 67' ' ' GLU . 24.5 t70 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 114.029 1.122 . . . . 73.31 114.029 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.811 0.815 . . . . 63.11 111.464 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 19.8 m-85 -121.09 148.72 43.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.546 -1.206 . . . . 73.33 108.254 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.87 159.57 26.53 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.72 -0.844 . . . . 74.33 108.72 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 86.9 t -86.8 138.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.282 -1.377 . . . . 71.3 107.282 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 46' ' ' LEU . 33.9 m -138.32 160.53 31.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.318 0.508 . . . . 74.31 111.295 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -168.61 169.15 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.786 -1.097 . . . . 74.21 110.242 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.8 p30 -154.36 139.74 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.993 -0.373 . . . . 44.45 109.993 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 t30 44.88 6.16 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.159 1.17 . . . . 73.12 114.159 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.7 pt-20 -112.27 -32.45 6.52 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.503 -0.748 . . . . 70.25 112.118 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 -22.58 4.57 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.242 -0.436 . . . . 21.2 112.911 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.16 174.05 5.94 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.915 0.486 . . . . 74.31 110.388 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -122.29 133.02 54.69 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.592 0.589 . . . . 73.1 112.592 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.3 m -132.82 -179.19 5.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.371 -0.831 . . . . 73.51 109.71 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.6 158.33 26.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 71.43 110.913 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 56.0 t90 -147.15 137.21 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.84 . . . . 74.31 109.6 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 ttt -83.09 121.46 27.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.284 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.15 165.36 22.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.347 . . . . 70.44 110.189 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.31 -4.85 29.93 Favored Glycine 0 C--N 1.328 0.125 0 N-CA-C 110.91 -0.876 . . . . 43.5 110.91 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.519 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.8 ptp180 -131.56 172.52 12.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.271 0.628 . . . . 74.1 109.737 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 p -101.67 143.65 31.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.999 -0.371 . . . . 72.32 109.999 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.41 HD11 HG13 ' A' ' 30' ' ' VAL . 8.5 mt -88.9 133.17 36.15 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.325 -0.398 . . . . 65.25 111.544 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.12 130.66 13.77 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 123.303 2.668 . . . . 72.34 112.352 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 126.52 15.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 71.5 110.493 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.88 -25.53 9.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.241 -0.504 . . . . 71.01 112.06 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 66.2 m95 -83.96 158.53 21.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.809 0.305 . . . . 74.55 110.784 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -135.21 154.26 51.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.318 -0.401 . . . . 74.23 110.048 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.414 ' O ' HG11 ' A' ' 53' ' ' VAL . 24.3 p -107.43 153.21 23.13 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 124.737 1.273 . . . . 63.35 110.244 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -167.51 175.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.676 0 C-N-CA 123.624 0.77 . . . . 74.21 110.023 -173.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.22 -115.3 4.19 Favored Glycine 0 C--O 1.219 -0.835 0 CA-C-N 115.681 -0.69 . . . . 72.2 113.111 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 16.4 tp10 -147.32 136.89 11.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.279 1.032 . . . . 72.41 108.597 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 73.6 Cg_endo -83.51 107.51 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.011 1.141 . . . . 72.4 110.286 166.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.68 -175.4 5.14 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.391 -0.822 . . . . 55.44 111.242 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -55.83 151.21 11.72 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.471 -0.786 . . . . 72.34 111.286 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.426 ' HG3' HD22 ' A' ' 63' ' ' LEU . 23.8 tptm -45.93 -41.0 10.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.225 -0.898 . . . . 75.31 110.269 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -59.86 -42.41 93.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.107 -0.952 . . . . 73.42 111.417 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -71.95 -48.06 47.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.884 0.373 . . . . 72.45 110.721 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 60.0 m -60.22 -46.6 89.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 63.15 111.578 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.08 -41.05 82.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.753 -0.379 . . . . 54.21 110.385 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.584 ' N ' HD13 ' A' ' 63' ' ' LEU . 9.4 tt0 -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.281 0.562 . . . . 74.01 110.877 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.4 ttm-85 -64.48 -47.42 79.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.965 -0.562 . . . . 74.43 111.202 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 pt -69.66 -37.66 74.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.64 0.257 . . . . 74.43 110.977 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.65 -48.99 76.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 71.01 110.214 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.6 mt-30 -73.29 8.73 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.795 0.331 . . . . 75.11 111.452 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 73.3 mt -103.54 -66.13 0.96 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.975 0.417 . . . . 70.13 110.618 170.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -85.29 -48.47 9.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.441 0.639 . . . . 73.15 110.837 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -76.81 -10.74 59.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.202 -0.908 . . . . 55.35 111.356 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 25.9 t70 . . . . . 0 N--CA 1.477 0.884 0 C-N-CA 124.182 0.993 . . . . 73.31 113.168 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.237 0.401 0 CA-C-O 121.176 0.512 . . . . 63.11 110.552 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.22 148.71 50.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 73.33 110.72 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.628 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -117.78 162.59 17.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.943 -1.026 . . . . 74.33 108.91 171.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -94.06 142.65 13.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.778 -1.193 . . . . 71.3 107.778 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.03 156.62 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.155 0.502 . . . . 74.31 111.227 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.475 ' HD3' ' CE1' ' A' ' 37' ' ' TYR . 29.5 ptt180 -154.25 155.18 34.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.196 -0.911 . . . . 74.21 109.581 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.7 p30 -156.56 139.35 15.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.983 -0.287 . . . . 44.45 110.894 168.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 35.43 13.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.652 1.723 . . . . 73.12 115.652 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.808 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 16.4 pt-20 -112.71 -31.92 6.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.745 0.646 . . . . 70.25 112.745 -170.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.42 89.01 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 21.2 112.473 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.808 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 77.7 mt-30 -120.77 174.09 6.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.348 0.659 . . . . 74.31 109.365 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.475 ' CE1' ' HD3' ' A' ' 31' ' ' ARG . 42.4 m-85 -122.54 146.46 47.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.739 1.014 . . . . 73.1 113.739 -171.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -138.9 -179.31 5.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.216 -1.357 . . . . 73.51 108.677 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.47 ' CG1' ' SG ' ' A' ' 62' ' ' CYS . 28.5 m -122.83 161.6 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.918 0.389 . . . . 71.43 111.084 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -145.89 156.47 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 74.31 109.32 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.4 ttt -86.07 147.5 26.15 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.828 -0.434 . . . . 73.3 109.828 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.62 156.88 38.88 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.017 0.437 . . . . 70.44 111.524 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.35 54.13 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.547 -0.751 . . . . 43.5 112.769 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -112.35 116.1 29.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.876 -0.416 . . . . 74.1 109.876 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.0 m -66.09 154.69 38.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.278 0.561 . . . . 72.32 112.048 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -111.05 152.88 43.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.075 -0.966 . . . . 65.25 111.151 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 74.1 Cg_endo -80.34 158.13 22.78 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.627 2.218 . . . . 72.34 111.921 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 131.13 26.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.797 -0.638 . . . . 71.5 111.237 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.96 -35.27 5.16 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.774 -0.648 . . . . 71.01 111.658 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.52 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 32.2 m95 -79.71 139.02 37.49 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.188 -0.301 . . . . 74.55 110.188 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.87 153.68 49.55 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.377 -0.374 . . . . 74.23 110.284 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.2 p -98.11 162.82 13.02 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.19 0.931 . . . . 63.35 111.459 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.56 150.02 3.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.41 -0.814 . . . . 74.21 109.978 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 -170.56 37.53 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.557 -0.747 . . . . 72.2 111.495 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 151.56 40.76 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 108.652 -0.87 . . . . 72.41 108.652 174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.628 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 21.9 Cg_endo -65.54 105.17 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.206 1.271 . . . . 72.4 110.046 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.17 169.45 17.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.412 -0.813 . . . . 55.44 110.669 -171.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 t -57.29 151.3 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.654 -0.703 . . . . 72.34 111.149 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -48.75 -44.91 39.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.751 -0.659 . . . . 75.31 110.576 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.57 ' H ' ' NE2' ' A' ' 60' ' ' GLN . 2.3 mp0 -56.19 -37.32 69.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.477 -0.783 . . . . 73.42 111.206 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -74.96 -39.72 61.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.909 0.385 . . . . 72.45 110.436 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 39' ' ' VAL . 5.5 t -65.23 -51.33 61.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.665 . . . . 63.15 110.56 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.0 -36.99 80.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.865 0.364 . . . . 54.21 110.384 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.3 tt0 -60.4 -43.15 96.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.01 110.237 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.655 ' HG3' HH11 ' A' ' 65' ' ' ARG . 18.8 ttm-85 -60.85 -53.18 60.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.63 -0.714 . . . . 74.43 111.764 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.8 pt -67.26 -37.39 79.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.953 0.406 . . . . 74.43 111.125 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.81 -33.17 75.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.02 -0.537 . . . . 71.01 110.527 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.486 ' C ' ' HB3' ' A' ' 72' ' ' ASP . 16.1 mm-40 -78.21 2.33 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.685 0.279 . . . . 75.11 111.226 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 71.6 mt -103.59 -66.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.099 0.476 . . . . 70.13 110.968 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -85.33 -55.21 4.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.578 0.704 . . . . 73.15 110.845 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -10.97 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.864 -1.062 . . . . 55.35 111.853 -170.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.486 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 6.8 p-10 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 113.978 1.103 . . . . 73.31 113.978 -167.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.233 0.226 0 CA-C-O 121.196 0.522 . . . . 63.11 110.256 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -129.62 153.0 48.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.367 -0.833 . . . . 73.33 109.751 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -116.02 167.45 10.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.083 -0.962 . . . . 74.33 108.896 169.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.3 t -92.47 146.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.131 -1.433 . . . . 71.3 107.131 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 46' ' ' LEU . 34.5 m -140.32 163.9 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 118.395 0.543 . . . . 74.31 110.927 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -164.16 159.69 20.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.159 -0.473 . . . . 74.21 111.189 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -171.32 140.21 1.41 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.029 -0.532 . . . . 44.45 110.619 168.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 50.02 4.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.058 1.133 . . . . 73.12 114.058 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.73 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 9.4 pt-20 -107.71 -29.49 9.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.824 -0.547 . . . . 70.25 112.371 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.97 19.28 67.6 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.644 -0.788 . . . . 21.2 111.411 -173.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.73 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 87.3 mt-30 -129.52 174.03 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.736 0.814 . . . . 74.31 108.807 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.5 132.64 56.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.593 0.711 . . . . 73.1 112.416 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 m -124.95 178.38 5.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.579 -1.191 . . . . 73.51 108.886 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG11 ' SG ' ' A' ' 62' ' ' CYS . 18.0 m -129.91 160.07 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.855 0.36 . . . . 71.43 111.337 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -157.67 154.38 28.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.863 -0.792 . . . . 74.31 108.863 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -80.26 135.12 36.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.976 -0.289 . . . . 73.3 110.625 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.75 136.23 52.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 70.44 110.529 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.78 -3.71 74.6 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.188 -0.46 . . . . 43.5 112.132 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -103.26 128.19 50.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.705 -0.48 . . . . 74.1 109.705 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -64.97 156.69 30.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.135 0.493 . . . . 72.32 112.025 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 HG11 ' A' ' 30' ' ' VAL . 19.9 mt -124.34 139.43 32.88 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.471 -0.786 . . . . 65.25 110.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -54.73 141.49 75.81 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.899 2.4 . . . . 72.34 111.612 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.25 127.65 25.27 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.829 0.347 . . . . 71.5 110.442 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.75 -34.54 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.538 -0.625 . . . . 71.01 111.538 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.4 m95 -78.15 142.81 37.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.989 -0.374 . . . . 74.55 109.989 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.5 152.92 48.5 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 120.774 0.321 . . . . 74.23 110.318 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 p -100.94 154.31 18.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.103 -0.953 . . . . 63.35 110.9 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.09 171.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.301 1.04 . . . . 74.21 109.182 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.95 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.713 -0.756 . . . . 72.2 112.522 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.67 132.92 10.16 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.122 -1.066 . . . . 72.41 108.122 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.66 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.9 Cg_endo -62.85 122.38 10.65 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.875 1.716 . . . . 72.4 112.42 -170.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.79 160.71 10.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.508 -0.769 . . . . 55.44 109.351 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -55.86 154.99 6.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.65 0.262 . . . . 72.34 111.104 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 87.4 tttt -49.05 -40.94 33.33 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.946 -0.57 . . . . 75.31 110.886 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.94 -48.16 70.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.464 -0.789 . . . . 73.42 110.923 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -74.77 -30.18 61.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 72.45 110.783 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.539 ' SG ' HG11 ' A' ' 39' ' ' VAL . 12.9 t -66.36 -50.94 61.84 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.911 -0.586 . . . . 63.15 110.667 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.2 pp -63.93 -37.97 89.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.954 0.407 . . . . 54.21 110.276 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.563 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 26.3 tt0 -58.68 -43.49 89.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.824 -0.626 . . . . 74.01 110.237 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.7 ttt180 -62.05 -43.58 98.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 74.43 111.166 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.67 -38.29 44.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 111.827 0.306 . . . . 74.43 111.827 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 34.9 mm-40 -64.12 -41.59 97.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 121.304 -0.158 . . . . 71.01 111.15 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 64.1 mt-30 -73.9 7.86 2.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.02 0.438 . . . . 75.11 111.18 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.5 mt -103.63 -65.92 0.98 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.307 -0.406 . . . . 70.13 110.874 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -85.79 -52.85 5.49 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.682 -0.69 . . . . 73.15 111.128 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -74.88 -11.69 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.414 -0.812 . . . . 55.35 111.054 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 4.0 p-10 . . . . . 0 N--CA 1.468 0.451 0 CA-C-N 115.842 -0.617 . . . . 73.31 112.398 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 57' ' ' ALA . 3.2 mm? . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.696 0.76 . . . . 63.11 111.867 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.0 m-85 -127.37 148.5 50.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.735 -1.121 . . . . 73.33 109.1 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.19 159.8 22.05 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.7 . . . . 74.33 109.111 174.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 53' ' ' VAL . 46.6 t -91.97 145.85 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.852 -1.536 . . . . 71.3 106.852 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.0 m -138.87 161.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 121.771 -0.581 . . . . 74.31 111.517 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 24.8 ptt180 -161.81 155.42 21.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.498 -0.773 . . . . 74.21 110.201 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.0 p30 -161.33 139.72 9.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.213 -0.292 . . . . 44.45 110.213 169.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 43.08 3.89 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.692 1.367 . . . . 73.12 114.692 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.8 pt-20 -112.49 -32.03 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.573 -0.705 . . . . 70.25 111.594 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.21 -22.52 18.9 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.411 -0.423 . . . . 21.2 113.095 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -86.29 174.11 9.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.97 0.385 . . . . 74.31 110.383 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -106.26 139.89 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 73.1 112.442 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 29' ' ' VAL . 23.0 m -134.87 178.24 7.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.379 -0.828 . . . . 73.51 109.464 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG1' ' SG ' ' A' ' 62' ' ' CYS . 36.0 m -123.1 159.13 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.521 0.201 . . . . 71.43 110.65 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -158.37 139.02 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.987 -0.746 . . . . 74.31 108.987 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.5 ttt -67.39 124.37 22.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.262 . . . . 73.3 110.81 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.82 130.97 44.62 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.297 -0.41 . . . . 70.44 110.123 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.13 -9.41 33.62 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.291 -0.724 . . . . 43.5 111.291 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -106.38 111.27 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 74.1 109.278 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 m -66.74 141.63 57.67 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.725 . . . . 72.32 112.11 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 45.3 mt -96.3 151.44 38.12 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 114.727 -1.124 . . . . 65.25 111.314 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 69.2 Cg_endo -77.97 152.55 28.35 Favored 'Trans proline' 0 C--O 1.242 0.697 0 C-N-CA 122.549 2.166 . . . . 72.34 111.774 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.24 19.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.67 -0.695 . . . . 71.5 111.018 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.78 -35.27 4.37 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.443 -0.799 . . . . 71.01 111.339 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 22.5 m95 -83.41 142.13 31.22 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.979 -0.378 . . . . 74.55 109.979 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -129.28 148.24 51.19 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 120.852 0.358 . . . . 74.23 110.582 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.412 HG23 HD12 ' A' ' 46' ' ' LEU . 19.9 p -99.04 150.75 21.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.659 -1.155 . . . . 63.35 110.315 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.533 HG21 HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.76 155.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.107 -172.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.73 -160.17 24.21 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.905 -1.043 . . . . 72.2 112.641 175.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -103.83 133.14 20.42 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.81 -0.811 . . . . 72.41 108.81 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.624 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 55.5 Cg_endo -70.24 111.14 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.322 1.348 . . . . 72.4 110.566 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 26' ' ' LEU . . . -147.53 171.98 14.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.799 -0.637 . . . . 55.44 110.241 -171.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 t -57.14 156.2 7.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.512 -0.313 . . . . 72.34 111.441 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -49.76 -43.7 48.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.953 0.501 . . . . 75.31 110.962 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.21 -51.31 62.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.947 -0.57 . . . . 73.42 110.806 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.28 -30.74 68.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 72.45 110.687 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' ' CG1' ' A' ' 39' ' ' VAL . 4.1 t -63.5 -50.09 70.98 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.076 -0.511 . . . . 63.15 110.288 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 64' ' ' GLN . 2.3 pp -68.06 -46.51 70.91 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.929 -0.397 . . . . 54.21 109.929 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD11 ' A' ' 63' ' ' LEU . 25.4 tt0 -56.87 -31.88 65.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 74.01 111.162 -175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.1 ttt85 -70.96 -53.54 14.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 74.43 111.435 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.9 pt -70.53 -37.75 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.777 0.288 . . . . 74.43 111.777 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.59 -37.75 77.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.205 -0.452 . . . . 71.01 111.095 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -81.33 1.74 31.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.844 0.354 . . . . 75.11 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 66.6 mt -103.77 -66.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 70.13 110.844 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -85.18 -53.36 5.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.709 -0.678 . . . . 73.15 110.911 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.7 m -75.35 -11.13 59.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.46 -0.791 . . . . 55.35 111.47 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 N--CA 1.47 0.562 0 C-N-CA 123.368 0.667 . . . . 73.31 112.339 -171.265 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 31.3 mt . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.997 0.903 . . . . 63.11 111.768 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.65 149.67 41.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.966 -1.47 . . . . 73.33 109.338 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.614 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 m-85 -107.94 164.08 12.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.782 -0.821 . . . . 74.33 108.782 168.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.567 HG23 HH11 ' A' ' 65' ' ' ARG . 40.1 t -92.3 137.24 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.27 -1.382 . . . . 71.3 107.27 174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 46' ' ' LEU . 13.7 m -139.03 164.95 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 118.113 0.415 . . . . 74.31 111.244 -174.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 39.2 ptt180 -169.19 170.02 8.93 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.571 -0.74 . . . . 74.21 110.473 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.6 p30 -156.19 139.79 15.97 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.337 -0.246 . . . . 44.45 110.337 170.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.4 t30 47.42 4.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.885 1.069 . . . . 73.12 113.885 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.2 pt-20 -112.26 -32.32 6.56 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.806 -0.559 . . . . 70.25 111.924 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 -22.73 4.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.388 -0.434 . . . . 21.2 112.73 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -73.45 174.06 8.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.872 0.336 . . . . 74.31 110.315 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -121.85 132.64 54.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.332 0.493 . . . . 73.1 112.332 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -129.02 176.89 7.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.267 -0.879 . . . . 73.51 109.393 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.22 149.19 21.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.915 0.388 . . . . 71.43 110.815 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.502 ' NE1' ' HB3' ' A' ' 44' ' ' ARG . 70.8 t-105 -149.18 137.87 21.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 74.31 109.728 -171.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.6 ttt -62.76 125.19 23.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.663 -0.244 . . . . 73.3 110.896 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.76 144.33 57.13 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.785 -0.45 . . . . 70.44 109.785 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.7 -34.55 4.94 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 111.144 -0.782 . . . . 43.5 111.144 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB3' ' NE1' ' A' ' 40' ' ' TRP . 4.8 ttt180 -69.82 95.42 0.9 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.804 -0.813 . . . . 74.1 108.804 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.1 m -61.3 126.07 26.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 72.32 111.929 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.8 mt -85.05 148.15 49.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.935 -1.03 . . . . 65.25 110.944 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.09 159.62 26.86 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.625 2.216 . . . . 72.34 112.045 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.84 126.65 23.02 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.006 -0.543 . . . . 71.5 110.773 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -35.18 4.43 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.578 -0.737 . . . . 71.01 111.488 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 44.3 m95 -83.51 134.89 34.82 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.988 -0.375 . . . . 74.55 109.988 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 10.6 pt-20 -119.25 146.95 44.8 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.424 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -105.2 156.7 17.86 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.456 1.097 . . . . 63.35 110.106 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -164.78 157.71 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.336 0.588 . . . . 74.21 111.265 -173.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 87.04 -174.05 45.35 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 114.872 -1.058 . . . . 72.2 112.077 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.3 144.49 28.9 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.784 -0.821 . . . . 72.41 108.784 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.614 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.6 Cg_endo -64.4 140.05 68.02 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.971 1.781 . . . . 72.4 112.36 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' HB3' ' A' ' 26' ' ' LEU . . . -171.65 147.03 2.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.708 -0.678 . . . . 55.44 109.676 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -59.77 168.3 1.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.391 0.138 . . . . 72.34 111.23 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE3' HD21 ' A' ' 63' ' ' LEU . 56.0 tptt -44.37 -51.59 8.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.108 0.563 . . . . 75.31 111.921 -174.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.05 -47.82 77.18 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.901 0.382 . . . . 73.42 111.488 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -74.73 -35.28 62.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 72.45 111.147 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.75 -45.94 80.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 63.15 109.971 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 pp -68.05 -44.33 76.65 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.85 -0.426 . . . . 54.21 109.85 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.581 ' N ' HD11 ' A' ' 63' ' ' LEU . 27.0 tt0 -55.06 -37.98 67.44 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.301 0.572 . . . . 74.01 109.825 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.567 HH11 HG23 ' A' ' 29' ' ' VAL . 65.9 ttt-85 -57.43 -53.33 59.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.436 -0.802 . . . . 74.43 111.137 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.4 pt -74.22 -33.9 36.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.449 -0.341 . . . . 74.43 111.892 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 74.4 mm-40 -64.12 -42.89 96.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.536 -0.302 . . . . 71.01 110.416 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.6 mm-40 -74.42 4.73 5.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.355 . . . . 75.11 111.078 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.9 mt -103.14 -64.98 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 70.13 110.695 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.42 -52.03 6.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 73.15 111.141 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 m -73.47 -11.26 60.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.549 -0.75 . . . . 55.35 111.036 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 123.679 0.792 . . . . 73.31 112.269 -173.271 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.334 0.588 . . . . 63.11 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -133.93 155.98 48.95 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.116 -0.947 . . . . 73.33 109.713 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.735 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -121.17 159.81 25.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.022 -0.99 . . . . 74.33 108.693 172.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 53' ' ' VAL . 42.3 t -91.47 125.61 44.18 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.098 -1.075 . . . . 71.3 108.098 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 52' ' ' THR . 16.7 m -133.17 166.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.9 0.381 . . . . 74.31 111.084 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -165.81 162.23 18.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.497 -0.774 . . . . 74.21 110.522 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.461 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.1 OUTLIER -151.94 139.78 19.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.647 0.26 . . . . 44.45 110.353 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 44.47 8.97 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.14 1.163 . . . . 73.12 114.14 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.41 -32.26 6.55 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.789 -0.569 . . . . 70.25 111.852 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -22.94 3.65 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.958 -0.564 . . . . 21.2 113.078 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -87.43 173.69 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.456 -0.572 . . . . 74.31 109.456 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.432 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 15.8 m-85 -106.89 138.75 42.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.365 0.876 . . . . 73.1 113.365 -172.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 m -134.96 -179.01 5.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.402 -1.272 . . . . 73.51 109.011 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG11 ' SG ' ' A' ' 62' ' ' CYS . 28.3 m -124.26 159.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.935 0.397 . . . . 71.43 111.29 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HB2' HG21 ' A' ' 30' ' ' VAL . 68.3 t-105 -142.8 143.38 32.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.252 -0.647 . . . . 74.31 109.252 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.5 ttt -81.37 127.44 32.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.234 -0.284 . . . . 73.3 110.234 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.79 157.11 18.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.256 -0.429 . . . . 70.44 111.26 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.32 10.6 55.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.191 -0.528 . . . . 43.5 112.669 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -151.47 130.0 12.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.903 0.382 . . . . 74.1 110.147 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -80.67 153.42 27.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.514 0.673 . . . . 72.32 111.643 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.626 HD13 HG23 ' A' ' 52' ' ' THR . 52.7 mt -95.26 145.81 30.19 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 114.857 -1.065 . . . . 65.25 111.013 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.31 168.35 14.95 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.642 2.228 . . . . 72.34 112.551 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.3 129.84 22.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.247 -0.888 . . . . 71.5 111.022 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.82 -33.03 6.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.022 -0.536 . . . . 71.01 111.804 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 45.0 m95 -88.48 141.46 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.786 0.327 . . . . 74.55 110.762 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.02 154.49 47.36 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.095 -0.502 . . . . 74.23 110.304 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.626 HG23 HD13 ' A' ' 46' ' ' LEU . 15.7 p -114.49 160.68 18.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.373 1.046 . . . . 63.35 111.194 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG21 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -165.72 149.35 2.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 C-N-CA 123.474 0.71 . . . . 74.21 110.907 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 108.27 -172.65 17.21 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.128 -0.942 . . . . 72.2 113.305 172.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' OE2' ' HD2' ' A' ' 56' ' ' PRO . 5.8 tp10 -103.27 129.45 25.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 107.983 -1.117 . . . . 72.41 107.983 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.735 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 18.9 Cg_endo -56.74 122.11 11.23 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.738 1.625 . . . . 72.4 111.32 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.72 157.78 30.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 55.44 110.431 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 t -55.73 152.93 8.83 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.088 0.243 . . . . 72.34 110.698 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.78 -42.44 25.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.853 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -53.92 -44.09 70.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.098 0.475 . . . . 73.42 111.036 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 82.6 mm-40 -74.85 -39.11 61.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 72.45 110.537 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.449 ' SG ' HG11 ' A' ' 39' ' ' VAL . 8.9 t -63.42 -43.69 96.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 63.15 110.561 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.4 pp -68.14 -36.63 80.0 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 109.621 -0.511 . . . . 54.21 109.621 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.589 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.4 tt0 -54.77 -44.61 73.82 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.308 -0.627 . . . . 74.01 109.308 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -56.34 -52.0 66.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.814 -0.63 . . . . 74.43 110.952 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.49 -35.97 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.653 -0.249 . . . . 74.43 111.637 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 26.5 mm-40 -66.42 -32.75 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.603 0.239 . . . . 71.01 110.624 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.7 mm100 -81.19 -18.91 44.59 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.273 -0.421 . . . . 75.11 111.396 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.89 -66.65 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.327 0.584 . . . . 70.13 112.187 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.432 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 65.5 t-105 -85.3 -46.1 11.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 73.15 110.66 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -82.71 -10.06 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.098 -0.955 . . . . 55.35 110.993 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 114.656 1.354 . . . . 73.31 114.656 -170.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.62 0.724 . . . . 63.11 111.419 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.585 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 22.7 m-85 -129.92 148.55 51.8 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.574 -1.194 . . . . 73.33 108.843 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.58 166.41 11.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 74.33 108.742 171.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 53' ' ' VAL . 25.6 t -94.56 111.72 25.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 107.1 -1.444 . . . . 71.3 107.1 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 40' ' ' TRP . 11.5 m -125.87 167.0 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.985 -0.447 . . . . 74.31 111.534 -170.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -166.19 169.68 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 74.21 110.997 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -156.15 139.75 15.97 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.538 -0.301 . . . . 44.45 110.757 172.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.3 t30 40.53 10.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.898 1.279 . . . . 73.12 114.216 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.0 pt-20 -112.61 -32.29 6.5 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.691 -0.631 . . . . 70.25 112.124 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 -22.96 2.19 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.165 -0.541 . . . . 21.2 112.633 -173.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' GLU . 13.9 mm100 -75.81 173.89 10.57 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -115.71 142.29 46.94 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.912 0.708 . . . . 73.1 112.912 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.0 m -137.59 -179.46 5.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.417 -1.265 . . . . 73.51 109.65 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.02 148.99 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.769 0.319 . . . . 71.43 110.983 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 70.3 t90 -144.44 129.88 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.958 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.6 ttm -69.93 143.58 52.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.477 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.09 -172.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 70.44 110.655 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.55 -34.41 4.2 Favored Glycine 0 CA--C 1.515 0.071 0 C-N-CA 121.175 -0.535 . . . . 43.5 112.831 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 mpt_? -95.97 -170.89 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.061 0.458 . . . . 74.1 110.384 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 p -135.3 117.26 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.991 -0.744 . . . . 72.32 108.991 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 52' ' ' THR . 17.6 mt -57.7 132.21 82.53 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.101 -0.5 . . . . 65.25 111.566 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.4 158.61 9.61 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.707 2.938 . . . . 72.34 112.794 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 123.37 17.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.07 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.79 -29.13 7.35 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.067 -0.813 . . . . 71.01 111.067 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 59.0 m95 -84.99 151.45 24.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.779 -0.452 . . . . 74.55 109.779 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.69 145.94 45.31 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 116.363 -0.381 . . . . 74.23 110.161 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.588 HG23 HD11 ' A' ' 46' ' ' LEU . 38.7 p -104.5 144.59 31.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.783 -1.099 . . . . 63.35 110.152 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.73 168.44 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.429 0.633 . . . . 74.21 110.466 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 -148.64 22.29 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.284 -0.871 . . . . 72.2 111.955 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 28.5 tt0 -132.65 132.93 22.92 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.618 -0.882 . . . . 72.41 108.618 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.588 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -70.48 125.66 12.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.882 1.721 . . . . 72.4 111.621 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.0 175.58 13.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.195 -0.457 . . . . 55.44 110.684 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 t -62.99 151.36 39.92 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.145 -0.317 . . . . 72.34 110.145 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -44.55 -43.26 7.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 75.31 111.373 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.56 -42.62 92.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 73.42 111.269 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.03 -36.61 61.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 72.45 111.132 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 62.5 m -64.92 -44.85 88.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 63.15 111.175 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.577 HD11 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.07 -41.85 81.34 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.76 -0.459 . . . . 54.21 109.76 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.577 ' N ' HD11 ' A' ' 63' ' ' LEU . 25.1 tt0 -59.37 -37.37 77.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.465 0.65 . . . . 74.01 110.436 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.488 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 11.4 ttt180 -64.38 -47.0 80.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.474 -0.785 . . . . 74.43 111.153 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.0 pt -74.4 -34.85 37.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.718 0.294 . . . . 74.43 111.63 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 69' ' ' LEU . 8.1 mm-40 -64.94 -48.55 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 71.01 110.961 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.475 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 22.1 mm-40 -70.43 8.46 0.81 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.073 0.464 . . . . 75.11 111.651 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 92.5 mt -103.42 -66.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.341 0.591 . . . . 70.13 110.203 172.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -83.49 -54.69 4.77 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.401 -0.818 . . . . 73.15 110.668 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -72.18 -11.16 60.61 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.426 -0.806 . . . . 55.35 110.712 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 13.0 t70 . . . . . 0 N--CA 1.469 0.502 0 CA-C-N 115.599 -0.728 . . . . 73.31 111.931 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 56' ' ' PRO . 8.2 mp . . . . . 0 C--O 1.238 0.457 0 CA-C-O 121.505 0.669 . . . . 63.11 111.129 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 13.0 m-85 -133.1 157.49 45.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.766 -1.106 . . . . 73.33 109.26 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.622 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.4 m-85 -113.79 167.67 10.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.634 -0.712 . . . . 74.33 109.224 170.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.55 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.905 -1.146 . . . . 71.3 107.905 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.459 HG11 HG23 ' A' ' 52' ' ' THR . 21.6 m -137.95 162.13 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 118.171 0.441 . . . . 74.31 111.349 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.49 168.17 9.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.569 -0.741 . . . . 74.21 110.798 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.629 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.1 p-10 -163.58 139.97 6.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 44.45 110.346 166.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 t30 46.5 4.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.085 1.143 . . . . 73.12 114.085 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.6 pt-20 -105.71 -25.42 12.23 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.418 -0.801 . . . . 70.25 112.312 -167.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 -22.3 9.6 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.481 -0.39 . . . . 21.2 113.171 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -100.1 173.97 6.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.903 -0.406 . . . . 74.31 109.903 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -106.43 153.72 21.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.436 . . . . 73.1 111.774 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -145.3 -178.72 6.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 73.51 109.217 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.12 158.14 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.929 0.395 . . . . 71.43 111.058 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 59.9 t90 -150.29 142.89 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 74.31 109.738 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.53 131.64 35.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 73.3 111.615 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.49 151.62 43.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 70.44 110.656 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.34 -12.75 43.85 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.171 -0.538 . . . . 43.5 112.883 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 74.8 mtt180 -104.87 -167.23 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.427 -0.582 . . . . 74.1 109.427 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.6 m -138.11 131.16 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 72.32 110.117 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.6 mt -80.71 135.19 52.76 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 65.25 112.13 -174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.09 138.99 21.45 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.449 2.766 . . . . 72.34 112.626 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 130.16 31.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.952 -0.567 . . . . 71.5 110.103 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.86 -35.4 4.31 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.042 -0.823 . . . . 71.01 111.042 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.629 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.0 m95 -76.35 149.49 36.99 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.914 -0.402 . . . . 74.55 109.914 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.16 152.11 50.78 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 110.049 -0.352 . . . . 74.23 110.049 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.459 HG23 HG11 ' A' ' 30' ' ' VAL . 21.5 p -109.44 161.51 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.103 . . . . 63.35 110.483 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.99 162.61 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.278 0.631 . . . . 74.21 109.931 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.48 -173.28 47.69 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.805 -0.634 . . . . 72.2 112.336 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.29 144.22 29.31 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.207 -1.034 . . . . 72.41 108.207 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.622 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 44.9 Cg_endo -65.67 115.48 3.41 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.652 1.568 . . . . 72.4 110.814 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -140.48 168.94 18.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.099 -0.5 . . . . 55.44 110.088 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -59.73 151.86 24.15 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.681 -0.408 . . . . 72.34 110.496 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -46.76 -40.82 14.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.02 -0.536 . . . . 75.31 111.424 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.59 -43.32 99.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 73.42 110.893 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 93.7 mt-30 -72.85 -33.15 65.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.256 -0.429 . . . . 72.45 111.034 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 77.0 m -68.58 -45.95 70.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.475 -0.33 . . . . 63.15 110.83 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.11 -36.49 79.83 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.006 -0.368 . . . . 54.21 110.006 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 35.9 tt0 -66.53 -31.48 72.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.656 0.741 . . . . 74.01 110.118 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 13.0 ttt85 -65.57 -49.71 67.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 74.43 110.27 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.1 pt -70.28 -42.0 78.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.111 -0.495 . . . . 74.43 111.866 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 11.5 pt-20 -60.91 -49.43 77.48 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.251 -0.18 . . . . 71.01 110.653 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.506 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 83.2 mt-30 -74.85 1.94 11.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.887 0.329 . . . . 75.11 111.887 -174.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 mt -103.93 -66.03 0.98 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.276 0.56 . . . . 70.13 111.227 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -86.01 -53.94 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.245 -0.889 . . . . 73.15 111.198 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.03 -10.73 52.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.9 -1.046 . . . . 55.35 111.791 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.429 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 2.4 p-10 . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 113.991 1.108 . . . . 73.31 113.991 -168.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 56' ' ' PRO . 10.9 mp . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.376 0.608 . . . . 63.11 110.248 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -124.92 148.66 48.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.037 -0.983 . . . . 73.33 109.238 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -119.34 159.8 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.694 -0.854 . . . . 74.33 108.694 174.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 53' ' ' VAL . 30.3 t -89.4 139.91 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.534 -1.284 . . . . 71.3 107.534 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 46' ' ' LEU . 29.6 m -139.58 164.9 23.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 121.981 -0.449 . . . . 74.31 111.367 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.64 HH21 ' HA2' ' A' ' 35' ' ' GLY . 9.4 ptm180 -158.16 161.78 37.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.881 -0.6 . . . . 74.21 111.118 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -166.26 140.02 4.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 44.45 110.389 166.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 46.1 5.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.845 1.424 . . . . 73.12 114.845 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.2 pt-20 -112.23 -32.02 6.67 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.934 -0.479 . . . . 70.25 112.283 -170.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.64 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 81.82 -22.72 5.54 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.66 -0.781 . . . . 21.2 112.291 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -93.81 174.02 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.84 -0.43 . . . . 74.31 109.84 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -107.61 152.24 24.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.997 0.739 . . . . 73.1 112.997 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -137.75 -179.22 5.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.563 -1.199 . . . . 73.51 108.989 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' SG ' ' A' ' 62' ' ' CYS . 30.5 m -126.08 152.5 33.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.053 0.454 . . . . 71.43 110.778 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.493 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 50.2 t90 -144.04 144.54 31.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.575 . . . . 74.31 110.458 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -90.62 135.47 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.811 -0.632 . . . . 73.3 110.724 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.39 175.27 6.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.258 -0.428 . . . . 70.44 110.154 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.48 61.82 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.798 -0.921 . . . . 43.5 110.798 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.493 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.2 ptm180 -140.89 176.86 8.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.952 -0.624 . . . . 74.1 109.366 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -126.69 126.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.42 . . . . 72.32 109.915 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 52' ' ' THR . 12.1 mt -56.22 135.04 75.21 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.454 -0.794 . . . . 65.25 112.144 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.71 155.48 70.27 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.018 2.479 . . . . 72.34 112.383 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 124.9 11.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.247 -0.888 . . . . 71.5 110.768 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.44 -30.16 6.87 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.986 -0.552 . . . . 71.01 112.208 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 30.6 m95 -93.3 148.44 22.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.768 0.284 . . . . 74.55 110.472 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -135.23 153.07 52.05 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.855 0.36 . . . . 74.23 111.581 173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.609 HG23 HD11 ' A' ' 46' ' ' LEU . 22.4 p -99.09 160.02 14.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.675 -1.148 . . . . 63.35 111.512 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -169.84 164.76 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.548 1.139 . . . . 74.21 109.661 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.16 -159.78 20.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.004 -0.617 . . . . 72.2 113.272 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -113.02 128.58 25.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.661 -0.866 . . . . 72.41 108.661 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 51.1 Cg_endo -68.31 112.22 2.72 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.742 1.628 . . . . 72.4 111.42 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.32 166.16 33.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 55.44 109.91 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 t -63.98 168.38 5.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.154 0.502 . . . . 72.34 111.236 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.2 tptp -48.83 -50.38 34.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.366 -0.834 . . . . 75.31 111.916 -173.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.49 -41.56 66.37 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.456 0.473 . . . . 73.42 111.336 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -72.94 -43.98 61.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.303 0.573 . . . . 72.45 110.532 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.424 ' SG ' HG12 ' A' ' 39' ' ' VAL . 3.8 t -60.49 -46.57 89.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.236 -0.893 . . . . 63.15 110.858 -173.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 64' ' ' GLN . 2.9 pp -67.92 -40.69 83.34 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.883 -0.327 . . . . 54.21 110.983 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.612 ' N ' HD13 ' A' ' 63' ' ' LEU . 30.0 tt0 -60.96 -35.77 77.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.168 0.509 . . . . 74.01 110.524 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.464 HH11 HG23 ' A' ' 29' ' ' VAL . 63.4 ttt-85 -62.3 -53.66 51.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.924 -0.58 . . . . 74.43 110.855 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.8 pt -69.68 -34.55 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.568 -0.287 . . . . 74.43 111.365 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.2 -55.23 19.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 71.01 110.939 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 68.6 mt-30 -70.96 1.3 5.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 75.11 111.705 -174.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.6 mt -103.47 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 70.13 111.024 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -85.27 -46.83 10.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.694 -0.684 . . . . 73.15 110.509 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -80.46 -10.66 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.183 -0.917 . . . . 55.35 111.092 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 113.067 0.765 . . . . 73.31 113.067 -170.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp . . . . . 0 C--O 1.235 0.291 0 CA-C-O 121.454 0.645 . . . . 63.11 111.152 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.14 148.68 52.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.082 -0.963 . . . . 73.33 109.537 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.05 162.43 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.155 -0.683 . . . . 74.33 109.155 176.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.472 HG23 HH11 ' A' ' 65' ' ' ARG . 71.1 t -95.4 137.76 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.35 -1.352 . . . . 71.3 107.35 172.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.57 164.71 33.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.109 0.481 . . . . 74.31 111.71 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 15.9 ptm180 -167.81 170.13 11.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.914 -1.039 . . . . 74.21 110.149 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.695 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -167.39 139.99 3.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.73 -0.213 . . . . 44.45 111.007 166.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 37.2 16.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.686 1.365 . . . . 73.12 114.686 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.8 pt-20 -112.31 -29.16 7.64 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.763 -0.585 . . . . 70.25 112.479 -172.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' NH2' ' A' ' 31' ' ' ARG . . . 74.62 7.69 79.97 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.599 -0.81 . . . . 21.2 111.666 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.741 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 6.7 tp60 -116.21 167.88 10.61 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.599 -0.889 . . . . 74.31 108.599 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -112.96 153.56 27.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.546 0.573 . . . . 73.1 112.546 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 m -147.61 -179.33 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.999 -1.0 . . . . 73.51 109.478 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG23 ' HE3' ' A' ' 59' ' ' LYS . 15.9 m -123.54 163.48 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 71.43 110.604 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -151.01 149.81 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 74.31 109.934 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.5 ttt -86.15 126.89 34.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 73.3 110.242 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.56 142.86 57.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.896 0.379 . . . . 70.44 110.949 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.66 -15.86 29.05 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.675 -0.693 . . . . 43.5 111.965 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.392 -0.225 . . . . 74.1 110.392 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -84.25 119.42 25.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.195 0.521 . . . . 72.32 110.485 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.9 mt -68.55 143.82 95.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 65.25 111.744 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 47.3 Cg_endo -75.29 154.21 40.99 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.451 2.1 . . . . 72.34 112.266 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.61 125.96 7.74 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.333 -0.848 . . . . 71.5 111.489 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.74 -35.0 4.83 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.972 -0.558 . . . . 71.01 112.177 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.695 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 16.8 m95 -77.19 157.27 30.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.629 0.252 . . . . 74.55 110.437 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 8.0 pt-20 -144.91 146.95 32.23 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.276 -0.42 . . . . 74.23 110.776 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 53' ' ' VAL . 25.1 p -98.86 163.37 12.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.649 -0.705 . . . . 63.35 111.442 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -166.26 152.71 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 123.663 0.785 . . . . 74.21 110.306 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 100.88 -175.25 26.2 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.33 -0.85 . . . . 72.2 113.472 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -103.03 116.14 62.93 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.784 -1.191 . . . . 72.41 107.784 172.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 32.1 Cg_endo -60.18 124.85 16.07 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.961 1.774 . . . . 72.4 111.926 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.91 173.45 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.503 . . . . 55.44 109.86 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -55.63 153.71 7.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.402 0.144 . . . . 72.34 111.144 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.51 ' HE3' HG23 ' A' ' 39' ' ' VAL . 23.7 tptm -44.05 -43.2 6.63 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.992 0.517 . . . . 75.31 111.054 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.99 -47.64 68.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.454 -0.794 . . . . 73.42 111.259 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.87 -32.07 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 72.45 110.51 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.492 ' SG ' HG11 ' A' ' 39' ' ' VAL . 7.5 t -64.08 -48.75 74.97 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.808 -0.633 . . . . 63.15 110.58 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -67.69 -34.83 77.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.882 0.372 . . . . 54.21 110.12 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.537 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.2 tt0 -58.86 -43.98 90.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.54 -0.755 . . . . 74.01 110.334 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 62.3 ttt-85 -56.94 -53.47 57.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.783 -0.644 . . . . 74.43 111.123 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.1 pt -71.04 -32.9 49.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.269 -0.423 . . . . 74.43 111.535 -174.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.65 -44.69 85.58 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.132 -0.322 . . . . 71.01 110.132 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.84 -1.9 6.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.052 0.39 . . . . 75.11 112.052 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.7 mt -103.59 -66.45 0.95 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.383 0.611 . . . . 70.13 111.222 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -85.61 -52.4 5.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 73.15 110.201 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -76.27 -11.05 59.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.757 -1.11 . . . . 55.35 111.57 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 122.967 0.507 . . . . 73.31 111.732 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 HD22 ' HB2' ' A' ' 56' ' ' PRO . 7.4 mp . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.226 0.536 . . . . 63.11 111.244 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 6.8 m-85 -127.83 162.12 27.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.309 -0.86 . . . . 73.33 110.637 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 m-85 -126.85 167.78 15.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.737 -0.665 . . . . 74.33 109.42 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.41 135.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 71.3 107.289 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG12 HG21 ' A' ' 52' ' ' THR . 33.4 m -139.94 169.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.867 0.303 . . . . 74.31 111.127 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -167.84 170.02 11.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.143 -0.481 . . . . 74.21 111.305 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.1 OUTLIER -161.65 140.03 9.39 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.113 -0.494 . . . . 44.45 110.862 171.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 46.07 8.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.055 1.131 . . . . 73.12 114.055 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.7 pt-20 -112.33 -32.09 6.62 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.786 -0.571 . . . . 70.25 112.073 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 -22.64 6.52 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 112.065 -0.414 . . . . 21.2 112.065 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -81.85 173.85 11.86 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.826 0.45 . . . . 74.31 109.961 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.552 ' HD2' ' HE1' ' A' ' 70' ' ' TRP . 14.7 m-85 -118.27 141.96 47.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 73.1 111.938 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -132.74 -179.35 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.79 -1.096 . . . . 73.51 109.246 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.35 160.35 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.704 0.287 . . . . 71.43 110.578 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 63.0 t-105 -148.13 151.25 35.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 74.31 109.9 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -91.37 129.28 37.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.289 -0.263 . . . . 73.3 110.289 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.38 150.87 25.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 70.44 110.609 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.26 16.47 Favored Glycine 0 N--CA 1.453 -0.177 0 N-CA-C 111.539 -0.624 . . . . 43.5 111.539 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 44' ' ' ARG . 53.4 mtt-85 -88.19 110.11 20.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 110.416 -0.216 . . . . 74.1 110.416 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -71.33 130.01 40.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.067 0.461 . . . . 72.32 109.961 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.556 HD11 HG23 ' A' ' 52' ' ' THR . 40.4 mt -76.05 142.82 72.91 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.337 -0.847 . . . . 65.25 111.396 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 67.3 Cg_endo -75.82 156.25 39.35 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.579 2.186 . . . . 72.34 111.711 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.59 122.41 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.698 -0.683 . . . . 71.5 111.49 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.9 -32.21 5.75 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.061 -0.518 . . . . 71.01 112.434 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.468 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 31.2 m95 -80.19 146.25 31.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.851 0.325 . . . . 74.55 110.697 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.58 155.71 49.15 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.524 -0.307 . . . . 74.23 110.729 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.556 HG23 HD11 ' A' ' 46' ' ' LEU . 17.4 p -112.57 162.18 15.95 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.543 1.152 . . . . 63.35 111.483 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.55 HG21 ' CE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -166.02 145.02 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.054 0.542 . . . . 74.21 111.009 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.13 -165.61 18.59 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.559 -0.746 . . . . 72.2 112.248 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -104.73 145.02 29.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.148 -0.686 . . . . 72.41 109.148 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.61 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.5 Cg_endo -67.3 105.31 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.051 1.167 . . . . 72.4 110.136 173.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.61 165.19 31.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.095 -0.957 . . . . 55.44 110.977 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -62.02 166.95 4.2 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.394 0.616 . . . . 72.34 112.487 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.625 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 58.9 tptt -46.34 -50.02 16.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.966 -1.016 . . . . 75.31 111.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.76 -39.24 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.951 -0.568 . . . . 73.42 111.303 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -73.7 -44.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 72.45 111.166 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 27.4 p -64.12 -45.15 89.85 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.002 -0.279 . . . . 63.15 111.25 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -68.15 -41.21 81.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 54.21 110.454 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.616 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.6 tt0 -63.2 -36.46 83.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 74.01 110.376 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 ttt180 -58.7 -53.73 55.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.878 0.37 . . . . 74.43 110.905 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.9 pt -72.78 -32.66 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 74.43 111.213 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -61.23 -44.62 96.97 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.193 -0.299 . . . . 71.01 110.193 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.8 mm-40 -73.09 0.93 10.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.93 0.395 . . . . 75.11 111.132 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 80.1 mt -103.62 -66.13 0.97 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 70.13 111.258 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.552 ' HE1' ' HD2' ' A' ' 37' ' ' TYR . 73.0 m95 -85.68 -45.69 11.44 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.979 -0.555 . . . . 73.15 111.027 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 m -81.71 -11.19 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.834 . . . . 55.35 110.901 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 115.993 -0.548 . . . . 73.31 111.565 -172.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.918 0.866 . . . . 63.11 111.358 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.37 161.54 33.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.914 -1.494 . . . . 73.33 108.738 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.662 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -130.0 160.08 34.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.08 -0.964 . . . . 74.33 108.621 172.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 53' ' ' VAL . 55.8 t -90.32 120.89 39.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 107.564 -1.272 . . . . 71.3 107.564 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.76 160.51 32.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.192 0.52 . . . . 74.31 111.973 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 36' ' ' GLN . 17.2 ptt85 -169.53 170.16 8.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.777 -1.101 . . . . 74.21 110.216 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -145.03 139.49 27.48 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.516 -0.473 . . . . 44.45 110.505 169.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.0 t30 30.95 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.208 1.559 . . . . 73.12 115.208 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.0 pt-20 -112.49 -32.06 6.6 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.471 -0.768 . . . . 70.25 112.536 -172.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.94 -22.48 8.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.156 -0.545 . . . . 21.2 112.641 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.433 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 33.8 tt0 -80.01 158.65 26.48 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.952 -0.758 . . . . 74.31 108.952 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.05 140.61 46.58 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.771 0.656 . . . . 73.1 112.771 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m -134.1 -179.23 5.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.031 -0.986 . . . . 73.51 109.351 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.64 158.34 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.621 0.248 . . . . 71.43 110.694 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CE2' ' HG ' ' A' ' 46' ' ' LEU . 75.0 t90 -155.14 145.41 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.212 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.1 ttt -81.49 125.53 30.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.746 0.308 . . . . 73.3 111.279 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.06 142.12 47.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.027 -0.533 . . . . 70.44 110.494 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.47 -5.52 29.81 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 111.582 -0.607 . . . . 43.5 111.582 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -108.12 166.29 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.147 0.579 . . . . 74.1 109.45 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -97.19 115.07 26.91 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.116 -0.365 . . . . 72.32 110.565 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 mt -69.68 138.76 88.4 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 65.25 110.745 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 19.2 Cg_endo -65.61 137.1 48.84 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 122.244 1.963 . . . . 72.34 111.75 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.11 124.9 4.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.47 -0.786 . . . . 71.5 111.509 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -34.12 4.92 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.773 -0.649 . . . . 71.01 111.772 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.1 m95 -77.6 139.81 39.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.716 0.293 . . . . 74.55 110.723 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 13.0 pt-20 -126.7 156.22 41.44 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 116.314 -0.403 . . . . 74.23 110.59 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.2 p -104.39 153.19 21.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.555 -1.202 . . . . 63.35 111.085 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.37 161.73 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 123.419 0.688 . . . . 74.21 109.985 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 -159.4 24.51 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.399 -0.819 . . . . 72.2 111.96 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.451 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -109.9 137.48 20.48 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 109.269 -0.641 . . . . 72.41 109.269 176.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.662 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 57.0 Cg_endo -68.79 116.48 4.47 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.406 1.404 . . . . 72.4 110.431 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -162.47 169.39 20.46 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.15 -0.477 . . . . 55.44 110.251 -169.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 61' ' ' GLN . 43.3 p -55.74 151.9 10.42 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.916 0.135 . . . . 72.34 111.035 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.13 -41.66 3.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.287 0.565 . . . . 75.31 110.147 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -56.66 -52.32 65.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.664 -1.153 . . . . 73.42 111.492 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 10.3 mm-40 -71.32 -41.8 69.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 72.45 110.754 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 57' ' ' ALA . 72.8 m -60.59 -45.95 92.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.395 -0.366 . . . . 63.15 111.167 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.09 -36.41 79.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.42 -0.585 . . . . 54.21 109.42 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -58.18 -31.58 67.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.428 -0.806 . . . . 74.01 110.318 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 34.1 ttt180 -65.83 -53.26 42.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.786 -0.643 . . . . 74.43 110.898 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 pt -73.35 -32.35 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 74.43 112.46 -171.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 12.4 pt-20 -58.47 -32.69 69.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.042 0.448 . . . . 71.01 109.925 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 79.3 mm-40 -87.7 -9.38 54.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.875 -0.602 . . . . 75.11 111.379 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -103.74 -65.69 1.0 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.708 0.766 . . . . 70.13 111.619 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -85.39 -43.21 13.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.07 -0.968 . . . . 73.15 110.78 -175.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.13 -10.83 51.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.82 -0.627 . . . . 55.35 112.268 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 4.9 p-10 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 115.321 1.6 . . . . 73.31 115.321 -163.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 56' ' ' PRO . 7.6 mp . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.883 0.373 . . . . 63.11 110.289 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.06 158.15 39.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.505 0.722 . . . . 73.33 110.367 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.649 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 22.0 m-85 -113.03 169.54 8.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 74.33 109.118 166.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.563 HG12 HG21 ' A' ' 66' ' ' ILE . 56.5 t -95.01 125.22 47.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.825 -1.176 . . . . 71.3 107.825 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 46' ' ' LEU . 27.4 m -125.95 160.86 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.258 0.551 . . . . 74.31 111.95 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 11.8 ptt180 -169.16 170.13 8.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.62 -1.173 . . . . 74.21 110.083 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.608 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -145.83 139.59 26.48 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 44.45 110.834 164.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 33.06 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.745 1.757 . . . . 73.12 115.745 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.9 pt-20 -112.59 -29.36 7.49 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.583 0.628 . . . . 70.25 111.917 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 -10.52 48.81 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.152 -0.547 . . . . 21.2 112.634 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.512 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 69.3 mt-30 -84.78 173.03 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.039 -0.726 . . . . 74.31 109.039 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.31 132.66 48.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.957 0.725 . . . . 73.1 112.957 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -131.69 -178.9 5.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.791 -1.095 . . . . 73.51 108.475 172.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 62' ' ' CYS . 23.7 m -124.17 149.53 28.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.204 0.526 . . . . 71.43 111.322 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.4 ' HB3' HG12 ' A' ' 30' ' ' VAL . 55.8 t-105 -148.83 143.4 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.755 . . . . 74.31 109.28 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -74.85 141.37 44.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.893 0.377 . . . . 73.3 111.311 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.55 147.04 44.31 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.828 -0.624 . . . . 70.44 110.374 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.79 4.83 67.05 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.392 -0.433 . . . . 43.5 112.304 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -121.81 112.35 18.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.88 -0.415 . . . . 74.1 109.88 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.9 m -57.98 123.0 14.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.583 -0.735 . . . . 72.32 111.469 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 15.9 mt -79.99 139.76 53.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.308 -0.86 . . . . 65.25 110.836 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.33 140.06 53.45 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.691 2.261 . . . . 72.34 111.632 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.82 126.19 15.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.96 -0.564 . . . . 71.5 110.384 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -29.54 7.06 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.11 -0.495 . . . . 71.01 112.295 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.6 m95 -75.5 155.05 36.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.028 0.414 . . . . 74.55 110.607 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.8 pt-20 -135.67 148.97 49.13 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 110.043 -0.355 . . . . 74.23 110.043 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p -109.19 153.01 24.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.431 -0.804 . . . . 63.35 110.983 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.2 t -149.98 152.9 11.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 122.842 0.457 . . . . 74.21 110.476 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.73 -170.12 37.9 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.797 -0.638 . . . . 72.2 113.198 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -108.43 143.71 28.03 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 109.102 -0.703 . . . . 72.41 109.102 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.649 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 36.8 Cg_endo -63.1 122.14 10.26 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.161 1.907 . . . . 72.4 112.678 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 157.35 42.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.453 -0.794 . . . . 55.44 109.604 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 t -56.32 156.7 5.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.61 0.243 . . . . 72.34 111.085 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -43.26 -50.18 6.56 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.663 -0.699 . . . . 75.31 111.635 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.39 -49.46 76.14 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.42 111.412 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -70.16 -35.1 73.77 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.093 0.473 . . . . 72.45 110.461 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 39' ' ' VAL . 18.2 t -62.09 -51.71 66.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 63.15 110.048 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.36 -33.43 74.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.016 -0.273 . . . . 54.21 110.347 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 8.6 tt0 -62.45 -31.93 72.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.531 0.681 . . . . 74.01 110.635 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.466 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 35.9 ttm180 -62.35 -53.1 59.92 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.035 -0.529 . . . . 74.43 112.091 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.563 HG21 HG12 ' A' ' 29' ' ' VAL . 17.8 pt -72.96 -35.11 47.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.363 -0.38 . . . . 74.43 111.737 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 4.2 pt-20 -57.78 -46.21 84.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.606 -0.438 . . . . 71.01 109.839 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.594 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 86.0 mt-30 -74.15 -0.41 16.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.388 -0.369 . . . . 75.11 111.633 -173.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.8 mt -103.37 -68.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.552 -0.459 . . . . 70.13 112.139 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -87.34 -55.08 3.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.621 -0.718 . . . . 73.15 111.976 -176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 67' ' ' GLU . 2.9 p -81.81 -10.89 59.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.708 -1.133 . . . . 55.35 111.752 -171.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.1 t70 . . . . . 0 N--CA 1.469 0.525 0 C-N-CA 123.948 0.899 . . . . 73.31 113.043 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.0 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.111 0.482 . . . . 63.11 110.97 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 33.8 m-85 -123.66 149.06 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.49 -0.777 . . . . 73.33 109.741 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -114.86 155.97 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 74.33 108.921 169.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.72 114.83 24.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 N-CA-C 107.86 -1.163 . . . . 71.3 107.86 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 52' ' ' THR . 12.7 m -125.14 159.62 31.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 122.164 -0.335 . . . . 74.31 110.561 -170.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -162.0 162.11 28.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.351 -0.84 . . . . 74.21 110.722 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 p30 -152.05 139.69 19.75 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.269 -0.271 . . . . 44.45 110.269 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t30 46.63 4.63 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.993 1.109 . . . . 73.12 113.993 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.19 -32.43 6.54 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.656 -0.653 . . . . 70.25 112.095 -169.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.51 -22.68 3.16 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.352 -0.452 . . . . 21.2 112.617 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -75.51 173.96 10.29 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.727 -0.471 . . . . 74.31 109.727 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.49 136.01 53.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 73.1 112.172 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -135.86 -178.74 5.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.066 -0.97 . . . . 73.51 109.456 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 HG11 ' SG ' ' A' ' 62' ' ' CYS . 27.7 m -128.72 150.02 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.68 0.276 . . . . 71.43 111.069 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.41 ' HB2' HG21 ' A' ' 30' ' ' VAL . 52.2 t-105 -149.45 141.48 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.851 -0.613 . . . . 74.31 109.736 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.6 mtt -65.45 134.24 53.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.1 0.476 . . . . 73.3 111.408 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.23 147.82 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.764 -0.653 . . . . 70.44 110.451 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.72 62.53 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.188 -0.765 . . . . 43.5 111.188 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -93.91 96.48 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.731 -0.84 . . . . 74.1 108.731 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -55.57 116.52 2.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.596 -0.729 . . . . 72.32 112.113 -169.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.435 HD13 HG13 ' A' ' 30' ' ' VAL . 42.6 mt -74.4 139.64 75.22 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.729 -1.123 . . . . 65.25 110.055 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.22 160.48 20.31 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.636 2.224 . . . . 72.34 112.478 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.3 129.92 18.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.549 -0.75 . . . . 71.5 110.53 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.54 -33.29 5.31 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.35 -0.7 . . . . 71.01 111.35 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 43.2 m95 -88.72 148.08 24.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.508 0.194 . . . . 74.55 110.519 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 149.37 52.13 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 110.262 -0.273 . . . . 74.23 110.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 30' ' ' VAL . 34.8 p -111.53 148.3 33.5 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.376 1.048 . . . . 63.35 111.057 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -154.05 156.4 5.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.573 0.749 . . . . 74.21 109.878 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.446 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.43 -158.58 23.7 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.406 -0.426 . . . . 72.2 113.483 169.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.89 131.68 21.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.611 . . . . 72.41 109.349 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.518 ' HB2' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -70.08 109.08 2.28 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 121.623 1.549 . . . . 72.4 111.255 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.07 171.09 20.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.236 -0.893 . . . . 55.44 110.442 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -58.28 166.19 1.75 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.254 0.55 . . . . 72.34 112.437 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.668 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 32.1 tptt -49.82 -49.77 47.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.055 -0.975 . . . . 75.31 110.669 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -54.42 -43.04 71.2 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.087 -0.96 . . . . 73.42 111.342 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -70.04 -48.45 57.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 72.45 110.746 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 9.1 p -62.93 -42.4 99.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.075 -0.511 . . . . 63.15 111.515 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -67.93 -40.82 83.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.492 -0.483 . . . . 54.21 110.093 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.6 tt0 -60.19 -31.43 70.13 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.789 -0.641 . . . . 74.01 110.454 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 75.5 ttt-85 -73.86 -53.3 10.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.844 -0.616 . . . . 74.43 110.627 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 63' ' ' LEU . 39.3 pt -66.23 -32.8 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 112.228 0.455 . . . . 74.43 112.228 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.42 -32.85 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.606 0.241 . . . . 71.01 110.353 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 91.2 mt-30 -87.53 -1.63 58.07 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.073 -0.512 . . . . 75.11 111.349 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 85.9 mt -104.0 -66.72 0.94 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.272 0.558 . . . . 70.13 111.656 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -86.09 -55.14 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.391 -0.822 . . . . 73.15 111.163 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.8 -10.99 59.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.205 -0.907 . . . . 55.35 111.311 -174.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.439 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.4 t70 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.693 0.797 . . . . 73.31 112.981 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 56' ' ' PRO . 6.4 mp . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.413 0.625 . . . . 63.11 112.34 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.599 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 6.3 m-85 -124.65 149.3 47.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.659 -1.155 . . . . 73.33 109.001 174.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.574 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -108.17 169.75 8.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.698 -0.482 . . . . 74.33 109.698 172.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 53' ' ' VAL . 51.0 t -99.0 137.53 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.412 -1.329 . . . . 71.3 107.412 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.62 161.91 29.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 118.405 0.548 . . . . 74.31 111.878 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -169.06 170.19 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.961 -1.018 . . . . 74.21 110.436 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.726 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 4.8 p30 -165.73 139.81 4.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.438 -0.208 . . . . 44.45 110.438 166.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.75 8.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.274 1.213 . . . . 73.12 114.274 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.8 pt-20 -112.08 -29.84 7.45 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.798 -0.564 . . . . 70.25 112.05 -169.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.66 -22.92 7.04 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.244 -0.503 . . . . 21.2 113.011 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.12 173.87 8.58 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.964 -0.384 . . . . 74.31 109.964 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -116.69 150.73 37.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.326 0.491 . . . . 73.1 112.326 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -144.47 -178.95 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.867 . . . . 73.51 109.453 168.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.55 165.41 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.784 0.326 . . . . 71.43 110.858 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 35.0 t90 -151.72 132.2 13.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 74.31 110.692 -170.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.457 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 15.8 tpt -68.06 127.32 32.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.051 -0.522 . . . . 73.3 110.136 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.93 159.58 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 70.44 109.606 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.42 21.04 25.58 Favored Glycine 0 C--N 1.329 0.166 0 C-N-CA 121.022 -0.608 . . . . 43.5 112.004 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.8 ptm180 -148.28 179.11 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.654 -0.499 . . . . 74.1 109.654 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 m -109.47 154.0 23.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.559 -0.534 . . . . 72.32 109.559 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 11.2 tp -104.22 129.19 25.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 65.25 110.193 -174.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.508 ' HD2' HD13 ' A' ' 46' ' ' LEU . 83.9 Cg_exo -40.42 132.82 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.522 2.814 . . . . 72.34 113.217 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 128.29 20.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.728 -0.669 . . . . 71.5 111.192 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.86 -34.22 5.09 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.875 -0.89 . . . . 71.01 110.875 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.726 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 45.6 m95 -76.69 157.64 31.62 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 110.167 -0.308 . . . . 74.55 110.167 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.63 152.99 48.58 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 116.314 -0.403 . . . . 74.23 110.111 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -105.67 154.52 20.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.738 -1.119 . . . . 63.35 110.528 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -163.05 161.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.225 0 C-N-CA 123.334 0.654 . . . . 74.21 110.863 -174.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.44 -140.09 14.96 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.823 -1.08 . . . . 72.2 112.72 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.68 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 26.0 tt0 -140.26 133.96 15.27 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.308 -0.997 . . . . 72.41 108.308 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.574 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 70.0 Cg_endo -70.29 112.48 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.603 . . . . 72.4 111.073 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -142.63 174.41 10.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.591 -0.731 . . . . 55.44 110.692 -172.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -64.44 157.88 25.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.589 0.233 . . . . 72.34 110.603 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -44.38 -51.78 8.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.444 0.698 . . . . 75.31 111.654 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -55.38 -46.09 76.56 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.854 -0.612 . . . . 73.42 111.825 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.451 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 99.2 mt-30 -71.46 -32.17 67.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 72.45 111.126 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 71.8 m -68.68 -47.22 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 63.15 111.011 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 64' ' ' GLN . 3.8 pp -68.01 -36.13 79.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.924 0.393 . . . . 54.21 110.619 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.5 tt0 -61.12 -43.55 98.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.532 . . . . 74.01 109.803 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.68 ' NH1' ' HB3' ' A' ' 55' ' ' GLU . 14.2 ttm180 -60.5 -53.45 57.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.38 -0.827 . . . . 74.43 111.924 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.5 pt -63.71 -32.48 57.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.779 0.324 . . . . 74.43 111.531 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.31 -32.56 74.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.471 . . . . 71.01 110.612 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 72.4 mm-40 -86.35 7.94 23.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.055 0.455 . . . . 75.11 110.592 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 36.9 mt -103.53 -62.58 1.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.515 0.674 . . . . 70.13 110.537 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -85.83 -50.03 7.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.12 . . . . 73.15 110.994 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -86.43 -10.52 54.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.739 -1.119 . . . . 55.35 112.176 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.489 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 12.1 p-10 . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 123.34 0.656 . . . . 73.31 112.726 -170.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 121.038 0.446 . . . . 63.11 110.15 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 3.0 m-85 -125.18 148.62 48.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 73.33 110.055 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.509 ' CE1' ' HD3' ' A' ' 56' ' ' PRO . 10.3 m-85 -109.68 157.67 18.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.176 -0.675 . . . . 74.33 109.176 168.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.4 124.17 40.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.367 -1.346 . . . . 71.3 107.367 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.459 HG11 HD12 ' A' ' 46' ' ' LEU . 19.3 m -125.54 162.52 28.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 122.103 -0.373 . . . . 74.31 111.054 -171.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.59 HH21 ' HA2' ' A' ' 35' ' ' GLY . 7.6 ptm180 -167.76 168.15 12.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.395 -0.366 . . . . 74.21 111.638 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -168.25 140.36 2.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.922 -0.581 . . . . 44.45 110.554 167.404 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.8 t30 45.89 13.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.029 0.932 . . . . 73.12 113.486 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' ASN . 9.8 pt-20 -112.43 -20.47 11.77 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.738 -0.601 . . . . 70.25 112.144 -172.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.59 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 75.52 -22.53 1.71 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.309 -0.472 . . . . 21.2 113.219 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' GLU . 6.0 pt20 -103.42 173.96 6.08 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.778 0.431 . . . . 74.31 110.148 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -108.74 158.13 17.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 73.1 112.471 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -141.73 -178.97 5.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.059 . . . . 73.51 108.646 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.753 HG23 ' HE3' ' A' ' 59' ' ' LYS . 20.6 m -127.79 152.34 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 118.237 0.472 . . . . 71.43 111.328 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.405 ' HB3' HG11 ' A' ' 30' ' ' VAL . 72.0 t-105 -153.1 146.89 25.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.96 -0.564 . . . . 74.31 110.216 -174.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 46.2 ttm -72.14 122.12 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.543 -0.299 . . . . 73.3 110.636 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.44 156.45 38.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 70.44 110.454 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.17 -31.81 8.22 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.302 -0.475 . . . . 43.5 112.145 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -106.6 130.34 54.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 74.1 110.216 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.5 m -66.0 159.37 25.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.22 0.534 . . . . 72.32 111.881 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.4 mt -107.3 155.5 39.33 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.228 -0.896 . . . . 65.25 111.227 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -55.85 152.36 36.13 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.172 2.581 . . . . 72.34 112.509 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.68 118.45 3.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.469 -0.787 . . . . 71.5 110.907 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.01 9.93 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.151 -0.477 . . . . 71.01 112.502 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.564 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.7 m95 -79.49 132.21 36.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.845 0.322 . . . . 74.55 111.037 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -115.88 154.26 30.05 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.662 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.436 HG21 HG13 ' A' ' 30' ' ' VAL . 40.1 p -112.77 146.22 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.439 1.087 . . . . 63.35 110.612 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 54' ' ' GLY . 17.3 t -154.86 156.12 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.606 0.363 . . . . 74.21 110.476 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 87.33 -179.83 48.13 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.121 -0.491 . . . . 72.2 113.958 169.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.98 118.35 62.61 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 123.237 0.615 . . . . 72.41 111.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 35.6 Cg_endo -64.68 111.71 1.76 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.768 1.645 . . . . 72.4 110.786 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.84 179.41 6.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.939 -0.573 . . . . 55.44 110.465 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 t -55.68 157.8 3.91 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.976 0.417 . . . . 72.34 111.631 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.753 ' HE3' HG23 ' A' ' 39' ' ' VAL . 22.2 tptm -45.97 -45.02 15.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.456 -0.793 . . . . 75.31 111.145 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 8.8 tt0 -56.67 -43.18 80.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 73.42 111.13 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -69.25 -50.2 49.23 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.435 -0.348 . . . . 72.45 111.031 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 15.2 p -60.73 -43.53 97.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.342 -0.39 . . . . 63.15 111.13 -174.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.63 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 pp -67.78 -42.42 81.72 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.636 -0.425 . . . . 54.21 109.993 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' HD13 ' A' ' 63' ' ' LEU . 31.7 tt0 -54.94 -40.7 70.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.111 0.482 . . . . 74.01 110.342 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.1 ttm-85 -58.37 -53.35 59.25 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.583 -0.735 . . . . 74.43 111.955 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.01 -34.63 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.507 -0.315 . . . . 74.43 111.797 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 10.0 mm-40 -61.59 -32.72 72.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 71.01 110.203 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -81.39 -8.42 59.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.272 -0.422 . . . . 75.11 111.722 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 94.8 mt -103.31 -67.03 0.9 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.886 0.374 . . . . 70.13 111.909 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -86.3 -52.9 5.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.511 0.672 . . . . 73.15 110.894 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.55 -11.35 60.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.758 -1.11 . . . . 55.35 111.052 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 123.734 0.814 . . . . 73.31 113.093 -172.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 56' ' ' PRO . 7.0 mp . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.504 0.669 . . . . 63.11 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -126.39 148.5 49.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.977 -1.01 . . . . 73.33 109.288 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.609 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.99 153.31 26.99 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.378 -0.971 . . . . 74.33 108.378 174.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 53' ' ' VAL . 77.2 t -84.77 135.61 24.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.22 -1.77 . . . . 71.3 106.22 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 46' ' ' LEU . 21.6 m -136.46 165.12 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 121.483 -0.761 . . . . 74.31 111.644 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -166.01 164.32 18.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.793 -1.094 . . . . 74.21 110.282 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.4 p-10 -153.39 139.77 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 44.45 110.137 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 42.44 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.052 1.501 . . . . 73.12 115.052 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.4 pt-20 -112.53 -32.22 6.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.461 0.573 . . . . 70.25 111.832 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.01 -22.59 4.94 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.462 -0.399 . . . . 21.2 112.381 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.39 173.95 8.84 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.931 -0.396 . . . . 74.31 109.931 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -112.75 137.59 50.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.478 0.656 . . . . 73.1 112.41 -176.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.7 m -137.27 -179.09 5.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.894 -1.048 . . . . 73.51 108.936 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG13 ' SG ' ' A' ' 62' ' ' CYS . 15.7 m -126.85 153.72 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.887 0.375 . . . . 71.43 111.125 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -144.19 156.08 44.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 74.31 109.259 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.8 ttt -82.59 121.3 26.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.017 -0.364 . . . . 73.3 110.017 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.34 157.81 34.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.985 0.421 . . . . 70.44 110.627 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -21.07 48.13 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.042 -0.823 . . . . 43.5 111.042 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 100.33 9.58 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.284 -0.636 . . . . 74.1 109.284 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -63.3 129.01 38.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.922 0.391 . . . . 72.32 110.422 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 2.7 mm? -58.72 145.19 78.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.635 -0.711 . . . . 65.25 112.418 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.99 144.12 99.5 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 123.007 2.472 . . . . 72.34 111.436 166.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.36 128.54 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 71.5 110.194 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.74 -29.75 7.02 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.551 -0.619 . . . . 71.01 111.551 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 36.0 m95 -86.69 170.9 11.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.068 -0.716 . . . . 74.55 109.068 172.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.83 146.57 28.03 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 120.937 0.399 . . . . 74.23 110.448 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.544 HG23 HD23 ' A' ' 46' ' ' LEU . 13.0 p -98.09 153.38 18.46 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.614 -1.176 . . . . 63.35 110.834 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -162.32 167.01 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 C-N-CA 124.266 1.026 . . . . 74.21 109.83 -175.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 83.44 179.46 52.32 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.171 -0.922 . . . . 72.2 111.412 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.485 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 47.6 tt0 -103.89 122.67 43.69 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.526 -1.286 . . . . 72.41 107.526 171.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.609 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 19.1 Cg_endo -55.72 124.9 17.42 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.119 . . . . 72.4 112.781 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . . . -151.02 156.36 40.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 55.44 109.194 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -62.21 169.95 2.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.667 0.247 . . . . 72.34 111.667 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -43.39 -59.09 2.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.305 0.642 . . . . 75.31 112.289 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.25 -40.29 70.75 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.87 0.367 . . . . 73.42 111.456 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 57' ' ' ALA . 96.4 mt-30 -74.8 -39.07 61.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 72.45 110.808 -176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.517 ' SG ' HG13 ' A' ' 39' ' ' VAL . 6.5 t -65.8 -51.05 62.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.122 -0.49 . . . . 63.15 110.637 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.1 pp -62.73 -43.67 98.19 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.021 0.438 . . . . 54.21 110.067 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.621 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.7 tt0 -63.07 -35.8 81.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.022 -0.535 . . . . 74.01 110.529 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.614 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 16.0 ttt180 -61.87 -50.43 72.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 74.43 110.641 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.4 pt -74.15 -42.13 51.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.816 0.341 . . . . 74.43 111.63 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.94 -37.74 88.52 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.34 -0.391 . . . . 71.01 111.678 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -78.97 0.28 28.18 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 121.023 -0.271 . . . . 75.11 111.368 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -103.92 -65.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.289 0.566 . . . . 70.13 111.141 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -85.45 -46.03 11.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.174 -0.921 . . . . 73.15 110.956 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -87.12 -11.17 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.561 -0.745 . . . . 55.35 112.545 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 113.413 0.894 . . . . 73.31 113.413 -166.845 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.759 0.79 . . . . 63.11 112.182 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.75 149.05 47.62 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.327 -1.306 . . . . 73.33 108.885 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.766 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -108.58 165.07 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.384 -0.599 . . . . 74.33 109.384 173.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 66' ' ' ILE . 36.5 t -102.26 114.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.94 -0.763 . . . . 71.3 108.94 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 52' ' ' THR . 17.3 m -125.74 165.32 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.59 0.234 . . . . 74.31 111.51 -169.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -169.25 170.36 8.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.963 -0.562 . . . . 74.21 111.032 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -149.36 139.79 22.42 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 120.773 -0.371 . . . . 44.45 110.727 168.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t30 33.31 20.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.531 1.533 . . . . 73.12 114.918 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.41 -32.43 6.5 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.617 -0.677 . . . . 70.25 112.134 -174.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.95 19.93 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.317 -0.468 . . . . 21.2 112.751 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -90.57 173.76 7.89 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.744 -0.835 . . . . 74.31 108.744 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.446 ' CD1' HG13 ' A' ' 29' ' ' VAL . 9.3 m-85 -117.43 171.72 7.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.934 0.873 . . . . 73.1 112.101 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -150.09 176.62 10.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.685 -1.598 . . . . 73.51 107.119 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' SG ' ' A' ' 62' ' ' CYS . 7.0 m -124.37 129.4 73.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.522 0.677 . . . . 71.43 111.186 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.494 ' HZ2' ' NH1' ' A' ' 44' ' ' ARG . 54.3 t-105 -119.05 135.96 54.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.806 -1.088 . . . . 74.31 109.292 -171.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.67 123.72 19.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.507 -0.183 . . . . 73.3 110.507 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.69 146.5 52.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.04 -0.356 . . . . 70.44 110.04 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.32 15.84 68.13 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.947 -0.644 . . . . 43.5 111.57 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 44' ' ' ARG . 34.8 ttt-85 -131.27 125.19 32.18 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.89 -0.782 . . . . 74.1 108.89 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.8 m -72.55 159.93 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 72.32 111.8 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.678 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 10.6 tp -119.49 135.66 24.2 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.459 -0.791 . . . . 65.25 109.5 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.55 158.19 58.11 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.87 2.38 . . . . 72.34 113.665 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.08 129.12 26.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.911 -1.04 . . . . 71.5 110.788 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.62 -28.66 10.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.917 -0.583 . . . . 71.01 111.725 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.678 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 14.9 m95 -91.04 153.72 19.92 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.647 0.261 . . . . 74.55 110.502 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.76 138.87 53.88 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.047 0.451 . . . . 74.23 110.36 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 30' ' ' VAL . 7.3 p -100.81 131.31 46.76 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.585 -1.189 . . . . 63.35 109.616 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 54' ' ' GLY . 3.1 t -146.23 166.26 8.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.146 0.498 . . . . 74.21 110.317 -170.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 98.31 -141.09 15.39 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.647 -0.706 . . . . 72.2 114.231 167.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -136.53 119.41 11.96 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.385 -0.908 . . . . 72.41 108.788 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.766 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.1 Cg_endo -63.05 115.8 3.18 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.648 1.565 . . . . 72.4 111.281 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.38 155.09 35.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.608 -0.724 . . . . 55.44 109.554 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -55.88 153.76 8.12 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.744 -0.465 . . . . 72.34 109.744 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 tptm -43.14 -48.8 6.41 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.606 0.566 . . . . 75.31 111.848 -172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -58.94 -51.08 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 73.42 111.03 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -69.42 -30.43 68.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.957 0.408 . . . . 72.45 110.406 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.531 ' SG ' HG12 ' A' ' 39' ' ' VAL . 13.8 t -65.67 -52.41 51.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.776 -0.647 . . . . 63.15 110.175 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD11 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.038 0.447 . . . . 54.21 110.387 176.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD11 ' A' ' 63' ' ' LEU . 32.9 tt0 -62.83 -42.32 99.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 74.01 110.772 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.432 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 12.3 ttm-85 -57.26 -53.28 59.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.202 -0.454 . . . . 74.43 111.608 -174.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.539 HG21 HG11 ' A' ' 29' ' ' VAL . 13.1 pt -67.22 -34.71 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.531 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.23 -32.49 73.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 71.01 110.178 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.56 0.35 17.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.07 -0.514 . . . . 75.11 111.816 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 95.5 mt -103.81 -67.11 0.91 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.794 0.664 . . . . 70.13 112.794 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -86.04 -55.07 4.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.678 0.752 . . . . 73.15 110.579 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -11.48 60.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.392 -1.277 . . . . 55.35 110.915 -177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 123.611 0.764 . . . . 73.31 112.799 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.702 0.287 . . . . 74.33 110.407 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.502 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . . . -60.01 164.51 3.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.898 -0.592 . . . . 73.44 111.03 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -130.52 30.55 4.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.929 0.344 . . . . 72.24 111.929 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -93.43 109.9 21.47 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.914 -1.143 . . . . 73.13 107.914 166.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.82 -47.75 73.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.549 0.574 . . . . 64.02 112.549 -166.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -141.23 142.32 33.96 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.134 -0.354 . . . . 74.21 111.054 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -78.57 128.55 33.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 74.54 110.514 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -64.21 100.77 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.757 -0.46 . . . . 71.44 109.757 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 19.2 mmt -64.62 146.7 54.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 72.24 112.016 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.81 161.43 47.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.341 -0.845 . . . . 73.32 111.188 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -58.6 -73.39 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.383 0.512 . . . . 64.11 112.383 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 48.7 tp -91.38 -61.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.669 -0.241 . . . . 73.43 110.61 -173.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 37.5 mt-10 -118.66 125.46 49.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 52.23 110.242 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' HB2' HH12 ' A' ' 65' ' ' ARG . . . -163.01 95.92 0.88 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.562 0.345 . . . . 61.0 110.461 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.416 ' HA ' HE22 ' A' ' 61' ' ' GLN . 50.2 mt-30 -75.18 114.36 13.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 73.03 110.662 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 m -108.8 51.12 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.593 0.711 . . . . 75.54 109.447 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.451 ' HB2' HE22 ' A' ' 64' ' ' GLN . 6.4 tp-100 -174.85 -64.5 0.01 OUTLIER 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.446 -0.797 . . . . 74.11 109.583 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 61' ' ' GLN . . . 157.24 -173.07 34.77 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.596 -0.729 . . . . 74.42 111.345 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 -48.54 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.23 1.954 . . . . 73.41 111.777 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.95 -137.05 4.39 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.788 -0.925 . . . . 44.34 110.788 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -98.92 -79.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.804 -0.443 . . . . 65.31 109.804 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 64.8 mtt -157.03 28.51 0.31 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.921 -1.14 . . . . 73.35 107.921 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 6.0 p-10 -111.82 170.96 7.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.581 -1.19 . . . . 74.42 112.142 -165.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -108.27 19.13 20.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.943 -1.026 . . . . 70.42 110.465 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 7.7 mm-40 -81.35 52.57 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.333 -0.394 . . . . 71.11 110.55 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 56' ' ' PRO . 9.1 mp -74.03 136.72 43.13 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.782 0.801 . . . . 63.11 111.193 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.57 151.13 49.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.366 -1.288 . . . . 73.33 109.306 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.626 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -116.46 157.68 24.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 74.33 109.397 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -85.86 134.83 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.16 -1.422 . . . . 71.3 107.16 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.73 159.32 37.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.954 0.407 . . . . 74.31 111.379 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 38.0 ptt180 -169.21 170.23 8.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.192 -0.913 . . . . 74.21 110.509 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.65 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.77 140.38 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.653 -0.249 . . . . 44.45 111.061 170.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 49.11 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.883 1.068 . . . . 73.12 113.883 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.09 -32.0 6.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.747 -0.596 . . . . 70.25 111.464 -174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.71 -22.81 6.19 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.262 -0.426 . . . . 21.2 113.014 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.03 174.04 10.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.749 -0.464 . . . . 74.31 109.749 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.21 143.3 45.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.901 0.704 . . . . 73.1 112.901 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -136.83 -179.91 5.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.987 -1.006 . . . . 73.51 109.694 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.9 m -125.67 155.34 34.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.807 0.337 . . . . 71.43 110.803 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -148.48 149.1 31.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 74.31 109.306 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.8 ttt -81.61 121.51 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.647 0.26 . . . . 73.3 110.326 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.56 148.89 44.64 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.231 -0.441 . . . . 70.44 111.014 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.97 -23.03 36.26 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.741 -0.544 . . . . 43.5 111.741 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -92.98 118.83 31.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.004 -0.369 . . . . 74.1 110.004 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.3 m -60.24 137.33 58.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.04 0.448 . . . . 72.32 111.391 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.4 mt -93.31 142.43 25.26 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.425 -0.807 . . . . 65.25 110.882 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.13 140.44 70.93 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.863 2.375 . . . . 72.34 111.714 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.67 124.89 11.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 71.5 110.386 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.2 -29.42 7.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.296 -0.478 . . . . 71.01 112.669 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.65 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.1 m95 -76.95 149.88 35.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.335 0.568 . . . . 74.55 111.46 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 18.8 pt-20 -129.62 151.23 50.45 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.977 -0.556 . . . . 74.23 110.245 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -107.99 160.59 15.66 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.214 0.946 . . . . 63.35 111.255 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.17 158.51 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 123.408 0.683 . . . . 74.21 110.608 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.461 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 89.61 -166.85 33.23 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.833 -0.621 . . . . 72.2 112.259 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.55 142.25 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.745 -0.835 . . . . 72.41 108.745 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.626 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.4 Cg_endo -72.57 108.74 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 120.816 1.01 . . . . 72.4 110.575 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.57 172.99 17.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.416 -0.811 . . . . 55.44 110.361 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -55.77 155.33 6.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.898 0.38 . . . . 72.34 111.503 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -49.55 -36.49 23.81 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.619 -0.719 . . . . 75.31 110.923 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -55.71 -55.67 29.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.516 -0.765 . . . . 73.42 110.302 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.416 HE22 ' HA ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -55.39 -52.0 64.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.776 -0.647 . . . . 72.45 111.003 176.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.562 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.0 t -55.86 -52.46 63.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.197 -0.91 . . . . 63.15 111.071 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.2 pp -68.26 -44.92 74.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.916 -0.313 . . . . 54.21 110.445 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.465 ' N ' HD13 ' A' ' 63' ' ' LEU . 22.0 tt0 -54.8 -36.51 65.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.968 0.413 . . . . 74.01 110.394 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.538 HH12 ' HB2' ' A' ' 14' ' ' ALA . 48.5 ttt85 -64.21 -53.53 47.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.774 -0.648 . . . . 74.43 111.046 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.07 -34.05 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 111.679 0.251 . . . . 74.43 111.679 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.668 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 39.7 mm-40 -65.97 -32.77 74.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.487 -0.324 . . . . 71.01 110.385 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 95.3 mt-30 -87.75 4.95 42.32 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.295 -0.411 . . . . 75.11 111.266 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 48.0 mt -103.73 -66.97 0.91 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.92 0.39 . . . . 70.13 111.195 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -86.32 -54.84 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.272 0.558 . . . . 73.15 111.417 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -78.19 -10.92 59.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.187 -0.915 . . . . 55.35 111.399 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -41.25 -42.33 2.1 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.977 1.103 . . . . 73.31 113.977 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.8 mtp -62.56 85.55 0.02 OUTLIER 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.742 0.782 . . . . 75.02 110.949 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.71 134.54 26.23 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 114.614 -1.176 . . . . 71.12 111.292 -175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.1 -156.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.055 2.503 . . . . 72.13 112.144 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.65 -22.14 8.21 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.31 0.485 . . . . 73.33 112.31 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.2 m -50.85 -25.26 4.29 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.242 -0.435 . . . . 75.44 112.121 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.497 HG23 HD21 ' A' ' 82' ' ' LEU . 13.1 p -68.59 -39.08 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.884 0.373 . . . . 75.13 110.485 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -62.05 -31.65 72.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.498 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -61.74 -35.59 78.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 73.11 111.104 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -109.27 -1.53 18.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 72.1 111.029 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -71.51 100.99 2.35 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.983 -0.377 . . . . 73.43 109.983 -177.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.71 -72.92 0.14 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.866 -0.606 . . . . 64.54 111.346 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -76.31 83.1 3.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 74.55 109.908 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -54.77 -29.16 53.35 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.363 -0.835 . . . . 73.5 111.697 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 t -69.18 -37.5 78.2 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.431 -0.35 . . . . 72.41 111.121 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.46 106.28 0.27 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.749 -0.54 . . . . 74.42 111.749 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.538 ' HB3' HD23 ' A' ' 82' ' ' LEU . 26.6 Cg_endo -60.46 -44.56 26.69 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.864 2.376 . . . . 73.53 112.982 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' HA2' ' HB3' ' A' ' 2' ' ' ALA . . . 72.95 -73.98 0.99 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.186 -0.766 . . . . 73.43 111.186 -173.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.5 mm -107.73 92.67 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.806 -0.813 . . . . 62.43 108.806 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.06 144.68 54.98 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.717 -0.674 . . . . 74.51 110.584 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -87.43 107.67 18.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.976 -0.556 . . . . 74.1 111.127 -172.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -66.4 173.86 3.04 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.734 -0.666 . . . . 75.12 111.027 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 94' ' ' VAL . 7.1 p -130.0 78.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.644 0.735 . . . . 75.41 112.203 -173.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.668 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 60.4 ttt-85 . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.271 -0.871 . . . . 75.0 110.234 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.288 -0.264 . . . . 74.33 110.288 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.24 70.09 0.63 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.918 -0.583 . . . . 73.44 111.538 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.16 89.99 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.837 -0.619 . . . . 72.24 110.134 176.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.466 ' HB3' ' HD2' ' A' ' 6' ' ' HIS . 40.9 m80 -78.04 110.47 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.644 -0.707 . . . . 73.13 110.538 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -70.2 89.58 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 64.02 110.134 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.577 ' HB3' ' HE2' ' A' ' 73' ' ' MET . 81.6 m-70 -142.97 168.26 20.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 74.21 109.898 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -167.32 166.04 14.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.89 -0.411 . . . . 74.54 109.89 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -107.53 168.41 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.234 -0.284 . . . . 71.44 110.234 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -157.6 163.71 38.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 72.24 109.982 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.93 -73.93 0.2 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.822 -0.511 . . . . 73.32 111.822 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -162.99 158.31 22.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.424 -0.584 . . . . 64.11 109.424 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.87 -92.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.27 -0.27 . . . . 73.43 110.27 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -138.95 173.74 11.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.083 0.468 . . . . 52.23 110.814 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.35 174.55 11.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.205 -0.907 . . . . 61.0 109.636 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.96 -25.23 58.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 73.03 110.367 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -77.96 60.91 2.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 75.54 109.874 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.552 ' NE2' ' HG3' ' A' ' 55' ' ' GLU . 39.4 tt0 -76.29 -54.64 6.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.703 -0.68 . . . . 74.11 109.959 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.41 -179.12 42.15 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.822 -0.911 . . . . 74.42 110.822 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.13 -64.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.632 2.222 . . . . 73.41 111.788 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.43 -164.3 33.91 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.738 -0.665 . . . . 44.34 111.5 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -176.55 -66.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.626 -0.509 . . . . 65.31 109.626 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.9 OUTLIER 57.02 20.42 5.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.835 -0.621 . . . . 73.35 110.974 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.87 -71.62 0.34 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 74.42 110.053 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.75 174.68 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.619 -0.719 . . . . 70.42 109.521 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -74.81 144.69 43.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.325 -0.25 . . . . 71.11 110.325 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.49 143.29 27.29 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.784 0.802 . . . . 63.11 111.455 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -127.31 148.7 50.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.502 -1.226 . . . . 73.33 109.156 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -114.1 162.39 16.54 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.61 0.569 . . . . 74.33 109.543 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.8 t -88.42 140.65 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.247 -1.02 . . . . 71.3 108.247 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 40' ' ' TRP . 23.4 m -144.99 158.23 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 122.195 -0.316 . . . . 74.31 110.85 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 19.9 ptt85 -169.36 170.1 8.63 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.335 -0.393 . . . . 74.21 111.542 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -157.89 139.82 14.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.342 -0.39 . . . . 44.45 111.063 171.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 35.12 21.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.137 1.375 . . . . 73.12 114.294 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ASN . 10.7 pt-20 -112.4 -32.11 6.6 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.616 -0.677 . . . . 70.25 111.385 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.86 -22.79 5.52 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.972 -0.558 . . . . 21.2 112.078 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -84.35 161.56 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.14 -0.689 . . . . 74.31 109.14 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -106.32 137.48 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.086 0.469 . . . . 73.1 111.711 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -124.13 -179.21 4.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.046 -0.979 . . . . 73.51 109.726 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -132.31 157.3 43.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.879 0.371 . . . . 71.43 110.877 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 30' ' ' VAL . 73.4 t-105 -155.75 149.41 25.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.823 -0.806 . . . . 74.31 108.823 -171.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.86 130.35 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 73.3 110.539 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.58 144.12 27.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.993 -0.548 . . . . 70.44 111.621 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -20.69 12.09 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.13 -0.486 . . . . 43.5 113.254 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -79.91 131.1 35.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.762 0.281 . . . . 74.1 110.274 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -65.92 148.76 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.314 0.578 . . . . 72.32 111.821 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 29.1 mt -111.35 147.71 37.25 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.094 -0.957 . . . . 65.25 111.204 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -81.07 176.1 9.2 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.913 2.409 . . . . 72.34 113.029 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 125.44 10.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.907 -1.042 . . . . 71.5 111.94 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.57 -32.32 7.52 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.634 -0.712 . . . . 71.01 112.847 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.3 m95 -76.91 133.54 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.034 0.417 . . . . 74.55 111.689 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 9.8 pt-20 -127.62 152.78 47.23 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.746 -0.661 . . . . 74.23 110.393 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' VAL . 39.5 p -102.13 159.66 15.19 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.289 0.993 . . . . 63.35 111.42 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -173.6 175.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.743 0.817 . . . . 74.21 110.285 -173.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 82.75 -161.2 40.05 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.723 -0.671 . . . . 72.2 112.882 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.552 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -108.5 138.62 20.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 123.366 0.666 . . . . 72.41 109.588 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.7 Cg_endo -71.59 113.38 3.62 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.673 1.582 . . . . 72.4 111.078 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.37 167.11 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.726 -0.67 . . . . 55.44 109.938 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -61.69 161.36 10.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.679 0.276 . . . . 72.34 110.961 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -46.89 -48.52 21.19 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.869 -0.605 . . . . 75.31 111.633 -176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.37 -45.09 84.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.978 -0.555 . . . . 73.42 111.406 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.75 -38.78 64.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 72.45 110.708 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.2 t -59.02 -49.26 78.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.73 -0.668 . . . . 63.15 110.202 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.6 pp -68.05 -37.22 81.06 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.43 -0.35 . . . . 54.21 110.508 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.472 ' N ' HD13 ' A' ' 63' ' ' LEU . 33.9 tt0 -60.31 -32.74 71.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.089 0.471 . . . . 74.01 110.411 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -76.57 -44.02 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.982 -0.554 . . . . 74.43 110.548 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 63' ' ' LEU . 44.4 pt -67.61 -34.55 68.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 121.153 -0.219 . . . . 74.43 110.675 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.841 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 34.3 mt-10 -54.03 -56.04 21.67 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.25 -0.432 . . . . 71.01 110.112 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -65.76 -10.18 34.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 75.11 112.384 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.02 -67.79 0.88 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.329 0.492 . . . . 70.13 112.329 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -87.01 -55.44 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.965 0.888 . . . . 73.15 111.168 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.707 HG22 HG12 ' A' ' 94' ' ' VAL . 5.5 m -74.09 -11.52 60.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.027 -1.442 . . . . 55.35 111.609 -170.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 67' ' ' GLU . 24.5 t70 -45.11 -25.43 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.029 1.122 . . . . 73.31 114.029 -170.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.577 ' HE2' ' HB3' ' A' ' 6' ' ' HIS . 20.2 mmt -66.8 75.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 75.02 110.409 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.95 133.1 34.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 71.12 111.092 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.65 -157.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.955 2.437 . . . . 72.13 112.72 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.51 -15.55 1.15 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.054 0.542 . . . . 73.33 112.145 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 t -50.15 -27.13 5.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.892 0.477 . . . . 75.44 110.988 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.46 -41.57 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.806 0.336 . . . . 75.13 111.227 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -71.29 -33.01 69.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.279 -0.418 . . . . 74.44 110.231 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -74.78 -29.14 61.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 73.11 110.399 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -63.34 -30.18 71.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.153 0.502 . . . . 72.1 110.429 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.82 -6.9 41.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.599 -0.728 . . . . 73.43 111.565 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -54.35 123.47 13.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.405 . . . . 64.54 111.724 -178.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 51.91 30.18 6.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.871 -0.604 . . . . 74.55 111.431 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.492 ' HA ' HG12 ' A' ' 90' ' ' ILE . 42.8 p-80 -37.16 106.27 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.581 -0.736 . . . . 73.5 111.925 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.1 m -96.49 133.51 40.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.458 -0.792 . . . . 72.41 111.718 -173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 88' ' ' PRO . . . 54.98 -123.08 28.22 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.817 -0.629 . . . . 74.42 113.607 172.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.413 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 27.5 Cg_exo -62.13 -11.17 20.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.044 2.496 . . . . 73.53 112.444 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.08 119.1 4.43 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.793 -0.523 . . . . 73.43 111.793 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 85' ' ' HIS . 19.4 pt -94.54 100.53 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.345 0.593 . . . . 62.43 110.126 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -146.69 156.51 43.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.826 -0.624 . . . . 74.51 110.471 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -162.13 -174.16 3.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.332 -0.849 . . . . 74.1 108.774 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -96.5 -142.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.365 -0.235 . . . . 75.12 110.365 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 71' ' ' THR . 3.7 p -115.99 60.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 122.364 1.078 . . . . 75.41 111.393 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.431 ' HB3' ' CD ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.249 0 CA-C-N 114.125 -1.398 . . . . 75.0 111.744 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.025 0.44 . . . . 74.33 109.981 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.05 87.36 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 73.44 110.344 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -65.24 89.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 72.24 110.111 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.33 115.04 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.718 -0.674 . . . . 73.13 110.442 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -85.57 80.49 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.6 . . . . 64.02 111.738 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -137.81 29.05 2.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 74.21 107.257 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -121.35 143.29 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.069 -1.423 . . . . 74.54 109.602 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 67.17 17.17 10.33 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.51 0.506 . . . . 71.44 111.476 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 ptm -77.25 -34.84 55.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 72.24 111.026 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.26 -132.34 45.86 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.084 -0.507 . . . . 73.32 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -149.08 -59.29 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.704 0.287 . . . . 64.11 110.278 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 30.5 tp -145.33 -113.8 0.09 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.644 -0.502 . . . . 73.43 109.644 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 34.8 mt-10 -94.35 131.49 39.93 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.925 -0.398 . . . . 52.23 109.925 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 172.97 1.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.09 0.556 . . . . 61.0 111.071 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -138.53 108.12 6.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.604 -0.271 . . . . 73.03 110.522 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -140.46 22.62 2.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.533 0.683 . . . . 75.54 109.696 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.193 -0.912 . . . . 74.11 110.565 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.2 71.07 0.12 Allowed Glycine 0 CA--C 1.518 0.249 0 N-CA-C 111.03 -0.828 . . . . 74.42 111.03 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.5 157.21 49.3 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.859 2.373 . . . . 73.41 112.868 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.32 111.39 1.68 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.478 -0.783 . . . . 44.34 111.297 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 p -70.27 -8.82 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.769 0.319 . . . . 65.31 111.459 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 22' ' ' MET . 1.2 pmm? -101.96 10.44 39.69 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.237 0.541 . . . . 73.35 110.912 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.76 97.67 5.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.314 -0.857 . . . . 74.42 110.525 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -92.88 -31.06 15.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.697 -0.683 . . . . 70.42 109.558 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.58 111.04 23.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 71.11 108.813 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.55 171.22 10.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.811 0.815 . . . . 63.11 111.464 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 19.8 m-85 -121.09 148.72 43.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.546 -1.206 . . . . 73.33 108.254 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.87 159.57 26.53 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.72 -0.844 . . . . 74.33 108.72 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 86.9 t -86.8 138.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.282 -1.377 . . . . 71.3 107.282 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 46' ' ' LEU . 33.9 m -138.32 160.53 31.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.318 0.508 . . . . 74.31 111.295 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -168.61 169.15 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.786 -1.097 . . . . 74.21 110.242 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.8 p30 -154.36 139.74 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.993 -0.373 . . . . 44.45 109.993 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 t30 44.88 6.16 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.159 1.17 . . . . 73.12 114.159 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.7 pt-20 -112.27 -32.45 6.52 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.503 -0.748 . . . . 70.25 112.118 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 -22.58 4.57 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.242 -0.436 . . . . 21.2 112.911 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.16 174.05 5.94 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.915 0.486 . . . . 74.31 110.388 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -122.29 133.02 54.69 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.592 0.589 . . . . 73.1 112.592 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.3 m -132.82 -179.19 5.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.371 -0.831 . . . . 73.51 109.71 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.6 158.33 26.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 71.43 110.913 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 56.0 t90 -147.15 137.21 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.84 . . . . 74.31 109.6 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 ttt -83.09 121.46 27.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.284 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.15 165.36 22.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.347 . . . . 70.44 110.189 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.31 -4.85 29.93 Favored Glycine 0 C--N 1.328 0.125 0 N-CA-C 110.91 -0.876 . . . . 43.5 110.91 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.519 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.8 ptp180 -131.56 172.52 12.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.271 0.628 . . . . 74.1 109.737 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 p -101.67 143.65 31.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.999 -0.371 . . . . 72.32 109.999 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.41 HD11 HG13 ' A' ' 30' ' ' VAL . 8.5 mt -88.9 133.17 36.15 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.325 -0.398 . . . . 65.25 111.544 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.12 130.66 13.77 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 123.303 2.668 . . . . 72.34 112.352 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 126.52 15.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 71.5 110.493 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.88 -25.53 9.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.241 -0.504 . . . . 71.01 112.06 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 66.2 m95 -83.96 158.53 21.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.809 0.305 . . . . 74.55 110.784 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -135.21 154.26 51.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.318 -0.401 . . . . 74.23 110.048 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.414 ' O ' HG11 ' A' ' 53' ' ' VAL . 24.3 p -107.43 153.21 23.13 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 124.737 1.273 . . . . 63.35 110.244 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -167.51 175.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.676 0 C-N-CA 123.624 0.77 . . . . 74.21 110.023 -173.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.22 -115.3 4.19 Favored Glycine 0 C--O 1.219 -0.835 0 CA-C-N 115.681 -0.69 . . . . 72.2 113.111 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 16.4 tp10 -147.32 136.89 11.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.279 1.032 . . . . 72.41 108.597 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 73.6 Cg_endo -83.51 107.51 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.011 1.141 . . . . 72.4 110.286 166.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.68 -175.4 5.14 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.391 -0.822 . . . . 55.44 111.242 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -55.83 151.21 11.72 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.471 -0.786 . . . . 72.34 111.286 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.426 ' HG3' HD22 ' A' ' 63' ' ' LEU . 23.8 tptm -45.93 -41.0 10.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.225 -0.898 . . . . 75.31 110.269 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -59.86 -42.41 93.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.107 -0.952 . . . . 73.42 111.417 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -71.95 -48.06 47.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.884 0.373 . . . . 72.45 110.721 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 60.0 m -60.22 -46.6 89.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 63.15 111.578 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.08 -41.05 82.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.753 -0.379 . . . . 54.21 110.385 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.584 ' N ' HD13 ' A' ' 63' ' ' LEU . 9.4 tt0 -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.281 0.562 . . . . 74.01 110.877 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.4 ttm-85 -64.48 -47.42 79.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.965 -0.562 . . . . 74.43 111.202 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 pt -69.66 -37.66 74.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.64 0.257 . . . . 74.43 110.977 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.611 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 8.6 mm-40 -62.65 -48.99 76.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 71.01 110.214 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.6 mt-30 -73.29 8.73 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.795 0.331 . . . . 75.11 111.452 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 73.3 mt -103.54 -66.13 0.96 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.975 0.417 . . . . 70.13 110.618 170.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -85.29 -48.47 9.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.441 0.639 . . . . 73.15 110.837 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.521 HG21 ' NH2' ' A' ' 95' ' ' ARG . 17.6 m -76.81 -10.74 59.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.202 -0.908 . . . . 55.35 111.356 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 25.9 t70 -41.43 -23.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.182 0.993 . . . . 73.31 113.168 -174.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 93.6 mmm -67.08 72.23 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.983 0.421 . . . . 75.02 110.735 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.32 133.92 41.57 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.843 -0.617 . . . . 71.12 110.19 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.93 -169.7 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.767 2.312 . . . . 72.13 112.183 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -15.2 8.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.37 -0.377 . . . . 73.33 111.376 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -57.75 -20.77 37.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.921 -0.581 . . . . 75.44 111.775 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.584 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.2 p -56.12 -41.95 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.854 0.359 . . . . 75.13 110.15 174.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.46 -37.13 86.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.865 -0.607 . . . . 74.44 110.442 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -61.58 -38.19 86.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.357 -0.838 . . . . 73.11 110.209 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -84.17 -30.37 25.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.297 -0.865 . . . . 72.1 112.04 -172.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 89.3 mt -51.93 -46.99 64.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.98 0.419 . . . . 73.43 111.144 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -150.07 114.22 5.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 64.54 109.419 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -65.18 86.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.5 0.667 . . . . 74.55 109.911 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -65.06 168.22 6.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.724 -1.125 . . . . 73.5 111.336 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -62.82 92.38 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 72.41 110.726 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.83 -139.97 5.6 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.328 -0.709 . . . . 74.42 111.328 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.14 165.25 14.92 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.706 2.271 . . . . 73.53 112.443 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.0 -157.62 8.3 Favored Glycine 0 C--O 1.235 0.218 0 N-CA-C 111.448 -0.661 . . . . 73.43 111.448 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.1 mt 55.55 83.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.356 0.598 . . . . 62.43 110.345 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -104.91 178.07 4.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 74.51 111.528 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -113.96 90.82 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 74.1 109.986 172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.83 173.17 6.44 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.6 -0.727 . . . . 75.12 110.233 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.3 140.63 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 75.41 109.353 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.611 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.044 -0.979 . . . . 75.0 110.775 -176.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.165 -0.309 . . . . 74.33 110.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.06 93.45 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 73.44 110.935 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -122.09 -64.67 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 72.24 110.108 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -148.11 147.47 29.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.155 -0.475 . . . . 73.13 110.584 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.59 99.05 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.798 -0.637 . . . . 64.02 109.811 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -95.47 103.32 15.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.021 -0.536 . . . . 74.21 111.547 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -85.93 134.74 33.86 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.671 -0.695 . . . . 74.54 109.948 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -141.7 120.81 12.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.42 -0.585 . . . . 71.44 109.42 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 9' ' ' MET . 1.3 tmt? -162.42 124.91 2.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 72.24 110.103 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' HD21 ' A' ' 69' ' ' LEU . . . 158.45 179.86 33.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.116 -0.564 . . . . 73.32 112.379 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 p 57.39 161.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.214 1.006 . . . . 64.11 113.52 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.636 HD12 ' HB ' ' A' ' 53' ' ' VAL . 3.7 mm? -132.54 -177.61 4.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.175 -0.921 . . . . 73.43 108.824 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.432 ' H ' ' HD3' ' A' ' 65' ' ' ARG . 20.2 mt-10 59.04 15.27 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.075 -0.511 . . . . 52.23 112.375 167.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.91 130.54 34.63 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.298 -0.26 . . . . 61.0 110.298 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -165.5 160.52 17.89 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.244 0.34 . . . . 73.03 110.578 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.1 p -108.84 -40.59 4.99 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.885 0.374 . . . . 75.54 110.754 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -145.49 142.52 29.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.88 -0.415 . . . . 74.11 109.88 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.86 -135.81 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.276 -0.42 . . . . 74.42 113.641 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' HB3' HG23 ' A' ' 58' ' ' THR . 57.5 Cg_endo -70.43 98.07 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.906 2.404 . . . . 73.41 112.451 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.39 27.54 18.79 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 111.762 -0.535 . . . . 44.34 111.762 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.7 m -153.56 167.41 29.6 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.253 -0.277 . . . . 65.31 110.253 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 61.3 mtt -88.25 106.45 18.22 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.962 -0.385 . . . . 73.35 109.962 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -112.6 -167.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.51 -0.314 . . . . 74.42 110.796 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -139.58 -83.16 0.26 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.717 0.266 . . . . 70.42 111.717 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.498 ' HG3' ' HE1' ' A' ' 41' ' ' MET . 9.3 mm-40 -92.73 165.17 13.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.664 0.269 . . . . 71.11 110.998 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.27 162.42 21.16 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.176 0.512 . . . . 63.11 110.552 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.22 148.71 50.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 73.33 110.72 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.628 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -117.78 162.59 17.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.943 -1.026 . . . . 74.33 108.91 171.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -94.06 142.65 13.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.778 -1.193 . . . . 71.3 107.778 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.03 156.62 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.155 0.502 . . . . 74.31 111.227 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.475 ' HD3' ' CE1' ' A' ' 37' ' ' TYR . 29.5 ptt180 -154.25 155.18 34.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.196 -0.911 . . . . 74.21 109.581 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.7 p30 -156.56 139.35 15.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.983 -0.287 . . . . 44.45 110.894 168.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 35.43 13.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.652 1.723 . . . . 73.12 115.652 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.808 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 16.4 pt-20 -112.71 -31.92 6.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.745 0.646 . . . . 70.25 112.745 -170.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.42 89.01 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 21.2 112.473 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.808 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 77.7 mt-30 -120.77 174.09 6.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.348 0.659 . . . . 74.31 109.365 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.475 ' CE1' ' HD3' ' A' ' 31' ' ' ARG . 42.4 m-85 -122.54 146.46 47.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.739 1.014 . . . . 73.1 113.739 -171.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -138.9 -179.31 5.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.216 -1.357 . . . . 73.51 108.677 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.47 ' CG1' ' SG ' ' A' ' 62' ' ' CYS . 28.5 m -122.83 161.6 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.918 0.389 . . . . 71.43 111.084 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -145.89 156.47 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 74.31 109.32 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.498 ' HE1' ' HG3' ' A' ' 25' ' ' GLU . 6.4 ttt -86.07 147.5 26.15 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.828 -0.434 . . . . 73.3 109.828 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.62 156.88 38.88 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.017 0.437 . . . . 70.44 111.524 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.35 54.13 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.547 -0.751 . . . . 43.5 112.769 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -112.35 116.1 29.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.876 -0.416 . . . . 74.1 109.876 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.0 m -66.09 154.69 38.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.278 0.561 . . . . 72.32 112.048 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -111.05 152.88 43.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.075 -0.966 . . . . 65.25 111.151 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 74.1 Cg_endo -80.34 158.13 22.78 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.627 2.218 . . . . 72.34 111.921 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 131.13 26.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.797 -0.638 . . . . 71.5 111.237 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.96 -35.27 5.16 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.774 -0.648 . . . . 71.01 111.658 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.52 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 32.2 m95 -79.71 139.02 37.49 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.188 -0.301 . . . . 74.55 110.188 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.87 153.68 49.55 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.377 -0.374 . . . . 74.23 110.284 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.2 p -98.11 162.82 13.02 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.19 0.931 . . . . 63.35 111.459 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.636 ' HB ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -162.56 150.02 3.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.41 -0.814 . . . . 74.21 109.978 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 -170.56 37.53 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.557 -0.747 . . . . 72.2 111.495 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 151.56 40.76 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 108.652 -0.87 . . . . 72.41 108.652 174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.628 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 21.9 Cg_endo -65.54 105.17 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.206 1.271 . . . . 72.4 110.046 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.17 169.45 17.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.412 -0.813 . . . . 55.44 110.669 -171.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 19' ' ' PRO . 3.5 t -57.29 151.3 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.654 -0.703 . . . . 72.34 111.149 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -48.75 -44.91 39.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.751 -0.659 . . . . 75.31 110.576 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.57 ' NE2' ' H ' ' A' ' 60' ' ' GLN . 2.3 mp0 -56.19 -37.32 69.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.477 -0.783 . . . . 73.42 111.206 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -74.96 -39.72 61.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.909 0.385 . . . . 72.45 110.436 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 39' ' ' VAL . 5.5 t -65.23 -51.33 61.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.665 . . . . 63.15 110.56 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.0 -36.99 80.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.865 0.364 . . . . 54.21 110.384 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.3 tt0 -60.4 -43.15 96.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.01 110.237 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.655 HH11 ' HG3' ' A' ' 65' ' ' ARG . 18.8 ttm-85 -60.85 -53.18 60.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.63 -0.714 . . . . 74.43 111.764 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.8 pt -67.26 -37.39 79.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.953 0.406 . . . . 74.43 111.125 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.923 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 35.2 mm-40 -66.81 -33.17 75.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.02 -0.537 . . . . 71.01 110.527 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.486 ' C ' ' HB3' ' A' ' 72' ' ' ASP . 16.1 mm-40 -78.21 2.33 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.685 0.279 . . . . 75.11 111.226 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 71.6 mt -103.59 -66.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.099 0.476 . . . . 70.13 110.968 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -85.33 -55.21 4.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.578 0.704 . . . . 73.15 110.845 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -10.97 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.864 -1.062 . . . . 55.35 111.853 -170.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.486 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 6.8 p-10 -42.15 -34.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.978 1.103 . . . . 73.31 113.978 -167.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 96.0 mmm -62.06 89.54 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.299 0.571 . . . . 75.02 111.069 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 94' ' ' VAL . 6.6 p -119.99 132.94 23.9 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.547 -0.751 . . . . 71.12 110.186 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.1 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.882 2.388 . . . . 72.13 112.019 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.5 -21.76 28.2 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.866 0.321 . . . . 73.33 111.866 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -56.15 -18.34 9.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.253 -0.43 . . . . 75.44 111.795 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 9.7 p -57.11 -40.2 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.919 0.39 . . . . 75.13 110.453 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -73.85 -31.1 63.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.077 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.51 -27.28 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.894 -0.594 . . . . 73.11 110.069 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -83.24 -2.86 56.63 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.552 -0.749 . . . . 72.1 110.277 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 94.2 mt -112.34 147.89 35.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 73.43 111.208 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -103.98 19.55 19.82 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.188 -1.041 . . . . 64.54 108.188 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -102.44 174.64 5.81 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.029 -0.987 . . . . 74.55 110.661 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -165.41 138.09 4.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.878 -0.601 . . . . 73.5 109.721 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 66.73 24.17 10.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.578 0.549 . . . . 72.41 111.132 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.31 124.28 13.18 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.954 -0.566 . . . . 74.42 111.905 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.32 -32.45 71.87 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.983 2.455 . . . . 73.53 112.549 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.61 54.11 0.18 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.304 -0.719 . . . . 73.43 111.304 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -115.31 108.56 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.626 0.25 . . . . 62.43 110.432 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.439 ' HA ' HD12 ' A' ' 82' ' ' LEU . 4.1 p30 -148.0 133.19 18.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.226 -0.443 . . . . 74.51 110.22 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -97.12 135.3 39.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.589 -0.893 . . . . 74.1 108.589 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.91 171.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 75.12 110.989 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 94' ' ' VAL . 7.7 p -80.18 41.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 122.719 1.247 . . . . 75.41 112.524 -171.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.923 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 6.1 tmm_? . . . . . 0 C--O 1.251 1.176 0 CA-C-N 114.677 -1.147 . . . . 75.0 108.284 164.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.606 0.241 . . . . 74.33 111.023 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.03 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.788 -0.449 . . . . 73.44 109.788 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -102.7 46.05 0.94 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.038 0.447 . . . . 72.24 111.012 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' HIS . 7.2 p-80 44.03 22.03 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.412 1.264 . . . . 73.13 114.412 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 59.79 -76.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.619 0.6 . . . . 64.02 112.619 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' HIS . 27.2 t-80 -56.39 111.96 1.12 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.984 0.421 . . . . 74.21 111.81 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -107.78 157.17 18.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.574 -0.739 . . . . 74.54 109.914 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -59.04 108.71 0.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.008 -0.368 . . . . 71.44 110.008 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 ttm -122.56 -45.29 2.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 72.24 110.215 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.36 58.05 1.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.619 -0.719 . . . . 73.32 111.543 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -61.16 -27.53 68.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.117 0.484 . . . . 64.11 110.471 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.4 mt -146.39 173.96 11.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.81 -0.811 . . . . 73.43 108.81 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.76 162.92 27.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 52.23 111.414 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.24 -175.61 2.9 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.662 -0.866 . . . . 61.0 108.662 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -84.68 58.64 5.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.45 0.643 . . . . 73.03 109.774 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -83.83 92.37 7.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.697 . . . . 75.54 110.442 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -112.57 134.16 54.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 74.11 109.981 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.81 178.72 18.47 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.33 -0.708 . . . . 74.42 111.33 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.46 141.03 49.67 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.75 2.3 . . . . 73.41 112.29 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.93 -168.33 39.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.984 -0.626 . . . . 44.34 112.327 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 m -117.08 162.92 17.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.943 -0.391 . . . . 65.31 109.943 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -109.93 123.56 49.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.172 0.511 . . . . 73.35 110.546 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.37 176.4 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.561 -0.745 . . . . 74.42 110.098 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.89 -35.48 32.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 70.42 110.234 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.93 133.58 47.46 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 71.11 111.075 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.27 141.47 37.56 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.196 0.522 . . . . 63.11 110.256 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -129.62 153.0 48.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.367 -0.833 . . . . 73.33 109.751 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -116.02 167.45 10.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.083 -0.962 . . . . 74.33 108.896 169.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.3 t -92.47 146.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.131 -1.433 . . . . 71.3 107.131 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 46' ' ' LEU . 34.5 m -140.32 163.9 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 118.395 0.543 . . . . 74.31 110.927 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -164.16 159.69 20.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.159 -0.473 . . . . 74.21 111.189 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -171.32 140.21 1.41 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.029 -0.532 . . . . 44.45 110.619 168.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 50.02 4.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.058 1.133 . . . . 73.12 114.058 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.73 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 9.4 pt-20 -107.71 -29.49 9.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.824 -0.547 . . . . 70.25 112.371 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.97 19.28 67.6 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.644 -0.788 . . . . 21.2 111.411 -173.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.73 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 87.3 mt-30 -129.52 174.03 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.736 0.814 . . . . 74.31 108.807 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.5 132.64 56.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.593 0.711 . . . . 73.1 112.416 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 m -124.95 178.38 5.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.579 -1.191 . . . . 73.51 108.886 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG11 ' SG ' ' A' ' 62' ' ' CYS . 18.0 m -129.91 160.07 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.855 0.36 . . . . 71.43 111.337 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -157.67 154.38 28.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.863 -0.792 . . . . 74.31 108.863 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -80.26 135.12 36.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.976 -0.289 . . . . 73.3 110.625 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.75 136.23 52.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 70.44 110.529 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.78 -3.71 74.6 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.188 -0.46 . . . . 43.5 112.132 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -103.26 128.19 50.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.705 -0.48 . . . . 74.1 109.705 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -64.97 156.69 30.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.135 0.493 . . . . 72.32 112.025 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 HG11 ' A' ' 30' ' ' VAL . 19.9 mt -124.34 139.43 32.88 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.471 -0.786 . . . . 65.25 110.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -54.73 141.49 75.81 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.899 2.4 . . . . 72.34 111.612 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.25 127.65 25.27 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.829 0.347 . . . . 71.5 110.442 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.75 -34.54 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.538 -0.625 . . . . 71.01 111.538 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.4 m95 -78.15 142.81 37.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.989 -0.374 . . . . 74.55 109.989 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.5 152.92 48.5 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 120.774 0.321 . . . . 74.23 110.318 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 p -100.94 154.31 18.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.103 -0.953 . . . . 63.35 110.9 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.09 171.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.301 1.04 . . . . 74.21 109.182 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.95 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.713 -0.756 . . . . 72.2 112.522 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.67 132.92 10.16 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.122 -1.066 . . . . 72.41 108.122 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.66 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.9 Cg_endo -62.85 122.38 10.65 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.875 1.716 . . . . 72.4 112.42 -170.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.79 160.71 10.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.508 -0.769 . . . . 55.44 109.351 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -55.86 154.99 6.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.65 0.262 . . . . 72.34 111.104 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 87.4 tttt -49.05 -40.94 33.33 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.946 -0.57 . . . . 75.31 110.886 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.94 -48.16 70.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.464 -0.789 . . . . 73.42 110.923 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -74.77 -30.18 61.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 72.45 110.783 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.539 ' SG ' HG11 ' A' ' 39' ' ' VAL . 12.9 t -66.36 -50.94 61.84 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.911 -0.586 . . . . 63.15 110.667 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.2 pp -63.93 -37.97 89.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.954 0.407 . . . . 54.21 110.276 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.563 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 26.3 tt0 -58.68 -43.49 89.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.824 -0.626 . . . . 74.01 110.237 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.7 ttt180 -62.05 -43.58 98.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 74.43 111.166 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.67 -38.29 44.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 111.827 0.306 . . . . 74.43 111.827 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 34.9 mm-40 -64.12 -41.59 97.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 121.304 -0.158 . . . . 71.01 111.15 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 64.1 mt-30 -73.9 7.86 2.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.02 0.438 . . . . 75.11 111.18 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.5 mt -103.63 -65.92 0.98 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.307 -0.406 . . . . 70.13 110.874 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -85.79 -52.85 5.49 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.682 -0.69 . . . . 73.15 111.128 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -74.88 -11.69 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.414 -0.812 . . . . 55.35 111.054 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 4.0 p-10 -43.14 -35.61 1.41 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.842 -0.617 . . . . 73.31 112.398 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -67.75 81.13 0.19 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.405 0.621 . . . . 75.02 110.068 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.909 HG22 ' HB ' ' A' ' 94' ' ' VAL . 1.3 t -119.22 144.39 36.14 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 71.12 110.989 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 74' ' ' VAL . 42.1 Cg_endo -65.74 -168.34 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.973 2.449 . . . . 72.13 113.035 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.72 -19.13 5.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.01 -0.541 . . . . 73.33 112.246 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.7 p -57.4 -23.06 47.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.322 -0.399 . . . . 75.44 111.346 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' O ' HD11 ' A' ' 82' ' ' LEU . 11.1 p -59.52 -41.15 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.172 0.51 . . . . 75.13 110.242 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.94 -30.49 62.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.858 -0.61 . . . . 74.44 110.416 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.74 -45.88 56.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.676 -0.693 . . . . 73.11 111.302 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -69.18 -26.58 64.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 72.1 110.891 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 78' ' ' VAL . 10.3 mp -91.78 56.5 2.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.637 0.732 . . . . 73.43 109.984 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 85' ' ' HIS . 25.0 t-20 -97.14 -45.68 6.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.855 -1.066 . . . . 64.54 110.674 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 73.44 -2.13 2.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.609 -0.723 . . . . 74.55 111.915 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.475 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 11.9 t60 -111.74 154.98 24.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.077 -0.712 . . . . 73.5 109.077 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.1 t -51.77 134.55 30.61 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.749 0.309 . . . . 72.41 110.767 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.68 -80.16 0.26 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.323 -0.711 . . . . 74.42 111.323 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 94.7 Cg_endo -80.41 -148.09 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.159 2.572 . . . . 73.53 111.837 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 88' ' ' PRO . . . 104.13 -47.32 1.1 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.312 -0.715 . . . . 73.43 111.312 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 pt -94.73 16.68 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 122.001 0.905 . . . . 62.43 110.178 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -88.7 170.07 11.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.905 -1.498 . . . . 74.51 110.273 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -100.69 135.24 42.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.319 -0.4 . . . . 74.1 111.077 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.75 -170.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.804 -0.634 . . . . 75.12 109.822 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.909 ' HB ' HG22 ' A' ' 74' ' ' VAL . 7.3 p -81.19 158.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.726 -0.472 . . . . 75.41 109.726 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.49 ' HD2' ' HB2' ' A' ' 64' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.831 0 CA-C-O 117.938 -1.03 . . . . 75.0 108.798 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.765 0.317 . . . . 74.33 110.985 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.38 148.71 22.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.179 -0.304 . . . . 73.44 110.179 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -121.65 11.04 10.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.213 0.53 . . . . 72.24 109.859 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.34 107.92 6.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.651 . . . . 73.13 110.786 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -95.85 157.67 15.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 64.02 110.276 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -173.22 85.25 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.947 -0.39 . . . . 74.21 109.947 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.442 ' ND1' ' O ' ' A' ' 7' ' ' HIS . 30.9 p80 -81.18 81.25 7.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.111 0.482 . . . . 74.54 111.841 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 179.28 96.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 71.44 110.218 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.81 -43.73 29.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 72.24 109.65 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.94 74.73 0.39 Allowed Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.642 -0.708 . . . . 73.32 112.37 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.602 HG23 ' HG ' ' A' ' 12' ' ' LEU . 6.0 m -92.71 -86.84 0.24 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.672 0.272 . . . . 64.11 111.318 -176.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 11' ' ' THR . 94.4 mt -127.61 176.29 7.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.772 0.32 . . . . 73.43 110.617 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.46 -169.31 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.856 -0.611 . . . . 52.23 110.628 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -69.75 -172.58 0.51 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 123.384 0.428 . . . . 61.0 111.413 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -134.1 106.67 7.32 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.101 -0.5 . . . . 73.03 110.189 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' GLY . 10.6 t -92.6 -38.02 12.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.562 -0.533 . . . . 75.54 109.562 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 37.67 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.075 0.95 . . . . 74.11 113.017 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 148.4 150.96 5.34 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.981 -0.848 . . . . 74.42 110.981 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.48 85.02 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.439 2.092 . . . . 73.41 111.665 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.45 -142.89 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.901 -0.59 . . . . 44.34 112.187 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -178.09 -65.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.388 0.613 . . . . 65.31 110.209 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.23 14.72 3.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.534 -0.757 . . . . 73.35 110.364 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 24' ' ' ASP . 6.2 p-10 -65.15 -89.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.812 -1.086 . . . . 74.42 112.458 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.4 m-20 -118.76 136.38 54.0 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 122.774 0.429 . . . . 70.42 110.736 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -65.14 154.04 39.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.159 -0.682 . . . . 71.11 109.159 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 57' ' ' ALA . 3.2 mm? -76.22 151.97 36.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.696 0.76 . . . . 63.11 111.867 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.0 m-85 -127.37 148.5 50.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.735 -1.121 . . . . 73.33 109.1 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.19 159.8 22.05 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.7 . . . . 74.33 109.111 174.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 53' ' ' VAL . 46.6 t -91.97 145.85 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.852 -1.536 . . . . 71.3 106.852 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.0 m -138.87 161.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 121.771 -0.581 . . . . 74.31 111.517 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 24.8 ptt180 -161.81 155.42 21.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.498 -0.773 . . . . 74.21 110.201 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.0 p30 -161.33 139.72 9.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.213 -0.292 . . . . 44.45 110.213 169.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 43.08 3.89 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.692 1.367 . . . . 73.12 114.692 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.8 pt-20 -112.49 -32.03 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.573 -0.705 . . . . 70.25 111.594 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.21 -22.52 18.9 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.411 -0.423 . . . . 21.2 113.095 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -86.29 174.11 9.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.97 0.385 . . . . 74.31 110.383 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -106.26 139.89 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 73.1 112.442 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 29' ' ' VAL . 23.0 m -134.87 178.24 7.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.379 -0.828 . . . . 73.51 109.464 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG1' ' SG ' ' A' ' 62' ' ' CYS . 36.0 m -123.1 159.13 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.521 0.201 . . . . 71.43 110.65 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -158.37 139.02 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.987 -0.746 . . . . 74.31 108.987 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.5 ttt -67.39 124.37 22.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.262 . . . . 73.3 110.81 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.82 130.97 44.62 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.297 -0.41 . . . . 70.44 110.123 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.13 -9.41 33.62 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.291 -0.724 . . . . 43.5 111.291 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -106.38 111.27 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 74.1 109.278 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 m -66.74 141.63 57.67 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.725 . . . . 72.32 112.11 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 45.3 mt -96.3 151.44 38.12 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 114.727 -1.124 . . . . 65.25 111.314 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 69.2 Cg_endo -77.97 152.55 28.35 Favored 'Trans proline' 0 C--O 1.242 0.697 0 C-N-CA 122.549 2.166 . . . . 72.34 111.774 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.24 19.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.67 -0.695 . . . . 71.5 111.018 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.78 -35.27 4.37 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.443 -0.799 . . . . 71.01 111.339 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 22.5 m95 -83.41 142.13 31.22 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.979 -0.378 . . . . 74.55 109.979 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -129.28 148.24 51.19 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 120.852 0.358 . . . . 74.23 110.582 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 HG23 HD12 ' A' ' 46' ' ' LEU . 19.9 p -99.04 150.75 21.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.659 -1.155 . . . . 63.35 110.315 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.533 HG21 HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.76 155.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.107 -172.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.73 -160.17 24.21 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.905 -1.043 . . . . 72.2 112.641 175.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 32.9 tt0 -103.83 133.14 20.42 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.81 -0.811 . . . . 72.41 108.81 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.624 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 55.5 Cg_endo -70.24 111.14 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.322 1.348 . . . . 72.4 110.566 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 26' ' ' LEU . . . -147.53 171.98 14.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.799 -0.637 . . . . 55.44 110.241 -171.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 t -57.14 156.2 7.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.512 -0.313 . . . . 72.34 111.441 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -49.76 -43.7 48.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.953 0.501 . . . . 75.31 110.962 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.21 -51.31 62.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.947 -0.57 . . . . 73.42 110.806 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.28 -30.74 68.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 72.45 110.687 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' SG ' ' CG1' ' A' ' 39' ' ' VAL . 4.1 t -63.5 -50.09 70.98 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.076 -0.511 . . . . 63.15 110.288 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 64' ' ' GLN . 2.3 pp -68.06 -46.51 70.91 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.929 -0.397 . . . . 54.21 109.929 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD11 ' A' ' 63' ' ' LEU . 25.4 tt0 -56.87 -31.88 65.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 74.01 111.162 -175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.1 ttt85 -70.96 -53.54 14.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 74.43 111.435 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.9 pt -70.53 -37.75 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.777 0.288 . . . . 74.43 111.777 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.713 ' HB2' HG22 ' A' ' 94' ' ' VAL . 13.2 pt-20 -69.59 -37.75 77.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.205 -0.452 . . . . 71.01 111.095 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -81.33 1.74 31.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.844 0.354 . . . . 75.11 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 66.6 mt -103.77 -66.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 70.13 110.844 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -85.18 -53.36 5.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.709 -0.678 . . . . 73.15 110.911 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.7 m -75.35 -11.13 59.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.46 -0.791 . . . . 55.35 111.47 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -43.92 -32.97 1.24 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.368 0.667 . . . . 73.31 112.339 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.0 ttt -66.33 77.89 0.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.836 -0.62 . . . . 75.02 109.981 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.55 HG23 ' HB1' ' A' ' 93' ' ' ALA . 5.8 p -74.14 133.45 78.33 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.084 -0.962 . . . . 71.12 110.597 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 Cg_exo -67.45 -158.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.033 2.489 . . . . 72.13 112.111 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.02 -23.54 13.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.712 0.292 . . . . 73.33 111.554 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -59.37 -8.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.176 -0.465 . . . . 75.44 111.206 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 74' ' ' VAL . 7.2 p -53.85 -44.32 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-O 121.164 0.507 . . . . 75.13 109.879 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -65.89 -32.7 74.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 74.44 110.086 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.646 ' HG3' ' CG ' ' A' ' 85' ' ' HIS . 29.2 tt0 -76.88 -28.74 55.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.517 -0.765 . . . . 73.11 111.3 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -86.49 -23.85 25.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.356 -0.384 . . . . 72.1 110.659 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 78' ' ' VAL . 10.1 mp -100.18 -47.88 4.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.298 -0.41 . . . . 73.43 110.925 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -97.97 150.8 20.97 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.341 -0.39 . . . . 64.54 110.474 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 11.6 pt20 -69.74 92.04 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 74.55 110.053 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.646 ' CG ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -60.28 90.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.671 -0.695 . . . . 73.5 111.394 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -75.14 85.51 2.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 72.41 109.828 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.17 -126.44 2.04 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.939 -0.573 . . . . 74.42 111.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.41 169.81 13.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.934 2.422 . . . . 73.53 112.416 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.4 99.0 0.23 Allowed Glycine 0 C--N 1.331 0.25 0 CA-C-N 116.159 -0.473 . . . . 73.43 112.275 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -105.45 80.32 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.284 0.564 . . . . 62.43 109.496 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.42 8.03 1.56 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.35 -0.841 . . . . 74.51 112.081 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -80.89 73.48 7.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.321 0.582 . . . . 74.1 109.725 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.55 ' HB1' HG23 ' A' ' 74' ' ' VAL . . . -151.32 -163.3 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.176 -0.92 . . . . 75.12 109.874 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 67' ' ' GLU . 8.7 p -75.84 136.59 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 110.12 -0.326 . . . . 75.41 110.12 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.763 -0.636 . . . . 75.0 111.098 -175.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.837 -0.431 . . . . 74.33 109.837 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.29 90.35 1.25 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.911 0.386 . . . . 73.44 110.417 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -60.51 -44.3 96.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 72.24 110.537 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -93.66 43.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.349 0.595 . . . . 73.13 109.735 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -58.77 143.84 45.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.19 -0.459 . . . . 64.02 110.805 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -153.48 -175.68 5.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.71 -0.677 . . . . 74.21 109.48 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -135.16 -80.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.678 0.275 . . . . 74.54 110.829 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -176.78 123.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 71.44 110.564 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.7 mtp -79.85 -53.8 6.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 72.24 110.224 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.63 114.46 3.87 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.944 -0.571 . . . . 73.32 112.524 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.0 p -115.97 -66.55 1.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 64.11 109.574 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.7 mt -116.56 -160.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 73.43 109.289 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.66 ' HG3' ' H ' ' A' ' 15' ' ' GLN . 7.0 pt-20 -102.98 -166.69 1.3 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.543 -0.54 . . . . 52.23 109.543 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.55 -13.49 52.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.873 0.368 . . . . 61.0 110.205 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.66 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 74.1 mt-30 67.46 77.41 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.097 -0.956 . . . . 73.03 109.71 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 71.3 p -97.96 -7.67 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.741 -1.118 . . . . 75.54 111.361 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.703 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 41.57 49.04 3.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.618 0.723 . . . . 74.11 110.544 -171.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.1 149.16 27.16 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.049 -0.978 . . . . 74.42 112.842 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.91 -24.35 8.53 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.711 2.274 . . . . 73.41 112.527 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.83 41.04 99.93 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.495 -0.642 . . . . 44.34 111.495 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -77.62 -178.51 5.35 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.254 0.222 . . . . 65.31 110.753 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 63.9 mtt 62.47 22.68 13.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.928 -0.578 . . . . 73.35 110.501 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -171.52 -170.34 0.8 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.553 -0.906 . . . . 74.42 108.553 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.66 -60.46 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.091 0.472 . . . . 70.42 110.536 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.96 97.72 8.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.616 -0.72 . . . . 71.11 110.009 -175.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 31.3 mt -82.27 166.78 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.997 0.903 . . . . 63.11 111.768 -174.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.65 149.67 41.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.966 -1.47 . . . . 73.33 109.338 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.614 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 m-85 -107.94 164.08 12.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.782 -0.821 . . . . 74.33 108.782 168.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.567 HG23 HH11 ' A' ' 65' ' ' ARG . 40.1 t -92.3 137.24 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.27 -1.382 . . . . 71.3 107.27 174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 46' ' ' LEU . 13.7 m -139.03 164.95 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 118.113 0.415 . . . . 74.31 111.244 -174.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 39.2 ptt180 -169.19 170.02 8.93 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.571 -0.74 . . . . 74.21 110.473 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.6 p30 -156.19 139.79 15.97 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.337 -0.246 . . . . 44.45 110.337 170.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.4 t30 47.42 4.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.885 1.069 . . . . 73.12 113.885 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.2 pt-20 -112.26 -32.32 6.56 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.806 -0.559 . . . . 70.25 111.924 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 -22.73 4.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.388 -0.434 . . . . 21.2 112.73 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -73.45 174.06 8.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.872 0.336 . . . . 74.31 110.315 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -121.85 132.64 54.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.332 0.493 . . . . 73.1 112.332 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -129.02 176.89 7.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.267 -0.879 . . . . 73.51 109.393 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.22 149.19 21.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.915 0.388 . . . . 71.43 110.815 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.502 ' NE1' ' HB3' ' A' ' 44' ' ' ARG . 70.8 t-105 -149.18 137.87 21.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 74.31 109.728 -171.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.6 ttt -62.76 125.19 23.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.663 -0.244 . . . . 73.3 110.896 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.76 144.33 57.13 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.785 -0.45 . . . . 70.44 109.785 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.7 -34.55 4.94 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 111.144 -0.782 . . . . 43.5 111.144 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HB3' ' NE1' ' A' ' 40' ' ' TRP . 4.8 ttt180 -69.82 95.42 0.9 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.804 -0.813 . . . . 74.1 108.804 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.1 m -61.3 126.07 26.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 72.32 111.929 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.8 mt -85.05 148.15 49.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.935 -1.03 . . . . 65.25 110.944 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.09 159.62 26.86 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.625 2.216 . . . . 72.34 112.045 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.84 126.65 23.02 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.006 -0.543 . . . . 71.5 110.773 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -35.18 4.43 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.578 -0.737 . . . . 71.01 111.488 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 44.3 m95 -83.51 134.89 34.82 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.988 -0.375 . . . . 74.55 109.988 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 10.6 pt-20 -119.25 146.95 44.8 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.424 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -105.2 156.7 17.86 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.456 1.097 . . . . 63.35 110.106 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -164.78 157.71 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.336 0.588 . . . . 74.21 111.265 -173.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 87.04 -174.05 45.35 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 114.872 -1.058 . . . . 72.2 112.077 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.703 ' HG2' ' HA ' ' A' ' 17' ' ' GLN . 0.4 OUTLIER -105.3 144.49 28.9 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.784 -0.821 . . . . 72.41 108.784 173.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.614 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.6 Cg_endo -64.4 140.05 68.02 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.971 1.781 . . . . 72.4 112.36 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' HB3' ' A' ' 26' ' ' LEU . . . -171.65 147.03 2.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.708 -0.678 . . . . 55.44 109.676 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -59.77 168.3 1.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.391 0.138 . . . . 72.34 111.23 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE3' HD21 ' A' ' 63' ' ' LEU . 56.0 tptt -44.37 -51.59 8.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.108 0.563 . . . . 75.31 111.921 -174.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.05 -47.82 77.18 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.901 0.382 . . . . 73.42 111.488 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -74.73 -35.28 62.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 72.45 111.147 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.75 -45.94 80.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 63.15 109.971 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 pp -68.05 -44.33 76.65 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.85 -0.426 . . . . 54.21 109.85 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.581 ' N ' HD11 ' A' ' 63' ' ' LEU . 27.0 tt0 -55.06 -37.98 67.44 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.301 0.572 . . . . 74.01 109.825 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.567 HH11 HG23 ' A' ' 29' ' ' VAL . 65.9 ttt-85 -57.43 -53.33 59.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.436 -0.802 . . . . 74.43 111.137 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.4 pt -74.22 -33.9 36.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.449 -0.341 . . . . 74.43 111.892 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.802 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 74.4 mm-40 -64.12 -42.89 96.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.536 -0.302 . . . . 71.01 110.416 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.6 mm-40 -74.42 4.73 5.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.355 . . . . 75.11 111.078 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.9 mt -103.14 -64.98 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 70.13 110.695 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.42 -52.03 6.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 73.15 111.141 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 m -73.47 -11.26 60.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.549 -0.75 . . . . 55.35 111.036 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -42.03 -37.16 1.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.679 0.792 . . . . 73.31 112.269 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.96 79.47 0.04 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.355 0.598 . . . . 75.02 110.035 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.5 p -97.1 135.31 22.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.555 -0.748 . . . . 71.12 110.8 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.58 -161.51 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.679 2.253 . . . . 72.13 111.66 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.39 -18.86 2.88 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.626 0.37 . . . . 73.33 111.883 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.7 t -52.11 -27.79 15.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.011 -0.54 . . . . 75.44 111.456 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.64 -40.65 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.96 0.409 . . . . 75.13 110.485 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -73.72 -34.53 64.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 74.44 110.206 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 91' ' ' ASP . 5.9 tp10 -64.75 -33.37 75.81 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.401 0.619 . . . . 73.11 109.432 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.612 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 50.2 t-80 -74.08 -20.21 60.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.421 -0.809 . . . . 72.1 110.634 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -43.9 9.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.132 -0.485 . . . . 73.43 109.963 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.77 111.8 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.378 -0.828 . . . . 64.54 111.101 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 140.53 22.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.934 -0.575 . . . . 74.55 109.912 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -116.67 85.2 2.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.974 -0.75 . . . . 73.5 108.974 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.9 t 68.18 -67.59 0.19 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.305 -0.861 . . . . 72.41 109.734 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.23 150.08 33.18 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.615 -0.594 . . . . 74.42 111.615 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.92 110.61 0.85 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.709 2.273 . . . . 73.53 112.734 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.65 50.59 0.76 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.547 -1.021 . . . . 73.43 110.547 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 81' ' ' HIS . 32.0 pt -90.15 172.23 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.33 -0.435 . . . . 62.43 112.02 -169.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.449 ' HB2' ' HG2' ' A' ' 80' ' ' GLU . 35.8 t70 -117.16 163.33 16.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.74 -0.663 . . . . 74.51 109.966 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -78.29 75.8 4.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.331 0.586 . . . . 74.1 110.943 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.323 -0.853 . . . . 75.12 110.084 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.33 134.66 25.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.602 -0.518 . . . . 75.41 109.602 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.802 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 54.5 mtt180 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.525 -0.75 . . . . 75.0 110.413 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mtp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.582 0.23 . . . . 74.33 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . . . -66.16 -46.93 75.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.97 0.414 . . . . 73.44 111.325 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -82.42 108.93 16.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 72.24 110.723 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -131.22 -85.48 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.327 -0.397 . . . . 73.13 110.046 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -62.89 134.22 55.89 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.141 -0.688 . . . . 64.02 109.141 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -143.23 109.94 5.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.204 0.526 . . . . 74.21 111.568 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -54.83 127.05 26.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 74.54 110.407 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -104.0 -71.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.436 -0.579 . . . . 71.44 109.436 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp 176.4 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.536 -0.756 . . . . 72.24 109.149 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.55 -111.57 2.09 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.098 -0.572 . . . . 73.32 112.716 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 p -82.97 136.4 34.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.609 0.242 . . . . 64.11 110.558 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.7 -37.9 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.013 -0.54 . . . . 73.43 110.079 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.644 ' HA ' HH12 ' A' ' 65' ' ' ARG . 2.9 mm-40 -108.79 -178.42 3.58 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.323 -0.398 . . . . 52.23 110.484 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -156.41 -166.19 2.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 61.0 110.095 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -88.23 91.32 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 73.03 110.481 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 p -70.39 94.27 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 75.54 109.641 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.55 174.25 8.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.576 -0.738 . . . . 74.11 111.139 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.49 -174.04 17.62 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.808 -0.633 . . . . 74.42 111.89 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.37 114.52 2.16 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.617 2.211 . . . . 73.41 111.911 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.57 70.32 1.68 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.903 -0.59 . . . . 44.34 112.206 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.7 t -71.85 100.14 2.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.049 -0.352 . . . . 65.31 110.049 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.62 12.79 17.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.23 0.538 . . . . 73.35 111.026 -178.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.94 -29.66 68.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.854 . . . . 74.42 110.415 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -114.85 145.16 42.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.318 -0.993 . . . . 70.42 108.318 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.48 -175.82 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.922 0.391 . . . . 71.11 111.734 -171.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.65 148.48 46.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.334 0.588 . . . . 63.11 111.21 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -133.93 155.98 48.95 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.116 -0.947 . . . . 73.33 109.713 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.735 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -121.17 159.81 25.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.022 -0.99 . . . . 74.33 108.693 172.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 53' ' ' VAL . 42.3 t -91.47 125.61 44.18 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.098 -1.075 . . . . 71.3 108.098 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 52' ' ' THR . 16.7 m -133.17 166.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.9 0.381 . . . . 74.31 111.084 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -165.81 162.23 18.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.497 -0.774 . . . . 74.21 110.522 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.461 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.1 OUTLIER -151.94 139.78 19.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.647 0.26 . . . . 44.45 110.353 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 44.47 8.97 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.14 1.163 . . . . 73.12 114.14 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.41 -32.26 6.55 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.789 -0.569 . . . . 70.25 111.852 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -22.94 3.65 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.958 -0.564 . . . . 21.2 113.078 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -87.43 173.69 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.456 -0.572 . . . . 74.31 109.456 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.432 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 15.8 m-85 -106.89 138.75 42.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.365 0.876 . . . . 73.1 113.365 -172.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 m -134.96 -179.01 5.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.402 -1.272 . . . . 73.51 109.011 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG11 ' SG ' ' A' ' 62' ' ' CYS . 28.3 m -124.26 159.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.935 0.397 . . . . 71.43 111.29 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HB2' HG21 ' A' ' 30' ' ' VAL . 68.3 t-105 -142.8 143.38 32.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.252 -0.647 . . . . 74.31 109.252 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.5 ttt -81.37 127.44 32.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.234 -0.284 . . . . 73.3 110.234 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.79 157.11 18.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.256 -0.429 . . . . 70.44 111.26 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.32 10.6 55.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.191 -0.528 . . . . 43.5 112.669 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -151.47 130.0 12.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.903 0.382 . . . . 74.1 110.147 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -80.67 153.42 27.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.514 0.673 . . . . 72.32 111.643 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.626 HD13 HG23 ' A' ' 52' ' ' THR . 52.7 mt -95.26 145.81 30.19 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 114.857 -1.065 . . . . 65.25 111.013 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.31 168.35 14.95 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.642 2.228 . . . . 72.34 112.551 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.3 129.84 22.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.247 -0.888 . . . . 71.5 111.022 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.82 -33.03 6.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.022 -0.536 . . . . 71.01 111.804 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 45.0 m95 -88.48 141.46 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.786 0.327 . . . . 74.55 110.762 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.02 154.49 47.36 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.095 -0.502 . . . . 74.23 110.304 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.626 HG23 HD13 ' A' ' 46' ' ' LEU . 15.7 p -114.49 160.68 18.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.373 1.046 . . . . 63.35 111.194 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG21 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -165.72 149.35 2.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 C-N-CA 123.474 0.71 . . . . 74.21 110.907 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 108.27 -172.65 17.21 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.128 -0.942 . . . . 72.2 113.305 172.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' OE2' ' HD2' ' A' ' 56' ' ' PRO . 5.8 tp10 -103.27 129.45 25.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 107.983 -1.117 . . . . 72.41 107.983 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.735 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 18.9 Cg_endo -56.74 122.11 11.23 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.738 1.625 . . . . 72.4 111.32 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.72 157.78 30.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 55.44 110.431 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 t -55.73 152.93 8.83 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.088 0.243 . . . . 72.34 110.698 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.78 -42.44 25.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.853 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -53.92 -44.09 70.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.098 0.475 . . . . 73.42 111.036 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 82.6 mm-40 -74.85 -39.11 61.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 72.45 110.537 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.449 ' SG ' HG11 ' A' ' 39' ' ' VAL . 8.9 t -63.42 -43.69 96.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 63.15 110.561 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.4 pp -68.14 -36.63 80.0 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 109.621 -0.511 . . . . 54.21 109.621 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.589 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.4 tt0 -54.77 -44.61 73.82 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.308 -0.627 . . . . 74.01 109.308 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.644 HH12 ' HA ' ' A' ' 13' ' ' GLU . 25.7 ttt85 -56.34 -52.0 66.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.814 -0.63 . . . . 74.43 110.952 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.49 -35.97 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.653 -0.249 . . . . 74.43 111.637 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 26.5 mm-40 -66.42 -32.75 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.603 0.239 . . . . 71.01 110.624 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.7 mm100 -81.19 -18.91 44.59 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.273 -0.421 . . . . 75.11 111.396 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.89 -66.65 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.327 0.584 . . . . 70.13 112.187 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.432 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 65.5 t-105 -85.3 -46.1 11.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 73.15 110.66 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -82.71 -10.06 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.098 -0.955 . . . . 55.35 110.993 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -40.89 -29.57 0.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.656 1.354 . . . . 73.31 114.656 -170.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.6 ttp -67.94 78.61 0.22 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.342 0.591 . . . . 75.02 109.969 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.17 134.65 19.55 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.42 -0.809 . . . . 71.12 111.437 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 80.2 Cg_endo -86.62 -151.38 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.33 2.687 . . . . 72.13 111.549 173.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.0 -11.11 7.07 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.036 0.384 . . . . 73.33 112.036 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 t -56.06 -21.05 19.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 75.44 111.245 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 p -55.79 -51.12 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.452 -0.34 . . . . 75.13 111.212 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -73.59 -20.55 60.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 74.44 110.758 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.99 -13.63 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.304 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -101.95 -53.23 2.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.003 -0.544 . . . . 72.1 110.393 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 91' ' ' ASP . 64.1 mt -90.0 175.13 7.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.589 -0.732 . . . . 73.43 110.795 -176.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -114.65 -66.03 1.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.46 -0.57 . . . . 64.54 109.46 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -87.23 75.39 9.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.797 0.808 . . . . 74.55 109.964 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -61.78 -21.81 64.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 73.5 111.623 -176.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.3 m -97.28 17.69 16.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.943 0.401 . . . . 72.41 110.826 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.6 164.27 43.17 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.094 -0.503 . . . . 74.42 112.541 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.9 79.09 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.149 2.566 . . . . 73.53 112.124 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.02 -50.05 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.981 -0.554 . . . . 73.43 111.899 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.551 ' O ' HG21 ' A' ' 90' ' ' ILE . 29.3 mt 58.15 34.61 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 122.442 1.115 . . . . 62.43 110.064 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.45 ' O ' HD12 ' A' ' 82' ' ' LEU . 9.1 p-10 -85.82 68.63 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.678 -1.146 . . . . 74.51 110.53 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -79.13 53.59 1.48 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.492 0.663 . . . . 74.1 111.403 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.98 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.524 -0.762 . . . . 75.12 110.422 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 94' ' ' VAL . 7.5 p -89.23 28.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.976 1.369 . . . . 75.41 111.162 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--O 1.251 1.139 0 CA-C-N 113.778 -1.555 . . . . 75.0 110.664 178.592 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.786 0.327 . . . . 74.33 110.124 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.05 61.13 3.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 73.44 111.14 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -98.48 123.7 42.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.82 -0.808 . . . . 72.24 108.82 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -96.66 103.63 15.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.869 0.366 . . . . 73.13 111.626 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -164.86 136.18 4.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.06 -0.719 . . . . 64.02 109.06 174.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -126.51 137.92 53.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.418 -0.215 . . . . 74.21 110.418 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.407 ' NE2' ' HB2' ' A' ' 9' ' ' MET . 82.0 t60 -110.53 98.9 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 74.54 109.786 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -83.96 62.14 6.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.943 -0.571 . . . . 71.44 111.473 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.407 ' HB2' ' NE2' ' A' ' 7' ' ' HIS . 19.8 mmt -148.8 161.05 42.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.998 -0.371 . . . . 72.24 109.998 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.99 170.19 44.47 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.888 -0.596 . . . . 73.32 112.688 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.2 m -80.55 -44.32 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 64.11 110.999 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 tt -151.93 -41.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.126 0.488 . . . . 73.43 109.768 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.84 16.3 0.91 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.09 -0.505 . . . . 52.23 111.206 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.69 127.35 31.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 61.0 110.671 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 10.2 pt20 -125.32 120.03 30.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 73.03 110.062 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -65.41 -32.39 74.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.213 0.53 . . . . 75.54 110.102 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -163.67 143.02 8.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.561 -0.745 . . . . 74.11 109.308 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.4 84.91 0.38 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.727 -0.549 . . . . 74.42 111.727 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.1 -19.35 45.26 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.844 2.363 . . . . 73.41 111.943 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.16 -147.21 18.59 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.591 -0.731 . . . . 44.34 111.836 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 p -160.78 173.93 14.66 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 110.176 -0.305 . . . . 65.31 110.176 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 86.6 mtp -122.91 74.99 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 73.35 109.408 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 38.21 47.33 0.98 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.76 1.266 . . . . 74.42 112.166 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.73 176.81 4.57 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.224 -1.807 . . . . 70.42 111.179 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.29 118.28 23.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.522 -0.918 . . . . 71.11 108.522 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.89 146.25 37.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 63.11 111.419 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.585 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 22.7 m-85 -129.92 148.55 51.8 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.574 -1.194 . . . . 73.33 108.843 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.58 166.41 11.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 74.33 108.742 171.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 53' ' ' VAL . 25.6 t -94.56 111.72 25.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 107.1 -1.444 . . . . 71.3 107.1 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 40' ' ' TRP . 11.5 m -125.87 167.0 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.985 -0.447 . . . . 74.31 111.534 -170.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -166.19 169.68 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 74.21 110.997 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -156.15 139.75 15.97 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.538 -0.301 . . . . 44.45 110.757 172.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.3 t30 40.53 10.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.898 1.279 . . . . 73.12 114.216 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.0 pt-20 -112.61 -32.29 6.5 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.691 -0.631 . . . . 70.25 112.124 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 -22.96 2.19 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.165 -0.541 . . . . 21.2 112.633 -173.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' GLU . 13.9 mm100 -75.81 173.89 10.57 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -115.71 142.29 46.94 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.912 0.708 . . . . 73.1 112.912 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.0 m -137.59 -179.46 5.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.417 -1.265 . . . . 73.51 109.65 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.02 148.99 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.769 0.319 . . . . 71.43 110.983 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 70.3 t90 -144.44 129.88 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 74.31 110.958 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.6 ttm -69.93 143.58 52.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.477 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.09 -172.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 70.44 110.655 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.55 -34.41 4.2 Favored Glycine 0 CA--C 1.515 0.071 0 C-N-CA 121.175 -0.535 . . . . 43.5 112.831 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 mpt_? -95.97 -170.89 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.061 0.458 . . . . 74.1 110.384 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 p -135.3 117.26 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.991 -0.744 . . . . 72.32 108.991 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 52' ' ' THR . 17.6 mt -57.7 132.21 82.53 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.101 -0.5 . . . . 65.25 111.566 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.4 158.61 9.61 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.707 2.938 . . . . 72.34 112.794 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 123.37 17.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.07 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.79 -29.13 7.35 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.067 -0.813 . . . . 71.01 111.067 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 59.0 m95 -84.99 151.45 24.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.779 -0.452 . . . . 74.55 109.779 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.69 145.94 45.31 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 116.363 -0.381 . . . . 74.23 110.161 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.588 HG23 HD11 ' A' ' 46' ' ' LEU . 38.7 p -104.5 144.59 31.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.783 -1.099 . . . . 63.35 110.152 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.73 168.44 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.429 0.633 . . . . 74.21 110.466 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 -148.64 22.29 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.284 -0.871 . . . . 72.2 111.955 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 28.5 tt0 -132.65 132.93 22.92 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.618 -0.882 . . . . 72.41 108.618 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.588 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -70.48 125.66 12.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.882 1.721 . . . . 72.4 111.621 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.0 175.58 13.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.195 -0.457 . . . . 55.44 110.684 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 t -62.99 151.36 39.92 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.145 -0.317 . . . . 72.34 110.145 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -44.55 -43.26 7.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 75.31 111.373 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.56 -42.62 92.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 73.42 111.269 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.03 -36.61 61.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 72.45 111.132 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 62.5 m -64.92 -44.85 88.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 63.15 111.175 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.577 HD11 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.07 -41.85 81.34 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.76 -0.459 . . . . 54.21 109.76 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.577 ' N ' HD11 ' A' ' 63' ' ' LEU . 25.1 tt0 -59.37 -37.37 77.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.465 0.65 . . . . 74.01 110.436 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 11.4 ttt180 -64.38 -47.0 80.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.474 -0.785 . . . . 74.43 111.153 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.0 pt -74.4 -34.85 37.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.718 0.294 . . . . 74.43 111.63 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.69 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 8.1 mm-40 -64.94 -48.55 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 71.01 110.961 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.475 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 22.1 mm-40 -70.43 8.46 0.81 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.073 0.464 . . . . 75.11 111.651 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 92.5 mt -103.42 -66.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.341 0.591 . . . . 70.13 110.203 172.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -83.49 -54.69 4.77 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.401 -0.818 . . . . 73.15 110.668 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -72.18 -11.16 60.61 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.426 -0.806 . . . . 55.35 110.712 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 13.0 t70 -41.81 -40.33 2.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.599 -0.728 . . . . 73.31 111.931 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.1 mtp -66.07 76.83 0.09 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.616 -0.72 . . . . 75.02 109.491 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 p -94.6 133.6 26.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.996 -1.002 . . . . 71.12 110.809 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -71.94 -166.46 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.87 2.38 . . . . 72.13 111.938 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.23 -17.8 5.06 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.284 -0.416 . . . . 73.33 111.828 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 t -50.01 -27.1 4.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.605 . . . . 75.44 111.701 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.96 -31.14 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.955 0.407 . . . . 75.13 111.264 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -63.67 -31.74 73.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.88 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -62.81 -29.74 70.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.922 0.391 . . . . 73.11 110.645 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 16.3 t-80 -87.15 -21.96 25.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 72.1 109.839 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -81.59 -21.72 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 73.43 108.891 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.23 83.88 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.725 -0.67 . . . . 64.54 110.687 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -78.78 -8.7 59.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.708 -0.678 . . . . 74.55 109.417 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -94.86 130.01 41.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.402 -0.817 . . . . 73.5 109.937 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 m 69.36 10.02 7.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.54 0.525 . . . . 72.41 111.886 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.34 160.79 21.64 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.233 -0.508 . . . . 74.42 112.124 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -99.71 16.89 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.379 2.719 . . . . 73.53 112.942 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.11 63.06 4.86 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.457 -0.401 . . . . 73.43 112.502 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -73.41 94.74 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.338 0.496 . . . . 62.43 112.338 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 65.53 2.95 2.2 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.494 0.924 . . . . 74.51 113.494 164.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 41.9 t80 -100.9 89.98 4.04 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.034 -0.417 . . . . 74.1 110.905 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 81' ' ' HIS . . . 164.83 -168.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.457 1.103 . . . . 75.12 108.33 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.37 130.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.543 -0.91 . . . . 75.41 108.543 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.69 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mmt85 . . . . . 0 C--O 1.241 0.624 0 CA-C-O 118.122 -0.942 . . . . 75.0 110.578 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.25 -0.278 . . . . 74.33 110.25 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.53 16.52 8.12 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.598 0.561 . . . . 73.44 112.423 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -93.05 6.48 47.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.913 0.387 . . . . 72.24 110.327 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -133.19 104.69 6.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.63 -0.713 . . . . 73.13 109.346 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.86 152.32 45.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 64.02 110.293 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -58.83 -45.16 90.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.503 0.502 . . . . 74.21 110.301 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t60 62.26 25.43 15.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.565 -0.743 . . . . 74.54 110.94 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.78 123.41 42.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.69 0.281 . . . . 71.44 110.643 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.3 ttm -80.65 -39.91 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.388 -0.597 . . . . 72.24 109.388 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.96 168.13 42.41 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.527 -0.76 . . . . 73.32 112.368 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 -54.03 5.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.529 0.68 . . . . 64.11 109.516 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -101.21 164.27 11.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.876 -1.057 . . . . 73.43 108.834 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.724 ' HG3' HH21 ' A' ' 65' ' ' ARG . 0.3 OUTLIER 64.07 26.9 14.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.099 0.476 . . . . 52.23 111.422 -177.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.61 40.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 61.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.456 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 92.5 mt-30 -130.94 124.61 31.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.25 -0.432 . . . . 73.03 110.91 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -76.71 78.56 3.35 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.269 -0.423 . . . . 75.54 110.413 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -92.86 121.34 34.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 74.11 110.181 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.95 145.97 25.07 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.139 -0.553 . . . . 74.42 111.848 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -85.26 24.16 0.78 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.994 2.463 . . . . 73.41 113.078 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.66 -11.4 60.04 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.444 -0.408 . . . . 44.34 113.315 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.2 m -131.08 32.59 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.187 0.518 . . . . 65.31 110.368 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.2 86.13 5.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.47 0.652 . . . . 73.35 109.708 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -101.68 -165.29 1.18 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.967 -1.015 . . . . 74.42 111.741 -175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.55 -38.55 91.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.45 0.907 . . . . 70.42 113.45 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' THR . 41.7 mt-10 -90.26 93.64 9.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 71.11 111.577 -168.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 56' ' ' PRO . 8.2 mp -89.89 143.1 27.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.505 0.669 . . . . 63.11 111.129 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 13.0 m-85 -133.1 157.49 45.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.766 -1.106 . . . . 73.33 109.26 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.622 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.4 m-85 -113.79 167.67 10.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.634 -0.712 . . . . 74.33 109.224 170.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.55 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.905 -1.146 . . . . 71.3 107.905 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.459 HG11 HG23 ' A' ' 52' ' ' THR . 21.6 m -137.95 162.13 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 118.171 0.441 . . . . 74.31 111.349 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.49 168.17 9.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.569 -0.741 . . . . 74.21 110.798 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.629 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.1 p-10 -163.58 139.97 6.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 44.45 110.346 166.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 t30 46.5 4.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.085 1.143 . . . . 73.12 114.085 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.6 pt-20 -105.71 -25.42 12.23 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.418 -0.801 . . . . 70.25 112.312 -167.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 -22.3 9.6 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.481 -0.39 . . . . 21.2 113.171 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -100.1 173.97 6.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.903 -0.406 . . . . 74.31 109.903 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -106.43 153.72 21.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.436 . . . . 73.1 111.774 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -145.3 -178.72 6.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 73.51 109.217 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.12 158.14 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.929 0.395 . . . . 71.43 111.058 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 59.9 t90 -150.29 142.89 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 74.31 109.738 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.53 131.64 35.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 73.3 111.615 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.49 151.62 43.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 70.44 110.656 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.34 -12.75 43.85 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.171 -0.538 . . . . 43.5 112.883 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 74.8 mtt180 -104.87 -167.23 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.427 -0.582 . . . . 74.1 109.427 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.6 m -138.11 131.16 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 72.32 110.117 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.6 mt -80.71 135.19 52.76 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 65.25 112.13 -174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.09 138.99 21.45 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.449 2.766 . . . . 72.34 112.626 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 130.16 31.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.952 -0.567 . . . . 71.5 110.103 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.86 -35.4 4.31 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.042 -0.823 . . . . 71.01 111.042 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.629 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.0 m95 -76.35 149.49 36.99 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.914 -0.402 . . . . 74.55 109.914 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.16 152.11 50.78 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 110.049 -0.352 . . . . 74.23 110.049 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.459 HG23 HG11 ' A' ' 30' ' ' VAL . 21.5 p -109.44 161.51 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.103 . . . . 63.35 110.483 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.99 162.61 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.278 0.631 . . . . 74.21 109.931 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' HA2' ' OE1' ' A' ' 13' ' ' GLU . . . 85.48 -173.28 47.69 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.805 -0.634 . . . . 72.2 112.336 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.29 144.22 29.31 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.207 -1.034 . . . . 72.41 108.207 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.622 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 44.9 Cg_endo -65.67 115.48 3.41 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.652 1.568 . . . . 72.4 110.814 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -140.48 168.94 18.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.099 -0.5 . . . . 55.44 110.088 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 8.8 t -59.73 151.86 24.15 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.681 -0.408 . . . . 72.34 110.496 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -46.76 -40.82 14.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.02 -0.536 . . . . 75.31 111.424 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.59 -43.32 99.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 73.42 110.893 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 93.7 mt-30 -72.85 -33.15 65.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.256 -0.429 . . . . 72.45 111.034 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 77.0 m -68.58 -45.95 70.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.475 -0.33 . . . . 63.15 110.83 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.11 -36.49 79.83 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.006 -0.368 . . . . 54.21 110.006 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 35.9 tt0 -66.53 -31.48 72.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.656 0.741 . . . . 74.01 110.118 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.724 HH21 ' HG3' ' A' ' 13' ' ' GLU . 13.0 ttt85 -65.57 -49.71 67.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 74.43 110.27 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.1 pt -70.28 -42.0 78.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.111 -0.495 . . . . 74.43 111.866 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 11.5 pt-20 -60.91 -49.43 77.48 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.251 -0.18 . . . . 71.01 110.653 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.506 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 83.2 mt-30 -74.85 1.94 11.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.887 0.329 . . . . 75.11 111.887 -174.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HG ' ' NE2' ' A' ' 15' ' ' GLN . 45.1 mt -103.93 -66.03 0.98 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.276 0.56 . . . . 70.13 111.227 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -86.01 -53.94 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.245 -0.889 . . . . 73.15 111.198 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.03 -10.73 52.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.9 -1.046 . . . . 55.35 111.791 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.4 p-10 -41.8 -27.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.991 1.108 . . . . 73.31 113.991 -168.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.8 mmm -70.83 78.95 0.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.162 -0.681 . . . . 75.02 109.162 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.77 HG11 HG11 ' A' ' 94' ' ' VAL . 2.5 m -76.94 161.23 74.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.498 -0.774 . . . . 71.12 111.374 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 74' ' ' VAL . 42.9 Cg_endo -67.79 -162.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.844 2.363 . . . . 72.13 112.619 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.15 -21.2 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.979 -0.555 . . . . 73.33 111.384 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.9 m -51.76 -18.32 1.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.739 -0.664 . . . . 75.44 112.306 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.493 HG11 ' HD2' ' A' ' 79' ' ' ARG . 13.4 p -54.05 -31.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.639 0.257 . . . . 75.13 111.028 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.493 ' HD2' HG11 ' A' ' 78' ' ' VAL . 7.4 mpt_? -61.2 -40.36 93.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.37 -0.377 . . . . 74.44 110.8 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -60.88 -26.67 67.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.936 0.398 . . . . 73.11 110.8 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -73.28 -29.37 62.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.453 -0.34 . . . . 72.1 110.551 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.81 -6.83 59.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.109 0.48 . . . . 73.43 110.075 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.53 2.97 51.92 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.695 -0.684 . . . . 64.54 110.28 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -62.08 130.21 44.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 74.55 111.4 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -93.62 71.02 4.23 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.592 -0.522 . . . . 73.5 109.592 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.7 t 57.95 26.46 13.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.94 -0.573 . . . . 72.41 110.732 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -121.49 73.19 0.36 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.028 -0.606 . . . . 74.42 113.232 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -97.29 -157.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.375 2.717 . . . . 73.53 111.634 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.25 -68.25 2.67 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.169 -0.772 . . . . 73.43 111.169 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.3 mm -78.95 62.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.476 -0.935 . . . . 62.43 108.476 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -135.31 123.78 23.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.77 -1.105 . . . . 74.51 108.91 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -129.45 149.4 51.24 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.026 0.441 . . . . 74.1 110.433 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.75 -152.3 0.31 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 75.12 111.199 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.77 HG11 HG11 ' A' ' 74' ' ' VAL . 7.5 p -82.77 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 122.484 1.135 . . . . 75.41 111.534 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-N 114.24 -1.345 . . . . 75.0 108.439 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.922 0.391 . . . . 74.33 110.353 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -177.84 179.23 0.89 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.821 -0.627 . . . . 73.44 109.728 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -111.51 39.86 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.72 -0.845 . . . . 72.24 108.72 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 60.05 -105.29 0.22 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.395 -1.275 . . . . 73.13 111.31 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 43.17 -91.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.701 0.4 . . . . 64.02 111.869 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -172.0 87.25 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.378 0.608 . . . . 74.21 110.144 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -70.86 129.87 40.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.651 -0.704 . . . . 74.54 110.157 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -56.84 110.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.324 . . . . 71.44 110.843 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -172.77 117.88 0.33 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.57 -0.9 . . . . 72.24 108.57 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.14 80.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.357 -0.449 . . . . 73.32 113.056 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.496 HG21 ' HG ' ' A' ' 12' ' ' LEU . 8.9 t -58.72 -32.23 69.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.992 0.425 . . . . 64.11 110.09 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.572 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 91.0 mt -111.33 -82.16 0.58 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.047 -0.524 . . . . 73.43 109.773 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.41 144.93 48.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.857 -0.423 . . . . 52.23 109.857 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.4 116.64 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.348 0.405 . . . . 61.0 111.298 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 59.97 33.1 21.38 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.187 0.81 . . . . 73.03 113.187 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 p -76.02 76.95 2.89 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.306 0.574 . . . . 75.54 109.813 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.99 124.98 28.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.402 -0.817 . . . . 74.11 110.826 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.9 92.7 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.895 -0.593 . . . . 74.42 111.674 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.01 144.97 66.01 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.578 2.186 . . . . 73.41 111.794 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.62 91.57 0.25 Allowed Glycine 0 C--O 1.236 0.231 0 C-N-CA 121.127 -0.558 . . . . 44.34 112.368 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -162.17 120.44 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 65.31 110.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.9 mmm -103.25 29.92 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.474 -0.565 . . . . 73.35 109.474 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 64.12 17.8 10.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.071 0.939 . . . . 74.42 109.382 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 25' ' ' GLU . 34.7 t70 -78.48 -157.33 0.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.844 -1.071 . . . . 70.42 108.819 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 24' ' ' ASP . 53.2 mm-40 -71.55 121.24 18.37 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.309 0.504 . . . . 71.11 110.638 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 56' ' ' PRO . 10.9 mp -87.37 147.5 25.44 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.376 0.608 . . . . 63.11 110.248 175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -124.92 148.66 48.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.037 -0.983 . . . . 73.33 109.238 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.53 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -119.34 159.8 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.694 -0.854 . . . . 74.33 108.694 174.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 53' ' ' VAL . 30.3 t -89.4 139.91 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.534 -1.284 . . . . 71.3 107.534 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 46' ' ' LEU . 29.6 m -139.58 164.9 23.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 121.981 -0.449 . . . . 74.31 111.367 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.64 HH21 ' HA2' ' A' ' 35' ' ' GLY . 9.4 ptm180 -158.16 161.78 37.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.881 -0.6 . . . . 74.21 111.118 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -166.26 140.02 4.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 44.45 110.389 166.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 46.1 5.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.845 1.424 . . . . 73.12 114.845 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.2 pt-20 -112.23 -32.02 6.67 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.934 -0.479 . . . . 70.25 112.283 -170.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.64 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 81.82 -22.72 5.54 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.66 -0.781 . . . . 21.2 112.291 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -93.81 174.02 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.84 -0.43 . . . . 74.31 109.84 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -107.61 152.24 24.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.997 0.739 . . . . 73.1 112.997 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -137.75 -179.22 5.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.563 -1.199 . . . . 73.51 108.989 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' SG ' ' A' ' 62' ' ' CYS . 30.5 m -126.08 152.5 33.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.053 0.454 . . . . 71.43 110.778 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.493 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 50.2 t90 -144.04 144.54 31.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.575 . . . . 74.31 110.458 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -90.62 135.47 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.811 -0.632 . . . . 73.3 110.724 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.39 175.27 6.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.258 -0.428 . . . . 70.44 110.154 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.48 61.82 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.798 -0.921 . . . . 43.5 110.798 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.493 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.2 ptm180 -140.89 176.86 8.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.952 -0.624 . . . . 74.1 109.366 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -126.69 126.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.42 . . . . 72.32 109.915 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 52' ' ' THR . 12.1 mt -56.22 135.04 75.21 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.454 -0.794 . . . . 65.25 112.144 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.71 155.48 70.27 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.018 2.479 . . . . 72.34 112.383 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 124.9 11.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.247 -0.888 . . . . 71.5 110.768 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.44 -30.16 6.87 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.986 -0.552 . . . . 71.01 112.208 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 30.6 m95 -93.3 148.44 22.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.768 0.284 . . . . 74.55 110.472 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -135.23 153.07 52.05 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.855 0.36 . . . . 74.23 111.581 173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.609 HG23 HD11 ' A' ' 46' ' ' LEU . 22.4 p -99.09 160.02 14.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.675 -1.148 . . . . 63.35 111.512 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -169.84 164.76 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.548 1.139 . . . . 74.21 109.661 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 12' ' ' LEU . . . 98.16 -159.78 20.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.004 -0.617 . . . . 72.2 113.272 173.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -113.02 128.58 25.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.661 -0.866 . . . . 72.41 108.661 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 51.1 Cg_endo -68.31 112.22 2.72 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.742 1.628 . . . . 72.4 111.42 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.32 166.16 33.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 55.44 109.91 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 t -63.98 168.38 5.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.154 0.502 . . . . 72.34 111.236 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.2 tptp -48.83 -50.38 34.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.366 -0.834 . . . . 75.31 111.916 -173.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.49 -41.56 66.37 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.456 0.473 . . . . 73.42 111.336 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -72.94 -43.98 61.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.303 0.573 . . . . 72.45 110.532 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.424 ' SG ' HG12 ' A' ' 39' ' ' VAL . 3.8 t -60.49 -46.57 89.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.236 -0.893 . . . . 63.15 110.858 -173.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 64' ' ' GLN . 2.9 pp -67.92 -40.69 83.34 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.883 -0.327 . . . . 54.21 110.983 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.612 ' N ' HD13 ' A' ' 63' ' ' LEU . 30.0 tt0 -60.96 -35.77 77.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.168 0.509 . . . . 74.01 110.524 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.464 HH11 HG23 ' A' ' 29' ' ' VAL . 63.4 ttt-85 -62.3 -53.66 51.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.924 -0.58 . . . . 74.43 110.855 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.8 pt -69.68 -34.55 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.568 -0.287 . . . . 74.43 111.365 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 95' ' ' ARG . 16.6 mm-40 -65.2 -55.23 19.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 71.01 110.939 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 68.6 mt-30 -70.96 1.3 5.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 75.11 111.705 -174.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.6 mt -103.47 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 70.13 111.024 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -85.27 -46.83 10.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.694 -0.684 . . . . 73.15 110.509 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -80.46 -10.66 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.183 -0.917 . . . . 55.35 111.092 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.612 ' HA ' HG22 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -41.88 -33.2 0.5 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.067 0.765 . . . . 73.31 113.067 -170.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 74.5 mtm -61.79 87.28 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.45 0.643 . . . . 75.02 110.807 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.6 p -91.94 134.6 28.54 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.138 -0.937 . . . . 71.12 110.809 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 15.0 Cg_exo -69.12 -158.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.905 2.404 . . . . 72.13 112.251 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.76 1.34 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.713 0.634 . . . . 73.33 112.713 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.0 t -50.1 -31.43 13.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.262 -0.426 . . . . 75.44 110.913 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 79' ' ' ARG . 7.2 p -52.78 -49.13 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.572 -0.286 . . . . 75.13 111.177 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.43 ' N ' HG11 ' A' ' 78' ' ' VAL . 70.6 mtp180 -73.35 -43.68 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.761 0.315 . . . . 74.44 110.488 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -66.48 -15.25 63.21 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.087 0.47 . . . . 73.11 110.576 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -101.29 -28.71 12.47 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.002 -0.544 . . . . 72.1 111.471 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.9 tp -87.2 -42.25 13.11 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.731 -0.213 . . . . 73.43 111.339 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -56.51 117.05 3.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.25 -0.432 . . . . 64.54 110.116 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.34 96.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.478 -0.783 . . . . 74.55 111.259 -175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -136.81 135.1 37.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 73.5 109.825 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 t -64.17 96.15 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.255 -0.646 . . . . 72.41 109.255 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.35 78.44 1.36 Allowed Glycine 0 CA--C 1.518 0.234 0 N-CA-C 111.088 -0.805 . . . . 74.42 111.088 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.41 -168.23 0.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.337 2.691 . . . . 73.53 111.697 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.99 108.35 2.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.202 -0.523 . . . . 73.43 112.33 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -82.69 76.49 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.577 0.703 . . . . 62.43 109.636 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.9 -179.49 7.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.045 -0.98 . . . . 74.51 108.559 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -136.35 156.69 48.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.5 . . . . 74.1 111.522 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.41 -138.84 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.224 -1.028 . . . . 75.12 108.224 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 72' ' ' ASP . 12.4 p -41.99 134.03 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 109.416 -0.587 . . . . 75.41 109.416 165.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.508 ' HG2' HD12 ' A' ' 63' ' ' LEU . 10.9 tpp85 . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.544 -0.741 . . . . 75.0 110.136 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' HD2' ' A' ' 3' ' ' HIS . 65.9 mtm . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.89 -0.411 . . . . 74.33 109.89 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -55.4 -32.76 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.809 0.67 . . . . 73.44 112.809 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 40.5 m-70 73.08 -31.66 0.23 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.248 0.619 . . . . 72.24 111.976 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' ' 2' ' ' ALA . 53.5 t-80 -63.84 86.78 0.04 OUTLIER 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 73.13 110.298 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -106.29 -14.28 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.141 -0.481 . . . . 64.02 111.153 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -70.37 92.28 0.79 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.891 -1.151 . . . . 74.21 107.891 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -88.01 -18.47 28.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 74.54 112.172 -164.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.443 ' ND1' ' HB2' ' A' ' 72' ' ' ASP . 77.8 m80 -92.97 131.6 37.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.917 -0.401 . . . . 71.44 109.917 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.8 ttp -140.27 135.24 32.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.036 -0.357 . . . . 72.24 110.036 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.87 33.2 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.968 -0.453 . . . . 73.32 111.968 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.3 m -71.21 -61.47 1.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.43 . . . . 64.11 110.468 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.05 -77.83 0.59 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.08 -0.509 . . . . 73.43 110.497 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.63 93.43 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.004 0.43 . . . . 52.23 110.609 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.88 24.32 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.474 -0.785 . . . . 61.0 109.55 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' HB2' ' OE1' ' A' ' 17' ' ' GLN . 13.9 pt20 -74.45 164.39 26.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.668 -1.151 . . . . 73.03 110.585 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -101.49 5.49 41.93 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 75.54 111.061 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.479 ' OE1' ' HB2' ' A' ' 15' ' ' GLN . 1.1 pm0 -137.83 -174.75 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 74.11 110.696 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.65 -174.87 13.89 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.893 -0.483 . . . . 74.42 111.893 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.84 82.89 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.7 2.267 . . . . 73.41 112.224 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 67.18 3.8 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.202 -0.523 . . . . 44.34 112.227 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 t -130.77 131.87 44.96 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.859 0.361 . . . . 65.31 110.552 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -110.66 9.47 22.88 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.33 0.586 . . . . 73.35 109.995 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -108.98 152.95 24.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.082 -0.963 . . . . 74.42 110.063 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.91 -21.51 29.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.42 0.526 . . . . 70.42 112.42 -171.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.67 80.18 3.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.07 0.462 . . . . 71.11 110.094 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp -76.04 161.34 28.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.454 0.645 . . . . 63.11 111.152 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.14 148.68 52.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.082 -0.963 . . . . 73.33 109.537 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.05 162.43 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.155 -0.683 . . . . 74.33 109.155 176.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.472 HG23 HH11 ' A' ' 65' ' ' ARG . 71.1 t -95.4 137.76 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.35 -1.352 . . . . 71.3 107.35 172.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.57 164.71 33.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.109 0.481 . . . . 74.31 111.71 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 15.9 ptm180 -167.81 170.13 11.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.914 -1.039 . . . . 74.21 110.149 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.695 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -167.39 139.99 3.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.73 -0.213 . . . . 44.45 111.007 166.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 37.2 16.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.686 1.365 . . . . 73.12 114.686 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.8 pt-20 -112.31 -29.16 7.64 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.763 -0.585 . . . . 70.25 112.479 -172.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' NH2' ' A' ' 31' ' ' ARG . . . 74.62 7.69 79.97 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.599 -0.81 . . . . 21.2 111.666 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.741 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 6.7 tp60 -116.21 167.88 10.61 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.599 -0.889 . . . . 74.31 108.599 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -112.96 153.56 27.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.546 0.573 . . . . 73.1 112.546 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 m -147.61 -179.33 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.999 -1.0 . . . . 73.51 109.478 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG23 ' HE3' ' A' ' 59' ' ' LYS . 15.9 m -123.54 163.48 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 71.43 110.604 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -151.01 149.81 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 74.31 109.934 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.5 ttt -86.15 126.89 34.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 73.3 110.242 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.56 142.86 57.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.896 0.379 . . . . 70.44 110.949 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.66 -15.86 29.05 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.675 -0.693 . . . . 43.5 111.965 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.392 -0.225 . . . . 74.1 110.392 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -84.25 119.42 25.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.195 0.521 . . . . 72.32 110.485 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.9 mt -68.55 143.82 95.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 65.25 111.744 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 47.3 Cg_endo -75.29 154.21 40.99 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.451 2.1 . . . . 72.34 112.266 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.61 125.96 7.74 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.333 -0.848 . . . . 71.5 111.489 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.74 -35.0 4.83 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.972 -0.558 . . . . 71.01 112.177 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.695 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 16.8 m95 -77.19 157.27 30.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.629 0.252 . . . . 74.55 110.437 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 8.0 pt-20 -144.91 146.95 32.23 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.276 -0.42 . . . . 74.23 110.776 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 53' ' ' VAL . 25.1 p -98.86 163.37 12.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.649 -0.705 . . . . 63.35 111.442 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -166.26 152.71 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 123.663 0.785 . . . . 74.21 110.306 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 100.88 -175.25 26.2 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.33 -0.85 . . . . 72.2 113.472 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -103.03 116.14 62.93 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.784 -1.191 . . . . 72.41 107.784 172.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 32.1 Cg_endo -60.18 124.85 16.07 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.961 1.774 . . . . 72.4 111.926 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.91 173.45 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.503 . . . . 55.44 109.86 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -55.63 153.71 7.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.402 0.144 . . . . 72.34 111.144 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.51 ' HE3' HG23 ' A' ' 39' ' ' VAL . 23.7 tptm -44.05 -43.2 6.63 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.992 0.517 . . . . 75.31 111.054 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.99 -47.64 68.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.454 -0.794 . . . . 73.42 111.259 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.87 -32.07 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 72.45 110.51 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.492 ' SG ' HG11 ' A' ' 39' ' ' VAL . 7.5 t -64.08 -48.75 74.97 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.808 -0.633 . . . . 63.15 110.58 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -67.69 -34.83 77.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.882 0.372 . . . . 54.21 110.12 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.537 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.2 tt0 -58.86 -43.98 90.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.54 -0.755 . . . . 74.01 110.334 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 62.3 ttt-85 -56.94 -53.47 57.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.783 -0.644 . . . . 74.43 111.123 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.1 pt -71.04 -32.9 49.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.269 -0.423 . . . . 74.43 111.535 -174.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 33.2 mm-40 -65.65 -44.69 85.58 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.132 -0.322 . . . . 71.01 110.132 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.84 -1.9 6.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.052 0.39 . . . . 75.11 112.052 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.7 mt -103.59 -66.45 0.95 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.383 0.611 . . . . 70.13 111.222 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -85.61 -52.4 5.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 73.15 110.201 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -76.27 -11.05 59.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.757 -1.11 . . . . 55.35 111.57 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' HA ' HG22 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -43.15 -30.97 0.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.967 0.507 . . . . 73.31 111.732 -173.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 58.9 ttp -62.69 83.32 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.615 -0.72 . . . . 75.02 110.133 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.4 p -73.36 133.79 80.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.103 -0.953 . . . . 71.12 110.291 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 4.3 Cg_exo -70.97 -154.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.949 2.432 . . . . 72.13 112.613 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -20.15 15.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.292 -0.413 . . . . 73.33 111.946 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -57.52 -27.08 62.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.376 -0.375 . . . . 75.44 110.907 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.62 -36.05 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 75.13 111.068 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -68.02 -26.45 65.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.372 -0.376 . . . . 74.44 110.827 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.666 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 35.2 tt0 -67.85 -44.31 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.442 0.639 . . . . 73.11 109.395 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -71.02 -36.9 72.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.369 -0.832 . . . . 72.1 110.185 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.31 -23.69 62.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.484 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -73.15 83.11 1.32 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.022 -0.535 . . . . 64.54 109.936 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -93.26 78.3 4.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.277 0.56 . . . . 74.55 110.16 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -104.35 84.21 2.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.963 -0.562 . . . . 73.5 109.611 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m 62.87 9.46 3.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.004 -0.543 . . . . 72.41 110.776 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.8 146.11 5.43 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.297 -1.121 . . . . 74.42 110.297 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -94.75 164.05 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.874 2.383 . . . . 73.53 112.67 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.666 ' HA3' ' HG2' ' A' ' 80' ' ' GLU . . . -80.92 169.11 51.7 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.227 -0.749 . . . . 73.43 111.227 171.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -122.46 103.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.096 0.474 . . . . 62.43 111.355 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -69.79 128.67 37.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.555 . . . . 74.51 110.887 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.39 14.35 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.321 -0.622 . . . . 74.1 109.321 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.7 -58.57 3.26 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 123.954 1.835 . . . . 75.12 110.632 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 72' ' ' ASP . 7.6 p -106.57 136.09 42.6 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 109.663 -3.426 . . . . 75.41 109.408 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.594 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 5.2 mpt_? . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.55 -0.75 . . . . 75.0 109.753 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.214 -0.291 . . . . 74.33 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.78 96.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.335 0.588 . . . . 73.44 109.571 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -77.08 93.15 3.83 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.583 -0.895 . . . . 72.24 108.583 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -60.0 97.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 73.13 111.277 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -135.31 96.55 3.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.765 -0.652 . . . . 64.02 109.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -161.15 159.76 29.39 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.34 -0.391 . . . . 74.21 110.992 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -122.52 120.07 32.76 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.827 -0.434 . . . . 74.54 109.827 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -176.41 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.547 0.689 . . . . 71.44 109.848 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 87.3 mmm -104.46 148.07 26.86 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.678 -0.692 . . . . 72.24 110.261 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.55 -106.43 1.74 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.136 -0.554 . . . . 73.32 112.634 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.6 m 60.49 79.23 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.53 0.681 . . . . 64.11 111.049 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HA ' HH21 ' A' ' 65' ' ' ARG . 4.2 mm? -80.29 -63.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.853 -0.612 . . . . 73.43 110.954 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' OE2' ' HB3' ' A' ' 12' ' ' LEU . 7.2 mp0 -109.46 165.03 11.96 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.897 -0.409 . . . . 52.23 109.897 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.13 101.23 1.74 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.014 0.435 . . . . 61.0 111.16 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -90.17 167.04 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 73.03 110.173 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.2 m 75.32 -24.48 0.22 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.932 0.716 . . . . 75.54 112.932 170.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -59.03 -38.26 78.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.832 0.348 . . . . 74.11 110.489 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.93 146.78 16.15 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 116.121 -0.491 . . . . 74.42 111.977 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.37 1.97 8.39 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.041 2.494 . . . . 73.41 112.577 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.9 146.53 16.31 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.097 -0.501 . . . . 44.34 112.183 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.446 ' HB3' HG21 ' A' ' 58' ' ' THR . 34.6 t -165.54 59.34 0.11 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.314 0.578 . . . . 65.31 109.809 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -77.24 68.94 3.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.882 0.849 . . . . 73.35 110.453 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -110.69 0.17 17.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.865 -1.061 . . . . 74.42 110.056 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -161.48 175.52 12.06 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.949 -0.569 . . . . 70.42 109.507 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -68.25 178.8 1.78 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.094 0.473 . . . . 71.11 111.597 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 HD22 ' HB2' ' A' ' 56' ' ' PRO . 7.4 mp -85.06 148.75 26.0 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.226 0.536 . . . . 63.11 111.244 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 6.8 m-85 -127.83 162.12 27.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.309 -0.86 . . . . 73.33 110.637 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 m-85 -126.85 167.78 15.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.737 -0.665 . . . . 74.33 109.42 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.41 135.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 71.3 107.289 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG12 HG21 ' A' ' 52' ' ' THR . 33.4 m -139.94 169.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.867 0.303 . . . . 74.31 111.127 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -167.84 170.02 11.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.143 -0.481 . . . . 74.21 111.305 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.1 OUTLIER -161.65 140.03 9.39 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.113 -0.494 . . . . 44.45 110.862 171.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 46.07 8.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.055 1.131 . . . . 73.12 114.055 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.7 pt-20 -112.33 -32.09 6.62 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.786 -0.571 . . . . 70.25 112.073 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 -22.64 6.52 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 112.065 -0.414 . . . . 21.2 112.065 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -81.85 173.85 11.86 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.826 0.45 . . . . 74.31 109.961 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.552 ' HD2' ' HE1' ' A' ' 70' ' ' TRP . 14.7 m-85 -118.27 141.96 47.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 73.1 111.938 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -132.74 -179.35 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.79 -1.096 . . . . 73.51 109.246 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.35 160.35 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.704 0.287 . . . . 71.43 110.578 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 63.0 t-105 -148.13 151.25 35.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 74.31 109.9 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -91.37 129.28 37.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.289 -0.263 . . . . 73.3 110.289 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.38 150.87 25.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 70.44 110.609 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.26 16.47 Favored Glycine 0 N--CA 1.453 -0.177 0 N-CA-C 111.539 -0.624 . . . . 43.5 111.539 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 44' ' ' ARG . 53.4 mtt-85 -88.19 110.11 20.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 110.416 -0.216 . . . . 74.1 110.416 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -71.33 130.01 40.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.067 0.461 . . . . 72.32 109.961 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD11 HG23 ' A' ' 52' ' ' THR . 40.4 mt -76.05 142.82 72.91 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.337 -0.847 . . . . 65.25 111.396 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 67.3 Cg_endo -75.82 156.25 39.35 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.579 2.186 . . . . 72.34 111.711 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.59 122.41 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.698 -0.683 . . . . 71.5 111.49 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.9 -32.21 5.75 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.061 -0.518 . . . . 71.01 112.434 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.468 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 31.2 m95 -80.19 146.25 31.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.851 0.325 . . . . 74.55 110.697 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.58 155.71 49.15 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.524 -0.307 . . . . 74.23 110.729 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.556 HG23 HD11 ' A' ' 46' ' ' LEU . 17.4 p -112.57 162.18 15.95 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.543 1.152 . . . . 63.35 111.483 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.55 HG21 ' CE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -166.02 145.02 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.054 0.542 . . . . 74.21 111.009 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.13 -165.61 18.59 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.559 -0.746 . . . . 72.2 112.248 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -104.73 145.02 29.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.148 -0.686 . . . . 72.41 109.148 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.61 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.5 Cg_endo -67.3 105.31 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.051 1.167 . . . . 72.4 110.136 173.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.61 165.19 31.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.095 -0.957 . . . . 55.44 110.977 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 21' ' ' SER . 9.7 t -62.02 166.95 4.2 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.394 0.616 . . . . 72.34 112.487 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.625 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 58.9 tptt -46.34 -50.02 16.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.966 -1.016 . . . . 75.31 111.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.76 -39.24 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.951 -0.568 . . . . 73.42 111.303 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -73.7 -44.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 72.45 111.166 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 27.4 p -64.12 -45.15 89.85 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.002 -0.279 . . . . 63.15 111.25 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -68.15 -41.21 81.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 54.21 110.454 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.616 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.6 tt0 -63.2 -36.46 83.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 74.01 110.376 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 ttt180 -58.7 -53.73 55.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.878 0.37 . . . . 74.43 110.905 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.9 pt -72.78 -32.66 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 74.43 111.213 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 37.6 mm-40 -61.23 -44.62 96.97 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.193 -0.299 . . . . 71.01 110.193 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.8 mm-40 -73.09 0.93 10.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.93 0.395 . . . . 75.11 111.132 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 80.1 mt -103.62 -66.13 0.97 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 70.13 111.258 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.552 ' HE1' ' HD2' ' A' ' 37' ' ' TYR . 73.0 m95 -85.68 -45.69 11.44 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.979 -0.555 . . . . 73.15 111.027 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 m -81.71 -11.19 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.834 . . . . 55.35 110.901 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -43.26 -36.98 1.99 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.993 -0.548 . . . . 73.31 111.565 -172.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.9 tpt -59.52 89.44 0.01 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 75.02 109.95 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 p -91.55 127.78 49.18 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.68 -0.691 . . . . 71.12 110.356 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.8 -158.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.814 2.343 . . . . 72.13 112.081 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.05 -18.92 10.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.895 0.378 . . . . 73.33 111.268 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.6 p -61.76 -14.38 31.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.891 -0.595 . . . . 75.44 111.305 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 11.6 p -55.88 -37.26 47.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-O 121.062 0.458 . . . . 75.13 110.451 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -74.04 -49.37 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 74.44 110.582 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.16 -45.45 84.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.804 -0.634 . . . . 73.11 110.666 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -74.45 -14.1 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.293 -0.867 . . . . 72.1 111.306 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 14.8 tp -91.52 -72.55 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.844 0.354 . . . . 73.43 110.793 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.21 76.85 8.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.458 0.646 . . . . 64.54 110.123 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -56.74 -65.4 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.278 -0.874 . . . . 74.55 110.34 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.9 t60 76.2 -37.15 0.29 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.71 0.804 . . . . 73.5 111.655 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 p -71.66 -54.27 10.89 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.861 0.362 . . . . 72.41 110.762 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.74 -66.03 0.42 Allowed Glycine 0 C--O 1.235 0.199 0 C-N-CA 121.266 -0.492 . . . . 74.42 112.195 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 156.1 56.23 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.618 2.212 . . . . 73.53 112.505 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 93.34 0.11 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.812 -0.631 . . . . 73.43 112.7 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.7 pt -93.78 134.11 32.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.889 0.376 . . . . 62.43 110.903 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.65 152.1 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 74.51 111.87 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.34 162.95 27.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.237 0.541 . . . . 74.1 111.452 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.71 -157.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.106 -0.952 . . . . 75.12 108.916 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.15 135.53 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.23 0.332 . . . . 75.41 110.829 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.581 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 8.0 mpt_? . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.531 -0.747 . . . . 75.0 110.244 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 121.21 0.529 . . . . 74.33 110.167 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.93 113.31 0.14 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.762 -0.654 . . . . 73.44 110.927 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -119.79 136.65 54.37 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.649 -0.5 . . . . 72.24 109.649 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -131.13 92.51 3.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.899 0.381 . . . . 73.13 111.429 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -129.18 102.65 6.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 64.02 110.189 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.492 ' HB3' ' HE2' ' A' ' 73' ' ' MET . 38.8 p-80 -165.97 150.51 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 74.21 109.799 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.643 ' HB3' ' HD1' ' A' ' 70' ' ' TRP . 21.8 p80 -166.09 129.59 2.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.846 0.355 . . . . 74.54 111.763 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -105.92 123.13 47.48 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.645 -0.872 . . . . 71.44 108.645 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 9' ' ' MET . 3.5 mpp? -90.81 110.42 21.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 72.24 111.631 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.55 150.01 18.34 Favored Glycine 0 C--O 1.237 0.326 0 N-CA-C 110.663 -0.975 . . . . 73.32 110.663 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -117.7 -78.78 0.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.202 0.501 . . . . 64.11 111.276 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.2 mt -112.1 106.24 14.82 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.339 -0.615 . . . . 73.43 109.339 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 173.65 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 52.23 110.842 -170.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.02 113.08 25.25 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.952 -0.567 . . . . 61.0 109.556 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 22.1 mt-30 -54.07 102.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.404 0.44 . . . . 73.03 111.623 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -65.99 -40.23 91.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.452 -0.573 . . . . 75.54 109.452 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -148.24 -167.38 2.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.353 -0.84 . . . . 74.11 108.789 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.21 -101.62 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.322 -0.711 . . . . 74.42 111.322 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.32 -163.74 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.726 2.284 . . . . 73.41 111.698 175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.64 146.76 5.31 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.104 -0.569 . . . . 44.34 111.926 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 22' ' ' MET . 17.4 t -74.72 121.0 21.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.526 -0.546 . . . . 65.31 109.526 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 21' ' ' SER . 61.8 mtt 72.84 11.02 5.4 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.798 -0.637 . . . . 73.35 110.997 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -94.33 -170.56 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.166 -1.42 . . . . 74.42 107.166 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 5.1 t70 -84.91 170.88 12.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.115 0.416 . . . . 70.42 110.489 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 58' ' ' THR . 8.3 mm-40 -77.72 171.84 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.903 -0.406 . . . . 71.11 109.903 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.44 138.43 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.918 0.866 . . . . 63.11 111.358 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.37 161.54 33.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.914 -1.494 . . . . 73.33 108.738 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.662 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -130.0 160.08 34.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.08 -0.964 . . . . 74.33 108.621 172.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 53' ' ' VAL . 55.8 t -90.32 120.89 39.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 107.564 -1.272 . . . . 71.3 107.564 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.76 160.51 32.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.192 0.52 . . . . 74.31 111.973 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 36' ' ' GLN . 17.2 ptt85 -169.53 170.16 8.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.777 -1.101 . . . . 74.21 110.216 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -145.03 139.49 27.48 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.516 -0.473 . . . . 44.45 110.505 169.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.0 t30 30.95 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.208 1.559 . . . . 73.12 115.208 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.0 pt-20 -112.49 -32.06 6.6 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.471 -0.768 . . . . 70.25 112.536 -172.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.94 -22.48 8.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.156 -0.545 . . . . 21.2 112.641 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.433 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 33.8 tt0 -80.01 158.65 26.48 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.952 -0.758 . . . . 74.31 108.952 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.05 140.61 46.58 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.771 0.656 . . . . 73.1 112.771 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m -134.1 -179.23 5.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.031 -0.986 . . . . 73.51 109.351 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.64 158.34 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.621 0.248 . . . . 71.43 110.694 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CE2' ' HG ' ' A' ' 46' ' ' LEU . 75.0 t90 -155.14 145.41 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.212 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.1 ttt -81.49 125.53 30.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.746 0.308 . . . . 73.3 111.279 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.06 142.12 47.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.027 -0.533 . . . . 70.44 110.494 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.47 -5.52 29.81 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 111.582 -0.607 . . . . 43.5 111.582 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -108.12 166.29 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.147 0.579 . . . . 74.1 109.45 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -97.19 115.07 26.91 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.116 -0.365 . . . . 72.32 110.565 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 mt -69.68 138.76 88.4 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 65.25 110.745 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 19.2 Cg_endo -65.61 137.1 48.84 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 122.244 1.963 . . . . 72.34 111.75 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.11 124.9 4.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.47 -0.786 . . . . 71.5 111.509 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -34.12 4.92 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.773 -0.649 . . . . 71.01 111.772 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.1 m95 -77.6 139.81 39.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.716 0.293 . . . . 74.55 110.723 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 13.0 pt-20 -126.7 156.22 41.44 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 116.314 -0.403 . . . . 74.23 110.59 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.2 p -104.39 153.19 21.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.555 -1.202 . . . . 63.35 111.085 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.37 161.73 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 123.419 0.688 . . . . 74.21 109.985 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 -159.4 24.51 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.399 -0.819 . . . . 72.2 111.96 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.723 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -109.9 137.48 20.48 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 109.269 -0.641 . . . . 72.41 109.269 176.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.662 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 57.0 Cg_endo -68.79 116.48 4.47 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.406 1.404 . . . . 72.4 110.431 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -162.47 169.39 20.46 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.15 -0.477 . . . . 55.44 110.251 -169.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 24' ' ' ASP . 43.3 p -55.74 151.9 10.42 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.916 0.135 . . . . 72.34 111.035 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.13 -41.66 3.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.287 0.565 . . . . 75.31 110.147 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -56.66 -52.32 65.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.664 -1.153 . . . . 73.42 111.492 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 10.3 mm-40 -71.32 -41.8 69.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 72.45 110.754 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 57' ' ' ALA . 72.8 m -60.59 -45.95 92.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.395 -0.366 . . . . 63.15 111.167 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD12 ' HG3' ' A' ' 95' ' ' ARG . 3.8 pp -68.09 -36.41 79.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.42 -0.585 . . . . 54.21 109.42 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -58.18 -31.58 67.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.428 -0.806 . . . . 74.01 110.318 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 34.1 ttt180 -65.83 -53.26 42.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.786 -0.643 . . . . 74.43 110.898 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 pt -73.35 -32.35 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 74.43 112.46 -171.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 95' ' ' ARG . 12.4 pt-20 -58.47 -32.69 69.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.042 0.448 . . . . 71.01 109.925 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 79.3 mm-40 -87.7 -9.38 54.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.875 -0.602 . . . . 75.11 111.379 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -103.74 -65.69 1.0 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.708 0.766 . . . . 70.13 111.619 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.643 ' HD1' ' HB3' ' A' ' 7' ' ' HIS . 29.1 t90 -85.39 -43.21 13.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.07 -0.968 . . . . 73.15 110.78 -175.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.13 -10.83 51.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.82 -0.627 . . . . 55.35 112.268 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 4.9 p-10 -40.74 -43.15 1.92 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.321 1.6 . . . . 73.31 115.321 -163.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.492 ' HE2' ' HB3' ' A' ' 6' ' ' HIS . 21.0 mtm -66.5 85.81 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.822 0.737 . . . . 75.02 110.582 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.98 142.06 72.19 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.49 -1.232 . . . . 71.12 111.015 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.67 -162.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.874 2.383 . . . . 72.13 111.923 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.18 -17.68 12.18 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.233 -0.439 . . . . 73.33 111.637 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.7 p -58.06 -17.23 16.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.096 -0.502 . . . . 75.44 111.412 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.5 p -58.82 -44.02 89.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.45 -0.341 . . . . 75.13 110.665 175.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -69.05 -28.37 66.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.304 -0.407 . . . . 74.44 110.122 -177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.05 -37.26 76.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 73.11 110.906 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -97.18 -5.59 36.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.632 -0.258 . . . . 72.1 111.665 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 36.7 mt -63.04 -18.57 63.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.634 0.254 . . . . 73.43 111.218 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.82 -44.58 96.57 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.913 0.387 . . . . 64.54 110.032 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -76.4 86.06 3.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 74.55 110.279 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -143.38 16.82 1.87 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.929 -0.578 . . . . 73.5 110.306 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 m -97.48 14.62 25.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.821 -0.627 . . . . 72.41 111.16 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 131.48 -72.47 0.48 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.523 -0.631 . . . . 74.42 111.523 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.04 52.77 3.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.89 2.393 . . . . 73.53 111.808 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.2 16.24 32.61 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.867 -0.606 . . . . 73.43 111.637 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.97 81.2 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 122.057 0.932 . . . . 62.43 110.639 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.1 160.19 32.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.502 -1.226 . . . . 74.51 109.605 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -76.54 177.5 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 74.1 110.658 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.93 -149.93 0.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 75.12 110.175 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.86 107.32 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.377 0.608 . . . . 75.41 111.221 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.619 ' HD3' ' H ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.319 -0.848 . . . . 75.0 108.743 171.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.522 0.201 . . . . 74.33 110.521 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.52 38.52 25.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.151 -0.477 . . . . 73.44 111.705 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -133.07 127.84 34.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.196 0.522 . . . . 72.24 110.971 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -140.54 115.36 9.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.615 -0.883 . . . . 73.13 108.615 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -84.68 -87.98 0.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.353 -0.24 . . . . 64.02 110.353 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -153.84 -175.65 5.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.384 -0.599 . . . . 74.21 109.384 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.93 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.738 -0.838 . . . . 74.54 108.738 171.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -101.61 154.18 19.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.118 -0.492 . . . . 71.44 110.646 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.4 ptp -150.83 150.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 72.24 109.733 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.65 7.64 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 123.428 0.455 . . . . 73.32 112.625 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.3 p -58.12 111.66 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 64.11 110.565 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.84 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 73.43 111.464 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -98.73 83.42 2.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.102 0.477 . . . . 52.23 111.236 -177.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.63 110.96 1.88 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.217 -0.66 . . . . 61.0 109.217 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 65.0 95.77 0.05 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 123.875 0.734 . . . . 73.03 109.738 -170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -83.93 91.25 7.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.866 0.841 . . . . 75.54 110.674 -175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.82 18.48 1.98 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.361 -0.836 . . . . 74.11 110.419 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.13 162.05 53.49 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 74.42 111.323 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 80.6 Cg_exo -46.87 112.0 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.792 2.328 . . . . 73.41 112.509 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.57 154.8 26.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 44.34 111.594 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 m -155.78 144.29 20.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.419 -0.215 . . . . 65.31 110.419 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 58.6 mtt -85.33 101.31 12.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.773 -0.454 . . . . 73.35 109.773 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -160.29 105.99 1.52 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.219 0.533 . . . . 74.42 111.484 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 44.37 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.336 -1.302 . . . . 70.42 113.568 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -84.23 140.39 31.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.777 0.322 . . . . 71.11 111.862 -171.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 56' ' ' PRO . 7.6 mp -119.04 138.42 52.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.308 -0.405 . . . . 63.11 110.289 176.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.06 158.15 39.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.505 0.722 . . . . 73.33 110.367 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.649 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 22.0 m-85 -113.03 169.54 8.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 74.33 109.118 166.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.563 HG12 HG21 ' A' ' 66' ' ' ILE . 56.5 t -95.01 125.22 47.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.825 -1.176 . . . . 71.3 107.825 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 46' ' ' LEU . 27.4 m -125.95 160.86 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.258 0.551 . . . . 74.31 111.95 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 11.8 ptt180 -169.16 170.13 8.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.62 -1.173 . . . . 74.21 110.083 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.608 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -145.83 139.59 26.48 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 44.45 110.834 164.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 33.06 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.745 1.757 . . . . 73.12 115.745 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.9 pt-20 -112.59 -29.36 7.49 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.583 0.628 . . . . 70.25 111.917 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 -10.52 48.81 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.152 -0.547 . . . . 21.2 112.634 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.512 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 69.3 mt-30 -84.78 173.03 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.039 -0.726 . . . . 74.31 109.039 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.31 132.66 48.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.957 0.725 . . . . 73.1 112.957 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -131.69 -178.9 5.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.791 -1.095 . . . . 73.51 108.475 172.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 62' ' ' CYS . 23.7 m -124.17 149.53 28.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.204 0.526 . . . . 71.43 111.322 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.4 ' HB3' HG12 ' A' ' 30' ' ' VAL . 55.8 t-105 -148.83 143.4 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.755 . . . . 74.31 109.28 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -74.85 141.37 44.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.893 0.377 . . . . 73.3 111.311 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.55 147.04 44.31 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.828 -0.624 . . . . 70.44 110.374 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.79 4.83 67.05 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.392 -0.433 . . . . 43.5 112.304 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -121.81 112.35 18.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.88 -0.415 . . . . 74.1 109.88 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.9 m -57.98 123.0 14.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.583 -0.735 . . . . 72.32 111.469 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 15.9 mt -79.99 139.76 53.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.308 -0.86 . . . . 65.25 110.836 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.33 140.06 53.45 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.691 2.261 . . . . 72.34 111.632 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.82 126.19 15.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.96 -0.564 . . . . 71.5 110.384 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -29.54 7.06 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.11 -0.495 . . . . 71.01 112.295 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.6 m95 -75.5 155.05 36.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.028 0.414 . . . . 74.55 110.607 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.8 pt-20 -135.67 148.97 49.13 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 110.043 -0.355 . . . . 74.23 110.043 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p -109.19 153.01 24.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.431 -0.804 . . . . 63.35 110.983 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.2 t -149.98 152.9 11.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 122.842 0.457 . . . . 74.21 110.476 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.73 -170.12 37.9 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.797 -0.638 . . . . 72.2 113.198 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 1.4 pm0 -108.43 143.71 28.03 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 109.102 -0.703 . . . . 72.41 109.102 173.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.649 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 36.8 Cg_endo -63.1 122.14 10.26 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.161 1.907 . . . . 72.4 112.678 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 157.35 42.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.453 -0.794 . . . . 55.44 109.604 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 t -56.32 156.7 5.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.61 0.243 . . . . 72.34 111.085 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -43.26 -50.18 6.56 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.663 -0.699 . . . . 75.31 111.635 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.39 -49.46 76.14 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.42 111.412 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -70.16 -35.1 73.77 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.093 0.473 . . . . 72.45 110.461 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 39' ' ' VAL . 18.2 t -62.09 -51.71 66.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 63.15 110.048 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.36 -33.43 74.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.016 -0.273 . . . . 54.21 110.347 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 8.6 tt0 -62.45 -31.93 72.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.531 0.681 . . . . 74.01 110.635 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' HA ' ' HG2' ' A' ' 19' ' ' PRO . 35.9 ttm180 -62.35 -53.1 59.92 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.035 -0.529 . . . . 74.43 112.091 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.563 HG21 HG12 ' A' ' 29' ' ' VAL . 17.8 pt -72.96 -35.11 47.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.363 -0.38 . . . . 74.43 111.737 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 4.2 pt-20 -57.78 -46.21 84.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.606 -0.438 . . . . 71.01 109.839 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.594 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 86.0 mt-30 -74.15 -0.41 16.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.388 -0.369 . . . . 75.11 111.633 -173.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.8 mt -103.37 -68.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.552 -0.459 . . . . 70.13 112.139 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -87.34 -55.08 3.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.621 -0.718 . . . . 73.15 111.976 -176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 67' ' ' GLU . 2.9 p -81.81 -10.89 59.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.708 -1.133 . . . . 55.35 111.752 -171.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.1 t70 -41.85 -28.33 0.15 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.948 0.899 . . . . 73.31 113.043 -172.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 22.4 mmt -68.33 73.16 0.21 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.197 -0.668 . . . . 75.02 109.197 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 3.9 p -84.38 137.4 39.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.217 -0.901 . . . . 71.12 111.077 -175.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 11.4 Cg_exo -70.91 -157.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.024 2.482 . . . . 72.13 112.049 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.65 -16.47 10.72 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.866 0.365 . . . . 73.33 111.468 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.9 m -50.1 -33.17 17.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.717 -0.674 . . . . 75.44 111.583 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.15 -35.61 72.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.131 0.491 . . . . 75.13 110.623 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 79' ' ' ARG . 40.9 mmm-85 -73.62 -42.98 60.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.654 -0.703 . . . . 74.44 110.108 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.82 -28.7 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.327 -0.851 . . . . 73.11 111.116 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -63.38 -21.76 66.48 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.267 -0.424 . . . . 72.1 111.116 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.1 tp -95.15 9.17 40.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.165 0.507 . . . . 73.43 110.571 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.4 83.38 2.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.918 -0.771 . . . . 64.54 108.918 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 2.8 mp0 -69.03 78.82 0.33 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.675 0.62 . . . . 74.55 112.675 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' GLN . 5.3 p80 177.28 135.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.277 -0.638 . . . . 73.5 109.277 168.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 87.0 0.28 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.242 0.544 . . . . 72.41 110.663 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -92.64 147.16 18.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.687 -0.688 . . . . 74.42 111.583 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.44 106.51 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.937 2.425 . . . . 73.53 112.192 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.38 -56.19 0.43 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.689 -0.964 . . . . 73.43 110.689 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt 48.04 83.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.416 0.686 . . . . 62.43 112.156 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -133.25 125.37 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.557 -0.905 . . . . 74.51 108.557 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -136.59 -171.19 2.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 111.819 0.303 . . . . 74.1 111.819 -172.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.58 169.84 0.63 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.819 0.674 . . . . 75.12 112.819 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.9 p -107.49 152.08 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.846 . . . . 75.41 110.436 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.435 -0.793 . . . . 75.0 110.015 176.315 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.15 -0.315 . . . . 74.33 110.15 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.06 64.59 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.198 0.523 . . . . 73.44 110.508 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -84.14 102.26 12.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.786 -0.643 . . . . 72.24 109.663 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -117.82 106.02 12.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.287 0.565 . . . . 73.13 111.268 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -106.26 3.46 27.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.551 0.691 . . . . 64.02 109.427 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -94.42 107.14 19.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.35 -0.841 . . . . 74.21 109.751 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -151.0 90.72 1.63 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 74.54 111.103 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -98.53 163.5 12.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.325 -0.62 . . . . 71.44 109.325 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 40.9 tpp -140.52 -79.03 0.29 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.411 -0.218 . . . . 72.24 110.411 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.29 -176.21 47.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.037 -0.601 . . . . 73.32 112.824 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -145.77 -73.52 0.23 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.063 0.459 . . . . 64.11 110.092 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.97 -167.04 1.38 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.109 -0.496 . . . . 73.43 110.133 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -178.24 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.993 0.425 . . . . 52.23 111.357 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -59.7 1.91 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.772 -0.825 . . . . 61.0 108.772 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -152.17 114.46 4.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.123 -0.944 . . . . 73.03 109.029 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -82.46 83.44 7.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.333 0.587 . . . . 75.54 110.294 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.16 130.78 45.29 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.428 -0.805 . . . . 74.11 111.066 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.92 -166.43 26.97 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.803 -0.919 . . . . 74.42 110.803 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HB2' HE22 ' A' ' 60' ' ' GLN . 24.6 Cg_exo -62.86 99.49 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.16 1.907 . . . . 73.41 111.15 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.68 82.76 0.03 OUTLIER Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.88 -0.6 . . . . 44.34 113.301 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.632 ' HB2' HG23 ' A' ' 58' ' ' THR . 20.0 m -91.32 54.03 2.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.058 0.456 . . . . 65.31 110.661 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.2 mpt? -76.94 70.82 3.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.13 0.491 . . . . 73.35 110.705 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -113.27 -49.63 2.9 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.725 0.774 . . . . 74.42 109.948 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.52 179.46 5.0 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 114.608 -1.178 . . . . 70.42 111.009 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -67.06 150.93 48.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 71.11 111.061 -174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.0 mp -69.17 151.56 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 63.11 110.97 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 33.8 m-85 -123.66 149.06 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.49 -0.777 . . . . 73.33 109.741 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -114.86 155.97 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 74.33 108.921 169.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.72 114.83 24.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 N-CA-C 107.86 -1.163 . . . . 71.3 107.86 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 52' ' ' THR . 12.7 m -125.14 159.62 31.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 122.164 -0.335 . . . . 74.31 110.561 -170.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -162.0 162.11 28.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.351 -0.84 . . . . 74.21 110.722 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 p30 -152.05 139.69 19.75 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.269 -0.271 . . . . 44.45 110.269 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t30 46.63 4.63 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.993 1.109 . . . . 73.12 113.993 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.19 -32.43 6.54 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.656 -0.653 . . . . 70.25 112.095 -169.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.51 -22.68 3.16 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.352 -0.452 . . . . 21.2 112.617 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -75.51 173.96 10.29 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.727 -0.471 . . . . 74.31 109.727 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.49 136.01 53.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 73.1 112.172 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -135.86 -178.74 5.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.066 -0.97 . . . . 73.51 109.456 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.467 HG11 ' SG ' ' A' ' 62' ' ' CYS . 27.7 m -128.72 150.02 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.68 0.276 . . . . 71.43 111.069 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.41 ' HB2' HG21 ' A' ' 30' ' ' VAL . 52.2 t-105 -149.45 141.48 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.851 -0.613 . . . . 74.31 109.736 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.6 mtt -65.45 134.24 53.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.1 0.476 . . . . 73.3 111.408 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.23 147.82 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.764 -0.653 . . . . 70.44 110.451 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.72 62.53 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.188 -0.765 . . . . 43.5 111.188 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -93.91 96.48 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.731 -0.84 . . . . 74.1 108.731 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -55.57 116.52 2.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.596 -0.729 . . . . 72.32 112.113 -169.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.435 HD13 HG13 ' A' ' 30' ' ' VAL . 42.6 mt -74.4 139.64 75.22 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.729 -1.123 . . . . 65.25 110.055 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.22 160.48 20.31 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.636 2.224 . . . . 72.34 112.478 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.3 129.92 18.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.549 -0.75 . . . . 71.5 110.53 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.54 -33.29 5.31 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.35 -0.7 . . . . 71.01 111.35 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 43.2 m95 -88.72 148.08 24.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.508 0.194 . . . . 74.55 110.519 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 149.37 52.13 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 110.262 -0.273 . . . . 74.23 110.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 30' ' ' VAL . 34.8 p -111.53 148.3 33.5 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.376 1.048 . . . . 63.35 111.057 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -154.05 156.4 5.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.573 0.749 . . . . 74.21 109.878 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.446 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.43 -158.58 23.7 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.406 -0.426 . . . . 72.2 113.483 169.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.89 131.68 21.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.611 . . . . 72.41 109.349 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' HB2' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -70.08 109.08 2.28 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 121.623 1.549 . . . . 72.4 111.255 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.07 171.09 20.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.236 -0.893 . . . . 55.44 110.442 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.632 HG23 ' HB2' ' A' ' 21' ' ' SER . 9.9 t -58.28 166.19 1.75 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.254 0.55 . . . . 72.34 112.437 -175.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.668 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 32.1 tptt -49.82 -49.77 47.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.055 -0.975 . . . . 75.31 110.669 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.609 HE22 ' HB2' ' A' ' 19' ' ' PRO . 28.0 tt0 -54.42 -43.04 71.2 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.087 -0.96 . . . . 73.42 111.342 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -70.04 -48.45 57.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 72.45 110.746 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 9.1 p -62.93 -42.4 99.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.075 -0.511 . . . . 63.15 111.515 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -67.93 -40.82 83.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.492 -0.483 . . . . 54.21 110.093 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.6 tt0 -60.19 -31.43 70.13 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.789 -0.641 . . . . 74.01 110.454 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 75.5 ttt-85 -73.86 -53.3 10.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.844 -0.616 . . . . 74.43 110.627 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 63' ' ' LEU . 39.3 pt -66.23 -32.8 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 112.228 0.455 . . . . 74.43 112.228 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.42 -32.85 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.606 0.241 . . . . 71.01 110.353 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 91.2 mt-30 -87.53 -1.63 58.07 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.073 -0.512 . . . . 75.11 111.349 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 85.9 mt -104.0 -66.72 0.94 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.272 0.558 . . . . 70.13 111.656 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -86.09 -55.14 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.391 -0.822 . . . . 73.15 111.163 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.506 HG23 HG12 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -78.8 -10.99 59.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.205 -0.907 . . . . 55.35 111.311 -174.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.439 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.4 t70 -41.76 -32.78 0.42 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.693 0.797 . . . . 73.31 112.981 -171.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.6 ttp -66.17 77.77 0.09 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.569 0.7 . . . . 75.02 110.207 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -85.3 132.07 46.26 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.028 -0.987 . . . . 71.12 110.456 -178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 Cg_exo -68.34 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.878 2.385 . . . . 72.13 112.518 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.95 -17.84 4.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.771 -0.65 . . . . 73.33 111.445 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m -50.96 -29.42 12.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.926 -0.579 . . . . 75.44 111.327 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.59 -35.88 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.452 -0.34 . . . . 75.13 110.868 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -55.03 -28.29 51.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.089 -0.505 . . . . 74.44 111.822 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.94 -39.63 83.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.01 0.433 . . . . 73.11 110.707 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.559 ' HE1' ' HA ' ' A' ' 91' ' ' ASP . 49.9 t-80 -94.69 -19.88 20.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 72.1 110.532 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.48 80.83 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.27 0.557 . . . . 73.43 109.889 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -85.93 139.38 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.362 -0.977 . . . . 64.54 108.362 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.83 101.55 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.808 -0.441 . . . . 74.55 109.808 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -124.31 112.35 16.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.265 0.555 . . . . 73.5 110.906 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.1 t -96.05 82.04 3.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.767 -0.651 . . . . 72.41 109.828 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.0 -176.61 22.44 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.721 -0.672 . . . . 74.42 111.793 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.07 148.05 93.92 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.939 2.426 . . . . 73.53 112.317 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.96 156.6 22.92 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.313 -0.715 . . . . 73.43 111.313 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.0 pt -72.8 89.61 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.614 0.721 . . . . 62.43 111.144 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.559 ' HA ' ' HE1' ' A' ' 81' ' ' HIS . 2.6 t0 -121.53 147.94 45.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.159 -0.928 . . . . 74.51 108.809 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -142.45 -175.72 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 74.1 110.977 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.4 -149.77 0.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.753 . . . . 75.12 109.395 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 71' ' ' THR . 3.1 p -115.21 93.83 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.524 0.678 . . . . 75.41 111.663 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 N-CA-C 107.93 -1.137 . . . . 75.0 107.93 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.36 -0.237 . . . . 74.33 110.36 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.51 176.96 7.75 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.715 -0.221 . . . . 73.44 110.473 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m170 56.0 50.22 14.24 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.694 0.621 . . . . 72.24 111.957 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -74.84 83.62 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.045 0.45 . . . . 73.13 110.648 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 12.6 p-80 -63.58 107.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.63 -0.714 . . . . 64.02 109.543 172.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 84.5 m-70 68.53 167.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.14 -0.482 . . . . 74.21 110.021 -168.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -71.02 -68.64 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.543 -0.299 . . . . 74.54 110.629 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -159.37 174.02 15.36 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.155 -0.683 . . . . 71.44 109.155 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.2 ptp -92.92 -41.6 9.95 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.985 -0.376 . . . . 72.24 109.985 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.06 113.46 0.52 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.242 -0.504 . . . . 73.32 113.224 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.551 HG21 ' H ' ' A' ' 12' ' ' LEU . 20.1 m -154.76 177.85 10.79 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.109 -1.071 . . . . 64.11 108.109 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.551 ' H ' HG21 ' A' ' 11' ' ' THR . 36.8 tp -153.33 -73.54 0.13 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.429 0.559 . . . . 73.43 110.867 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.432 ' HA ' HH11 ' A' ' 65' ' ' ARG . 4.6 mp0 -90.94 91.87 8.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.735 0.302 . . . . 52.23 110.384 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -157.48 102.94 1.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 61.0 109.843 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -62.81 -41.5 99.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.962 0.41 . . . . 73.03 110.897 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 54.93 26.44 7.91 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.316 -0.856 . . . . 75.54 110.051 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 21' ' ' SER . 55.8 tp60 -66.61 -44.17 82.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.021 -0.99 . . . . 74.11 110.469 -175.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.58 -125.87 7.51 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.493 -0.776 . . . . 74.42 111.209 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.25 140.75 15.72 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.991 2.46 . . . . 73.41 111.66 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.89 78.74 0.77 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 121.324 -0.465 . . . . 44.34 112.572 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 17' ' ' GLN . 27.1 m -74.81 114.23 13.02 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.071 -0.344 . . . . 65.31 110.071 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.3 tpt -74.34 109.02 7.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 73.35 110.546 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -96.81 113.35 24.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.893 -0.594 . . . . 74.42 110.195 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB3' ' HG1' ' A' ' 58' ' ' THR . 12.6 t70 -156.31 -178.82 7.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.76 -0.83 . . . . 70.42 108.76 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HB3' ' HE3' ' A' ' 41' ' ' MET . 23.4 mm-40 -56.32 135.34 53.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.713 0.292 . . . . 71.11 110.492 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 56' ' ' PRO . 6.4 mp -85.14 143.47 28.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.413 0.625 . . . . 63.11 112.34 -172.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.599 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 6.3 m-85 -124.65 149.3 47.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.659 -1.155 . . . . 73.33 109.001 174.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.574 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -108.17 169.75 8.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.698 -0.482 . . . . 74.33 109.698 172.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 53' ' ' VAL . 51.0 t -99.0 137.53 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.412 -1.329 . . . . 71.3 107.412 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.62 161.91 29.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 118.405 0.548 . . . . 74.31 111.878 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -169.06 170.19 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.961 -1.018 . . . . 74.21 110.436 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.726 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 4.8 p30 -165.73 139.81 4.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.438 -0.208 . . . . 44.45 110.438 166.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.75 8.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.274 1.213 . . . . 73.12 114.274 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.8 pt-20 -112.08 -29.84 7.45 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.798 -0.564 . . . . 70.25 112.05 -169.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.66 -22.92 7.04 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.244 -0.503 . . . . 21.2 113.011 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.12 173.87 8.58 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.964 -0.384 . . . . 74.31 109.964 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -116.69 150.73 37.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.326 0.491 . . . . 73.1 112.326 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -144.47 -178.95 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.867 . . . . 73.51 109.453 168.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.55 165.41 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.784 0.326 . . . . 71.43 110.858 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 35.0 t90 -151.72 132.2 13.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 74.31 110.692 -170.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.506 ' HE3' ' HB3' ' A' ' 25' ' ' GLU . 15.8 tpt -68.06 127.32 32.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.051 -0.522 . . . . 73.3 110.136 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.93 159.58 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 70.44 109.606 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.42 21.04 25.58 Favored Glycine 0 C--N 1.329 0.166 0 C-N-CA 121.022 -0.608 . . . . 43.5 112.004 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.8 ptm180 -148.28 179.11 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.654 -0.499 . . . . 74.1 109.654 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 m -109.47 154.0 23.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.559 -0.534 . . . . 72.32 109.559 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 11.2 tp -104.22 129.19 25.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 65.25 110.193 -174.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.508 ' HD2' HD13 ' A' ' 46' ' ' LEU . 83.9 Cg_exo -40.42 132.82 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.522 2.814 . . . . 72.34 113.217 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 128.29 20.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.728 -0.669 . . . . 71.5 111.192 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.86 -34.22 5.09 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.875 -0.89 . . . . 71.01 110.875 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.726 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 45.6 m95 -76.69 157.64 31.62 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 110.167 -0.308 . . . . 74.55 110.167 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.63 152.99 48.58 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 116.314 -0.403 . . . . 74.23 110.111 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -105.67 154.52 20.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.738 -1.119 . . . . 63.35 110.528 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -163.05 161.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.225 0 C-N-CA 123.334 0.654 . . . . 74.21 110.863 -174.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 92.44 -140.09 14.96 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.823 -1.08 . . . . 72.2 112.72 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.68 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 26.0 tt0 -140.26 133.96 15.27 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.308 -0.997 . . . . 72.41 108.308 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.574 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 70.0 Cg_endo -70.29 112.48 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.603 . . . . 72.4 111.073 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -142.63 174.41 10.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.591 -0.731 . . . . 55.44 110.692 -172.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.422 ' HG1' ' HB3' ' A' ' 24' ' ' ASP . 14.8 t -64.44 157.88 25.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.589 0.233 . . . . 72.34 110.603 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -44.38 -51.78 8.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.444 0.698 . . . . 75.31 111.654 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -55.38 -46.09 76.56 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.854 -0.612 . . . . 73.42 111.825 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.451 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 99.2 mt-30 -71.46 -32.17 67.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 72.45 111.126 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 71.8 m -68.68 -47.22 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 63.15 111.011 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 64' ' ' GLN . 3.8 pp -68.01 -36.13 79.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.924 0.393 . . . . 54.21 110.619 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.5 tt0 -61.12 -43.55 98.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.532 . . . . 74.01 109.803 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.68 ' NH1' ' HB3' ' A' ' 55' ' ' GLU . 14.2 ttm180 -60.5 -53.45 57.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.38 -0.827 . . . . 74.43 111.924 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.5 pt -63.71 -32.48 57.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.779 0.324 . . . . 74.43 111.531 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' HB3' HG21 ' A' ' 94' ' ' VAL . 8.6 mm-40 -64.31 -32.56 74.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.471 . . . . 71.01 110.612 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 72.4 mm-40 -86.35 7.94 23.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.055 0.455 . . . . 75.11 110.592 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 36.9 mt -103.53 -62.58 1.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.515 0.674 . . . . 70.13 110.537 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -85.83 -50.03 7.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.12 . . . . 73.15 110.994 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -86.43 -10.52 54.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.739 -1.119 . . . . 55.35 112.176 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.489 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 12.1 p-10 -41.83 -40.19 2.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.34 0.656 . . . . 73.31 112.726 -170.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.1 tpp -72.34 78.42 1.01 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.284 0.564 . . . . 75.02 109.612 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.9 133.27 48.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.12 -0.945 . . . . 71.12 110.906 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.91 -155.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.719 2.279 . . . . 72.13 111.536 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.79 -18.78 2.04 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.638 0.375 . . . . 73.33 111.959 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -57.99 -15.71 9.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.636 0.375 . . . . 75.44 111.502 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.01 -38.86 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.715 0.293 . . . . 75.13 110.657 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 84.2 mtt180 -68.99 -20.15 64.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.911 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 5.2 mm-40 -63.12 -33.58 75.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 73.11 110.334 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.487 ' HB3' HD22 ' A' ' 82' ' ' LEU . 12.9 t-80 -102.49 -33.93 9.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.256 -0.429 . . . . 72.1 110.765 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 2.6 mm? -120.06 103.75 9.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.516 -0.311 . . . . 73.43 110.88 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -96.13 149.88 21.13 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.512 -0.551 . . . . 64.54 109.512 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -60.41 -46.01 91.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.776 0.322 . . . . 74.55 111.072 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -93.37 148.32 22.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.456 -0.572 . . . . 73.5 109.456 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -57.2 122.88 13.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.939 0.4 . . . . 72.41 111.115 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.05 152.3 23.49 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.737 -0.665 . . . . 74.42 111.623 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.82 13.75 2.53 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.791 2.327 . . . . 73.53 112.712 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.42 72.27 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.43 112.202 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 pt -93.82 92.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.487 0.66 . . . . 62.43 110.557 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 38.4 t70 -112.0 171.14 7.68 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.424 -0.807 . . . . 74.51 110.31 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -57.58 134.61 56.28 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.57 0.581 . . . . 74.1 112.57 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.49 -156.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.371 -0.832 . . . . 75.12 109.298 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 67' ' ' GLU . 6.7 p -70.87 121.3 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.625 -0.509 . . . . 75.41 109.625 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.862 1.265 . . . . 75.0 110.778 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.978 -0.379 . . . . 74.33 109.978 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.24 -52.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 73.44 110.22 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.9 p80 39.24 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.075 0.95 . . . . 72.24 112.806 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -151.43 41.01 0.7 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 73.13 110.148 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -65.58 78.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 64.02 110.848 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -151.81 40.8 0.66 Allowed 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.304 -0.628 . . . . 74.21 109.304 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -64.54 118.25 8.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.775 -0.648 . . . . 74.54 109.312 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -126.31 97.55 5.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.304 0.573 . . . . 71.44 111.333 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 tpt -111.86 -60.64 1.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.669 -1.234 . . . . 72.24 107.669 171.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.68 -87.85 0.01 OUTLIER Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.916 -1.038 . . . . 73.32 114.364 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -44.37 -71.18 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.583 0.753 . . . . 64.11 112.916 -171.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' A' ' 13' ' ' GLU . 27.6 tp -170.48 176.43 4.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.565 -0.532 . . . . 73.43 109.565 -173.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 11.2 tp10 -56.31 142.66 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.445 0.466 . . . . 52.23 110.573 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.88 7.92 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 61.0 111.751 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -108.3 108.15 19.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.221 0.534 . . . . 73.03 110.911 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.7 t -116.94 11.37 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.585 -0.734 . . . . 75.54 109.781 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -106.05 91.82 3.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.617 -0.719 . . . . 74.11 109.913 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.44 124.9 3.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.194 -0.527 . . . . 74.42 111.955 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.19 150.75 60.05 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.463 2.109 . . . . 73.41 111.223 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.29 136.0 14.0 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.792 -0.718 . . . . 44.34 112.021 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 24' ' ' ASP . 23.0 t -70.14 169.96 12.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.306 -0.628 . . . . 65.31 109.306 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.5 ptm -99.73 6.6 45.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.136 0.493 . . . . 73.35 111.112 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -150.84 -66.64 0.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.359 -0.837 . . . . 74.42 110.441 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' SER . 38.1 t70 -73.26 134.34 44.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.682 -0.69 . . . . 70.42 111.065 -175.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -73.97 -172.72 1.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.242 0.544 . . . . 71.11 111.518 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp -85.2 142.23 29.59 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.585 . . . . 63.11 110.15 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 3.0 m-85 -125.18 148.62 48.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 73.33 110.055 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.509 ' CE1' ' HD3' ' A' ' 56' ' ' PRO . 10.3 m-85 -109.68 157.67 18.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.176 -0.675 . . . . 74.33 109.176 168.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.4 124.17 40.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.367 -1.346 . . . . 71.3 107.367 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.459 HG11 HD12 ' A' ' 46' ' ' LEU . 19.3 m -125.54 162.52 28.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 122.103 -0.373 . . . . 74.31 111.054 -171.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.59 HH21 ' HA2' ' A' ' 35' ' ' GLY . 7.6 ptm180 -167.76 168.15 12.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.395 -0.366 . . . . 74.21 111.638 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -168.25 140.36 2.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.922 -0.581 . . . . 44.45 110.554 167.404 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.8 t30 45.89 13.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.029 0.932 . . . . 73.12 113.486 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' ASN . 9.8 pt-20 -112.43 -20.47 11.77 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.738 -0.601 . . . . 70.25 112.144 -172.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.59 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 75.52 -22.53 1.71 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.309 -0.472 . . . . 21.2 113.219 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' GLU . 6.0 pt20 -103.42 173.96 6.08 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.778 0.431 . . . . 74.31 110.148 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -108.74 158.13 17.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 73.1 112.471 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -141.73 -178.97 5.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.059 . . . . 73.51 108.646 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.753 HG23 ' HE3' ' A' ' 59' ' ' LYS . 20.6 m -127.79 152.34 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 118.237 0.472 . . . . 71.43 111.328 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.405 ' HB3' HG11 ' A' ' 30' ' ' VAL . 72.0 t-105 -153.1 146.89 25.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.96 -0.564 . . . . 74.31 110.216 -174.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 46.2 ttm -72.14 122.12 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.543 -0.299 . . . . 73.3 110.636 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.44 156.45 38.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 70.44 110.454 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.17 -31.81 8.22 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.302 -0.475 . . . . 43.5 112.145 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -106.6 130.34 54.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 74.1 110.216 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.5 m -66.0 159.37 25.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.22 0.534 . . . . 72.32 111.881 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.4 mt -107.3 155.5 39.33 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.228 -0.896 . . . . 65.25 111.227 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -55.85 152.36 36.13 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.172 2.581 . . . . 72.34 112.509 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.68 118.45 3.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.469 -0.787 . . . . 71.5 110.907 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.01 9.93 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.151 -0.477 . . . . 71.01 112.502 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.564 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.7 m95 -79.49 132.21 36.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.845 0.322 . . . . 74.55 111.037 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -115.88 154.26 30.05 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.662 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.436 HG21 HG13 ' A' ' 30' ' ' VAL . 40.1 p -112.77 146.22 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.439 1.087 . . . . 63.35 110.612 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 54' ' ' GLY . 17.3 t -154.86 156.12 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.606 0.363 . . . . 74.21 110.476 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 87.33 -179.83 48.13 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.121 -0.491 . . . . 72.2 113.958 169.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.98 118.35 62.61 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 123.237 0.615 . . . . 72.41 111.062 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 35.6 Cg_endo -64.68 111.71 1.76 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.768 1.645 . . . . 72.4 110.786 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.84 179.41 6.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.939 -0.573 . . . . 55.44 110.465 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 t -55.68 157.8 3.91 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.976 0.417 . . . . 72.34 111.631 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.753 ' HE3' HG23 ' A' ' 39' ' ' VAL . 22.2 tptm -45.97 -45.02 15.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.456 -0.793 . . . . 75.31 111.145 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 8.8 tt0 -56.67 -43.18 80.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 73.42 111.13 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -69.25 -50.2 49.23 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.435 -0.348 . . . . 72.45 111.031 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 15.2 p -60.73 -43.53 97.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.342 -0.39 . . . . 63.15 111.13 -174.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.63 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 pp -67.78 -42.42 81.72 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.636 -0.425 . . . . 54.21 109.993 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' HD13 ' A' ' 63' ' ' LEU . 31.7 tt0 -54.94 -40.7 70.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.111 0.482 . . . . 74.01 110.342 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.1 ttm-85 -58.37 -53.35 59.25 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.583 -0.735 . . . . 74.43 111.955 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.01 -34.63 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.507 -0.315 . . . . 74.43 111.797 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 10.0 mm-40 -61.59 -32.72 72.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 71.01 110.203 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -81.39 -8.42 59.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.272 -0.422 . . . . 75.11 111.722 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 94.8 mt -103.31 -67.03 0.9 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.886 0.374 . . . . 70.13 111.909 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -86.3 -52.9 5.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.511 0.672 . . . . 73.15 110.894 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.531 HG21 HG11 ' A' ' 94' ' ' VAL . 1.5 m -70.55 -11.35 60.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.758 -1.11 . . . . 55.35 111.052 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.527 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 1.1 p-10 -42.16 -34.95 0.83 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.734 0.814 . . . . 73.31 113.093 -172.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -65.78 85.82 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.575 0.702 . . . . 75.02 111.651 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 7.4 p -106.57 130.56 22.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.565 -0.743 . . . . 71.12 110.19 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 5.0 Cg_exo -73.42 -158.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.917 2.412 . . . . 72.13 112.151 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.96 -20.69 17.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 73.33 111.939 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.1 p -58.83 -16.35 16.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.794 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.17 -34.94 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.01 0.433 . . . . 75.13 110.682 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -66.94 -20.04 65.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.743 -0.662 . . . . 74.44 110.83 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -58.14 -35.87 72.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.097 -0.501 . . . . 73.11 110.158 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -97.45 -48.73 5.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.925 -0.58 . . . . 72.1 109.943 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 tt -94.95 95.15 8.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.312 -0.858 . . . . 73.43 109.783 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -67.16 146.88 53.78 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.847 -0.615 . . . . 64.54 111.013 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.92 87.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.941 -0.572 . . . . 74.55 111.32 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -126.68 146.71 50.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.923 -0.581 . . . . 73.5 109.514 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 p -83.05 88.53 6.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 72.41 110.364 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.98 169.05 29.09 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.694 -0.684 . . . . 74.42 111.74 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.28 176.29 2.74 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.974 2.449 . . . . 73.53 112.365 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.3 124.1 1.26 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.085 -0.579 . . . . 73.43 112.235 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.12 87.05 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.886 -0.783 . . . . 62.43 108.886 173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -127.53 179.09 5.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 74.51 109.886 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -118.29 -178.77 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.636 0.375 . . . . 74.1 110.04 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 72' ' ' ASP . . . -113.29 87.07 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 75.12 110.225 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.586 ' O ' HG22 ' A' ' 94' ' ' VAL . 11.3 p 43.21 31.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.672 1.189 . . . . 75.41 113.855 176.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 114.764 -1.107 . . . . 75.0 110.316 171.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 110.429 -0.211 . . . . 74.33 110.429 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.25 105.32 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.654 0.596 . . . . 73.44 112.144 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 149.18 10.17 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.837 -0.619 . . . . 72.24 109.365 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -145.99 101.76 3.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.763 0.316 . . . . 73.13 110.233 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -102.99 145.45 29.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 64.02 110.126 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -94.9 -174.53 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.251 -0.648 . . . . 74.21 109.251 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -84.94 144.85 28.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.003 0.43 . . . . 74.54 110.975 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -151.5 137.3 18.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 71.44 109.229 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 80.9 mtp -65.09 -61.41 2.16 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.297 0.373 . . . . 72.24 110.632 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.66 51.06 12.46 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.908 -0.587 . . . . 73.32 112.922 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.437 ' HA ' ' HH ' ' A' ' 37' ' ' TYR . 34.4 p -80.07 -62.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.364 -0.606 . . . . 64.11 109.364 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.41 117.98 27.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 73.43 109.294 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 6.8 mm-40 -92.04 130.03 37.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.538 -0.542 . . . . 52.23 109.538 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.75 132.13 36.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.211 -0.292 . . . . 61.0 110.211 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.33 42.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 73.03 110.753 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -60.42 -26.32 66.62 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.804 -0.634 . . . . 75.54 110.352 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -88.83 -45.9 9.38 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.161 -0.681 . . . . 74.11 109.161 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.97 144.71 7.03 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.409 -0.814 . . . . 74.42 111.849 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HB3' ' HG2' ' A' ' 56' ' ' PRO . 85.2 Cg_endo -78.96 27.18 0.52 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.25 2.634 . . . . 73.41 112.401 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.55 -76.05 0.39 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.62 -0.592 . . . . 44.34 111.62 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.4 t -172.68 36.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 65.31 108.881 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.1 ptm 39.33 60.78 1.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.221 1.01 . . . . 73.35 110.418 -170.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.64 -67.26 0.45 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.059 -1.428 . . . . 74.42 111.086 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -87.9 171.96 9.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.761 -0.654 . . . . 70.42 109.712 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.79 87.3 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.37 0.605 . . . . 71.11 110.19 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 56' ' ' PRO . 7.0 mp -71.29 163.11 28.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 63.11 111.107 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -126.39 148.5 49.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.977 -1.01 . . . . 73.33 109.288 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.609 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.99 153.31 26.99 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.378 -0.971 . . . . 74.33 108.378 174.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 53' ' ' VAL . 77.2 t -84.77 135.61 24.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.22 -1.77 . . . . 71.3 106.22 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 46' ' ' LEU . 21.6 m -136.46 165.12 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 121.483 -0.761 . . . . 74.31 111.644 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -166.01 164.32 18.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.793 -1.094 . . . . 74.21 110.282 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.4 p-10 -153.39 139.77 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 44.45 110.137 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 42.44 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.052 1.501 . . . . 73.12 115.052 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.4 pt-20 -112.53 -32.22 6.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.461 0.573 . . . . 70.25 111.832 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.01 -22.59 4.94 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.462 -0.399 . . . . 21.2 112.381 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.39 173.95 8.84 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.931 -0.396 . . . . 74.31 109.931 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' HH ' ' HA ' ' A' ' 11' ' ' THR . 13.5 m-85 -112.75 137.59 50.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.478 0.656 . . . . 73.1 112.41 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.7 m -137.27 -179.09 5.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.894 -1.048 . . . . 73.51 108.936 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG13 ' SG ' ' A' ' 62' ' ' CYS . 15.7 m -126.85 153.72 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.887 0.375 . . . . 71.43 111.125 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -144.19 156.08 44.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 74.31 109.259 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.8 ttt -82.59 121.3 26.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.017 -0.364 . . . . 73.3 110.017 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.34 157.81 34.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.985 0.421 . . . . 70.44 110.627 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -21.07 48.13 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.042 -0.823 . . . . 43.5 111.042 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 100.33 9.58 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.284 -0.636 . . . . 74.1 109.284 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -63.3 129.01 38.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.922 0.391 . . . . 72.32 110.422 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 2.7 mm? -58.72 145.19 78.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.635 -0.711 . . . . 65.25 112.418 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.99 144.12 99.5 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 123.007 2.472 . . . . 72.34 111.436 166.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.36 128.54 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 71.5 110.194 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.74 -29.75 7.02 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.551 -0.619 . . . . 71.01 111.551 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 36.0 m95 -86.69 170.9 11.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.068 -0.716 . . . . 74.55 109.068 172.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.83 146.57 28.03 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 120.937 0.399 . . . . 74.23 110.448 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.544 HG23 HD23 ' A' ' 46' ' ' LEU . 13.0 p -98.09 153.38 18.46 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.614 -1.176 . . . . 63.35 110.834 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG21 HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -162.32 167.01 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 C-N-CA 124.266 1.026 . . . . 74.21 109.83 -175.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 13' ' ' GLU . . . 83.44 179.46 52.32 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.171 -0.922 . . . . 72.2 111.412 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.485 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 47.6 tt0 -103.89 122.67 43.69 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.526 -1.286 . . . . 72.41 107.526 171.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.609 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 19.1 Cg_endo -55.72 124.9 17.42 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.119 . . . . 72.4 112.781 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . . . -151.02 156.36 40.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 55.44 109.194 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -62.21 169.95 2.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.667 0.247 . . . . 72.34 111.667 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -43.39 -59.09 2.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.305 0.642 . . . . 75.31 112.289 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.25 -40.29 70.75 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.87 0.367 . . . . 73.42 111.456 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 57' ' ' ALA . 96.4 mt-30 -74.8 -39.07 61.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 72.45 110.808 -176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.517 ' SG ' HG13 ' A' ' 39' ' ' VAL . 6.5 t -65.8 -51.05 62.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.122 -0.49 . . . . 63.15 110.637 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 64' ' ' GLN . 4.1 pp -62.73 -43.67 98.19 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.021 0.438 . . . . 54.21 110.067 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.621 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.7 tt0 -63.07 -35.8 81.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.022 -0.535 . . . . 74.01 110.529 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.614 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 16.0 ttt180 -61.87 -50.43 72.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 74.43 110.641 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.4 pt -74.15 -42.13 51.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.816 0.341 . . . . 74.43 111.63 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.94 -37.74 88.52 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.34 -0.391 . . . . 71.01 111.678 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.544 HE22 HG13 ' A' ' 94' ' ' VAL . 86.6 mm-40 -78.97 0.28 28.18 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 121.023 -0.271 . . . . 75.11 111.368 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -103.92 -65.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.289 0.566 . . . . 70.13 111.141 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -85.45 -46.03 11.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.174 -0.921 . . . . 73.15 110.956 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -87.12 -11.17 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.561 -0.745 . . . . 55.35 112.545 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' HA ' HG21 ' A' ' 94' ' ' VAL . 4.4 p-10 -41.74 -40.51 2.03 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.413 0.894 . . . . 73.31 113.413 -166.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.2 mtm -66.68 84.28 0.11 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.614 0.721 . . . . 75.02 110.312 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -73.17 137.03 78.82 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.833 -1.076 . . . . 71.12 110.46 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.486 ' O ' HG11 ' A' ' 78' ' ' VAL . 16.6 Cg_exo -67.2 -165.98 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.924 2.416 . . . . 72.13 112.557 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 79' ' ' ARG . . . -54.74 -20.97 9.51 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.259 -0.428 . . . . 73.33 111.543 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 p -53.37 -24.54 12.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.84 -0.618 . . . . 75.44 111.542 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.5 p -64.23 -53.45 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.481 -0.327 . . . . 75.13 111.142 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.467 ' N ' HG13 ' A' ' 78' ' ' VAL . 14.4 ptp180 -65.62 -32.38 73.93 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 121.037 0.446 . . . . 74.44 110.057 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.94 -39.7 90.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 73.11 109.554 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 91' ' ' ASP . 5.9 t60 -72.5 -35.65 68.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 72.1 110.829 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 87.2 mt -57.16 -22.19 38.42 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.343 0.497 . . . . 73.43 112.343 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -60.95 -25.44 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.718 -0.219 . . . . 64.54 111.446 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.507 HE22 ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -117.41 156.47 27.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.681 0.277 . . . . 74.55 110.507 -178.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -159.09 23.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 73.5 110.656 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.9 t -74.4 174.99 8.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.263 -0.426 . . . . 72.41 110.769 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.39 -62.53 5.51 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.969 -0.559 . . . . 74.42 112.356 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.39 40.7 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.818 2.346 . . . . 73.53 112.273 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.507 ' HA3' HE22 ' A' ' 84' ' ' GLN . . . -85.37 51.51 4.51 Favored Glycine 0 C--O 1.236 0.246 0 C-N-CA 121.334 -0.46 . . . . 73.43 112.227 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -76.47 102.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 62.43 109.997 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 23.6 t70 -147.51 165.32 30.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.795 -0.639 . . . . 74.51 109.604 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -54.75 138.87 41.09 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.453 0.471 . . . . 74.1 111.97 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.34 167.97 17.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 75.12 109.051 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.544 HG13 HE22 ' A' ' 68' ' ' GLN . 3.0 p -72.73 105.24 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.198 0.523 . . . . 75.41 110.83 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-N 115.039 -0.982 . . . . 75.0 109.419 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.238 -0.282 . . . . 74.33 110.238 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.14 -63.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.435 -0.348 . . . . 73.44 110.481 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 59.19 91.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.985 -0.552 . . . . 72.24 111.682 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -151.66 86.09 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.557 -0.535 . . . . 73.13 109.557 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -142.55 130.66 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 64.02 110.229 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 93.02 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.506 0.67 . . . . 74.21 110.32 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -74.2 99.15 3.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 74.54 111.115 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -73.6 73.93 1.48 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.175 0.512 . . . . 71.44 109.699 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 81.6 mtp -75.69 -79.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 72.24 111.002 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.32 107.18 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.619 -0.592 . . . . 73.32 111.619 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.3 m -157.8 154.09 27.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.475 -0.565 . . . . 64.11 109.475 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.425 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 64.3 mt -76.81 -140.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 119.22 -0.419 . . . . 73.43 110.764 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.536 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 5.7 mp0 -58.08 -0.44 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.155 1.169 . . . . 52.23 114.155 -163.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -69.47 136.26 51.27 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.008 -0.432 . . . . 61.0 111.178 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.631 ' NE2' ' HB ' ' A' ' 66' ' ' ILE . 21.6 pt20 -151.85 -162.63 1.56 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.429 -0.351 . . . . 73.03 110.921 -175.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.56 ' HB ' ' HG3' ' A' ' 36' ' ' GLN . 7.7 m -101.25 -51.4 3.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.095 -0.502 . . . . 75.54 110.025 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -174.18 143.38 0.89 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.112 -0.699 . . . . 74.11 109.112 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.06 112.16 1.26 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.969 -0.634 . . . . 74.42 112.858 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.4 153.95 21.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.615 2.21 . . . . 73.41 111.873 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.11 146.49 9.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.711 . . . . 44.34 112.458 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 m -92.81 171.84 8.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.718 0.407 . . . . 65.31 110.58 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.4 mtt -91.01 111.1 22.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.94 0.4 . . . . 73.35 111.018 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -129.99 -171.32 2.5 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.713 -0.676 . . . . 74.42 109.412 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.5 t70 -124.54 172.84 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.861 -0.422 . . . . 70.42 109.861 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 43.9 mt-10 73.99 164.53 0.28 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.483 0.713 . . . . 71.11 111.537 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.06 144.65 53.93 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.759 0.79 . . . . 63.11 112.182 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.75 149.05 47.62 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.327 -1.306 . . . . 73.33 108.885 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.766 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -108.58 165.07 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.384 -0.599 . . . . 74.33 109.384 173.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 66' ' ' ILE . 36.5 t -102.26 114.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.94 -0.763 . . . . 71.3 108.94 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 52' ' ' THR . 17.3 m -125.74 165.32 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.59 0.234 . . . . 74.31 111.51 -169.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -169.25 170.36 8.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.963 -0.562 . . . . 74.21 111.032 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -149.36 139.79 22.42 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 120.773 -0.371 . . . . 44.45 110.727 168.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t30 33.31 20.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.531 1.533 . . . . 73.12 114.918 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.41 -32.43 6.5 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.617 -0.677 . . . . 70.25 112.134 -174.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.95 19.93 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.317 -0.468 . . . . 21.2 112.751 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.56 ' HG3' ' HB ' ' A' ' 16' ' ' THR . 25.6 mp0 -90.57 173.76 7.89 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.744 -0.835 . . . . 74.31 108.744 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.591 ' HD2' ' HB3' ' A' ' 15' ' ' GLN . 9.3 m-85 -117.43 171.72 7.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.934 0.873 . . . . 73.1 112.101 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -150.09 176.62 10.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.685 -1.598 . . . . 73.51 107.119 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' SG ' ' A' ' 62' ' ' CYS . 7.0 m -124.37 129.4 73.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.522 0.677 . . . . 71.43 111.186 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.494 ' HZ2' ' NH1' ' A' ' 44' ' ' ARG . 54.3 t-105 -119.05 135.96 54.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.806 -1.088 . . . . 74.31 109.292 -171.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.67 123.72 19.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.507 -0.183 . . . . 73.3 110.507 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.69 146.5 52.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.04 -0.356 . . . . 70.44 110.04 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.32 15.84 68.13 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.947 -0.644 . . . . 43.5 111.57 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 44' ' ' ARG . 34.8 ttt-85 -131.27 125.19 32.18 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.89 -0.782 . . . . 74.1 108.89 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.8 m -72.55 159.93 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 72.32 111.8 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.678 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 10.6 tp -119.49 135.66 24.2 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.459 -0.791 . . . . 65.25 109.5 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.55 158.19 58.11 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.87 2.38 . . . . 72.34 113.665 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.08 129.12 26.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.911 -1.04 . . . . 71.5 110.788 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.62 -28.66 10.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.917 -0.583 . . . . 71.01 111.725 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.678 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 14.9 m95 -91.04 153.72 19.92 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.647 0.261 . . . . 74.55 110.502 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.76 138.87 53.88 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.047 0.451 . . . . 74.23 110.36 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 30' ' ' VAL . 7.3 p -100.81 131.31 46.76 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.585 -1.189 . . . . 63.35 109.616 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 54' ' ' GLY . 3.1 t -146.23 166.26 8.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.146 0.498 . . . . 74.21 110.317 -170.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.536 ' HA2' ' HG3' ' A' ' 13' ' ' GLU . . . 98.31 -141.09 15.39 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.647 -0.706 . . . . 72.2 114.231 167.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -136.53 119.41 11.96 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.385 -0.908 . . . . 72.41 108.788 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.766 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.1 Cg_endo -63.05 115.8 3.18 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.648 1.565 . . . . 72.4 111.281 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.38 155.09 35.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.608 -0.724 . . . . 55.44 109.554 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 10.0 t -55.88 153.76 8.12 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.744 -0.465 . . . . 72.34 109.744 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 tptm -43.14 -48.8 6.41 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.606 0.566 . . . . 75.31 111.848 -172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -58.94 -51.08 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 73.42 111.03 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -69.42 -30.43 68.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.957 0.408 . . . . 72.45 110.406 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.531 ' SG ' HG12 ' A' ' 39' ' ' VAL . 13.8 t -65.67 -52.41 51.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.776 -0.647 . . . . 63.15 110.175 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.794 HD13 ' HG2' ' A' ' 95' ' ' ARG . 4.0 pp -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.038 0.447 . . . . 54.21 110.387 176.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD11 ' A' ' 63' ' ' LEU . 32.9 tt0 -62.83 -42.32 99.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 74.01 110.772 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.455 ' HD3' ' HG2' ' A' ' 13' ' ' GLU . 12.3 ttm-85 -57.26 -53.28 59.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.202 -0.454 . . . . 74.43 111.608 -174.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.631 ' HB ' ' NE2' ' A' ' 15' ' ' GLN . 13.1 pt -67.22 -34.71 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.531 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.826 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 14.0 mm-40 -66.23 -32.49 73.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 71.01 110.178 174.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.621 ' HG2' ' HB1' ' A' ' 93' ' ' ALA . 17.3 mm-40 -75.56 0.35 17.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.07 -0.514 . . . . 75.11 111.816 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 95.5 mt -103.81 -67.11 0.91 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.794 0.664 . . . . 70.13 112.794 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -86.04 -55.07 4.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.678 0.752 . . . . 73.15 110.579 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -11.48 60.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.392 -1.277 . . . . 55.35 110.915 -177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.46 -28.29 2.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.611 0.764 . . . . 73.31 112.799 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 86.4 mtp -68.76 74.36 0.27 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.282 0.563 . . . . 75.02 110.153 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.24 134.44 19.77 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.273 -0.876 . . . . 71.12 110.271 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -157.84 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.827 2.352 . . . . 72.13 111.662 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.59 -18.85 13.28 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.59 0.356 . . . . 73.33 111.405 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.3 p -53.82 -26.25 23.33 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.974 -0.557 . . . . 75.44 111.556 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.53 -36.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.195 0.521 . . . . 75.13 110.421 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 79' ' ' ARG . 17.7 mtp180 -73.84 -37.03 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.751 -0.659 . . . . 74.44 109.991 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.15 -25.83 67.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.762 -0.654 . . . . 73.11 110.632 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -70.25 -27.15 64.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.642 -0.708 . . . . 72.1 110.643 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.96 146.44 47.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.66 . . . . 73.43 110.82 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -79.27 136.53 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.693 -0.484 . . . . 64.54 109.693 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.02 -13.46 60.5 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.446 -0.343 . . . . 74.55 111.591 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -83.16 48.78 1.43 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.872 0.368 . . . . 73.5 111.012 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p 53.37 100.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.002 0.921 . . . . 72.41 112.274 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.59 179.68 46.15 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.411 -0.675 . . . . 74.42 111.411 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.04 -7.66 21.9 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.669 2.246 . . . . 73.53 112.379 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.49 -17.38 56.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-N 115.916 -0.583 . . . . 73.43 112.027 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.6 mt -75.43 134.63 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.572 0.349 . . . . 62.43 110.161 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -82.2 159.1 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.89 -0.411 . . . . 74.51 109.89 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -133.96 175.59 9.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 74.1 110.181 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.621 ' HB1' ' HG2' ' A' ' 68' ' ' GLN . . . -67.49 165.67 16.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.925 -0.579 . . . . 75.12 110.39 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.597 ' O ' HG21 ' A' ' 94' ' ' VAL . 11.7 p -88.86 22.09 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 122.883 1.325 . . . . 75.41 112.193 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.826 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 22.7 tpt180 . . . . . 0 C--N 1.297 -1.685 0 CA-C-N 113.626 -1.624 . . . . 75.0 109.272 168.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 56' ' ' PRO . 9.1 mp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.782 0.801 . . . . 63.109999999999999 111.193 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.2 m-85 -127.57 151.13 49.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.366 -1.288 . . . . 64.219999999999999 109.306 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -116.46 157.68 24.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 74.329999999999998 109.397 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -85.86 134.83 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.16 -1.422 . . . . 71.299999999999997 107.16 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 46' ' ' LEU . 29.0 m -136.73 159.32 37.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.954 0.407 . . . . 74.310000000000002 111.379 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 38.0 ptt180 -169.21 170.23 8.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.192 -0.913 . . . . 74.209999999999994 110.509 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.668 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 25.6 p-10 -165.77 140.38 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.653 -0.249 . . . . 44.450000000000003 111.061 170.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 49.11 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.883 1.068 . . . . 73.120000000000005 113.883 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.09 -32.0 6.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.747 -0.596 . . . . 70.25 111.464 -174.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.71 -22.81 6.19 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.262 -0.426 . . . . 21.199999999999999 113.014 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.03 174.04 10.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.749 -0.464 . . . . 74.310000000000002 109.749 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.21 143.3 45.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.901 0.704 . . . . 73.099999999999994 112.901 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -136.83 -179.91 5.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.987 -1.006 . . . . 73.510000000000005 109.694 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.65 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.9 m -125.67 155.34 34.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.807 0.337 . . . . 63.030000000000001 110.803 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -148.48 149.1 31.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.306 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.8 ttt -81.61 121.51 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.647 0.26 . . . . 73.299999999999997 110.326 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.56 148.89 44.64 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.231 -0.441 . . . . 70.439999999999998 111.014 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.97 -23.03 36.26 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.741 -0.544 . . . . 43.5 111.741 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -92.98 118.83 31.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.004 -0.369 . . . . 65.319999999999993 110.004 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.3 m -60.24 137.33 58.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.04 0.448 . . . . 72.319999999999993 111.391 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -93.31 142.43 25.26 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.425 -0.807 . . . . 65.25 110.882 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.13 140.44 70.93 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.863 2.375 . . . . 72.340000000000003 111.714 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.67 124.89 11.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 71.430000000000007 110.386 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.2 -29.42 7.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.296 -0.478 . . . . 71.010000000000005 112.669 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.668 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.1 m95 -76.95 149.88 35.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.335 0.568 . . . . 71.239999999999995 111.46 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 18.8 pt-20 -129.62 151.23 50.45 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.977 -0.556 . . . . 74.230000000000004 110.245 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -107.99 160.59 15.66 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.214 0.946 . . . . 63.350000000000001 111.255 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.17 158.51 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 123.408 0.683 . . . . 74.209999999999994 110.608 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 89.61 -166.85 33.23 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.833 -0.621 . . . . 72.200000000000003 112.259 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.55 142.25 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.745 -0.835 . . . . 72.409999999999997 108.745 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.4 Cg_endo -72.57 108.74 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 120.816 1.01 . . . . 72.400000000000006 110.575 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.57 172.99 17.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.416 -0.811 . . . . 55.439999999999998 110.361 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -55.77 155.33 6.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.898 0.38 . . . . 72.340000000000003 111.503 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -49.55 -36.49 23.81 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.619 -0.719 . . . . 75.310000000000002 110.923 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -55.71 -55.67 29.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.516 -0.765 . . . . 73.420000000000002 110.302 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -52.0 64.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.776 -0.647 . . . . 72.450000000000003 111.003 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.65 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.0 t -55.86 -52.46 63.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.197 -0.91 . . . . 63.149999999999999 111.071 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.2 pp -68.26 -44.92 74.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.916 -0.313 . . . . 54.210000000000001 110.445 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' N ' HD12 ' A' ' 63' ' ' LEU . 22.0 tt0 -54.8 -36.51 65.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.394 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 48.5 ttt85 -64.21 -53.53 47.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.774 -0.648 . . . . 74.430000000000007 111.046 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.07 -34.05 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 111.679 0.251 . . . . 74.430000000000007 111.679 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 39.7 mm-40 -65.97 -32.77 74.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.487 -0.324 . . . . 71.010000000000005 110.385 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.75 4.95 42.32 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 111.266 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 48.0 mt -103.73 -66.97 0.91 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.92 0.39 . . . . 70.129999999999995 111.195 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -86.32 -54.84 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.272 0.558 . . . . 45.109999999999999 111.417 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -78.19 -10.92 59.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.187 -0.915 . . . . 55.350000000000001 111.399 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 113.977 1.103 . . . . 73.310000000000002 113.977 -171.168 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.236 0.367 0 CA-C-O 121.784 0.802 . . . . 63.109999999999999 111.455 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -127.31 148.7 50.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.502 -1.226 . . . . 64.219999999999999 109.156 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.584 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -114.1 162.39 16.54 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.61 0.569 . . . . 74.329999999999998 109.543 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 53' ' ' VAL . 75.8 t -88.42 140.65 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.247 -1.02 . . . . 71.299999999999997 108.247 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 40' ' ' TRP . 23.4 m -144.99 158.23 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 122.195 -0.316 . . . . 74.310000000000002 110.85 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 19.9 ptt85 -169.36 170.1 8.63 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.335 -0.393 . . . . 74.209999999999994 111.542 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 22.4 p-10 -157.89 139.82 14.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.342 -0.39 . . . . 44.450000000000003 111.063 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 35.12 21.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.137 1.375 . . . . 73.120000000000005 114.294 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ASN . 10.7 pt-20 -112.4 -32.11 6.6 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.616 -0.677 . . . . 70.25 111.385 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.86 -22.79 5.52 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.972 -0.558 . . . . 21.199999999999999 112.078 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -84.35 161.56 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.14 -0.689 . . . . 74.310000000000002 109.14 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 18.9 m-85 -106.32 137.48 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.086 0.469 . . . . 73.099999999999994 111.711 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -124.13 -179.21 4.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.046 -0.979 . . . . 73.510000000000005 109.726 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -132.31 157.3 43.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.879 0.371 . . . . 63.030000000000001 110.877 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HB2' HG21 ' A' ' 30' ' ' VAL . 73.4 t-105 -155.75 149.41 25.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.823 -0.806 . . . . 74.310000000000002 108.823 -171.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.86 130.35 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 73.299999999999997 110.539 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.58 144.12 27.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.993 -0.548 . . . . 70.439999999999998 111.621 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -20.69 12.09 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.13 -0.486 . . . . 43.5 113.254 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -79.91 131.1 35.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.762 0.281 . . . . 65.319999999999993 110.274 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -65.92 148.76 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.314 0.578 . . . . 72.319999999999993 111.821 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 29.1 mt -111.35 147.71 37.25 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.094 -0.957 . . . . 65.25 111.204 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -81.07 176.1 9.2 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.913 2.409 . . . . 72.340000000000003 113.029 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 125.44 10.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.907 -1.042 . . . . 71.430000000000007 111.94 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.57 -32.32 7.52 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 112.847 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.3 m95 -76.91 133.54 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.034 0.417 . . . . 71.239999999999995 111.689 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 9.8 pt-20 -127.62 152.78 47.23 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.746 -0.661 . . . . 74.230000000000004 110.393 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 53' ' ' VAL . 39.5 p -102.13 159.66 15.19 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.289 0.993 . . . . 63.350000000000001 111.42 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -173.6 175.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 110.285 -173.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 82.75 -161.2 40.05 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.723 -0.671 . . . . 72.200000000000003 112.882 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.5 138.62 20.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 123.366 0.666 . . . . 72.409999999999997 109.588 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.7 Cg_endo -71.59 113.38 3.62 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.673 1.582 . . . . 72.400000000000006 111.078 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.37 167.11 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.726 -0.67 . . . . 55.439999999999998 109.938 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -61.69 161.36 10.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.679 0.276 . . . . 72.340000000000003 110.961 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -46.89 -48.52 21.19 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.869 -0.605 . . . . 75.310000000000002 111.633 -176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -57.37 -45.09 84.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.978 -0.555 . . . . 73.420000000000002 111.406 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.75 -38.78 64.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 72.450000000000003 110.708 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.531 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.2 t -59.02 -49.26 78.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.73 -0.668 . . . . 63.149999999999999 110.202 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.6 pp -68.05 -37.22 81.06 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.43 -0.35 . . . . 54.210000000000001 110.508 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' LEU . 33.9 tt0 -60.31 -32.74 71.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.089 0.471 . . . . 74.010000000000005 110.411 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.3 ttt85 -76.57 -44.02 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.982 -0.554 . . . . 74.430000000000007 110.548 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' LEU . 44.4 pt -67.61 -34.55 68.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 121.153 -0.219 . . . . 74.430000000000007 110.675 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 71' ' ' THR . 34.3 mt-10 -54.03 -56.04 21.67 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.25 -0.432 . . . . 71.010000000000005 110.112 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -65.76 -10.18 34.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 75.109999999999999 112.384 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 97.6 mt -104.02 -67.79 0.88 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.329 0.492 . . . . 70.129999999999995 112.329 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 70.6 t-105 -87.01 -55.44 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.965 0.888 . . . . 45.109999999999999 111.168 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 5.5 m -74.09 -11.52 60.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.027 -1.442 . . . . 55.350000000000001 111.609 -170.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 67' ' ' GLU . 24.5 t70 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 114.029 1.122 . . . . 73.310000000000002 114.029 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.811 0.815 . . . . 63.109999999999999 111.464 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.585 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 19.8 m-85 -121.09 148.72 43.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.546 -1.206 . . . . 64.219999999999999 108.254 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.87 159.57 26.53 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.72 -0.844 . . . . 74.329999999999998 108.72 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 86.9 t -86.8 138.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.282 -1.377 . . . . 71.299999999999997 107.282 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 46' ' ' LEU . 33.9 m -138.32 160.53 31.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.318 0.508 . . . . 74.310000000000002 111.295 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -168.61 169.15 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.786 -1.097 . . . . 74.209999999999994 110.242 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.8 p30 -154.36 139.74 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.993 -0.373 . . . . 44.450000000000003 109.993 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 t30 44.88 6.16 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.159 1.17 . . . . 73.120000000000005 114.159 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.7 pt-20 -112.27 -32.45 6.52 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.503 -0.748 . . . . 70.25 112.118 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 -22.58 4.57 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.242 -0.436 . . . . 21.199999999999999 112.911 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.16 174.05 5.94 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.388 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -122.29 133.02 54.69 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.592 0.589 . . . . 73.099999999999994 112.592 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.3 m -132.82 -179.19 5.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.371 -0.831 . . . . 73.510000000000005 109.71 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.6 158.33 26.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 63.030000000000001 110.913 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.527 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 56.0 t90 -147.15 137.21 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.84 . . . . 74.310000000000002 109.6 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 ttt -83.09 121.46 27.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 110.284 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.15 165.36 22.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.347 . . . . 70.439999999999998 110.189 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.31 -4.85 29.93 Favored Glycine 0 C--N 1.328 0.125 0 N-CA-C 110.91 -0.876 . . . . 43.5 110.91 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.8 ptp180 -131.56 172.52 12.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.271 0.628 . . . . 65.319999999999993 109.737 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 p -101.67 143.65 31.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.999 -0.371 . . . . 72.319999999999993 109.999 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 30' ' ' VAL . 8.5 mt -88.9 133.17 36.15 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.325 -0.398 . . . . 65.25 111.544 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 46' ' ' LEU . 76.1 Cg_exo -46.12 130.66 13.77 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 123.303 2.668 . . . . 72.340000000000003 112.352 171.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 126.52 15.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 71.430000000000007 110.493 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.88 -25.53 9.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.241 -0.504 . . . . 71.010000000000005 112.06 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 66.2 m95 -83.96 158.53 21.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.809 0.305 . . . . 71.239999999999995 110.784 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -135.21 154.26 51.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.318 -0.401 . . . . 74.230000000000004 110.048 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 53' ' ' VAL . 24.3 p -107.43 153.21 23.13 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 124.737 1.273 . . . . 63.350000000000001 110.244 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -167.51 175.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.676 0 C-N-CA 123.624 0.77 . . . . 74.209999999999994 110.023 -173.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.22 -115.3 4.19 Favored Glycine 0 C--O 1.219 -0.835 0 CA-C-N 115.681 -0.69 . . . . 72.200000000000003 113.111 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 16.4 tp10 -147.32 136.89 11.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.279 1.032 . . . . 72.409999999999997 108.597 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 73.6 Cg_endo -83.51 107.51 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.011 1.141 . . . . 72.400000000000006 110.286 166.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.68 -175.4 5.14 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.391 -0.822 . . . . 55.439999999999998 111.242 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 61' ' ' GLN . 1.1 t -55.83 151.21 11.72 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.286 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HG3' HD23 ' A' ' 63' ' ' LEU . 23.8 tptm -45.93 -41.0 10.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.225 -0.898 . . . . 75.310000000000002 110.269 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -59.86 -42.41 93.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.107 -0.952 . . . . 73.420000000000002 111.417 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' H ' HG23 ' A' ' 58' ' ' THR . 14.7 mm100 -71.95 -48.06 47.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.884 0.373 . . . . 72.450000000000003 110.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 60.0 m -60.22 -46.6 89.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 63.149999999999999 111.578 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.08 -41.05 82.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.753 -0.379 . . . . 54.210000000000001 110.385 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.592 ' N ' HD12 ' A' ' 63' ' ' LEU . 60.1 tt0 -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.281 0.562 . . . . 74.010000000000005 110.877 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.4 ttm-85 -64.48 -47.42 79.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.965 -0.562 . . . . 74.430000000000007 111.202 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 pt -69.66 -37.66 74.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.64 0.257 . . . . 74.430000000000007 110.977 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.65 -48.99 76.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 71.010000000000005 110.214 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 18.5 mt-30 -73.29 8.73 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.795 0.331 . . . . 75.109999999999999 111.452 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 73.3 mt -103.54 -66.13 0.96 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.975 0.417 . . . . 70.129999999999995 110.618 170.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -85.29 -48.47 9.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.441 0.639 . . . . 45.109999999999999 110.837 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -76.81 -10.74 59.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.202 -0.908 . . . . 55.350000000000001 111.356 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 25.9 t70 . . . . . 0 N--CA 1.477 0.884 0 C-N-CA 124.182 0.993 . . . . 73.310000000000002 113.168 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.237 0.401 0 CA-C-O 121.176 0.512 . . . . 63.109999999999999 110.552 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.22 148.71 50.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 64.219999999999999 110.72 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -117.78 162.59 17.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.943 -1.026 . . . . 74.329999999999998 108.91 171.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -94.06 142.65 13.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.778 -1.193 . . . . 71.299999999999997 107.778 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.03 156.62 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.155 0.502 . . . . 74.310000000000002 111.227 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HD3' ' CE1' ' A' ' 37' ' ' TYR . 29.5 ptt180 -154.25 155.18 34.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.196 -0.911 . . . . 74.209999999999994 109.581 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.7 p30 -156.56 139.35 15.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.983 -0.287 . . . . 44.450000000000003 110.894 168.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 35.43 13.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.652 1.723 . . . . 73.120000000000005 115.652 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.883 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 16.4 pt-20 -112.71 -31.92 6.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.745 0.646 . . . . 70.25 112.745 -170.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.42 89.01 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 21.199999999999999 112.473 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.883 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 77.7 mt-30 -120.77 174.09 6.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.348 0.659 . . . . 74.310000000000002 109.365 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 31' ' ' ARG . 42.4 m-85 -122.54 146.46 47.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.739 1.014 . . . . 73.099999999999994 113.739 -171.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -138.9 -179.31 5.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.216 -1.357 . . . . 73.510000000000005 108.677 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.5 m -122.83 161.6 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.918 0.389 . . . . 63.030000000000001 111.084 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -145.89 156.47 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.32 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.4 ttt -86.07 147.5 26.15 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.828 -0.434 . . . . 73.299999999999997 109.828 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.62 156.88 38.88 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.017 0.437 . . . . 70.439999999999998 111.524 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.35 54.13 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.547 -0.751 . . . . 43.5 112.769 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -112.35 116.1 29.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.876 -0.416 . . . . 65.319999999999993 109.876 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.0 m -66.09 154.69 38.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 112.048 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -111.05 152.88 43.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.075 -0.966 . . . . 65.25 111.151 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 74.1 Cg_endo -80.34 158.13 22.78 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 111.921 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 131.13 26.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 111.237 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.96 -35.27 5.16 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.774 -0.648 . . . . 71.010000000000005 111.658 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 32.2 m95 -79.71 139.02 37.49 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.188 -0.301 . . . . 71.239999999999995 110.188 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.87 153.68 49.55 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.377 -0.374 . . . . 74.230000000000004 110.284 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.2 p -98.11 162.82 13.02 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.19 0.931 . . . . 63.350000000000001 111.459 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.56 150.02 3.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.41 -0.814 . . . . 74.209999999999994 109.978 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 -170.56 37.53 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.557 -0.747 . . . . 72.200000000000003 111.495 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 151.56 40.76 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 108.652 -0.87 . . . . 72.409999999999997 108.652 174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 21.9 Cg_endo -65.54 105.17 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.206 1.271 . . . . 72.400000000000006 110.046 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.17 169.45 17.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.412 -0.813 . . . . 55.439999999999998 110.669 -171.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 61' ' ' GLN . 3.5 t -57.29 151.3 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.654 -0.703 . . . . 72.340000000000003 111.149 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -48.75 -44.91 39.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.751 -0.659 . . . . 75.310000000000002 110.576 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -56.19 -37.32 69.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.477 -0.783 . . . . 73.420000000000002 111.206 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.422 ' H ' HG23 ' A' ' 58' ' ' THR . 12.2 mm-40 -74.96 -39.72 61.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.909 0.385 . . . . 72.450000000000003 110.436 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 39' ' ' VAL . 5.5 t -65.23 -51.33 61.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.665 . . . . 63.149999999999999 110.56 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.0 -36.99 80.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.865 0.364 . . . . 54.210000000000001 110.384 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' LEU . 52.4 tt0 -60.4 -43.15 96.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 110.237 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.67 HH11 ' HG3' ' A' ' 65' ' ' ARG . 18.8 ttm-85 -60.85 -53.18 60.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.63 -0.714 . . . . 74.430000000000007 111.764 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.8 pt -67.26 -37.39 79.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.953 0.406 . . . . 74.430000000000007 111.125 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.81 -33.17 75.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.02 -0.537 . . . . 71.010000000000005 110.527 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.504 ' C ' ' HB3' ' A' ' 72' ' ' ASP . 16.1 mm-40 -78.21 2.33 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.685 0.279 . . . . 75.109999999999999 111.226 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 71.6 mt -103.59 -66.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.099 0.476 . . . . 70.129999999999995 110.968 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -85.33 -55.21 4.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.578 0.704 . . . . 45.109999999999999 110.845 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -10.97 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.864 -1.062 . . . . 55.350000000000001 111.853 -170.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 6.8 p-10 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 113.978 1.103 . . . . 73.310000000000002 113.978 -167.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.233 0.226 0 CA-C-O 121.196 0.522 . . . . 63.109999999999999 110.256 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -129.62 153.0 48.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.367 -0.833 . . . . 64.219999999999999 109.751 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -116.02 167.45 10.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.083 -0.962 . . . . 74.329999999999998 108.896 169.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.3 t -92.47 146.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.131 -1.433 . . . . 71.299999999999997 107.131 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 46' ' ' LEU . 34.5 m -140.32 163.9 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 118.395 0.543 . . . . 74.310000000000002 110.927 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -164.16 159.69 20.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.189 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 23.2 p-10 -171.32 140.21 1.41 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.029 -0.532 . . . . 44.450000000000003 110.619 168.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 50.02 4.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.058 1.133 . . . . 73.120000000000005 114.058 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 9.4 pt-20 -107.71 -29.49 9.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.824 -0.547 . . . . 70.25 112.371 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.97 19.28 67.6 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.644 -0.788 . . . . 21.199999999999999 111.411 -173.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.815 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 87.3 mt-30 -129.52 174.03 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.736 0.814 . . . . 74.310000000000002 108.807 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.5 132.64 56.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.593 0.711 . . . . 73.099999999999994 112.416 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 m -124.95 178.38 5.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.579 -1.191 . . . . 73.510000000000005 108.886 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 62' ' ' CYS . 18.0 m -129.91 160.07 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.855 0.36 . . . . 63.030000000000001 111.337 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -157.67 154.38 28.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.863 -0.792 . . . . 74.310000000000002 108.863 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -80.26 135.12 36.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.976 -0.289 . . . . 73.299999999999997 110.625 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.75 136.23 52.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 70.439999999999998 110.529 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.78 -3.71 74.6 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.188 -0.46 . . . . 43.5 112.132 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -103.26 128.19 50.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.705 -0.48 . . . . 65.319999999999993 109.705 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -64.97 156.69 30.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.025 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 30' ' ' VAL . 19.9 mt -124.34 139.43 32.88 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.471 -0.786 . . . . 65.25 110.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -54.73 141.49 75.81 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.899 2.4 . . . . 72.340000000000003 111.612 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.25 127.65 25.27 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.829 0.347 . . . . 71.430000000000007 110.442 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.75 -34.54 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.538 -0.625 . . . . 71.010000000000005 111.538 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.4 m95 -78.15 142.81 37.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.989 -0.374 . . . . 71.239999999999995 109.989 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.5 152.92 48.5 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 120.774 0.321 . . . . 74.230000000000004 110.318 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 p -100.94 154.31 18.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.103 -0.953 . . . . 63.350000000000001 110.9 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.09 171.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.301 1.04 . . . . 74.209999999999994 109.182 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.95 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.713 -0.756 . . . . 72.200000000000003 112.522 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.67 132.92 10.16 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.122 -1.066 . . . . 72.409999999999997 108.122 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.65 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.9 Cg_endo -62.85 122.38 10.65 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.875 1.716 . . . . 72.400000000000006 112.42 -170.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.79 160.71 10.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.508 -0.769 . . . . 55.439999999999998 109.351 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -55.86 154.99 6.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.65 0.262 . . . . 72.340000000000003 111.104 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 87.4 tttt -49.05 -40.94 33.33 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.946 -0.57 . . . . 75.310000000000002 110.886 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -53.94 -48.16 70.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.464 -0.789 . . . . 73.420000000000002 110.923 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -74.77 -30.18 61.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 72.450000000000003 110.783 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 39' ' ' VAL . 12.9 t -66.36 -50.94 61.84 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.911 -0.586 . . . . 63.149999999999999 110.667 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.2 pp -63.93 -37.97 89.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.954 0.407 . . . . 54.210000000000001 110.276 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.565 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 26.3 tt0 -58.68 -43.49 89.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.824 -0.626 . . . . 74.010000000000005 110.237 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.7 ttt180 -62.05 -43.58 98.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.166 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.67 -38.29 44.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 111.827 0.306 . . . . 74.430000000000007 111.827 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 34.9 mm-40 -64.12 -41.59 97.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 121.304 -0.158 . . . . 71.010000000000005 111.15 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 64.1 mt-30 -73.9 7.86 2.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.02 0.438 . . . . 75.109999999999999 111.18 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.5 mt -103.63 -65.92 0.98 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.307 -0.406 . . . . 70.129999999999995 110.874 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -85.79 -52.85 5.49 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.682 -0.69 . . . . 45.109999999999999 111.128 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -74.88 -11.69 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.414 -0.812 . . . . 55.350000000000001 111.054 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 4.0 p-10 . . . . . 0 N--CA 1.468 0.451 0 CA-C-N 115.842 -0.617 . . . . 73.310000000000002 112.398 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 57' ' ' ALA . 3.2 mm? . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.696 0.76 . . . . 63.109999999999999 111.867 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.0 m-85 -127.37 148.5 50.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.735 -1.121 . . . . 64.219999999999999 109.1 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.608 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.19 159.8 22.05 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.7 . . . . 74.329999999999998 109.111 174.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 53' ' ' VAL . 46.6 t -91.97 145.85 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 46' ' ' LEU . 26.0 m -138.87 161.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 121.771 -0.581 . . . . 74.310000000000002 111.517 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 24.8 ptt180 -161.81 155.42 21.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.498 -0.773 . . . . 74.209999999999994 110.201 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.606 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.0 p30 -161.33 139.72 9.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.213 -0.292 . . . . 44.450000000000003 110.213 169.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 43.08 3.89 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.692 1.367 . . . . 73.120000000000005 114.692 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.8 pt-20 -112.49 -32.03 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.573 -0.705 . . . . 70.25 111.594 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.21 -22.52 18.9 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.411 -0.423 . . . . 21.199999999999999 113.095 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -86.29 174.11 9.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.97 0.385 . . . . 74.310000000000002 110.383 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -106.26 139.89 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 73.099999999999994 112.442 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 29' ' ' VAL . 23.0 m -134.87 178.24 7.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.379 -0.828 . . . . 73.510000000000005 109.464 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 62' ' ' CYS . 36.0 m -123.1 159.13 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.521 0.201 . . . . 63.030000000000001 110.65 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -158.37 139.02 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.987 -0.746 . . . . 74.310000000000002 108.987 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.5 ttt -67.39 124.37 22.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.262 . . . . 73.299999999999997 110.81 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.82 130.97 44.62 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.297 -0.41 . . . . 70.439999999999998 110.123 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.13 -9.41 33.62 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.291 -0.724 . . . . 43.5 111.291 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -106.38 111.27 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 65.319999999999993 109.278 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 m -66.74 141.63 57.67 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.725 . . . . 72.319999999999993 112.11 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 HD12 HG23 ' A' ' 52' ' ' THR . 45.3 mt -96.3 151.44 38.12 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 114.727 -1.124 . . . . 65.25 111.314 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 69.2 Cg_endo -77.97 152.55 28.35 Favored 'Trans proline' 0 C--O 1.242 0.697 0 C-N-CA 122.549 2.166 . . . . 72.340000000000003 111.774 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.24 19.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.67 -0.695 . . . . 71.430000000000007 111.018 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.78 -35.27 4.37 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.443 -0.799 . . . . 71.010000000000005 111.339 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 22.5 m95 -83.41 142.13 31.22 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.979 -0.378 . . . . 71.239999999999995 109.979 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -129.28 148.24 51.19 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 120.852 0.358 . . . . 74.230000000000004 110.582 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 HD12 ' A' ' 46' ' ' LEU . 19.9 p -99.04 150.75 21.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.659 -1.155 . . . . 63.350000000000001 110.315 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.76 155.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.107 -172.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.73 -160.17 24.21 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.905 -1.043 . . . . 72.200000000000003 112.641 175.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -103.83 133.14 20.42 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 55.5 Cg_endo -70.24 111.14 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.322 1.348 . . . . 72.400000000000006 110.566 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 26' ' ' LEU . . . -147.53 171.98 14.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.799 -0.637 . . . . 55.439999999999998 110.241 -171.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 61' ' ' GLN . 5.9 t -57.14 156.2 7.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.512 -0.313 . . . . 72.340000000000003 111.441 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -49.76 -43.7 48.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.953 0.501 . . . . 75.310000000000002 110.962 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.21 -51.31 62.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.806 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 58' ' ' THR . 85.6 mm-40 -69.28 -30.74 68.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 72.450000000000003 110.687 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 39' ' ' VAL . 4.1 t -63.5 -50.09 70.98 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.076 -0.511 . . . . 63.149999999999999 110.288 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.3 pp -68.06 -46.51 70.91 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.929 -0.397 . . . . 54.210000000000001 109.929 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.4 tt0 -56.87 -31.88 65.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 74.010000000000005 111.162 -175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.1 ttt85 -70.96 -53.54 14.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 111.435 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.9 pt -70.53 -37.75 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.777 0.288 . . . . 74.430000000000007 111.777 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.59 -37.75 77.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 111.095 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -81.33 1.74 31.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 66.6 mt -103.77 -66.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 70.129999999999995 110.844 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -85.18 -53.36 5.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.709 -0.678 . . . . 45.109999999999999 110.911 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.7 m -75.35 -11.13 59.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.46 -0.791 . . . . 55.350000000000001 111.47 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 N--CA 1.47 0.562 0 C-N-CA 123.368 0.667 . . . . 73.310000000000002 112.339 -171.265 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 31.3 mt . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.997 0.903 . . . . 63.109999999999999 111.768 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.65 149.67 41.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.966 -1.47 . . . . 64.219999999999999 109.338 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.603 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 m-85 -107.94 164.08 12.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.782 -0.821 . . . . 74.329999999999998 108.782 168.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HH11 ' A' ' 65' ' ' ARG . 40.1 t -92.3 137.24 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.27 -1.382 . . . . 71.299999999999997 107.27 174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 13.7 m -139.03 164.95 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 118.113 0.415 . . . . 74.310000000000002 111.244 -174.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 39.2 ptt180 -169.19 170.02 8.93 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.571 -0.74 . . . . 74.209999999999994 110.473 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.6 p30 -156.19 139.79 15.97 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.337 -0.246 . . . . 44.450000000000003 110.337 170.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.4 t30 47.42 4.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.885 1.069 . . . . 73.120000000000005 113.885 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.2 pt-20 -112.26 -32.32 6.56 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.806 -0.559 . . . . 70.25 111.924 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 -22.73 4.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.388 -0.434 . . . . 21.199999999999999 112.73 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -73.45 174.06 8.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.872 0.336 . . . . 74.310000000000002 110.315 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -121.85 132.64 54.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.332 0.493 . . . . 73.099999999999994 112.332 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -129.02 176.89 7.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.267 -0.879 . . . . 73.510000000000005 109.393 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.22 149.19 21.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.915 0.388 . . . . 63.030000000000001 110.815 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' ' HB3' ' A' ' 44' ' ' ARG . 70.8 t-105 -149.18 137.87 21.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 74.310000000000002 109.728 -171.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.6 ttt -62.76 125.19 23.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.663 -0.244 . . . . 73.299999999999997 110.896 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.76 144.33 57.13 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.785 -0.45 . . . . 70.439999999999998 109.785 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.7 -34.55 4.94 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 111.144 -0.782 . . . . 43.5 111.144 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HB3' ' NE1' ' A' ' 40' ' ' TRP . 4.8 ttt180 -69.82 95.42 0.9 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.804 -0.813 . . . . 65.319999999999993 108.804 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.1 m -61.3 126.07 26.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 111.929 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.8 mt -85.05 148.15 49.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.935 -1.03 . . . . 65.25 110.944 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 61.6 Cg_endo -79.09 159.62 26.86 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.625 2.216 . . . . 72.340000000000003 112.045 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.84 126.65 23.02 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.006 -0.543 . . . . 71.430000000000007 110.773 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -35.18 4.43 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.578 -0.737 . . . . 71.010000000000005 111.488 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 44.3 m95 -83.51 134.89 34.82 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.988 -0.375 . . . . 71.239999999999995 109.988 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 10.6 pt-20 -119.25 146.95 44.8 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.424 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 46' ' ' LEU . 37.1 p -105.2 156.7 17.86 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.456 1.097 . . . . 63.350000000000001 110.106 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -164.78 157.71 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.336 0.588 . . . . 74.209999999999994 111.265 -173.007 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 87.04 -174.05 45.35 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 114.872 -1.058 . . . . 72.200000000000003 112.077 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.3 144.49 28.9 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.784 -0.821 . . . . 72.409999999999997 108.784 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.6 Cg_endo -64.4 140.05 68.02 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.971 1.781 . . . . 72.400000000000006 112.36 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' HB3' ' A' ' 26' ' ' LEU . . . -171.65 147.03 2.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.708 -0.678 . . . . 55.439999999999998 109.676 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -59.77 168.3 1.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.391 0.138 . . . . 72.340000000000003 111.23 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE3' HD23 ' A' ' 63' ' ' LEU . 56.0 tptt -44.37 -51.59 8.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.921 -174.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.05 -47.82 77.18 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.901 0.382 . . . . 73.420000000000002 111.488 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 46.7 mt-30 -74.73 -35.28 62.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 72.450000000000003 111.147 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.75 -45.94 80.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 63.149999999999999 109.971 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 pp -68.05 -44.33 76.65 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.85 -0.426 . . . . 54.210000000000001 109.85 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.587 ' N ' HD12 ' A' ' 63' ' ' LEU . 27.0 tt0 -55.06 -37.98 67.44 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.301 0.572 . . . . 74.010000000000005 109.825 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.573 HH11 HG21 ' A' ' 29' ' ' VAL . 65.9 ttt-85 -57.43 -53.33 59.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.436 -0.802 . . . . 74.430000000000007 111.137 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.4 pt -74.22 -33.9 36.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.449 -0.341 . . . . 74.430000000000007 111.892 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 74.4 mm-40 -64.12 -42.89 96.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.536 -0.302 . . . . 71.010000000000005 110.416 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.6 mm-40 -74.42 4.73 5.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.355 . . . . 75.109999999999999 111.078 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.9 mt -103.14 -64.98 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 70.129999999999995 110.695 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.42 -52.03 6.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 45.109999999999999 111.141 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 m -73.47 -11.26 60.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.549 -0.75 . . . . 55.350000000000001 111.036 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 123.679 0.792 . . . . 73.310000000000002 112.269 -173.271 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.334 0.588 . . . . 63.109999999999999 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -133.93 155.98 48.95 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.116 -0.947 . . . . 64.219999999999999 109.713 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -121.17 159.81 25.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.022 -0.99 . . . . 74.329999999999998 108.693 172.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 HG23 ' A' ' 53' ' ' VAL . 42.3 t -91.47 125.61 44.18 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.098 -1.075 . . . . 71.299999999999997 108.098 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 52' ' ' THR . 16.7 m -133.17 166.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.9 0.381 . . . . 74.310000000000002 111.084 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -165.81 162.23 18.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.497 -0.774 . . . . 74.209999999999994 110.522 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 23.9 p-10 -151.94 139.78 19.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.647 0.26 . . . . 44.450000000000003 110.353 171.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 44.47 8.97 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.14 1.163 . . . . 73.120000000000005 114.14 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.41 -32.26 6.55 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.789 -0.569 . . . . 70.25 111.852 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -22.94 3.65 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.958 -0.564 . . . . 21.199999999999999 113.078 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -87.43 173.69 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.456 -0.572 . . . . 74.310000000000002 109.456 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 15.8 m-85 -106.89 138.75 42.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.365 0.876 . . . . 73.099999999999994 113.365 -172.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 m -134.96 -179.01 5.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.402 -1.272 . . . . 73.510000000000005 109.011 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.3 m -124.26 159.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.935 0.397 . . . . 63.030000000000001 111.29 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.465 ' HB2' HG21 ' A' ' 30' ' ' VAL . 68.3 t-105 -142.8 143.38 32.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.252 -0.647 . . . . 74.310000000000002 109.252 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.5 ttt -81.37 127.44 32.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.234 -0.284 . . . . 73.299999999999997 110.234 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.79 157.11 18.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.256 -0.429 . . . . 70.439999999999998 111.26 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.32 10.6 55.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.191 -0.528 . . . . 43.5 112.669 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -151.47 130.0 12.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.903 0.382 . . . . 65.319999999999993 110.147 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -80.67 153.42 27.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.514 0.673 . . . . 72.319999999999993 111.643 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 52' ' ' THR . 52.7 mt -95.26 145.81 30.19 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 114.857 -1.065 . . . . 65.25 111.013 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.31 168.35 14.95 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.642 2.228 . . . . 72.340000000000003 112.551 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.3 129.84 22.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 111.022 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.82 -33.03 6.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.022 -0.536 . . . . 71.010000000000005 111.804 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 45.0 m95 -88.48 141.46 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.786 0.327 . . . . 71.239999999999995 110.762 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.02 154.49 47.36 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 110.304 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.625 HG23 HD12 ' A' ' 46' ' ' LEU . 15.7 p -114.49 160.68 18.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.373 1.046 . . . . 63.350000000000001 111.194 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.452 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -165.72 149.35 2.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 C-N-CA 123.474 0.71 . . . . 74.209999999999994 110.907 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 108.27 -172.65 17.21 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.128 -0.942 . . . . 72.200000000000003 113.305 172.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' OE2' ' HD2' ' A' ' 56' ' ' PRO . 5.8 tp10 -103.27 129.45 25.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 107.983 -1.117 . . . . 72.409999999999997 107.983 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 18.9 Cg_endo -56.74 122.11 11.23 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.738 1.625 . . . . 72.400000000000006 111.32 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.72 157.78 30.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 55.439999999999998 110.431 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 t -55.73 152.93 8.83 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.088 0.243 . . . . 72.340000000000003 110.698 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.78 -42.44 25.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 111.853 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -53.92 -44.09 70.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.098 0.475 . . . . 73.420000000000002 111.036 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 82.6 mm-40 -74.85 -39.11 61.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 72.450000000000003 110.537 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 39' ' ' VAL . 8.9 t -63.42 -43.69 96.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 63.149999999999999 110.561 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.4 pp -68.14 -36.63 80.0 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 109.621 -0.511 . . . . 54.210000000000001 109.621 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 36.6 tt0 -54.77 -44.61 73.82 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.308 -0.627 . . . . 74.010000000000005 109.308 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -56.34 -52.0 66.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.814 -0.63 . . . . 74.430000000000007 110.952 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.49 -35.97 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.653 -0.249 . . . . 74.430000000000007 111.637 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 26.5 mm-40 -66.42 -32.75 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.603 0.239 . . . . 71.010000000000005 110.624 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.7 mm100 -81.19 -18.91 44.59 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.273 -0.421 . . . . 75.109999999999999 111.396 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.89 -66.65 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.327 0.584 . . . . 70.129999999999995 112.187 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 65.5 t-105 -85.3 -46.1 11.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 45.109999999999999 110.66 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -82.71 -10.06 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.098 -0.955 . . . . 55.350000000000001 110.993 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 114.656 1.354 . . . . 73.310000000000002 114.656 -170.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.62 0.724 . . . . 63.109999999999999 111.419 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 22.7 m-85 -129.92 148.55 51.8 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.574 -1.194 . . . . 64.219999999999999 108.843 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.581 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.58 166.41 11.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 74.329999999999998 108.742 171.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.6 t -94.56 111.72 25.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 107.1 -1.444 . . . . 71.299999999999997 107.1 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 40' ' ' TRP . 11.5 m -125.87 167.0 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.985 -0.447 . . . . 74.310000000000002 111.534 -170.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -166.19 169.68 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 74.209999999999994 110.997 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 26.0 p-10 -156.15 139.75 15.97 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.538 -0.301 . . . . 44.450000000000003 110.757 172.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.3 t30 40.53 10.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.898 1.279 . . . . 73.120000000000005 114.216 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.0 pt-20 -112.61 -32.29 6.5 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.691 -0.631 . . . . 70.25 112.124 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 -22.96 2.19 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.165 -0.541 . . . . 21.199999999999999 112.633 -173.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -75.81 173.89 10.57 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.624 -0.51 . . . . 74.310000000000002 109.624 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -115.71 142.29 46.94 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.912 0.708 . . . . 73.099999999999994 112.912 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.0 m -137.59 -179.46 5.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.417 -1.265 . . . . 73.510000000000005 109.65 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.02 148.99 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.769 0.319 . . . . 63.030000000000001 110.983 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.488 ' HB2' HG21 ' A' ' 30' ' ' VAL . 70.3 t90 -144.44 129.88 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 110.958 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.6 ttm -69.93 143.58 52.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 73.299999999999997 110.477 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.09 -172.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 110.655 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.55 -34.41 4.2 Favored Glycine 0 CA--C 1.515 0.071 0 C-N-CA 121.175 -0.535 . . . . 43.5 112.831 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 mpt_? -95.97 -170.89 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.061 0.458 . . . . 65.319999999999993 110.384 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 p -135.3 117.26 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.991 -0.744 . . . . 72.319999999999993 108.991 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 HG23 ' A' ' 52' ' ' THR . 17.6 mt -57.7 132.21 82.53 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.101 -0.5 . . . . 65.25 111.566 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.4 158.61 9.61 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.707 2.938 . . . . 72.340000000000003 112.794 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 123.37 17.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.92 -0.582 . . . . 71.430000000000007 110.07 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.79 -29.13 7.35 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.067 -0.813 . . . . 71.010000000000005 111.067 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 59.0 m95 -84.99 151.45 24.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.779 -0.452 . . . . 71.239999999999995 109.779 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.69 145.94 45.31 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 116.363 -0.381 . . . . 74.230000000000004 110.161 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.608 HG23 HD12 ' A' ' 46' ' ' LEU . 38.7 p -104.5 144.59 31.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.783 -1.099 . . . . 63.350000000000001 110.152 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.73 168.44 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.429 0.633 . . . . 74.209999999999994 110.466 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 -148.64 22.29 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.284 -0.871 . . . . 72.200000000000003 111.955 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 28.5 tt0 -132.65 132.93 22.92 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.618 -0.882 . . . . 72.409999999999997 108.618 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.581 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -70.48 125.66 12.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.882 1.721 . . . . 72.400000000000006 111.621 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.0 175.58 13.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.195 -0.457 . . . . 55.439999999999998 110.684 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 t -62.99 151.36 39.92 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.145 -0.317 . . . . 72.340000000000003 110.145 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -44.55 -43.26 7.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 75.310000000000002 111.373 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.56 -42.62 92.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 73.420000000000002 111.269 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.03 -36.61 61.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 72.450000000000003 111.132 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 62.5 m -64.92 -44.85 88.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 63.149999999999999 111.175 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.07 -41.85 81.34 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.76 -0.459 . . . . 54.210000000000001 109.76 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.585 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.1 tt0 -59.37 -37.37 77.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.465 0.65 . . . . 74.010000000000005 110.436 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 11.4 ttt180 -64.38 -47.0 80.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.474 -0.785 . . . . 74.430000000000007 111.153 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.0 pt -74.4 -34.85 37.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.718 0.294 . . . . 74.430000000000007 111.63 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.94 -48.55 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 71.010000000000005 110.961 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 22.1 mm-40 -70.43 8.46 0.81 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.073 0.464 . . . . 75.109999999999999 111.651 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 92.5 mt -103.42 -66.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.341 0.591 . . . . 70.129999999999995 110.203 172.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -83.49 -54.69 4.77 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.401 -0.818 . . . . 45.109999999999999 110.668 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -72.18 -11.16 60.61 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.426 -0.806 . . . . 55.350000000000001 110.712 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 13.0 t70 . . . . . 0 N--CA 1.469 0.502 0 CA-C-N 115.599 -0.728 . . . . 73.310000000000002 111.931 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 56' ' ' PRO . 8.2 mp . . . . . 0 C--O 1.238 0.457 0 CA-C-O 121.505 0.669 . . . . 63.109999999999999 111.129 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.631 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 13.0 m-85 -133.1 157.49 45.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.766 -1.106 . . . . 64.219999999999999 109.26 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.614 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.4 m-85 -113.79 167.67 10.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.634 -0.712 . . . . 74.329999999999998 109.224 170.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.55 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.905 -1.146 . . . . 71.299999999999997 107.905 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.483 HG12 HG22 ' A' ' 52' ' ' THR . 21.6 m -137.95 162.13 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 118.171 0.441 . . . . 74.310000000000002 111.349 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.49 168.17 9.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.569 -0.741 . . . . 74.209999999999994 110.798 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.1 p-10 -163.58 139.97 6.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 44.450000000000003 110.346 166.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 t30 46.5 4.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.085 1.143 . . . . 73.120000000000005 114.085 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.6 pt-20 -105.71 -25.42 12.23 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.418 -0.801 . . . . 70.25 112.312 -167.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 -22.3 9.6 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.481 -0.39 . . . . 21.199999999999999 113.171 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -100.1 173.97 6.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.903 -0.406 . . . . 74.310000000000002 109.903 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -106.43 153.72 21.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.436 . . . . 73.099999999999994 111.774 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -145.3 -178.72 6.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 73.510000000000005 109.217 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.12 158.14 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.929 0.395 . . . . 63.030000000000001 111.058 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 59.9 t90 -150.29 142.89 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 109.738 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.53 131.64 35.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 73.299999999999997 111.615 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.49 151.62 43.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.656 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.34 -12.75 43.85 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.171 -0.538 . . . . 43.5 112.883 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 74.8 mtt180 -104.87 -167.23 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.427 -0.582 . . . . 65.319999999999993 109.427 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.6 m -138.11 131.16 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 72.319999999999993 110.117 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HG11 ' A' ' 30' ' ' VAL . 17.6 mt -80.71 135.19 52.76 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 65.25 112.13 -174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.09 138.99 21.45 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.449 2.766 . . . . 72.340000000000003 112.626 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 130.16 31.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.952 -0.567 . . . . 71.430000000000007 110.103 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.86 -35.4 4.31 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.042 -0.823 . . . . 71.010000000000005 111.042 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.0 m95 -76.35 149.49 36.99 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.914 -0.402 . . . . 71.239999999999995 109.914 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.16 152.11 50.78 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 110.049 -0.352 . . . . 74.230000000000004 110.049 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 30' ' ' VAL . 21.5 p -109.44 161.51 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.103 . . . . 63.350000000000001 110.483 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.99 162.61 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.278 0.631 . . . . 74.209999999999994 109.931 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.48 -173.28 47.69 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.805 -0.634 . . . . 72.200000000000003 112.336 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.29 144.22 29.31 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.207 -1.034 . . . . 72.409999999999997 108.207 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.614 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 44.9 Cg_endo -65.67 115.48 3.41 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.652 1.568 . . . . 72.400000000000006 110.814 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -140.48 168.94 18.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.099 -0.5 . . . . 55.439999999999998 110.088 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 61' ' ' GLN . 8.8 t -59.73 151.86 24.15 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.681 -0.408 . . . . 72.340000000000003 110.496 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -46.76 -40.82 14.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.02 -0.536 . . . . 75.310000000000002 111.424 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.59 -43.32 99.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 73.420000000000002 110.893 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 93.7 mt-30 -72.85 -33.15 65.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.034 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 77.0 m -68.58 -45.95 70.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.475 -0.33 . . . . 63.149999999999999 110.83 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.11 -36.49 79.83 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.006 -0.368 . . . . 54.210000000000001 110.006 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 35.9 tt0 -66.53 -31.48 72.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.656 0.741 . . . . 74.010000000000005 110.118 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 13.0 ttt85 -65.57 -49.71 67.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 74.430000000000007 110.27 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.1 pt -70.28 -42.0 78.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 111.866 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 11.5 pt-20 -60.91 -49.43 77.48 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.251 -0.18 . . . . 71.010000000000005 110.653 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 83.2 mt-30 -74.85 1.94 11.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.887 0.329 . . . . 75.109999999999999 111.887 -174.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 mt -103.93 -66.03 0.98 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.276 0.56 . . . . 70.129999999999995 111.227 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -86.01 -53.94 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.245 -0.889 . . . . 45.109999999999999 111.198 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.03 -10.73 52.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.9 -1.046 . . . . 55.350000000000001 111.791 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 2.4 p-10 . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 113.991 1.108 . . . . 73.310000000000002 113.991 -168.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.9 mp . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.376 0.608 . . . . 63.109999999999999 110.248 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -124.92 148.66 48.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.037 -0.983 . . . . 64.219999999999999 109.238 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -119.34 159.8 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.694 -0.854 . . . . 74.329999999999998 108.694 174.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG21 HH11 ' A' ' 65' ' ' ARG . 30.3 t -89.4 139.91 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.534 -1.284 . . . . 71.299999999999997 107.534 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 29.6 m -139.58 164.9 23.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 121.981 -0.449 . . . . 74.310000000000002 111.367 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.655 HH21 ' HA2' ' A' ' 35' ' ' GLY . 9.4 ptm180 -158.16 161.78 37.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.881 -0.6 . . . . 74.209999999999994 111.118 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 25.5 p-10 -166.26 140.02 4.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 44.450000000000003 110.389 166.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 46.1 5.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.845 1.424 . . . . 73.120000000000005 114.845 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.2 pt-20 -112.23 -32.02 6.67 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.934 -0.479 . . . . 70.25 112.283 -170.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.655 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 81.82 -22.72 5.54 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.66 -0.781 . . . . 21.199999999999999 112.291 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -93.81 174.02 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.84 -0.43 . . . . 74.310000000000002 109.84 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -107.61 152.24 24.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.997 0.739 . . . . 73.099999999999994 112.997 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -137.75 -179.22 5.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.563 -1.199 . . . . 73.510000000000005 108.989 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 62' ' ' CYS . 30.5 m -126.08 152.5 33.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.053 0.454 . . . . 63.030000000000001 110.778 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.504 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 50.2 t90 -144.04 144.54 31.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.575 . . . . 74.310000000000002 110.458 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -90.62 135.47 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.811 -0.632 . . . . 73.299999999999997 110.724 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.39 175.27 6.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 110.154 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.48 61.82 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.798 -0.921 . . . . 43.5 110.798 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.2 ptm180 -140.89 176.86 8.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.952 -0.624 . . . . 65.319999999999993 109.366 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -126.69 126.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.42 . . . . 72.319999999999993 109.915 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 52' ' ' THR . 12.1 mt -56.22 135.04 75.21 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.454 -0.794 . . . . 65.25 112.144 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.71 155.48 70.27 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.018 2.479 . . . . 72.340000000000003 112.383 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 124.9 11.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 110.768 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.44 -30.16 6.87 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.986 -0.552 . . . . 71.010000000000005 112.208 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.53 ' HB3' HD13 ' A' ' 46' ' ' LEU . 30.6 m95 -93.3 148.44 22.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.768 0.284 . . . . 71.239999999999995 110.472 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -135.23 153.07 52.05 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.855 0.36 . . . . 74.230000000000004 111.581 173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.602 HG23 HD12 ' A' ' 46' ' ' LEU . 22.4 p -99.09 160.02 14.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.675 -1.148 . . . . 63.350000000000001 111.512 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -169.84 164.76 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.548 1.139 . . . . 74.209999999999994 109.661 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.16 -159.78 20.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.004 -0.617 . . . . 72.200000000000003 113.272 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -113.02 128.58 25.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.661 -0.866 . . . . 72.409999999999997 108.661 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 26' ' ' LEU . 51.1 Cg_endo -68.31 112.22 2.72 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.742 1.628 . . . . 72.400000000000006 111.42 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.32 166.16 33.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 55.439999999999998 109.91 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 t -63.98 168.38 5.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.154 0.502 . . . . 72.340000000000003 111.236 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.2 tptp -48.83 -50.38 34.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.366 -0.834 . . . . 75.310000000000002 111.916 -173.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -53.49 -41.56 66.37 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.456 0.473 . . . . 73.420000000000002 111.336 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -72.94 -43.98 61.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.303 0.573 . . . . 72.450000000000003 110.532 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 39' ' ' VAL . 3.8 t -60.49 -46.57 89.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.236 -0.893 . . . . 63.149999999999999 110.858 -173.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.9 pp -67.92 -40.69 83.34 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.883 -0.327 . . . . 54.210000000000001 110.983 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.627 ' N ' HD12 ' A' ' 63' ' ' LEU . 30.0 tt0 -60.96 -35.77 77.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.168 0.509 . . . . 74.010000000000005 110.524 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.483 HH11 HG21 ' A' ' 29' ' ' VAL . 63.4 ttt-85 -62.3 -53.66 51.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.924 -0.58 . . . . 74.430000000000007 110.855 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.8 pt -69.68 -34.55 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.568 -0.287 . . . . 74.430000000000007 111.365 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.2 -55.23 19.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 71.010000000000005 110.939 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 68.6 mt-30 -70.96 1.3 5.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 75.109999999999999 111.705 -174.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.6 mt -103.47 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 70.129999999999995 111.024 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -85.27 -46.83 10.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.694 -0.684 . . . . 45.109999999999999 110.509 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -80.46 -10.66 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.183 -0.917 . . . . 55.350000000000001 111.092 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 113.067 0.765 . . . . 73.310000000000002 113.067 -170.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp . . . . . 0 C--O 1.235 0.291 0 CA-C-O 121.454 0.645 . . . . 63.109999999999999 111.152 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 18.7 m-85 -131.14 148.68 52.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.082 -0.963 . . . . 64.219999999999999 109.537 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.05 162.43 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.155 -0.683 . . . . 74.329999999999998 109.155 176.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG21 HH11 ' A' ' 65' ' ' ARG . 71.1 t -95.4 137.76 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.35 -1.352 . . . . 71.299999999999997 107.35 172.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 HD11 ' A' ' 46' ' ' LEU . 33.4 m -134.57 164.71 33.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.109 0.481 . . . . 74.310000000000002 111.71 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.632 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 15.9 ptm180 -167.81 170.13 11.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.914 -1.039 . . . . 74.209999999999994 110.149 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.704 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 24.0 p-10 -167.39 139.99 3.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.73 -0.213 . . . . 44.450000000000003 111.007 166.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 37.2 16.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.686 1.365 . . . . 73.120000000000005 114.686 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.806 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.8 pt-20 -112.31 -29.16 7.64 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.763 -0.585 . . . . 70.25 112.479 -172.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' NH2' ' A' ' 31' ' ' ARG . . . 74.62 7.69 79.97 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.599 -0.81 . . . . 21.199999999999999 111.666 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.806 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 6.7 tp60 -116.21 167.88 10.61 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.599 -0.889 . . . . 74.310000000000002 108.599 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -112.96 153.56 27.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.546 0.573 . . . . 73.099999999999994 112.546 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.407 ' O ' HG13 ' A' ' 29' ' ' VAL . 66.2 m -147.61 -179.33 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.999 -1.0 . . . . 73.510000000000005 109.478 172.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -123.54 163.48 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 63.030000000000001 110.604 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -151.01 149.81 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 74.310000000000002 109.934 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.5 ttt -86.15 126.89 34.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 73.299999999999997 110.242 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.56 142.86 57.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.896 0.379 . . . . 70.439999999999998 110.949 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.66 -15.86 29.05 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.675 -0.693 . . . . 43.5 111.965 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.392 -0.225 . . . . 65.319999999999993 110.392 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -84.25 119.42 25.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.195 0.521 . . . . 72.319999999999993 110.485 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 52' ' ' THR . 33.9 mt -68.55 143.82 95.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 65.25 111.744 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 47.3 Cg_endo -75.29 154.21 40.99 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.451 2.1 . . . . 72.340000000000003 112.266 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.61 125.96 7.74 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.333 -0.848 . . . . 71.430000000000007 111.489 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.74 -35.0 4.83 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.972 -0.558 . . . . 71.010000000000005 112.177 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.704 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 16.8 m95 -77.19 157.27 30.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.629 0.252 . . . . 71.239999999999995 110.437 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 8.0 pt-20 -144.91 146.95 32.23 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.276 -0.42 . . . . 74.230000000000004 110.776 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 HD12 ' A' ' 46' ' ' LEU . 25.1 p -98.86 163.37 12.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.649 -0.705 . . . . 63.350000000000001 111.442 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -166.26 152.71 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 123.663 0.785 . . . . 74.209999999999994 110.306 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 100.88 -175.25 26.2 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.33 -0.85 . . . . 72.200000000000003 113.472 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -103.03 116.14 62.93 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.784 -1.191 . . . . 72.409999999999997 107.784 172.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 32.1 Cg_endo -60.18 124.85 16.07 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.961 1.774 . . . . 72.400000000000006 111.926 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.91 173.45 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.503 . . . . 55.439999999999998 109.86 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -55.63 153.71 7.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.402 0.144 . . . . 72.340000000000003 111.144 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HE3' HG21 ' A' ' 39' ' ' VAL . 23.7 tptm -44.05 -43.2 6.63 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.992 0.517 . . . . 75.310000000000002 111.054 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.99 -47.64 68.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.454 -0.794 . . . . 73.420000000000002 111.259 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.87 -32.07 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 72.450000000000003 110.51 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.5 t -64.08 -48.75 74.97 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.808 -0.633 . . . . 63.149999999999999 110.58 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -67.69 -34.83 77.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.882 0.372 . . . . 54.210000000000001 110.12 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 63' ' ' LEU . 56.6 tt0 -58.86 -43.98 90.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.54 -0.755 . . . . 74.010000000000005 110.334 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 62.3 ttt-85 -56.94 -53.47 57.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.123 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.1 pt -71.04 -32.9 49.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.269 -0.423 . . . . 74.430000000000007 111.535 -174.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.65 -44.69 85.58 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.132 -0.322 . . . . 71.010000000000005 110.132 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.84 -1.9 6.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.052 0.39 . . . . 75.109999999999999 112.052 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.7 mt -103.59 -66.45 0.95 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.383 0.611 . . . . 70.129999999999995 111.222 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -85.61 -52.4 5.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 45.109999999999999 110.201 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -76.27 -11.05 59.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.757 -1.11 . . . . 55.350000000000001 111.57 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 122.967 0.507 . . . . 73.310000000000002 111.732 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.4 mp . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.226 0.536 . . . . 63.109999999999999 111.244 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 6.8 m-85 -127.83 162.12 27.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.309 -0.86 . . . . 64.219999999999999 110.637 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 m-85 -126.85 167.78 15.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 109.42 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.41 135.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 71.299999999999997 107.289 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 52' ' ' THR . 33.4 m -139.94 169.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.867 0.303 . . . . 74.310000000000002 111.127 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -167.84 170.02 11.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.143 -0.481 . . . . 74.209999999999994 111.305 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 23.8 p-10 -161.65 140.03 9.39 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.113 -0.494 . . . . 44.450000000000003 110.862 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 46.07 8.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.055 1.131 . . . . 73.120000000000005 114.055 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.7 pt-20 -112.33 -32.09 6.62 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.786 -0.571 . . . . 70.25 112.073 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 -22.64 6.52 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 112.065 -0.414 . . . . 21.199999999999999 112.065 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -81.85 173.85 11.86 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.826 0.45 . . . . 74.310000000000002 109.961 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.587 ' HD2' ' HE1' ' A' ' 70' ' ' TRP . 14.7 m-85 -118.27 141.96 47.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 73.099999999999994 111.938 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -132.74 -179.35 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.79 -1.096 . . . . 73.510000000000005 109.246 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.35 160.35 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.704 0.287 . . . . 63.030000000000001 110.578 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 63.0 t-105 -148.13 151.25 35.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 74.310000000000002 109.9 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -91.37 129.28 37.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.289 -0.263 . . . . 73.299999999999997 110.289 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.38 150.87 25.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 70.439999999999998 110.609 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.26 16.47 Favored Glycine 0 N--CA 1.453 -0.177 0 N-CA-C 111.539 -0.624 . . . . 43.5 111.539 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 53.4 mtt-85 -88.19 110.11 20.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 110.416 -0.216 . . . . 65.319999999999993 110.416 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -71.33 130.01 40.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.067 0.461 . . . . 72.319999999999993 109.961 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD12 HG23 ' A' ' 52' ' ' THR . 40.4 mt -76.05 142.82 72.91 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.337 -0.847 . . . . 65.25 111.396 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 67.3 Cg_endo -75.82 156.25 39.35 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.579 2.186 . . . . 72.340000000000003 111.711 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.59 122.41 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.698 -0.683 . . . . 71.430000000000007 111.49 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.9 -32.21 5.75 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.061 -0.518 . . . . 71.010000000000005 112.434 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.502 ' HB3' HD13 ' A' ' 46' ' ' LEU . 31.2 m95 -80.19 146.25 31.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.851 0.325 . . . . 71.239999999999995 110.697 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.58 155.71 49.15 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.524 -0.307 . . . . 74.230000000000004 110.729 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 HD12 ' A' ' 46' ' ' LEU . 17.4 p -112.57 162.18 15.95 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.543 1.152 . . . . 63.350000000000001 111.483 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG21 ' CE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -166.02 145.02 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.054 0.542 . . . . 74.209999999999994 111.009 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.13 -165.61 18.59 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.559 -0.746 . . . . 72.200000000000003 112.248 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -104.73 145.02 29.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.148 -0.686 . . . . 72.409999999999997 109.148 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.5 Cg_endo -67.3 105.31 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.051 1.167 . . . . 72.400000000000006 110.136 173.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.61 165.19 31.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.095 -0.957 . . . . 55.439999999999998 110.977 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -62.02 166.95 4.2 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.394 0.616 . . . . 72.340000000000003 112.487 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.651 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 58.9 tptt -46.34 -50.02 16.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.966 -1.016 . . . . 75.310000000000002 111.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.76 -39.24 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.951 -0.568 . . . . 73.420000000000002 111.303 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -73.7 -44.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.166 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 27.4 p -64.12 -45.15 89.85 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.002 -0.279 . . . . 63.149999999999999 111.25 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -68.15 -41.21 81.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 54.210000000000001 110.454 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.626 ' N ' HD12 ' A' ' 63' ' ' LEU . 52.4 tt0 -63.2 -36.46 83.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 74.010000000000005 110.376 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.541 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 ttt180 -58.7 -53.73 55.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.878 0.37 . . . . 74.430000000000007 110.905 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.9 pt -72.78 -32.66 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 74.430000000000007 111.213 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -61.23 -44.62 96.97 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.193 -0.299 . . . . 71.010000000000005 110.193 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.8 mm-40 -73.09 0.93 10.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.93 0.395 . . . . 75.109999999999999 111.132 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 80.1 mt -103.62 -66.13 0.97 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 70.129999999999995 111.258 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.587 ' HE1' ' HD2' ' A' ' 37' ' ' TYR . 73.0 m95 -85.68 -45.69 11.44 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.979 -0.555 . . . . 45.109999999999999 111.027 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 m -81.71 -11.19 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.834 . . . . 55.350000000000001 110.901 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 115.993 -0.548 . . . . 73.310000000000002 111.565 -172.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.918 0.866 . . . . 63.109999999999999 111.358 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.37 161.54 33.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.914 -1.494 . . . . 64.219999999999999 108.738 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -130.0 160.08 34.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.08 -0.964 . . . . 74.329999999999998 108.621 172.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' VAL . 55.8 t -90.32 120.89 39.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 107.564 -1.272 . . . . 71.299999999999997 107.564 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.76 160.51 32.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.192 0.52 . . . . 74.310000000000002 111.973 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 36' ' ' GLN . 17.2 ptt85 -169.53 170.16 8.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.777 -1.101 . . . . 74.209999999999994 110.216 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.608 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 25.9 p-10 -145.03 139.49 27.48 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.516 -0.473 . . . . 44.450000000000003 110.505 169.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.0 t30 30.95 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.208 1.559 . . . . 73.120000000000005 115.208 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.0 pt-20 -112.49 -32.06 6.6 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.471 -0.768 . . . . 70.25 112.536 -172.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.94 -22.48 8.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.156 -0.545 . . . . 21.199999999999999 112.641 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.44 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 33.8 tt0 -80.01 158.65 26.48 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.952 -0.758 . . . . 74.310000000000002 108.952 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.05 140.61 46.58 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.771 0.656 . . . . 73.099999999999994 112.771 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m -134.1 -179.23 5.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.031 -0.986 . . . . 73.510000000000005 109.351 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.64 158.34 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.621 0.248 . . . . 63.030000000000001 110.694 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CE2' ' HG ' ' A' ' 46' ' ' LEU . 75.0 t90 -155.14 145.41 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.212 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.1 ttt -81.49 125.53 30.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.746 0.308 . . . . 73.299999999999997 111.279 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.06 142.12 47.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.027 -0.533 . . . . 70.439999999999998 110.494 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.47 -5.52 29.81 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 111.582 -0.607 . . . . 43.5 111.582 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -108.12 166.29 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.147 0.579 . . . . 65.319999999999993 109.45 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -97.19 115.07 26.91 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.116 -0.365 . . . . 72.319999999999993 110.565 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 mt -69.68 138.76 88.4 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 65.25 110.745 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 19.2 Cg_endo -65.61 137.1 48.84 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 122.244 1.963 . . . . 72.340000000000003 111.75 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.11 124.9 4.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.47 -0.786 . . . . 71.430000000000007 111.509 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -34.12 4.92 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.773 -0.649 . . . . 71.010000000000005 111.772 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.1 m95 -77.6 139.81 39.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.716 0.293 . . . . 71.239999999999995 110.723 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 13.0 pt-20 -126.7 156.22 41.44 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.59 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.2 p -104.39 153.19 21.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.555 -1.202 . . . . 63.350000000000001 111.085 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.37 161.73 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 123.419 0.688 . . . . 74.209999999999994 109.985 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 -159.4 24.51 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.399 -0.819 . . . . 72.200000000000003 111.96 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -109.9 137.48 20.48 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 109.269 -0.641 . . . . 72.409999999999997 109.269 176.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.645 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 57.0 Cg_endo -68.79 116.48 4.47 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.406 1.404 . . . . 72.400000000000006 110.431 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -162.47 169.39 20.46 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.15 -0.477 . . . . 55.439999999999998 110.251 -169.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 61' ' ' GLN . 43.3 p -55.74 151.9 10.42 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.916 0.135 . . . . 72.340000000000003 111.035 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.13 -41.66 3.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.287 0.565 . . . . 75.310000000000002 110.147 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -56.66 -52.32 65.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.664 -1.153 . . . . 73.420000000000002 111.492 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.504 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 10.3 mm-40 -71.32 -41.8 69.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 72.450000000000003 110.754 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 57' ' ' ALA . 72.8 m -60.59 -45.95 92.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.395 -0.366 . . . . 63.149999999999999 111.167 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.09 -36.41 79.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.42 -0.585 . . . . 54.210000000000001 109.42 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -58.18 -31.58 67.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.428 -0.806 . . . . 74.010000000000005 110.318 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 34.1 ttt180 -65.83 -53.26 42.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.898 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 pt -73.35 -32.35 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 74.430000000000007 112.46 -171.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 12.4 pt-20 -58.47 -32.69 69.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.042 0.448 . . . . 71.010000000000005 109.925 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 79.3 mm-40 -87.7 -9.38 54.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 111.379 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -103.74 -65.69 1.0 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.708 0.766 . . . . 70.129999999999995 111.619 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -85.39 -43.21 13.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.07 -0.968 . . . . 45.109999999999999 110.78 -175.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.13 -10.83 51.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.82 -0.627 . . . . 55.350000000000001 112.268 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 4.9 p-10 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 115.321 1.6 . . . . 73.310000000000002 115.321 -163.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.6 mp . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.883 0.373 . . . . 63.109999999999999 110.289 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.06 158.15 39.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.505 0.722 . . . . 64.219999999999999 110.367 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.638 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 22.0 m-85 -113.03 169.54 8.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 74.329999999999998 109.118 166.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 HG21 ' A' ' 66' ' ' ILE . 56.5 t -95.01 125.22 47.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.825 -1.176 . . . . 71.299999999999997 107.825 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 HD11 ' A' ' 46' ' ' LEU . 27.4 m -125.95 160.86 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.258 0.551 . . . . 74.310000000000002 111.95 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 11.8 ptt180 -169.16 170.13 8.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.62 -1.173 . . . . 74.209999999999994 110.083 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -145.83 139.59 26.48 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 44.450000000000003 110.834 164.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 33.06 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.745 1.757 . . . . 73.120000000000005 115.745 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.9 pt-20 -112.59 -29.36 7.49 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.583 0.628 . . . . 70.25 111.917 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 -10.52 48.81 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.152 -0.547 . . . . 21.199999999999999 112.634 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.564 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 69.3 mt-30 -84.78 173.03 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.039 -0.726 . . . . 74.310000000000002 109.039 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.31 132.66 48.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.957 0.725 . . . . 73.099999999999994 112.957 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -131.69 -178.9 5.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.791 -1.095 . . . . 73.510000000000005 108.475 172.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' SG ' ' A' ' 62' ' ' CYS . 23.7 m -124.17 149.53 28.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.204 0.526 . . . . 63.030000000000001 111.322 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HB2' HG21 ' A' ' 30' ' ' VAL . 55.8 t-105 -148.83 143.4 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.755 . . . . 74.310000000000002 109.28 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -74.85 141.37 44.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.893 0.377 . . . . 73.299999999999997 111.311 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.55 147.04 44.31 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.374 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.79 4.83 67.05 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.392 -0.433 . . . . 43.5 112.304 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -121.81 112.35 18.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.88 -0.415 . . . . 65.319999999999993 109.88 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.9 m -57.98 123.0 14.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.583 -0.735 . . . . 72.319999999999993 111.469 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 15.9 mt -79.99 139.76 53.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.308 -0.86 . . . . 65.25 110.836 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.33 140.06 53.45 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.691 2.261 . . . . 72.340000000000003 111.632 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.82 126.19 15.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.96 -0.564 . . . . 71.430000000000007 110.384 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -29.54 7.06 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.11 -0.495 . . . . 71.010000000000005 112.295 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.618 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.6 m95 -75.5 155.05 36.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.028 0.414 . . . . 71.239999999999995 110.607 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.8 pt-20 -135.67 148.97 49.13 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 110.043 -0.355 . . . . 74.230000000000004 110.043 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.409 HG22 HG12 ' A' ' 30' ' ' VAL . 19.6 p -109.19 153.01 24.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.431 -0.804 . . . . 63.350000000000001 110.983 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.2 t -149.98 152.9 11.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 122.842 0.457 . . . . 74.209999999999994 110.476 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.73 -170.12 37.9 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.797 -0.638 . . . . 72.200000000000003 113.198 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -108.43 143.71 28.03 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 109.102 -0.703 . . . . 72.409999999999997 109.102 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.638 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 36.8 Cg_endo -63.1 122.14 10.26 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.161 1.907 . . . . 72.400000000000006 112.678 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 157.35 42.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.453 -0.794 . . . . 55.439999999999998 109.604 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 t -56.32 156.7 5.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.61 0.243 . . . . 72.340000000000003 111.085 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -43.26 -50.18 6.56 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.663 -0.699 . . . . 75.310000000000002 111.635 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.39 -49.46 76.14 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.412 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -70.16 -35.1 73.77 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.093 0.473 . . . . 72.450000000000003 110.461 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.484 ' SG ' HG12 ' A' ' 39' ' ' VAL . 18.2 t -62.09 -51.71 66.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 63.149999999999999 110.048 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.36 -33.43 74.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.016 -0.273 . . . . 54.210000000000001 110.347 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 51.8 tt0 -62.45 -31.93 72.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.531 0.681 . . . . 74.010000000000005 110.635 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 35.9 ttm180 -62.35 -53.1 59.92 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.035 -0.529 . . . . 74.430000000000007 112.091 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.608 HG21 HG11 ' A' ' 29' ' ' VAL . 17.8 pt -72.96 -35.11 47.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.737 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 4.2 pt-20 -57.78 -46.21 84.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.606 -0.438 . . . . 71.010000000000005 109.839 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.621 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 86.0 mt-30 -74.15 -0.41 16.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.388 -0.369 . . . . 75.109999999999999 111.633 -173.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.8 mt -103.37 -68.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.552 -0.459 . . . . 70.129999999999995 112.139 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -87.34 -55.08 3.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.621 -0.718 . . . . 45.109999999999999 111.976 -176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 67' ' ' GLU . 2.9 p -81.81 -10.89 59.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.708 -1.133 . . . . 55.350000000000001 111.752 -171.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.1 t70 . . . . . 0 N--CA 1.469 0.525 0 C-N-CA 123.948 0.899 . . . . 73.310000000000002 113.043 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.0 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.111 0.482 . . . . 63.109999999999999 110.97 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 33.8 m-85 -123.66 149.06 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.49 -0.777 . . . . 64.219999999999999 109.741 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -114.86 155.97 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 74.329999999999998 108.921 169.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.72 114.83 24.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 N-CA-C 107.86 -1.163 . . . . 71.299999999999997 107.86 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 40' ' ' TRP . 12.7 m -125.14 159.62 31.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 122.164 -0.335 . . . . 74.310000000000002 110.561 -170.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -162.0 162.11 28.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.351 -0.84 . . . . 74.209999999999994 110.722 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 p30 -152.05 139.69 19.75 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.269 -0.271 . . . . 44.450000000000003 110.269 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t30 46.63 4.63 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.993 1.109 . . . . 73.120000000000005 113.993 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.19 -32.43 6.54 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.656 -0.653 . . . . 70.25 112.095 -169.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.51 -22.68 3.16 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.352 -0.452 . . . . 21.199999999999999 112.617 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -75.51 173.96 10.29 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.727 -0.471 . . . . 74.310000000000002 109.727 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.49 136.01 53.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 73.099999999999994 112.172 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -135.86 -178.74 5.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.066 -0.97 . . . . 73.510000000000005 109.456 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG11 ' SG ' ' A' ' 62' ' ' CYS . 27.7 m -128.72 150.02 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.68 0.276 . . . . 63.030000000000001 111.069 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 30' ' ' VAL . 52.2 t-105 -149.45 141.48 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.851 -0.613 . . . . 74.310000000000002 109.736 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.6 mtt -65.45 134.24 53.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.1 0.476 . . . . 73.299999999999997 111.408 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.23 147.82 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.764 -0.653 . . . . 70.439999999999998 110.451 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.72 62.53 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.188 -0.765 . . . . 43.5 111.188 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -93.91 96.48 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.731 -0.84 . . . . 65.319999999999993 108.731 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -55.57 116.52 2.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 112.113 -169.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.441 HD11 HG11 ' A' ' 30' ' ' VAL . 42.6 mt -74.4 139.64 75.22 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.729 -1.123 . . . . 65.25 110.055 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.22 160.48 20.31 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.636 2.224 . . . . 72.340000000000003 112.478 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.3 129.92 18.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.549 -0.75 . . . . 71.430000000000007 110.53 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.54 -33.29 5.31 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.35 -0.7 . . . . 71.010000000000005 111.35 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 43.2 m95 -88.72 148.08 24.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.508 0.194 . . . . 71.239999999999995 110.519 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 149.37 52.13 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 110.262 -0.273 . . . . 74.230000000000004 110.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 30' ' ' VAL . 34.8 p -111.53 148.3 33.5 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.376 1.048 . . . . 63.350000000000001 111.057 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -154.05 156.4 5.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.573 0.749 . . . . 74.209999999999994 109.878 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.43 -158.58 23.7 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.406 -0.426 . . . . 72.200000000000003 113.483 169.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.89 131.68 21.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.611 . . . . 72.409999999999997 109.349 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HB2' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -70.08 109.08 2.28 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 121.623 1.549 . . . . 72.400000000000006 111.255 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.07 171.09 20.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.236 -0.893 . . . . 55.439999999999998 110.442 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -58.28 166.19 1.75 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.254 0.55 . . . . 72.340000000000003 112.437 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.683 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 32.1 tptt -49.82 -49.77 47.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.055 -0.975 . . . . 75.310000000000002 110.669 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -54.42 -43.04 71.2 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.087 -0.96 . . . . 73.420000000000002 111.342 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -70.04 -48.45 57.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 72.450000000000003 110.746 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 9.1 p -62.93 -42.4 99.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.075 -0.511 . . . . 63.149999999999999 111.515 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -67.93 -40.82 83.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.492 -0.483 . . . . 54.210000000000001 110.093 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . 59.3 tt0 -60.19 -31.43 70.13 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.789 -0.641 . . . . 74.010000000000005 110.454 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 75.5 ttt-85 -73.86 -53.3 10.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.627 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 63' ' ' LEU . 39.3 pt -66.23 -32.8 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 112.228 0.455 . . . . 74.430000000000007 112.228 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.42 -32.85 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.606 0.241 . . . . 71.010000000000005 110.353 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.448 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 91.2 mt-30 -87.53 -1.63 58.07 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.073 -0.512 . . . . 75.109999999999999 111.349 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 85.9 mt -104.0 -66.72 0.94 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.272 0.558 . . . . 70.129999999999995 111.656 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -86.09 -55.14 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.391 -0.822 . . . . 45.109999999999999 111.163 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.8 -10.99 59.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.205 -0.907 . . . . 55.350000000000001 111.311 -174.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.4 t70 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.693 0.797 . . . . 73.310000000000002 112.981 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 56' ' ' PRO . 6.4 mp . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.413 0.625 . . . . 63.109999999999999 112.34 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.625 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 6.3 m-85 -124.65 149.3 47.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.659 -1.155 . . . . 64.219999999999999 109.001 174.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.567 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -108.17 169.75 8.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.698 -0.482 . . . . 74.329999999999998 109.698 172.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 53' ' ' VAL . 51.0 t -99.0 137.53 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.412 -1.329 . . . . 71.299999999999997 107.412 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.62 161.91 29.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 118.405 0.548 . . . . 74.310000000000002 111.878 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -169.06 170.19 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.961 -1.018 . . . . 74.209999999999994 110.436 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 4.8 p30 -165.73 139.81 4.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.438 -0.208 . . . . 44.450000000000003 110.438 166.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.75 8.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.274 1.213 . . . . 73.120000000000005 114.274 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.8 pt-20 -112.08 -29.84 7.45 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.798 -0.564 . . . . 70.25 112.05 -169.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.66 -22.92 7.04 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.244 -0.503 . . . . 21.199999999999999 113.011 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.12 173.87 8.58 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -116.69 150.73 37.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.326 0.491 . . . . 73.099999999999994 112.326 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -144.47 -178.95 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.867 . . . . 73.510000000000005 109.453 168.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.55 165.41 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.784 0.326 . . . . 63.030000000000001 110.858 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.509 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 35.0 t90 -151.72 132.2 13.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 74.310000000000002 110.692 -170.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.457 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 15.8 tpt -68.06 127.32 32.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.051 -0.522 . . . . 73.299999999999997 110.136 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.93 159.58 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 70.439999999999998 109.606 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.42 21.04 25.58 Favored Glycine 0 C--N 1.329 0.166 0 C-N-CA 121.022 -0.608 . . . . 43.5 112.004 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.8 ptm180 -148.28 179.11 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.654 -0.499 . . . . 65.319999999999993 109.654 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 m -109.47 154.0 23.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.559 -0.534 . . . . 72.319999999999993 109.559 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 47' ' ' PRO . 11.2 tp -104.22 129.19 25.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 65.25 110.193 -174.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 46' ' ' LEU . 83.9 Cg_exo -40.42 132.82 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.522 2.814 . . . . 72.340000000000003 113.217 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 128.29 20.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.728 -0.669 . . . . 71.430000000000007 111.192 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.86 -34.22 5.09 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.875 -0.89 . . . . 71.010000000000005 110.875 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.755 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 45.6 m95 -76.69 157.64 31.62 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 110.167 -0.308 . . . . 71.239999999999995 110.167 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.63 152.99 48.58 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.111 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -105.67 154.52 20.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.738 -1.119 . . . . 63.350000000000001 110.528 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -163.05 161.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.225 0 C-N-CA 123.334 0.654 . . . . 74.209999999999994 110.863 -174.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.44 -140.09 14.96 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.823 -1.08 . . . . 72.200000000000003 112.72 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 26.0 tt0 -140.26 133.96 15.27 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.308 -0.997 . . . . 72.409999999999997 108.308 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 70.0 Cg_endo -70.29 112.48 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.603 . . . . 72.400000000000006 111.073 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -142.63 174.41 10.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.591 -0.731 . . . . 55.439999999999998 110.692 -172.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -64.44 157.88 25.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.589 0.233 . . . . 72.340000000000003 110.603 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -44.38 -51.78 8.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.444 0.698 . . . . 75.310000000000002 111.654 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -55.38 -46.09 76.56 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.854 -0.612 . . . . 73.420000000000002 111.825 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.448 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 99.2 mt-30 -71.46 -32.17 67.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 72.450000000000003 111.126 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 71.8 m -68.68 -47.22 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 63.149999999999999 111.011 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 3.8 pp -68.01 -36.13 79.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.924 0.393 . . . . 54.210000000000001 110.619 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.5 tt0 -61.12 -43.55 98.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.532 . . . . 74.010000000000005 109.803 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.688 ' NH1' ' HB3' ' A' ' 55' ' ' GLU . 14.2 ttm180 -60.5 -53.45 57.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.38 -0.827 . . . . 74.430000000000007 111.924 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 19.5 pt -63.71 -32.48 57.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.779 0.324 . . . . 74.430000000000007 111.531 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.31 -32.56 74.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.471 . . . . 71.010000000000005 110.612 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 72.4 mm-40 -86.35 7.94 23.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.055 0.455 . . . . 75.109999999999999 110.592 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 36.9 mt -103.53 -62.58 1.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.515 0.674 . . . . 70.129999999999995 110.537 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -85.83 -50.03 7.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.12 . . . . 45.109999999999999 110.994 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -86.43 -10.52 54.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.739 -1.119 . . . . 55.350000000000001 112.176 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 12.1 p-10 . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 123.34 0.656 . . . . 73.310000000000002 112.726 -170.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 121.038 0.446 . . . . 63.109999999999999 110.15 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 3.0 m-85 -125.18 148.62 48.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 64.219999999999999 110.055 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 56' ' ' PRO . 10.3 m-85 -109.68 157.67 18.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.176 -0.675 . . . . 74.329999999999998 109.176 168.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 37' ' ' TYR . 40.4 t -86.4 124.17 40.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.367 -1.346 . . . . 71.299999999999997 107.367 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 46' ' ' LEU . 19.3 m -125.54 162.52 28.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 122.103 -0.373 . . . . 74.310000000000002 111.054 -171.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.597 HH21 ' HA2' ' A' ' 35' ' ' GLY . 7.6 ptm180 -167.76 168.15 12.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.395 -0.366 . . . . 74.209999999999994 111.638 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 24.1 p-10 -168.25 140.36 2.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.922 -0.581 . . . . 44.450000000000003 110.554 167.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.8 t30 45.89 13.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.029 0.932 . . . . 73.120000000000005 113.486 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' ASN . 9.8 pt-20 -112.43 -20.47 11.77 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.738 -0.601 . . . . 70.25 112.144 -172.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.597 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 75.52 -22.53 1.71 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.309 -0.472 . . . . 21.199999999999999 113.219 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 6.0 pt20 -103.42 173.96 6.08 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.778 0.431 . . . . 74.310000000000002 110.148 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.462 ' CD1' HG12 ' A' ' 29' ' ' VAL . 21.6 m-85 -108.74 158.13 17.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 73.099999999999994 112.471 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -141.73 -178.97 5.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.059 . . . . 73.510000000000005 108.646 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.757 HG21 ' HE3' ' A' ' 59' ' ' LYS . 20.6 m -127.79 152.34 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 118.237 0.472 . . . . 63.030000000000001 111.328 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -153.1 146.89 25.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.96 -0.564 . . . . 74.310000000000002 110.216 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 46.2 ttm -72.14 122.12 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.543 -0.299 . . . . 73.299999999999997 110.636 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.44 156.45 38.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 70.439999999999998 110.454 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.17 -31.81 8.22 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.302 -0.475 . . . . 43.5 112.145 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -106.6 130.34 54.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 65.319999999999993 110.216 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.5 m -66.0 159.37 25.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.22 0.534 . . . . 72.319999999999993 111.881 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.4 mt -107.3 155.5 39.33 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.228 -0.896 . . . . 65.25 111.227 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -55.85 152.36 36.13 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.172 2.581 . . . . 72.340000000000003 112.509 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.68 118.45 3.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.469 -0.787 . . . . 71.430000000000007 110.907 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.01 9.93 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.151 -0.477 . . . . 71.010000000000005 112.502 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.58 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.7 m95 -79.49 132.21 36.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.845 0.322 . . . . 71.239999999999995 111.037 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -115.88 154.26 30.05 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.662 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 30' ' ' VAL . 40.1 p -112.77 146.22 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.439 1.087 . . . . 63.350000000000001 110.612 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 54' ' ' GLY . 17.3 t -154.86 156.12 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.606 0.363 . . . . 74.209999999999994 110.476 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 87.33 -179.83 48.13 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.121 -0.491 . . . . 72.200000000000003 113.958 169.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 29.9 tt0 -69.98 118.35 62.61 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 123.237 0.615 . . . . 72.409999999999997 111.062 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 35.6 Cg_endo -64.68 111.71 1.76 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.768 1.645 . . . . 72.400000000000006 110.786 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.84 179.41 6.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.939 -0.573 . . . . 55.439999999999998 110.465 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 t -55.68 157.8 3.91 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.976 0.417 . . . . 72.340000000000003 111.631 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.757 ' HE3' HG21 ' A' ' 39' ' ' VAL . 22.2 tptm -45.97 -45.02 15.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.456 -0.793 . . . . 75.310000000000002 111.145 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 52.2 tt0 -56.67 -43.18 80.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 73.420000000000002 111.13 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -69.25 -50.2 49.23 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.435 -0.348 . . . . 72.450000000000003 111.031 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.752 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 15.2 p -60.73 -43.53 97.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.342 -0.39 . . . . 63.149999999999999 111.13 -174.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.642 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 pp -67.78 -42.42 81.72 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.636 -0.425 . . . . 54.210000000000001 109.993 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' LEU . 31.7 tt0 -54.94 -40.7 70.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.111 0.482 . . . . 74.010000000000005 110.342 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.1 ttm-85 -58.37 -53.35 59.25 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.583 -0.735 . . . . 74.430000000000007 111.955 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 29' ' ' VAL . 17.4 pt -73.01 -34.63 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.507 -0.315 . . . . 74.430000000000007 111.797 -175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 10.0 mm-40 -61.59 -32.72 72.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 110.203 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -81.39 -8.42 59.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.272 -0.422 . . . . 75.109999999999999 111.722 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 94.8 mt -103.31 -67.03 0.9 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.886 0.374 . . . . 70.129999999999995 111.909 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -86.3 -52.9 5.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.511 0.672 . . . . 45.109999999999999 110.894 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.55 -11.35 60.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.758 -1.11 . . . . 55.350000000000001 111.052 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 123.734 0.814 . . . . 73.310000000000002 113.093 -172.99 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.0 mp . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.504 0.669 . . . . 63.109999999999999 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -126.39 148.5 49.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.977 -1.01 . . . . 64.219999999999999 109.288 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.99 153.31 26.99 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.378 -0.971 . . . . 74.329999999999998 108.378 174.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 53' ' ' VAL . 77.2 t -84.77 135.61 24.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.22 -1.77 . . . . 71.299999999999997 106.22 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 46' ' ' LEU . 21.6 m -136.46 165.12 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 121.483 -0.761 . . . . 74.310000000000002 111.644 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -166.01 164.32 18.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.793 -1.094 . . . . 74.209999999999994 110.282 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.4 p-10 -153.39 139.77 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 44.450000000000003 110.137 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 42.44 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.052 1.501 . . . . 73.120000000000005 115.052 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.4 pt-20 -112.53 -32.22 6.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.461 0.573 . . . . 70.25 111.832 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.01 -22.59 4.94 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.462 -0.399 . . . . 21.199999999999999 112.381 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.39 173.95 8.84 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -112.75 137.59 50.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.478 0.656 . . . . 73.099999999999994 112.41 -176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.7 m -137.27 -179.09 5.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.894 -1.048 . . . . 73.510000000000005 108.936 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.578 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.7 m -126.85 153.72 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.887 0.375 . . . . 63.030000000000001 111.125 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -144.19 156.08 44.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 74.310000000000002 109.259 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.8 ttt -82.59 121.3 26.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.017 -0.364 . . . . 73.299999999999997 110.017 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.34 157.81 34.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.985 0.421 . . . . 70.439999999999998 110.627 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -21.07 48.13 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.042 -0.823 . . . . 43.5 111.042 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 100.33 9.58 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.284 -0.636 . . . . 65.319999999999993 109.284 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -63.3 129.01 38.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.922 0.391 . . . . 72.319999999999993 110.422 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 2.7 mm? -58.72 145.19 78.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.635 -0.711 . . . . 65.25 112.418 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.99 144.12 99.5 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 123.007 2.472 . . . . 72.340000000000003 111.436 166.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.36 128.54 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 110.194 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.74 -29.75 7.02 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.551 -0.619 . . . . 71.010000000000005 111.551 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 36.0 m95 -86.69 170.9 11.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.068 -0.716 . . . . 71.239999999999995 109.068 172.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.83 146.57 28.03 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 120.937 0.399 . . . . 74.230000000000004 110.448 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 46' ' ' LEU . 13.0 p -98.09 153.38 18.46 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.614 -1.176 . . . . 63.350000000000001 110.834 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -162.32 167.01 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 C-N-CA 124.266 1.026 . . . . 74.209999999999994 109.83 -175.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.463 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 83.44 179.46 52.32 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.171 -0.922 . . . . 72.200000000000003 111.412 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 47.6 tt0 -103.89 122.67 43.69 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.526 -1.286 . . . . 72.409999999999997 107.526 171.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.604 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 19.1 Cg_endo -55.72 124.9 17.42 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.119 . . . . 72.400000000000006 112.781 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -151.02 156.36 40.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 55.439999999999998 109.194 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -62.21 169.95 2.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.667 0.247 . . . . 72.340000000000003 111.667 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -43.39 -59.09 2.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.305 0.642 . . . . 75.310000000000002 112.289 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.25 -40.29 70.75 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.87 0.367 . . . . 73.420000000000002 111.456 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.461 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 96.4 mt-30 -74.8 -39.07 61.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 72.450000000000003 110.808 -176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.5 t -65.8 -51.05 62.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.637 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.1 pp -62.73 -43.67 98.19 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.021 0.438 . . . . 54.210000000000001 110.067 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' LEU . 52.5 tt0 -63.07 -35.8 81.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.022 -0.535 . . . . 74.010000000000005 110.529 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.622 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 16.0 ttt180 -61.87 -50.43 72.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 110.641 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.4 pt -74.15 -42.13 51.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.816 0.341 . . . . 74.430000000000007 111.63 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.94 -37.74 88.52 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.34 -0.391 . . . . 71.010000000000005 111.678 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -78.97 0.28 28.18 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 121.023 -0.271 . . . . 75.109999999999999 111.368 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -103.92 -65.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.289 0.566 . . . . 70.129999999999995 111.141 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -85.45 -46.03 11.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.174 -0.921 . . . . 45.109999999999999 110.956 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -87.12 -11.17 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.561 -0.745 . . . . 55.350000000000001 112.545 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 113.413 0.894 . . . . 73.310000000000002 113.413 -166.845 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.759 0.79 . . . . 63.109999999999999 112.182 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.75 149.05 47.62 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.327 -1.306 . . . . 64.219999999999999 108.885 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.765 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -108.58 165.07 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.384 -0.599 . . . . 74.329999999999998 109.384 173.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.582 HG11 HG21 ' A' ' 66' ' ' ILE . 36.5 t -102.26 114.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.94 -0.763 . . . . 71.299999999999997 108.94 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 52' ' ' THR . 17.3 m -125.74 165.32 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.59 0.234 . . . . 74.310000000000002 111.51 -169.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 21.3 ptt180 -169.25 170.36 8.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.032 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' GLU . 23.4 p-10 -149.36 139.79 22.42 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 120.773 -0.371 . . . . 44.450000000000003 110.727 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t30 33.31 20.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.531 1.533 . . . . 73.120000000000005 114.918 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.41 -32.43 6.5 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.617 -0.677 . . . . 70.25 112.134 -174.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.95 19.93 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.317 -0.468 . . . . 21.199999999999999 112.751 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -90.57 173.76 7.89 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.744 -0.835 . . . . 74.310000000000002 108.744 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.462 ' CD1' HG12 ' A' ' 29' ' ' VAL . 9.3 m-85 -117.43 171.72 7.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.934 0.873 . . . . 73.099999999999994 112.101 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -150.09 176.62 10.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.685 -1.598 . . . . 73.510000000000005 107.119 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' SG ' ' A' ' 62' ' ' CYS . 7.0 m -124.37 129.4 73.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.522 0.677 . . . . 63.030000000000001 111.186 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' HZ2' ' NH1' ' A' ' 44' ' ' ARG . 54.3 t-105 -119.05 135.96 54.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.806 -1.088 . . . . 74.310000000000002 109.292 -171.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.67 123.72 19.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.507 -0.183 . . . . 73.299999999999997 110.507 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.69 146.5 52.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.04 -0.356 . . . . 70.439999999999998 110.04 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.32 15.84 68.13 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.947 -0.644 . . . . 43.5 111.57 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 44' ' ' ARG . 34.8 ttt-85 -131.27 125.19 32.18 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.89 -0.782 . . . . 65.319999999999993 108.89 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.8 m -72.55 159.93 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 72.319999999999993 111.8 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.677 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 10.6 tp -119.49 135.66 24.2 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.459 -0.791 . . . . 65.25 109.5 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD2' HD12 ' A' ' 46' ' ' LEU . 55.7 Cg_endo -69.55 158.19 58.11 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.87 2.38 . . . . 72.340000000000003 113.665 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.08 129.12 26.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.911 -1.04 . . . . 71.430000000000007 110.788 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.62 -28.66 10.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.917 -0.583 . . . . 71.010000000000005 111.725 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.677 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 14.9 m95 -91.04 153.72 19.92 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.647 0.261 . . . . 71.239999999999995 110.502 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.76 138.87 53.88 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 110.36 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.586 ' HA ' HG12 ' A' ' 30' ' ' VAL . 7.3 p -100.81 131.31 46.76 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.585 -1.189 . . . . 63.350000000000001 109.616 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 54' ' ' GLY . 3.1 t -146.23 166.26 8.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.146 0.498 . . . . 74.209999999999994 110.317 -170.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 98.31 -141.09 15.39 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.647 -0.706 . . . . 72.200000000000003 114.231 167.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -136.53 119.41 11.96 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.385 -0.908 . . . . 72.409999999999997 108.788 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.765 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.1 Cg_endo -63.05 115.8 3.18 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.648 1.565 . . . . 72.400000000000006 111.281 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.38 155.09 35.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.608 -0.724 . . . . 55.439999999999998 109.554 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -55.88 153.76 8.12 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.744 -0.465 . . . . 72.340000000000003 109.744 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE3' HG23 ' A' ' 39' ' ' VAL . 24.6 tptm -43.14 -48.8 6.41 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.606 0.566 . . . . 75.310000000000002 111.848 -172.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -58.94 -51.08 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 73.420000000000002 111.03 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -69.42 -30.43 68.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.957 0.408 . . . . 72.450000000000003 110.406 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 39' ' ' VAL . 13.8 t -65.67 -52.41 51.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.776 -0.647 . . . . 63.149999999999999 110.175 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.038 0.447 . . . . 54.210000000000001 110.387 176.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' LEU . 32.9 tt0 -62.83 -42.32 99.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 74.010000000000005 110.772 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 12.3 ttm-85 -57.26 -53.28 59.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 111.608 -174.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.582 HG21 HG11 ' A' ' 29' ' ' VAL . 13.1 pt -67.22 -34.71 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 111.531 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.23 -32.49 73.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 71.010000000000005 110.178 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.56 0.35 17.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.07 -0.514 . . . . 75.109999999999999 111.816 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 95.5 mt -103.81 -67.11 0.91 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.794 0.664 . . . . 70.129999999999995 112.794 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -86.04 -55.07 4.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.678 0.752 . . . . 45.109999999999999 110.579 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -11.48 60.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.392 -1.277 . . . . 55.350000000000001 110.915 -177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 123.611 0.764 . . . . 73.310000000000002 112.799 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.702 0.287 . . . . 73.219999999999999 110.407 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . . . -60.01 164.51 3.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.898 -0.592 . . . . 73.439999999999998 111.03 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -130.52 30.55 4.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.929 0.344 . . . . 72.239999999999995 111.929 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -93.43 109.9 21.47 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.914 -1.143 . . . . 53.229999999999997 107.914 166.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.82 -47.75 73.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.549 0.574 . . . . 64.019999999999996 112.549 -166.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -141.23 142.32 33.96 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.134 -0.354 . . . . 74.209999999999994 111.054 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -78.57 128.55 33.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 52.520000000000003 110.514 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -64.21 100.77 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.757 -0.46 . . . . 71.439999999999998 109.757 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 19.2 mmt -64.62 146.7 54.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 71.540000000000006 112.016 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.81 161.43 47.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.341 -0.845 . . . . 73.319999999999993 111.188 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -58.6 -73.39 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.383 0.512 . . . . 64.109999999999999 112.383 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.43 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 48.7 tp -91.38 -61.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.669 -0.241 . . . . 73.430000000000007 110.61 -173.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.43 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 37.5 mt-10 -118.66 125.46 49.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 52.229999999999997 110.242 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.572 ' HB3' HH12 ' A' ' 65' ' ' ARG . . . -163.01 95.92 0.88 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.562 0.345 . . . . 61.0 110.461 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -75.18 114.36 13.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 73.030000000000001 110.662 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 m -108.8 51.12 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.593 0.711 . . . . 75.239999999999995 109.447 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -174.85 -64.5 0.01 OUTLIER 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.446 -0.797 . . . . 74.109999999999999 109.583 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 61' ' ' GLN . . . 157.24 -173.07 34.77 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.596 -0.729 . . . . 74.420000000000002 111.345 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 -48.54 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.23 1.954 . . . . 73.409999999999997 111.777 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.95 -137.05 4.39 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.788 -0.925 . . . . 44.340000000000003 110.788 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -98.92 -79.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.804 -0.443 . . . . 65.310000000000002 109.804 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 64.8 mtt -157.03 28.51 0.31 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.921 -1.14 . . . . 73.349999999999994 107.921 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 6.0 p-10 -111.82 170.96 7.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.581 -1.19 . . . . 74.420000000000002 112.142 -165.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -108.27 19.13 20.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.943 -1.026 . . . . 70.420000000000002 110.465 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 7.7 mm-40 -81.35 52.57 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.333 -0.394 . . . . 71.109999999999999 110.55 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 56' ' ' PRO . 9.1 mp -74.03 136.72 43.13 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.782 0.801 . . . . 63.109999999999999 111.193 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.2 m-85 -127.57 151.13 49.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.366 -1.288 . . . . 64.219999999999999 109.306 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -116.46 157.68 24.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 74.329999999999998 109.397 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -85.86 134.83 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.16 -1.422 . . . . 71.299999999999997 107.16 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 46' ' ' LEU . 29.0 m -136.73 159.32 37.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.954 0.407 . . . . 74.310000000000002 111.379 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 38.0 ptt180 -169.21 170.23 8.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.192 -0.913 . . . . 74.209999999999994 110.509 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.668 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 25.6 p-10 -165.77 140.38 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.653 -0.249 . . . . 44.450000000000003 111.061 170.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 49.11 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.883 1.068 . . . . 73.120000000000005 113.883 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.09 -32.0 6.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.747 -0.596 . . . . 70.25 111.464 -174.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.71 -22.81 6.19 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.262 -0.426 . . . . 21.199999999999999 113.014 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.03 174.04 10.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.749 -0.464 . . . . 74.310000000000002 109.749 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.21 143.3 45.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.901 0.704 . . . . 73.099999999999994 112.901 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -136.83 -179.91 5.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.987 -1.006 . . . . 73.510000000000005 109.694 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.65 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.9 m -125.67 155.34 34.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.807 0.337 . . . . 63.030000000000001 110.803 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -148.48 149.1 31.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.306 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.8 ttt -81.61 121.51 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.647 0.26 . . . . 73.299999999999997 110.326 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.56 148.89 44.64 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.231 -0.441 . . . . 70.439999999999998 111.014 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.97 -23.03 36.26 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.741 -0.544 . . . . 43.5 111.741 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -92.98 118.83 31.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.004 -0.369 . . . . 65.319999999999993 110.004 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.3 m -60.24 137.33 58.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.04 0.448 . . . . 72.319999999999993 111.391 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -93.31 142.43 25.26 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.425 -0.807 . . . . 65.25 110.882 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.13 140.44 70.93 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.863 2.375 . . . . 72.340000000000003 111.714 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.67 124.89 11.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 71.430000000000007 110.386 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.2 -29.42 7.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.296 -0.478 . . . . 71.010000000000005 112.669 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.668 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.1 m95 -76.95 149.88 35.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.335 0.568 . . . . 71.239999999999995 111.46 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 18.8 pt-20 -129.62 151.23 50.45 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.977 -0.556 . . . . 74.230000000000004 110.245 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -107.99 160.59 15.66 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.214 0.946 . . . . 63.350000000000001 111.255 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.17 158.51 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 123.408 0.683 . . . . 74.209999999999994 110.608 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 89.61 -166.85 33.23 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.833 -0.621 . . . . 72.200000000000003 112.259 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.55 142.25 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.745 -0.835 . . . . 72.409999999999997 108.745 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.4 Cg_endo -72.57 108.74 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 120.816 1.01 . . . . 72.400000000000006 110.575 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.57 172.99 17.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.416 -0.811 . . . . 55.439999999999998 110.361 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -55.77 155.33 6.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.898 0.38 . . . . 72.340000000000003 111.503 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -49.55 -36.49 23.81 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.619 -0.719 . . . . 75.310000000000002 110.923 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -55.71 -55.67 29.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.516 -0.765 . . . . 73.420000000000002 110.302 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 0.9 OUTLIER -55.39 -52.0 64.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.776 -0.647 . . . . 72.450000000000003 111.003 176.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.65 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.0 t -55.86 -52.46 63.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.197 -0.91 . . . . 63.149999999999999 111.071 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.2 pp -68.26 -44.92 74.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.916 -0.313 . . . . 54.210000000000001 110.445 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' N ' HD12 ' A' ' 63' ' ' LEU . 32.7 tt0 -54.8 -36.51 65.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.394 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 14' ' ' ALA . 48.5 ttt85 -64.21 -53.53 47.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.774 -0.648 . . . . 74.430000000000007 111.046 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.07 -34.05 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 111.679 0.251 . . . . 74.430000000000007 111.679 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 39.7 mm-40 -65.97 -32.77 74.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.487 -0.324 . . . . 71.010000000000005 110.385 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 95.3 mt-30 -87.75 4.95 42.32 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 111.266 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 48.0 mt -103.73 -66.97 0.91 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.92 0.39 . . . . 70.129999999999995 111.195 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -86.32 -54.84 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.272 0.558 . . . . 45.109999999999999 111.417 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -78.19 -10.92 59.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.187 -0.915 . . . . 55.350000000000001 111.399 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -41.25 -42.33 2.1 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.977 1.103 . . . . 73.310000000000002 113.977 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.8 mtp -62.56 85.55 0.02 OUTLIER 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.742 0.782 . . . . 75.019999999999996 110.949 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -93.71 134.54 26.23 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 114.614 -1.176 . . . . 71.120000000000005 111.292 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 4.5 Cg_exo -78.1 -156.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.055 2.503 . . . . 72.129999999999995 112.144 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.65 -22.14 8.21 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.31 0.485 . . . . 60.32 112.31 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.2 m -50.85 -25.26 4.29 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.242 -0.435 . . . . 75.439999999999998 112.121 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG22 HD23 ' A' ' 82' ' ' LEU . 13.1 p -68.59 -39.08 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.884 0.373 . . . . 72.150000000000006 110.485 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -62.05 -31.65 72.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.058 -0.519 . . . . 74.439999999999998 110.498 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -61.74 -35.59 78.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 73.109999999999999 111.104 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -109.27 -1.53 18.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 54.530000000000001 111.029 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -71.51 100.99 2.35 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.983 -0.377 . . . . 73.430000000000007 109.983 -177.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.71 -72.92 0.14 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.866 -0.606 . . . . 64.540000000000006 111.346 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -76.31 83.1 3.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 74.549999999999997 109.908 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -54.77 -29.16 53.35 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.363 -0.835 . . . . 73.5 111.697 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 t -69.18 -37.5 78.2 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.431 -0.35 . . . . 53.329999999999998 111.121 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.46 106.28 0.27 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.749 -0.54 . . . . 74.420000000000002 111.749 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.603 ' HB3' HD21 ' A' ' 82' ' ' LEU . 26.6 Cg_endo -60.46 -44.56 26.69 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.864 2.376 . . . . 73.530000000000001 112.982 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 2' ' ' ALA . . . 72.95 -73.98 0.99 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.186 -0.766 . . . . 73.430000000000007 111.186 -173.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.5 mm -107.73 92.67 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.806 -0.813 . . . . 44.039999999999999 108.806 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.06 144.68 54.98 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.717 -0.674 . . . . 74.510000000000005 110.584 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -87.43 107.67 18.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.976 -0.556 . . . . 74.099999999999994 111.127 -172.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -66.4 173.86 3.04 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.734 -0.666 . . . . 75.120000000000005 111.027 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 94' ' ' VAL . 7.1 p -130.0 78.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.644 0.735 . . . . 75.409999999999997 112.203 -173.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 60.4 ttt-85 . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.271 -0.871 . . . . 74.540000000000006 110.234 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.288 -0.264 . . . . 73.219999999999999 110.288 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.24 70.09 0.63 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.918 -0.583 . . . . 73.439999999999998 111.538 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -60.16 89.99 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.837 -0.619 . . . . 72.239999999999995 110.134 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -78.04 110.47 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.644 -0.707 . . . . 53.229999999999997 110.538 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -70.2 89.58 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 64.019999999999996 110.134 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.97 168.26 20.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 74.209999999999994 109.898 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -167.32 166.04 14.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.89 -0.411 . . . . 52.520000000000003 109.89 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -107.53 168.41 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.234 -0.284 . . . . 71.439999999999998 110.234 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -157.6 163.71 38.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 71.540000000000006 109.982 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.93 -73.93 0.2 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.822 -0.511 . . . . 73.319999999999993 111.822 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -162.99 158.31 22.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.424 -0.584 . . . . 64.109999999999999 109.424 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.87 -92.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.27 -0.27 . . . . 73.430000000000007 110.27 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 78.5 mm-40 -138.95 173.74 11.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.083 0.468 . . . . 52.229999999999997 110.814 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.35 174.55 11.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.205 -0.907 . . . . 61.0 109.636 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.96 -25.23 58.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 73.030000000000001 110.367 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -77.96 60.91 2.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 109.874 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.553 ' NE2' ' HG3' ' A' ' 55' ' ' GLU . 39.4 tt0 -76.29 -54.64 6.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.703 -0.68 . . . . 74.109999999999999 109.959 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.41 -179.12 42.15 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.822 -0.911 . . . . 74.420000000000002 110.822 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.13 -64.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.632 2.222 . . . . 73.409999999999997 111.788 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.43 -164.3 33.91 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.738 -0.665 . . . . 44.340000000000003 111.5 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -176.55 -66.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.626 -0.509 . . . . 65.310000000000002 109.626 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.9 OUTLIER 57.02 20.42 5.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.835 -0.621 . . . . 73.349999999999994 110.974 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.87 -71.62 0.34 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 74.420000000000002 110.053 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.75 174.68 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.619 -0.719 . . . . 70.420000000000002 109.521 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -74.81 144.69 43.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.325 -0.25 . . . . 71.109999999999999 110.325 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.49 143.29 27.29 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.784 0.802 . . . . 63.109999999999999 111.455 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -127.31 148.7 50.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.502 -1.226 . . . . 64.219999999999999 109.156 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.584 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -114.1 162.39 16.54 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.61 0.569 . . . . 74.329999999999998 109.543 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 53' ' ' VAL . 75.8 t -88.42 140.65 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.247 -1.02 . . . . 71.299999999999997 108.247 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 40' ' ' TRP . 23.4 m -144.99 158.23 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 122.195 -0.316 . . . . 74.310000000000002 110.85 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 19.9 ptt85 -169.36 170.1 8.63 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.335 -0.393 . . . . 74.209999999999994 111.542 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 22.4 p-10 -157.89 139.82 14.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.342 -0.39 . . . . 44.450000000000003 111.063 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 35.12 21.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.137 1.375 . . . . 73.120000000000005 114.294 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ASN . 10.7 pt-20 -112.4 -32.11 6.6 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.616 -0.677 . . . . 70.25 111.385 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.86 -22.79 5.52 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.972 -0.558 . . . . 21.199999999999999 112.078 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -84.35 161.56 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.14 -0.689 . . . . 74.310000000000002 109.14 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 18.9 m-85 -106.32 137.48 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.086 0.469 . . . . 73.099999999999994 111.711 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -124.13 -179.21 4.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.046 -0.979 . . . . 73.510000000000005 109.726 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -132.31 157.3 43.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.879 0.371 . . . . 63.030000000000001 110.877 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HB2' HG21 ' A' ' 30' ' ' VAL . 73.4 t-105 -155.75 149.41 25.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.823 -0.806 . . . . 74.310000000000002 108.823 -171.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.86 130.35 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 73.299999999999997 110.539 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.58 144.12 27.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.993 -0.548 . . . . 70.439999999999998 111.621 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -20.69 12.09 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.13 -0.486 . . . . 43.5 113.254 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -79.91 131.1 35.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.762 0.281 . . . . 65.319999999999993 110.274 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -65.92 148.76 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.314 0.578 . . . . 72.319999999999993 111.821 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 29.1 mt -111.35 147.71 37.25 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.094 -0.957 . . . . 65.25 111.204 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -81.07 176.1 9.2 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.913 2.409 . . . . 72.340000000000003 113.029 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 125.44 10.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.907 -1.042 . . . . 71.430000000000007 111.94 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.57 -32.32 7.52 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 112.847 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.3 m95 -76.91 133.54 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.034 0.417 . . . . 71.239999999999995 111.689 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 9.8 pt-20 -127.62 152.78 47.23 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.746 -0.661 . . . . 74.230000000000004 110.393 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 53' ' ' VAL . 39.5 p -102.13 159.66 15.19 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.289 0.993 . . . . 63.350000000000001 111.42 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -173.6 175.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 110.285 -173.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 82.75 -161.2 40.05 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.723 -0.671 . . . . 72.200000000000003 112.882 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.553 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -108.5 138.62 20.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 123.366 0.666 . . . . 72.409999999999997 109.588 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.7 Cg_endo -71.59 113.38 3.62 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.673 1.582 . . . . 72.400000000000006 111.078 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.37 167.11 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.726 -0.67 . . . . 55.439999999999998 109.938 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -61.69 161.36 10.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.679 0.276 . . . . 72.340000000000003 110.961 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -46.89 -48.52 21.19 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.869 -0.605 . . . . 75.310000000000002 111.633 -176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -57.37 -45.09 84.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.978 -0.555 . . . . 73.420000000000002 111.406 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.75 -38.78 64.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 72.450000000000003 110.708 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.531 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.2 t -59.02 -49.26 78.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.73 -0.668 . . . . 63.149999999999999 110.202 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.6 pp -68.05 -37.22 81.06 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.43 -0.35 . . . . 54.210000000000001 110.508 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' LEU . 33.9 tt0 -60.31 -32.74 71.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.089 0.471 . . . . 74.010000000000005 110.411 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.3 ttt85 -76.57 -44.02 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.982 -0.554 . . . . 74.430000000000007 110.548 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' LEU . 44.4 pt -67.61 -34.55 68.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 121.153 -0.219 . . . . 74.430000000000007 110.675 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 34.3 mt-10 -54.03 -56.04 21.67 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.25 -0.432 . . . . 71.010000000000005 110.112 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -65.76 -10.18 34.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 75.109999999999999 112.384 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 97.6 mt -104.02 -67.79 0.88 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.329 0.492 . . . . 70.129999999999995 112.329 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 70.6 t-105 -87.01 -55.44 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.965 0.888 . . . . 45.109999999999999 111.168 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.762 HG22 HG13 ' A' ' 94' ' ' VAL . 5.5 m -74.09 -11.52 60.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.027 -1.442 . . . . 55.350000000000001 111.609 -170.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 67' ' ' GLU . 24.5 t70 -45.11 -25.43 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.029 1.122 . . . . 73.310000000000002 114.029 -170.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mmt -66.8 75.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 75.019999999999996 110.409 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 5.9 p -89.95 133.1 34.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 71.120000000000005 111.092 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 23.0 Cg_exo -66.65 -157.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.955 2.437 . . . . 72.129999999999995 112.72 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.51 -15.55 1.15 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.054 0.542 . . . . 60.32 112.145 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 t -50.15 -27.13 5.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.892 0.477 . . . . 75.439999999999998 110.988 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.46 -41.57 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.806 0.336 . . . . 72.150000000000006 111.227 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -71.29 -33.01 69.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.279 -0.418 . . . . 74.439999999999998 110.231 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -74.78 -29.14 61.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 73.109999999999999 110.399 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -63.34 -30.18 71.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.153 0.502 . . . . 54.530000000000001 110.429 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.82 -6.9 41.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.599 -0.728 . . . . 73.430000000000007 111.565 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -54.35 123.47 13.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.405 . . . . 64.540000000000006 111.724 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 51.91 30.18 6.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.871 -0.604 . . . . 74.549999999999997 111.431 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.519 ' HA ' HG12 ' A' ' 90' ' ' ILE . 42.8 p-80 -37.16 106.27 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.581 -0.736 . . . . 73.5 111.925 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.1 m -96.49 133.51 40.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.458 -0.792 . . . . 53.329999999999998 111.718 -173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' HA3' ' HD3' ' A' ' 88' ' ' PRO . . . 54.98 -123.08 28.22 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.817 -0.629 . . . . 74.420000000000002 113.607 172.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 27.5 Cg_exo -62.13 -11.17 20.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.044 2.496 . . . . 73.530000000000001 112.444 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.08 119.1 4.43 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.793 -0.523 . . . . 73.430000000000007 111.793 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 85' ' ' HIS . 19.4 pt -94.54 100.53 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.345 0.593 . . . . 44.039999999999999 110.126 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -146.69 156.51 43.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.826 -0.624 . . . . 74.510000000000005 110.471 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -162.13 -174.16 3.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.332 -0.849 . . . . 74.099999999999994 108.774 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -96.5 -142.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.365 -0.235 . . . . 75.120000000000005 110.365 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 71' ' ' THR . 3.7 p -115.99 60.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 122.364 1.078 . . . . 75.409999999999997 111.393 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HE ' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.249 0 CA-C-N 114.125 -1.398 . . . . 74.540000000000006 111.744 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.025 0.44 . . . . 73.219999999999999 109.981 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.05 87.36 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 73.439999999999998 110.344 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -65.24 89.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 72.239999999999995 110.111 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.33 115.04 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.718 -0.674 . . . . 53.229999999999997 110.442 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -85.57 80.49 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.6 . . . . 64.019999999999996 111.738 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -137.81 29.05 2.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 74.209999999999994 107.257 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -121.35 143.29 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.069 -1.423 . . . . 52.520000000000003 109.602 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.442 ' CE1' ' OE1' ' A' ' 15' ' ' GLN . 84.8 t60 67.17 17.17 10.33 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.51 0.506 . . . . 71.439999999999998 111.476 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 ptm -77.25 -34.84 55.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 71.540000000000006 111.026 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.26 -132.34 45.86 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.084 -0.507 . . . . 73.319999999999993 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -149.08 -59.29 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.704 0.287 . . . . 64.109999999999999 110.278 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 30.5 tp -145.33 -113.8 0.09 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.644 -0.502 . . . . 73.430000000000007 109.644 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 34.8 mt-10 -94.35 131.49 39.93 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.925 -0.398 . . . . 52.229999999999997 109.925 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 172.97 1.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.09 0.556 . . . . 61.0 111.071 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.442 ' OE1' ' CE1' ' A' ' 8' ' ' HIS . 79.6 mt-30 -138.53 108.12 6.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.604 -0.271 . . . . 73.030000000000001 110.522 -173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -140.46 22.62 2.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.533 0.683 . . . . 75.239999999999995 109.696 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.193 -0.912 . . . . 74.109999999999999 110.565 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.2 71.07 0.12 Allowed Glycine 0 CA--C 1.518 0.249 0 N-CA-C 111.03 -0.828 . . . . 74.420000000000002 111.03 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.5 157.21 49.3 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.859 2.373 . . . . 73.409999999999997 112.868 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.32 111.39 1.68 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.478 -0.783 . . . . 44.340000000000003 111.297 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 p -70.27 -8.82 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.769 0.319 . . . . 65.310000000000002 111.459 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 22' ' ' MET . 1.2 pmm? -101.96 10.44 39.69 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.237 0.541 . . . . 73.349999999999994 110.912 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.76 97.67 5.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.314 -0.857 . . . . 74.420000000000002 110.525 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -92.88 -31.06 15.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.697 -0.683 . . . . 70.420000000000002 109.558 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.58 111.04 23.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 71.109999999999999 108.813 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.55 171.22 10.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.811 0.815 . . . . 63.109999999999999 111.464 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.585 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 19.8 m-85 -121.09 148.72 43.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.546 -1.206 . . . . 64.219999999999999 108.254 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.87 159.57 26.53 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.72 -0.844 . . . . 74.329999999999998 108.72 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 86.9 t -86.8 138.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.282 -1.377 . . . . 71.299999999999997 107.282 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 46' ' ' LEU . 33.9 m -138.32 160.53 31.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.318 0.508 . . . . 74.310000000000002 111.295 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -168.61 169.15 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.786 -1.097 . . . . 74.209999999999994 110.242 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.8 p30 -154.36 139.74 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.993 -0.373 . . . . 44.450000000000003 109.993 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 t30 44.88 6.16 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.159 1.17 . . . . 73.120000000000005 114.159 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.7 pt-20 -112.27 -32.45 6.52 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.503 -0.748 . . . . 70.25 112.118 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 -22.58 4.57 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.242 -0.436 . . . . 21.199999999999999 112.911 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.16 174.05 5.94 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.388 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -122.29 133.02 54.69 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.592 0.589 . . . . 73.099999999999994 112.592 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.3 m -132.82 -179.19 5.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.371 -0.831 . . . . 73.510000000000005 109.71 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.6 158.33 26.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 63.030000000000001 110.913 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.527 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 56.0 t90 -147.15 137.21 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.84 . . . . 74.310000000000002 109.6 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 ttt -83.09 121.46 27.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 110.284 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.15 165.36 22.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.347 . . . . 70.439999999999998 110.189 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.31 -4.85 29.93 Favored Glycine 0 C--N 1.328 0.125 0 N-CA-C 110.91 -0.876 . . . . 43.5 110.91 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.8 ptp180 -131.56 172.52 12.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.271 0.628 . . . . 65.319999999999993 109.737 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 p -101.67 143.65 31.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.999 -0.371 . . . . 72.319999999999993 109.999 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 30' ' ' VAL . 8.5 mt -88.9 133.17 36.15 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.325 -0.398 . . . . 65.25 111.544 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 46' ' ' LEU . 76.1 Cg_exo -46.12 130.66 13.77 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 123.303 2.668 . . . . 72.340000000000003 112.352 171.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 126.52 15.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 71.430000000000007 110.493 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.88 -25.53 9.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.241 -0.504 . . . . 71.010000000000005 112.06 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 66.2 m95 -83.96 158.53 21.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.809 0.305 . . . . 71.239999999999995 110.784 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -135.21 154.26 51.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.318 -0.401 . . . . 74.230000000000004 110.048 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 53' ' ' VAL . 24.3 p -107.43 153.21 23.13 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 124.737 1.273 . . . . 63.350000000000001 110.244 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -167.51 175.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.676 0 C-N-CA 123.624 0.77 . . . . 74.209999999999994 110.023 -173.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.22 -115.3 4.19 Favored Glycine 0 C--O 1.219 -0.835 0 CA-C-N 115.681 -0.69 . . . . 72.200000000000003 113.111 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 16.4 tp10 -147.32 136.89 11.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.279 1.032 . . . . 72.409999999999997 108.597 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 73.6 Cg_endo -83.51 107.51 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.011 1.141 . . . . 72.400000000000006 110.286 166.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.68 -175.4 5.14 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.391 -0.822 . . . . 55.439999999999998 111.242 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 61' ' ' GLN . 1.1 t -55.83 151.21 11.72 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.286 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HG3' HD23 ' A' ' 63' ' ' LEU . 23.8 tptm -45.93 -41.0 10.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.225 -0.898 . . . . 75.310000000000002 110.269 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -59.86 -42.41 93.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.107 -0.952 . . . . 73.420000000000002 111.417 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' H ' HG23 ' A' ' 58' ' ' THR . 26.2 mm-40 -71.95 -48.06 47.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.884 0.373 . . . . 72.450000000000003 110.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 60.0 m -60.22 -46.6 89.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 63.149999999999999 111.578 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.08 -41.05 82.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.753 -0.379 . . . . 54.210000000000001 110.385 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.592 ' N ' HD12 ' A' ' 63' ' ' LEU . 60.1 tt0 -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.281 0.562 . . . . 74.010000000000005 110.877 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.4 ttm-85 -64.48 -47.42 79.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.965 -0.562 . . . . 74.430000000000007 111.202 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 pt -69.66 -37.66 74.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.64 0.257 . . . . 74.430000000000007 110.977 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 8.6 mm-40 -62.65 -48.99 76.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 71.010000000000005 110.214 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 18.5 mt-30 -73.29 8.73 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.795 0.331 . . . . 75.109999999999999 111.452 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 73.3 mt -103.54 -66.13 0.96 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.975 0.417 . . . . 70.129999999999995 110.618 170.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -85.29 -48.47 9.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.441 0.639 . . . . 45.109999999999999 110.837 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.531 HG21 ' NH2' ' A' ' 95' ' ' ARG . 17.6 m -76.81 -10.74 59.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.202 -0.908 . . . . 55.350000000000001 111.356 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 25.9 t70 -41.43 -23.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.182 0.993 . . . . 73.310000000000002 113.168 -174.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 93.6 mmm -67.08 72.23 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.983 0.421 . . . . 75.019999999999996 110.735 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.32 133.92 41.57 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.843 -0.617 . . . . 71.120000000000005 110.19 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.93 -169.7 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.767 2.312 . . . . 72.129999999999995 112.183 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -15.2 8.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.37 -0.377 . . . . 60.32 111.376 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -57.75 -20.77 37.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.921 -0.581 . . . . 75.439999999999998 111.775 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.2 p -56.12 -41.95 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.854 0.359 . . . . 72.150000000000006 110.15 174.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.46 -37.13 86.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 110.442 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 91' ' ' ASP . 2.5 tp10 -61.58 -38.19 86.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.357 -0.838 . . . . 73.109999999999999 110.209 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -84.17 -30.37 25.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.297 -0.865 . . . . 54.530000000000001 112.04 -172.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 89.3 mt -51.93 -46.99 64.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.98 0.419 . . . . 73.430000000000007 111.144 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -150.07 114.22 5.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 64.540000000000006 109.419 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -65.18 86.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.5 0.667 . . . . 74.549999999999997 109.911 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -65.06 168.22 6.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.724 -1.125 . . . . 73.5 111.336 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -62.82 92.38 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 53.329999999999998 110.726 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.83 -139.97 5.6 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.328 -0.709 . . . . 74.420000000000002 111.328 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.14 165.25 14.92 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.706 2.271 . . . . 73.530000000000001 112.443 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.0 -157.62 8.3 Favored Glycine 0 C--O 1.235 0.218 0 N-CA-C 111.448 -0.661 . . . . 73.430000000000007 111.448 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.1 mt 55.55 83.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.356 0.598 . . . . 44.039999999999999 110.345 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 6.5 p-10 -104.91 178.07 4.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 74.510000000000005 111.528 -173.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -113.96 90.82 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 74.099999999999994 109.986 172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.83 173.17 6.44 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.6 -0.727 . . . . 75.120000000000005 110.233 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.3 140.63 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 75.409999999999997 109.353 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.044 -0.979 . . . . 74.540000000000006 110.775 -176.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.165 -0.309 . . . . 73.219999999999999 110.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.06 93.45 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.935 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -122.09 -64.67 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 110.108 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -148.11 147.47 29.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.155 -0.475 . . . . 53.229999999999997 110.584 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -162.59 99.05 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.798 -0.637 . . . . 64.019999999999996 109.811 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -95.47 103.32 15.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.021 -0.536 . . . . 74.209999999999994 111.547 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -85.93 134.74 33.86 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.671 -0.695 . . . . 52.520000000000003 109.948 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -141.7 120.81 12.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.42 -0.585 . . . . 71.439999999999998 109.42 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 9' ' ' MET . 1.3 tmt? -162.42 124.91 2.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 71.540000000000006 110.103 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 158.45 179.86 33.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.116 -0.564 . . . . 73.319999999999993 112.379 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 p 57.39 161.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.214 1.006 . . . . 64.109999999999999 113.52 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.585 HD11 ' HB ' ' A' ' 53' ' ' VAL . 3.7 mm? -132.54 -177.61 4.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.175 -0.921 . . . . 73.430000000000007 108.824 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' H ' ' HD3' ' A' ' 65' ' ' ARG . 20.2 mt-10 59.04 15.27 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.075 -0.511 . . . . 52.229999999999997 112.375 167.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.91 130.54 34.63 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.298 -0.26 . . . . 61.0 110.298 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -165.5 160.52 17.89 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.244 0.34 . . . . 73.030000000000001 110.578 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.1 p -108.84 -40.59 4.99 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.885 0.374 . . . . 75.239999999999995 110.754 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -145.49 142.52 29.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.88 -0.415 . . . . 74.109999999999999 109.88 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.86 -135.81 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 113.641 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HB3' HG21 ' A' ' 58' ' ' THR . 57.5 Cg_endo -70.43 98.07 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.906 2.404 . . . . 73.409999999999997 112.451 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.39 27.54 18.79 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 111.762 -0.535 . . . . 44.340000000000003 111.762 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.7 m -153.56 167.41 29.6 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.253 -0.277 . . . . 65.310000000000002 110.253 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 61.3 mtt -88.25 106.45 18.22 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.962 -0.385 . . . . 73.349999999999994 109.962 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -112.6 -167.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.51 -0.314 . . . . 74.420000000000002 110.796 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -139.58 -83.16 0.26 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.717 0.266 . . . . 70.420000000000002 111.717 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' A' ' 41' ' ' MET . 9.3 mm-40 -92.73 165.17 13.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.664 0.269 . . . . 71.109999999999999 110.998 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.27 162.42 21.16 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.176 0.512 . . . . 63.109999999999999 110.552 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.22 148.71 50.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 64.219999999999999 110.72 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -117.78 162.59 17.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.943 -1.026 . . . . 74.329999999999998 108.91 171.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -94.06 142.65 13.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.778 -1.193 . . . . 71.299999999999997 107.778 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.03 156.62 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.155 0.502 . . . . 74.310000000000002 111.227 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HD3' ' CE1' ' A' ' 37' ' ' TYR . 29.5 ptt180 -154.25 155.18 34.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.196 -0.911 . . . . 74.209999999999994 109.581 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.7 p30 -156.56 139.35 15.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.983 -0.287 . . . . 44.450000000000003 110.894 168.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 35.43 13.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.652 1.723 . . . . 73.120000000000005 115.652 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.883 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 16.4 pt-20 -112.71 -31.92 6.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.745 0.646 . . . . 70.25 112.745 -170.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.42 89.01 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 21.199999999999999 112.473 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.883 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 77.7 mt-30 -120.77 174.09 6.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.348 0.659 . . . . 74.310000000000002 109.365 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 31' ' ' ARG . 42.4 m-85 -122.54 146.46 47.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.739 1.014 . . . . 73.099999999999994 113.739 -171.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -138.9 -179.31 5.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.216 -1.357 . . . . 73.510000000000005 108.677 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.5 m -122.83 161.6 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.918 0.389 . . . . 63.030000000000001 111.084 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -145.89 156.47 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.32 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.48 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 6.4 ttt -86.07 147.5 26.15 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.828 -0.434 . . . . 73.299999999999997 109.828 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.62 156.88 38.88 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.017 0.437 . . . . 70.439999999999998 111.524 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.35 54.13 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.547 -0.751 . . . . 43.5 112.769 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -112.35 116.1 29.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.876 -0.416 . . . . 65.319999999999993 109.876 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.0 m -66.09 154.69 38.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 112.048 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -111.05 152.88 43.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.075 -0.966 . . . . 65.25 111.151 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 74.1 Cg_endo -80.34 158.13 22.78 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 111.921 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 131.13 26.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 111.237 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.96 -35.27 5.16 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.774 -0.648 . . . . 71.010000000000005 111.658 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 32.2 m95 -79.71 139.02 37.49 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.188 -0.301 . . . . 71.239999999999995 110.188 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.87 153.68 49.55 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.377 -0.374 . . . . 74.230000000000004 110.284 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.2 p -98.11 162.82 13.02 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.19 0.931 . . . . 63.350000000000001 111.459 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -162.56 150.02 3.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.41 -0.814 . . . . 74.209999999999994 109.978 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 -170.56 37.53 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.557 -0.747 . . . . 72.200000000000003 111.495 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 151.56 40.76 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 108.652 -0.87 . . . . 72.409999999999997 108.652 174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 21.9 Cg_endo -65.54 105.17 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.206 1.271 . . . . 72.400000000000006 110.046 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.17 169.45 17.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.412 -0.813 . . . . 55.439999999999998 110.669 -171.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 19' ' ' PRO . 3.5 t -57.29 151.3 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.654 -0.703 . . . . 72.340000000000003 111.149 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -48.75 -44.91 39.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.751 -0.659 . . . . 75.310000000000002 110.576 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -56.19 -37.32 69.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.477 -0.783 . . . . 73.420000000000002 111.206 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.422 ' H ' HG23 ' A' ' 58' ' ' THR . 12.2 mm-40 -74.96 -39.72 61.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.909 0.385 . . . . 72.450000000000003 110.436 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 39' ' ' VAL . 5.5 t -65.23 -51.33 61.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.665 . . . . 63.149999999999999 110.56 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.0 -36.99 80.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.865 0.364 . . . . 54.210000000000001 110.384 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.3 tt0 -60.4 -43.15 96.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 110.237 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.67 ' HG3' HH11 ' A' ' 65' ' ' ARG . 18.8 ttm-85 -60.85 -53.18 60.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.63 -0.714 . . . . 74.430000000000007 111.764 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.8 pt -67.26 -37.39 79.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.953 0.406 . . . . 74.430000000000007 111.125 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.921 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 35.2 mm-40 -66.81 -33.17 75.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.02 -0.537 . . . . 71.010000000000005 110.527 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.504 ' C ' ' HB3' ' A' ' 72' ' ' ASP . 16.1 mm-40 -78.21 2.33 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.685 0.279 . . . . 75.109999999999999 111.226 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 71.6 mt -103.59 -66.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.099 0.476 . . . . 70.129999999999995 110.968 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -85.33 -55.21 4.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.578 0.704 . . . . 45.109999999999999 110.845 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -10.97 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.864 -1.062 . . . . 55.350000000000001 111.853 -170.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 6.8 p-10 -42.15 -34.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.978 1.103 . . . . 73.310000000000002 113.978 -167.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 96.0 mmm -62.06 89.54 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.299 0.571 . . . . 75.019999999999996 111.069 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 94' ' ' VAL . 6.6 p -119.99 132.94 23.9 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.547 -0.751 . . . . 71.120000000000005 110.186 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 8.2 Cg_exo -73.1 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.882 2.388 . . . . 72.129999999999995 112.019 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.5 -21.76 28.2 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.866 0.321 . . . . 60.32 111.866 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -56.15 -18.34 9.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.253 -0.43 . . . . 75.439999999999998 111.795 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 9.7 p -57.11 -40.2 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.919 0.39 . . . . 72.150000000000006 110.453 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -73.85 -31.1 63.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 74.439999999999998 110.077 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.51 -27.28 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.894 -0.594 . . . . 73.109999999999999 110.069 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -83.24 -2.86 56.63 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.552 -0.749 . . . . 54.530000000000001 110.277 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 94.2 mt -112.34 147.89 35.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.208 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.98 19.55 19.82 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.188 -1.041 . . . . 64.540000000000006 108.188 172.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -102.44 174.64 5.81 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.029 -0.987 . . . . 74.549999999999997 110.661 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -165.41 138.09 4.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.878 -0.601 . . . . 73.5 109.721 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 66.73 24.17 10.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.578 0.549 . . . . 53.329999999999998 111.132 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.31 124.28 13.18 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.954 -0.566 . . . . 74.420000000000002 111.905 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.32 -32.45 71.87 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.983 2.455 . . . . 73.530000000000001 112.549 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.61 54.11 0.18 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.304 -0.719 . . . . 73.430000000000007 111.304 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -115.31 108.56 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.626 0.25 . . . . 44.039999999999999 110.432 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' HA ' HD11 ' A' ' 82' ' ' LEU . 4.1 p30 -148.0 133.19 18.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.226 -0.443 . . . . 74.510000000000005 110.22 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -97.12 135.3 39.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.589 -0.893 . . . . 74.099999999999994 108.589 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.91 171.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 75.120000000000005 110.989 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 94' ' ' VAL . 7.7 p -80.18 41.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 122.719 1.247 . . . . 75.409999999999997 112.524 -171.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.921 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 6.1 tmm_? . . . . . 0 C--O 1.251 1.176 0 CA-C-N 114.677 -1.147 . . . . 74.540000000000006 108.284 164.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.606 0.241 . . . . 73.219999999999999 111.023 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.03 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.788 -0.449 . . . . 73.439999999999998 109.788 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -102.7 46.05 0.94 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.038 0.447 . . . . 72.239999999999995 111.012 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' HIS . 7.2 p-80 44.03 22.03 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.412 1.264 . . . . 53.229999999999997 114.412 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 59.79 -76.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.619 0.6 . . . . 64.019999999999996 112.619 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' HIS . 27.2 t-80 -56.39 111.96 1.12 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.81 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -107.78 157.17 18.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.574 -0.739 . . . . 52.520000000000003 109.914 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -59.04 108.71 0.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.008 -0.368 . . . . 71.439999999999998 110.008 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 ttm -122.56 -45.29 2.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 71.540000000000006 110.215 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.36 58.05 1.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.619 -0.719 . . . . 73.319999999999993 111.543 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -61.16 -27.53 68.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.117 0.484 . . . . 64.109999999999999 110.471 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.4 mt -146.39 173.96 11.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.81 -0.811 . . . . 73.430000000000007 108.81 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.76 162.92 27.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 52.229999999999997 111.414 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.24 -175.61 2.9 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.662 -0.866 . . . . 61.0 108.662 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -84.68 58.64 5.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.45 0.643 . . . . 73.030000000000001 109.774 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -83.83 92.37 7.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.697 . . . . 75.239999999999995 110.442 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -112.57 134.16 54.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 74.109999999999999 109.981 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' H ' ' NE2' ' A' ' 64' ' ' GLN . . . -135.81 178.72 18.47 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.33 -0.708 . . . . 74.420000000000002 111.33 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.46 141.03 49.67 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.75 2.3 . . . . 73.409999999999997 112.29 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.93 -168.33 39.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.984 -0.626 . . . . 44.340000000000003 112.327 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 m -117.08 162.92 17.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.943 -0.391 . . . . 65.310000000000002 109.943 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.462 ' O ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -109.93 123.56 49.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.172 0.511 . . . . 73.349999999999994 110.546 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.37 176.4 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.561 -0.745 . . . . 74.420000000000002 110.098 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.89 -35.48 32.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 70.420000000000002 110.234 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.93 133.58 47.46 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 71.109999999999999 111.075 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.27 141.47 37.56 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.196 0.522 . . . . 63.109999999999999 110.256 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -129.62 153.0 48.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.367 -0.833 . . . . 64.219999999999999 109.751 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -116.02 167.45 10.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.083 -0.962 . . . . 74.329999999999998 108.896 169.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.3 t -92.47 146.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.131 -1.433 . . . . 71.299999999999997 107.131 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 46' ' ' LEU . 34.5 m -140.32 163.9 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 118.395 0.543 . . . . 74.310000000000002 110.927 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -164.16 159.69 20.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.189 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 23.2 p-10 -171.32 140.21 1.41 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.029 -0.532 . . . . 44.450000000000003 110.619 168.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 50.02 4.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.058 1.133 . . . . 73.120000000000005 114.058 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 9.4 pt-20 -107.71 -29.49 9.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.824 -0.547 . . . . 70.25 112.371 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.97 19.28 67.6 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.644 -0.788 . . . . 21.199999999999999 111.411 -173.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.815 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 87.3 mt-30 -129.52 174.03 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.736 0.814 . . . . 74.310000000000002 108.807 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.5 132.64 56.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.593 0.711 . . . . 73.099999999999994 112.416 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 m -124.95 178.38 5.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.579 -1.191 . . . . 73.510000000000005 108.886 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 62' ' ' CYS . 18.0 m -129.91 160.07 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.855 0.36 . . . . 63.030000000000001 111.337 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -157.67 154.38 28.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.863 -0.792 . . . . 74.310000000000002 108.863 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -80.26 135.12 36.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.976 -0.289 . . . . 73.299999999999997 110.625 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.75 136.23 52.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 70.439999999999998 110.529 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.78 -3.71 74.6 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.188 -0.46 . . . . 43.5 112.132 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -103.26 128.19 50.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.705 -0.48 . . . . 65.319999999999993 109.705 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -64.97 156.69 30.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.025 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 30' ' ' VAL . 19.9 mt -124.34 139.43 32.88 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.471 -0.786 . . . . 65.25 110.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -54.73 141.49 75.81 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.899 2.4 . . . . 72.340000000000003 111.612 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.25 127.65 25.27 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.829 0.347 . . . . 71.430000000000007 110.442 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.75 -34.54 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.538 -0.625 . . . . 71.010000000000005 111.538 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.4 m95 -78.15 142.81 37.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.989 -0.374 . . . . 71.239999999999995 109.989 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.5 152.92 48.5 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 120.774 0.321 . . . . 74.230000000000004 110.318 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 p -100.94 154.31 18.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.103 -0.953 . . . . 63.350000000000001 110.9 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.09 171.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.301 1.04 . . . . 74.209999999999994 109.182 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.95 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.713 -0.756 . . . . 72.200000000000003 112.522 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.67 132.92 10.16 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.122 -1.066 . . . . 72.409999999999997 108.122 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.65 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.9 Cg_endo -62.85 122.38 10.65 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.875 1.716 . . . . 72.400000000000006 112.42 -170.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.79 160.71 10.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.508 -0.769 . . . . 55.439999999999998 109.351 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -55.86 154.99 6.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.65 0.262 . . . . 72.340000000000003 111.104 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 87.4 tttt -49.05 -40.94 33.33 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.946 -0.57 . . . . 75.310000000000002 110.886 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.94 -48.16 70.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.464 -0.789 . . . . 73.420000000000002 110.923 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -74.77 -30.18 61.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 72.450000000000003 110.783 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 39' ' ' VAL . 12.9 t -66.36 -50.94 61.84 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.911 -0.586 . . . . 63.149999999999999 110.667 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.2 pp -63.93 -37.97 89.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.954 0.407 . . . . 54.210000000000001 110.276 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 26.3 tt0 -58.68 -43.49 89.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.824 -0.626 . . . . 74.010000000000005 110.237 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.7 ttt180 -62.05 -43.58 98.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.166 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.67 -38.29 44.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 111.827 0.306 . . . . 74.430000000000007 111.827 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 34.9 mm-40 -64.12 -41.59 97.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 121.304 -0.158 . . . . 71.010000000000005 111.15 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 64.1 mt-30 -73.9 7.86 2.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.02 0.438 . . . . 75.109999999999999 111.18 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.5 mt -103.63 -65.92 0.98 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.307 -0.406 . . . . 70.129999999999995 110.874 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -85.79 -52.85 5.49 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.682 -0.69 . . . . 45.109999999999999 111.128 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -74.88 -11.69 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.414 -0.812 . . . . 55.350000000000001 111.054 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 4.0 p-10 -43.14 -35.61 1.41 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.842 -0.617 . . . . 73.310000000000002 112.398 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -67.75 81.13 0.19 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.405 0.621 . . . . 75.019999999999996 110.068 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.973 HG21 ' HB ' ' A' ' 94' ' ' VAL . 1.3 t -119.22 144.39 36.14 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 71.120000000000005 110.989 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 74' ' ' VAL . 42.1 Cg_endo -65.74 -168.34 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.973 2.449 . . . . 72.129999999999995 113.035 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.72 -19.13 5.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.01 -0.541 . . . . 60.32 112.246 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 50.7 p -57.4 -23.06 47.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.322 -0.399 . . . . 75.439999999999998 111.346 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' O ' HD13 ' A' ' 82' ' ' LEU . 11.1 p -59.52 -41.15 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.172 0.51 . . . . 72.150000000000006 110.242 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.94 -30.49 62.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.858 -0.61 . . . . 74.439999999999998 110.416 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 3.7 mm-40 -72.74 -45.88 56.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.676 -0.693 . . . . 73.109999999999999 111.302 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -69.18 -26.58 64.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 54.530000000000001 110.891 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 78' ' ' VAL . 10.3 mp -91.78 56.5 2.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.637 0.732 . . . . 73.430000000000007 109.984 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 85' ' ' HIS . 25.0 t-20 -97.14 -45.68 6.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.855 -1.066 . . . . 64.540000000000006 110.674 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 73.44 -2.13 2.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.609 -0.723 . . . . 74.549999999999997 111.915 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.494 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 11.9 t60 -111.74 154.98 24.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.077 -0.712 . . . . 73.5 109.077 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.1 t -51.77 134.55 30.61 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.749 0.309 . . . . 53.329999999999998 110.767 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.68 -80.16 0.26 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.323 -0.711 . . . . 74.420000000000002 111.323 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.41 -148.09 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.159 2.572 . . . . 73.530000000000001 111.837 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.13 -47.32 1.1 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.312 -0.715 . . . . 73.430000000000007 111.312 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 pt -94.73 16.68 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 122.001 0.905 . . . . 44.039999999999999 110.178 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -88.7 170.07 11.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.905 -1.498 . . . . 74.510000000000005 110.273 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -100.69 135.24 42.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.319 -0.4 . . . . 74.099999999999994 111.077 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.75 -170.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.804 -0.634 . . . . 75.120000000000005 109.822 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.973 ' HB ' HG21 ' A' ' 74' ' ' VAL . 7.3 p -81.19 158.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.726 -0.472 . . . . 75.409999999999997 109.726 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.501 ' HD2' ' HB2' ' A' ' 64' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.831 0 CA-C-O 117.938 -1.03 . . . . 74.540000000000006 108.798 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.765 0.317 . . . . 73.219999999999999 110.985 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.38 148.71 22.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.179 -0.304 . . . . 73.439999999999998 110.179 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -121.65 11.04 10.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.213 0.53 . . . . 72.239999999999995 109.859 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.34 107.92 6.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.651 . . . . 53.229999999999997 110.786 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.85 157.67 15.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 64.019999999999996 110.276 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -173.22 85.25 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.947 -0.39 . . . . 74.209999999999994 109.947 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.442 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 30.9 p80 -81.18 81.25 7.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.111 0.482 . . . . 52.520000000000003 111.841 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 179.28 96.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 71.439999999999998 110.218 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.81 -43.73 29.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 71.540000000000006 109.65 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.94 74.73 0.39 Allowed Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.642 -0.708 . . . . 73.319999999999993 112.37 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.625 HG22 ' HG ' ' A' ' 12' ' ' LEU . 6.0 m -92.71 -86.84 0.24 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.672 0.272 . . . . 64.109999999999999 111.318 -176.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 11' ' ' THR . 94.4 mt -127.61 176.29 7.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.772 0.32 . . . . 73.430000000000007 110.617 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.46 -169.31 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.856 -0.611 . . . . 52.229999999999997 110.628 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -69.75 -172.58 0.51 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 123.384 0.428 . . . . 61.0 111.413 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -134.1 106.67 7.32 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.101 -0.5 . . . . 73.030000000000001 110.189 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' GLY . 10.6 t -92.6 -38.02 12.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.562 -0.533 . . . . 75.239999999999995 109.562 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 37.67 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.075 0.95 . . . . 74.109999999999999 113.017 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 148.4 150.96 5.34 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.981 -0.848 . . . . 74.420000000000002 110.981 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.48 85.02 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.439 2.092 . . . . 73.409999999999997 111.665 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.45 -142.89 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.901 -0.59 . . . . 44.340000000000003 112.187 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -178.09 -65.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.388 0.613 . . . . 65.310000000000002 110.209 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.23 14.72 3.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.534 -0.757 . . . . 73.349999999999994 110.364 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 24' ' ' ASP . 6.2 p-10 -65.15 -89.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.812 -1.086 . . . . 74.420000000000002 112.458 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.4 m-20 -118.76 136.38 54.0 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 122.774 0.429 . . . . 70.420000000000002 110.736 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -65.14 154.04 39.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.159 -0.682 . . . . 71.109999999999999 109.159 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 57' ' ' ALA . 3.2 mm? -76.22 151.97 36.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.696 0.76 . . . . 63.109999999999999 111.867 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.0 m-85 -127.37 148.5 50.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.735 -1.121 . . . . 64.219999999999999 109.1 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.608 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.19 159.8 22.05 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.7 . . . . 74.329999999999998 109.111 174.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 53' ' ' VAL . 46.6 t -91.97 145.85 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 46' ' ' LEU . 26.0 m -138.87 161.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 121.771 -0.581 . . . . 74.310000000000002 111.517 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 24.8 ptt180 -161.81 155.42 21.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.498 -0.773 . . . . 74.209999999999994 110.201 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.606 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.0 p30 -161.33 139.72 9.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.213 -0.292 . . . . 44.450000000000003 110.213 169.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 43.08 3.89 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.692 1.367 . . . . 73.120000000000005 114.692 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.8 pt-20 -112.49 -32.03 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.573 -0.705 . . . . 70.25 111.594 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.21 -22.52 18.9 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.411 -0.423 . . . . 21.199999999999999 113.095 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -86.29 174.11 9.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.97 0.385 . . . . 74.310000000000002 110.383 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -106.26 139.89 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 73.099999999999994 112.442 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 29' ' ' VAL . 23.0 m -134.87 178.24 7.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.379 -0.828 . . . . 73.510000000000005 109.464 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 62' ' ' CYS . 36.0 m -123.1 159.13 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.521 0.201 . . . . 63.030000000000001 110.65 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -158.37 139.02 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.987 -0.746 . . . . 74.310000000000002 108.987 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.5 ttt -67.39 124.37 22.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.262 . . . . 73.299999999999997 110.81 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.82 130.97 44.62 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.297 -0.41 . . . . 70.439999999999998 110.123 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.13 -9.41 33.62 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.291 -0.724 . . . . 43.5 111.291 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -106.38 111.27 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 65.319999999999993 109.278 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 m -66.74 141.63 57.67 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.725 . . . . 72.319999999999993 112.11 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 HD12 HG23 ' A' ' 52' ' ' THR . 45.3 mt -96.3 151.44 38.12 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 114.727 -1.124 . . . . 65.25 111.314 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 69.2 Cg_endo -77.97 152.55 28.35 Favored 'Trans proline' 0 C--O 1.242 0.697 0 C-N-CA 122.549 2.166 . . . . 72.340000000000003 111.774 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.24 19.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.67 -0.695 . . . . 71.430000000000007 111.018 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.78 -35.27 4.37 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.443 -0.799 . . . . 71.010000000000005 111.339 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 22.5 m95 -83.41 142.13 31.22 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.979 -0.378 . . . . 71.239999999999995 109.979 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -129.28 148.24 51.19 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 120.852 0.358 . . . . 74.230000000000004 110.582 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 HD12 ' A' ' 46' ' ' LEU . 19.9 p -99.04 150.75 21.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.659 -1.155 . . . . 63.350000000000001 110.315 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.76 155.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.107 -172.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.73 -160.17 24.21 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.905 -1.043 . . . . 72.200000000000003 112.641 175.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 32.9 tt0 -103.83 133.14 20.42 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 55.5 Cg_endo -70.24 111.14 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.322 1.348 . . . . 72.400000000000006 110.566 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 26' ' ' LEU . . . -147.53 171.98 14.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.799 -0.637 . . . . 55.439999999999998 110.241 -171.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 61' ' ' GLN . 5.9 t -57.14 156.2 7.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.512 -0.313 . . . . 72.340000000000003 111.441 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -49.76 -43.7 48.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.953 0.501 . . . . 75.310000000000002 110.962 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.21 -51.31 62.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.806 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 58' ' ' THR . 85.6 mm-40 -69.28 -30.74 68.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 72.450000000000003 110.687 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 39' ' ' VAL . 4.1 t -63.5 -50.09 70.98 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.076 -0.511 . . . . 63.149999999999999 110.288 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.3 pp -68.06 -46.51 70.91 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.929 -0.397 . . . . 54.210000000000001 109.929 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.4 tt0 -56.87 -31.88 65.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 74.010000000000005 111.162 -175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.1 ttt85 -70.96 -53.54 14.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 111.435 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.9 pt -70.53 -37.75 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.777 0.288 . . . . 74.430000000000007 111.777 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.719 ' HB2' HG23 ' A' ' 94' ' ' VAL . 13.2 pt-20 -69.59 -37.75 77.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 111.095 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -81.33 1.74 31.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 66.6 mt -103.77 -66.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 70.129999999999995 110.844 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -85.18 -53.36 5.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.709 -0.678 . . . . 45.109999999999999 110.911 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.7 m -75.35 -11.13 59.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.46 -0.791 . . . . 55.350000000000001 111.47 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -43.92 -32.97 1.24 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.368 0.667 . . . . 73.310000000000002 112.339 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.0 ttt -66.33 77.89 0.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.836 -0.62 . . . . 75.019999999999996 109.981 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.56 HG23 ' HB1' ' A' ' 93' ' ' ALA . 5.8 p -74.14 133.45 78.33 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.084 -0.962 . . . . 71.120000000000005 110.597 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 Cg_exo -67.45 -158.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.033 2.489 . . . . 72.129999999999995 112.111 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.02 -23.54 13.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.712 0.292 . . . . 60.32 111.554 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -59.37 -8.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.176 -0.465 . . . . 75.439999999999998 111.206 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HB ' HG13 ' A' ' 74' ' ' VAL . 7.2 p -53.85 -44.32 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-O 121.164 0.507 . . . . 72.150000000000006 109.879 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -65.89 -32.7 74.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 74.439999999999998 110.086 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.657 ' HG3' ' CG ' ' A' ' 85' ' ' HIS . 29.2 tt0 -76.88 -28.74 55.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.517 -0.765 . . . . 73.109999999999999 111.3 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -86.49 -23.85 25.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.356 -0.384 . . . . 54.530000000000001 110.659 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 78' ' ' VAL . 10.1 mp -100.18 -47.88 4.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.298 -0.41 . . . . 73.430000000000007 110.925 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -97.97 150.8 20.97 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.341 -0.39 . . . . 64.540000000000006 110.474 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 11.6 pt20 -69.74 92.04 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 74.549999999999997 110.053 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.657 ' CG ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -60.28 90.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.671 -0.695 . . . . 73.5 111.394 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -75.14 85.51 2.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 53.329999999999998 109.828 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.17 -126.44 2.04 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.939 -0.573 . . . . 74.420000000000002 111.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.41 169.81 13.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.934 2.422 . . . . 73.530000000000001 112.416 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.4 99.0 0.23 Allowed Glycine 0 C--N 1.331 0.25 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 112.275 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -105.45 80.32 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.284 0.564 . . . . 44.039999999999999 109.496 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.42 8.03 1.56 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.35 -0.841 . . . . 74.510000000000005 112.081 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -80.89 73.48 7.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.321 0.582 . . . . 74.099999999999994 109.725 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 74' ' ' VAL . . . -151.32 -163.3 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.176 -0.92 . . . . 75.120000000000005 109.874 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 67' ' ' GLU . 8.7 p -75.84 136.59 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 110.12 -0.326 . . . . 75.409999999999997 110.12 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.763 -0.636 . . . . 74.540000000000006 111.098 -175.992 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.837 -0.431 . . . . 73.219999999999999 109.837 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.29 90.35 1.25 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.911 0.386 . . . . 73.439999999999998 110.417 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -60.51 -44.3 96.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 72.239999999999995 110.537 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -93.66 43.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.349 0.595 . . . . 53.229999999999997 109.735 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -58.77 143.84 45.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.805 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -153.48 -175.68 5.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.71 -0.677 . . . . 74.209999999999994 109.48 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -135.16 -80.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.678 0.275 . . . . 52.520000000000003 110.829 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -176.78 123.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 71.439999999999998 110.564 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.7 mtp -79.85 -53.8 6.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 71.540000000000006 110.224 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.63 114.46 3.87 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.944 -0.571 . . . . 73.319999999999993 112.524 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.0 p -115.97 -66.55 1.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 64.109999999999999 109.574 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.7 mt -116.56 -160.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 73.430000000000007 109.289 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.735 ' HG3' ' H ' ' A' ' 15' ' ' GLN . 7.0 pt-20 -102.98 -166.69 1.3 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.543 -0.54 . . . . 52.229999999999997 109.543 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.55 -13.49 52.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.873 0.368 . . . . 61.0 110.205 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.735 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 74.1 mt-30 67.46 77.41 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.097 -0.956 . . . . 73.030000000000001 109.71 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 71.3 p -97.96 -7.67 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.741 -1.118 . . . . 75.239999999999995 111.361 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.695 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 0.5 OUTLIER 41.57 49.04 3.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.618 0.723 . . . . 74.109999999999999 110.544 -171.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.1 149.16 27.16 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.049 -0.978 . . . . 74.420000000000002 112.842 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.91 -24.35 8.53 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.711 2.274 . . . . 73.409999999999997 112.527 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.83 41.04 99.93 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.495 -0.642 . . . . 44.340000000000003 111.495 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -77.62 -178.51 5.35 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.254 0.222 . . . . 65.310000000000002 110.753 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 63.9 mtt 62.47 22.68 13.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.928 -0.578 . . . . 73.349999999999994 110.501 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -171.52 -170.34 0.8 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.553 -0.906 . . . . 74.420000000000002 108.553 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.66 -60.46 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.091 0.472 . . . . 70.420000000000002 110.536 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.96 97.72 8.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.616 -0.72 . . . . 71.109999999999999 110.009 -175.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 31.3 mt -82.27 166.78 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.997 0.903 . . . . 63.109999999999999 111.768 -174.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.65 149.67 41.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.966 -1.47 . . . . 64.219999999999999 109.338 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.603 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 m-85 -107.94 164.08 12.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.782 -0.821 . . . . 74.329999999999998 108.782 168.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HH11 ' A' ' 65' ' ' ARG . 40.1 t -92.3 137.24 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.27 -1.382 . . . . 71.299999999999997 107.27 174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 13.7 m -139.03 164.95 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 118.113 0.415 . . . . 74.310000000000002 111.244 -174.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 39.2 ptt180 -169.19 170.02 8.93 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.571 -0.74 . . . . 74.209999999999994 110.473 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.6 p30 -156.19 139.79 15.97 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.337 -0.246 . . . . 44.450000000000003 110.337 170.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.4 t30 47.42 4.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.885 1.069 . . . . 73.120000000000005 113.885 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.2 pt-20 -112.26 -32.32 6.56 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.806 -0.559 . . . . 70.25 111.924 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 -22.73 4.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.388 -0.434 . . . . 21.199999999999999 112.73 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -73.45 174.06 8.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.872 0.336 . . . . 74.310000000000002 110.315 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -121.85 132.64 54.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.332 0.493 . . . . 73.099999999999994 112.332 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -129.02 176.89 7.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.267 -0.879 . . . . 73.510000000000005 109.393 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.22 149.19 21.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.915 0.388 . . . . 63.030000000000001 110.815 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' ' HB3' ' A' ' 44' ' ' ARG . 70.8 t-105 -149.18 137.87 21.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 74.310000000000002 109.728 -171.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.6 ttt -62.76 125.19 23.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.663 -0.244 . . . . 73.299999999999997 110.896 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.76 144.33 57.13 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.785 -0.45 . . . . 70.439999999999998 109.785 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.7 -34.55 4.94 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 111.144 -0.782 . . . . 43.5 111.144 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HB3' ' NE1' ' A' ' 40' ' ' TRP . 4.8 ttt180 -69.82 95.42 0.9 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.804 -0.813 . . . . 65.319999999999993 108.804 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.1 m -61.3 126.07 26.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 111.929 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.8 mt -85.05 148.15 49.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.935 -1.03 . . . . 65.25 110.944 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 61.6 Cg_endo -79.09 159.62 26.86 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.625 2.216 . . . . 72.340000000000003 112.045 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.84 126.65 23.02 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.006 -0.543 . . . . 71.430000000000007 110.773 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -35.18 4.43 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.578 -0.737 . . . . 71.010000000000005 111.488 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 44.3 m95 -83.51 134.89 34.82 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.988 -0.375 . . . . 71.239999999999995 109.988 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 10.6 pt-20 -119.25 146.95 44.8 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.424 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 46' ' ' LEU . 37.1 p -105.2 156.7 17.86 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.456 1.097 . . . . 63.350000000000001 110.106 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -164.78 157.71 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.336 0.588 . . . . 74.209999999999994 111.265 -173.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 87.04 -174.05 45.35 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 114.872 -1.058 . . . . 72.200000000000003 112.077 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 17' ' ' GLN . 0.4 OUTLIER -105.3 144.49 28.9 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.784 -0.821 . . . . 72.409999999999997 108.784 173.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.6 Cg_endo -64.4 140.05 68.02 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.971 1.781 . . . . 72.400000000000006 112.36 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' HB3' ' A' ' 26' ' ' LEU . . . -171.65 147.03 2.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.708 -0.678 . . . . 55.439999999999998 109.676 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -59.77 168.3 1.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.391 0.138 . . . . 72.340000000000003 111.23 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE3' HD23 ' A' ' 63' ' ' LEU . 56.0 tptt -44.37 -51.59 8.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.921 -174.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -56.05 -47.82 77.18 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.901 0.382 . . . . 73.420000000000002 111.488 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 46.7 mt-30 -74.73 -35.28 62.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 72.450000000000003 111.147 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.75 -45.94 80.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 63.149999999999999 109.971 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 pp -68.05 -44.33 76.65 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.85 -0.426 . . . . 54.210000000000001 109.85 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.587 ' N ' HD12 ' A' ' 63' ' ' LEU . 27.0 tt0 -55.06 -37.98 67.44 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.301 0.572 . . . . 74.010000000000005 109.825 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.573 HH11 HG21 ' A' ' 29' ' ' VAL . 65.9 ttt-85 -57.43 -53.33 59.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.436 -0.802 . . . . 74.430000000000007 111.137 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.4 pt -74.22 -33.9 36.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.449 -0.341 . . . . 74.430000000000007 111.892 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.81 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 74.4 mm-40 -64.12 -42.89 96.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.536 -0.302 . . . . 71.010000000000005 110.416 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.6 mm-40 -74.42 4.73 5.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.355 . . . . 75.109999999999999 111.078 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.9 mt -103.14 -64.98 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 70.129999999999995 110.695 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.42 -52.03 6.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 45.109999999999999 111.141 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 m -73.47 -11.26 60.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.549 -0.75 . . . . 55.350000000000001 111.036 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -42.03 -37.16 1.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.679 0.792 . . . . 73.310000000000002 112.269 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.96 79.47 0.04 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.355 0.598 . . . . 75.019999999999996 110.035 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.5 p -97.1 135.31 22.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.555 -0.748 . . . . 71.120000000000005 110.8 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.58 -161.51 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.679 2.253 . . . . 72.129999999999995 111.66 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.39 -18.86 2.88 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.626 0.37 . . . . 60.32 111.883 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.7 t -52.11 -27.79 15.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.011 -0.54 . . . . 75.439999999999998 111.456 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.64 -40.65 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.96 0.409 . . . . 72.150000000000006 110.485 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -73.72 -34.53 64.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 74.439999999999998 110.206 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 91' ' ' ASP . 5.9 tp10 -64.75 -33.37 75.81 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.401 0.619 . . . . 73.109999999999999 109.432 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.619 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 50.2 t-80 -74.08 -20.21 60.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.421 -0.809 . . . . 54.530000000000001 110.634 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -43.9 9.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.132 -0.485 . . . . 73.430000000000007 109.963 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.77 111.8 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.378 -0.828 . . . . 64.540000000000006 111.101 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -149.81 140.53 22.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.934 -0.575 . . . . 74.549999999999997 109.912 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -116.67 85.2 2.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.974 -0.75 . . . . 73.5 108.974 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.9 t 68.18 -67.59 0.19 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.305 -0.861 . . . . 53.329999999999998 109.734 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.23 150.08 33.18 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.615 -0.594 . . . . 74.420000000000002 111.615 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.92 110.61 0.85 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.709 2.273 . . . . 73.530000000000001 112.734 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.65 50.59 0.76 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.547 -1.021 . . . . 73.430000000000007 110.547 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 81' ' ' HIS . 32.0 pt -90.15 172.23 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.33 -0.435 . . . . 44.039999999999999 112.02 -169.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' A' ' 80' ' ' GLU . 35.8 t70 -117.16 163.33 16.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.74 -0.663 . . . . 74.510000000000005 109.966 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -78.29 75.8 4.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.331 0.586 . . . . 74.099999999999994 110.943 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.323 -0.853 . . . . 75.120000000000005 110.084 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.33 134.66 25.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.602 -0.518 . . . . 75.409999999999997 109.602 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.81 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 54.5 mtt180 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.525 -0.75 . . . . 74.540000000000006 110.413 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mtp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.582 0.23 . . . . 73.219999999999999 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 75' ' ' PRO . . . -66.16 -46.93 75.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.97 0.414 . . . . 73.439999999999998 111.325 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -82.42 108.93 16.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 72.239999999999995 110.723 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -131.22 -85.48 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.327 -0.397 . . . . 53.229999999999997 110.046 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -62.89 134.22 55.89 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.141 -0.688 . . . . 64.019999999999996 109.141 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -143.23 109.94 5.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.204 0.526 . . . . 74.209999999999994 111.568 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -54.83 127.05 26.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 52.520000000000003 110.407 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -104.0 -71.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.436 -0.579 . . . . 71.439999999999998 109.436 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp 176.4 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.536 -0.756 . . . . 71.540000000000006 109.149 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.55 -111.57 2.09 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.098 -0.572 . . . . 73.319999999999993 112.716 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 p -82.97 136.4 34.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.609 0.242 . . . . 64.109999999999999 110.558 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.7 -37.9 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 110.079 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.663 ' HA ' HH12 ' A' ' 65' ' ' ARG . 2.9 mm-40 -108.79 -178.42 3.58 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.323 -0.398 . . . . 52.229999999999997 110.484 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -156.41 -166.19 2.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 61.0 110.095 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -88.23 91.32 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 73.030000000000001 110.481 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 p -70.39 94.27 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 75.239999999999995 109.641 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.55 174.25 8.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.576 -0.738 . . . . 74.109999999999999 111.139 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.49 -174.04 17.62 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.808 -0.633 . . . . 74.420000000000002 111.89 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.37 114.52 2.16 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.617 2.211 . . . . 73.409999999999997 111.911 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.57 70.32 1.68 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.903 -0.59 . . . . 44.340000000000003 112.206 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.7 t -71.85 100.14 2.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.049 -0.352 . . . . 65.310000000000002 110.049 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.62 12.79 17.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.23 0.538 . . . . 73.349999999999994 111.026 -178.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.94 -29.66 68.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.854 . . . . 74.420000000000002 110.415 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -114.85 145.16 42.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.318 -0.993 . . . . 70.420000000000002 108.318 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.48 -175.82 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.922 0.391 . . . . 71.109999999999999 111.734 -171.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.65 148.48 46.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.334 0.588 . . . . 63.109999999999999 111.21 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -133.93 155.98 48.95 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.116 -0.947 . . . . 64.219999999999999 109.713 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -121.17 159.81 25.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.022 -0.99 . . . . 74.329999999999998 108.693 172.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 HG23 ' A' ' 53' ' ' VAL . 42.3 t -91.47 125.61 44.18 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.098 -1.075 . . . . 71.299999999999997 108.098 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 52' ' ' THR . 16.7 m -133.17 166.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.9 0.381 . . . . 74.310000000000002 111.084 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -165.81 162.23 18.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.497 -0.774 . . . . 74.209999999999994 110.522 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 23.9 p-10 -151.94 139.78 19.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.647 0.26 . . . . 44.450000000000003 110.353 171.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 44.47 8.97 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.14 1.163 . . . . 73.120000000000005 114.14 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.41 -32.26 6.55 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.789 -0.569 . . . . 70.25 111.852 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -22.94 3.65 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.958 -0.564 . . . . 21.199999999999999 113.078 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -87.43 173.69 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.456 -0.572 . . . . 74.310000000000002 109.456 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 15.8 m-85 -106.89 138.75 42.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.365 0.876 . . . . 73.099999999999994 113.365 -172.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 m -134.96 -179.01 5.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.402 -1.272 . . . . 73.510000000000005 109.011 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.3 m -124.26 159.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.935 0.397 . . . . 63.030000000000001 111.29 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.465 ' HB2' HG21 ' A' ' 30' ' ' VAL . 68.3 t-105 -142.8 143.38 32.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.252 -0.647 . . . . 74.310000000000002 109.252 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.5 ttt -81.37 127.44 32.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.234 -0.284 . . . . 73.299999999999997 110.234 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.79 157.11 18.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.256 -0.429 . . . . 70.439999999999998 111.26 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.32 10.6 55.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.191 -0.528 . . . . 43.5 112.669 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -151.47 130.0 12.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.903 0.382 . . . . 65.319999999999993 110.147 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -80.67 153.42 27.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.514 0.673 . . . . 72.319999999999993 111.643 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 52' ' ' THR . 52.7 mt -95.26 145.81 30.19 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 114.857 -1.065 . . . . 65.25 111.013 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.31 168.35 14.95 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.642 2.228 . . . . 72.340000000000003 112.551 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.3 129.84 22.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 111.022 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.82 -33.03 6.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.022 -0.536 . . . . 71.010000000000005 111.804 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 45.0 m95 -88.48 141.46 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.786 0.327 . . . . 71.239999999999995 110.762 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.02 154.49 47.36 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 110.304 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.625 HG23 HD12 ' A' ' 46' ' ' LEU . 15.7 p -114.49 160.68 18.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.373 1.046 . . . . 63.350000000000001 111.194 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.452 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -165.72 149.35 2.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 C-N-CA 123.474 0.71 . . . . 74.209999999999994 110.907 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 108.27 -172.65 17.21 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.128 -0.942 . . . . 72.200000000000003 113.305 172.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' OE2' ' HD2' ' A' ' 56' ' ' PRO . 5.8 tp10 -103.27 129.45 25.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 107.983 -1.117 . . . . 72.409999999999997 107.983 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 18.9 Cg_endo -56.74 122.11 11.23 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.738 1.625 . . . . 72.400000000000006 111.32 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.72 157.78 30.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 55.439999999999998 110.431 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 t -55.73 152.93 8.83 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.088 0.243 . . . . 72.340000000000003 110.698 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.78 -42.44 25.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 111.853 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -53.92 -44.09 70.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.098 0.475 . . . . 73.420000000000002 111.036 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 82.6 mm-40 -74.85 -39.11 61.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 72.450000000000003 110.537 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 39' ' ' VAL . 8.9 t -63.42 -43.69 96.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 63.149999999999999 110.561 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.4 pp -68.14 -36.63 80.0 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 109.621 -0.511 . . . . 54.210000000000001 109.621 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.4 tt0 -54.77 -44.61 73.82 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.308 -0.627 . . . . 74.010000000000005 109.308 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.663 HH12 ' HA ' ' A' ' 13' ' ' GLU . 25.7 ttt85 -56.34 -52.0 66.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.814 -0.63 . . . . 74.430000000000007 110.952 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.49 -35.97 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.653 -0.249 . . . . 74.430000000000007 111.637 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 26.5 mm-40 -66.42 -32.75 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.603 0.239 . . . . 71.010000000000005 110.624 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.7 mm100 -81.19 -18.91 44.59 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.273 -0.421 . . . . 75.109999999999999 111.396 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.89 -66.65 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.327 0.584 . . . . 70.129999999999995 112.187 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 65.5 t-105 -85.3 -46.1 11.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 45.109999999999999 110.66 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -82.71 -10.06 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.098 -0.955 . . . . 55.350000000000001 110.993 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -40.89 -29.57 0.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.656 1.354 . . . . 73.310000000000002 114.656 -170.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.6 ttp -67.94 78.61 0.22 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.342 0.591 . . . . 75.019999999999996 109.969 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.17 134.65 19.55 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.42 -0.809 . . . . 71.120000000000005 111.437 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 80.2 Cg_endo -86.62 -151.38 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.33 2.687 . . . . 72.129999999999995 111.549 173.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.0 -11.11 7.07 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.036 0.384 . . . . 60.32 112.036 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 t -56.06 -21.05 19.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 75.439999999999998 111.245 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 79' ' ' ARG . 4.9 p -55.79 -51.12 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.452 -0.34 . . . . 72.150000000000006 111.212 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 78' ' ' VAL . 5.2 ptm180 -73.59 -20.55 60.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 74.439999999999998 110.758 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.99 -13.63 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.304 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -101.95 -53.23 2.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.003 -0.544 . . . . 54.530000000000001 110.393 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 91' ' ' ASP . 64.1 mt -90.0 175.13 7.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.589 -0.732 . . . . 73.430000000000007 110.795 -176.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -114.65 -66.03 1.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.46 -0.57 . . . . 64.540000000000006 109.46 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -87.23 75.39 9.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.797 0.808 . . . . 74.549999999999997 109.964 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -61.78 -21.81 64.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 73.5 111.623 -176.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.3 m -97.28 17.69 16.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.943 0.401 . . . . 53.329999999999998 110.826 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.6 164.27 43.17 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.094 -0.503 . . . . 74.420000000000002 112.541 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.9 79.09 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.149 2.566 . . . . 73.530000000000001 112.124 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.02 -50.05 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.981 -0.554 . . . . 73.430000000000007 111.899 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 90' ' ' ILE . 29.3 mt 58.15 34.61 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 122.442 1.115 . . . . 44.039999999999999 110.064 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' HD11 ' A' ' 82' ' ' LEU . 9.1 p-10 -85.82 68.63 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.678 -1.146 . . . . 74.510000000000005 110.53 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -79.13 53.59 1.48 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.492 0.663 . . . . 74.099999999999994 111.403 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.98 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.524 -0.762 . . . . 75.120000000000005 110.422 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 94' ' ' VAL . 7.5 p -89.23 28.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.976 1.369 . . . . 75.409999999999997 111.162 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--O 1.251 1.139 0 CA-C-N 113.778 -1.555 . . . . 74.540000000000006 110.664 178.592 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.786 0.327 . . . . 73.219999999999999 110.124 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.05 61.13 3.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 73.439999999999998 111.14 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -98.48 123.7 42.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.82 -0.808 . . . . 72.239999999999995 108.82 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -96.66 103.63 15.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.869 0.366 . . . . 53.229999999999997 111.626 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -164.86 136.18 4.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.06 -0.719 . . . . 64.019999999999996 109.06 174.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -126.51 137.92 53.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.418 -0.215 . . . . 74.209999999999994 110.418 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.421 ' NE2' ' HB2' ' A' ' 9' ' ' MET . 82.0 t60 -110.53 98.9 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 52.520000000000003 109.786 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -83.96 62.14 6.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.943 -0.571 . . . . 71.439999999999998 111.473 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.421 ' HB2' ' NE2' ' A' ' 7' ' ' HIS . 19.8 mmt -148.8 161.05 42.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.998 -0.371 . . . . 71.540000000000006 109.998 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.99 170.19 44.47 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.888 -0.596 . . . . 73.319999999999993 112.688 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.2 m -80.55 -44.32 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 64.109999999999999 110.999 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 tt -151.93 -41.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.126 0.488 . . . . 73.430000000000007 109.768 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.84 16.3 0.91 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.09 -0.505 . . . . 52.229999999999997 111.206 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.69 127.35 31.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 61.0 110.671 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.481 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 10.2 pt20 -125.32 120.03 30.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 73.030000000000001 110.062 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -65.41 -32.39 74.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.213 0.53 . . . . 75.239999999999995 110.102 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -163.67 143.02 8.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.561 -0.745 . . . . 74.109999999999999 109.308 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.4 84.91 0.38 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.727 -0.549 . . . . 74.420000000000002 111.727 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.1 -19.35 45.26 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.844 2.363 . . . . 73.409999999999997 111.943 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.16 -147.21 18.59 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.591 -0.731 . . . . 44.340000000000003 111.836 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 p -160.78 173.93 14.66 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 110.176 -0.305 . . . . 65.310000000000002 110.176 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 86.6 mtp -122.91 74.99 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 73.349999999999994 109.408 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 38.21 47.33 0.98 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.76 1.266 . . . . 74.420000000000002 112.166 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.73 176.81 4.57 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.224 -1.807 . . . . 70.420000000000002 111.179 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.29 118.28 23.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.522 -0.918 . . . . 71.109999999999999 108.522 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.89 146.25 37.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 63.109999999999999 111.419 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 22.7 m-85 -129.92 148.55 51.8 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.574 -1.194 . . . . 64.219999999999999 108.843 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.581 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.58 166.41 11.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 74.329999999999998 108.742 171.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.6 t -94.56 111.72 25.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 107.1 -1.444 . . . . 71.299999999999997 107.1 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 40' ' ' TRP . 11.5 m -125.87 167.0 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.985 -0.447 . . . . 74.310000000000002 111.534 -170.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -166.19 169.68 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 74.209999999999994 110.997 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 26.0 p-10 -156.15 139.75 15.97 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.538 -0.301 . . . . 44.450000000000003 110.757 172.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.3 t30 40.53 10.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.898 1.279 . . . . 73.120000000000005 114.216 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.0 pt-20 -112.61 -32.29 6.5 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.691 -0.631 . . . . 70.25 112.124 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 -22.96 2.19 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.165 -0.541 . . . . 21.199999999999999 112.633 -173.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -75.81 173.89 10.57 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.624 -0.51 . . . . 74.310000000000002 109.624 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -115.71 142.29 46.94 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.912 0.708 . . . . 73.099999999999994 112.912 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.0 m -137.59 -179.46 5.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.417 -1.265 . . . . 73.510000000000005 109.65 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.02 148.99 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.769 0.319 . . . . 63.030000000000001 110.983 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.488 ' HB2' HG21 ' A' ' 30' ' ' VAL . 70.3 t90 -144.44 129.88 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 110.958 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.6 ttm -69.93 143.58 52.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 73.299999999999997 110.477 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.09 -172.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 110.655 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.55 -34.41 4.2 Favored Glycine 0 CA--C 1.515 0.071 0 C-N-CA 121.175 -0.535 . . . . 43.5 112.831 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 mpt_? -95.97 -170.89 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.061 0.458 . . . . 65.319999999999993 110.384 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 p -135.3 117.26 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.991 -0.744 . . . . 72.319999999999993 108.991 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 HG23 ' A' ' 52' ' ' THR . 17.6 mt -57.7 132.21 82.53 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.101 -0.5 . . . . 65.25 111.566 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.4 158.61 9.61 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.707 2.938 . . . . 72.340000000000003 112.794 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 123.37 17.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.92 -0.582 . . . . 71.430000000000007 110.07 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.79 -29.13 7.35 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.067 -0.813 . . . . 71.010000000000005 111.067 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 59.0 m95 -84.99 151.45 24.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.779 -0.452 . . . . 71.239999999999995 109.779 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.69 145.94 45.31 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 116.363 -0.381 . . . . 74.230000000000004 110.161 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.608 HG23 HD12 ' A' ' 46' ' ' LEU . 38.7 p -104.5 144.59 31.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.783 -1.099 . . . . 63.350000000000001 110.152 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.73 168.44 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.429 0.633 . . . . 74.209999999999994 110.466 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 -148.64 22.29 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.284 -0.871 . . . . 72.200000000000003 111.955 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 28.5 tt0 -132.65 132.93 22.92 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.618 -0.882 . . . . 72.409999999999997 108.618 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.581 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -70.48 125.66 12.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.882 1.721 . . . . 72.400000000000006 111.621 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.0 175.58 13.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.195 -0.457 . . . . 55.439999999999998 110.684 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 t -62.99 151.36 39.92 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.145 -0.317 . . . . 72.340000000000003 110.145 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -44.55 -43.26 7.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 75.310000000000002 111.373 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.56 -42.62 92.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 73.420000000000002 111.269 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.03 -36.61 61.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 72.450000000000003 111.132 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 62.5 m -64.92 -44.85 88.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 63.149999999999999 111.175 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.07 -41.85 81.34 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.76 -0.459 . . . . 54.210000000000001 109.76 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.585 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.1 tt0 -59.37 -37.37 77.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.465 0.65 . . . . 74.010000000000005 110.436 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 11.4 ttt180 -64.38 -47.0 80.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.474 -0.785 . . . . 74.430000000000007 111.153 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.0 pt -74.4 -34.85 37.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.718 0.294 . . . . 74.430000000000007 111.63 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 8.1 mm-40 -64.94 -48.55 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 71.010000000000005 110.961 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 22.1 mm-40 -70.43 8.46 0.81 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.073 0.464 . . . . 75.109999999999999 111.651 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 92.5 mt -103.42 -66.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.341 0.591 . . . . 70.129999999999995 110.203 172.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -83.49 -54.69 4.77 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.401 -0.818 . . . . 45.109999999999999 110.668 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -72.18 -11.16 60.61 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.426 -0.806 . . . . 55.350000000000001 110.712 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 13.0 t70 -41.81 -40.33 2.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.599 -0.728 . . . . 73.310000000000002 111.931 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.1 mtp -66.07 76.83 0.09 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.616 -0.72 . . . . 75.019999999999996 109.491 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 4.3 p -94.6 133.6 26.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.996 -1.002 . . . . 71.120000000000005 110.809 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 9.4 Cg_exo -71.94 -166.46 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.87 2.38 . . . . 72.129999999999995 111.938 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.23 -17.8 5.06 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.284 -0.416 . . . . 60.32 111.828 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 t -50.01 -27.1 4.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.605 . . . . 75.439999999999998 111.701 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.96 -31.14 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.955 0.407 . . . . 72.150000000000006 111.264 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -63.67 -31.74 73.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.474 . . . . 74.439999999999998 110.88 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -62.81 -29.74 70.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.922 0.391 . . . . 73.109999999999999 110.645 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 16.3 t-80 -87.15 -21.96 25.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 54.530000000000001 109.839 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -81.59 -21.72 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 73.430000000000007 108.891 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.23 83.88 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.725 -0.67 . . . . 64.540000000000006 110.687 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -78.78 -8.7 59.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.708 -0.678 . . . . 74.549999999999997 109.417 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -94.86 130.01 41.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.402 -0.817 . . . . 73.5 109.937 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 m 69.36 10.02 7.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.54 0.525 . . . . 53.329999999999998 111.886 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.34 160.79 21.64 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.233 -0.508 . . . . 74.420000000000002 112.124 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -99.71 16.89 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.379 2.719 . . . . 73.530000000000001 112.942 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.11 63.06 4.86 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.457 -0.401 . . . . 73.430000000000007 112.502 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -73.41 94.74 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.338 0.496 . . . . 44.039999999999999 112.338 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 65.53 2.95 2.2 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.494 0.924 . . . . 74.510000000000005 113.494 164.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 41.9 t80 -100.9 89.98 4.04 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.034 -0.417 . . . . 74.099999999999994 110.905 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 81' ' ' HIS . . . 164.83 -168.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.457 1.103 . . . . 75.120000000000005 108.33 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.37 130.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.543 -0.91 . . . . 75.409999999999997 108.543 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.691 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mmt85 . . . . . 0 C--O 1.241 0.624 0 CA-C-O 118.122 -0.942 . . . . 74.540000000000006 110.578 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.25 -0.278 . . . . 73.219999999999999 110.25 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.53 16.52 8.12 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.598 0.561 . . . . 73.439999999999998 112.423 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -93.05 6.48 47.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.327 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -133.19 104.69 6.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.63 -0.713 . . . . 53.229999999999997 109.346 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.86 152.32 45.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 64.019999999999996 110.293 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -58.83 -45.16 90.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.503 0.502 . . . . 74.209999999999994 110.301 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 62.26 25.43 15.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.565 -0.743 . . . . 52.520000000000003 110.94 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.78 123.41 42.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.69 0.281 . . . . 71.439999999999998 110.643 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.3 ttm -80.65 -39.91 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.388 -0.597 . . . . 71.540000000000006 109.388 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.96 168.13 42.41 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.527 -0.76 . . . . 73.319999999999993 112.368 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 -54.03 5.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.529 0.68 . . . . 64.109999999999999 109.516 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.9 pt? -101.21 164.27 11.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.876 -1.057 . . . . 73.430000000000007 108.834 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.732 ' HG3' HH21 ' A' ' 65' ' ' ARG . 0.3 OUTLIER 64.07 26.9 14.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.099 0.476 . . . . 52.229999999999997 111.422 -177.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.61 40.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 61.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 92.5 mt-30 -130.94 124.61 31.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.25 -0.432 . . . . 73.030000000000001 110.91 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -76.71 78.56 3.35 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 110.413 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -92.86 121.34 34.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 74.109999999999999 110.181 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.95 145.97 25.07 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.139 -0.553 . . . . 74.420000000000002 111.848 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -85.26 24.16 0.78 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.994 2.463 . . . . 73.409999999999997 113.078 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.66 -11.4 60.04 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.444 -0.408 . . . . 44.340000000000003 113.315 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.2 m -131.08 32.59 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.187 0.518 . . . . 65.310000000000002 110.368 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.2 86.13 5.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.47 0.652 . . . . 73.349999999999994 109.708 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -101.68 -165.29 1.18 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.967 -1.015 . . . . 74.420000000000002 111.741 -175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.55 -38.55 91.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.45 0.907 . . . . 70.420000000000002 113.45 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 58' ' ' THR . 41.7 mt-10 -90.26 93.64 9.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 71.109999999999999 111.577 -168.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 56' ' ' PRO . 8.2 mp -89.89 143.1 27.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.505 0.669 . . . . 63.109999999999999 111.129 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.631 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 13.0 m-85 -133.1 157.49 45.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.766 -1.106 . . . . 64.219999999999999 109.26 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.614 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.4 m-85 -113.79 167.67 10.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.634 -0.712 . . . . 74.329999999999998 109.224 170.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.55 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.905 -1.146 . . . . 71.299999999999997 107.905 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.483 HG12 HG22 ' A' ' 52' ' ' THR . 21.6 m -137.95 162.13 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 118.171 0.441 . . . . 74.310000000000002 111.349 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.49 168.17 9.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.569 -0.741 . . . . 74.209999999999994 110.798 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.1 p-10 -163.58 139.97 6.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 44.450000000000003 110.346 166.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 t30 46.5 4.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.085 1.143 . . . . 73.120000000000005 114.085 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.6 pt-20 -105.71 -25.42 12.23 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.418 -0.801 . . . . 70.25 112.312 -167.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 -22.3 9.6 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.481 -0.39 . . . . 21.199999999999999 113.171 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -100.1 173.97 6.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.903 -0.406 . . . . 74.310000000000002 109.903 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -106.43 153.72 21.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.436 . . . . 73.099999999999994 111.774 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -145.3 -178.72 6.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 73.510000000000005 109.217 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.12 158.14 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.929 0.395 . . . . 63.030000000000001 111.058 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 59.9 t90 -150.29 142.89 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 109.738 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.53 131.64 35.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 73.299999999999997 111.615 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.49 151.62 43.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.656 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.34 -12.75 43.85 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.171 -0.538 . . . . 43.5 112.883 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 74.8 mtt180 -104.87 -167.23 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.427 -0.582 . . . . 65.319999999999993 109.427 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.6 m -138.11 131.16 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 72.319999999999993 110.117 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HG11 ' A' ' 30' ' ' VAL . 17.6 mt -80.71 135.19 52.76 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 65.25 112.13 -174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.09 138.99 21.45 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.449 2.766 . . . . 72.340000000000003 112.626 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 130.16 31.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.952 -0.567 . . . . 71.430000000000007 110.103 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.86 -35.4 4.31 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.042 -0.823 . . . . 71.010000000000005 111.042 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.0 m95 -76.35 149.49 36.99 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.914 -0.402 . . . . 71.239999999999995 109.914 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.16 152.11 50.78 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 110.049 -0.352 . . . . 74.230000000000004 110.049 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 30' ' ' VAL . 21.5 p -109.44 161.51 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.103 . . . . 63.350000000000001 110.483 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.99 162.61 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.278 0.631 . . . . 74.209999999999994 109.931 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' OE1' ' A' ' 13' ' ' GLU . . . 85.48 -173.28 47.69 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.805 -0.634 . . . . 72.200000000000003 112.336 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.29 144.22 29.31 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.207 -1.034 . . . . 72.409999999999997 108.207 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.614 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 44.9 Cg_endo -65.67 115.48 3.41 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.652 1.568 . . . . 72.400000000000006 110.814 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -140.48 168.94 18.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.099 -0.5 . . . . 55.439999999999998 110.088 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 8.8 t -59.73 151.86 24.15 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.681 -0.408 . . . . 72.340000000000003 110.496 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -46.76 -40.82 14.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.02 -0.536 . . . . 75.310000000000002 111.424 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.59 -43.32 99.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 73.420000000000002 110.893 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 93.7 mt-30 -72.85 -33.15 65.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.034 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 77.0 m -68.58 -45.95 70.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.475 -0.33 . . . . 63.149999999999999 110.83 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.11 -36.49 79.83 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.006 -0.368 . . . . 54.210000000000001 110.006 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 35.9 tt0 -66.53 -31.48 72.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.656 0.741 . . . . 74.010000000000005 110.118 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.732 HH21 ' HG3' ' A' ' 13' ' ' GLU . 13.0 ttt85 -65.57 -49.71 67.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 74.430000000000007 110.27 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.1 pt -70.28 -42.0 78.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 111.866 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 11.5 pt-20 -60.91 -49.43 77.48 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.251 -0.18 . . . . 71.010000000000005 110.653 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 83.2 mt-30 -74.85 1.94 11.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.887 0.329 . . . . 75.109999999999999 111.887 -174.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HG ' ' NE2' ' A' ' 15' ' ' GLN . 45.1 mt -103.93 -66.03 0.98 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.276 0.56 . . . . 70.129999999999995 111.227 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -86.01 -53.94 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.245 -0.889 . . . . 45.109999999999999 111.198 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.03 -10.73 52.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.9 -1.046 . . . . 55.350000000000001 111.791 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.4 p-10 -41.8 -27.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.991 1.108 . . . . 73.310000000000002 113.991 -168.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.8 mmm -70.83 78.95 0.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.162 -0.681 . . . . 75.019999999999996 109.162 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.772 HG12 HG12 ' A' ' 94' ' ' VAL . 2.5 m -76.94 161.23 74.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.498 -0.774 . . . . 71.120000000000005 111.374 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 74' ' ' VAL . 42.9 Cg_endo -67.79 -162.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.844 2.363 . . . . 72.129999999999995 112.619 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.15 -21.2 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.979 -0.555 . . . . 60.32 111.384 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.9 m -51.76 -18.32 1.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.739 -0.664 . . . . 75.439999999999998 112.306 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.619 HG13 ' HD2' ' A' ' 79' ' ' ARG . 13.4 p -54.05 -31.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.639 0.257 . . . . 72.150000000000006 111.028 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HD2' HG13 ' A' ' 78' ' ' VAL . 7.4 mpt_? -61.2 -40.36 93.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.37 -0.377 . . . . 74.439999999999998 110.8 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -60.88 -26.67 67.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.936 0.398 . . . . 73.109999999999999 110.8 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -73.28 -29.37 62.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.453 -0.34 . . . . 54.530000000000001 110.551 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.81 -6.83 59.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 110.075 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.53 2.97 51.92 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.695 -0.684 . . . . 64.540000000000006 110.28 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -62.08 130.21 44.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 74.549999999999997 111.4 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -93.62 71.02 4.23 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.592 -0.522 . . . . 73.5 109.592 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.7 t 57.95 26.46 13.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.94 -0.573 . . . . 53.329999999999998 110.732 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -121.49 73.19 0.36 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.028 -0.606 . . . . 74.420000000000002 113.232 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -97.29 -157.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.375 2.717 . . . . 73.530000000000001 111.634 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.25 -68.25 2.67 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.169 -0.772 . . . . 73.430000000000007 111.169 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.3 mm -78.95 62.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.476 -0.935 . . . . 44.039999999999999 108.476 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -135.31 123.78 23.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.77 -1.105 . . . . 74.510000000000005 108.91 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -129.45 149.4 51.24 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.026 0.441 . . . . 74.099999999999994 110.433 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.75 -152.3 0.31 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 75.120000000000005 111.199 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.772 HG12 HG12 ' A' ' 74' ' ' VAL . 7.5 p -82.77 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 122.484 1.135 . . . . 75.409999999999997 111.534 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 63' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-N 114.24 -1.345 . . . . 74.540000000000006 108.439 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.922 0.391 . . . . 73.219999999999999 110.353 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -177.84 179.23 0.89 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.821 -0.627 . . . . 73.439999999999998 109.728 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -111.51 39.86 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.72 -0.845 . . . . 72.239999999999995 108.72 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 60.05 -105.29 0.22 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.395 -1.275 . . . . 53.229999999999997 111.31 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 43.17 -91.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.701 0.4 . . . . 64.019999999999996 111.869 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -172.0 87.25 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.378 0.608 . . . . 74.209999999999994 110.144 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -70.86 129.87 40.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.651 -0.704 . . . . 52.520000000000003 110.157 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -56.84 110.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.324 . . . . 71.439999999999998 110.843 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -172.77 117.88 0.33 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.57 -0.9 . . . . 71.540000000000006 108.57 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' H ' HD22 ' A' ' 69' ' ' LEU . . . -69.14 80.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.357 -0.449 . . . . 73.319999999999993 113.056 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.519 HG23 ' HG ' ' A' ' 12' ' ' LEU . 8.9 t -58.72 -32.23 69.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.992 0.425 . . . . 64.109999999999999 110.09 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 91.0 mt -111.33 -82.16 0.58 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.047 -0.524 . . . . 73.430000000000007 109.773 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.41 144.93 48.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.857 -0.423 . . . . 52.229999999999997 109.857 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.4 116.64 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.348 0.405 . . . . 61.0 111.298 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 59.97 33.1 21.38 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.187 0.81 . . . . 73.030000000000001 113.187 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 p -76.02 76.95 2.89 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.306 0.574 . . . . 75.239999999999995 109.813 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.99 124.98 28.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.402 -0.817 . . . . 74.109999999999999 110.826 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.9 92.7 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.895 -0.593 . . . . 74.420000000000002 111.674 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.01 144.97 66.01 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.578 2.186 . . . . 73.409999999999997 111.794 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.62 91.57 0.25 Allowed Glycine 0 C--O 1.236 0.231 0 C-N-CA 121.127 -0.558 . . . . 44.340000000000003 112.368 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -162.17 120.44 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 65.310000000000002 110.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.9 mmm -103.25 29.92 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.474 -0.565 . . . . 73.349999999999994 109.474 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 64.12 17.8 10.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.071 0.939 . . . . 74.420000000000002 109.382 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 25' ' ' GLU . 34.7 t70 -78.48 -157.33 0.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.844 -1.071 . . . . 70.420000000000002 108.819 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 24' ' ' ASP . 53.2 mm-40 -71.55 121.24 18.37 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.309 0.504 . . . . 71.109999999999999 110.638 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.9 mp -87.37 147.5 25.44 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.376 0.608 . . . . 63.109999999999999 110.248 175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -124.92 148.66 48.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.037 -0.983 . . . . 64.219999999999999 109.238 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -119.34 159.8 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.694 -0.854 . . . . 74.329999999999998 108.694 174.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG21 HH11 ' A' ' 65' ' ' ARG . 30.3 t -89.4 139.91 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.534 -1.284 . . . . 71.299999999999997 107.534 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 29.6 m -139.58 164.9 23.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 121.981 -0.449 . . . . 74.310000000000002 111.367 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.655 HH21 ' HA2' ' A' ' 35' ' ' GLY . 9.4 ptm180 -158.16 161.78 37.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.881 -0.6 . . . . 74.209999999999994 111.118 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 25.5 p-10 -166.26 140.02 4.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 44.450000000000003 110.389 166.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 46.1 5.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.845 1.424 . . . . 73.120000000000005 114.845 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.2 pt-20 -112.23 -32.02 6.67 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.934 -0.479 . . . . 70.25 112.283 -170.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.655 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 81.82 -22.72 5.54 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.66 -0.781 . . . . 21.199999999999999 112.291 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -93.81 174.02 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.84 -0.43 . . . . 74.310000000000002 109.84 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -107.61 152.24 24.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.997 0.739 . . . . 73.099999999999994 112.997 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -137.75 -179.22 5.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.563 -1.199 . . . . 73.510000000000005 108.989 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 62' ' ' CYS . 30.5 m -126.08 152.5 33.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.053 0.454 . . . . 63.030000000000001 110.778 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.504 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 50.2 t90 -144.04 144.54 31.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.575 . . . . 74.310000000000002 110.458 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -90.62 135.47 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.811 -0.632 . . . . 73.299999999999997 110.724 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.39 175.27 6.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 110.154 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.48 61.82 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.798 -0.921 . . . . 43.5 110.798 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.2 ptm180 -140.89 176.86 8.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.952 -0.624 . . . . 65.319999999999993 109.366 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -126.69 126.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.42 . . . . 72.319999999999993 109.915 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 52' ' ' THR . 12.1 mt -56.22 135.04 75.21 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.454 -0.794 . . . . 65.25 112.144 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.71 155.48 70.27 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.018 2.479 . . . . 72.340000000000003 112.383 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 124.9 11.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 110.768 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.44 -30.16 6.87 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.986 -0.552 . . . . 71.010000000000005 112.208 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.53 ' HB3' HD13 ' A' ' 46' ' ' LEU . 30.6 m95 -93.3 148.44 22.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.768 0.284 . . . . 71.239999999999995 110.472 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -135.23 153.07 52.05 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.855 0.36 . . . . 74.230000000000004 111.581 173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.602 HG23 HD12 ' A' ' 46' ' ' LEU . 22.4 p -99.09 160.02 14.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.675 -1.148 . . . . 63.350000000000001 111.512 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -169.84 164.76 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.548 1.139 . . . . 74.209999999999994 109.661 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 12' ' ' LEU . . . 98.16 -159.78 20.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.004 -0.617 . . . . 72.200000000000003 113.272 173.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -113.02 128.58 25.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.661 -0.866 . . . . 72.409999999999997 108.661 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 26' ' ' LEU . 51.1 Cg_endo -68.31 112.22 2.72 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.742 1.628 . . . . 72.400000000000006 111.42 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.32 166.16 33.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 55.439999999999998 109.91 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 t -63.98 168.38 5.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.154 0.502 . . . . 72.340000000000003 111.236 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.2 tptp -48.83 -50.38 34.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.366 -0.834 . . . . 75.310000000000002 111.916 -173.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -53.49 -41.56 66.37 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.456 0.473 . . . . 73.420000000000002 111.336 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -72.94 -43.98 61.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.303 0.573 . . . . 72.450000000000003 110.532 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 39' ' ' VAL . 3.8 t -60.49 -46.57 89.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.236 -0.893 . . . . 63.149999999999999 110.858 -173.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.9 pp -67.92 -40.69 83.34 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.883 -0.327 . . . . 54.210000000000001 110.983 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.627 ' N ' HD12 ' A' ' 63' ' ' LEU . 30.0 tt0 -60.96 -35.77 77.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.168 0.509 . . . . 74.010000000000005 110.524 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.483 HH11 HG21 ' A' ' 29' ' ' VAL . 63.4 ttt-85 -62.3 -53.66 51.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.924 -0.58 . . . . 74.430000000000007 110.855 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.8 pt -69.68 -34.55 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.568 -0.287 . . . . 74.430000000000007 111.365 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 95' ' ' ARG . 16.6 mm-40 -65.2 -55.23 19.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 71.010000000000005 110.939 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 68.6 mt-30 -70.96 1.3 5.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 75.109999999999999 111.705 -174.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD22 ' H ' ' A' ' 10' ' ' GLY . 87.6 mt -103.47 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 70.129999999999995 111.024 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -85.27 -46.83 10.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.694 -0.684 . . . . 45.109999999999999 110.509 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -80.46 -10.66 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.183 -0.917 . . . . 55.350000000000001 111.092 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.682 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -41.88 -33.2 0.5 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.067 0.765 . . . . 73.310000000000002 113.067 -170.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 74.5 mtm -61.79 87.28 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.45 0.643 . . . . 75.019999999999996 110.807 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.499 HG13 ' HB ' ' A' ' 78' ' ' VAL . 2.6 p -91.94 134.6 28.54 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.138 -0.937 . . . . 71.120000000000005 110.809 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 15.0 Cg_exo -69.12 -158.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.905 2.404 . . . . 72.129999999999995 112.251 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.76 1.34 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.713 0.634 . . . . 60.32 112.713 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.0 t -50.1 -31.43 13.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.262 -0.426 . . . . 75.439999999999998 110.913 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 74' ' ' VAL . 7.2 p -52.78 -49.13 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.572 -0.286 . . . . 72.150000000000006 111.177 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.436 ' N ' HG13 ' A' ' 78' ' ' VAL . 70.6 mtp180 -73.35 -43.68 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 110.488 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -66.48 -15.25 63.21 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.087 0.47 . . . . 73.109999999999999 110.576 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -101.29 -28.71 12.47 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.002 -0.544 . . . . 54.530000000000001 111.471 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.9 tp -87.2 -42.25 13.11 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.731 -0.213 . . . . 73.430000000000007 111.339 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -56.51 117.05 3.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 110.116 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.34 96.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.478 -0.783 . . . . 74.549999999999997 111.259 -175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -136.81 135.1 37.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 73.5 109.825 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 t -64.17 96.15 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.255 -0.646 . . . . 53.329999999999998 109.255 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.35 78.44 1.36 Allowed Glycine 0 CA--C 1.518 0.234 0 N-CA-C 111.088 -0.805 . . . . 74.420000000000002 111.088 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.41 -168.23 0.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.337 2.691 . . . . 73.530000000000001 111.697 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.99 108.35 2.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.202 -0.523 . . . . 73.430000000000007 112.33 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -82.69 76.49 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.577 0.703 . . . . 44.039999999999999 109.636 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.9 -179.49 7.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.045 -0.98 . . . . 74.510000000000005 108.559 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -136.35 156.69 48.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.5 . . . . 74.099999999999994 111.522 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.41 -138.84 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.224 -1.028 . . . . 75.120000000000005 108.224 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 72' ' ' ASP . 12.4 p -41.99 134.03 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 109.416 -0.587 . . . . 75.409999999999997 109.416 165.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HG2' HD13 ' A' ' 63' ' ' LEU . 10.9 tpp85 . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.544 -0.741 . . . . 74.540000000000006 110.136 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtm . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.89 -0.411 . . . . 73.219999999999999 109.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -55.4 -32.76 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.809 0.67 . . . . 73.439999999999998 112.809 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 51.8 m80 73.08 -31.66 0.23 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.248 0.619 . . . . 72.239999999999995 111.976 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -63.84 86.78 0.04 OUTLIER 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 53.229999999999997 110.298 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -106.29 -14.28 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.141 -0.481 . . . . 64.019999999999996 111.153 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -70.37 92.28 0.79 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.891 -1.151 . . . . 74.209999999999994 107.891 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -88.01 -18.47 28.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 52.520000000000003 112.172 -164.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.451 ' ND1' ' HB2' ' A' ' 72' ' ' ASP . 77.8 m80 -92.97 131.6 37.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.917 -0.401 . . . . 71.439999999999998 109.917 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.8 ttp -140.27 135.24 32.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.036 -0.357 . . . . 71.540000000000006 110.036 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.87 33.2 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.968 -0.453 . . . . 73.319999999999993 111.968 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.3 m -71.21 -61.47 1.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.43 . . . . 64.109999999999999 110.468 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.05 -77.83 0.59 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.08 -0.509 . . . . 73.430000000000007 110.497 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.63 93.43 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.004 0.43 . . . . 52.229999999999997 110.609 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.88 24.32 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.474 -0.785 . . . . 61.0 109.55 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.482 ' HB2' ' OE1' ' A' ' 17' ' ' GLN . 13.9 pt20 -74.45 164.39 26.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.668 -1.151 . . . . 73.030000000000001 110.585 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -101.49 5.49 41.93 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 75.239999999999995 111.061 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 15' ' ' GLN . 1.1 pm0 -137.83 -174.75 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 74.109999999999999 110.696 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.65 -174.87 13.89 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.893 -0.483 . . . . 74.420000000000002 111.893 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.84 82.89 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.7 2.267 . . . . 73.409999999999997 112.224 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 67.18 3.8 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.202 -0.523 . . . . 44.340000000000003 112.227 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 t -130.77 131.87 44.96 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.859 0.361 . . . . 65.310000000000002 110.552 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -110.66 9.47 22.88 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.33 0.586 . . . . 73.349999999999994 109.995 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -108.98 152.95 24.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.082 -0.963 . . . . 74.420000000000002 110.063 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.91 -21.51 29.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.42 0.526 . . . . 70.420000000000002 112.42 -171.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.67 80.18 3.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.07 0.462 . . . . 71.109999999999999 110.094 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp -76.04 161.34 28.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.454 0.645 . . . . 63.109999999999999 111.152 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 18.7 m-85 -131.14 148.68 52.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.082 -0.963 . . . . 64.219999999999999 109.537 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.05 162.43 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.155 -0.683 . . . . 74.329999999999998 109.155 176.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG21 HH11 ' A' ' 65' ' ' ARG . 71.1 t -95.4 137.76 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.35 -1.352 . . . . 71.299999999999997 107.35 172.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 HD11 ' A' ' 46' ' ' LEU . 33.4 m -134.57 164.71 33.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.109 0.481 . . . . 74.310000000000002 111.71 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.632 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 15.9 ptm180 -167.81 170.13 11.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.914 -1.039 . . . . 74.209999999999994 110.149 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.704 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 24.0 p-10 -167.39 139.99 3.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.73 -0.213 . . . . 44.450000000000003 111.007 166.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 37.2 16.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.686 1.365 . . . . 73.120000000000005 114.686 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.806 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.8 pt-20 -112.31 -29.16 7.64 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.763 -0.585 . . . . 70.25 112.479 -172.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' NH2' ' A' ' 31' ' ' ARG . . . 74.62 7.69 79.97 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.599 -0.81 . . . . 21.199999999999999 111.666 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.806 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 6.7 tp60 -116.21 167.88 10.61 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.599 -0.889 . . . . 74.310000000000002 108.599 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -112.96 153.56 27.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.546 0.573 . . . . 73.099999999999994 112.546 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.407 ' O ' HG13 ' A' ' 29' ' ' VAL . 66.2 m -147.61 -179.33 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.999 -1.0 . . . . 73.510000000000005 109.478 172.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -123.54 163.48 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 63.030000000000001 110.604 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -151.01 149.81 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 74.310000000000002 109.934 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.5 ttt -86.15 126.89 34.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 73.299999999999997 110.242 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.56 142.86 57.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.896 0.379 . . . . 70.439999999999998 110.949 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.66 -15.86 29.05 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.675 -0.693 . . . . 43.5 111.965 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.392 -0.225 . . . . 65.319999999999993 110.392 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -84.25 119.42 25.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.195 0.521 . . . . 72.319999999999993 110.485 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 52' ' ' THR . 33.9 mt -68.55 143.82 95.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 65.25 111.744 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 47.3 Cg_endo -75.29 154.21 40.99 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.451 2.1 . . . . 72.340000000000003 112.266 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.61 125.96 7.74 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.333 -0.848 . . . . 71.430000000000007 111.489 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.74 -35.0 4.83 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.972 -0.558 . . . . 71.010000000000005 112.177 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.704 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 16.8 m95 -77.19 157.27 30.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.629 0.252 . . . . 71.239999999999995 110.437 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 8.0 pt-20 -144.91 146.95 32.23 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.276 -0.42 . . . . 74.230000000000004 110.776 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 HD12 ' A' ' 46' ' ' LEU . 25.1 p -98.86 163.37 12.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.649 -0.705 . . . . 63.350000000000001 111.442 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -166.26 152.71 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 123.663 0.785 . . . . 74.209999999999994 110.306 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 100.88 -175.25 26.2 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.33 -0.85 . . . . 72.200000000000003 113.472 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -103.03 116.14 62.93 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.784 -1.191 . . . . 72.409999999999997 107.784 172.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 32.1 Cg_endo -60.18 124.85 16.07 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.961 1.774 . . . . 72.400000000000006 111.926 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.91 173.45 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.503 . . . . 55.439999999999998 109.86 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -55.63 153.71 7.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.402 0.144 . . . . 72.340000000000003 111.144 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HE3' HG21 ' A' ' 39' ' ' VAL . 23.7 tptm -44.05 -43.2 6.63 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.992 0.517 . . . . 75.310000000000002 111.054 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.99 -47.64 68.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.454 -0.794 . . . . 73.420000000000002 111.259 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.87 -32.07 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 72.450000000000003 110.51 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.5 t -64.08 -48.75 74.97 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.808 -0.633 . . . . 63.149999999999999 110.58 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -67.69 -34.83 77.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.882 0.372 . . . . 54.210000000000001 110.12 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.2 tt0 -58.86 -43.98 90.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.54 -0.755 . . . . 74.010000000000005 110.334 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 62.3 ttt-85 -56.94 -53.47 57.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.123 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.1 pt -71.04 -32.9 49.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.269 -0.423 . . . . 74.430000000000007 111.535 -174.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 33.2 mm-40 -65.65 -44.69 85.58 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.132 -0.322 . . . . 71.010000000000005 110.132 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.84 -1.9 6.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.052 0.39 . . . . 75.109999999999999 112.052 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.7 mt -103.59 -66.45 0.95 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.383 0.611 . . . . 70.129999999999995 111.222 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -85.61 -52.4 5.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 45.109999999999999 110.201 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -76.27 -11.05 59.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.757 -1.11 . . . . 55.350000000000001 111.57 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -43.15 -30.97 0.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.967 0.507 . . . . 73.310000000000002 111.732 -173.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 58.9 ttp -62.69 83.32 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.615 -0.72 . . . . 75.019999999999996 110.133 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.495 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.4 p -73.36 133.79 80.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.103 -0.953 . . . . 71.120000000000005 110.291 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 4.3 Cg_exo -70.97 -154.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.949 2.432 . . . . 72.129999999999995 112.613 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -20.15 15.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.292 -0.413 . . . . 60.32 111.946 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -57.52 -27.08 62.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.376 -0.375 . . . . 75.439999999999998 110.907 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.62 -36.05 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 72.150000000000006 111.068 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -68.02 -26.45 65.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.372 -0.376 . . . . 74.439999999999998 110.827 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.692 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 35.2 tt0 -67.85 -44.31 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.442 0.639 . . . . 73.109999999999999 109.395 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -71.02 -36.9 72.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.369 -0.832 . . . . 54.530000000000001 110.185 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.31 -23.69 62.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.484 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -73.15 83.11 1.32 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.022 -0.535 . . . . 64.540000000000006 109.936 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -93.26 78.3 4.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.277 0.56 . . . . 74.549999999999997 110.16 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -104.35 84.21 2.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.963 -0.562 . . . . 73.5 109.611 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m 62.87 9.46 3.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.004 -0.543 . . . . 53.329999999999998 110.776 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.8 146.11 5.43 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.297 -1.121 . . . . 74.420000000000002 110.297 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -94.75 164.05 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.874 2.383 . . . . 73.530000000000001 112.67 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.692 ' HA3' ' HG2' ' A' ' 80' ' ' GLU . . . -80.92 169.11 51.7 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.227 -0.749 . . . . 73.430000000000007 111.227 171.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -122.46 103.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.096 0.474 . . . . 44.039999999999999 111.355 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -69.79 128.67 37.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.555 . . . . 74.510000000000005 110.887 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.39 14.35 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.321 -0.622 . . . . 74.099999999999994 109.321 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.7 -58.57 3.26 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 123.954 1.835 . . . . 75.120000000000005 110.632 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 72' ' ' ASP . 7.6 p -106.57 136.09 42.6 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 109.663 -3.426 . . . . 75.409999999999997 109.408 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.602 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 5.2 mpt_? . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.55 -0.75 . . . . 74.540000000000006 109.753 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.214 -0.291 . . . . 73.219999999999999 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.78 96.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.335 0.588 . . . . 73.439999999999998 109.571 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -77.08 93.15 3.83 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.583 -0.895 . . . . 72.239999999999995 108.583 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -60.0 97.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 53.229999999999997 111.277 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -135.31 96.55 3.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.765 -0.652 . . . . 64.019999999999996 109.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -161.15 159.76 29.39 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.34 -0.391 . . . . 74.209999999999994 110.992 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -122.52 120.07 32.76 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.827 -0.434 . . . . 52.520000000000003 109.827 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -176.41 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.547 0.689 . . . . 71.439999999999998 109.848 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 87.3 mmm -104.46 148.07 26.86 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.678 -0.692 . . . . 71.540000000000006 110.261 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.55 -106.43 1.74 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.136 -0.554 . . . . 73.319999999999993 112.634 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.6 m 60.49 79.23 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.53 0.681 . . . . 64.109999999999999 111.049 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HA ' HH21 ' A' ' 65' ' ' ARG . 4.2 mm? -80.29 -63.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 110.954 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' OE2' ' HB3' ' A' ' 12' ' ' LEU . 7.2 mp0 -109.46 165.03 11.96 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.897 -0.409 . . . . 52.229999999999997 109.897 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.13 101.23 1.74 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.014 0.435 . . . . 61.0 111.16 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -90.17 167.04 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 73.030000000000001 110.173 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.2 m 75.32 -24.48 0.22 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.932 0.716 . . . . 75.239999999999995 112.932 170.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -59.03 -38.26 78.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.832 0.348 . . . . 74.109999999999999 110.489 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.93 146.78 16.15 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 116.121 -0.491 . . . . 74.420000000000002 111.977 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.37 1.97 8.39 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.041 2.494 . . . . 73.409999999999997 112.577 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.9 146.53 16.31 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.097 -0.501 . . . . 44.340000000000003 112.183 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 58' ' ' THR . 34.6 t -165.54 59.34 0.11 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.314 0.578 . . . . 65.310000000000002 109.809 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -77.24 68.94 3.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.882 0.849 . . . . 73.349999999999994 110.453 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -110.69 0.17 17.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.865 -1.061 . . . . 74.420000000000002 110.056 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -161.48 175.52 12.06 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.949 -0.569 . . . . 70.420000000000002 109.507 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -68.25 178.8 1.78 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.094 0.473 . . . . 71.109999999999999 111.597 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.4 mp -85.06 148.75 26.0 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.226 0.536 . . . . 63.109999999999999 111.244 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 6.8 m-85 -127.83 162.12 27.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.309 -0.86 . . . . 64.219999999999999 110.637 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 m-85 -126.85 167.78 15.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 109.42 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.41 135.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 71.299999999999997 107.289 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 52' ' ' THR . 33.4 m -139.94 169.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.867 0.303 . . . . 74.310000000000002 111.127 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -167.84 170.02 11.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.143 -0.481 . . . . 74.209999999999994 111.305 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 23.8 p-10 -161.65 140.03 9.39 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.113 -0.494 . . . . 44.450000000000003 110.862 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 46.07 8.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.055 1.131 . . . . 73.120000000000005 114.055 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.7 pt-20 -112.33 -32.09 6.62 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.786 -0.571 . . . . 70.25 112.073 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 -22.64 6.52 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 112.065 -0.414 . . . . 21.199999999999999 112.065 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -81.85 173.85 11.86 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.826 0.45 . . . . 74.310000000000002 109.961 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.587 ' HD2' ' HE1' ' A' ' 70' ' ' TRP . 14.7 m-85 -118.27 141.96 47.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 73.099999999999994 111.938 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -132.74 -179.35 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.79 -1.096 . . . . 73.510000000000005 109.246 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.35 160.35 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.704 0.287 . . . . 63.030000000000001 110.578 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 63.0 t-105 -148.13 151.25 35.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 74.310000000000002 109.9 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -91.37 129.28 37.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.289 -0.263 . . . . 73.299999999999997 110.289 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.38 150.87 25.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 70.439999999999998 110.609 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.26 16.47 Favored Glycine 0 N--CA 1.453 -0.177 0 N-CA-C 111.539 -0.624 . . . . 43.5 111.539 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 53.4 mtt-85 -88.19 110.11 20.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 110.416 -0.216 . . . . 65.319999999999993 110.416 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -71.33 130.01 40.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.067 0.461 . . . . 72.319999999999993 109.961 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD12 HG23 ' A' ' 52' ' ' THR . 40.4 mt -76.05 142.82 72.91 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.337 -0.847 . . . . 65.25 111.396 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 67.3 Cg_endo -75.82 156.25 39.35 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.579 2.186 . . . . 72.340000000000003 111.711 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.59 122.41 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.698 -0.683 . . . . 71.430000000000007 111.49 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.9 -32.21 5.75 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.061 -0.518 . . . . 71.010000000000005 112.434 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.502 ' HB3' HD13 ' A' ' 46' ' ' LEU . 31.2 m95 -80.19 146.25 31.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.851 0.325 . . . . 71.239999999999995 110.697 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.58 155.71 49.15 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.524 -0.307 . . . . 74.230000000000004 110.729 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 HD12 ' A' ' 46' ' ' LEU . 17.4 p -112.57 162.18 15.95 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.543 1.152 . . . . 63.350000000000001 111.483 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG21 ' CE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -166.02 145.02 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.054 0.542 . . . . 74.209999999999994 111.009 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.13 -165.61 18.59 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.559 -0.746 . . . . 72.200000000000003 112.248 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -104.73 145.02 29.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.148 -0.686 . . . . 72.409999999999997 109.148 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.5 Cg_endo -67.3 105.31 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.051 1.167 . . . . 72.400000000000006 110.136 173.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.61 165.19 31.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.095 -0.957 . . . . 55.439999999999998 110.977 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 21' ' ' SER . 9.7 t -62.02 166.95 4.2 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.394 0.616 . . . . 72.340000000000003 112.487 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.651 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 58.9 tptt -46.34 -50.02 16.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.966 -1.016 . . . . 75.310000000000002 111.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.76 -39.24 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.951 -0.568 . . . . 73.420000000000002 111.303 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -73.7 -44.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.166 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 27.4 p -64.12 -45.15 89.85 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.002 -0.279 . . . . 63.149999999999999 111.25 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -68.15 -41.21 81.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 54.210000000000001 110.454 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.626 ' N ' HD12 ' A' ' 63' ' ' LEU . 52.4 tt0 -63.2 -36.46 83.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 74.010000000000005 110.376 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.541 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 ttt180 -58.7 -53.73 55.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.878 0.37 . . . . 74.430000000000007 110.905 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.9 pt -72.78 -32.66 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 74.430000000000007 111.213 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 37.6 mm-40 -61.23 -44.62 96.97 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.193 -0.299 . . . . 71.010000000000005 110.193 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.8 mm-40 -73.09 0.93 10.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.93 0.395 . . . . 75.109999999999999 111.132 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 80.1 mt -103.62 -66.13 0.97 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 70.129999999999995 111.258 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.587 ' HE1' ' HD2' ' A' ' 37' ' ' TYR . 73.0 m95 -85.68 -45.69 11.44 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.979 -0.555 . . . . 45.109999999999999 111.027 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 m -81.71 -11.19 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.834 . . . . 55.350000000000001 110.901 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -43.26 -36.98 1.99 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.993 -0.548 . . . . 73.310000000000002 111.565 -172.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.9 tpt -59.52 89.44 0.01 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 75.019999999999996 109.95 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 p -91.55 127.78 49.18 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.68 -0.691 . . . . 71.120000000000005 110.356 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.8 -158.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.814 2.343 . . . . 72.129999999999995 112.081 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.05 -18.92 10.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.895 0.378 . . . . 60.32 111.268 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.6 p -61.76 -14.38 31.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.891 -0.595 . . . . 75.439999999999998 111.305 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 11.6 p -55.88 -37.26 47.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-O 121.062 0.458 . . . . 72.150000000000006 110.451 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -74.04 -49.37 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 74.439999999999998 110.582 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.16 -45.45 84.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.804 -0.634 . . . . 73.109999999999999 110.666 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -74.45 -14.1 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.293 -0.867 . . . . 54.530000000000001 111.306 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 14.8 tp -91.52 -72.55 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.844 0.354 . . . . 73.430000000000007 110.793 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.21 76.85 8.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.458 0.646 . . . . 64.540000000000006 110.123 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -56.74 -65.4 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.278 -0.874 . . . . 74.549999999999997 110.34 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.9 t60 76.2 -37.15 0.29 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.71 0.804 . . . . 73.5 111.655 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 p -71.66 -54.27 10.89 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.861 0.362 . . . . 53.329999999999998 110.762 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.74 -66.03 0.42 Allowed Glycine 0 C--O 1.235 0.199 0 C-N-CA 121.266 -0.492 . . . . 74.420000000000002 112.195 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 156.1 56.23 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.618 2.212 . . . . 73.530000000000001 112.505 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 93.34 0.11 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.812 -0.631 . . . . 73.430000000000007 112.7 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.7 pt -93.78 134.11 32.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.889 0.376 . . . . 44.039999999999999 110.903 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.65 152.1 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 74.510000000000005 111.87 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.34 162.95 27.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.237 0.541 . . . . 74.099999999999994 111.452 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.71 -157.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.106 -0.952 . . . . 75.120000000000005 108.916 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.15 135.53 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.23 0.332 . . . . 75.409999999999997 110.829 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.59 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 8.0 mpt_? . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.531 -0.747 . . . . 74.540000000000006 110.244 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 121.21 0.529 . . . . 73.219999999999999 110.167 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.93 113.31 0.14 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.762 -0.654 . . . . 73.439999999999998 110.927 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -119.79 136.65 54.37 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.649 -0.5 . . . . 72.239999999999995 109.649 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -131.13 92.51 3.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.899 0.381 . . . . 53.229999999999997 111.429 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -129.18 102.65 6.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 64.019999999999996 110.189 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 73' ' ' MET . 38.8 p-80 -165.97 150.51 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 74.209999999999994 109.799 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.677 ' HB3' ' HD1' ' A' ' 70' ' ' TRP . 21.8 p80 -166.09 129.59 2.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.846 0.355 . . . . 52.520000000000003 111.763 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -105.92 123.13 47.48 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.645 -0.872 . . . . 71.439999999999998 108.645 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 9' ' ' MET . 3.5 mpp? -90.81 110.42 21.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 71.540000000000006 111.631 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.55 150.01 18.34 Favored Glycine 0 C--O 1.237 0.326 0 N-CA-C 110.663 -0.975 . . . . 73.319999999999993 110.663 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -117.7 -78.78 0.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.202 0.501 . . . . 64.109999999999999 111.276 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.2 mt -112.1 106.24 14.82 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.339 -0.615 . . . . 73.430000000000007 109.339 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 173.65 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 52.229999999999997 110.842 -170.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.02 113.08 25.25 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.952 -0.567 . . . . 61.0 109.556 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 73.0 mt-30 -54.07 102.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.404 0.44 . . . . 73.030000000000001 111.623 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -65.99 -40.23 91.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.452 -0.573 . . . . 75.239999999999995 109.452 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -148.24 -167.38 2.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.353 -0.84 . . . . 74.109999999999999 108.789 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.21 -101.62 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.322 -0.711 . . . . 74.420000000000002 111.322 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.32 -163.74 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.726 2.284 . . . . 73.409999999999997 111.698 175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.64 146.76 5.31 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.104 -0.569 . . . . 44.340000000000003 111.926 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' MET . 17.4 t -74.72 121.0 21.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.526 -0.546 . . . . 65.310000000000002 109.526 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 21' ' ' SER . 61.8 mtt 72.84 11.02 5.4 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.798 -0.637 . . . . 73.349999999999994 110.997 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -94.33 -170.56 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.166 -1.42 . . . . 74.420000000000002 107.166 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.66 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 5.1 t70 -84.91 170.88 12.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.115 0.416 . . . . 70.420000000000002 110.489 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 58' ' ' THR . 8.3 mm-40 -77.72 171.84 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.903 -0.406 . . . . 71.109999999999999 109.903 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.44 138.43 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.918 0.866 . . . . 63.109999999999999 111.358 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.37 161.54 33.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.914 -1.494 . . . . 64.219999999999999 108.738 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -130.0 160.08 34.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.08 -0.964 . . . . 74.329999999999998 108.621 172.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' VAL . 55.8 t -90.32 120.89 39.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 107.564 -1.272 . . . . 71.299999999999997 107.564 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.76 160.51 32.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.192 0.52 . . . . 74.310000000000002 111.973 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 36' ' ' GLN . 17.2 ptt85 -169.53 170.16 8.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.777 -1.101 . . . . 74.209999999999994 110.216 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.608 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 25.9 p-10 -145.03 139.49 27.48 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.516 -0.473 . . . . 44.450000000000003 110.505 169.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.0 t30 30.95 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.208 1.559 . . . . 73.120000000000005 115.208 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.0 pt-20 -112.49 -32.06 6.6 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.471 -0.768 . . . . 70.25 112.536 -172.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.94 -22.48 8.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.156 -0.545 . . . . 21.199999999999999 112.641 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.44 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 33.8 tt0 -80.01 158.65 26.48 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.952 -0.758 . . . . 74.310000000000002 108.952 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.05 140.61 46.58 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.771 0.656 . . . . 73.099999999999994 112.771 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m -134.1 -179.23 5.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.031 -0.986 . . . . 73.510000000000005 109.351 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.64 158.34 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.621 0.248 . . . . 63.030000000000001 110.694 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CE2' ' HG ' ' A' ' 46' ' ' LEU . 75.0 t90 -155.14 145.41 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.212 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.1 ttt -81.49 125.53 30.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.746 0.308 . . . . 73.299999999999997 111.279 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.06 142.12 47.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.027 -0.533 . . . . 70.439999999999998 110.494 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.47 -5.52 29.81 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 111.582 -0.607 . . . . 43.5 111.582 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -108.12 166.29 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.147 0.579 . . . . 65.319999999999993 109.45 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -97.19 115.07 26.91 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.116 -0.365 . . . . 72.319999999999993 110.565 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 mt -69.68 138.76 88.4 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 65.25 110.745 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 19.2 Cg_endo -65.61 137.1 48.84 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 122.244 1.963 . . . . 72.340000000000003 111.75 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.11 124.9 4.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.47 -0.786 . . . . 71.430000000000007 111.509 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -34.12 4.92 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.773 -0.649 . . . . 71.010000000000005 111.772 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.1 m95 -77.6 139.81 39.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.716 0.293 . . . . 71.239999999999995 110.723 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 13.0 pt-20 -126.7 156.22 41.44 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.59 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.2 p -104.39 153.19 21.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.555 -1.202 . . . . 63.350000000000001 111.085 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.37 161.73 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 123.419 0.688 . . . . 74.209999999999994 109.985 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 -159.4 24.51 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.399 -0.819 . . . . 72.200000000000003 111.96 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.76 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -109.9 137.48 20.48 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 109.269 -0.641 . . . . 72.409999999999997 109.269 176.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.645 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 57.0 Cg_endo -68.79 116.48 4.47 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.406 1.404 . . . . 72.400000000000006 110.431 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -162.47 169.39 20.46 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.15 -0.477 . . . . 55.439999999999998 110.251 -169.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 24' ' ' ASP . 43.3 p -55.74 151.9 10.42 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.916 0.135 . . . . 72.340000000000003 111.035 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.13 -41.66 3.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.287 0.565 . . . . 75.310000000000002 110.147 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -56.66 -52.32 65.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.664 -1.153 . . . . 73.420000000000002 111.492 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.504 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 10.3 mm-40 -71.32 -41.8 69.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 72.450000000000003 110.754 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 57' ' ' ALA . 72.8 m -60.59 -45.95 92.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.395 -0.366 . . . . 63.149999999999999 111.167 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 95' ' ' ARG . 3.8 pp -68.09 -36.41 79.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.42 -0.585 . . . . 54.210000000000001 109.42 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -58.18 -31.58 67.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.428 -0.806 . . . . 74.010000000000005 110.318 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 34.1 ttt180 -65.83 -53.26 42.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.898 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 pt -73.35 -32.35 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 74.430000000000007 112.46 -171.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 95' ' ' ARG . 12.4 pt-20 -58.47 -32.69 69.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.042 0.448 . . . . 71.010000000000005 109.925 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 79.3 mm-40 -87.7 -9.38 54.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 111.379 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -103.74 -65.69 1.0 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.708 0.766 . . . . 70.129999999999995 111.619 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.677 ' HD1' ' HB3' ' A' ' 7' ' ' HIS . 29.1 t90 -85.39 -43.21 13.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.07 -0.968 . . . . 45.109999999999999 110.78 -175.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.13 -10.83 51.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.82 -0.627 . . . . 55.350000000000001 112.268 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 4.9 p-10 -40.74 -43.15 1.92 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.321 1.6 . . . . 73.310000000000002 115.321 -163.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.403 ' HB2' ' CE1' ' A' ' 6' ' ' HIS . 21.0 mtm -66.5 85.81 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.822 0.737 . . . . 75.019999999999996 110.582 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.98 142.06 72.19 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.49 -1.232 . . . . 71.120000000000005 111.015 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.67 -162.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.874 2.383 . . . . 72.129999999999995 111.923 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.18 -17.68 12.18 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.233 -0.439 . . . . 60.32 111.637 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.7 p -58.06 -17.23 16.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.096 -0.502 . . . . 75.439999999999998 111.412 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.5 p -58.82 -44.02 89.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.45 -0.341 . . . . 72.150000000000006 110.665 175.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -69.05 -28.37 66.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.304 -0.407 . . . . 74.439999999999998 110.122 -177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.05 -37.26 76.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 73.109999999999999 110.906 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -97.18 -5.59 36.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.632 -0.258 . . . . 54.530000000000001 111.665 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 36.7 mt -63.04 -18.57 63.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.634 0.254 . . . . 73.430000000000007 111.218 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.82 -44.58 96.57 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.913 0.387 . . . . 64.540000000000006 110.032 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -76.4 86.06 3.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 74.549999999999997 110.279 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -143.38 16.82 1.87 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.929 -0.578 . . . . 73.5 110.306 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 m -97.48 14.62 25.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.821 -0.627 . . . . 53.329999999999998 111.16 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 131.48 -72.47 0.48 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.523 -0.631 . . . . 74.420000000000002 111.523 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.04 52.77 3.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.89 2.393 . . . . 73.530000000000001 111.808 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.2 16.24 32.61 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.867 -0.606 . . . . 73.430000000000007 111.637 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.97 81.2 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 122.057 0.932 . . . . 44.039999999999999 110.639 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.1 160.19 32.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.502 -1.226 . . . . 74.510000000000005 109.605 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -76.54 177.5 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 74.099999999999994 110.658 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.93 -149.93 0.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 75.120000000000005 110.175 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.86 107.32 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.377 0.608 . . . . 75.409999999999997 111.221 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.682 ' HD3' ' H ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.319 -0.848 . . . . 74.540000000000006 108.743 171.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.522 0.201 . . . . 73.219999999999999 110.521 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.52 38.52 25.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.705 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -133.07 127.84 34.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.196 0.522 . . . . 72.239999999999995 110.971 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -140.54 115.36 9.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.615 -0.883 . . . . 53.229999999999997 108.615 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -84.68 -87.98 0.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.353 -0.24 . . . . 64.019999999999996 110.353 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -153.84 -175.65 5.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.384 -0.599 . . . . 74.209999999999994 109.384 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.93 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.738 -0.838 . . . . 52.520000000000003 108.738 171.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -101.61 154.18 19.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.118 -0.492 . . . . 71.439999999999998 110.646 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.4 ptp -150.83 150.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 71.540000000000006 109.733 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.65 7.64 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 123.428 0.455 . . . . 73.319999999999993 112.625 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.3 p -58.12 111.66 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 64.109999999999999 110.565 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.84 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 73.430000000000007 111.464 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -98.73 83.42 2.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.102 0.477 . . . . 52.229999999999997 111.236 -177.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.63 110.96 1.88 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.217 -0.66 . . . . 61.0 109.217 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 65.0 95.77 0.05 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 123.875 0.734 . . . . 73.030000000000001 109.738 -170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 16' ' ' THR . 7.8 t -83.93 91.25 7.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.866 0.841 . . . . 75.239999999999995 110.674 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.82 18.48 1.98 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.361 -0.836 . . . . 74.109999999999999 110.419 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.13 162.05 53.49 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 74.420000000000002 111.323 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 80.6 Cg_exo -46.87 112.0 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.792 2.328 . . . . 73.409999999999997 112.509 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.57 154.8 26.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 44.340000000000003 111.594 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 m -155.78 144.29 20.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.419 -0.215 . . . . 65.310000000000002 110.419 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 58.6 mtt -85.33 101.31 12.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.773 -0.454 . . . . 73.349999999999994 109.773 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -160.29 105.99 1.52 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.219 0.533 . . . . 74.420000000000002 111.484 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 44.37 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.336 -1.302 . . . . 70.420000000000002 113.568 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 58' ' ' THR . 10.8 pt-20 -84.23 140.39 31.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.777 0.322 . . . . 71.109999999999999 111.862 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.6 mp -119.04 138.42 52.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.308 -0.405 . . . . 63.109999999999999 110.289 176.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.06 158.15 39.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.505 0.722 . . . . 64.219999999999999 110.367 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.638 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 22.0 m-85 -113.03 169.54 8.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 74.329999999999998 109.118 166.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 HG21 ' A' ' 66' ' ' ILE . 56.5 t -95.01 125.22 47.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.825 -1.176 . . . . 71.299999999999997 107.825 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 HD11 ' A' ' 46' ' ' LEU . 27.4 m -125.95 160.86 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.258 0.551 . . . . 74.310000000000002 111.95 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 11.8 ptt180 -169.16 170.13 8.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.62 -1.173 . . . . 74.209999999999994 110.083 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -145.83 139.59 26.48 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 44.450000000000003 110.834 164.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 33.06 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.745 1.757 . . . . 73.120000000000005 115.745 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.9 pt-20 -112.59 -29.36 7.49 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.583 0.628 . . . . 70.25 111.917 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 -10.52 48.81 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.152 -0.547 . . . . 21.199999999999999 112.634 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.564 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 69.3 mt-30 -84.78 173.03 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.039 -0.726 . . . . 74.310000000000002 109.039 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.31 132.66 48.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.957 0.725 . . . . 73.099999999999994 112.957 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -131.69 -178.9 5.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.791 -1.095 . . . . 73.510000000000005 108.475 172.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' SG ' ' A' ' 62' ' ' CYS . 23.7 m -124.17 149.53 28.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.204 0.526 . . . . 63.030000000000001 111.322 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HB2' HG21 ' A' ' 30' ' ' VAL . 55.8 t-105 -148.83 143.4 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.755 . . . . 74.310000000000002 109.28 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -74.85 141.37 44.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.893 0.377 . . . . 73.299999999999997 111.311 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.55 147.04 44.31 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.374 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.79 4.83 67.05 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.392 -0.433 . . . . 43.5 112.304 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -121.81 112.35 18.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.88 -0.415 . . . . 65.319999999999993 109.88 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.9 m -57.98 123.0 14.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.583 -0.735 . . . . 72.319999999999993 111.469 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 15.9 mt -79.99 139.76 53.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.308 -0.86 . . . . 65.25 110.836 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.33 140.06 53.45 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.691 2.261 . . . . 72.340000000000003 111.632 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.82 126.19 15.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.96 -0.564 . . . . 71.430000000000007 110.384 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -29.54 7.06 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.11 -0.495 . . . . 71.010000000000005 112.295 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.618 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.6 m95 -75.5 155.05 36.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.028 0.414 . . . . 71.239999999999995 110.607 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.8 pt-20 -135.67 148.97 49.13 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 110.043 -0.355 . . . . 74.230000000000004 110.043 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.409 HG22 HG12 ' A' ' 30' ' ' VAL . 19.6 p -109.19 153.01 24.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.431 -0.804 . . . . 63.350000000000001 110.983 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.2 t -149.98 152.9 11.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 122.842 0.457 . . . . 74.209999999999994 110.476 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.73 -170.12 37.9 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.797 -0.638 . . . . 72.200000000000003 113.198 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 1.4 pm0 -108.43 143.71 28.03 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 109.102 -0.703 . . . . 72.409999999999997 109.102 173.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.638 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 36.8 Cg_endo -63.1 122.14 10.26 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.161 1.907 . . . . 72.400000000000006 112.678 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 157.35 42.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.453 -0.794 . . . . 55.439999999999998 109.604 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 11.1 t -56.32 156.7 5.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.61 0.243 . . . . 72.340000000000003 111.085 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -43.26 -50.18 6.56 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.663 -0.699 . . . . 75.310000000000002 111.635 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.39 -49.46 76.14 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.412 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -70.16 -35.1 73.77 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.093 0.473 . . . . 72.450000000000003 110.461 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.484 ' SG ' HG12 ' A' ' 39' ' ' VAL . 18.2 t -62.09 -51.71 66.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 63.149999999999999 110.048 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.36 -33.43 74.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.016 -0.273 . . . . 54.210000000000001 110.347 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 51.8 tt0 -62.45 -31.93 72.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.531 0.681 . . . . 74.010000000000005 110.635 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' HA ' ' HG2' ' A' ' 19' ' ' PRO . 35.9 ttm180 -62.35 -53.1 59.92 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.035 -0.529 . . . . 74.430000000000007 112.091 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.608 HG21 HG11 ' A' ' 29' ' ' VAL . 17.8 pt -72.96 -35.11 47.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.737 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 4.2 pt-20 -57.78 -46.21 84.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.606 -0.438 . . . . 71.010000000000005 109.839 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.621 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 86.0 mt-30 -74.15 -0.41 16.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.388 -0.369 . . . . 75.109999999999999 111.633 -173.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.8 mt -103.37 -68.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.552 -0.459 . . . . 70.129999999999995 112.139 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -87.34 -55.08 3.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.621 -0.718 . . . . 45.109999999999999 111.976 -176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 67' ' ' GLU . 2.9 p -81.81 -10.89 59.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.708 -1.133 . . . . 55.350000000000001 111.752 -171.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.1 t70 -41.85 -28.33 0.15 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.948 0.899 . . . . 73.310000000000002 113.043 -172.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 22.4 mmt -68.33 73.16 0.21 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.197 -0.668 . . . . 75.019999999999996 109.197 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 3.9 p -84.38 137.4 39.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.217 -0.901 . . . . 71.120000000000005 111.077 -175.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 11.4 Cg_exo -70.91 -157.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.024 2.482 . . . . 72.129999999999995 112.049 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.65 -16.47 10.72 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.866 0.365 . . . . 60.32 111.468 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 13.9 m -50.1 -33.17 17.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.717 -0.674 . . . . 75.439999999999998 111.583 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.15 -35.61 72.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.131 0.491 . . . . 72.150000000000006 110.623 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 79' ' ' ARG . 40.9 mmm-85 -73.62 -42.98 60.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.654 -0.703 . . . . 74.439999999999998 110.108 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.82 -28.7 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.327 -0.851 . . . . 73.109999999999999 111.116 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -63.38 -21.76 66.48 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.267 -0.424 . . . . 54.530000000000001 111.116 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.1 tp -95.15 9.17 40.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.165 0.507 . . . . 73.430000000000007 110.571 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.4 83.38 2.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.918 -0.771 . . . . 64.540000000000006 108.918 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 2.8 mp0 -69.03 78.82 0.33 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.675 0.62 . . . . 74.549999999999997 112.675 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.474 ' HB3' ' O ' ' A' ' 84' ' ' GLN . 5.3 p80 177.28 135.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.277 -0.638 . . . . 73.5 109.277 168.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 87.0 0.28 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.242 0.544 . . . . 53.329999999999998 110.663 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -92.64 147.16 18.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.687 -0.688 . . . . 74.420000000000002 111.583 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.44 106.51 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.937 2.425 . . . . 73.530000000000001 112.192 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.38 -56.19 0.43 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.689 -0.964 . . . . 73.430000000000007 110.689 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt 48.04 83.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.416 0.686 . . . . 44.039999999999999 112.156 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -133.25 125.37 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.557 -0.905 . . . . 74.510000000000005 108.557 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 77' ' ' SER . 74.7 m-85 -136.59 -171.19 2.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 111.819 0.303 . . . . 74.099999999999994 111.819 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.58 169.84 0.63 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.819 0.674 . . . . 75.120000000000005 112.819 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.9 p -107.49 152.08 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.846 . . . . 75.409999999999997 110.436 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' GLU . 39.3 ptt85 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.435 -0.793 . . . . 74.540000000000006 110.015 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.15 -0.315 . . . . 73.219999999999999 110.15 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.06 64.59 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.198 0.523 . . . . 73.439999999999998 110.508 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -84.14 102.26 12.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.786 -0.643 . . . . 72.239999999999995 109.663 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -117.82 106.02 12.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.287 0.565 . . . . 53.229999999999997 111.268 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -106.26 3.46 27.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.551 0.691 . . . . 64.019999999999996 109.427 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -94.42 107.14 19.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.35 -0.841 . . . . 74.209999999999994 109.751 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -151.0 90.72 1.63 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 52.520000000000003 111.103 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -98.53 163.5 12.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.325 -0.62 . . . . 71.439999999999998 109.325 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 40.9 tpp -140.52 -79.03 0.29 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.411 -0.218 . . . . 71.540000000000006 110.411 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.29 -176.21 47.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.037 -0.601 . . . . 73.319999999999993 112.824 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -145.77 -73.52 0.23 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.063 0.459 . . . . 64.109999999999999 110.092 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.97 -167.04 1.38 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.109 -0.496 . . . . 73.430000000000007 110.133 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -178.24 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.993 0.425 . . . . 52.229999999999997 111.357 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -59.7 1.91 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.772 -0.825 . . . . 61.0 108.772 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -152.17 114.46 4.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.123 -0.944 . . . . 73.030000000000001 109.029 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -82.46 83.44 7.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.333 0.587 . . . . 75.239999999999995 110.294 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.16 130.78 45.29 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.428 -0.805 . . . . 74.109999999999999 111.066 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.92 -166.43 26.97 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.803 -0.919 . . . . 74.420000000000002 110.803 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.86 99.49 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.16 1.907 . . . . 73.409999999999997 111.15 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.68 82.76 0.03 OUTLIER Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.88 -0.6 . . . . 44.340000000000003 113.301 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.654 ' HB2' HG21 ' A' ' 58' ' ' THR . 20.0 m -91.32 54.03 2.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.058 0.456 . . . . 65.310000000000002 110.661 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.2 mpt? -76.94 70.82 3.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.13 0.491 . . . . 73.349999999999994 110.705 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -113.27 -49.63 2.9 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.725 0.774 . . . . 74.420000000000002 109.948 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.52 179.46 5.0 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 114.608 -1.178 . . . . 70.420000000000002 111.009 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -67.06 150.93 48.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 71.109999999999999 111.061 -174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.0 mp -69.17 151.56 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 63.109999999999999 110.97 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 33.8 m-85 -123.66 149.06 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.49 -0.777 . . . . 64.219999999999999 109.741 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -114.86 155.97 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 74.329999999999998 108.921 169.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.72 114.83 24.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 N-CA-C 107.86 -1.163 . . . . 71.299999999999997 107.86 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 40' ' ' TRP . 12.7 m -125.14 159.62 31.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 122.164 -0.335 . . . . 74.310000000000002 110.561 -170.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -162.0 162.11 28.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.351 -0.84 . . . . 74.209999999999994 110.722 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 p30 -152.05 139.69 19.75 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.269 -0.271 . . . . 44.450000000000003 110.269 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t30 46.63 4.63 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.993 1.109 . . . . 73.120000000000005 113.993 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.19 -32.43 6.54 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.656 -0.653 . . . . 70.25 112.095 -169.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.51 -22.68 3.16 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.352 -0.452 . . . . 21.199999999999999 112.617 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -75.51 173.96 10.29 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.727 -0.471 . . . . 74.310000000000002 109.727 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.49 136.01 53.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 73.099999999999994 112.172 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -135.86 -178.74 5.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.066 -0.97 . . . . 73.510000000000005 109.456 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG11 ' SG ' ' A' ' 62' ' ' CYS . 27.7 m -128.72 150.02 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.68 0.276 . . . . 63.030000000000001 111.069 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 30' ' ' VAL . 52.2 t-105 -149.45 141.48 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.851 -0.613 . . . . 74.310000000000002 109.736 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.6 mtt -65.45 134.24 53.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.1 0.476 . . . . 73.299999999999997 111.408 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.23 147.82 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.764 -0.653 . . . . 70.439999999999998 110.451 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.72 62.53 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.188 -0.765 . . . . 43.5 111.188 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -93.91 96.48 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.731 -0.84 . . . . 65.319999999999993 108.731 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -55.57 116.52 2.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 112.113 -169.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.441 HD11 HG11 ' A' ' 30' ' ' VAL . 42.6 mt -74.4 139.64 75.22 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.729 -1.123 . . . . 65.25 110.055 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.22 160.48 20.31 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.636 2.224 . . . . 72.340000000000003 112.478 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.3 129.92 18.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.549 -0.75 . . . . 71.430000000000007 110.53 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.54 -33.29 5.31 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.35 -0.7 . . . . 71.010000000000005 111.35 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 43.2 m95 -88.72 148.08 24.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.508 0.194 . . . . 71.239999999999995 110.519 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 149.37 52.13 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 110.262 -0.273 . . . . 74.230000000000004 110.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 30' ' ' VAL . 34.8 p -111.53 148.3 33.5 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.376 1.048 . . . . 63.350000000000001 111.057 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -154.05 156.4 5.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.573 0.749 . . . . 74.209999999999994 109.878 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.43 -158.58 23.7 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.406 -0.426 . . . . 72.200000000000003 113.483 169.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.89 131.68 21.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.611 . . . . 72.409999999999997 109.349 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HB2' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -70.08 109.08 2.28 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 121.623 1.549 . . . . 72.400000000000006 111.255 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.07 171.09 20.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.236 -0.893 . . . . 55.439999999999998 110.442 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.654 HG21 ' HB2' ' A' ' 21' ' ' SER . 9.9 t -58.28 166.19 1.75 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.254 0.55 . . . . 72.340000000000003 112.437 -175.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.683 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 32.1 tptt -49.82 -49.77 47.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.055 -0.975 . . . . 75.310000000000002 110.669 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -54.42 -43.04 71.2 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.087 -0.96 . . . . 73.420000000000002 111.342 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -70.04 -48.45 57.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 72.450000000000003 110.746 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 9.1 p -62.93 -42.4 99.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.075 -0.511 . . . . 63.149999999999999 111.515 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -67.93 -40.82 83.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.492 -0.483 . . . . 54.210000000000001 110.093 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . 59.3 tt0 -60.19 -31.43 70.13 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.789 -0.641 . . . . 74.010000000000005 110.454 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 75.5 ttt-85 -73.86 -53.3 10.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.627 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 63' ' ' LEU . 39.3 pt -66.23 -32.8 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 112.228 0.455 . . . . 74.430000000000007 112.228 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.42 -32.85 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.606 0.241 . . . . 71.010000000000005 110.353 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.448 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 91.2 mt-30 -87.53 -1.63 58.07 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.073 -0.512 . . . . 75.109999999999999 111.349 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 85.9 mt -104.0 -66.72 0.94 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.272 0.558 . . . . 70.129999999999995 111.656 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -86.09 -55.14 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.391 -0.822 . . . . 45.109999999999999 111.163 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.507 HG22 HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -78.8 -10.99 59.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.205 -0.907 . . . . 55.350000000000001 111.311 -174.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.4 t70 -41.76 -32.78 0.42 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.693 0.797 . . . . 73.310000000000002 112.981 -171.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.6 ttp -66.17 77.77 0.09 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.569 0.7 . . . . 75.019999999999996 110.207 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -85.3 132.07 46.26 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.028 -0.987 . . . . 71.120000000000005 110.456 -178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 Cg_exo -68.34 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.878 2.385 . . . . 72.129999999999995 112.518 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.95 -17.84 4.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.771 -0.65 . . . . 60.32 111.445 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m -50.96 -29.42 12.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.926 -0.579 . . . . 75.439999999999998 111.327 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.59 -35.88 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.452 -0.34 . . . . 72.150000000000006 110.868 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -55.03 -28.29 51.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.089 -0.505 . . . . 74.439999999999998 111.822 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.94 -39.63 83.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.01 0.433 . . . . 73.109999999999999 110.707 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.584 ' HE1' ' HA ' ' A' ' 91' ' ' ASP . 49.9 t-80 -94.69 -19.88 20.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 54.530000000000001 110.532 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.48 80.83 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.27 0.557 . . . . 73.430000000000007 109.889 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -85.93 139.38 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.362 -0.977 . . . . 64.540000000000006 108.362 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.83 101.55 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.808 -0.441 . . . . 74.549999999999997 109.808 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -124.31 112.35 16.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.265 0.555 . . . . 73.5 110.906 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.1 t -96.05 82.04 3.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.767 -0.651 . . . . 53.329999999999998 109.828 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.0 -176.61 22.44 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.721 -0.672 . . . . 74.420000000000002 111.793 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.07 148.05 93.92 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.939 2.426 . . . . 73.530000000000001 112.317 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.96 156.6 22.92 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.313 -0.715 . . . . 73.430000000000007 111.313 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.0 pt -72.8 89.61 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.614 0.721 . . . . 44.039999999999999 111.144 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.584 ' HA ' ' HE1' ' A' ' 81' ' ' HIS . 2.6 t0 -121.53 147.94 45.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.159 -0.928 . . . . 74.510000000000005 108.809 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -142.45 -175.72 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 74.099999999999994 110.977 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.4 -149.77 0.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.753 . . . . 75.120000000000005 109.395 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 71' ' ' THR . 3.1 p -115.21 93.83 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.524 0.678 . . . . 75.409999999999997 111.663 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 N-CA-C 107.93 -1.137 . . . . 74.540000000000006 107.93 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.36 -0.237 . . . . 73.219999999999999 110.36 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.51 176.96 7.75 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.715 -0.221 . . . . 73.439999999999998 110.473 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m170 56.0 50.22 14.24 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.694 0.621 . . . . 72.239999999999995 111.957 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -74.84 83.62 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.045 0.45 . . . . 53.229999999999997 110.648 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 12.6 p-80 -63.58 107.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.63 -0.714 . . . . 64.019999999999996 109.543 172.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 84.5 m-70 68.53 167.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 110.021 -168.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -71.02 -68.64 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.543 -0.299 . . . . 52.520000000000003 110.629 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.479 ' CE1' ' O ' ' A' ' 70' ' ' TRP . 8.4 m-70 -159.37 174.02 15.36 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.155 -0.683 . . . . 71.439999999999998 109.155 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.2 ptp -92.92 -41.6 9.95 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.985 -0.376 . . . . 71.540000000000006 109.985 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.06 113.46 0.52 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.242 -0.504 . . . . 73.319999999999993 113.224 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 12' ' ' LEU . 20.1 m -154.76 177.85 10.79 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.109 -1.071 . . . . 64.109999999999999 108.109 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 11' ' ' THR . 36.8 tp -153.33 -73.54 0.13 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.429 0.559 . . . . 73.430000000000007 110.867 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HA ' HH11 ' A' ' 65' ' ' ARG . 4.6 mp0 -90.94 91.87 8.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.735 0.302 . . . . 52.229999999999997 110.384 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -157.48 102.94 1.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 61.0 109.843 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -62.81 -41.5 99.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.962 0.41 . . . . 73.030000000000001 110.897 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 54.93 26.44 7.91 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.316 -0.856 . . . . 75.239999999999995 110.051 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 21' ' ' SER . 55.8 tp60 -66.61 -44.17 82.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.021 -0.99 . . . . 74.109999999999999 110.469 -175.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.58 -125.87 7.51 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.493 -0.776 . . . . 74.420000000000002 111.209 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.25 140.75 15.72 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.991 2.46 . . . . 73.409999999999997 111.66 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.89 78.74 0.77 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 121.324 -0.465 . . . . 44.340000000000003 112.572 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 17' ' ' GLN . 27.1 m -74.81 114.23 13.02 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.071 -0.344 . . . . 65.310000000000002 110.071 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.3 tpt -74.34 109.02 7.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 73.349999999999994 110.546 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -96.81 113.35 24.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.893 -0.594 . . . . 74.420000000000002 110.195 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -156.31 -178.82 7.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.76 -0.83 . . . . 70.420000000000002 108.76 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.32 135.34 53.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.713 0.292 . . . . 71.109999999999999 110.492 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 56' ' ' PRO . 6.4 mp -85.14 143.47 28.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.413 0.625 . . . . 63.109999999999999 112.34 -172.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.625 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 6.3 m-85 -124.65 149.3 47.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.659 -1.155 . . . . 64.219999999999999 109.001 174.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.567 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -108.17 169.75 8.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.698 -0.482 . . . . 74.329999999999998 109.698 172.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 53' ' ' VAL . 51.0 t -99.0 137.53 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.412 -1.329 . . . . 71.299999999999997 107.412 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.62 161.91 29.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 118.405 0.548 . . . . 74.310000000000002 111.878 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -169.06 170.19 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.961 -1.018 . . . . 74.209999999999994 110.436 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 4.8 p30 -165.73 139.81 4.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.438 -0.208 . . . . 44.450000000000003 110.438 166.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.75 8.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.274 1.213 . . . . 73.120000000000005 114.274 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.8 pt-20 -112.08 -29.84 7.45 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.798 -0.564 . . . . 70.25 112.05 -169.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.66 -22.92 7.04 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.244 -0.503 . . . . 21.199999999999999 113.011 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.12 173.87 8.58 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -116.69 150.73 37.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.326 0.491 . . . . 73.099999999999994 112.326 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -144.47 -178.95 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.867 . . . . 73.510000000000005 109.453 168.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.55 165.41 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.784 0.326 . . . . 63.030000000000001 110.858 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.509 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 35.0 t90 -151.72 132.2 13.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 74.310000000000002 110.692 -170.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.457 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 15.8 tpt -68.06 127.32 32.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.051 -0.522 . . . . 73.299999999999997 110.136 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.93 159.58 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 70.439999999999998 109.606 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.42 21.04 25.58 Favored Glycine 0 C--N 1.329 0.166 0 C-N-CA 121.022 -0.608 . . . . 43.5 112.004 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.8 ptm180 -148.28 179.11 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.654 -0.499 . . . . 65.319999999999993 109.654 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 m -109.47 154.0 23.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.559 -0.534 . . . . 72.319999999999993 109.559 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 47' ' ' PRO . 11.2 tp -104.22 129.19 25.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 65.25 110.193 -174.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 46' ' ' LEU . 83.9 Cg_exo -40.42 132.82 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.522 2.814 . . . . 72.340000000000003 113.217 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 128.29 20.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.728 -0.669 . . . . 71.430000000000007 111.192 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.86 -34.22 5.09 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.875 -0.89 . . . . 71.010000000000005 110.875 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.755 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 45.6 m95 -76.69 157.64 31.62 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 110.167 -0.308 . . . . 71.239999999999995 110.167 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.63 152.99 48.58 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.111 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -105.67 154.52 20.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.738 -1.119 . . . . 63.350000000000001 110.528 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -163.05 161.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.225 0 C-N-CA 123.334 0.654 . . . . 74.209999999999994 110.863 -174.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.464 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 92.44 -140.09 14.96 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.823 -1.08 . . . . 72.200000000000003 112.72 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 26.0 tt0 -140.26 133.96 15.27 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.308 -0.997 . . . . 72.409999999999997 108.308 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 70.0 Cg_endo -70.29 112.48 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.603 . . . . 72.400000000000006 111.073 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -142.63 174.41 10.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.591 -0.731 . . . . 55.439999999999998 110.692 -172.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -64.44 157.88 25.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.589 0.233 . . . . 72.340000000000003 110.603 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -44.38 -51.78 8.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.444 0.698 . . . . 75.310000000000002 111.654 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -55.38 -46.09 76.56 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.854 -0.612 . . . . 73.420000000000002 111.825 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.448 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 99.2 mt-30 -71.46 -32.17 67.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 72.450000000000003 111.126 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 71.8 m -68.68 -47.22 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 63.149999999999999 111.011 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 3.8 pp -68.01 -36.13 79.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.924 0.393 . . . . 54.210000000000001 110.619 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.5 tt0 -61.12 -43.55 98.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.532 . . . . 74.010000000000005 109.803 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.688 ' NH1' ' HB3' ' A' ' 55' ' ' GLU . 14.2 ttm180 -60.5 -53.45 57.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.38 -0.827 . . . . 74.430000000000007 111.924 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 19.5 pt -63.71 -32.48 57.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.779 0.324 . . . . 74.430000000000007 111.531 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 94' ' ' VAL . 8.6 mm-40 -64.31 -32.56 74.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.471 . . . . 71.010000000000005 110.612 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 72.4 mm-40 -86.35 7.94 23.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.055 0.455 . . . . 75.109999999999999 110.592 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 36.9 mt -103.53 -62.58 1.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.515 0.674 . . . . 70.129999999999995 110.537 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.479 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 40.2 t-105 -85.83 -50.03 7.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.12 . . . . 45.109999999999999 110.994 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -86.43 -10.52 54.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.739 -1.119 . . . . 55.350000000000001 112.176 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 12.1 p-10 -41.83 -40.19 2.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.34 0.656 . . . . 73.310000000000002 112.726 -170.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.1 tpp -72.34 78.42 1.01 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.284 0.564 . . . . 75.019999999999996 109.612 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.9 133.27 48.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.12 -0.945 . . . . 71.120000000000005 110.906 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.91 -155.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.719 2.279 . . . . 72.129999999999995 111.536 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.79 -18.78 2.04 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.638 0.375 . . . . 60.32 111.959 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -57.99 -15.71 9.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.636 0.375 . . . . 75.439999999999998 111.502 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.01 -38.86 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.715 0.293 . . . . 72.150000000000006 110.657 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 84.2 mtt180 -68.99 -20.15 64.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.911 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 5.2 mm-40 -63.12 -33.58 75.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 73.109999999999999 110.334 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.477 ' HB3' HD22 ' A' ' 82' ' ' LEU . 12.9 t-80 -102.49 -33.93 9.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.256 -0.429 . . . . 54.530000000000001 110.765 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 2.6 mm? -120.06 103.75 9.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.516 -0.311 . . . . 73.430000000000007 110.88 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -96.13 149.88 21.13 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.512 -0.551 . . . . 64.540000000000006 109.512 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -60.41 -46.01 91.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.776 0.322 . . . . 74.549999999999997 111.072 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -93.37 148.32 22.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.456 -0.572 . . . . 73.5 109.456 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -57.2 122.88 13.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.939 0.4 . . . . 53.329999999999998 111.115 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.05 152.3 23.49 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.737 -0.665 . . . . 74.420000000000002 111.623 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.82 13.75 2.53 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.791 2.327 . . . . 73.530000000000001 112.712 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.42 72.27 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.430000000000007 112.202 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 pt -93.82 92.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.487 0.66 . . . . 44.039999999999999 110.557 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 38.4 t70 -112.0 171.14 7.68 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.424 -0.807 . . . . 74.510000000000005 110.31 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -57.58 134.61 56.28 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.57 0.581 . . . . 74.099999999999994 112.57 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.49 -156.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.371 -0.832 . . . . 75.120000000000005 109.298 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 67' ' ' GLU . 6.7 p -70.87 121.3 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.625 -0.509 . . . . 75.409999999999997 109.625 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.862 1.265 . . . . 74.540000000000006 110.778 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.978 -0.379 . . . . 73.219999999999999 109.978 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.24 -52.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 73.439999999999998 110.22 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.9 p80 39.24 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.075 0.95 . . . . 72.239999999999995 112.806 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -151.43 41.01 0.7 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 53.229999999999997 110.148 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -65.58 78.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 64.019999999999996 110.848 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -151.81 40.8 0.66 Allowed 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.304 -0.628 . . . . 74.209999999999994 109.304 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -64.54 118.25 8.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.775 -0.648 . . . . 52.520000000000003 109.312 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -126.31 97.55 5.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.304 0.573 . . . . 71.439999999999998 111.333 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 tpt -111.86 -60.64 1.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.669 -1.234 . . . . 71.540000000000006 107.669 171.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.68 -87.85 0.01 OUTLIER Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.916 -1.038 . . . . 73.319999999999993 114.364 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -44.37 -71.18 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.583 0.753 . . . . 64.109999999999999 112.916 -171.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HG ' ' H ' ' A' ' 13' ' ' GLU . 27.6 tp -170.48 176.43 4.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.565 -0.532 . . . . 73.430000000000007 109.565 -173.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.477 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 11.2 tp10 -56.31 142.66 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.445 0.466 . . . . 52.229999999999997 110.573 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.88 7.92 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 61.0 111.751 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -108.3 108.15 19.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.221 0.534 . . . . 73.030000000000001 110.911 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.7 t -116.94 11.37 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.585 -0.734 . . . . 75.239999999999995 109.781 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -106.05 91.82 3.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.617 -0.719 . . . . 74.109999999999999 109.913 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.44 124.9 3.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.194 -0.527 . . . . 74.420000000000002 111.955 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.19 150.75 60.05 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.463 2.109 . . . . 73.409999999999997 111.223 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.29 136.0 14.0 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.792 -0.718 . . . . 44.340000000000003 112.021 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' A' ' 24' ' ' ASP . 23.0 t -70.14 169.96 12.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.306 -0.628 . . . . 65.310000000000002 109.306 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.5 ptm -99.73 6.6 45.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.136 0.493 . . . . 73.349999999999994 111.112 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -150.84 -66.64 0.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.359 -0.837 . . . . 74.420000000000002 110.441 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 21' ' ' SER . 38.1 t70 -73.26 134.34 44.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.682 -0.69 . . . . 70.420000000000002 111.065 -175.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -73.97 -172.72 1.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.242 0.544 . . . . 71.109999999999999 111.518 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp -85.2 142.23 29.59 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.585 . . . . 63.109999999999999 110.15 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 3.0 m-85 -125.18 148.62 48.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 64.219999999999999 110.055 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 56' ' ' PRO . 10.3 m-85 -109.68 157.67 18.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.176 -0.675 . . . . 74.329999999999998 109.176 168.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 37' ' ' TYR . 40.4 t -86.4 124.17 40.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.367 -1.346 . . . . 71.299999999999997 107.367 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 46' ' ' LEU . 19.3 m -125.54 162.52 28.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 122.103 -0.373 . . . . 74.310000000000002 111.054 -171.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.597 HH21 ' HA2' ' A' ' 35' ' ' GLY . 7.6 ptm180 -167.76 168.15 12.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.395 -0.366 . . . . 74.209999999999994 111.638 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 24.1 p-10 -168.25 140.36 2.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.922 -0.581 . . . . 44.450000000000003 110.554 167.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.8 t30 45.89 13.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.029 0.932 . . . . 73.120000000000005 113.486 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' ASN . 9.8 pt-20 -112.43 -20.47 11.77 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.738 -0.601 . . . . 70.25 112.144 -172.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.597 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 75.52 -22.53 1.71 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.309 -0.472 . . . . 21.199999999999999 113.219 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 6.0 pt20 -103.42 173.96 6.08 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.778 0.431 . . . . 74.310000000000002 110.148 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.462 ' CD1' HG12 ' A' ' 29' ' ' VAL . 21.6 m-85 -108.74 158.13 17.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 73.099999999999994 112.471 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -141.73 -178.97 5.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.059 . . . . 73.510000000000005 108.646 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.757 HG21 ' HE3' ' A' ' 59' ' ' LYS . 20.6 m -127.79 152.34 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 118.237 0.472 . . . . 63.030000000000001 111.328 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -153.1 146.89 25.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.96 -0.564 . . . . 74.310000000000002 110.216 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 46.2 ttm -72.14 122.12 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.543 -0.299 . . . . 73.299999999999997 110.636 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.44 156.45 38.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 70.439999999999998 110.454 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.17 -31.81 8.22 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.302 -0.475 . . . . 43.5 112.145 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -106.6 130.34 54.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 65.319999999999993 110.216 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.5 m -66.0 159.37 25.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.22 0.534 . . . . 72.319999999999993 111.881 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.4 mt -107.3 155.5 39.33 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.228 -0.896 . . . . 65.25 111.227 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -55.85 152.36 36.13 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.172 2.581 . . . . 72.340000000000003 112.509 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.68 118.45 3.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.469 -0.787 . . . . 71.430000000000007 110.907 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.01 9.93 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.151 -0.477 . . . . 71.010000000000005 112.502 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.58 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.7 m95 -79.49 132.21 36.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.845 0.322 . . . . 71.239999999999995 111.037 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -115.88 154.26 30.05 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.662 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 30' ' ' VAL . 40.1 p -112.77 146.22 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.439 1.087 . . . . 63.350000000000001 110.612 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 54' ' ' GLY . 17.3 t -154.86 156.12 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.606 0.363 . . . . 74.209999999999994 110.476 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 87.33 -179.83 48.13 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.121 -0.491 . . . . 72.200000000000003 113.958 169.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 29.9 tt0 -69.98 118.35 62.61 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 123.237 0.615 . . . . 72.409999999999997 111.062 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 35.6 Cg_endo -64.68 111.71 1.76 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.768 1.645 . . . . 72.400000000000006 110.786 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.84 179.41 6.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.939 -0.573 . . . . 55.439999999999998 110.465 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 t -55.68 157.8 3.91 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.976 0.417 . . . . 72.340000000000003 111.631 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.757 ' HE3' HG21 ' A' ' 39' ' ' VAL . 22.2 tptm -45.97 -45.02 15.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.456 -0.793 . . . . 75.310000000000002 111.145 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 52.2 tt0 -56.67 -43.18 80.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 73.420000000000002 111.13 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -69.25 -50.2 49.23 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.435 -0.348 . . . . 72.450000000000003 111.031 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.752 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 15.2 p -60.73 -43.53 97.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.342 -0.39 . . . . 63.149999999999999 111.13 -174.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.642 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 pp -67.78 -42.42 81.72 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.636 -0.425 . . . . 54.210000000000001 109.993 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' LEU . 31.7 tt0 -54.94 -40.7 70.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.111 0.482 . . . . 74.010000000000005 110.342 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.1 ttm-85 -58.37 -53.35 59.25 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.583 -0.735 . . . . 74.430000000000007 111.955 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 29' ' ' VAL . 17.4 pt -73.01 -34.63 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.507 -0.315 . . . . 74.430000000000007 111.797 -175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 10.0 mm-40 -61.59 -32.72 72.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 110.203 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -81.39 -8.42 59.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.272 -0.422 . . . . 75.109999999999999 111.722 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 94.8 mt -103.31 -67.03 0.9 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.886 0.374 . . . . 70.129999999999995 111.909 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -86.3 -52.9 5.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.511 0.672 . . . . 45.109999999999999 110.894 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 94' ' ' VAL . 1.5 m -70.55 -11.35 60.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.758 -1.11 . . . . 55.350000000000001 111.052 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 1.1 p-10 -42.16 -34.95 0.83 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.734 0.814 . . . . 73.310000000000002 113.093 -172.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -65.78 85.82 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.575 0.702 . . . . 75.019999999999996 111.651 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 7.4 p -106.57 130.56 22.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.565 -0.743 . . . . 71.120000000000005 110.19 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 5.0 Cg_exo -73.42 -158.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.917 2.412 . . . . 72.129999999999995 112.151 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.96 -20.69 17.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 60.32 111.939 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.1 p -58.83 -16.35 16.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.155 -0.475 . . . . 75.439999999999998 111.794 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.17 -34.94 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.01 0.433 . . . . 72.150000000000006 110.682 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -66.94 -20.04 65.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.743 -0.662 . . . . 74.439999999999998 110.83 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -58.14 -35.87 72.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.097 -0.501 . . . . 73.109999999999999 110.158 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -97.45 -48.73 5.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.925 -0.58 . . . . 54.530000000000001 109.943 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 tt -94.95 95.15 8.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.783 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -67.16 146.88 53.78 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.847 -0.615 . . . . 64.540000000000006 111.013 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.92 87.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.941 -0.572 . . . . 74.549999999999997 111.32 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -126.68 146.71 50.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.923 -0.581 . . . . 73.5 109.514 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 p -83.05 88.53 6.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 53.329999999999998 110.364 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.98 169.05 29.09 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.694 -0.684 . . . . 74.420000000000002 111.74 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.28 176.29 2.74 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.974 2.449 . . . . 73.530000000000001 112.365 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.3 124.1 1.26 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.085 -0.579 . . . . 73.430000000000007 112.235 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.12 87.05 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.886 -0.783 . . . . 44.039999999999999 108.886 173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -127.53 179.09 5.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 74.510000000000005 109.886 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -118.29 -178.77 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.636 0.375 . . . . 74.099999999999994 110.04 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 72' ' ' ASP . . . -113.29 87.07 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 75.120000000000005 110.225 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 71' ' ' THR . 11.3 p 43.21 31.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.672 1.189 . . . . 75.409999999999997 113.855 176.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.531 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 114.764 -1.107 . . . . 74.540000000000006 110.316 171.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 110.429 -0.211 . . . . 73.219999999999999 110.429 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.25 105.32 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.654 0.596 . . . . 73.439999999999998 112.144 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.22 149.18 10.17 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.837 -0.619 . . . . 72.239999999999995 109.365 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -145.99 101.76 3.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.763 0.316 . . . . 53.229999999999997 110.233 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.409 ' NE2' ' NE2' ' A' ' 68' ' ' GLN . 17.8 p80 -102.99 145.45 29.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.126 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -94.9 -174.53 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.251 -0.648 . . . . 74.209999999999994 109.251 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -84.94 144.85 28.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.003 0.43 . . . . 52.520000000000003 110.975 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -151.5 137.3 18.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 71.439999999999998 109.229 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 80.9 mtp -65.09 -61.41 2.16 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.297 0.373 . . . . 71.540000000000006 110.632 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.66 51.06 12.46 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.908 -0.587 . . . . 73.319999999999993 112.922 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.4 p -80.07 -62.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.364 -0.606 . . . . 64.109999999999999 109.364 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.41 117.98 27.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 73.430000000000007 109.294 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 6.8 mm-40 -92.04 130.03 37.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.538 -0.542 . . . . 52.229999999999997 109.538 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.75 132.13 36.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.211 -0.292 . . . . 61.0 110.211 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.33 42.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 73.030000000000001 110.753 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -60.42 -26.32 66.62 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.804 -0.634 . . . . 75.239999999999995 110.352 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -88.83 -45.9 9.38 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.161 -0.681 . . . . 74.109999999999999 109.161 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.97 144.71 7.03 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.409 -0.814 . . . . 74.420000000000002 111.849 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HB3' ' HG2' ' A' ' 56' ' ' PRO . 85.2 Cg_endo -78.96 27.18 0.52 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.25 2.634 . . . . 73.409999999999997 112.401 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.55 -76.05 0.39 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.62 -0.592 . . . . 44.340000000000003 111.62 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.4 t -172.68 36.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 65.310000000000002 108.881 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.424 ' HA ' HD22 ' A' ' 26' ' ' LEU . 22.1 ptm 39.33 60.78 1.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.221 1.01 . . . . 73.349999999999994 110.418 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.64 -67.26 0.45 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.059 -1.428 . . . . 74.420000000000002 111.086 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -87.9 171.96 9.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.761 -0.654 . . . . 70.420000000000002 109.712 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.79 87.3 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.37 0.605 . . . . 71.109999999999999 110.19 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.0 mp -71.29 163.11 28.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 63.109999999999999 111.107 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -126.39 148.5 49.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.977 -1.01 . . . . 64.219999999999999 109.288 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.99 153.31 26.99 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.378 -0.971 . . . . 74.329999999999998 108.378 174.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 53' ' ' VAL . 77.2 t -84.77 135.61 24.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.22 -1.77 . . . . 71.299999999999997 106.22 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 46' ' ' LEU . 21.6 m -136.46 165.12 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 121.483 -0.761 . . . . 74.310000000000002 111.644 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -166.01 164.32 18.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.793 -1.094 . . . . 74.209999999999994 110.282 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.4 p-10 -153.39 139.77 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 44.450000000000003 110.137 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 42.44 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.052 1.501 . . . . 73.120000000000005 115.052 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.4 pt-20 -112.53 -32.22 6.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.461 0.573 . . . . 70.25 111.832 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.01 -22.59 4.94 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.462 -0.399 . . . . 21.199999999999999 112.381 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.39 173.95 8.84 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -112.75 137.59 50.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.478 0.656 . . . . 73.099999999999994 112.41 -176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.7 m -137.27 -179.09 5.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.894 -1.048 . . . . 73.510000000000005 108.936 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.7 m -126.85 153.72 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.887 0.375 . . . . 63.030000000000001 111.125 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -144.19 156.08 44.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 74.310000000000002 109.259 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.8 ttt -82.59 121.3 26.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.017 -0.364 . . . . 73.299999999999997 110.017 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.34 157.81 34.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.985 0.421 . . . . 70.439999999999998 110.627 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -21.07 48.13 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.042 -0.823 . . . . 43.5 111.042 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 100.33 9.58 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.284 -0.636 . . . . 65.319999999999993 109.284 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -63.3 129.01 38.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.922 0.391 . . . . 72.319999999999993 110.422 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 2.7 mm? -58.72 145.19 78.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.635 -0.711 . . . . 65.25 112.418 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.99 144.12 99.5 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 123.007 2.472 . . . . 72.340000000000003 111.436 166.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.36 128.54 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 110.194 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.74 -29.75 7.02 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.551 -0.619 . . . . 71.010000000000005 111.551 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 36.0 m95 -86.69 170.9 11.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.068 -0.716 . . . . 71.239999999999995 109.068 172.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.83 146.57 28.03 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 120.937 0.399 . . . . 74.230000000000004 110.448 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 46' ' ' LEU . 13.0 p -98.09 153.38 18.46 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.614 -1.176 . . . . 63.350000000000001 110.834 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -162.32 167.01 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 C-N-CA 124.266 1.026 . . . . 74.209999999999994 109.83 -175.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.499 ' HA2' ' HG3' ' A' ' 13' ' ' GLU . . . 83.44 179.46 52.32 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.171 -0.922 . . . . 72.200000000000003 111.412 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 47.6 tt0 -103.89 122.67 43.69 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.526 -1.286 . . . . 72.409999999999997 107.526 171.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.604 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 19.1 Cg_endo -55.72 124.9 17.42 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.119 . . . . 72.400000000000006 112.781 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -151.02 156.36 40.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 55.439999999999998 109.194 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -62.21 169.95 2.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.667 0.247 . . . . 72.340000000000003 111.667 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -43.39 -59.09 2.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.305 0.642 . . . . 75.310000000000002 112.289 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.25 -40.29 70.75 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.87 0.367 . . . . 73.420000000000002 111.456 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.461 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 96.4 mt-30 -74.8 -39.07 61.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 72.450000000000003 110.808 -176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.5 t -65.8 -51.05 62.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.637 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.1 pp -62.73 -43.67 98.19 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.021 0.438 . . . . 54.210000000000001 110.067 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' LEU . 52.5 tt0 -63.07 -35.8 81.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.022 -0.535 . . . . 74.010000000000005 110.529 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.622 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 16.0 ttt180 -61.87 -50.43 72.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 110.641 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.4 pt -74.15 -42.13 51.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.816 0.341 . . . . 74.430000000000007 111.63 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.94 -37.74 88.52 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.34 -0.391 . . . . 71.010000000000005 111.678 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' NE2' ' NE2' ' A' ' 5' ' ' HIS . 17.0 mm100 -78.97 0.28 28.18 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 121.023 -0.271 . . . . 75.109999999999999 111.368 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -103.92 -65.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.289 0.566 . . . . 70.129999999999995 111.141 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -85.45 -46.03 11.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.174 -0.921 . . . . 45.109999999999999 110.956 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -87.12 -11.17 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.561 -0.745 . . . . 55.350000000000001 112.545 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' HA ' HG21 ' A' ' 94' ' ' VAL . 4.4 p-10 -41.74 -40.51 2.03 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.413 0.894 . . . . 73.310000000000002 113.413 -166.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.2 mtm -66.68 84.28 0.11 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.614 0.721 . . . . 75.019999999999996 110.312 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -73.17 137.03 78.82 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.833 -1.076 . . . . 71.120000000000005 110.46 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' O ' HG12 ' A' ' 78' ' ' VAL . 16.6 Cg_exo -67.2 -165.98 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.924 2.416 . . . . 72.129999999999995 112.557 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 79' ' ' ARG . . . -54.74 -20.97 9.51 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.259 -0.428 . . . . 60.32 111.543 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 p -53.37 -24.54 12.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.84 -0.618 . . . . 75.439999999999998 111.542 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.5 p -64.23 -53.45 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.481 -0.327 . . . . 72.150000000000006 111.142 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.49 ' N ' HG13 ' A' ' 78' ' ' VAL . 14.4 ptp180 -65.62 -32.38 73.93 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 121.037 0.446 . . . . 74.439999999999998 110.057 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.94 -39.7 90.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 73.109999999999999 109.554 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 91' ' ' ASP . 5.9 t60 -72.5 -35.65 68.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 54.530000000000001 110.829 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 87.2 mt -57.16 -22.19 38.42 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.343 0.497 . . . . 73.430000000000007 112.343 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -60.95 -25.44 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.718 -0.219 . . . . 64.540000000000006 111.446 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.558 HE22 ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -117.41 156.47 27.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.681 0.277 . . . . 74.549999999999997 110.507 -178.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -159.09 23.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 73.5 110.656 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.9 t -74.4 174.99 8.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.263 -0.426 . . . . 53.329999999999998 110.769 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.39 -62.53 5.51 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.969 -0.559 . . . . 74.420000000000002 112.356 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.39 40.7 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.818 2.346 . . . . 73.530000000000001 112.273 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' HA3' HE22 ' A' ' 84' ' ' GLN . . . -85.37 51.51 4.51 Favored Glycine 0 C--O 1.236 0.246 0 C-N-CA 121.334 -0.46 . . . . 73.430000000000007 112.227 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -76.47 102.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 44.039999999999999 109.997 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 23.6 t70 -147.51 165.32 30.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.795 -0.639 . . . . 74.510000000000005 109.604 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -54.75 138.87 41.09 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.453 0.471 . . . . 74.099999999999994 111.97 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.34 167.97 17.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 75.120000000000005 109.051 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 72' ' ' ASP . 3.0 p -72.73 105.24 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.198 0.523 . . . . 75.409999999999997 110.83 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-N 115.039 -0.982 . . . . 74.540000000000006 109.419 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.238 -0.282 . . . . 73.219999999999999 110.238 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.14 -63.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.435 -0.348 . . . . 73.439999999999998 110.481 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 59.19 91.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.985 -0.552 . . . . 72.239999999999995 111.682 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -151.66 86.09 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.557 -0.535 . . . . 53.229999999999997 109.557 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -142.55 130.66 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 64.019999999999996 110.229 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.75 93.02 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.506 0.67 . . . . 74.209999999999994 110.32 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -74.2 99.15 3.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 52.520000000000003 111.115 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -73.6 73.93 1.48 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.175 0.512 . . . . 71.439999999999998 109.699 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 81.6 mtp -75.69 -79.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 71.540000000000006 111.002 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.32 107.18 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.619 -0.592 . . . . 73.319999999999993 111.619 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.3 m -157.8 154.09 27.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.475 -0.565 . . . . 64.109999999999999 109.475 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 64.3 mt -76.81 -140.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 119.22 -0.419 . . . . 73.430000000000007 110.764 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.577 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 5.7 mp0 -58.08 -0.44 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.155 1.169 . . . . 52.229999999999997 114.155 -163.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -69.47 136.26 51.27 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.008 -0.432 . . . . 61.0 111.178 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.651 ' NE2' ' HB ' ' A' ' 66' ' ' ILE . 21.6 pt20 -151.85 -162.63 1.56 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.429 -0.351 . . . . 73.030000000000001 110.921 -175.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.568 ' HB ' ' HG3' ' A' ' 36' ' ' GLN . 7.7 m -101.25 -51.4 3.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.095 -0.502 . . . . 75.239999999999995 110.025 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -174.18 143.38 0.89 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.06 112.16 1.26 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.969 -0.634 . . . . 74.420000000000002 112.858 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.4 153.95 21.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.615 2.21 . . . . 73.409999999999997 111.873 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.11 146.49 9.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.711 . . . . 44.340000000000003 112.458 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 m -92.81 171.84 8.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.718 0.407 . . . . 65.310000000000002 110.58 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.4 mtt -91.01 111.1 22.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.94 0.4 . . . . 73.349999999999994 111.018 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -129.99 -171.32 2.5 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.713 -0.676 . . . . 74.420000000000002 109.412 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.5 t70 -124.54 172.84 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.861 -0.422 . . . . 70.420000000000002 109.861 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' THR . 43.9 mt-10 73.99 164.53 0.28 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.483 0.713 . . . . 71.109999999999999 111.537 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.06 144.65 53.93 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.759 0.79 . . . . 63.109999999999999 112.182 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.75 149.05 47.62 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.327 -1.306 . . . . 64.219999999999999 108.885 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.765 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -108.58 165.07 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.384 -0.599 . . . . 74.329999999999998 109.384 173.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.582 HG11 HG21 ' A' ' 66' ' ' ILE . 36.5 t -102.26 114.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.94 -0.763 . . . . 71.299999999999997 108.94 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 52' ' ' THR . 17.3 m -125.74 165.32 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.59 0.234 . . . . 74.310000000000002 111.51 -169.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 21.3 ptt180 -169.25 170.36 8.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.032 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' GLU . 23.4 p-10 -149.36 139.79 22.42 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 120.773 -0.371 . . . . 44.450000000000003 110.727 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t30 33.31 20.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.531 1.533 . . . . 73.120000000000005 114.918 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.41 -32.43 6.5 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.617 -0.677 . . . . 70.25 112.134 -174.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.95 19.93 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.317 -0.468 . . . . 21.199999999999999 112.751 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HG3' ' HB ' ' A' ' 16' ' ' THR . 25.6 mp0 -90.57 173.76 7.89 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.744 -0.835 . . . . 74.310000000000002 108.744 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.591 ' HD2' ' HB3' ' A' ' 15' ' ' GLN . 9.3 m-85 -117.43 171.72 7.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.934 0.873 . . . . 73.099999999999994 112.101 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -150.09 176.62 10.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.685 -1.598 . . . . 73.510000000000005 107.119 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' SG ' ' A' ' 62' ' ' CYS . 7.0 m -124.37 129.4 73.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.522 0.677 . . . . 63.030000000000001 111.186 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' HZ2' ' NH1' ' A' ' 44' ' ' ARG . 54.3 t-105 -119.05 135.96 54.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.806 -1.088 . . . . 74.310000000000002 109.292 -171.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.67 123.72 19.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.507 -0.183 . . . . 73.299999999999997 110.507 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.69 146.5 52.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.04 -0.356 . . . . 70.439999999999998 110.04 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.32 15.84 68.13 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.947 -0.644 . . . . 43.5 111.57 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HG2' HH11 ' A' ' 44' ' ' ARG . 34.8 ttt-85 -131.27 125.19 32.18 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.89 -0.782 . . . . 65.319999999999993 108.89 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.8 m -72.55 159.93 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 72.319999999999993 111.8 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.677 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 10.6 tp -119.49 135.66 24.2 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.459 -0.791 . . . . 65.25 109.5 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD2' HD12 ' A' ' 46' ' ' LEU . 55.7 Cg_endo -69.55 158.19 58.11 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.87 2.38 . . . . 72.340000000000003 113.665 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.08 129.12 26.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.911 -1.04 . . . . 71.430000000000007 110.788 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.62 -28.66 10.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.917 -0.583 . . . . 71.010000000000005 111.725 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.677 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 14.9 m95 -91.04 153.72 19.92 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.647 0.261 . . . . 71.239999999999995 110.502 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.76 138.87 53.88 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 110.36 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.586 ' HA ' HG12 ' A' ' 30' ' ' VAL . 7.3 p -100.81 131.31 46.76 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.585 -1.189 . . . . 63.350000000000001 109.616 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 54' ' ' GLY . 3.1 t -146.23 166.26 8.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.146 0.498 . . . . 74.209999999999994 110.317 -170.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' HA2' ' HG3' ' A' ' 13' ' ' GLU . . . 98.31 -141.09 15.39 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.647 -0.706 . . . . 72.200000000000003 114.231 167.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -136.53 119.41 11.96 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.385 -0.908 . . . . 72.409999999999997 108.788 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.765 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.1 Cg_endo -63.05 115.8 3.18 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.648 1.565 . . . . 72.400000000000006 111.281 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.38 155.09 35.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.608 -0.724 . . . . 55.439999999999998 109.554 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 10.0 t -55.88 153.76 8.12 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.744 -0.465 . . . . 72.340000000000003 109.744 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE3' HG23 ' A' ' 39' ' ' VAL . 24.6 tptm -43.14 -48.8 6.41 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.606 0.566 . . . . 75.310000000000002 111.848 -172.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -58.94 -51.08 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 73.420000000000002 111.03 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -69.42 -30.43 68.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.957 0.408 . . . . 72.450000000000003 110.406 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 39' ' ' VAL . 13.8 t -65.67 -52.41 51.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.776 -0.647 . . . . 63.149999999999999 110.175 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.815 HD13 ' HG2' ' A' ' 95' ' ' ARG . 4.0 pp -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.038 0.447 . . . . 54.210000000000001 110.387 176.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' LEU . 32.9 tt0 -62.83 -42.32 99.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 74.010000000000005 110.772 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.48 ' HD3' ' HG2' ' A' ' 13' ' ' GLU . 12.3 ttm-85 -57.26 -53.28 59.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 111.608 -174.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.651 ' HB ' ' NE2' ' A' ' 15' ' ' GLN . 13.1 pt -67.22 -34.71 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 111.531 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.849 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 14.0 mm-40 -66.23 -32.49 73.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 71.010000000000005 110.178 174.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 17.3 mm-40 -75.56 0.35 17.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.07 -0.514 . . . . 75.109999999999999 111.816 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 95.5 mt -103.81 -67.11 0.91 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.794 0.664 . . . . 70.129999999999995 112.794 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -86.04 -55.07 4.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.678 0.752 . . . . 45.109999999999999 110.579 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -11.48 60.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.392 -1.277 . . . . 55.350000000000001 110.915 -177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.46 -28.29 2.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.611 0.764 . . . . 73.310000000000002 112.799 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 86.4 mtp -68.76 74.36 0.27 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.282 0.563 . . . . 75.019999999999996 110.153 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.24 134.44 19.77 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.273 -0.876 . . . . 71.120000000000005 110.271 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -157.84 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.827 2.352 . . . . 72.129999999999995 111.662 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.59 -18.85 13.28 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.59 0.356 . . . . 60.32 111.405 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.3 p -53.82 -26.25 23.33 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.974 -0.557 . . . . 75.439999999999998 111.556 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.53 -36.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.195 0.521 . . . . 72.150000000000006 110.421 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 79' ' ' ARG . 17.7 mtp180 -73.84 -37.03 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.751 -0.659 . . . . 74.439999999999998 109.991 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.15 -25.83 67.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.762 -0.654 . . . . 73.109999999999999 110.632 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -70.25 -27.15 64.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.642 -0.708 . . . . 54.530000000000001 110.643 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.96 146.44 47.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.66 . . . . 73.430000000000007 110.82 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -79.27 136.53 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.693 -0.484 . . . . 64.540000000000006 109.693 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -75.02 -13.46 60.5 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.446 -0.343 . . . . 74.549999999999997 111.591 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -83.16 48.78 1.43 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.872 0.368 . . . . 73.5 111.012 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p 53.37 100.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.002 0.921 . . . . 53.329999999999998 112.274 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.59 179.68 46.15 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.411 -0.675 . . . . 74.420000000000002 111.411 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.04 -7.66 21.9 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.669 2.246 . . . . 73.530000000000001 112.379 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.49 -17.38 56.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-N 115.916 -0.583 . . . . 73.430000000000007 112.027 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.6 mt -75.43 134.63 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.572 0.349 . . . . 44.039999999999999 110.161 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -82.2 159.1 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.89 -0.411 . . . . 74.510000000000005 109.89 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -133.96 175.59 9.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 74.099999999999994 110.181 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.668 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -67.49 165.67 16.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.925 -0.579 . . . . 75.120000000000005 110.39 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 94' ' ' VAL . 11.7 p -88.86 22.09 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 122.883 1.325 . . . . 75.409999999999997 112.193 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.849 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 22.7 tpt180 . . . . . 0 C--N 1.297 -1.685 0 CA-C-N 113.626 -1.624 . . . . 74.540000000000006 109.272 168.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 56' ' ' PRO . 9.1 mp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.782 0.801 . . . . 63.109999999999999 111.193 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.2 m-85 -127.57 151.13 49.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.366 -1.288 . . . . 64.219999999999999 109.306 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -116.46 157.68 24.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 74.329999999999998 109.397 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -85.86 134.83 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.16 -1.422 . . . . 71.299999999999997 107.16 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 46' ' ' LEU . 29.0 m -136.73 159.32 37.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.954 0.407 . . . . 74.310000000000002 111.379 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 38.0 ptt180 -169.21 170.23 8.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.192 -0.913 . . . . 74.209999999999994 110.509 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.668 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.77 140.38 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.653 -0.249 . . . . 44.450000000000003 111.061 170.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 49.11 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.883 1.068 . . . . 73.120000000000005 113.883 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.09 -32.0 6.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.747 -0.596 . . . . 70.25 111.464 -174.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.71 -22.81 6.19 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.262 -0.426 . . . . 21.199999999999999 113.014 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.03 174.04 10.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.749 -0.464 . . . . 74.310000000000002 109.749 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.21 143.3 45.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.901 0.704 . . . . 73.099999999999994 112.901 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -136.83 -179.91 5.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.987 -1.006 . . . . 73.510000000000005 109.694 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.65 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.9 m -125.67 155.34 34.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.807 0.337 . . . . 63.030000000000001 110.803 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -148.48 149.1 31.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.306 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.8 ttt -81.61 121.51 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.647 0.26 . . . . 73.299999999999997 110.326 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.56 148.89 44.64 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.231 -0.441 . . . . 70.439999999999998 111.014 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.97 -23.03 36.26 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.741 -0.544 . . . . 43.5 111.741 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -92.98 118.83 31.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.004 -0.369 . . . . 65.319999999999993 110.004 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.3 m -60.24 137.33 58.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.04 0.448 . . . . 72.319999999999993 111.391 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -93.31 142.43 25.26 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.425 -0.807 . . . . 65.25 110.882 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.13 140.44 70.93 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.863 2.375 . . . . 72.340000000000003 111.714 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.67 124.89 11.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 71.430000000000007 110.386 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.2 -29.42 7.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.296 -0.478 . . . . 71.010000000000005 112.669 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.668 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.1 m95 -76.95 149.88 35.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.335 0.568 . . . . 71.239999999999995 111.46 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 18.8 pt-20 -129.62 151.23 50.45 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.977 -0.556 . . . . 74.230000000000004 110.245 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -107.99 160.59 15.66 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.214 0.946 . . . . 63.350000000000001 111.255 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.17 158.51 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 123.408 0.683 . . . . 74.209999999999994 110.608 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 89.61 -166.85 33.23 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.833 -0.621 . . . . 72.200000000000003 112.259 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.55 142.25 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.745 -0.835 . . . . 72.409999999999997 108.745 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.4 Cg_endo -72.57 108.74 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 120.816 1.01 . . . . 72.400000000000006 110.575 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.57 172.99 17.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.416 -0.811 . . . . 55.439999999999998 110.361 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -55.77 155.33 6.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.898 0.38 . . . . 72.340000000000003 111.503 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -49.55 -36.49 23.81 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.619 -0.719 . . . . 75.310000000000002 110.923 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -55.71 -55.67 29.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.516 -0.765 . . . . 73.420000000000002 110.302 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -52.0 64.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.776 -0.647 . . . . 72.450000000000003 111.003 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.65 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.0 t -55.86 -52.46 63.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.197 -0.91 . . . . 63.149999999999999 111.071 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.2 pp -68.26 -44.92 74.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.916 -0.313 . . . . 54.210000000000001 110.445 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' N ' HD12 ' A' ' 63' ' ' LEU . 22.0 tt0 -54.8 -36.51 65.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.394 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 48.5 ttt85 -64.21 -53.53 47.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.774 -0.648 . . . . 74.430000000000007 111.046 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.07 -34.05 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 111.679 0.251 . . . . 74.430000000000007 111.679 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 39.7 mm-40 -65.97 -32.77 74.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.487 -0.324 . . . . 71.010000000000005 110.385 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.75 4.95 42.32 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 111.266 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 48.0 mt -103.73 -66.97 0.91 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.92 0.39 . . . . 70.129999999999995 111.195 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -86.32 -54.84 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.272 0.558 . . . . 45.109999999999999 111.417 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -78.19 -10.92 59.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.187 -0.915 . . . . 55.350000000000001 111.399 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 113.977 1.103 . . . . 73.310000000000002 113.977 -171.168 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.236 0.367 0 CA-C-O 121.784 0.802 . . . . 63.109999999999999 111.455 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -127.31 148.7 50.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.502 -1.226 . . . . 64.219999999999999 109.156 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.584 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -114.1 162.39 16.54 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.61 0.569 . . . . 74.329999999999998 109.543 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 53' ' ' VAL . 75.8 t -88.42 140.65 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.247 -1.02 . . . . 71.299999999999997 108.247 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 40' ' ' TRP . 23.4 m -144.99 158.23 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 122.195 -0.316 . . . . 74.310000000000002 110.85 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 19.9 ptt85 -169.36 170.1 8.63 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.335 -0.393 . . . . 74.209999999999994 111.542 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -157.89 139.82 14.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.342 -0.39 . . . . 44.450000000000003 111.063 171.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 35.12 21.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.137 1.375 . . . . 73.120000000000005 114.294 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ASN . 10.7 pt-20 -112.4 -32.11 6.6 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.616 -0.677 . . . . 70.25 111.385 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.86 -22.79 5.52 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.972 -0.558 . . . . 21.199999999999999 112.078 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -84.35 161.56 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.14 -0.689 . . . . 74.310000000000002 109.14 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 18.9 m-85 -106.32 137.48 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.086 0.469 . . . . 73.099999999999994 111.711 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -124.13 -179.21 4.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.046 -0.979 . . . . 73.510000000000005 109.726 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -132.31 157.3 43.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.879 0.371 . . . . 63.030000000000001 110.877 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HB2' HG21 ' A' ' 30' ' ' VAL . 73.4 t-105 -155.75 149.41 25.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.823 -0.806 . . . . 74.310000000000002 108.823 -171.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.86 130.35 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 73.299999999999997 110.539 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.58 144.12 27.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.993 -0.548 . . . . 70.439999999999998 111.621 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -20.69 12.09 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.13 -0.486 . . . . 43.5 113.254 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -79.91 131.1 35.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.762 0.281 . . . . 65.319999999999993 110.274 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -65.92 148.76 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.314 0.578 . . . . 72.319999999999993 111.821 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 29.1 mt -111.35 147.71 37.25 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.094 -0.957 . . . . 65.25 111.204 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -81.07 176.1 9.2 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.913 2.409 . . . . 72.340000000000003 113.029 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 125.44 10.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.907 -1.042 . . . . 71.430000000000007 111.94 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.57 -32.32 7.52 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 112.847 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.3 m95 -76.91 133.54 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.034 0.417 . . . . 71.239999999999995 111.689 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 9.8 pt-20 -127.62 152.78 47.23 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.746 -0.661 . . . . 74.230000000000004 110.393 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 53' ' ' VAL . 39.5 p -102.13 159.66 15.19 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.289 0.993 . . . . 63.350000000000001 111.42 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -173.6 175.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 110.285 -173.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 82.75 -161.2 40.05 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.723 -0.671 . . . . 72.200000000000003 112.882 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.5 138.62 20.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 123.366 0.666 . . . . 72.409999999999997 109.588 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.7 Cg_endo -71.59 113.38 3.62 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.673 1.582 . . . . 72.400000000000006 111.078 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.37 167.11 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.726 -0.67 . . . . 55.439999999999998 109.938 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -61.69 161.36 10.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.679 0.276 . . . . 72.340000000000003 110.961 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -46.89 -48.52 21.19 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.869 -0.605 . . . . 75.310000000000002 111.633 -176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.37 -45.09 84.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.978 -0.555 . . . . 73.420000000000002 111.406 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.75 -38.78 64.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 72.450000000000003 110.708 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.531 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.2 t -59.02 -49.26 78.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.73 -0.668 . . . . 63.149999999999999 110.202 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.6 pp -68.05 -37.22 81.06 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.43 -0.35 . . . . 54.210000000000001 110.508 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' LEU . 33.9 tt0 -60.31 -32.74 71.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.089 0.471 . . . . 74.010000000000005 110.411 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.3 ttt85 -76.57 -44.02 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.982 -0.554 . . . . 74.430000000000007 110.548 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' LEU . 44.4 pt -67.61 -34.55 68.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 121.153 -0.219 . . . . 74.430000000000007 110.675 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 71' ' ' THR . 34.3 mt-10 -54.03 -56.04 21.67 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.25 -0.432 . . . . 71.010000000000005 110.112 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -65.76 -10.18 34.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 75.109999999999999 112.384 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 97.6 mt -104.02 -67.79 0.88 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.329 0.492 . . . . 70.129999999999995 112.329 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 70.6 t-105 -87.01 -55.44 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.965 0.888 . . . . 45.109999999999999 111.168 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 5.5 m -74.09 -11.52 60.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.027 -1.442 . . . . 55.350000000000001 111.609 -170.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 67' ' ' GLU . 24.5 t70 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 114.029 1.122 . . . . 73.310000000000002 114.029 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.811 0.815 . . . . 63.109999999999999 111.464 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.585 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 19.8 m-85 -121.09 148.72 43.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.546 -1.206 . . . . 64.219999999999999 108.254 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.87 159.57 26.53 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.72 -0.844 . . . . 74.329999999999998 108.72 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 86.9 t -86.8 138.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.282 -1.377 . . . . 71.299999999999997 107.282 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 46' ' ' LEU . 33.9 m -138.32 160.53 31.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.318 0.508 . . . . 74.310000000000002 111.295 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -168.61 169.15 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.786 -1.097 . . . . 74.209999999999994 110.242 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.8 p30 -154.36 139.74 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.993 -0.373 . . . . 44.450000000000003 109.993 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 t30 44.88 6.16 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.159 1.17 . . . . 73.120000000000005 114.159 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.7 pt-20 -112.27 -32.45 6.52 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.503 -0.748 . . . . 70.25 112.118 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 -22.58 4.57 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.242 -0.436 . . . . 21.199999999999999 112.911 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.16 174.05 5.94 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.388 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -122.29 133.02 54.69 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.592 0.589 . . . . 73.099999999999994 112.592 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.3 m -132.82 -179.19 5.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.371 -0.831 . . . . 73.510000000000005 109.71 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.6 158.33 26.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 63.030000000000001 110.913 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.527 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 56.0 t90 -147.15 137.21 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.84 . . . . 74.310000000000002 109.6 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 ttt -83.09 121.46 27.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 110.284 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.15 165.36 22.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.347 . . . . 70.439999999999998 110.189 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.31 -4.85 29.93 Favored Glycine 0 C--N 1.328 0.125 0 N-CA-C 110.91 -0.876 . . . . 43.5 110.91 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.8 ptp180 -131.56 172.52 12.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.271 0.628 . . . . 65.319999999999993 109.737 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 p -101.67 143.65 31.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.999 -0.371 . . . . 72.319999999999993 109.999 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 30' ' ' VAL . 8.5 mt -88.9 133.17 36.15 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.325 -0.398 . . . . 65.25 111.544 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 46' ' ' LEU . 76.1 Cg_exo -46.12 130.66 13.77 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 123.303 2.668 . . . . 72.340000000000003 112.352 171.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 126.52 15.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 71.430000000000007 110.493 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.88 -25.53 9.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.241 -0.504 . . . . 71.010000000000005 112.06 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 66.2 m95 -83.96 158.53 21.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.809 0.305 . . . . 71.239999999999995 110.784 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -135.21 154.26 51.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.318 -0.401 . . . . 74.230000000000004 110.048 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 53' ' ' VAL . 24.3 p -107.43 153.21 23.13 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 124.737 1.273 . . . . 63.350000000000001 110.244 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -167.51 175.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.676 0 C-N-CA 123.624 0.77 . . . . 74.209999999999994 110.023 -173.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.22 -115.3 4.19 Favored Glycine 0 C--O 1.219 -0.835 0 CA-C-N 115.681 -0.69 . . . . 72.200000000000003 113.111 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 16.4 tp10 -147.32 136.89 11.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.279 1.032 . . . . 72.409999999999997 108.597 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 73.6 Cg_endo -83.51 107.51 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.011 1.141 . . . . 72.400000000000006 110.286 166.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.68 -175.4 5.14 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.391 -0.822 . . . . 55.439999999999998 111.242 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 61' ' ' GLN . 1.1 t -55.83 151.21 11.72 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.286 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HG3' HD23 ' A' ' 63' ' ' LEU . 23.8 tptm -45.93 -41.0 10.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.225 -0.898 . . . . 75.310000000000002 110.269 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -59.86 -42.41 93.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.107 -0.952 . . . . 73.420000000000002 111.417 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' H ' HG23 ' A' ' 58' ' ' THR . 26.2 mm-40 -71.95 -48.06 47.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.884 0.373 . . . . 72.450000000000003 110.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 60.0 m -60.22 -46.6 89.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 63.149999999999999 111.578 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.08 -41.05 82.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.753 -0.379 . . . . 54.210000000000001 110.385 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.592 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.4 tt0 -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.281 0.562 . . . . 74.010000000000005 110.877 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.4 ttm-85 -64.48 -47.42 79.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.965 -0.562 . . . . 74.430000000000007 111.202 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 pt -69.66 -37.66 74.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.64 0.257 . . . . 74.430000000000007 110.977 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.65 -48.99 76.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 71.010000000000005 110.214 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 79.6 mt-30 -73.29 8.73 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.795 0.331 . . . . 75.109999999999999 111.452 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 73.3 mt -103.54 -66.13 0.96 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.975 0.417 . . . . 70.129999999999995 110.618 170.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -85.29 -48.47 9.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.441 0.639 . . . . 45.109999999999999 110.837 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -76.81 -10.74 59.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.202 -0.908 . . . . 55.350000000000001 111.356 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 25.9 t70 . . . . . 0 N--CA 1.477 0.884 0 C-N-CA 124.182 0.993 . . . . 73.310000000000002 113.168 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.237 0.401 0 CA-C-O 121.176 0.512 . . . . 63.109999999999999 110.552 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.22 148.71 50.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 64.219999999999999 110.72 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -117.78 162.59 17.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.943 -1.026 . . . . 74.329999999999998 108.91 171.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -94.06 142.65 13.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.778 -1.193 . . . . 71.299999999999997 107.778 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.03 156.62 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.155 0.502 . . . . 74.310000000000002 111.227 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HD3' ' CE1' ' A' ' 37' ' ' TYR . 29.5 ptt180 -154.25 155.18 34.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.196 -0.911 . . . . 74.209999999999994 109.581 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.7 p30 -156.56 139.35 15.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.983 -0.287 . . . . 44.450000000000003 110.894 168.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 35.43 13.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.652 1.723 . . . . 73.120000000000005 115.652 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.883 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 16.4 pt-20 -112.71 -31.92 6.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.745 0.646 . . . . 70.25 112.745 -170.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.42 89.01 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 21.199999999999999 112.473 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.883 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 77.7 mt-30 -120.77 174.09 6.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.348 0.659 . . . . 74.310000000000002 109.365 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 31' ' ' ARG . 42.4 m-85 -122.54 146.46 47.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.739 1.014 . . . . 73.099999999999994 113.739 -171.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -138.9 -179.31 5.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.216 -1.357 . . . . 73.510000000000005 108.677 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.5 m -122.83 161.6 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.918 0.389 . . . . 63.030000000000001 111.084 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -145.89 156.47 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.32 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.4 ttt -86.07 147.5 26.15 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.828 -0.434 . . . . 73.299999999999997 109.828 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.62 156.88 38.88 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.017 0.437 . . . . 70.439999999999998 111.524 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.35 54.13 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.547 -0.751 . . . . 43.5 112.769 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -112.35 116.1 29.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.876 -0.416 . . . . 65.319999999999993 109.876 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.0 m -66.09 154.69 38.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 112.048 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -111.05 152.88 43.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.075 -0.966 . . . . 65.25 111.151 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 74.1 Cg_endo -80.34 158.13 22.78 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 111.921 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 131.13 26.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 111.237 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.96 -35.27 5.16 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.774 -0.648 . . . . 71.010000000000005 111.658 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 32.2 m95 -79.71 139.02 37.49 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.188 -0.301 . . . . 71.239999999999995 110.188 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.87 153.68 49.55 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.377 -0.374 . . . . 74.230000000000004 110.284 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.2 p -98.11 162.82 13.02 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.19 0.931 . . . . 63.350000000000001 111.459 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.56 150.02 3.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.41 -0.814 . . . . 74.209999999999994 109.978 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 -170.56 37.53 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.557 -0.747 . . . . 72.200000000000003 111.495 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 151.56 40.76 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 108.652 -0.87 . . . . 72.409999999999997 108.652 174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 21.9 Cg_endo -65.54 105.17 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.206 1.271 . . . . 72.400000000000006 110.046 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.17 169.45 17.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.412 -0.813 . . . . 55.439999999999998 110.669 -171.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 61' ' ' GLN . 3.5 t -57.29 151.3 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.654 -0.703 . . . . 72.340000000000003 111.149 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -48.75 -44.91 39.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.751 -0.659 . . . . 75.310000000000002 110.576 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.628 ' NE2' ' H ' ' A' ' 60' ' ' GLN . 2.3 mp0 -56.19 -37.32 69.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.477 -0.783 . . . . 73.420000000000002 111.206 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.422 ' H ' HG23 ' A' ' 58' ' ' THR . 12.2 mm-40 -74.96 -39.72 61.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.909 0.385 . . . . 72.450000000000003 110.436 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 39' ' ' VAL . 5.5 t -65.23 -51.33 61.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.665 . . . . 63.149999999999999 110.56 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.0 -36.99 80.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.865 0.364 . . . . 54.210000000000001 110.384 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.3 tt0 -60.4 -43.15 96.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 110.237 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.67 HH11 ' HG3' ' A' ' 65' ' ' ARG . 18.8 ttm-85 -60.85 -53.18 60.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.63 -0.714 . . . . 74.430000000000007 111.764 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.8 pt -67.26 -37.39 79.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.953 0.406 . . . . 74.430000000000007 111.125 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.81 -33.17 75.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.02 -0.537 . . . . 71.010000000000005 110.527 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.504 ' C ' ' HB3' ' A' ' 72' ' ' ASP . 16.1 mm-40 -78.21 2.33 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.685 0.279 . . . . 75.109999999999999 111.226 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 71.6 mt -103.59 -66.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.099 0.476 . . . . 70.129999999999995 110.968 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -85.33 -55.21 4.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.578 0.704 . . . . 45.109999999999999 110.845 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -10.97 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.864 -1.062 . . . . 55.350000000000001 111.853 -170.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 6.8 p-10 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 113.978 1.103 . . . . 73.310000000000002 113.978 -167.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.233 0.226 0 CA-C-O 121.196 0.522 . . . . 63.109999999999999 110.256 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -129.62 153.0 48.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.367 -0.833 . . . . 64.219999999999999 109.751 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -116.02 167.45 10.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.083 -0.962 . . . . 74.329999999999998 108.896 169.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.3 t -92.47 146.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.131 -1.433 . . . . 71.299999999999997 107.131 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 46' ' ' LEU . 34.5 m -140.32 163.9 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 118.395 0.543 . . . . 74.310000000000002 110.927 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -164.16 159.69 20.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.189 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -171.32 140.21 1.41 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.029 -0.532 . . . . 44.450000000000003 110.619 168.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 50.02 4.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.058 1.133 . . . . 73.120000000000005 114.058 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 9.4 pt-20 -107.71 -29.49 9.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.824 -0.547 . . . . 70.25 112.371 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.97 19.28 67.6 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.644 -0.788 . . . . 21.199999999999999 111.411 -173.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.815 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 87.3 mt-30 -129.52 174.03 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.736 0.814 . . . . 74.310000000000002 108.807 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.5 132.64 56.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.593 0.711 . . . . 73.099999999999994 112.416 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 m -124.95 178.38 5.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.579 -1.191 . . . . 73.510000000000005 108.886 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 62' ' ' CYS . 18.0 m -129.91 160.07 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.855 0.36 . . . . 63.030000000000001 111.337 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -157.67 154.38 28.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.863 -0.792 . . . . 74.310000000000002 108.863 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -80.26 135.12 36.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.976 -0.289 . . . . 73.299999999999997 110.625 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.75 136.23 52.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 70.439999999999998 110.529 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.78 -3.71 74.6 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.188 -0.46 . . . . 43.5 112.132 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -103.26 128.19 50.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.705 -0.48 . . . . 65.319999999999993 109.705 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -64.97 156.69 30.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.025 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 30' ' ' VAL . 19.9 mt -124.34 139.43 32.88 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.471 -0.786 . . . . 65.25 110.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -54.73 141.49 75.81 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.899 2.4 . . . . 72.340000000000003 111.612 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.25 127.65 25.27 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.829 0.347 . . . . 71.430000000000007 110.442 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.75 -34.54 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.538 -0.625 . . . . 71.010000000000005 111.538 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.4 m95 -78.15 142.81 37.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.989 -0.374 . . . . 71.239999999999995 109.989 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.5 152.92 48.5 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 120.774 0.321 . . . . 74.230000000000004 110.318 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 p -100.94 154.31 18.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.103 -0.953 . . . . 63.350000000000001 110.9 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.09 171.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.301 1.04 . . . . 74.209999999999994 109.182 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.95 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.713 -0.756 . . . . 72.200000000000003 112.522 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.67 132.92 10.16 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.122 -1.066 . . . . 72.409999999999997 108.122 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.65 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.9 Cg_endo -62.85 122.38 10.65 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.875 1.716 . . . . 72.400000000000006 112.42 -170.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.79 160.71 10.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.508 -0.769 . . . . 55.439999999999998 109.351 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -55.86 154.99 6.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.65 0.262 . . . . 72.340000000000003 111.104 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 87.4 tttt -49.05 -40.94 33.33 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.946 -0.57 . . . . 75.310000000000002 110.886 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.94 -48.16 70.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.464 -0.789 . . . . 73.420000000000002 110.923 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -74.77 -30.18 61.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 72.450000000000003 110.783 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 39' ' ' VAL . 12.9 t -66.36 -50.94 61.84 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.911 -0.586 . . . . 63.149999999999999 110.667 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.2 pp -63.93 -37.97 89.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.954 0.407 . . . . 54.210000000000001 110.276 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.565 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 26.3 tt0 -58.68 -43.49 89.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.824 -0.626 . . . . 74.010000000000005 110.237 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.7 ttt180 -62.05 -43.58 98.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.166 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.67 -38.29 44.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 111.827 0.306 . . . . 74.430000000000007 111.827 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 34.9 mm-40 -64.12 -41.59 97.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 121.304 -0.158 . . . . 71.010000000000005 111.15 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 64.1 mt-30 -73.9 7.86 2.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.02 0.438 . . . . 75.109999999999999 111.18 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.5 mt -103.63 -65.92 0.98 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.307 -0.406 . . . . 70.129999999999995 110.874 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -85.79 -52.85 5.49 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.682 -0.69 . . . . 45.109999999999999 111.128 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -74.88 -11.69 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.414 -0.812 . . . . 55.350000000000001 111.054 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 4.0 p-10 . . . . . 0 N--CA 1.468 0.451 0 CA-C-N 115.842 -0.617 . . . . 73.310000000000002 112.398 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 57' ' ' ALA . 3.2 mm? . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.696 0.76 . . . . 63.109999999999999 111.867 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.0 m-85 -127.37 148.5 50.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.735 -1.121 . . . . 64.219999999999999 109.1 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.608 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.19 159.8 22.05 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.7 . . . . 74.329999999999998 109.111 174.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 53' ' ' VAL . 46.6 t -91.97 145.85 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 46' ' ' LEU . 26.0 m -138.87 161.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 121.771 -0.581 . . . . 74.310000000000002 111.517 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 24.8 ptt180 -161.81 155.42 21.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.498 -0.773 . . . . 74.209999999999994 110.201 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.606 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.0 p30 -161.33 139.72 9.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.213 -0.292 . . . . 44.450000000000003 110.213 169.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 43.08 3.89 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.692 1.367 . . . . 73.120000000000005 114.692 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.8 pt-20 -112.49 -32.03 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.573 -0.705 . . . . 70.25 111.594 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.21 -22.52 18.9 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.411 -0.423 . . . . 21.199999999999999 113.095 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -86.29 174.11 9.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.97 0.385 . . . . 74.310000000000002 110.383 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -106.26 139.89 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 73.099999999999994 112.442 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 29' ' ' VAL . 23.0 m -134.87 178.24 7.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.379 -0.828 . . . . 73.510000000000005 109.464 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 62' ' ' CYS . 36.0 m -123.1 159.13 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.521 0.201 . . . . 63.030000000000001 110.65 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -158.37 139.02 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.987 -0.746 . . . . 74.310000000000002 108.987 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.5 ttt -67.39 124.37 22.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.262 . . . . 73.299999999999997 110.81 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.82 130.97 44.62 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.297 -0.41 . . . . 70.439999999999998 110.123 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.13 -9.41 33.62 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.291 -0.724 . . . . 43.5 111.291 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -106.38 111.27 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 65.319999999999993 109.278 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 m -66.74 141.63 57.67 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.725 . . . . 72.319999999999993 112.11 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 HD12 HG23 ' A' ' 52' ' ' THR . 45.3 mt -96.3 151.44 38.12 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 114.727 -1.124 . . . . 65.25 111.314 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 69.2 Cg_endo -77.97 152.55 28.35 Favored 'Trans proline' 0 C--O 1.242 0.697 0 C-N-CA 122.549 2.166 . . . . 72.340000000000003 111.774 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.24 19.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.67 -0.695 . . . . 71.430000000000007 111.018 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.78 -35.27 4.37 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.443 -0.799 . . . . 71.010000000000005 111.339 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 22.5 m95 -83.41 142.13 31.22 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.979 -0.378 . . . . 71.239999999999995 109.979 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -129.28 148.24 51.19 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 120.852 0.358 . . . . 74.230000000000004 110.582 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 HD12 ' A' ' 46' ' ' LEU . 19.9 p -99.04 150.75 21.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.659 -1.155 . . . . 63.350000000000001 110.315 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.76 155.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.107 -172.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.73 -160.17 24.21 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.905 -1.043 . . . . 72.200000000000003 112.641 175.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -103.83 133.14 20.42 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 55.5 Cg_endo -70.24 111.14 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.322 1.348 . . . . 72.400000000000006 110.566 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 26' ' ' LEU . . . -147.53 171.98 14.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.799 -0.637 . . . . 55.439999999999998 110.241 -171.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 61' ' ' GLN . 5.9 t -57.14 156.2 7.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.512 -0.313 . . . . 72.340000000000003 111.441 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -49.76 -43.7 48.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.953 0.501 . . . . 75.310000000000002 110.962 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.21 -51.31 62.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.806 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 58' ' ' THR . 85.6 mm-40 -69.28 -30.74 68.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 72.450000000000003 110.687 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 39' ' ' VAL . 4.1 t -63.5 -50.09 70.98 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.076 -0.511 . . . . 63.149999999999999 110.288 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.3 pp -68.06 -46.51 70.91 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.929 -0.397 . . . . 54.210000000000001 109.929 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.4 tt0 -56.87 -31.88 65.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 74.010000000000005 111.162 -175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.1 ttt85 -70.96 -53.54 14.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 111.435 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.9 pt -70.53 -37.75 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.777 0.288 . . . . 74.430000000000007 111.777 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.59 -37.75 77.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 111.095 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -81.33 1.74 31.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 66.6 mt -103.77 -66.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 70.129999999999995 110.844 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -85.18 -53.36 5.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.709 -0.678 . . . . 45.109999999999999 110.911 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.7 m -75.35 -11.13 59.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.46 -0.791 . . . . 55.350000000000001 111.47 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 N--CA 1.47 0.562 0 C-N-CA 123.368 0.667 . . . . 73.310000000000002 112.339 -171.265 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 31.3 mt . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.997 0.903 . . . . 63.109999999999999 111.768 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.65 149.67 41.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.966 -1.47 . . . . 64.219999999999999 109.338 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.603 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 m-85 -107.94 164.08 12.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.782 -0.821 . . . . 74.329999999999998 108.782 168.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HH11 ' A' ' 65' ' ' ARG . 40.1 t -92.3 137.24 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.27 -1.382 . . . . 71.299999999999997 107.27 174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 13.7 m -139.03 164.95 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 118.113 0.415 . . . . 74.310000000000002 111.244 -174.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 39.2 ptt180 -169.19 170.02 8.93 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.571 -0.74 . . . . 74.209999999999994 110.473 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.6 p30 -156.19 139.79 15.97 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.337 -0.246 . . . . 44.450000000000003 110.337 170.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.4 t30 47.42 4.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.885 1.069 . . . . 73.120000000000005 113.885 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.2 pt-20 -112.26 -32.32 6.56 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.806 -0.559 . . . . 70.25 111.924 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 -22.73 4.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.388 -0.434 . . . . 21.199999999999999 112.73 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -73.45 174.06 8.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.872 0.336 . . . . 74.310000000000002 110.315 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -121.85 132.64 54.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.332 0.493 . . . . 73.099999999999994 112.332 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -129.02 176.89 7.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.267 -0.879 . . . . 73.510000000000005 109.393 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.22 149.19 21.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.915 0.388 . . . . 63.030000000000001 110.815 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' ' HB3' ' A' ' 44' ' ' ARG . 70.8 t-105 -149.18 137.87 21.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 74.310000000000002 109.728 -171.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.6 ttt -62.76 125.19 23.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.663 -0.244 . . . . 73.299999999999997 110.896 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.76 144.33 57.13 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.785 -0.45 . . . . 70.439999999999998 109.785 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.7 -34.55 4.94 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 111.144 -0.782 . . . . 43.5 111.144 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HB3' ' NE1' ' A' ' 40' ' ' TRP . 4.8 ttt180 -69.82 95.42 0.9 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.804 -0.813 . . . . 65.319999999999993 108.804 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.1 m -61.3 126.07 26.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 111.929 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.8 mt -85.05 148.15 49.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.935 -1.03 . . . . 65.25 110.944 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 61.6 Cg_endo -79.09 159.62 26.86 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.625 2.216 . . . . 72.340000000000003 112.045 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.84 126.65 23.02 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.006 -0.543 . . . . 71.430000000000007 110.773 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -35.18 4.43 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.578 -0.737 . . . . 71.010000000000005 111.488 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 44.3 m95 -83.51 134.89 34.82 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.988 -0.375 . . . . 71.239999999999995 109.988 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 10.6 pt-20 -119.25 146.95 44.8 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.424 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 46' ' ' LEU . 37.1 p -105.2 156.7 17.86 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.456 1.097 . . . . 63.350000000000001 110.106 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -164.78 157.71 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.336 0.588 . . . . 74.209999999999994 111.265 -173.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 87.04 -174.05 45.35 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 114.872 -1.058 . . . . 72.200000000000003 112.077 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.3 144.49 28.9 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.784 -0.821 . . . . 72.409999999999997 108.784 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.6 Cg_endo -64.4 140.05 68.02 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.971 1.781 . . . . 72.400000000000006 112.36 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' HB3' ' A' ' 26' ' ' LEU . . . -171.65 147.03 2.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.708 -0.678 . . . . 55.439999999999998 109.676 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.442 HG22 HE21 ' A' ' 61' ' ' GLN . 14.7 t -59.77 168.3 1.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.391 0.138 . . . . 72.340000000000003 111.23 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE3' HD23 ' A' ' 63' ' ' LEU . 56.0 tptt -44.37 -51.59 8.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.921 -174.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.05 -47.82 77.18 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.901 0.382 . . . . 73.420000000000002 111.488 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.442 HE21 HG22 ' A' ' 58' ' ' THR . 50.1 mt-30 -74.73 -35.28 62.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 72.450000000000003 111.147 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.75 -45.94 80.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 63.149999999999999 109.971 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 pp -68.05 -44.33 76.65 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.85 -0.426 . . . . 54.210000000000001 109.85 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.587 ' N ' HD12 ' A' ' 63' ' ' LEU . 27.0 tt0 -55.06 -37.98 67.44 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.301 0.572 . . . . 74.010000000000005 109.825 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.573 HH11 HG21 ' A' ' 29' ' ' VAL . 65.9 ttt-85 -57.43 -53.33 59.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.436 -0.802 . . . . 74.430000000000007 111.137 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.4 pt -74.22 -33.9 36.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.449 -0.341 . . . . 74.430000000000007 111.892 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 74.4 mm-40 -64.12 -42.89 96.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.536 -0.302 . . . . 71.010000000000005 110.416 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.6 mm-40 -74.42 4.73 5.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.355 . . . . 75.109999999999999 111.078 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.9 mt -103.14 -64.98 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 70.129999999999995 110.695 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.42 -52.03 6.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 45.109999999999999 111.141 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 m -73.47 -11.26 60.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.549 -0.75 . . . . 55.350000000000001 111.036 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 123.679 0.792 . . . . 73.310000000000002 112.269 -173.271 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.334 0.588 . . . . 63.109999999999999 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -133.93 155.98 48.95 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.116 -0.947 . . . . 64.219999999999999 109.713 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -121.17 159.81 25.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.022 -0.99 . . . . 74.329999999999998 108.693 172.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 HG23 ' A' ' 53' ' ' VAL . 42.3 t -91.47 125.61 44.18 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.098 -1.075 . . . . 71.299999999999997 108.098 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 52' ' ' THR . 16.7 m -133.17 166.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.9 0.381 . . . . 74.310000000000002 111.084 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -165.81 162.23 18.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.497 -0.774 . . . . 74.209999999999994 110.522 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.477 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.1 OUTLIER -151.94 139.78 19.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.647 0.26 . . . . 44.450000000000003 110.353 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 44.47 8.97 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.14 1.163 . . . . 73.120000000000005 114.14 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.41 -32.26 6.55 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.789 -0.569 . . . . 70.25 111.852 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -22.94 3.65 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.958 -0.564 . . . . 21.199999999999999 113.078 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -87.43 173.69 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.456 -0.572 . . . . 74.310000000000002 109.456 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 15.8 m-85 -106.89 138.75 42.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.365 0.876 . . . . 73.099999999999994 113.365 -172.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 m -134.96 -179.01 5.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.402 -1.272 . . . . 73.510000000000005 109.011 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.3 m -124.26 159.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.935 0.397 . . . . 63.030000000000001 111.29 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.465 ' HB2' HG21 ' A' ' 30' ' ' VAL . 68.3 t-105 -142.8 143.38 32.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.252 -0.647 . . . . 74.310000000000002 109.252 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.5 ttt -81.37 127.44 32.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.234 -0.284 . . . . 73.299999999999997 110.234 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.79 157.11 18.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.256 -0.429 . . . . 70.439999999999998 111.26 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.32 10.6 55.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.191 -0.528 . . . . 43.5 112.669 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -151.47 130.0 12.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.903 0.382 . . . . 65.319999999999993 110.147 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -80.67 153.42 27.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.514 0.673 . . . . 72.319999999999993 111.643 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 52' ' ' THR . 52.7 mt -95.26 145.81 30.19 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 114.857 -1.065 . . . . 65.25 111.013 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.31 168.35 14.95 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.642 2.228 . . . . 72.340000000000003 112.551 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.3 129.84 22.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 111.022 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.82 -33.03 6.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.022 -0.536 . . . . 71.010000000000005 111.804 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 45.0 m95 -88.48 141.46 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.786 0.327 . . . . 71.239999999999995 110.762 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.02 154.49 47.36 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 110.304 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.625 HG23 HD12 ' A' ' 46' ' ' LEU . 15.7 p -114.49 160.68 18.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.373 1.046 . . . . 63.350000000000001 111.194 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.452 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -165.72 149.35 2.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 C-N-CA 123.474 0.71 . . . . 74.209999999999994 110.907 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 108.27 -172.65 17.21 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.128 -0.942 . . . . 72.200000000000003 113.305 172.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' OE2' ' HD2' ' A' ' 56' ' ' PRO . 5.8 tp10 -103.27 129.45 25.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 107.983 -1.117 . . . . 72.409999999999997 107.983 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 18.9 Cg_endo -56.74 122.11 11.23 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.738 1.625 . . . . 72.400000000000006 111.32 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.72 157.78 30.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 55.439999999999998 110.431 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 t -55.73 152.93 8.83 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.088 0.243 . . . . 72.340000000000003 110.698 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.78 -42.44 25.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 111.853 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -53.92 -44.09 70.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.098 0.475 . . . . 73.420000000000002 111.036 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 82.6 mm-40 -74.85 -39.11 61.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 72.450000000000003 110.537 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 39' ' ' VAL . 8.9 t -63.42 -43.69 96.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 63.149999999999999 110.561 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.4 pp -68.14 -36.63 80.0 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 109.621 -0.511 . . . . 54.210000000000001 109.621 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.4 tt0 -54.77 -44.61 73.82 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.308 -0.627 . . . . 74.010000000000005 109.308 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -56.34 -52.0 66.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.814 -0.63 . . . . 74.430000000000007 110.952 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.49 -35.97 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.653 -0.249 . . . . 74.430000000000007 111.637 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 26.5 mm-40 -66.42 -32.75 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.603 0.239 . . . . 71.010000000000005 110.624 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.7 mm100 -81.19 -18.91 44.59 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.273 -0.421 . . . . 75.109999999999999 111.396 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.89 -66.65 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.327 0.584 . . . . 70.129999999999995 112.187 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 65.5 t-105 -85.3 -46.1 11.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 45.109999999999999 110.66 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -82.71 -10.06 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.098 -0.955 . . . . 55.350000000000001 110.993 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 114.656 1.354 . . . . 73.310000000000002 114.656 -170.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.62 0.724 . . . . 63.109999999999999 111.419 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 22.7 m-85 -129.92 148.55 51.8 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.574 -1.194 . . . . 64.219999999999999 108.843 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.581 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.58 166.41 11.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 74.329999999999998 108.742 171.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.6 t -94.56 111.72 25.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 107.1 -1.444 . . . . 71.299999999999997 107.1 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 40' ' ' TRP . 11.5 m -125.87 167.0 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.985 -0.447 . . . . 74.310000000000002 111.534 -170.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -166.19 169.68 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 74.209999999999994 110.997 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -156.15 139.75 15.97 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.538 -0.301 . . . . 44.450000000000003 110.757 172.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.3 t30 40.53 10.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.898 1.279 . . . . 73.120000000000005 114.216 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.0 pt-20 -112.61 -32.29 6.5 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.691 -0.631 . . . . 70.25 112.124 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 -22.96 2.19 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.165 -0.541 . . . . 21.199999999999999 112.633 -173.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -75.81 173.89 10.57 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.624 -0.51 . . . . 74.310000000000002 109.624 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -115.71 142.29 46.94 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.912 0.708 . . . . 73.099999999999994 112.912 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.0 m -137.59 -179.46 5.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.417 -1.265 . . . . 73.510000000000005 109.65 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.02 148.99 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.769 0.319 . . . . 63.030000000000001 110.983 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.488 ' HB2' HG21 ' A' ' 30' ' ' VAL . 70.3 t90 -144.44 129.88 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 110.958 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.6 ttm -69.93 143.58 52.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 73.299999999999997 110.477 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.09 -172.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 110.655 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.55 -34.41 4.2 Favored Glycine 0 CA--C 1.515 0.071 0 C-N-CA 121.175 -0.535 . . . . 43.5 112.831 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 mpt_? -95.97 -170.89 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.061 0.458 . . . . 65.319999999999993 110.384 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 p -135.3 117.26 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.991 -0.744 . . . . 72.319999999999993 108.991 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 HG23 ' A' ' 52' ' ' THR . 17.6 mt -57.7 132.21 82.53 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.101 -0.5 . . . . 65.25 111.566 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.4 158.61 9.61 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.707 2.938 . . . . 72.340000000000003 112.794 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 123.37 17.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.92 -0.582 . . . . 71.430000000000007 110.07 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.79 -29.13 7.35 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.067 -0.813 . . . . 71.010000000000005 111.067 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 59.0 m95 -84.99 151.45 24.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.779 -0.452 . . . . 71.239999999999995 109.779 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.69 145.94 45.31 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 116.363 -0.381 . . . . 74.230000000000004 110.161 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.608 HG23 HD12 ' A' ' 46' ' ' LEU . 38.7 p -104.5 144.59 31.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.783 -1.099 . . . . 63.350000000000001 110.152 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.73 168.44 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.429 0.633 . . . . 74.209999999999994 110.466 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 -148.64 22.29 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.284 -0.871 . . . . 72.200000000000003 111.955 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 28.5 tt0 -132.65 132.93 22.92 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.618 -0.882 . . . . 72.409999999999997 108.618 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.581 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -70.48 125.66 12.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.882 1.721 . . . . 72.400000000000006 111.621 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.0 175.58 13.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.195 -0.457 . . . . 55.439999999999998 110.684 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 t -62.99 151.36 39.92 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.145 -0.317 . . . . 72.340000000000003 110.145 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -44.55 -43.26 7.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 75.310000000000002 111.373 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.56 -42.62 92.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 73.420000000000002 111.269 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.03 -36.61 61.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 72.450000000000003 111.132 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 62.5 m -64.92 -44.85 88.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 63.149999999999999 111.175 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.07 -41.85 81.34 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.76 -0.459 . . . . 54.210000000000001 109.76 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.585 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.1 tt0 -59.37 -37.37 77.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.465 0.65 . . . . 74.010000000000005 110.436 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 11.4 ttt180 -64.38 -47.0 80.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.474 -0.785 . . . . 74.430000000000007 111.153 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.0 pt -74.4 -34.85 37.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.718 0.294 . . . . 74.430000000000007 111.63 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.94 -48.55 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 71.010000000000005 110.961 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 22.1 mm-40 -70.43 8.46 0.81 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.073 0.464 . . . . 75.109999999999999 111.651 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 92.5 mt -103.42 -66.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.341 0.591 . . . . 70.129999999999995 110.203 172.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -83.49 -54.69 4.77 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.401 -0.818 . . . . 45.109999999999999 110.668 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -72.18 -11.16 60.61 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.426 -0.806 . . . . 55.350000000000001 110.712 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 13.0 t70 . . . . . 0 N--CA 1.469 0.502 0 CA-C-N 115.599 -0.728 . . . . 73.310000000000002 111.931 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 56' ' ' PRO . 8.2 mp . . . . . 0 C--O 1.238 0.457 0 CA-C-O 121.505 0.669 . . . . 63.109999999999999 111.129 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.631 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 13.0 m-85 -133.1 157.49 45.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.766 -1.106 . . . . 64.219999999999999 109.26 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.614 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.4 m-85 -113.79 167.67 10.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.634 -0.712 . . . . 74.329999999999998 109.224 170.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.55 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.905 -1.146 . . . . 71.299999999999997 107.905 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.483 HG12 HG22 ' A' ' 52' ' ' THR . 21.6 m -137.95 162.13 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 118.171 0.441 . . . . 74.310000000000002 111.349 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.49 168.17 9.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.569 -0.741 . . . . 74.209999999999994 110.798 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.1 p-10 -163.58 139.97 6.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 44.450000000000003 110.346 166.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 t30 46.5 4.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.085 1.143 . . . . 73.120000000000005 114.085 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.6 pt-20 -105.71 -25.42 12.23 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.418 -0.801 . . . . 70.25 112.312 -167.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 -22.3 9.6 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.481 -0.39 . . . . 21.199999999999999 113.171 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -100.1 173.97 6.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.903 -0.406 . . . . 74.310000000000002 109.903 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -106.43 153.72 21.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.436 . . . . 73.099999999999994 111.774 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -145.3 -178.72 6.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 73.510000000000005 109.217 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.12 158.14 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.929 0.395 . . . . 63.030000000000001 111.058 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 59.9 t90 -150.29 142.89 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 109.738 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.53 131.64 35.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 73.299999999999997 111.615 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.49 151.62 43.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.656 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.34 -12.75 43.85 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.171 -0.538 . . . . 43.5 112.883 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 74.8 mtt180 -104.87 -167.23 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.427 -0.582 . . . . 65.319999999999993 109.427 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.6 m -138.11 131.16 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 72.319999999999993 110.117 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HG11 ' A' ' 30' ' ' VAL . 17.6 mt -80.71 135.19 52.76 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 65.25 112.13 -174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.09 138.99 21.45 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.449 2.766 . . . . 72.340000000000003 112.626 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 130.16 31.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.952 -0.567 . . . . 71.430000000000007 110.103 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.86 -35.4 4.31 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.042 -0.823 . . . . 71.010000000000005 111.042 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.0 m95 -76.35 149.49 36.99 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.914 -0.402 . . . . 71.239999999999995 109.914 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.16 152.11 50.78 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 110.049 -0.352 . . . . 74.230000000000004 110.049 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 30' ' ' VAL . 21.5 p -109.44 161.51 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.103 . . . . 63.350000000000001 110.483 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.99 162.61 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.278 0.631 . . . . 74.209999999999994 109.931 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.48 -173.28 47.69 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.805 -0.634 . . . . 72.200000000000003 112.336 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.29 144.22 29.31 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.207 -1.034 . . . . 72.409999999999997 108.207 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.614 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 44.9 Cg_endo -65.67 115.48 3.41 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.652 1.568 . . . . 72.400000000000006 110.814 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -140.48 168.94 18.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.099 -0.5 . . . . 55.439999999999998 110.088 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 61' ' ' GLN . 8.8 t -59.73 151.86 24.15 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.681 -0.408 . . . . 72.340000000000003 110.496 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -46.76 -40.82 14.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.02 -0.536 . . . . 75.310000000000002 111.424 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.59 -43.32 99.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 73.420000000000002 110.893 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 93.7 mt-30 -72.85 -33.15 65.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.034 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 77.0 m -68.58 -45.95 70.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.475 -0.33 . . . . 63.149999999999999 110.83 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.11 -36.49 79.83 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.006 -0.368 . . . . 54.210000000000001 110.006 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 35.9 tt0 -66.53 -31.48 72.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.656 0.741 . . . . 74.010000000000005 110.118 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 13.0 ttt85 -65.57 -49.71 67.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 74.430000000000007 110.27 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.1 pt -70.28 -42.0 78.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 111.866 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 11.5 pt-20 -60.91 -49.43 77.48 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.251 -0.18 . . . . 71.010000000000005 110.653 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 83.2 mt-30 -74.85 1.94 11.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.887 0.329 . . . . 75.109999999999999 111.887 -174.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 mt -103.93 -66.03 0.98 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.276 0.56 . . . . 70.129999999999995 111.227 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -86.01 -53.94 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.245 -0.889 . . . . 45.109999999999999 111.198 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.03 -10.73 52.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.9 -1.046 . . . . 55.350000000000001 111.791 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 2.4 p-10 . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 113.991 1.108 . . . . 73.310000000000002 113.991 -168.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.9 mp . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.376 0.608 . . . . 63.109999999999999 110.248 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -124.92 148.66 48.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.037 -0.983 . . . . 64.219999999999999 109.238 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -119.34 159.8 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.694 -0.854 . . . . 74.329999999999998 108.694 174.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG21 HH11 ' A' ' 65' ' ' ARG . 30.3 t -89.4 139.91 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.534 -1.284 . . . . 71.299999999999997 107.534 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 29.6 m -139.58 164.9 23.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 121.981 -0.449 . . . . 74.310000000000002 111.367 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.655 HH21 ' HA2' ' A' ' 35' ' ' GLY . 9.4 ptm180 -158.16 161.78 37.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.881 -0.6 . . . . 74.209999999999994 111.118 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.573 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -166.26 140.02 4.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 44.450000000000003 110.389 166.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 46.1 5.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.845 1.424 . . . . 73.120000000000005 114.845 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.2 pt-20 -112.23 -32.02 6.67 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.934 -0.479 . . . . 70.25 112.283 -170.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.655 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 81.82 -22.72 5.54 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.66 -0.781 . . . . 21.199999999999999 112.291 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -93.81 174.02 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.84 -0.43 . . . . 74.310000000000002 109.84 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -107.61 152.24 24.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.997 0.739 . . . . 73.099999999999994 112.997 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -137.75 -179.22 5.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.563 -1.199 . . . . 73.510000000000005 108.989 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 62' ' ' CYS . 30.5 m -126.08 152.5 33.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.053 0.454 . . . . 63.030000000000001 110.778 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.504 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 50.2 t90 -144.04 144.54 31.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.575 . . . . 74.310000000000002 110.458 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -90.62 135.47 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.811 -0.632 . . . . 73.299999999999997 110.724 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.39 175.27 6.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 110.154 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.48 61.82 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.798 -0.921 . . . . 43.5 110.798 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.2 ptm180 -140.89 176.86 8.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.952 -0.624 . . . . 65.319999999999993 109.366 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -126.69 126.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.42 . . . . 72.319999999999993 109.915 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 52' ' ' THR . 12.1 mt -56.22 135.04 75.21 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.454 -0.794 . . . . 65.25 112.144 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.71 155.48 70.27 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.018 2.479 . . . . 72.340000000000003 112.383 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 124.9 11.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 110.768 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.44 -30.16 6.87 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.986 -0.552 . . . . 71.010000000000005 112.208 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.53 ' HB3' HD13 ' A' ' 46' ' ' LEU . 30.6 m95 -93.3 148.44 22.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.768 0.284 . . . . 71.239999999999995 110.472 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -135.23 153.07 52.05 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.855 0.36 . . . . 74.230000000000004 111.581 173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.602 HG23 HD12 ' A' ' 46' ' ' LEU . 22.4 p -99.09 160.02 14.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.675 -1.148 . . . . 63.350000000000001 111.512 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -169.84 164.76 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.548 1.139 . . . . 74.209999999999994 109.661 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.16 -159.78 20.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.004 -0.617 . . . . 72.200000000000003 113.272 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -113.02 128.58 25.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.661 -0.866 . . . . 72.409999999999997 108.661 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 26' ' ' LEU . 51.1 Cg_endo -68.31 112.22 2.72 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.742 1.628 . . . . 72.400000000000006 111.42 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.32 166.16 33.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 55.439999999999998 109.91 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 t -63.98 168.38 5.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.154 0.502 . . . . 72.340000000000003 111.236 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.2 tptp -48.83 -50.38 34.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.366 -0.834 . . . . 75.310000000000002 111.916 -173.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.49 -41.56 66.37 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.456 0.473 . . . . 73.420000000000002 111.336 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -72.94 -43.98 61.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.303 0.573 . . . . 72.450000000000003 110.532 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 39' ' ' VAL . 3.8 t -60.49 -46.57 89.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.236 -0.893 . . . . 63.149999999999999 110.858 -173.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.9 pp -67.92 -40.69 83.34 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.883 -0.327 . . . . 54.210000000000001 110.983 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.627 ' N ' HD12 ' A' ' 63' ' ' LEU . 30.0 tt0 -60.96 -35.77 77.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.168 0.509 . . . . 74.010000000000005 110.524 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.483 HH11 HG21 ' A' ' 29' ' ' VAL . 63.4 ttt-85 -62.3 -53.66 51.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.924 -0.58 . . . . 74.430000000000007 110.855 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.8 pt -69.68 -34.55 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.568 -0.287 . . . . 74.430000000000007 111.365 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.2 -55.23 19.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 71.010000000000005 110.939 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 68.6 mt-30 -70.96 1.3 5.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 75.109999999999999 111.705 -174.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.6 mt -103.47 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 70.129999999999995 111.024 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -85.27 -46.83 10.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.694 -0.684 . . . . 45.109999999999999 110.509 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -80.46 -10.66 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.183 -0.917 . . . . 55.350000000000001 111.092 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 113.067 0.765 . . . . 73.310000000000002 113.067 -170.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp . . . . . 0 C--O 1.235 0.291 0 CA-C-O 121.454 0.645 . . . . 63.109999999999999 111.152 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 18.7 m-85 -131.14 148.68 52.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.082 -0.963 . . . . 64.219999999999999 109.537 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.05 162.43 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.155 -0.683 . . . . 74.329999999999998 109.155 176.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG21 HH11 ' A' ' 65' ' ' ARG . 71.1 t -95.4 137.76 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.35 -1.352 . . . . 71.299999999999997 107.35 172.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 HD11 ' A' ' 46' ' ' LEU . 33.4 m -134.57 164.71 33.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.109 0.481 . . . . 74.310000000000002 111.71 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.632 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 15.9 ptm180 -167.81 170.13 11.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.914 -1.039 . . . . 74.209999999999994 110.149 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.704 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -167.39 139.99 3.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.73 -0.213 . . . . 44.450000000000003 111.007 166.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 37.2 16.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.686 1.365 . . . . 73.120000000000005 114.686 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.806 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.8 pt-20 -112.31 -29.16 7.64 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.763 -0.585 . . . . 70.25 112.479 -172.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' NH2' ' A' ' 31' ' ' ARG . . . 74.62 7.69 79.97 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.599 -0.81 . . . . 21.199999999999999 111.666 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.806 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 6.7 tp60 -116.21 167.88 10.61 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.599 -0.889 . . . . 74.310000000000002 108.599 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -112.96 153.56 27.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.546 0.573 . . . . 73.099999999999994 112.546 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.407 ' O ' HG13 ' A' ' 29' ' ' VAL . 66.2 m -147.61 -179.33 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.999 -1.0 . . . . 73.510000000000005 109.478 172.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -123.54 163.48 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 63.030000000000001 110.604 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -151.01 149.81 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 74.310000000000002 109.934 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.5 ttt -86.15 126.89 34.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 73.299999999999997 110.242 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.56 142.86 57.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.896 0.379 . . . . 70.439999999999998 110.949 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.66 -15.86 29.05 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.675 -0.693 . . . . 43.5 111.965 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.392 -0.225 . . . . 65.319999999999993 110.392 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -84.25 119.42 25.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.195 0.521 . . . . 72.319999999999993 110.485 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 52' ' ' THR . 33.9 mt -68.55 143.82 95.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 65.25 111.744 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 47.3 Cg_endo -75.29 154.21 40.99 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.451 2.1 . . . . 72.340000000000003 112.266 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.61 125.96 7.74 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.333 -0.848 . . . . 71.430000000000007 111.489 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.74 -35.0 4.83 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.972 -0.558 . . . . 71.010000000000005 112.177 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.704 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 16.8 m95 -77.19 157.27 30.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.629 0.252 . . . . 71.239999999999995 110.437 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 8.0 pt-20 -144.91 146.95 32.23 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.276 -0.42 . . . . 74.230000000000004 110.776 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 HD12 ' A' ' 46' ' ' LEU . 25.1 p -98.86 163.37 12.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.649 -0.705 . . . . 63.350000000000001 111.442 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -166.26 152.71 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 123.663 0.785 . . . . 74.209999999999994 110.306 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 100.88 -175.25 26.2 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.33 -0.85 . . . . 72.200000000000003 113.472 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -103.03 116.14 62.93 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.784 -1.191 . . . . 72.409999999999997 107.784 172.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 32.1 Cg_endo -60.18 124.85 16.07 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.961 1.774 . . . . 72.400000000000006 111.926 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.91 173.45 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.503 . . . . 55.439999999999998 109.86 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -55.63 153.71 7.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.402 0.144 . . . . 72.340000000000003 111.144 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HE3' HG21 ' A' ' 39' ' ' VAL . 23.7 tptm -44.05 -43.2 6.63 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.992 0.517 . . . . 75.310000000000002 111.054 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.99 -47.64 68.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.454 -0.794 . . . . 73.420000000000002 111.259 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.87 -32.07 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 72.450000000000003 110.51 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.5 t -64.08 -48.75 74.97 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.808 -0.633 . . . . 63.149999999999999 110.58 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -67.69 -34.83 77.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.882 0.372 . . . . 54.210000000000001 110.12 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.2 tt0 -58.86 -43.98 90.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.54 -0.755 . . . . 74.010000000000005 110.334 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 62.3 ttt-85 -56.94 -53.47 57.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.123 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.1 pt -71.04 -32.9 49.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.269 -0.423 . . . . 74.430000000000007 111.535 -174.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.65 -44.69 85.58 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.132 -0.322 . . . . 71.010000000000005 110.132 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.84 -1.9 6.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.052 0.39 . . . . 75.109999999999999 112.052 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.7 mt -103.59 -66.45 0.95 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.383 0.611 . . . . 70.129999999999995 111.222 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -85.61 -52.4 5.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 45.109999999999999 110.201 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -76.27 -11.05 59.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.757 -1.11 . . . . 55.350000000000001 111.57 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 122.967 0.507 . . . . 73.310000000000002 111.732 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.4 mp . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.226 0.536 . . . . 63.109999999999999 111.244 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 6.8 m-85 -127.83 162.12 27.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.309 -0.86 . . . . 64.219999999999999 110.637 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 m-85 -126.85 167.78 15.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 109.42 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.41 135.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 71.299999999999997 107.289 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 52' ' ' THR . 33.4 m -139.94 169.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.867 0.303 . . . . 74.310000000000002 111.127 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -167.84 170.02 11.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.143 -0.481 . . . . 74.209999999999994 111.305 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -161.65 140.03 9.39 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.113 -0.494 . . . . 44.450000000000003 110.862 171.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 46.07 8.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.055 1.131 . . . . 73.120000000000005 114.055 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.7 pt-20 -112.33 -32.09 6.62 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.786 -0.571 . . . . 70.25 112.073 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 -22.64 6.52 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 112.065 -0.414 . . . . 21.199999999999999 112.065 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -81.85 173.85 11.86 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.826 0.45 . . . . 74.310000000000002 109.961 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.587 ' HD2' ' HE1' ' A' ' 70' ' ' TRP . 14.7 m-85 -118.27 141.96 47.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 73.099999999999994 111.938 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -132.74 -179.35 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.79 -1.096 . . . . 73.510000000000005 109.246 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.35 160.35 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.704 0.287 . . . . 63.030000000000001 110.578 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 63.0 t-105 -148.13 151.25 35.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 74.310000000000002 109.9 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -91.37 129.28 37.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.289 -0.263 . . . . 73.299999999999997 110.289 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.38 150.87 25.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 70.439999999999998 110.609 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.26 16.47 Favored Glycine 0 N--CA 1.453 -0.177 0 N-CA-C 111.539 -0.624 . . . . 43.5 111.539 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 53.4 mtt-85 -88.19 110.11 20.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 110.416 -0.216 . . . . 65.319999999999993 110.416 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -71.33 130.01 40.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.067 0.461 . . . . 72.319999999999993 109.961 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD12 HG23 ' A' ' 52' ' ' THR . 40.4 mt -76.05 142.82 72.91 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.337 -0.847 . . . . 65.25 111.396 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 67.3 Cg_endo -75.82 156.25 39.35 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.579 2.186 . . . . 72.340000000000003 111.711 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.59 122.41 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.698 -0.683 . . . . 71.430000000000007 111.49 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.9 -32.21 5.75 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.061 -0.518 . . . . 71.010000000000005 112.434 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.502 ' HB3' HD13 ' A' ' 46' ' ' LEU . 31.2 m95 -80.19 146.25 31.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.851 0.325 . . . . 71.239999999999995 110.697 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.58 155.71 49.15 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.524 -0.307 . . . . 74.230000000000004 110.729 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 HD12 ' A' ' 46' ' ' LEU . 17.4 p -112.57 162.18 15.95 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.543 1.152 . . . . 63.350000000000001 111.483 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG21 ' CE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -166.02 145.02 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.054 0.542 . . . . 74.209999999999994 111.009 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.13 -165.61 18.59 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.559 -0.746 . . . . 72.200000000000003 112.248 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -104.73 145.02 29.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.148 -0.686 . . . . 72.409999999999997 109.148 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.5 Cg_endo -67.3 105.31 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.051 1.167 . . . . 72.400000000000006 110.136 173.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.61 165.19 31.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.095 -0.957 . . . . 55.439999999999998 110.977 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -62.02 166.95 4.2 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.394 0.616 . . . . 72.340000000000003 112.487 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.651 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 58.9 tptt -46.34 -50.02 16.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.966 -1.016 . . . . 75.310000000000002 111.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.76 -39.24 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.951 -0.568 . . . . 73.420000000000002 111.303 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -73.7 -44.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.166 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 27.4 p -64.12 -45.15 89.85 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.002 -0.279 . . . . 63.149999999999999 111.25 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -68.15 -41.21 81.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 54.210000000000001 110.454 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.626 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.6 tt0 -63.2 -36.46 83.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 74.010000000000005 110.376 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.541 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 ttt180 -58.7 -53.73 55.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.878 0.37 . . . . 74.430000000000007 110.905 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.9 pt -72.78 -32.66 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 74.430000000000007 111.213 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -61.23 -44.62 96.97 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.193 -0.299 . . . . 71.010000000000005 110.193 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.8 mm-40 -73.09 0.93 10.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.93 0.395 . . . . 75.109999999999999 111.132 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 80.1 mt -103.62 -66.13 0.97 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 70.129999999999995 111.258 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.587 ' HE1' ' HD2' ' A' ' 37' ' ' TYR . 73.0 m95 -85.68 -45.69 11.44 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.979 -0.555 . . . . 45.109999999999999 111.027 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 m -81.71 -11.19 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.834 . . . . 55.350000000000001 110.901 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 115.993 -0.548 . . . . 73.310000000000002 111.565 -172.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.918 0.866 . . . . 63.109999999999999 111.358 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.37 161.54 33.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.914 -1.494 . . . . 64.219999999999999 108.738 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -130.0 160.08 34.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.08 -0.964 . . . . 74.329999999999998 108.621 172.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' VAL . 55.8 t -90.32 120.89 39.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 107.564 -1.272 . . . . 71.299999999999997 107.564 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.76 160.51 32.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.192 0.52 . . . . 74.310000000000002 111.973 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 36' ' ' GLN . 17.2 ptt85 -169.53 170.16 8.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.777 -1.101 . . . . 74.209999999999994 110.216 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.608 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -145.03 139.49 27.48 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.516 -0.473 . . . . 44.450000000000003 110.505 169.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.0 t30 30.95 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.208 1.559 . . . . 73.120000000000005 115.208 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.0 pt-20 -112.49 -32.06 6.6 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.471 -0.768 . . . . 70.25 112.536 -172.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.94 -22.48 8.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.156 -0.545 . . . . 21.199999999999999 112.641 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.44 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 33.8 tt0 -80.01 158.65 26.48 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.952 -0.758 . . . . 74.310000000000002 108.952 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.05 140.61 46.58 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.771 0.656 . . . . 73.099999999999994 112.771 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m -134.1 -179.23 5.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.031 -0.986 . . . . 73.510000000000005 109.351 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.64 158.34 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.621 0.248 . . . . 63.030000000000001 110.694 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CE2' ' HG ' ' A' ' 46' ' ' LEU . 75.0 t90 -155.14 145.41 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.212 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.1 ttt -81.49 125.53 30.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.746 0.308 . . . . 73.299999999999997 111.279 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.06 142.12 47.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.027 -0.533 . . . . 70.439999999999998 110.494 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.47 -5.52 29.81 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 111.582 -0.607 . . . . 43.5 111.582 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -108.12 166.29 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.147 0.579 . . . . 65.319999999999993 109.45 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -97.19 115.07 26.91 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.116 -0.365 . . . . 72.319999999999993 110.565 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 mt -69.68 138.76 88.4 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 65.25 110.745 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 19.2 Cg_endo -65.61 137.1 48.84 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 122.244 1.963 . . . . 72.340000000000003 111.75 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.11 124.9 4.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.47 -0.786 . . . . 71.430000000000007 111.509 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -34.12 4.92 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.773 -0.649 . . . . 71.010000000000005 111.772 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.1 m95 -77.6 139.81 39.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.716 0.293 . . . . 71.239999999999995 110.723 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 13.0 pt-20 -126.7 156.22 41.44 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.59 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.2 p -104.39 153.19 21.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.555 -1.202 . . . . 63.350000000000001 111.085 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.37 161.73 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 123.419 0.688 . . . . 74.209999999999994 109.985 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 -159.4 24.51 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.399 -0.819 . . . . 72.200000000000003 111.96 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -109.9 137.48 20.48 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 109.269 -0.641 . . . . 72.409999999999997 109.269 176.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.645 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 57.0 Cg_endo -68.79 116.48 4.47 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.406 1.404 . . . . 72.400000000000006 110.431 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -162.47 169.39 20.46 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.15 -0.477 . . . . 55.439999999999998 110.251 -169.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 61' ' ' GLN . 43.3 p -55.74 151.9 10.42 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.916 0.135 . . . . 72.340000000000003 111.035 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.13 -41.66 3.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.287 0.565 . . . . 75.310000000000002 110.147 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -56.66 -52.32 65.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.664 -1.153 . . . . 73.420000000000002 111.492 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.504 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 10.3 mm-40 -71.32 -41.8 69.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 72.450000000000003 110.754 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 57' ' ' ALA . 72.8 m -60.59 -45.95 92.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.395 -0.366 . . . . 63.149999999999999 111.167 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.09 -36.41 79.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.42 -0.585 . . . . 54.210000000000001 109.42 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -58.18 -31.58 67.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.428 -0.806 . . . . 74.010000000000005 110.318 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 34.1 ttt180 -65.83 -53.26 42.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.898 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 pt -73.35 -32.35 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 74.430000000000007 112.46 -171.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 12.4 pt-20 -58.47 -32.69 69.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.042 0.448 . . . . 71.010000000000005 109.925 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 79.3 mm-40 -87.7 -9.38 54.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 111.379 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -103.74 -65.69 1.0 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.708 0.766 . . . . 70.129999999999995 111.619 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -85.39 -43.21 13.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.07 -0.968 . . . . 45.109999999999999 110.78 -175.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.13 -10.83 51.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.82 -0.627 . . . . 55.350000000000001 112.268 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 4.9 p-10 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 115.321 1.6 . . . . 73.310000000000002 115.321 -163.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.6 mp . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.883 0.373 . . . . 63.109999999999999 110.289 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.06 158.15 39.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.505 0.722 . . . . 64.219999999999999 110.367 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.638 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 22.0 m-85 -113.03 169.54 8.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 74.329999999999998 109.118 166.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 HG21 ' A' ' 66' ' ' ILE . 56.5 t -95.01 125.22 47.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.825 -1.176 . . . . 71.299999999999997 107.825 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 HD11 ' A' ' 46' ' ' LEU . 27.4 m -125.95 160.86 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.258 0.551 . . . . 74.310000000000002 111.95 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 11.8 ptt180 -169.16 170.13 8.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.62 -1.173 . . . . 74.209999999999994 110.083 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -145.83 139.59 26.48 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 44.450000000000003 110.834 164.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 33.06 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.745 1.757 . . . . 73.120000000000005 115.745 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.9 pt-20 -112.59 -29.36 7.49 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.583 0.628 . . . . 70.25 111.917 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 -10.52 48.81 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.152 -0.547 . . . . 21.199999999999999 112.634 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.564 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 69.3 mt-30 -84.78 173.03 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.039 -0.726 . . . . 74.310000000000002 109.039 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.31 132.66 48.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.957 0.725 . . . . 73.099999999999994 112.957 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -131.69 -178.9 5.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.791 -1.095 . . . . 73.510000000000005 108.475 172.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' SG ' ' A' ' 62' ' ' CYS . 23.7 m -124.17 149.53 28.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.204 0.526 . . . . 63.030000000000001 111.322 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HB2' HG21 ' A' ' 30' ' ' VAL . 55.8 t-105 -148.83 143.4 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.755 . . . . 74.310000000000002 109.28 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -74.85 141.37 44.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.893 0.377 . . . . 73.299999999999997 111.311 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.55 147.04 44.31 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.374 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.79 4.83 67.05 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.392 -0.433 . . . . 43.5 112.304 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -121.81 112.35 18.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.88 -0.415 . . . . 65.319999999999993 109.88 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.9 m -57.98 123.0 14.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.583 -0.735 . . . . 72.319999999999993 111.469 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 15.9 mt -79.99 139.76 53.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.308 -0.86 . . . . 65.25 110.836 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.33 140.06 53.45 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.691 2.261 . . . . 72.340000000000003 111.632 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.82 126.19 15.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.96 -0.564 . . . . 71.430000000000007 110.384 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -29.54 7.06 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.11 -0.495 . . . . 71.010000000000005 112.295 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.618 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.6 m95 -75.5 155.05 36.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.028 0.414 . . . . 71.239999999999995 110.607 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.8 pt-20 -135.67 148.97 49.13 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 110.043 -0.355 . . . . 74.230000000000004 110.043 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.409 HG22 HG12 ' A' ' 30' ' ' VAL . 19.6 p -109.19 153.01 24.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.431 -0.804 . . . . 63.350000000000001 110.983 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.2 t -149.98 152.9 11.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 122.842 0.457 . . . . 74.209999999999994 110.476 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.73 -170.12 37.9 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.797 -0.638 . . . . 72.200000000000003 113.198 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -108.43 143.71 28.03 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 109.102 -0.703 . . . . 72.409999999999997 109.102 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.638 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 36.8 Cg_endo -63.1 122.14 10.26 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.161 1.907 . . . . 72.400000000000006 112.678 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 157.35 42.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.453 -0.794 . . . . 55.439999999999998 109.604 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 t -56.32 156.7 5.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.61 0.243 . . . . 72.340000000000003 111.085 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -43.26 -50.18 6.56 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.663 -0.699 . . . . 75.310000000000002 111.635 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.39 -49.46 76.14 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.412 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -70.16 -35.1 73.77 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.093 0.473 . . . . 72.450000000000003 110.461 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.484 ' SG ' HG12 ' A' ' 39' ' ' VAL . 18.2 t -62.09 -51.71 66.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 63.149999999999999 110.048 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.36 -33.43 74.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.016 -0.273 . . . . 54.210000000000001 110.347 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 8.6 tt0 -62.45 -31.93 72.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.531 0.681 . . . . 74.010000000000005 110.635 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 35.9 ttm180 -62.35 -53.1 59.92 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.035 -0.529 . . . . 74.430000000000007 112.091 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.608 HG21 HG11 ' A' ' 29' ' ' VAL . 17.8 pt -72.96 -35.11 47.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.737 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 4.2 pt-20 -57.78 -46.21 84.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.606 -0.438 . . . . 71.010000000000005 109.839 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.621 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 86.0 mt-30 -74.15 -0.41 16.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.388 -0.369 . . . . 75.109999999999999 111.633 -173.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.8 mt -103.37 -68.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.552 -0.459 . . . . 70.129999999999995 112.139 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -87.34 -55.08 3.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.621 -0.718 . . . . 45.109999999999999 111.976 -176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 67' ' ' GLU . 2.9 p -81.81 -10.89 59.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.708 -1.133 . . . . 55.350000000000001 111.752 -171.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.1 t70 . . . . . 0 N--CA 1.469 0.525 0 C-N-CA 123.948 0.899 . . . . 73.310000000000002 113.043 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.0 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.111 0.482 . . . . 63.109999999999999 110.97 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 33.8 m-85 -123.66 149.06 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.49 -0.777 . . . . 64.219999999999999 109.741 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -114.86 155.97 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 74.329999999999998 108.921 169.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.72 114.83 24.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 N-CA-C 107.86 -1.163 . . . . 71.299999999999997 107.86 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 40' ' ' TRP . 12.7 m -125.14 159.62 31.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 122.164 -0.335 . . . . 74.310000000000002 110.561 -170.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -162.0 162.11 28.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.351 -0.84 . . . . 74.209999999999994 110.722 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 p30 -152.05 139.69 19.75 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.269 -0.271 . . . . 44.450000000000003 110.269 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t30 46.63 4.63 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.993 1.109 . . . . 73.120000000000005 113.993 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.19 -32.43 6.54 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.656 -0.653 . . . . 70.25 112.095 -169.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.51 -22.68 3.16 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.352 -0.452 . . . . 21.199999999999999 112.617 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -75.51 173.96 10.29 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.727 -0.471 . . . . 74.310000000000002 109.727 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.49 136.01 53.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 73.099999999999994 112.172 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -135.86 -178.74 5.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.066 -0.97 . . . . 73.510000000000005 109.456 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG11 ' SG ' ' A' ' 62' ' ' CYS . 27.7 m -128.72 150.02 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.68 0.276 . . . . 63.030000000000001 111.069 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 30' ' ' VAL . 52.2 t-105 -149.45 141.48 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.851 -0.613 . . . . 74.310000000000002 109.736 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.6 mtt -65.45 134.24 53.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.1 0.476 . . . . 73.299999999999997 111.408 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.23 147.82 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.764 -0.653 . . . . 70.439999999999998 110.451 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.72 62.53 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.188 -0.765 . . . . 43.5 111.188 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -93.91 96.48 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.731 -0.84 . . . . 65.319999999999993 108.731 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -55.57 116.52 2.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 112.113 -169.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.441 HD11 HG11 ' A' ' 30' ' ' VAL . 42.6 mt -74.4 139.64 75.22 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.729 -1.123 . . . . 65.25 110.055 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.22 160.48 20.31 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.636 2.224 . . . . 72.340000000000003 112.478 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.3 129.92 18.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.549 -0.75 . . . . 71.430000000000007 110.53 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.54 -33.29 5.31 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.35 -0.7 . . . . 71.010000000000005 111.35 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 43.2 m95 -88.72 148.08 24.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.508 0.194 . . . . 71.239999999999995 110.519 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 149.37 52.13 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 110.262 -0.273 . . . . 74.230000000000004 110.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 30' ' ' VAL . 34.8 p -111.53 148.3 33.5 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.376 1.048 . . . . 63.350000000000001 111.057 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -154.05 156.4 5.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.573 0.749 . . . . 74.209999999999994 109.878 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.43 -158.58 23.7 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.406 -0.426 . . . . 72.200000000000003 113.483 169.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.89 131.68 21.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.611 . . . . 72.409999999999997 109.349 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HB2' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -70.08 109.08 2.28 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 121.623 1.549 . . . . 72.400000000000006 111.255 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.07 171.09 20.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.236 -0.893 . . . . 55.439999999999998 110.442 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -58.28 166.19 1.75 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.254 0.55 . . . . 72.340000000000003 112.437 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.683 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 32.1 tptt -49.82 -49.77 47.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.055 -0.975 . . . . 75.310000000000002 110.669 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -54.42 -43.04 71.2 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.087 -0.96 . . . . 73.420000000000002 111.342 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -70.04 -48.45 57.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 72.450000000000003 110.746 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 9.1 p -62.93 -42.4 99.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.075 -0.511 . . . . 63.149999999999999 111.515 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -67.93 -40.82 83.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.492 -0.483 . . . . 54.210000000000001 110.093 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.6 tt0 -60.19 -31.43 70.13 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.789 -0.641 . . . . 74.010000000000005 110.454 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 75.5 ttt-85 -73.86 -53.3 10.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.627 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 63' ' ' LEU . 39.3 pt -66.23 -32.8 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 112.228 0.455 . . . . 74.430000000000007 112.228 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.42 -32.85 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.606 0.241 . . . . 71.010000000000005 110.353 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.448 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 91.2 mt-30 -87.53 -1.63 58.07 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.073 -0.512 . . . . 75.109999999999999 111.349 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 85.9 mt -104.0 -66.72 0.94 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.272 0.558 . . . . 70.129999999999995 111.656 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -86.09 -55.14 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.391 -0.822 . . . . 45.109999999999999 111.163 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.8 -10.99 59.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.205 -0.907 . . . . 55.350000000000001 111.311 -174.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.4 t70 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.693 0.797 . . . . 73.310000000000002 112.981 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 56' ' ' PRO . 6.4 mp . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.413 0.625 . . . . 63.109999999999999 112.34 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.625 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 6.3 m-85 -124.65 149.3 47.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.659 -1.155 . . . . 64.219999999999999 109.001 174.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.567 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -108.17 169.75 8.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.698 -0.482 . . . . 74.329999999999998 109.698 172.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 53' ' ' VAL . 51.0 t -99.0 137.53 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.412 -1.329 . . . . 71.299999999999997 107.412 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.62 161.91 29.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 118.405 0.548 . . . . 74.310000000000002 111.878 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -169.06 170.19 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.961 -1.018 . . . . 74.209999999999994 110.436 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 4.8 p30 -165.73 139.81 4.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.438 -0.208 . . . . 44.450000000000003 110.438 166.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.75 8.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.274 1.213 . . . . 73.120000000000005 114.274 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.8 pt-20 -112.08 -29.84 7.45 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.798 -0.564 . . . . 70.25 112.05 -169.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.66 -22.92 7.04 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.244 -0.503 . . . . 21.199999999999999 113.011 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.12 173.87 8.58 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -116.69 150.73 37.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.326 0.491 . . . . 73.099999999999994 112.326 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -144.47 -178.95 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.867 . . . . 73.510000000000005 109.453 168.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.55 165.41 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.784 0.326 . . . . 63.030000000000001 110.858 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.509 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 35.0 t90 -151.72 132.2 13.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 74.310000000000002 110.692 -170.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.457 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 15.8 tpt -68.06 127.32 32.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.051 -0.522 . . . . 73.299999999999997 110.136 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.93 159.58 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 70.439999999999998 109.606 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.42 21.04 25.58 Favored Glycine 0 C--N 1.329 0.166 0 C-N-CA 121.022 -0.608 . . . . 43.5 112.004 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.8 ptm180 -148.28 179.11 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.654 -0.499 . . . . 65.319999999999993 109.654 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 m -109.47 154.0 23.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.559 -0.534 . . . . 72.319999999999993 109.559 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 47' ' ' PRO . 11.2 tp -104.22 129.19 25.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 65.25 110.193 -174.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 46' ' ' LEU . 83.9 Cg_exo -40.42 132.82 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.522 2.814 . . . . 72.340000000000003 113.217 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 128.29 20.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.728 -0.669 . . . . 71.430000000000007 111.192 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.86 -34.22 5.09 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.875 -0.89 . . . . 71.010000000000005 110.875 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.755 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 45.6 m95 -76.69 157.64 31.62 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 110.167 -0.308 . . . . 71.239999999999995 110.167 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.63 152.99 48.58 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.111 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -105.67 154.52 20.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.738 -1.119 . . . . 63.350000000000001 110.528 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -163.05 161.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.225 0 C-N-CA 123.334 0.654 . . . . 74.209999999999994 110.863 -174.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.44 -140.09 14.96 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.823 -1.08 . . . . 72.200000000000003 112.72 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 26.0 tt0 -140.26 133.96 15.27 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.308 -0.997 . . . . 72.409999999999997 108.308 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 70.0 Cg_endo -70.29 112.48 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.603 . . . . 72.400000000000006 111.073 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -142.63 174.41 10.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.591 -0.731 . . . . 55.439999999999998 110.692 -172.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -64.44 157.88 25.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.589 0.233 . . . . 72.340000000000003 110.603 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -44.38 -51.78 8.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.444 0.698 . . . . 75.310000000000002 111.654 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -55.38 -46.09 76.56 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.854 -0.612 . . . . 73.420000000000002 111.825 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.448 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 99.2 mt-30 -71.46 -32.17 67.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 72.450000000000003 111.126 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 71.8 m -68.68 -47.22 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 63.149999999999999 111.011 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 3.8 pp -68.01 -36.13 79.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.924 0.393 . . . . 54.210000000000001 110.619 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.5 tt0 -61.12 -43.55 98.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.532 . . . . 74.010000000000005 109.803 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.688 ' NH1' ' HB3' ' A' ' 55' ' ' GLU . 14.2 ttm180 -60.5 -53.45 57.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.38 -0.827 . . . . 74.430000000000007 111.924 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 19.5 pt -63.71 -32.48 57.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.779 0.324 . . . . 74.430000000000007 111.531 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.31 -32.56 74.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.471 . . . . 71.010000000000005 110.612 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 72.4 mm-40 -86.35 7.94 23.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.055 0.455 . . . . 75.109999999999999 110.592 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 36.9 mt -103.53 -62.58 1.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.515 0.674 . . . . 70.129999999999995 110.537 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -85.83 -50.03 7.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.12 . . . . 45.109999999999999 110.994 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -86.43 -10.52 54.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.739 -1.119 . . . . 55.350000000000001 112.176 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 12.1 p-10 . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 123.34 0.656 . . . . 73.310000000000002 112.726 -170.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 121.038 0.446 . . . . 63.109999999999999 110.15 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 3.0 m-85 -125.18 148.62 48.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 64.219999999999999 110.055 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 56' ' ' PRO . 10.3 m-85 -109.68 157.67 18.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.176 -0.675 . . . . 74.329999999999998 109.176 168.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 37' ' ' TYR . 40.4 t -86.4 124.17 40.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.367 -1.346 . . . . 71.299999999999997 107.367 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 46' ' ' LEU . 19.3 m -125.54 162.52 28.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 122.103 -0.373 . . . . 74.310000000000002 111.054 -171.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.597 HH21 ' HA2' ' A' ' 35' ' ' GLY . 7.6 ptm180 -167.76 168.15 12.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.395 -0.366 . . . . 74.209999999999994 111.638 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -168.25 140.36 2.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.922 -0.581 . . . . 44.450000000000003 110.554 167.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.8 t30 45.89 13.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.029 0.932 . . . . 73.120000000000005 113.486 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' ASN . 9.8 pt-20 -112.43 -20.47 11.77 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.738 -0.601 . . . . 70.25 112.144 -172.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.597 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 75.52 -22.53 1.71 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.309 -0.472 . . . . 21.199999999999999 113.219 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 6.0 pt20 -103.42 173.96 6.08 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.778 0.431 . . . . 74.310000000000002 110.148 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.462 ' CD1' HG12 ' A' ' 29' ' ' VAL . 21.6 m-85 -108.74 158.13 17.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 73.099999999999994 112.471 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -141.73 -178.97 5.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.059 . . . . 73.510000000000005 108.646 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.757 HG21 ' HE3' ' A' ' 59' ' ' LYS . 20.6 m -127.79 152.34 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 118.237 0.472 . . . . 63.030000000000001 111.328 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -153.1 146.89 25.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.96 -0.564 . . . . 74.310000000000002 110.216 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 46.2 ttm -72.14 122.12 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.543 -0.299 . . . . 73.299999999999997 110.636 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.44 156.45 38.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 70.439999999999998 110.454 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.17 -31.81 8.22 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.302 -0.475 . . . . 43.5 112.145 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -106.6 130.34 54.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 65.319999999999993 110.216 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.5 m -66.0 159.37 25.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.22 0.534 . . . . 72.319999999999993 111.881 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.4 mt -107.3 155.5 39.33 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.228 -0.896 . . . . 65.25 111.227 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -55.85 152.36 36.13 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.172 2.581 . . . . 72.340000000000003 112.509 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.68 118.45 3.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.469 -0.787 . . . . 71.430000000000007 110.907 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.01 9.93 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.151 -0.477 . . . . 71.010000000000005 112.502 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.58 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.7 m95 -79.49 132.21 36.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.845 0.322 . . . . 71.239999999999995 111.037 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -115.88 154.26 30.05 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.662 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 30' ' ' VAL . 40.1 p -112.77 146.22 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.439 1.087 . . . . 63.350000000000001 110.612 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 54' ' ' GLY . 17.3 t -154.86 156.12 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.606 0.363 . . . . 74.209999999999994 110.476 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 87.33 -179.83 48.13 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.121 -0.491 . . . . 72.200000000000003 113.958 169.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 29.9 tt0 -69.98 118.35 62.61 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 123.237 0.615 . . . . 72.409999999999997 111.062 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 35.6 Cg_endo -64.68 111.71 1.76 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.768 1.645 . . . . 72.400000000000006 110.786 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.84 179.41 6.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.939 -0.573 . . . . 55.439999999999998 110.465 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 t -55.68 157.8 3.91 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.976 0.417 . . . . 72.340000000000003 111.631 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.757 ' HE3' HG21 ' A' ' 39' ' ' VAL . 22.2 tptm -45.97 -45.02 15.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.456 -0.793 . . . . 75.310000000000002 111.145 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 8.8 tt0 -56.67 -43.18 80.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 73.420000000000002 111.13 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -69.25 -50.2 49.23 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.435 -0.348 . . . . 72.450000000000003 111.031 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.752 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 15.2 p -60.73 -43.53 97.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.342 -0.39 . . . . 63.149999999999999 111.13 -174.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.642 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 pp -67.78 -42.42 81.72 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.636 -0.425 . . . . 54.210000000000001 109.993 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' LEU . 31.7 tt0 -54.94 -40.7 70.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.111 0.482 . . . . 74.010000000000005 110.342 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.1 ttm-85 -58.37 -53.35 59.25 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.583 -0.735 . . . . 74.430000000000007 111.955 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 29' ' ' VAL . 17.4 pt -73.01 -34.63 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.507 -0.315 . . . . 74.430000000000007 111.797 -175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 10.0 mm-40 -61.59 -32.72 72.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 110.203 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -81.39 -8.42 59.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.272 -0.422 . . . . 75.109999999999999 111.722 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 94.8 mt -103.31 -67.03 0.9 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.886 0.374 . . . . 70.129999999999995 111.909 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -86.3 -52.9 5.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.511 0.672 . . . . 45.109999999999999 110.894 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.55 -11.35 60.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.758 -1.11 . . . . 55.350000000000001 111.052 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 123.734 0.814 . . . . 73.310000000000002 113.093 -172.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.0 mp . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.504 0.669 . . . . 63.109999999999999 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -126.39 148.5 49.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.977 -1.01 . . . . 64.219999999999999 109.288 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.99 153.31 26.99 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.378 -0.971 . . . . 74.329999999999998 108.378 174.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 53' ' ' VAL . 77.2 t -84.77 135.61 24.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.22 -1.77 . . . . 71.299999999999997 106.22 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 46' ' ' LEU . 21.6 m -136.46 165.12 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 121.483 -0.761 . . . . 74.310000000000002 111.644 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -166.01 164.32 18.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.793 -1.094 . . . . 74.209999999999994 110.282 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.4 p-10 -153.39 139.77 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 44.450000000000003 110.137 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 42.44 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.052 1.501 . . . . 73.120000000000005 115.052 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.4 pt-20 -112.53 -32.22 6.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.461 0.573 . . . . 70.25 111.832 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.01 -22.59 4.94 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.462 -0.399 . . . . 21.199999999999999 112.381 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.39 173.95 8.84 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -112.75 137.59 50.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.478 0.656 . . . . 73.099999999999994 112.41 -176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.7 m -137.27 -179.09 5.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.894 -1.048 . . . . 73.510000000000005 108.936 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.578 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.7 m -126.85 153.72 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.887 0.375 . . . . 63.030000000000001 111.125 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -144.19 156.08 44.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 74.310000000000002 109.259 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.8 ttt -82.59 121.3 26.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.017 -0.364 . . . . 73.299999999999997 110.017 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.34 157.81 34.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.985 0.421 . . . . 70.439999999999998 110.627 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -21.07 48.13 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.042 -0.823 . . . . 43.5 111.042 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 100.33 9.58 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.284 -0.636 . . . . 65.319999999999993 109.284 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -63.3 129.01 38.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.922 0.391 . . . . 72.319999999999993 110.422 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 2.7 mm? -58.72 145.19 78.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.635 -0.711 . . . . 65.25 112.418 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.99 144.12 99.5 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 123.007 2.472 . . . . 72.340000000000003 111.436 166.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.36 128.54 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 110.194 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.74 -29.75 7.02 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.551 -0.619 . . . . 71.010000000000005 111.551 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 36.0 m95 -86.69 170.9 11.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.068 -0.716 . . . . 71.239999999999995 109.068 172.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.83 146.57 28.03 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 120.937 0.399 . . . . 74.230000000000004 110.448 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 46' ' ' LEU . 13.0 p -98.09 153.38 18.46 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.614 -1.176 . . . . 63.350000000000001 110.834 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -162.32 167.01 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 C-N-CA 124.266 1.026 . . . . 74.209999999999994 109.83 -175.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.463 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 83.44 179.46 52.32 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.171 -0.922 . . . . 72.200000000000003 111.412 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 47.6 tt0 -103.89 122.67 43.69 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.526 -1.286 . . . . 72.409999999999997 107.526 171.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.604 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 19.1 Cg_endo -55.72 124.9 17.42 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.119 . . . . 72.400000000000006 112.781 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -151.02 156.36 40.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 55.439999999999998 109.194 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -62.21 169.95 2.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.667 0.247 . . . . 72.340000000000003 111.667 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -43.39 -59.09 2.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.305 0.642 . . . . 75.310000000000002 112.289 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.25 -40.29 70.75 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.87 0.367 . . . . 73.420000000000002 111.456 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.461 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 96.4 mt-30 -74.8 -39.07 61.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 72.450000000000003 110.808 -176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.5 t -65.8 -51.05 62.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.637 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.1 pp -62.73 -43.67 98.19 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.021 0.438 . . . . 54.210000000000001 110.067 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.7 tt0 -63.07 -35.8 81.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.022 -0.535 . . . . 74.010000000000005 110.529 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.622 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 16.0 ttt180 -61.87 -50.43 72.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 110.641 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.4 pt -74.15 -42.13 51.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.816 0.341 . . . . 74.430000000000007 111.63 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.94 -37.74 88.52 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.34 -0.391 . . . . 71.010000000000005 111.678 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -78.97 0.28 28.18 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 121.023 -0.271 . . . . 75.109999999999999 111.368 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -103.92 -65.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.289 0.566 . . . . 70.129999999999995 111.141 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -85.45 -46.03 11.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.174 -0.921 . . . . 45.109999999999999 110.956 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -87.12 -11.17 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.561 -0.745 . . . . 55.350000000000001 112.545 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 113.413 0.894 . . . . 73.310000000000002 113.413 -166.845 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.759 0.79 . . . . 63.109999999999999 112.182 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.75 149.05 47.62 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.327 -1.306 . . . . 64.219999999999999 108.885 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.765 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -108.58 165.07 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.384 -0.599 . . . . 74.329999999999998 109.384 173.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.582 HG11 HG21 ' A' ' 66' ' ' ILE . 36.5 t -102.26 114.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.94 -0.763 . . . . 71.299999999999997 108.94 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 52' ' ' THR . 17.3 m -125.74 165.32 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.59 0.234 . . . . 74.310000000000002 111.51 -169.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 21.3 ptt180 -169.25 170.36 8.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.032 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -149.36 139.79 22.42 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 120.773 -0.371 . . . . 44.450000000000003 110.727 168.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t30 33.31 20.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.531 1.533 . . . . 73.120000000000005 114.918 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.41 -32.43 6.5 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.617 -0.677 . . . . 70.25 112.134 -174.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.95 19.93 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.317 -0.468 . . . . 21.199999999999999 112.751 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -90.57 173.76 7.89 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.744 -0.835 . . . . 74.310000000000002 108.744 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.462 ' CD1' HG12 ' A' ' 29' ' ' VAL . 9.3 m-85 -117.43 171.72 7.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.934 0.873 . . . . 73.099999999999994 112.101 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -150.09 176.62 10.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.685 -1.598 . . . . 73.510000000000005 107.119 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' SG ' ' A' ' 62' ' ' CYS . 7.0 m -124.37 129.4 73.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.522 0.677 . . . . 63.030000000000001 111.186 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' HZ2' ' NH1' ' A' ' 44' ' ' ARG . 54.3 t-105 -119.05 135.96 54.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.806 -1.088 . . . . 74.310000000000002 109.292 -171.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.67 123.72 19.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.507 -0.183 . . . . 73.299999999999997 110.507 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.69 146.5 52.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.04 -0.356 . . . . 70.439999999999998 110.04 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.32 15.84 68.13 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.947 -0.644 . . . . 43.5 111.57 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HG2' HH11 ' A' ' 44' ' ' ARG . 34.8 ttt-85 -131.27 125.19 32.18 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.89 -0.782 . . . . 65.319999999999993 108.89 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.8 m -72.55 159.93 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 72.319999999999993 111.8 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.677 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 10.6 tp -119.49 135.66 24.2 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.459 -0.791 . . . . 65.25 109.5 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD2' HD12 ' A' ' 46' ' ' LEU . 55.7 Cg_endo -69.55 158.19 58.11 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.87 2.38 . . . . 72.340000000000003 113.665 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.08 129.12 26.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.911 -1.04 . . . . 71.430000000000007 110.788 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.62 -28.66 10.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.917 -0.583 . . . . 71.010000000000005 111.725 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.677 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 14.9 m95 -91.04 153.72 19.92 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.647 0.261 . . . . 71.239999999999995 110.502 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.76 138.87 53.88 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 110.36 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.586 ' HA ' HG12 ' A' ' 30' ' ' VAL . 7.3 p -100.81 131.31 46.76 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.585 -1.189 . . . . 63.350000000000001 109.616 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 54' ' ' GLY . 3.1 t -146.23 166.26 8.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.146 0.498 . . . . 74.209999999999994 110.317 -170.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 98.31 -141.09 15.39 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.647 -0.706 . . . . 72.200000000000003 114.231 167.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -136.53 119.41 11.96 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.385 -0.908 . . . . 72.409999999999997 108.788 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.765 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.1 Cg_endo -63.05 115.8 3.18 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.648 1.565 . . . . 72.400000000000006 111.281 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.38 155.09 35.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.608 -0.724 . . . . 55.439999999999998 109.554 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -55.88 153.76 8.12 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.744 -0.465 . . . . 72.340000000000003 109.744 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE3' HG23 ' A' ' 39' ' ' VAL . 24.6 tptm -43.14 -48.8 6.41 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.606 0.566 . . . . 75.310000000000002 111.848 -172.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -58.94 -51.08 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 73.420000000000002 111.03 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -69.42 -30.43 68.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.957 0.408 . . . . 72.450000000000003 110.406 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 39' ' ' VAL . 13.8 t -65.67 -52.41 51.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.776 -0.647 . . . . 63.149999999999999 110.175 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.038 0.447 . . . . 54.210000000000001 110.387 176.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' LEU . 32.9 tt0 -62.83 -42.32 99.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 74.010000000000005 110.772 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 12.3 ttm-85 -57.26 -53.28 59.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 111.608 -174.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.582 HG21 HG11 ' A' ' 29' ' ' VAL . 13.1 pt -67.22 -34.71 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 111.531 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.23 -32.49 73.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 71.010000000000005 110.178 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.56 0.35 17.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.07 -0.514 . . . . 75.109999999999999 111.816 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 95.5 mt -103.81 -67.11 0.91 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.794 0.664 . . . . 70.129999999999995 112.794 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -86.04 -55.07 4.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.678 0.752 . . . . 45.109999999999999 110.579 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -11.48 60.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.392 -1.277 . . . . 55.350000000000001 110.915 -177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 123.611 0.764 . . . . 73.310000000000002 112.799 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.702 0.287 . . . . 73.219999999999999 110.407 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . . . -60.01 164.51 3.91 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.898 -0.592 . . . . 73.439999999999998 111.03 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -130.52 30.55 4.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.929 0.344 . . . . 72.239999999999995 111.929 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -93.43 109.9 21.47 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.914 -1.143 . . . . 53.229999999999997 107.914 166.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.82 -47.75 73.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.549 0.574 . . . . 64.019999999999996 112.549 -166.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -141.23 142.32 33.96 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.134 -0.354 . . . . 74.209999999999994 111.054 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -78.57 128.55 33.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 52.520000000000003 110.514 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -64.21 100.77 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.757 -0.46 . . . . 71.439999999999998 109.757 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 19.2 mmt -64.62 146.7 54.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 71.540000000000006 112.016 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.81 161.43 47.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.341 -0.845 . . . . 73.319999999999993 111.188 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -58.6 -73.39 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.383 0.512 . . . . 64.109999999999999 112.383 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.43 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 48.7 tp -91.38 -61.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.669 -0.241 . . . . 73.430000000000007 110.61 -173.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.43 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 37.5 mt-10 -118.66 125.46 49.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 52.229999999999997 110.242 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.572 ' HB3' HH12 ' A' ' 65' ' ' ARG . . . -163.01 95.92 0.88 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.562 0.345 . . . . 61.0 110.461 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.445 ' HA ' HE22 ' A' ' 61' ' ' GLN . 50.2 mt-30 -75.18 114.36 13.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 73.030000000000001 110.662 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 m -108.8 51.12 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.593 0.711 . . . . 75.239999999999995 109.447 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HB2' HE22 ' A' ' 64' ' ' GLN . 6.4 tp-100 -174.85 -64.5 0.01 OUTLIER 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.446 -0.797 . . . . 74.109999999999999 109.583 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 61' ' ' GLN . . . 157.24 -173.07 34.77 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.596 -0.729 . . . . 74.420000000000002 111.345 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 -48.54 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.23 1.954 . . . . 73.409999999999997 111.777 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.95 -137.05 4.39 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.788 -0.925 . . . . 44.340000000000003 110.788 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -98.92 -79.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.804 -0.443 . . . . 65.310000000000002 109.804 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 64.8 mtt -157.03 28.51 0.31 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.921 -1.14 . . . . 73.349999999999994 107.921 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 6.0 p-10 -111.82 170.96 7.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.581 -1.19 . . . . 74.420000000000002 112.142 -165.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -108.27 19.13 20.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.943 -1.026 . . . . 70.420000000000002 110.465 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 23' ' ' ASP . 7.7 mm-40 -81.35 52.57 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.333 -0.394 . . . . 71.109999999999999 110.55 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 56' ' ' PRO . 9.1 mp -74.03 136.72 43.13 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.782 0.801 . . . . 63.109999999999999 111.193 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.2 m-85 -127.57 151.13 49.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.366 -1.288 . . . . 64.219999999999999 109.306 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -116.46 157.68 24.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 74.329999999999998 109.397 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -85.86 134.83 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.16 -1.422 . . . . 71.299999999999997 107.16 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 46' ' ' LEU . 29.0 m -136.73 159.32 37.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.954 0.407 . . . . 74.310000000000002 111.379 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 38.0 ptt180 -169.21 170.23 8.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.192 -0.913 . . . . 74.209999999999994 110.509 174.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.668 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.77 140.38 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.653 -0.249 . . . . 44.450000000000003 111.061 170.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 49.11 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.883 1.068 . . . . 73.120000000000005 113.883 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.09 -32.0 6.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.747 -0.596 . . . . 70.25 111.464 -174.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.71 -22.81 6.19 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.262 -0.426 . . . . 21.199999999999999 113.014 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -84.03 174.04 10.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.749 -0.464 . . . . 74.310000000000002 109.749 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.21 143.3 45.45 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.901 0.704 . . . . 73.099999999999994 112.901 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 65.5 m -136.83 -179.91 5.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.987 -1.006 . . . . 73.510000000000005 109.694 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.65 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.9 m -125.67 155.34 34.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.807 0.337 . . . . 63.030000000000001 110.803 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -148.48 149.1 31.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.306 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.8 ttt -81.61 121.51 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.647 0.26 . . . . 73.299999999999997 110.326 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.56 148.89 44.64 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.231 -0.441 . . . . 70.439999999999998 111.014 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.97 -23.03 36.26 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.741 -0.544 . . . . 43.5 111.741 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -92.98 118.83 31.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.004 -0.369 . . . . 65.319999999999993 110.004 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.3 m -60.24 137.33 58.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.04 0.448 . . . . 72.319999999999993 111.391 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -93.31 142.43 25.26 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.425 -0.807 . . . . 65.25 110.882 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -54.13 140.44 70.93 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.863 2.375 . . . . 72.340000000000003 111.714 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.67 124.89 11.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 71.430000000000007 110.386 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.2 -29.42 7.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.296 -0.478 . . . . 71.010000000000005 112.669 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.668 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.1 m95 -76.95 149.88 35.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.335 0.568 . . . . 71.239999999999995 111.46 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 18.8 pt-20 -129.62 151.23 50.45 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.977 -0.556 . . . . 74.230000000000004 110.245 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -107.99 160.59 15.66 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.214 0.946 . . . . 63.350000000000001 111.255 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.17 158.51 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 123.408 0.683 . . . . 74.209999999999994 110.608 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 89.61 -166.85 33.23 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.833 -0.621 . . . . 72.200000000000003 112.259 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.55 142.25 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.745 -0.835 . . . . 72.409999999999997 108.745 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.4 Cg_endo -72.57 108.74 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 120.816 1.01 . . . . 72.400000000000006 110.575 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.57 172.99 17.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.416 -0.811 . . . . 55.439999999999998 110.361 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -55.77 155.33 6.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.898 0.38 . . . . 72.340000000000003 111.503 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -49.55 -36.49 23.81 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.619 -0.719 . . . . 75.310000000000002 110.923 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -55.71 -55.67 29.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.516 -0.765 . . . . 73.420000000000002 110.302 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.445 HE22 ' HA ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -55.39 -52.0 64.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.776 -0.647 . . . . 72.450000000000003 111.003 176.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.65 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.0 t -55.86 -52.46 63.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.197 -0.91 . . . . 63.149999999999999 111.071 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.2 pp -68.26 -44.92 74.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.916 -0.313 . . . . 54.210000000000001 110.445 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.498 HE22 ' HB2' ' A' ' 17' ' ' GLN . 22.0 tt0 -54.8 -36.51 65.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.968 0.413 . . . . 74.010000000000005 110.394 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 14' ' ' ALA . 48.5 ttt85 -64.21 -53.53 47.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.774 -0.648 . . . . 74.430000000000007 111.046 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 pt -74.07 -34.05 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 111.679 0.251 . . . . 74.430000000000007 111.679 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 39.7 mm-40 -65.97 -32.77 74.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.487 -0.324 . . . . 71.010000000000005 110.385 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 95.3 mt-30 -87.75 4.95 42.32 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 111.266 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 48.0 mt -103.73 -66.97 0.91 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.92 0.39 . . . . 70.129999999999995 111.195 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -86.32 -54.84 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.272 0.558 . . . . 45.109999999999999 111.417 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -78.19 -10.92 59.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.187 -0.915 . . . . 55.350000000000001 111.399 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -41.25 -42.33 2.1 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.977 1.103 . . . . 73.310000000000002 113.977 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.8 mtp -62.56 85.55 0.02 OUTLIER 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.742 0.782 . . . . 75.019999999999996 110.949 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -93.71 134.54 26.23 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 114.614 -1.176 . . . . 71.120000000000005 111.292 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 4.5 Cg_exo -78.1 -156.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.055 2.503 . . . . 72.129999999999995 112.144 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.65 -22.14 8.21 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.31 0.485 . . . . 60.32 112.31 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.2 m -50.85 -25.26 4.29 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.242 -0.435 . . . . 75.439999999999998 112.121 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG22 HD23 ' A' ' 82' ' ' LEU . 13.1 p -68.59 -39.08 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.884 0.373 . . . . 72.150000000000006 110.485 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -62.05 -31.65 72.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.058 -0.519 . . . . 74.439999999999998 110.498 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -61.74 -35.59 78.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 73.109999999999999 111.104 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -109.27 -1.53 18.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 54.530000000000001 111.029 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -71.51 100.99 2.35 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.983 -0.377 . . . . 73.430000000000007 109.983 -177.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.71 -72.92 0.14 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.866 -0.606 . . . . 64.540000000000006 111.346 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -76.31 83.1 3.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 74.549999999999997 109.908 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -54.77 -29.16 53.35 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.363 -0.835 . . . . 73.5 111.697 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 t -69.18 -37.5 78.2 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.431 -0.35 . . . . 53.329999999999998 111.121 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.46 106.28 0.27 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.749 -0.54 . . . . 74.420000000000002 111.749 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.603 ' HB3' HD21 ' A' ' 82' ' ' LEU . 26.6 Cg_endo -60.46 -44.56 26.69 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.864 2.376 . . . . 73.530000000000001 112.982 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 2' ' ' ALA . . . 72.95 -73.98 0.99 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.186 -0.766 . . . . 73.430000000000007 111.186 -173.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.5 mm -107.73 92.67 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.806 -0.813 . . . . 44.039999999999999 108.806 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.06 144.68 54.98 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.717 -0.674 . . . . 74.510000000000005 110.584 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -87.43 107.67 18.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.976 -0.556 . . . . 74.099999999999994 111.127 -172.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -66.4 173.86 3.04 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.734 -0.666 . . . . 75.120000000000005 111.027 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 94' ' ' VAL . 7.1 p -130.0 78.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.644 0.735 . . . . 75.409999999999997 112.203 -173.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 60.4 ttt-85 . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.271 -0.871 . . . . 74.540000000000006 110.234 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.288 -0.264 . . . . 73.219999999999999 110.288 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.24 70.09 0.63 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.918 -0.583 . . . . 73.439999999999998 111.538 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.16 89.99 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.837 -0.619 . . . . 72.239999999999995 110.134 176.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.486 ' HB3' ' HD2' ' A' ' 6' ' ' HIS . 40.9 m80 -78.04 110.47 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.644 -0.707 . . . . 53.229999999999997 110.538 -178.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -70.2 89.58 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 64.019999999999996 110.134 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.486 ' HD2' ' HB3' ' A' ' 4' ' ' HIS . 81.6 m-70 -142.97 168.26 20.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 74.209999999999994 109.898 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -167.32 166.04 14.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.89 -0.411 . . . . 52.520000000000003 109.89 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -107.53 168.41 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.234 -0.284 . . . . 71.439999999999998 110.234 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -157.6 163.71 38.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 71.540000000000006 109.982 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.93 -73.93 0.2 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.822 -0.511 . . . . 73.319999999999993 111.822 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 t -162.99 158.31 22.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.424 -0.584 . . . . 64.109999999999999 109.424 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.87 -92.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.27 -0.27 . . . . 73.430000000000007 110.27 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 78.5 mm-40 -138.95 173.74 11.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.083 0.468 . . . . 52.229999999999997 110.814 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.35 174.55 11.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.205 -0.907 . . . . 61.0 109.636 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.96 -25.23 58.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 73.030000000000001 110.367 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -77.96 60.91 2.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 109.874 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.553 ' NE2' ' HG3' ' A' ' 55' ' ' GLU . 39.4 tt0 -76.29 -54.64 6.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.703 -0.68 . . . . 74.109999999999999 109.959 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.41 -179.12 42.15 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.822 -0.911 . . . . 74.420000000000002 110.822 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.13 -64.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.632 2.222 . . . . 73.409999999999997 111.788 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.43 -164.3 33.91 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.738 -0.665 . . . . 44.340000000000003 111.5 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -176.55 -66.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.626 -0.509 . . . . 65.310000000000002 109.626 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.9 OUTLIER 57.02 20.42 5.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.835 -0.621 . . . . 73.349999999999994 110.974 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.87 -71.62 0.34 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 74.420000000000002 110.053 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.75 174.68 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.619 -0.719 . . . . 70.420000000000002 109.521 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -74.81 144.69 43.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.325 -0.25 . . . . 71.109999999999999 110.325 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.49 143.29 27.29 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.784 0.802 . . . . 63.109999999999999 111.455 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -127.31 148.7 50.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.502 -1.226 . . . . 64.219999999999999 109.156 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.584 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -114.1 162.39 16.54 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.61 0.569 . . . . 74.329999999999998 109.543 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 53' ' ' VAL . 75.8 t -88.42 140.65 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.247 -1.02 . . . . 71.299999999999997 108.247 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 40' ' ' TRP . 23.4 m -144.99 158.23 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 122.195 -0.316 . . . . 74.310000000000002 110.85 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 19.9 ptt85 -169.36 170.1 8.63 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.335 -0.393 . . . . 74.209999999999994 111.542 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -157.89 139.82 14.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.342 -0.39 . . . . 44.450000000000003 111.063 171.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 35.12 21.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.137 1.375 . . . . 73.120000000000005 114.294 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ASN . 10.7 pt-20 -112.4 -32.11 6.6 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.616 -0.677 . . . . 70.25 111.385 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.86 -22.79 5.52 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.972 -0.558 . . . . 21.199999999999999 112.078 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -84.35 161.56 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.14 -0.689 . . . . 74.310000000000002 109.14 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 18.9 m-85 -106.32 137.48 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.086 0.469 . . . . 73.099999999999994 111.711 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -124.13 -179.21 4.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.046 -0.979 . . . . 73.510000000000005 109.726 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -132.31 157.3 43.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.879 0.371 . . . . 63.030000000000001 110.877 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HB2' HG21 ' A' ' 30' ' ' VAL . 73.4 t-105 -155.75 149.41 25.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.823 -0.806 . . . . 74.310000000000002 108.823 -171.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.86 130.35 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 73.299999999999997 110.539 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -55.58 144.12 27.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.993 -0.548 . . . . 70.439999999999998 111.621 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -20.69 12.09 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.13 -0.486 . . . . 43.5 113.254 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -79.91 131.1 35.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.762 0.281 . . . . 65.319999999999993 110.274 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -65.92 148.76 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.314 0.578 . . . . 72.319999999999993 111.821 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 29.1 mt -111.35 147.71 37.25 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.094 -0.957 . . . . 65.25 111.204 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -81.07 176.1 9.2 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.913 2.409 . . . . 72.340000000000003 113.029 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 125.44 10.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.907 -1.042 . . . . 71.430000000000007 111.94 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.57 -32.32 7.52 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 112.847 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.3 m95 -76.91 133.54 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.034 0.417 . . . . 71.239999999999995 111.689 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 9.8 pt-20 -127.62 152.78 47.23 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.746 -0.661 . . . . 74.230000000000004 110.393 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 53' ' ' VAL . 39.5 p -102.13 159.66 15.19 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.289 0.993 . . . . 63.350000000000001 111.42 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -173.6 175.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 110.285 -173.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 82.75 -161.2 40.05 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.723 -0.671 . . . . 72.200000000000003 112.882 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.553 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -108.5 138.62 20.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 123.366 0.666 . . . . 72.409999999999997 109.588 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 58.7 Cg_endo -71.59 113.38 3.62 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.673 1.582 . . . . 72.400000000000006 111.078 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.37 167.11 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.726 -0.67 . . . . 55.439999999999998 109.938 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.1 t -61.69 161.36 10.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.679 0.276 . . . . 72.340000000000003 110.961 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -46.89 -48.52 21.19 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.869 -0.605 . . . . 75.310000000000002 111.633 -176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.37 -45.09 84.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.978 -0.555 . . . . 73.420000000000002 111.406 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.75 -38.78 64.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 72.450000000000003 110.708 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.531 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.2 t -59.02 -49.26 78.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.73 -0.668 . . . . 63.149999999999999 110.202 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.6 pp -68.05 -37.22 81.06 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.43 -0.35 . . . . 54.210000000000001 110.508 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' LEU . 33.9 tt0 -60.31 -32.74 71.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.089 0.471 . . . . 74.010000000000005 110.411 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.3 ttt85 -76.57 -44.02 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.982 -0.554 . . . . 74.430000000000007 110.548 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' LEU . 44.4 pt -67.61 -34.55 68.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 121.153 -0.219 . . . . 74.430000000000007 110.675 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 34.3 mt-10 -54.03 -56.04 21.67 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.25 -0.432 . . . . 71.010000000000005 110.112 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -65.76 -10.18 34.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 75.109999999999999 112.384 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 97.6 mt -104.02 -67.79 0.88 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.329 0.492 . . . . 70.129999999999995 112.329 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 70.6 t-105 -87.01 -55.44 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.965 0.888 . . . . 45.109999999999999 111.168 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.762 HG22 HG13 ' A' ' 94' ' ' VAL . 5.5 m -74.09 -11.52 60.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.027 -1.442 . . . . 55.350000000000001 111.609 -170.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 67' ' ' GLU . 24.5 t70 -45.11 -25.43 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.029 1.122 . . . . 73.310000000000002 114.029 -170.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mmt -66.8 75.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 75.019999999999996 110.409 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 5.9 p -89.95 133.1 34.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 71.120000000000005 111.092 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 23.0 Cg_exo -66.65 -157.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.955 2.437 . . . . 72.129999999999995 112.72 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.51 -15.55 1.15 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.054 0.542 . . . . 60.32 112.145 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 t -50.15 -27.13 5.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.892 0.477 . . . . 75.439999999999998 110.988 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.46 -41.57 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.806 0.336 . . . . 72.150000000000006 111.227 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -71.29 -33.01 69.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.279 -0.418 . . . . 74.439999999999998 110.231 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -74.78 -29.14 61.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 73.109999999999999 110.399 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -63.34 -30.18 71.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.153 0.502 . . . . 54.530000000000001 110.429 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.82 -6.9 41.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.599 -0.728 . . . . 73.430000000000007 111.565 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.49 ' N ' HD22 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -54.35 123.47 13.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.405 . . . . 64.540000000000006 111.724 -178.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 51.91 30.18 6.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.871 -0.604 . . . . 74.549999999999997 111.431 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.519 ' HA ' HG12 ' A' ' 90' ' ' ILE . 42.8 p-80 -37.16 106.27 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.581 -0.736 . . . . 73.5 111.925 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.1 m -96.49 133.51 40.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.458 -0.792 . . . . 53.329999999999998 111.718 -173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' HA3' ' HD3' ' A' ' 88' ' ' PRO . . . 54.98 -123.08 28.22 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.817 -0.629 . . . . 74.420000000000002 113.607 172.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 27.5 Cg_exo -62.13 -11.17 20.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.044 2.496 . . . . 73.530000000000001 112.444 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.08 119.1 4.43 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.793 -0.523 . . . . 73.430000000000007 111.793 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 85' ' ' HIS . 19.4 pt -94.54 100.53 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.345 0.593 . . . . 44.039999999999999 110.126 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -146.69 156.51 43.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.826 -0.624 . . . . 74.510000000000005 110.471 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -162.13 -174.16 3.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.332 -0.849 . . . . 74.099999999999994 108.774 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -96.5 -142.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.365 -0.235 . . . . 75.120000000000005 110.365 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 71' ' ' THR . 3.7 p -115.99 60.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 122.364 1.078 . . . . 75.409999999999997 111.393 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HE ' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.249 0 CA-C-N 114.125 -1.398 . . . . 74.540000000000006 111.744 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.025 0.44 . . . . 73.219999999999999 109.981 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.05 87.36 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 73.439999999999998 110.344 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -65.24 89.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 72.239999999999995 110.111 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.33 115.04 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.718 -0.674 . . . . 53.229999999999997 110.442 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -85.57 80.49 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.6 . . . . 64.019999999999996 111.738 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -137.81 29.05 2.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 74.209999999999994 107.257 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -121.35 143.29 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.069 -1.423 . . . . 52.520000000000003 109.602 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 67.17 17.17 10.33 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.51 0.506 . . . . 71.439999999999998 111.476 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 ptm -77.25 -34.84 55.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 71.540000000000006 111.026 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.26 -132.34 45.86 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.084 -0.507 . . . . 73.319999999999993 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -149.08 -59.29 0.22 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.704 0.287 . . . . 64.109999999999999 110.278 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 30.5 tp -145.33 -113.8 0.09 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.644 -0.502 . . . . 73.430000000000007 109.644 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 34.8 mt-10 -94.35 131.49 39.93 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.925 -0.398 . . . . 52.229999999999997 109.925 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 172.97 1.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.09 0.556 . . . . 61.0 111.071 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -138.53 108.12 6.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.604 -0.271 . . . . 73.030000000000001 110.522 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -140.46 22.62 2.35 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.533 0.683 . . . . 75.239999999999995 109.696 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.193 -0.912 . . . . 74.109999999999999 110.565 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.2 71.07 0.12 Allowed Glycine 0 CA--C 1.518 0.249 0 N-CA-C 111.03 -0.828 . . . . 74.420000000000002 111.03 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.5 157.21 49.3 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.859 2.373 . . . . 73.409999999999997 112.868 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.32 111.39 1.68 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.478 -0.783 . . . . 44.340000000000003 111.297 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 p -70.27 -8.82 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.769 0.319 . . . . 65.310000000000002 111.459 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 22' ' ' MET . 1.2 pmm? -101.96 10.44 39.69 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.237 0.541 . . . . 73.349999999999994 110.912 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.76 97.67 5.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.314 -0.857 . . . . 74.420000000000002 110.525 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -92.88 -31.06 15.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.697 -0.683 . . . . 70.420000000000002 109.558 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.58 111.04 23.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 71.109999999999999 108.813 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.55 171.22 10.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.811 0.815 . . . . 63.109999999999999 111.464 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.585 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 19.8 m-85 -121.09 148.72 43.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.546 -1.206 . . . . 64.219999999999999 108.254 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.87 159.57 26.53 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.72 -0.844 . . . . 74.329999999999998 108.72 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 86.9 t -86.8 138.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.282 -1.377 . . . . 71.299999999999997 107.282 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 46' ' ' LEU . 33.9 m -138.32 160.53 31.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.318 0.508 . . . . 74.310000000000002 111.295 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -168.61 169.15 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.786 -1.097 . . . . 74.209999999999994 110.242 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.8 p30 -154.36 139.74 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.993 -0.373 . . . . 44.450000000000003 109.993 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 t30 44.88 6.16 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.159 1.17 . . . . 73.120000000000005 114.159 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.7 pt-20 -112.27 -32.45 6.52 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.503 -0.748 . . . . 70.25 112.118 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 -22.58 4.57 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.242 -0.436 . . . . 21.199999999999999 112.911 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.16 174.05 5.94 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.388 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -122.29 133.02 54.69 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.592 0.589 . . . . 73.099999999999994 112.592 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.3 m -132.82 -179.19 5.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.371 -0.831 . . . . 73.510000000000005 109.71 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.6 158.33 26.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.04 0.448 . . . . 63.030000000000001 110.913 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.527 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 56.0 t90 -147.15 137.21 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.84 . . . . 74.310000000000002 109.6 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 ttt -83.09 121.46 27.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 110.284 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.15 165.36 22.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.347 . . . . 70.439999999999998 110.189 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.31 -4.85 29.93 Favored Glycine 0 C--N 1.328 0.125 0 N-CA-C 110.91 -0.876 . . . . 43.5 110.91 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.8 ptp180 -131.56 172.52 12.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.271 0.628 . . . . 65.319999999999993 109.737 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 p -101.67 143.65 31.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.999 -0.371 . . . . 72.319999999999993 109.999 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 30' ' ' VAL . 8.5 mt -88.9 133.17 36.15 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.325 -0.398 . . . . 65.25 111.544 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 46' ' ' LEU . 76.1 Cg_exo -46.12 130.66 13.77 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 123.303 2.668 . . . . 72.340000000000003 112.352 171.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 126.52 15.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 71.430000000000007 110.493 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.88 -25.53 9.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.241 -0.504 . . . . 71.010000000000005 112.06 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 66.2 m95 -83.96 158.53 21.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.809 0.305 . . . . 71.239999999999995 110.784 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -135.21 154.26 51.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.318 -0.401 . . . . 74.230000000000004 110.048 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 53' ' ' VAL . 24.3 p -107.43 153.21 23.13 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 124.737 1.273 . . . . 63.350000000000001 110.244 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -167.51 175.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.676 0 C-N-CA 123.624 0.77 . . . . 74.209999999999994 110.023 -173.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.22 -115.3 4.19 Favored Glycine 0 C--O 1.219 -0.835 0 CA-C-N 115.681 -0.69 . . . . 72.200000000000003 113.111 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 16.4 tp10 -147.32 136.89 11.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.279 1.032 . . . . 72.409999999999997 108.597 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 73.6 Cg_endo -83.51 107.51 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.011 1.141 . . . . 72.400000000000006 110.286 166.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.68 -175.4 5.14 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.391 -0.822 . . . . 55.439999999999998 111.242 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 61' ' ' GLN . 1.1 t -55.83 151.21 11.72 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 111.286 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HG3' HD23 ' A' ' 63' ' ' LEU . 23.8 tptm -45.93 -41.0 10.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.225 -0.898 . . . . 75.310000000000002 110.269 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -59.86 -42.41 93.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.107 -0.952 . . . . 73.420000000000002 111.417 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' H ' HG23 ' A' ' 58' ' ' THR . 26.2 mm-40 -71.95 -48.06 47.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.884 0.373 . . . . 72.450000000000003 110.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 60.0 m -60.22 -46.6 89.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 63.149999999999999 111.578 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.08 -41.05 82.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.753 -0.379 . . . . 54.210000000000001 110.385 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.592 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.4 tt0 -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.281 0.562 . . . . 74.010000000000005 110.877 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.4 ttm-85 -64.48 -47.42 79.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.965 -0.562 . . . . 74.430000000000007 111.202 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 pt -69.66 -37.66 74.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.64 0.257 . . . . 74.430000000000007 110.977 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 8.6 mm-40 -62.65 -48.99 76.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 71.010000000000005 110.214 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 79.6 mt-30 -73.29 8.73 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.795 0.331 . . . . 75.109999999999999 111.452 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 73.3 mt -103.54 -66.13 0.96 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.975 0.417 . . . . 70.129999999999995 110.618 170.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -85.29 -48.47 9.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.441 0.639 . . . . 45.109999999999999 110.837 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.531 HG21 ' NH2' ' A' ' 95' ' ' ARG . 17.6 m -76.81 -10.74 59.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.202 -0.908 . . . . 55.350000000000001 111.356 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 25.9 t70 -41.43 -23.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.182 0.993 . . . . 73.310000000000002 113.168 -174.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 93.6 mmm -67.08 72.23 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.983 0.421 . . . . 75.019999999999996 110.735 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.32 133.92 41.57 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.843 -0.617 . . . . 71.120000000000005 110.19 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.93 -169.7 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.767 2.312 . . . . 72.129999999999995 112.183 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -15.2 8.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.37 -0.377 . . . . 60.32 111.376 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -57.75 -20.77 37.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.921 -0.581 . . . . 75.439999999999998 111.775 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.2 p -56.12 -41.95 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.854 0.359 . . . . 72.150000000000006 110.15 174.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.46 -37.13 86.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 110.442 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 91' ' ' ASP . 2.5 tp10 -61.58 -38.19 86.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.357 -0.838 . . . . 73.109999999999999 110.209 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -84.17 -30.37 25.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.297 -0.865 . . . . 54.530000000000001 112.04 -172.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 89.3 mt -51.93 -46.99 64.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.98 0.419 . . . . 73.430000000000007 111.144 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -150.07 114.22 5.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.758 -0.655 . . . . 64.540000000000006 109.419 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -65.18 86.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.5 0.667 . . . . 74.549999999999997 109.911 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -65.06 168.22 6.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.724 -1.125 . . . . 73.5 111.336 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -62.82 92.38 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 53.329999999999998 110.726 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.83 -139.97 5.6 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.328 -0.709 . . . . 74.420000000000002 111.328 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.14 165.25 14.92 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.706 2.271 . . . . 73.530000000000001 112.443 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.0 -157.62 8.3 Favored Glycine 0 C--O 1.235 0.218 0 N-CA-C 111.448 -0.661 . . . . 73.430000000000007 111.448 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.1 mt 55.55 83.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.356 0.598 . . . . 44.039999999999999 110.345 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 6.5 p-10 -104.91 178.07 4.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 74.510000000000005 111.528 -173.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -113.96 90.82 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 74.099999999999994 109.986 172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.83 173.17 6.44 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.6 -0.727 . . . . 75.120000000000005 110.233 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.3 140.63 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 75.409999999999997 109.353 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.044 -0.979 . . . . 74.540000000000006 110.775 -176.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.165 -0.309 . . . . 73.219999999999999 110.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.06 93.45 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.935 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -122.09 -64.67 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 110.108 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -148.11 147.47 29.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.155 -0.475 . . . . 53.229999999999997 110.584 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.59 99.05 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.798 -0.637 . . . . 64.019999999999996 109.811 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -95.47 103.32 15.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.021 -0.536 . . . . 74.209999999999994 111.547 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -85.93 134.74 33.86 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.671 -0.695 . . . . 52.520000000000003 109.948 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -141.7 120.81 12.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.42 -0.585 . . . . 71.439999999999998 109.42 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 9' ' ' MET . 1.3 tmt? -162.42 124.91 2.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 71.540000000000006 110.103 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 158.45 179.86 33.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.116 -0.564 . . . . 73.319999999999993 112.379 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 p 57.39 161.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.214 1.006 . . . . 64.109999999999999 113.52 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.585 HD11 ' HB ' ' A' ' 53' ' ' VAL . 3.7 mm? -132.54 -177.61 4.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.175 -0.921 . . . . 73.430000000000007 108.824 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' H ' ' HD3' ' A' ' 65' ' ' ARG . 20.2 mt-10 59.04 15.27 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.075 -0.511 . . . . 52.229999999999997 112.375 167.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.91 130.54 34.63 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.298 -0.26 . . . . 61.0 110.298 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -165.5 160.52 17.89 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.244 0.34 . . . . 73.030000000000001 110.578 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.1 p -108.84 -40.59 4.99 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.885 0.374 . . . . 75.239999999999995 110.754 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -145.49 142.52 29.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.88 -0.415 . . . . 74.109999999999999 109.88 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.86 -135.81 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 113.641 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HB3' HG21 ' A' ' 58' ' ' THR . 57.5 Cg_endo -70.43 98.07 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.906 2.404 . . . . 73.409999999999997 112.451 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.39 27.54 18.79 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 111.762 -0.535 . . . . 44.340000000000003 111.762 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.7 m -153.56 167.41 29.6 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.253 -0.277 . . . . 65.310000000000002 110.253 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 61.3 mtt -88.25 106.45 18.22 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.962 -0.385 . . . . 73.349999999999994 109.962 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -112.6 -167.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.51 -0.314 . . . . 74.420000000000002 110.796 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -139.58 -83.16 0.26 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.717 0.266 . . . . 70.420000000000002 111.717 -170.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' A' ' 41' ' ' MET . 9.3 mm-40 -92.73 165.17 13.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.664 0.269 . . . . 71.109999999999999 110.998 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.27 162.42 21.16 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.176 0.512 . . . . 63.109999999999999 110.552 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.22 148.71 50.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 64.219999999999999 110.72 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -117.78 162.59 17.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.943 -1.026 . . . . 74.329999999999998 108.91 171.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -94.06 142.65 13.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.778 -1.193 . . . . 71.299999999999997 107.778 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.03 156.62 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.155 0.502 . . . . 74.310000000000002 111.227 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HD3' ' CE1' ' A' ' 37' ' ' TYR . 29.5 ptt180 -154.25 155.18 34.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.196 -0.911 . . . . 74.209999999999994 109.581 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.7 p30 -156.56 139.35 15.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.983 -0.287 . . . . 44.450000000000003 110.894 168.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.4 m120 35.43 13.38 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.652 1.723 . . . . 73.120000000000005 115.652 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.883 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 16.4 pt-20 -112.71 -31.92 6.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.745 0.646 . . . . 70.25 112.745 -170.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.42 89.01 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 21.199999999999999 112.473 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.883 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 77.7 mt-30 -120.77 174.09 6.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.348 0.659 . . . . 74.310000000000002 109.365 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 31' ' ' ARG . 42.4 m-85 -122.54 146.46 47.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.739 1.014 . . . . 73.099999999999994 113.739 -171.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -138.9 -179.31 5.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.216 -1.357 . . . . 73.510000000000005 108.677 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.5 m -122.83 161.6 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.918 0.389 . . . . 63.030000000000001 111.084 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -145.89 156.47 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 109.32 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.48 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 6.4 ttt -86.07 147.5 26.15 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.828 -0.434 . . . . 73.299999999999997 109.828 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.62 156.88 38.88 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.017 0.437 . . . . 70.439999999999998 111.524 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.35 54.13 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.547 -0.751 . . . . 43.5 112.769 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -112.35 116.1 29.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.876 -0.416 . . . . 65.319999999999993 109.876 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.0 m -66.09 154.69 38.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 112.048 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -111.05 152.88 43.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.075 -0.966 . . . . 65.25 111.151 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 74.1 Cg_endo -80.34 158.13 22.78 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 111.921 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 131.13 26.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 111.237 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.96 -35.27 5.16 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.774 -0.648 . . . . 71.010000000000005 111.658 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 32.2 m95 -79.71 139.02 37.49 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.188 -0.301 . . . . 71.239999999999995 110.188 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.87 153.68 49.55 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.377 -0.374 . . . . 74.230000000000004 110.284 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.2 p -98.11 162.82 13.02 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.19 0.931 . . . . 63.350000000000001 111.459 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -162.56 150.02 3.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.41 -0.814 . . . . 74.209999999999994 109.978 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 -170.56 37.53 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.557 -0.747 . . . . 72.200000000000003 111.495 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 151.56 40.76 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 108.652 -0.87 . . . . 72.409999999999997 108.652 174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 21.9 Cg_endo -65.54 105.17 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.206 1.271 . . . . 72.400000000000006 110.046 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.17 169.45 17.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.412 -0.813 . . . . 55.439999999999998 110.669 -171.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 19' ' ' PRO . 3.5 t -57.29 151.3 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.654 -0.703 . . . . 72.340000000000003 111.149 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -48.75 -44.91 39.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.751 -0.659 . . . . 75.310000000000002 110.576 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.628 ' NE2' ' H ' ' A' ' 60' ' ' GLN . 2.3 mp0 -56.19 -37.32 69.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.477 -0.783 . . . . 73.420000000000002 111.206 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.422 ' H ' HG23 ' A' ' 58' ' ' THR . 12.2 mm-40 -74.96 -39.72 61.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.909 0.385 . . . . 72.450000000000003 110.436 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 39' ' ' VAL . 5.5 t -65.23 -51.33 61.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.665 . . . . 63.149999999999999 110.56 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.0 -36.99 80.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.865 0.364 . . . . 54.210000000000001 110.384 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.3 tt0 -60.4 -43.15 96.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 110.237 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.67 ' HG3' HH11 ' A' ' 65' ' ' ARG . 18.8 ttm-85 -60.85 -53.18 60.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.63 -0.714 . . . . 74.430000000000007 111.764 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.8 pt -67.26 -37.39 79.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.953 0.406 . . . . 74.430000000000007 111.125 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.921 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 35.2 mm-40 -66.81 -33.17 75.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.02 -0.537 . . . . 71.010000000000005 110.527 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.504 ' C ' ' HB3' ' A' ' 72' ' ' ASP . 16.1 mm-40 -78.21 2.33 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.685 0.279 . . . . 75.109999999999999 111.226 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 71.6 mt -103.59 -66.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.099 0.476 . . . . 70.129999999999995 110.968 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -85.33 -55.21 4.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.578 0.704 . . . . 45.109999999999999 110.845 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -10.97 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.864 -1.062 . . . . 55.350000000000001 111.853 -170.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 6.8 p-10 -42.15 -34.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.978 1.103 . . . . 73.310000000000002 113.978 -167.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 96.0 mmm -62.06 89.54 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.299 0.571 . . . . 75.019999999999996 111.069 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 94' ' ' VAL . 6.6 p -119.99 132.94 23.9 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.547 -0.751 . . . . 71.120000000000005 110.186 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 8.2 Cg_exo -73.1 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.882 2.388 . . . . 72.129999999999995 112.019 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.5 -21.76 28.2 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.866 0.321 . . . . 60.32 111.866 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -56.15 -18.34 9.75 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.253 -0.43 . . . . 75.439999999999998 111.795 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 9.7 p -57.11 -40.2 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.919 0.39 . . . . 72.150000000000006 110.453 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -73.85 -31.1 63.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 74.439999999999998 110.077 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.51 -27.28 67.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.894 -0.594 . . . . 73.109999999999999 110.069 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -83.24 -2.86 56.63 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.552 -0.749 . . . . 54.530000000000001 110.277 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 94.2 mt -112.34 147.89 35.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.208 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -103.98 19.55 19.82 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.188 -1.041 . . . . 64.540000000000006 108.188 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -102.44 174.64 5.81 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.029 -0.987 . . . . 74.549999999999997 110.661 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -165.41 138.09 4.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.878 -0.601 . . . . 73.5 109.721 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 66.73 24.17 10.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.578 0.549 . . . . 53.329999999999998 111.132 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.31 124.28 13.18 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.954 -0.566 . . . . 74.420000000000002 111.905 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.32 -32.45 71.87 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.983 2.455 . . . . 73.530000000000001 112.549 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.61 54.11 0.18 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.304 -0.719 . . . . 73.430000000000007 111.304 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -115.31 108.56 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.626 0.25 . . . . 44.039999999999999 110.432 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' HA ' HD11 ' A' ' 82' ' ' LEU . 4.1 p30 -148.0 133.19 18.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.226 -0.443 . . . . 74.510000000000005 110.22 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -97.12 135.3 39.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.589 -0.893 . . . . 74.099999999999994 108.589 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.91 171.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 75.120000000000005 110.989 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 94' ' ' VAL . 7.7 p -80.18 41.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 122.719 1.247 . . . . 75.409999999999997 112.524 -171.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.921 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 6.1 tmm_? . . . . . 0 C--O 1.251 1.176 0 CA-C-N 114.677 -1.147 . . . . 74.540000000000006 108.284 164.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.606 0.241 . . . . 73.219999999999999 111.023 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.03 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.788 -0.449 . . . . 73.439999999999998 109.788 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -102.7 46.05 0.94 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.038 0.447 . . . . 72.239999999999995 111.012 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' HIS . 7.2 p-80 44.03 22.03 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.412 1.264 . . . . 53.229999999999997 114.412 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 59.79 -76.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.619 0.6 . . . . 64.019999999999996 112.619 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 4' ' ' HIS . 27.2 t-80 -56.39 111.96 1.12 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.81 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -107.78 157.17 18.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.574 -0.739 . . . . 52.520000000000003 109.914 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -59.04 108.71 0.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.008 -0.368 . . . . 71.439999999999998 110.008 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 ttm -122.56 -45.29 2.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 71.540000000000006 110.215 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.36 58.05 1.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.619 -0.719 . . . . 73.319999999999993 111.543 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -61.16 -27.53 68.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.117 0.484 . . . . 64.109999999999999 110.471 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.4 mt -146.39 173.96 11.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.81 -0.811 . . . . 73.430000000000007 108.81 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.76 162.92 27.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 52.229999999999997 111.414 -175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.24 -175.61 2.9 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.662 -0.866 . . . . 61.0 108.662 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -84.68 58.64 5.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.45 0.643 . . . . 73.030000000000001 109.774 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -83.83 92.37 7.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.697 . . . . 75.239999999999995 110.442 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -112.57 134.16 54.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 74.109999999999999 109.981 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' H ' ' NE2' ' A' ' 64' ' ' GLN . . . -135.81 178.72 18.47 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.33 -0.708 . . . . 74.420000000000002 111.33 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.46 141.03 49.67 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.75 2.3 . . . . 73.409999999999997 112.29 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.93 -168.33 39.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.984 -0.626 . . . . 44.340000000000003 112.327 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 m -117.08 162.92 17.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.943 -0.391 . . . . 65.310000000000002 109.943 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.462 ' O ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -109.93 123.56 49.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.172 0.511 . . . . 73.349999999999994 110.546 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.37 176.4 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.561 -0.745 . . . . 74.420000000000002 110.098 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.89 -35.48 32.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 70.420000000000002 110.234 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.93 133.58 47.46 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 71.109999999999999 111.075 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.27 141.47 37.56 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.196 0.522 . . . . 63.109999999999999 110.256 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -129.62 153.0 48.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.367 -0.833 . . . . 64.219999999999999 109.751 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -116.02 167.45 10.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.083 -0.962 . . . . 74.329999999999998 108.896 169.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.3 t -92.47 146.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.131 -1.433 . . . . 71.299999999999997 107.131 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.454 HG11 HD11 ' A' ' 46' ' ' LEU . 34.5 m -140.32 163.9 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 118.395 0.543 . . . . 74.310000000000002 110.927 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -164.16 159.69 20.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.189 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -171.32 140.21 1.41 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.029 -0.532 . . . . 44.450000000000003 110.619 168.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 t30 50.02 4.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.058 1.133 . . . . 73.120000000000005 114.058 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 9.4 pt-20 -107.71 -29.49 9.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.824 -0.547 . . . . 70.25 112.371 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.97 19.28 67.6 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.644 -0.788 . . . . 21.199999999999999 111.411 -173.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.815 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 87.3 mt-30 -129.52 174.03 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.736 0.814 . . . . 74.310000000000002 108.807 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.5 132.64 56.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.593 0.711 . . . . 73.099999999999994 112.416 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 m -124.95 178.38 5.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.579 -1.191 . . . . 73.510000000000005 108.886 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 62' ' ' CYS . 18.0 m -129.91 160.07 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.855 0.36 . . . . 63.030000000000001 111.337 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -157.67 154.38 28.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.863 -0.792 . . . . 74.310000000000002 108.863 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -80.26 135.12 36.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.976 -0.289 . . . . 73.299999999999997 110.625 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.75 136.23 52.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 70.439999999999998 110.529 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.78 -3.71 74.6 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.188 -0.46 . . . . 43.5 112.132 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -103.26 128.19 50.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.705 -0.48 . . . . 65.319999999999993 109.705 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -64.97 156.69 30.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.025 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.454 HD11 HG11 ' A' ' 30' ' ' VAL . 19.9 mt -124.34 139.43 32.88 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.471 -0.786 . . . . 65.25 110.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -54.73 141.49 75.81 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.899 2.4 . . . . 72.340000000000003 111.612 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.25 127.65 25.27 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.829 0.347 . . . . 71.430000000000007 110.442 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.75 -34.54 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.538 -0.625 . . . . 71.010000000000005 111.538 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.4 m95 -78.15 142.81 37.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.989 -0.374 . . . . 71.239999999999995 109.989 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.5 152.92 48.5 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 120.774 0.321 . . . . 74.230000000000004 110.318 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 p -100.94 154.31 18.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.103 -0.953 . . . . 63.350000000000001 110.9 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.09 171.08 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.301 1.04 . . . . 74.209999999999994 109.182 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.95 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.713 -0.756 . . . . 72.200000000000003 112.522 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.67 132.92 10.16 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.122 -1.066 . . . . 72.409999999999997 108.122 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.65 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.9 Cg_endo -62.85 122.38 10.65 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.875 1.716 . . . . 72.400000000000006 112.42 -170.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.79 160.71 10.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.508 -0.769 . . . . 55.439999999999998 109.351 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -55.86 154.99 6.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.65 0.262 . . . . 72.340000000000003 111.104 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 87.4 tttt -49.05 -40.94 33.33 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.946 -0.57 . . . . 75.310000000000002 110.886 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.94 -48.16 70.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.464 -0.789 . . . . 73.420000000000002 110.923 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -74.77 -30.18 61.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 72.450000000000003 110.783 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 39' ' ' VAL . 12.9 t -66.36 -50.94 61.84 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.911 -0.586 . . . . 63.149999999999999 110.667 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.2 pp -63.93 -37.97 89.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.954 0.407 . . . . 54.210000000000001 110.276 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 26.3 tt0 -58.68 -43.49 89.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.824 -0.626 . . . . 74.010000000000005 110.237 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.7 ttt180 -62.05 -43.58 98.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.166 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.67 -38.29 44.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 111.827 0.306 . . . . 74.430000000000007 111.827 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 34.9 mm-40 -64.12 -41.59 97.18 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 121.304 -0.158 . . . . 71.010000000000005 111.15 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 64.1 mt-30 -73.9 7.86 2.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.02 0.438 . . . . 75.109999999999999 111.18 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.5 mt -103.63 -65.92 0.98 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.307 -0.406 . . . . 70.129999999999995 110.874 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -85.79 -52.85 5.49 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.682 -0.69 . . . . 45.109999999999999 111.128 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -74.88 -11.69 60.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.414 -0.812 . . . . 55.350000000000001 111.054 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 4.0 p-10 -43.14 -35.61 1.41 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.842 -0.617 . . . . 73.310000000000002 112.398 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -67.75 81.13 0.19 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.405 0.621 . . . . 75.019999999999996 110.068 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.973 HG21 ' HB ' ' A' ' 94' ' ' VAL . 1.3 t -119.22 144.39 36.14 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 71.120000000000005 110.989 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 74' ' ' VAL . 42.1 Cg_endo -65.74 -168.34 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.973 2.449 . . . . 72.129999999999995 113.035 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.72 -19.13 5.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.01 -0.541 . . . . 60.32 112.246 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 50.7 p -57.4 -23.06 47.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.322 -0.399 . . . . 75.439999999999998 111.346 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' O ' HD13 ' A' ' 82' ' ' LEU . 11.1 p -59.52 -41.15 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.172 0.51 . . . . 72.150000000000006 110.242 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.94 -30.49 62.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.858 -0.61 . . . . 74.439999999999998 110.416 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 3.7 mm-40 -72.74 -45.88 56.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.676 -0.693 . . . . 73.109999999999999 111.302 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -69.18 -26.58 64.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 54.530000000000001 110.891 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 78' ' ' VAL . 10.3 mp -91.78 56.5 2.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.637 0.732 . . . . 73.430000000000007 109.984 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 85' ' ' HIS . 25.0 t-20 -97.14 -45.68 6.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.855 -1.066 . . . . 64.540000000000006 110.674 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 73.44 -2.13 2.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.609 -0.723 . . . . 74.549999999999997 111.915 174.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.494 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 11.9 t60 -111.74 154.98 24.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.077 -0.712 . . . . 73.5 109.077 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.1 t -51.77 134.55 30.61 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.749 0.309 . . . . 53.329999999999998 110.767 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.68 -80.16 0.26 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.323 -0.711 . . . . 74.420000000000002 111.323 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.41 -148.09 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.159 2.572 . . . . 73.530000000000001 111.837 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.13 -47.32 1.1 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.312 -0.715 . . . . 73.430000000000007 111.312 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 pt -94.73 16.68 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 122.001 0.905 . . . . 44.039999999999999 110.178 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -88.7 170.07 11.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.905 -1.498 . . . . 74.510000000000005 110.273 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -100.69 135.24 42.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.319 -0.4 . . . . 74.099999999999994 111.077 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.75 -170.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.804 -0.634 . . . . 75.120000000000005 109.822 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.973 ' HB ' HG21 ' A' ' 74' ' ' VAL . 7.3 p -81.19 158.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.726 -0.472 . . . . 75.409999999999997 109.726 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.501 ' HD2' ' HB2' ' A' ' 64' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.831 0 CA-C-O 117.938 -1.03 . . . . 74.540000000000006 108.798 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.765 0.317 . . . . 73.219999999999999 110.985 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.38 148.71 22.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.179 -0.304 . . . . 73.439999999999998 110.179 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -121.65 11.04 10.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.213 0.53 . . . . 72.239999999999995 109.859 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -74.34 107.92 6.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.651 . . . . 53.229999999999997 110.786 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -95.85 157.67 15.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 64.019999999999996 110.276 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -173.22 85.25 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.947 -0.39 . . . . 74.209999999999994 109.947 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.442 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 30.9 p80 -81.18 81.25 7.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.111 0.482 . . . . 52.520000000000003 111.841 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 179.28 96.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 71.439999999999998 110.218 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.81 -43.73 29.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 71.540000000000006 109.65 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.94 74.73 0.39 Allowed Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.642 -0.708 . . . . 73.319999999999993 112.37 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.625 HG22 ' HG ' ' A' ' 12' ' ' LEU . 6.0 m -92.71 -86.84 0.24 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.672 0.272 . . . . 64.109999999999999 111.318 -176.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 11' ' ' THR . 94.4 mt -127.61 176.29 7.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.772 0.32 . . . . 73.430000000000007 110.617 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.46 -169.31 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.856 -0.611 . . . . 52.229999999999997 110.628 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -69.75 -172.58 0.51 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 123.384 0.428 . . . . 61.0 111.413 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -134.1 106.67 7.32 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.101 -0.5 . . . . 73.030000000000001 110.189 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' GLY . 10.6 t -92.6 -38.02 12.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.562 -0.533 . . . . 75.239999999999995 109.562 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 37.67 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.075 0.95 . . . . 74.109999999999999 113.017 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 148.4 150.96 5.34 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.981 -0.848 . . . . 74.420000000000002 110.981 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.48 85.02 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.439 2.092 . . . . 73.409999999999997 111.665 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.45 -142.89 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.901 -0.59 . . . . 44.340000000000003 112.187 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -178.09 -65.96 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.388 0.613 . . . . 65.310000000000002 110.209 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -137.23 14.72 3.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.534 -0.757 . . . . 73.349999999999994 110.364 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 24' ' ' ASP . 6.2 p-10 -65.15 -89.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.812 -1.086 . . . . 74.420000000000002 112.458 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.4 m-20 -118.76 136.38 54.0 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 122.774 0.429 . . . . 70.420000000000002 110.736 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -65.14 154.04 39.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.159 -0.682 . . . . 71.109999999999999 109.159 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 57' ' ' ALA . 3.2 mm? -76.22 151.97 36.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.696 0.76 . . . . 63.109999999999999 111.867 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 10.0 m-85 -127.37 148.5 50.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.735 -1.121 . . . . 64.219999999999999 109.1 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.608 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.19 159.8 22.05 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.7 . . . . 74.329999999999998 109.111 174.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG12 HG23 ' A' ' 53' ' ' VAL . 46.6 t -91.97 145.85 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 46' ' ' LEU . 26.0 m -138.87 161.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 121.771 -0.581 . . . . 74.310000000000002 111.517 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 24.8 ptt180 -161.81 155.42 21.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.498 -0.773 . . . . 74.209999999999994 110.201 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.606 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.0 p30 -161.33 139.72 9.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.213 -0.292 . . . . 44.450000000000003 110.213 169.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 43.08 3.89 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.692 1.367 . . . . 73.120000000000005 114.692 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 32' ' ' ASN . 14.8 pt-20 -112.49 -32.03 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.573 -0.705 . . . . 70.25 111.594 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.21 -22.52 18.9 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.411 -0.423 . . . . 21.199999999999999 113.095 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -86.29 174.11 9.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.97 0.385 . . . . 74.310000000000002 110.383 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -106.26 139.89 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 73.099999999999994 112.442 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 29' ' ' VAL . 23.0 m -134.87 178.24 7.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.379 -0.828 . . . . 73.510000000000005 109.464 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 62' ' ' CYS . 36.0 m -123.1 159.13 27.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.521 0.201 . . . . 63.030000000000001 110.65 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -158.37 139.02 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.987 -0.746 . . . . 74.310000000000002 108.987 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.5 ttt -67.39 124.37 22.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.262 . . . . 73.299999999999997 110.81 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.82 130.97 44.62 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.297 -0.41 . . . . 70.439999999999998 110.123 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.13 -9.41 33.62 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.291 -0.724 . . . . 43.5 111.291 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -106.38 111.27 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 65.319999999999993 109.278 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 m -66.74 141.63 57.67 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.725 . . . . 72.319999999999993 112.11 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 HD12 HG23 ' A' ' 52' ' ' THR . 45.3 mt -96.3 151.44 38.12 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 114.727 -1.124 . . . . 65.25 111.314 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 69.2 Cg_endo -77.97 152.55 28.35 Favored 'Trans proline' 0 C--O 1.242 0.697 0 C-N-CA 122.549 2.166 . . . . 72.340000000000003 111.774 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.24 19.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.67 -0.695 . . . . 71.430000000000007 111.018 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.78 -35.27 4.37 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.443 -0.799 . . . . 71.010000000000005 111.339 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 22.5 m95 -83.41 142.13 31.22 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.979 -0.378 . . . . 71.239999999999995 109.979 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -129.28 148.24 51.19 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 120.852 0.358 . . . . 74.230000000000004 110.582 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 HD12 ' A' ' 46' ' ' LEU . 19.9 p -99.04 150.75 21.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.659 -1.155 . . . . 63.350000000000001 110.315 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.76 155.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.107 -172.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.73 -160.17 24.21 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.905 -1.043 . . . . 72.200000000000003 112.641 175.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 32.9 tt0 -103.83 133.14 20.42 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 55.5 Cg_endo -70.24 111.14 2.83 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.322 1.348 . . . . 72.400000000000006 110.566 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 26' ' ' LEU . . . -147.53 171.98 14.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.799 -0.637 . . . . 55.439999999999998 110.241 -171.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 61' ' ' GLN . 5.9 t -57.14 156.2 7.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.512 -0.313 . . . . 72.340000000000003 111.441 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -49.76 -43.7 48.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.953 0.501 . . . . 75.310000000000002 110.962 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.21 -51.31 62.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.806 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 58' ' ' THR . 85.6 mm-40 -69.28 -30.74 68.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 72.450000000000003 110.687 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 39' ' ' VAL . 4.1 t -63.5 -50.09 70.98 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.076 -0.511 . . . . 63.149999999999999 110.288 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.3 pp -68.06 -46.51 70.91 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.929 -0.397 . . . . 54.210000000000001 109.929 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.4 tt0 -56.87 -31.88 65.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 74.010000000000005 111.162 -175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.1 ttt85 -70.96 -53.54 14.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 111.435 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.9 pt -70.53 -37.75 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.777 0.288 . . . . 74.430000000000007 111.777 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.719 ' HB2' HG23 ' A' ' 94' ' ' VAL . 13.2 pt-20 -69.59 -37.75 77.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 111.095 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -81.33 1.74 31.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 66.6 mt -103.77 -66.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 70.129999999999995 110.844 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -85.18 -53.36 5.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.709 -0.678 . . . . 45.109999999999999 110.911 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.7 m -75.35 -11.13 59.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.46 -0.791 . . . . 55.350000000000001 111.47 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -43.92 -32.97 1.24 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.368 0.667 . . . . 73.310000000000002 112.339 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.0 ttt -66.33 77.89 0.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.836 -0.62 . . . . 75.019999999999996 109.981 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.56 HG23 ' HB1' ' A' ' 93' ' ' ALA . 5.8 p -74.14 133.45 78.33 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.084 -0.962 . . . . 71.120000000000005 110.597 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 Cg_exo -67.45 -158.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.033 2.489 . . . . 72.129999999999995 112.111 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.02 -23.54 13.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.712 0.292 . . . . 60.32 111.554 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t -59.37 -8.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.176 -0.465 . . . . 75.439999999999998 111.206 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HB ' HG13 ' A' ' 74' ' ' VAL . 7.2 p -53.85 -44.32 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-O 121.164 0.507 . . . . 72.150000000000006 109.879 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -65.89 -32.7 74.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 74.439999999999998 110.086 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.657 ' HG3' ' CG ' ' A' ' 85' ' ' HIS . 29.2 tt0 -76.88 -28.74 55.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.517 -0.765 . . . . 73.109999999999999 111.3 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -86.49 -23.85 25.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.356 -0.384 . . . . 54.530000000000001 110.659 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 78' ' ' VAL . 10.1 mp -100.18 -47.88 4.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.298 -0.41 . . . . 73.430000000000007 110.925 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -97.97 150.8 20.97 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.341 -0.39 . . . . 64.540000000000006 110.474 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 11.6 pt20 -69.74 92.04 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 74.549999999999997 110.053 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.657 ' CG ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -60.28 90.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.671 -0.695 . . . . 73.5 111.394 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -75.14 85.51 2.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 53.329999999999998 109.828 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.17 -126.44 2.04 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.939 -0.573 . . . . 74.420000000000002 111.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.41 169.81 13.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.934 2.422 . . . . 73.530000000000001 112.416 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.4 99.0 0.23 Allowed Glycine 0 C--N 1.331 0.25 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 112.275 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -105.45 80.32 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.284 0.564 . . . . 44.039999999999999 109.496 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.42 8.03 1.56 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.35 -0.841 . . . . 74.510000000000005 112.081 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -80.89 73.48 7.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.321 0.582 . . . . 74.099999999999994 109.725 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 74' ' ' VAL . . . -151.32 -163.3 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.176 -0.92 . . . . 75.120000000000005 109.874 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 67' ' ' GLU . 8.7 p -75.84 136.59 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 110.12 -0.326 . . . . 75.409999999999997 110.12 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.763 -0.636 . . . . 74.540000000000006 111.098 -175.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.837 -0.431 . . . . 73.219999999999999 109.837 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.29 90.35 1.25 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.911 0.386 . . . . 73.439999999999998 110.417 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -60.51 -44.3 96.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 72.239999999999995 110.537 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -93.66 43.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.349 0.595 . . . . 53.229999999999997 109.735 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -58.77 143.84 45.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.805 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -153.48 -175.68 5.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.71 -0.677 . . . . 74.209999999999994 109.48 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -135.16 -80.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.678 0.275 . . . . 52.520000000000003 110.829 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -176.78 123.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 71.439999999999998 110.564 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.7 mtp -79.85 -53.8 6.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 71.540000000000006 110.224 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.63 114.46 3.87 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.944 -0.571 . . . . 73.319999999999993 112.524 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.0 p -115.97 -66.55 1.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 64.109999999999999 109.574 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.7 mt -116.56 -160.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 73.430000000000007 109.289 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.735 ' HG3' ' H ' ' A' ' 15' ' ' GLN . 7.0 pt-20 -102.98 -166.69 1.3 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.543 -0.54 . . . . 52.229999999999997 109.543 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.55 -13.49 52.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.873 0.368 . . . . 61.0 110.205 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.735 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 74.1 mt-30 67.46 77.41 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.097 -0.956 . . . . 73.030000000000001 109.71 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 71.3 p -97.96 -7.67 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.741 -1.118 . . . . 75.239999999999995 111.361 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.695 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 41.57 49.04 3.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.618 0.723 . . . . 74.109999999999999 110.544 -171.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.1 149.16 27.16 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.049 -0.978 . . . . 74.420000000000002 112.842 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.91 -24.35 8.53 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.711 2.274 . . . . 73.409999999999997 112.527 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.83 41.04 99.93 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.495 -0.642 . . . . 44.340000000000003 111.495 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -77.62 -178.51 5.35 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.254 0.222 . . . . 65.310000000000002 110.753 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 63.9 mtt 62.47 22.68 13.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.928 -0.578 . . . . 73.349999999999994 110.501 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -171.52 -170.34 0.8 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.553 -0.906 . . . . 74.420000000000002 108.553 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.66 -60.46 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.091 0.472 . . . . 70.420000000000002 110.536 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.96 97.72 8.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.616 -0.72 . . . . 71.109999999999999 110.009 -175.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 31.3 mt -82.27 166.78 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.997 0.903 . . . . 63.109999999999999 111.768 -174.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.65 149.67 41.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.966 -1.47 . . . . 64.219999999999999 109.338 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.603 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 m-85 -107.94 164.08 12.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.782 -0.821 . . . . 74.329999999999998 108.782 168.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HH11 ' A' ' 65' ' ' ARG . 40.1 t -92.3 137.24 22.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.27 -1.382 . . . . 71.299999999999997 107.27 174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 13.7 m -139.03 164.95 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 118.113 0.415 . . . . 74.310000000000002 111.244 -174.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 39.2 ptt180 -169.19 170.02 8.93 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.571 -0.74 . . . . 74.209999999999994 110.473 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.6 p30 -156.19 139.79 15.97 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.337 -0.246 . . . . 44.450000000000003 110.337 170.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.4 t30 47.42 4.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.885 1.069 . . . . 73.120000000000005 113.885 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.2 pt-20 -112.26 -32.32 6.56 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.806 -0.559 . . . . 70.25 111.924 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.95 -22.73 4.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.388 -0.434 . . . . 21.199999999999999 112.73 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -73.45 174.06 8.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.872 0.336 . . . . 74.310000000000002 110.315 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -121.85 132.64 54.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.332 0.493 . . . . 73.099999999999994 112.332 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -129.02 176.89 7.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.267 -0.879 . . . . 73.510000000000005 109.393 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.22 149.19 21.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.915 0.388 . . . . 63.030000000000001 110.815 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' ' HB3' ' A' ' 44' ' ' ARG . 70.8 t-105 -149.18 137.87 21.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 74.310000000000002 109.728 -171.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.6 ttt -62.76 125.19 23.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.663 -0.244 . . . . 73.299999999999997 110.896 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.76 144.33 57.13 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.785 -0.45 . . . . 70.439999999999998 109.785 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.7 -34.55 4.94 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 111.144 -0.782 . . . . 43.5 111.144 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HB3' ' NE1' ' A' ' 40' ' ' TRP . 4.8 ttt180 -69.82 95.42 0.9 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.804 -0.813 . . . . 65.319999999999993 108.804 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.1 m -61.3 126.07 26.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 111.929 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.8 mt -85.05 148.15 49.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.935 -1.03 . . . . 65.25 110.944 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 61.6 Cg_endo -79.09 159.62 26.86 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.625 2.216 . . . . 72.340000000000003 112.045 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.84 126.65 23.02 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.006 -0.543 . . . . 71.430000000000007 110.773 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -35.18 4.43 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.578 -0.737 . . . . 71.010000000000005 111.488 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 44.3 m95 -83.51 134.89 34.82 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.988 -0.375 . . . . 71.239999999999995 109.988 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 10.6 pt-20 -119.25 146.95 44.8 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.424 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 46' ' ' LEU . 37.1 p -105.2 156.7 17.86 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.456 1.097 . . . . 63.350000000000001 110.106 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -164.78 157.71 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-O 121.336 0.588 . . . . 74.209999999999994 111.265 -173.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 87.04 -174.05 45.35 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 114.872 -1.058 . . . . 72.200000000000003 112.077 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 17' ' ' GLN . 0.4 OUTLIER -105.3 144.49 28.9 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.784 -0.821 . . . . 72.409999999999997 108.784 173.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.603 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 34.6 Cg_endo -64.4 140.05 68.02 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.971 1.781 . . . . 72.400000000000006 112.36 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' HB3' ' A' ' 26' ' ' LEU . . . -171.65 147.03 2.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.708 -0.678 . . . . 55.439999999999998 109.676 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.442 HG22 HE21 ' A' ' 61' ' ' GLN . 14.7 t -59.77 168.3 1.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.391 0.138 . . . . 72.340000000000003 111.23 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE3' HD23 ' A' ' 63' ' ' LEU . 56.0 tptt -44.37 -51.59 8.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.108 0.563 . . . . 75.310000000000002 111.921 -174.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.05 -47.82 77.18 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.901 0.382 . . . . 73.420000000000002 111.488 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.442 HE21 HG22 ' A' ' 58' ' ' THR . 50.1 mt-30 -74.73 -35.28 62.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 72.450000000000003 111.147 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.75 -45.94 80.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 63.149999999999999 109.971 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 pp -68.05 -44.33 76.65 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.85 -0.426 . . . . 54.210000000000001 109.85 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.587 ' N ' HD12 ' A' ' 63' ' ' LEU . 27.0 tt0 -55.06 -37.98 67.44 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.301 0.572 . . . . 74.010000000000005 109.825 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.573 HH11 HG21 ' A' ' 29' ' ' VAL . 65.9 ttt-85 -57.43 -53.33 59.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.436 -0.802 . . . . 74.430000000000007 111.137 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.4 pt -74.22 -33.9 36.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.449 -0.341 . . . . 74.430000000000007 111.892 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.81 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 74.4 mm-40 -64.12 -42.89 96.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.536 -0.302 . . . . 71.010000000000005 110.416 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.6 mm-40 -74.42 4.73 5.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.355 . . . . 75.109999999999999 111.078 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 87.9 mt -103.14 -64.98 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.37 . . . . 70.129999999999995 110.695 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.42 -52.03 6.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.818 -0.628 . . . . 45.109999999999999 111.141 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 m -73.47 -11.26 60.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.549 -0.75 . . . . 55.350000000000001 111.036 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -42.03 -37.16 1.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.679 0.792 . . . . 73.310000000000002 112.269 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.96 79.47 0.04 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.355 0.598 . . . . 75.019999999999996 110.035 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.5 p -97.1 135.31 22.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.555 -0.748 . . . . 71.120000000000005 110.8 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.58 -161.51 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.679 2.253 . . . . 72.129999999999995 111.66 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.39 -18.86 2.88 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.626 0.37 . . . . 60.32 111.883 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.7 t -52.11 -27.79 15.37 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.011 -0.54 . . . . 75.439999999999998 111.456 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.64 -40.65 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.96 0.409 . . . . 72.150000000000006 110.485 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -73.72 -34.53 64.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 74.439999999999998 110.206 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 91' ' ' ASP . 5.9 tp10 -64.75 -33.37 75.81 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.401 0.619 . . . . 73.109999999999999 109.432 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.619 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 50.2 t-80 -74.08 -20.21 60.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.421 -0.809 . . . . 54.530000000000001 110.634 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -43.9 9.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.132 -0.485 . . . . 73.430000000000007 109.963 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.77 111.8 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.378 -0.828 . . . . 64.540000000000006 111.101 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 140.53 22.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.934 -0.575 . . . . 74.549999999999997 109.912 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -116.67 85.2 2.27 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.974 -0.75 . . . . 73.5 108.974 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.9 t 68.18 -67.59 0.19 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.305 -0.861 . . . . 53.329999999999998 109.734 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.23 150.08 33.18 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.615 -0.594 . . . . 74.420000000000002 111.615 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.92 110.61 0.85 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.709 2.273 . . . . 73.530000000000001 112.734 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.65 50.59 0.76 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.547 -1.021 . . . . 73.430000000000007 110.547 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 81' ' ' HIS . 32.0 pt -90.15 172.23 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.33 -0.435 . . . . 44.039999999999999 112.02 -169.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' A' ' 80' ' ' GLU . 35.8 t70 -117.16 163.33 16.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.74 -0.663 . . . . 74.510000000000005 109.966 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -78.29 75.8 4.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.331 0.586 . . . . 74.099999999999994 110.943 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.323 -0.853 . . . . 75.120000000000005 110.084 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.33 134.66 25.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.602 -0.518 . . . . 75.409999999999997 109.602 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.81 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 54.5 mtt180 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.525 -0.75 . . . . 74.540000000000006 110.413 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mtp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.582 0.23 . . . . 73.219999999999999 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 75' ' ' PRO . . . -66.16 -46.93 75.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.97 0.414 . . . . 73.439999999999998 111.325 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -82.42 108.93 16.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 72.239999999999995 110.723 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -131.22 -85.48 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.327 -0.397 . . . . 53.229999999999997 110.046 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -62.89 134.22 55.89 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.141 -0.688 . . . . 64.019999999999996 109.141 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -143.23 109.94 5.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.204 0.526 . . . . 74.209999999999994 111.568 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -54.83 127.05 26.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 52.520000000000003 110.407 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -104.0 -71.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.436 -0.579 . . . . 71.439999999999998 109.436 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp 176.4 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.536 -0.756 . . . . 71.540000000000006 109.149 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.55 -111.57 2.09 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.098 -0.572 . . . . 73.319999999999993 112.716 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 p -82.97 136.4 34.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.609 0.242 . . . . 64.109999999999999 110.558 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.7 -37.9 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 110.079 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.663 ' HA ' HH12 ' A' ' 65' ' ' ARG . 2.9 mm-40 -108.79 -178.42 3.58 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.323 -0.398 . . . . 52.229999999999997 110.484 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -156.41 -166.19 2.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 61.0 110.095 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -88.23 91.32 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 73.030000000000001 110.481 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 p -70.39 94.27 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 75.239999999999995 109.641 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.55 174.25 8.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.576 -0.738 . . . . 74.109999999999999 111.139 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.49 -174.04 17.62 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.808 -0.633 . . . . 74.420000000000002 111.89 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.37 114.52 2.16 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.617 2.211 . . . . 73.409999999999997 111.911 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.57 70.32 1.68 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.903 -0.59 . . . . 44.340000000000003 112.206 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.7 t -71.85 100.14 2.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.049 -0.352 . . . . 65.310000000000002 110.049 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -90.62 12.79 17.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.23 0.538 . . . . 73.349999999999994 111.026 -178.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.94 -29.66 68.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.32 -0.854 . . . . 74.420000000000002 110.415 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -114.85 145.16 42.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.318 -0.993 . . . . 70.420000000000002 108.318 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.48 -175.82 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.922 0.391 . . . . 71.109999999999999 111.734 -171.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.65 148.48 46.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.334 0.588 . . . . 63.109999999999999 111.21 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -133.93 155.98 48.95 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.116 -0.947 . . . . 64.219999999999999 109.713 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -121.17 159.81 25.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.022 -0.99 . . . . 74.329999999999998 108.693 172.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG12 HG23 ' A' ' 53' ' ' VAL . 42.3 t -91.47 125.61 44.18 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.098 -1.075 . . . . 71.299999999999997 108.098 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 52' ' ' THR . 16.7 m -133.17 166.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.9 0.381 . . . . 74.310000000000002 111.084 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -165.81 162.23 18.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.497 -0.774 . . . . 74.209999999999994 110.522 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.477 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.1 OUTLIER -151.94 139.78 19.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.647 0.26 . . . . 44.450000000000003 110.353 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t30 44.47 8.97 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.14 1.163 . . . . 73.120000000000005 114.14 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.3 pt-20 -112.41 -32.26 6.55 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.789 -0.569 . . . . 70.25 111.852 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -22.94 3.65 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.958 -0.564 . . . . 21.199999999999999 113.078 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -87.43 173.69 8.97 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.456 -0.572 . . . . 74.310000000000002 109.456 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 70' ' ' TRP . 15.8 m-85 -106.89 138.75 42.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.365 0.876 . . . . 73.099999999999994 113.365 -172.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 m -134.96 -179.01 5.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.402 -1.272 . . . . 73.510000000000005 109.011 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 62' ' ' CYS . 28.3 m -124.26 159.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.935 0.397 . . . . 63.030000000000001 111.29 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.465 ' HB2' HG21 ' A' ' 30' ' ' VAL . 68.3 t-105 -142.8 143.38 32.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.252 -0.647 . . . . 74.310000000000002 109.252 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.5 ttt -81.37 127.44 32.77 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.234 -0.284 . . . . 73.299999999999997 110.234 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.79 157.11 18.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.256 -0.429 . . . . 70.439999999999998 111.26 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.32 10.6 55.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.191 -0.528 . . . . 43.5 112.669 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -151.47 130.0 12.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.903 0.382 . . . . 65.319999999999993 110.147 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -80.67 153.42 27.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.514 0.673 . . . . 72.319999999999993 111.643 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 52' ' ' THR . 52.7 mt -95.26 145.81 30.19 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 114.857 -1.065 . . . . 65.25 111.013 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.31 168.35 14.95 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.642 2.228 . . . . 72.340000000000003 112.551 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.3 129.84 22.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 111.022 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.82 -33.03 6.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.022 -0.536 . . . . 71.010000000000005 111.804 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 45.0 m95 -88.48 141.46 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.786 0.327 . . . . 71.239999999999995 110.762 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.02 154.49 47.36 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 110.304 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.625 HG23 HD12 ' A' ' 46' ' ' LEU . 15.7 p -114.49 160.68 18.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.373 1.046 . . . . 63.350000000000001 111.194 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.452 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -165.72 149.35 2.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 C-N-CA 123.474 0.71 . . . . 74.209999999999994 110.907 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 108.27 -172.65 17.21 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.128 -0.942 . . . . 72.200000000000003 113.305 172.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' OE2' ' HD2' ' A' ' 56' ' ' PRO . 5.8 tp10 -103.27 129.45 25.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 107.983 -1.117 . . . . 72.409999999999997 107.983 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 18.9 Cg_endo -56.74 122.11 11.23 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.738 1.625 . . . . 72.400000000000006 111.32 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.72 157.78 30.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 55.439999999999998 110.431 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 t -55.73 152.93 8.83 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.088 0.243 . . . . 72.340000000000003 110.698 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.78 -42.44 25.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 111.853 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -53.92 -44.09 70.3 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.098 0.475 . . . . 73.420000000000002 111.036 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 82.6 mm-40 -74.85 -39.11 61.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 72.450000000000003 110.537 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 39' ' ' VAL . 8.9 t -63.42 -43.69 96.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 63.149999999999999 110.561 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.4 pp -68.14 -36.63 80.0 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 109.621 -0.511 . . . . 54.210000000000001 109.621 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 5.4 tt0 -54.77 -44.61 73.82 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.308 -0.627 . . . . 74.010000000000005 109.308 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.663 HH12 ' HA ' ' A' ' 13' ' ' GLU . 25.7 ttt85 -56.34 -52.0 66.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.814 -0.63 . . . . 74.430000000000007 110.952 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.49 -35.97 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.653 -0.249 . . . . 74.430000000000007 111.637 -176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 26.5 mm-40 -66.42 -32.75 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.603 0.239 . . . . 71.010000000000005 110.624 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.7 mm100 -81.19 -18.91 44.59 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.273 -0.421 . . . . 75.109999999999999 111.396 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.89 -66.65 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.327 0.584 . . . . 70.129999999999995 112.187 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . 65.5 t-105 -85.3 -46.1 11.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 45.109999999999999 110.66 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -82.71 -10.06 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.098 -0.955 . . . . 55.350000000000001 110.993 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -40.89 -29.57 0.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.656 1.354 . . . . 73.310000000000002 114.656 -170.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.6 ttp -67.94 78.61 0.22 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.342 0.591 . . . . 75.019999999999996 109.969 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.17 134.65 19.55 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.42 -0.809 . . . . 71.120000000000005 111.437 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 80.2 Cg_endo -86.62 -151.38 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.33 2.687 . . . . 72.129999999999995 111.549 173.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.0 -11.11 7.07 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.036 0.384 . . . . 60.32 112.036 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 t -56.06 -21.05 19.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 75.439999999999998 111.245 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 79' ' ' ARG . 4.9 p -55.79 -51.12 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.452 -0.34 . . . . 72.150000000000006 111.212 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 78' ' ' VAL . 5.2 ptm180 -73.59 -20.55 60.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 74.439999999999998 110.758 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.99 -13.63 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.304 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -101.95 -53.23 2.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.003 -0.544 . . . . 54.530000000000001 110.393 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 91' ' ' ASP . 64.1 mt -90.0 175.13 7.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.589 -0.732 . . . . 73.430000000000007 110.795 -176.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -114.65 -66.03 1.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.46 -0.57 . . . . 64.540000000000006 109.46 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -87.23 75.39 9.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.797 0.808 . . . . 74.549999999999997 109.964 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -61.78 -21.81 64.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 73.5 111.623 -176.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.3 m -97.28 17.69 16.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.943 0.401 . . . . 53.329999999999998 110.826 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.6 164.27 43.17 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.094 -0.503 . . . . 74.420000000000002 112.541 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.9 79.09 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.149 2.566 . . . . 73.530000000000001 112.124 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.02 -50.05 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.981 -0.554 . . . . 73.430000000000007 111.899 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 90' ' ' ILE . 29.3 mt 58.15 34.61 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 122.442 1.115 . . . . 44.039999999999999 110.064 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.471 ' O ' HD11 ' A' ' 82' ' ' LEU . 9.1 p-10 -85.82 68.63 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.678 -1.146 . . . . 74.510000000000005 110.53 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -79.13 53.59 1.48 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.492 0.663 . . . . 74.099999999999994 111.403 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.98 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.524 -0.762 . . . . 75.120000000000005 110.422 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 94' ' ' VAL . 7.5 p -89.23 28.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 122.976 1.369 . . . . 75.409999999999997 111.162 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--O 1.251 1.139 0 CA-C-N 113.778 -1.555 . . . . 74.540000000000006 110.664 178.592 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.786 0.327 . . . . 73.219999999999999 110.124 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.05 61.13 3.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 73.439999999999998 111.14 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -98.48 123.7 42.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.82 -0.808 . . . . 72.239999999999995 108.82 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -96.66 103.63 15.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.869 0.366 . . . . 53.229999999999997 111.626 -171.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -164.86 136.18 4.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.06 -0.719 . . . . 64.019999999999996 109.06 174.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -126.51 137.92 53.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.418 -0.215 . . . . 74.209999999999994 110.418 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.421 ' NE2' ' HB2' ' A' ' 9' ' ' MET . 82.0 t60 -110.53 98.9 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 52.520000000000003 109.786 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -83.96 62.14 6.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.943 -0.571 . . . . 71.439999999999998 111.473 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.421 ' HB2' ' NE2' ' A' ' 7' ' ' HIS . 19.8 mmt -148.8 161.05 42.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.998 -0.371 . . . . 71.540000000000006 109.998 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.99 170.19 44.47 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.888 -0.596 . . . . 73.319999999999993 112.688 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.2 m -80.55 -44.32 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 64.109999999999999 110.999 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 tt -151.93 -41.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.126 0.488 . . . . 73.430000000000007 109.768 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -78.84 16.3 0.91 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.09 -0.505 . . . . 52.229999999999997 111.206 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.69 127.35 31.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 61.0 110.671 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.481 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 10.2 pt20 -125.32 120.03 30.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 73.030000000000001 110.062 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -65.41 -32.39 74.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.213 0.53 . . . . 75.239999999999995 110.102 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -163.67 143.02 8.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.561 -0.745 . . . . 74.109999999999999 109.308 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.4 84.91 0.38 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.727 -0.549 . . . . 74.420000000000002 111.727 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.1 -19.35 45.26 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.844 2.363 . . . . 73.409999999999997 111.943 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.16 -147.21 18.59 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.591 -0.731 . . . . 44.340000000000003 111.836 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.5 p -160.78 173.93 14.66 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 110.176 -0.305 . . . . 65.310000000000002 110.176 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 86.6 mtp -122.91 74.99 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 73.349999999999994 109.408 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 38.21 47.33 0.98 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.76 1.266 . . . . 74.420000000000002 112.166 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.73 176.81 4.57 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.224 -1.807 . . . . 70.420000000000002 111.179 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.29 118.28 23.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.522 -0.918 . . . . 71.109999999999999 108.522 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.89 146.25 37.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 63.109999999999999 111.419 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 22.7 m-85 -129.92 148.55 51.8 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.574 -1.194 . . . . 64.219999999999999 108.843 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.581 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.58 166.41 11.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.742 -0.836 . . . . 74.329999999999998 108.742 171.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.6 t -94.56 111.72 25.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 107.1 -1.444 . . . . 71.299999999999997 107.1 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 40' ' ' TRP . 11.5 m -125.87 167.0 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.985 -0.447 . . . . 74.310000000000002 111.534 -170.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -166.19 169.68 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 74.209999999999994 110.997 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -156.15 139.75 15.97 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.538 -0.301 . . . . 44.450000000000003 110.757 172.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.3 t30 40.53 10.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.898 1.279 . . . . 73.120000000000005 114.216 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.0 pt-20 -112.61 -32.29 6.5 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.691 -0.631 . . . . 70.25 112.124 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.91 -22.96 2.19 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.165 -0.541 . . . . 21.199999999999999 112.633 -173.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -75.81 173.89 10.57 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.624 -0.51 . . . . 74.310000000000002 109.624 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -115.71 142.29 46.94 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.912 0.708 . . . . 73.099999999999994 112.912 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.0 m -137.59 -179.46 5.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.417 -1.265 . . . . 73.510000000000005 109.65 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.02 148.99 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.769 0.319 . . . . 63.030000000000001 110.983 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.488 ' HB2' HG21 ' A' ' 30' ' ' VAL . 70.3 t90 -144.44 129.88 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 110.958 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.6 ttm -69.93 143.58 52.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 73.299999999999997 110.477 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.09 -172.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 110.655 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.55 -34.41 4.2 Favored Glycine 0 CA--C 1.515 0.071 0 C-N-CA 121.175 -0.535 . . . . 43.5 112.831 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 mpt_? -95.97 -170.89 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.061 0.458 . . . . 65.319999999999993 110.384 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 p -135.3 117.26 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.991 -0.744 . . . . 72.319999999999993 108.991 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 HG23 ' A' ' 52' ' ' THR . 17.6 mt -57.7 132.21 82.53 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.101 -0.5 . . . . 65.25 111.566 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.4 158.61 9.61 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.707 2.938 . . . . 72.340000000000003 112.794 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 123.37 17.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.92 -0.582 . . . . 71.430000000000007 110.07 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.79 -29.13 7.35 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.067 -0.813 . . . . 71.010000000000005 111.067 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 59.0 m95 -84.99 151.45 24.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.779 -0.452 . . . . 71.239999999999995 109.779 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.69 145.94 45.31 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 116.363 -0.381 . . . . 74.230000000000004 110.161 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.608 HG23 HD12 ' A' ' 46' ' ' LEU . 38.7 p -104.5 144.59 31.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.783 -1.099 . . . . 63.350000000000001 110.152 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.73 168.44 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.429 0.633 . . . . 74.209999999999994 110.466 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 -148.64 22.29 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.284 -0.871 . . . . 72.200000000000003 111.955 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 28.5 tt0 -132.65 132.93 22.92 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.618 -0.882 . . . . 72.409999999999997 108.618 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.581 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 72.5 Cg_endo -70.48 125.66 12.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 121.882 1.721 . . . . 72.400000000000006 111.621 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.0 175.58 13.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.195 -0.457 . . . . 55.439999999999998 110.684 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 t -62.99 151.36 39.92 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.145 -0.317 . . . . 72.340000000000003 110.145 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -44.55 -43.26 7.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 75.310000000000002 111.373 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.56 -42.62 92.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 73.420000000000002 111.269 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.03 -36.61 61.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.762 0.315 . . . . 72.450000000000003 111.132 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 62.5 m -64.92 -44.85 88.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 63.149999999999999 111.175 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.07 -41.85 81.34 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.76 -0.459 . . . . 54.210000000000001 109.76 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.585 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.1 tt0 -59.37 -37.37 77.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.465 0.65 . . . . 74.010000000000005 110.436 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 11.4 ttt180 -64.38 -47.0 80.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.474 -0.785 . . . . 74.430000000000007 111.153 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.0 pt -74.4 -34.85 37.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.718 0.294 . . . . 74.430000000000007 111.63 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 8.1 mm-40 -64.94 -48.55 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 71.010000000000005 110.961 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 22.1 mm-40 -70.43 8.46 0.81 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.073 0.464 . . . . 75.109999999999999 111.651 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 92.5 mt -103.42 -66.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.341 0.591 . . . . 70.129999999999995 110.203 172.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -83.49 -54.69 4.77 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.401 -0.818 . . . . 45.109999999999999 110.668 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -72.18 -11.16 60.61 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.426 -0.806 . . . . 55.350000000000001 110.712 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 13.0 t70 -41.81 -40.33 2.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.599 -0.728 . . . . 73.310000000000002 111.931 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.1 mtp -66.07 76.83 0.09 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.616 -0.72 . . . . 75.019999999999996 109.491 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 4.3 p -94.6 133.6 26.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.996 -1.002 . . . . 71.120000000000005 110.809 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 9.4 Cg_exo -71.94 -166.46 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.87 2.38 . . . . 72.129999999999995 111.938 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.23 -17.8 5.06 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.284 -0.416 . . . . 60.32 111.828 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 t -50.01 -27.1 4.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.605 . . . . 75.439999999999998 111.701 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.96 -31.14 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.955 0.407 . . . . 72.150000000000006 111.264 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -63.67 -31.74 73.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.474 . . . . 74.439999999999998 110.88 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -62.81 -29.74 70.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.922 0.391 . . . . 73.109999999999999 110.645 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 16.3 t-80 -87.15 -21.96 25.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 54.530000000000001 109.839 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -81.59 -21.72 38.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 73.430000000000007 108.891 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.23 83.88 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.725 -0.67 . . . . 64.540000000000006 110.687 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -78.78 -8.7 59.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.708 -0.678 . . . . 74.549999999999997 109.417 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -94.86 130.01 41.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.402 -0.817 . . . . 73.5 109.937 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 m 69.36 10.02 7.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.54 0.525 . . . . 53.329999999999998 111.886 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.34 160.79 21.64 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 121.233 -0.508 . . . . 74.420000000000002 112.124 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -99.71 16.89 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.379 2.719 . . . . 73.530000000000001 112.942 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.11 63.06 4.86 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.457 -0.401 . . . . 73.430000000000007 112.502 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -73.41 94.74 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.338 0.496 . . . . 44.039999999999999 112.338 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t70 65.53 2.95 2.2 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.494 0.924 . . . . 74.510000000000005 113.494 164.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 41.9 t80 -100.9 89.98 4.04 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.034 -0.417 . . . . 74.099999999999994 110.905 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 81' ' ' HIS . . . 164.83 -168.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.457 1.103 . . . . 75.120000000000005 108.33 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.37 130.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.543 -0.91 . . . . 75.409999999999997 108.543 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.691 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mmt85 . . . . . 0 C--O 1.241 0.624 0 CA-C-O 118.122 -0.942 . . . . 74.540000000000006 110.578 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.25 -0.278 . . . . 73.219999999999999 110.25 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.53 16.52 8.12 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.598 0.561 . . . . 73.439999999999998 112.423 173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -93.05 6.48 47.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.327 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -133.19 104.69 6.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.63 -0.713 . . . . 53.229999999999997 109.346 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.86 152.32 45.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 64.019999999999996 110.293 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -58.83 -45.16 90.66 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.503 0.502 . . . . 74.209999999999994 110.301 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t60 62.26 25.43 15.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.565 -0.743 . . . . 52.520000000000003 110.94 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.78 123.41 42.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.69 0.281 . . . . 71.439999999999998 110.643 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.3 ttm -80.65 -39.91 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.388 -0.597 . . . . 71.540000000000006 109.388 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.96 168.13 42.41 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.527 -0.76 . . . . 73.319999999999993 112.368 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 -54.03 5.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.529 0.68 . . . . 64.109999999999999 109.516 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.9 pt? -101.21 164.27 11.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.876 -1.057 . . . . 73.430000000000007 108.834 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.732 ' HG3' HH21 ' A' ' 65' ' ' ARG . 0.3 OUTLIER 64.07 26.9 14.1 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.099 0.476 . . . . 52.229999999999997 111.422 -177.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.61 40.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 61.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 92.5 mt-30 -130.94 124.61 31.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.25 -0.432 . . . . 73.030000000000001 110.91 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -76.71 78.56 3.35 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 110.413 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -92.86 121.34 34.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 74.109999999999999 110.181 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.95 145.97 25.07 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.139 -0.553 . . . . 74.420000000000002 111.848 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -85.26 24.16 0.78 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.994 2.463 . . . . 73.409999999999997 113.078 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.66 -11.4 60.04 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.444 -0.408 . . . . 44.340000000000003 113.315 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.2 m -131.08 32.59 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.187 0.518 . . . . 65.310000000000002 110.368 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.0 tpt -79.2 86.13 5.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.47 0.652 . . . . 73.349999999999994 109.708 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -101.68 -165.29 1.18 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.967 -1.015 . . . . 74.420000000000002 111.741 -175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.55 -38.55 91.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.45 0.907 . . . . 70.420000000000002 113.45 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 58' ' ' THR . 41.7 mt-10 -90.26 93.64 9.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 71.109999999999999 111.577 -168.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 56' ' ' PRO . 8.2 mp -89.89 143.1 27.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.505 0.669 . . . . 63.109999999999999 111.129 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.631 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 13.0 m-85 -133.1 157.49 45.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.766 -1.106 . . . . 64.219999999999999 109.26 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.614 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 1.4 m-85 -113.79 167.67 10.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.634 -0.712 . . . . 74.329999999999998 109.224 170.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.55 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.905 -1.146 . . . . 71.299999999999997 107.905 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.483 HG12 HG22 ' A' ' 52' ' ' THR . 21.6 m -137.95 162.13 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 118.171 0.441 . . . . 74.310000000000002 111.349 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -169.49 168.17 9.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.569 -0.741 . . . . 74.209999999999994 110.798 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.1 p-10 -163.58 139.97 6.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 44.450000000000003 110.346 166.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 t30 46.5 4.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.085 1.143 . . . . 73.120000000000005 114.085 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' ASN . 12.6 pt-20 -105.71 -25.42 12.23 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.418 -0.801 . . . . 70.25 112.312 -167.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 -22.3 9.6 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.481 -0.39 . . . . 21.199999999999999 113.171 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -100.1 173.97 6.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.903 -0.406 . . . . 74.310000000000002 109.903 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -106.43 153.72 21.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.242 -0.436 . . . . 73.099999999999994 111.774 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -145.3 -178.72 6.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 73.510000000000005 109.217 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.12 158.14 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.929 0.395 . . . . 63.030000000000001 111.058 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 44' ' ' ARG . 59.9 t90 -150.29 142.89 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 109.738 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -80.53 131.64 35.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 73.299999999999997 111.615 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -64.49 151.62 43.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.656 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.34 -12.75 43.85 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.171 -0.538 . . . . 43.5 112.883 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 74.8 mtt180 -104.87 -167.23 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.427 -0.582 . . . . 65.319999999999993 109.427 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.6 m -138.11 131.16 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 72.319999999999993 110.117 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HG11 ' A' ' 30' ' ' VAL . 17.6 mt -80.71 135.19 52.76 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 65.25 112.13 -174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.09 138.99 21.45 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.449 2.766 . . . . 72.340000000000003 112.626 168.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 130.16 31.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.952 -0.567 . . . . 71.430000000000007 110.103 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.86 -35.4 4.31 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.042 -0.823 . . . . 71.010000000000005 111.042 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 52.0 m95 -76.35 149.49 36.99 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.914 -0.402 . . . . 71.239999999999995 109.914 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.16 152.11 50.78 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 110.049 -0.352 . . . . 74.230000000000004 110.049 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 30' ' ' VAL . 21.5 p -109.44 161.51 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.103 . . . . 63.350000000000001 110.483 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.99 162.61 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.278 0.631 . . . . 74.209999999999994 109.931 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' OE1' ' A' ' 13' ' ' GLU . . . 85.48 -173.28 47.69 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.805 -0.634 . . . . 72.200000000000003 112.336 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.29 144.22 29.31 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.207 -1.034 . . . . 72.409999999999997 108.207 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.614 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 44.9 Cg_endo -65.67 115.48 3.41 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.652 1.568 . . . . 72.400000000000006 110.814 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -140.48 168.94 18.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.099 -0.5 . . . . 55.439999999999998 110.088 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 8.8 t -59.73 151.86 24.15 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.681 -0.408 . . . . 72.340000000000003 110.496 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -46.76 -40.82 14.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.02 -0.536 . . . . 75.310000000000002 111.424 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.59 -43.32 99.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 73.420000000000002 110.893 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 93.7 mt-30 -72.85 -33.15 65.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.034 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 77.0 m -68.58 -45.95 70.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.475 -0.33 . . . . 63.149999999999999 110.83 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.4 pp -68.11 -36.49 79.83 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.006 -0.368 . . . . 54.210000000000001 110.006 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 35.9 tt0 -66.53 -31.48 72.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.656 0.741 . . . . 74.010000000000005 110.118 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.732 HH21 ' HG3' ' A' ' 13' ' ' GLU . 13.0 ttt85 -65.57 -49.71 67.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.256 -0.883 . . . . 74.430000000000007 110.27 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.1 pt -70.28 -42.0 78.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 111.866 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 11.5 pt-20 -60.91 -49.43 77.48 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.251 -0.18 . . . . 71.010000000000005 110.653 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 83.2 mt-30 -74.85 1.94 11.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.887 0.329 . . . . 75.109999999999999 111.887 -174.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HG ' ' NE2' ' A' ' 15' ' ' GLN . 45.1 mt -103.93 -66.03 0.98 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.276 0.56 . . . . 70.129999999999995 111.227 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -86.01 -53.94 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.245 -0.889 . . . . 45.109999999999999 111.198 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.03 -10.73 52.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.9 -1.046 . . . . 55.350000000000001 111.791 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.4 p-10 -41.8 -27.15 0.1 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.991 1.108 . . . . 73.310000000000002 113.991 -168.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.8 mmm -70.83 78.95 0.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.162 -0.681 . . . . 75.019999999999996 109.162 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.772 HG12 HG12 ' A' ' 94' ' ' VAL . 2.5 m -76.94 161.23 74.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.498 -0.774 . . . . 71.120000000000005 111.374 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 74' ' ' VAL . 42.9 Cg_endo -67.79 -162.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.844 2.363 . . . . 72.129999999999995 112.619 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.15 -21.2 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.979 -0.555 . . . . 60.32 111.384 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.9 m -51.76 -18.32 1.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.739 -0.664 . . . . 75.439999999999998 112.306 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.619 HG13 ' HD2' ' A' ' 79' ' ' ARG . 13.4 p -54.05 -31.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.639 0.257 . . . . 72.150000000000006 111.028 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HD2' HG13 ' A' ' 78' ' ' VAL . 7.4 mpt_? -61.2 -40.36 93.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.37 -0.377 . . . . 74.439999999999998 110.8 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -60.88 -26.67 67.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.936 0.398 . . . . 73.109999999999999 110.8 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -73.28 -29.37 62.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.453 -0.34 . . . . 54.530000000000001 110.551 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.81 -6.83 59.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 110.075 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.53 2.97 51.92 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.695 -0.684 . . . . 64.540000000000006 110.28 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -62.08 130.21 44.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 74.549999999999997 111.4 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -93.62 71.02 4.23 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.592 -0.522 . . . . 73.5 109.592 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.7 t 57.95 26.46 13.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.94 -0.573 . . . . 53.329999999999998 110.732 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -121.49 73.19 0.36 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.028 -0.606 . . . . 74.420000000000002 113.232 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -97.29 -157.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.375 2.717 . . . . 73.530000000000001 111.634 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.25 -68.25 2.67 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.169 -0.772 . . . . 73.430000000000007 111.169 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.3 mm -78.95 62.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.476 -0.935 . . . . 44.039999999999999 108.476 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -135.31 123.78 23.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.77 -1.105 . . . . 74.510000000000005 108.91 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -129.45 149.4 51.24 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.026 0.441 . . . . 74.099999999999994 110.433 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.75 -152.3 0.31 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 75.120000000000005 111.199 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.772 HG12 HG12 ' A' ' 74' ' ' VAL . 7.5 p -82.77 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 122.484 1.135 . . . . 75.409999999999997 111.534 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 63' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-N 114.24 -1.345 . . . . 74.540000000000006 108.439 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.922 0.391 . . . . 73.219999999999999 110.353 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -177.84 179.23 0.89 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.821 -0.627 . . . . 73.439999999999998 109.728 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -111.51 39.86 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.72 -0.845 . . . . 72.239999999999995 108.72 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 60.05 -105.29 0.22 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.395 -1.275 . . . . 53.229999999999997 111.31 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 43.17 -91.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.701 0.4 . . . . 64.019999999999996 111.869 -172.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -172.0 87.25 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.378 0.608 . . . . 74.209999999999994 110.144 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -70.86 129.87 40.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.651 -0.704 . . . . 52.520000000000003 110.157 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -56.84 110.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.324 . . . . 71.439999999999998 110.843 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -172.77 117.88 0.33 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.57 -0.9 . . . . 71.540000000000006 108.57 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' H ' HD22 ' A' ' 69' ' ' LEU . . . -69.14 80.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.357 -0.449 . . . . 73.319999999999993 113.056 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.519 HG23 ' HG ' ' A' ' 12' ' ' LEU . 8.9 t -58.72 -32.23 69.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.992 0.425 . . . . 64.109999999999999 110.09 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 91.0 mt -111.33 -82.16 0.58 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.047 -0.524 . . . . 73.430000000000007 109.773 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.41 144.93 48.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.857 -0.423 . . . . 52.229999999999997 109.857 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.4 116.64 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.348 0.405 . . . . 61.0 111.298 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 59.97 33.1 21.38 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.187 0.81 . . . . 73.030000000000001 113.187 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 p -76.02 76.95 2.89 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.306 0.574 . . . . 75.239999999999995 109.813 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.99 124.98 28.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.402 -0.817 . . . . 74.109999999999999 110.826 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.9 92.7 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.895 -0.593 . . . . 74.420000000000002 111.674 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.01 144.97 66.01 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.578 2.186 . . . . 73.409999999999997 111.794 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.62 91.57 0.25 Allowed Glycine 0 C--O 1.236 0.231 0 C-N-CA 121.127 -0.558 . . . . 44.340000000000003 112.368 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -162.17 120.44 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 65.310000000000002 110.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.9 mmm -103.25 29.92 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.474 -0.565 . . . . 73.349999999999994 109.474 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 64.12 17.8 10.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.071 0.939 . . . . 74.420000000000002 109.382 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 25' ' ' GLU . 34.7 t70 -78.48 -157.33 0.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.844 -1.071 . . . . 70.420000000000002 108.819 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 24' ' ' ASP . 53.2 mm-40 -71.55 121.24 18.37 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.309 0.504 . . . . 71.109999999999999 110.638 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.9 mp -87.37 147.5 25.44 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.376 0.608 . . . . 63.109999999999999 110.248 175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -124.92 148.66 48.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.037 -0.983 . . . . 64.219999999999999 109.238 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -119.34 159.8 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.694 -0.854 . . . . 74.329999999999998 108.694 174.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG21 HH11 ' A' ' 65' ' ' ARG . 30.3 t -89.4 139.91 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.534 -1.284 . . . . 71.299999999999997 107.534 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 46' ' ' LEU . 29.6 m -139.58 164.9 23.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 121.981 -0.449 . . . . 74.310000000000002 111.367 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.655 HH21 ' HA2' ' A' ' 35' ' ' GLY . 9.4 ptm180 -158.16 161.78 37.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.881 -0.6 . . . . 74.209999999999994 111.118 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.573 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -166.26 140.02 4.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 44.450000000000003 110.389 166.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 46.1 5.97 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.845 1.424 . . . . 73.120000000000005 114.845 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.2 pt-20 -112.23 -32.02 6.67 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.934 -0.479 . . . . 70.25 112.283 -170.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.655 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 81.82 -22.72 5.54 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.66 -0.781 . . . . 21.199999999999999 112.291 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -93.81 174.02 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.84 -0.43 . . . . 74.310000000000002 109.84 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -107.61 152.24 24.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.997 0.739 . . . . 73.099999999999994 112.997 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -137.75 -179.22 5.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.563 -1.199 . . . . 73.510000000000005 108.989 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' ' 62' ' ' CYS . 30.5 m -126.08 152.5 33.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.053 0.454 . . . . 63.030000000000001 110.778 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.504 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 50.2 t90 -144.04 144.54 31.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.575 . . . . 74.310000000000002 110.458 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -90.62 135.47 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.811 -0.632 . . . . 73.299999999999997 110.724 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.39 175.27 6.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 110.154 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.48 61.82 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.798 -0.921 . . . . 43.5 110.798 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 3.2 ptm180 -140.89 176.86 8.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.952 -0.624 . . . . 65.319999999999993 109.366 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -126.69 126.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.42 . . . . 72.319999999999993 109.915 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 52' ' ' THR . 12.1 mt -56.22 135.04 75.21 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.454 -0.794 . . . . 65.25 112.144 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.71 155.48 70.27 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.018 2.479 . . . . 72.340000000000003 112.383 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 124.9 11.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.247 -0.888 . . . . 71.430000000000007 110.768 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.44 -30.16 6.87 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.986 -0.552 . . . . 71.010000000000005 112.208 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.53 ' HB3' HD13 ' A' ' 46' ' ' LEU . 30.6 m95 -93.3 148.44 22.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.768 0.284 . . . . 71.239999999999995 110.472 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -135.23 153.07 52.05 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.855 0.36 . . . . 74.230000000000004 111.581 173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.602 HG23 HD12 ' A' ' 46' ' ' LEU . 22.4 p -99.09 160.02 14.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 114.675 -1.148 . . . . 63.350000000000001 111.512 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -169.84 164.76 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 124.548 1.139 . . . . 74.209999999999994 109.661 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 12' ' ' LEU . . . 98.16 -159.78 20.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.004 -0.617 . . . . 72.200000000000003 113.272 173.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -113.02 128.58 25.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.661 -0.866 . . . . 72.409999999999997 108.661 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 26' ' ' LEU . 51.1 Cg_endo -68.31 112.22 2.72 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.742 1.628 . . . . 72.400000000000006 111.42 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.32 166.16 33.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 55.439999999999998 109.91 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 t -63.98 168.38 5.29 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.154 0.502 . . . . 72.340000000000003 111.236 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.2 tptp -48.83 -50.38 34.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.366 -0.834 . . . . 75.310000000000002 111.916 -173.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.49 -41.56 66.37 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.456 0.473 . . . . 73.420000000000002 111.336 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -72.94 -43.98 61.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.303 0.573 . . . . 72.450000000000003 110.532 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' ' 39' ' ' VAL . 3.8 t -60.49 -46.57 89.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.236 -0.893 . . . . 63.149999999999999 110.858 -173.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 64' ' ' GLN . 2.9 pp -67.92 -40.69 83.34 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.883 -0.327 . . . . 54.210000000000001 110.983 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.627 ' N ' HD12 ' A' ' 63' ' ' LEU . 30.0 tt0 -60.96 -35.77 77.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.168 0.509 . . . . 74.010000000000005 110.524 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.483 HH11 HG21 ' A' ' 29' ' ' VAL . 63.4 ttt-85 -62.3 -53.66 51.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.924 -0.58 . . . . 74.430000000000007 110.855 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.8 pt -69.68 -34.55 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.568 -0.287 . . . . 74.430000000000007 111.365 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 95' ' ' ARG . 16.6 mm-40 -65.2 -55.23 19.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 71.010000000000005 110.939 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 68.6 mt-30 -70.96 1.3 5.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 75.109999999999999 111.705 -174.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD22 ' H ' ' A' ' 10' ' ' GLY . 87.6 mt -103.47 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 70.129999999999995 111.024 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -85.27 -46.83 10.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.694 -0.684 . . . . 45.109999999999999 110.509 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -80.46 -10.66 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.183 -0.917 . . . . 55.350000000000001 111.092 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.682 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.8 OUTLIER -41.88 -33.2 0.5 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.067 0.765 . . . . 73.310000000000002 113.067 -170.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 74.5 mtm -61.79 87.28 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.45 0.643 . . . . 75.019999999999996 110.807 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.499 HG13 ' HB ' ' A' ' 78' ' ' VAL . 2.6 p -91.94 134.6 28.54 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.138 -0.937 . . . . 71.120000000000005 110.809 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 15.0 Cg_exo -69.12 -158.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.905 2.404 . . . . 72.129999999999995 112.251 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.76 1.34 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.713 0.634 . . . . 60.32 112.713 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.0 t -50.1 -31.43 13.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.262 -0.426 . . . . 75.439999999999998 110.913 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 74' ' ' VAL . 7.2 p -52.78 -49.13 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.572 -0.286 . . . . 72.150000000000006 111.177 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.436 ' N ' HG13 ' A' ' 78' ' ' VAL . 70.6 mtp180 -73.35 -43.68 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 110.488 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -66.48 -15.25 63.21 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.087 0.47 . . . . 73.109999999999999 110.576 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -101.29 -28.71 12.47 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.002 -0.544 . . . . 54.530000000000001 111.471 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.9 tp -87.2 -42.25 13.11 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.731 -0.213 . . . . 73.430000000000007 111.339 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -56.51 117.05 3.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 110.116 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.34 96.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.478 -0.783 . . . . 74.549999999999997 111.259 -175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -136.81 135.1 37.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 73.5 109.825 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 t -64.17 96.15 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.255 -0.646 . . . . 53.329999999999998 109.255 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.35 78.44 1.36 Allowed Glycine 0 CA--C 1.518 0.234 0 N-CA-C 111.088 -0.805 . . . . 74.420000000000002 111.088 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.41 -168.23 0.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.337 2.691 . . . . 73.530000000000001 111.697 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.99 108.35 2.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.202 -0.523 . . . . 73.430000000000007 112.33 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -82.69 76.49 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.577 0.703 . . . . 44.039999999999999 109.636 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.9 -179.49 7.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.045 -0.98 . . . . 74.510000000000005 108.559 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -136.35 156.69 48.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.5 . . . . 74.099999999999994 111.522 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.41 -138.84 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.224 -1.028 . . . . 75.120000000000005 108.224 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 72' ' ' ASP . 12.4 p -41.99 134.03 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 109.416 -0.587 . . . . 75.409999999999997 109.416 165.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HG2' HD13 ' A' ' 63' ' ' LEU . 10.9 tpp85 . . . . . 0 C--O 1.242 0.668 0 CA-C-O 118.544 -0.741 . . . . 74.540000000000006 110.136 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' HD2' ' A' ' 3' ' ' HIS . 65.9 mtm . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.89 -0.411 . . . . 73.219999999999999 109.89 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -55.4 -32.76 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.809 0.67 . . . . 73.439999999999998 112.809 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 40.5 m-70 73.08 -31.66 0.23 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.248 0.619 . . . . 72.239999999999995 111.976 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -63.84 86.78 0.04 OUTLIER 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 53.229999999999997 110.298 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -106.29 -14.28 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.141 -0.481 . . . . 64.019999999999996 111.153 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -70.37 92.28 0.79 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.891 -1.151 . . . . 74.209999999999994 107.891 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -88.01 -18.47 28.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 52.520000000000003 112.172 -164.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.451 ' ND1' ' HB2' ' A' ' 72' ' ' ASP . 77.8 m80 -92.97 131.6 37.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.917 -0.401 . . . . 71.439999999999998 109.917 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.8 ttp -140.27 135.24 32.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.036 -0.357 . . . . 71.540000000000006 110.036 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.87 33.2 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.968 -0.453 . . . . 73.319999999999993 111.968 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.3 m -71.21 -61.47 1.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.43 . . . . 64.109999999999999 110.468 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.05 -77.83 0.59 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.08 -0.509 . . . . 73.430000000000007 110.497 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.63 93.43 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.004 0.43 . . . . 52.229999999999997 110.609 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.88 24.32 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.474 -0.785 . . . . 61.0 109.55 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.482 ' HB2' ' OE1' ' A' ' 17' ' ' GLN . 13.9 pt20 -74.45 164.39 26.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.668 -1.151 . . . . 73.030000000000001 110.585 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -101.49 5.49 41.93 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 75.239999999999995 111.061 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 15' ' ' GLN . 1.1 pm0 -137.83 -174.75 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 74.109999999999999 110.696 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.65 -174.87 13.89 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.893 -0.483 . . . . 74.420000000000002 111.893 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.84 82.89 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.7 2.267 . . . . 73.409999999999997 112.224 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 67.18 3.8 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.202 -0.523 . . . . 44.340000000000003 112.227 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.9 t -130.77 131.87 44.96 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.859 0.361 . . . . 65.310000000000002 110.552 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -110.66 9.47 22.88 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.33 0.586 . . . . 73.349999999999994 109.995 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -108.98 152.95 24.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.082 -0.963 . . . . 74.420000000000002 110.063 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.91 -21.51 29.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.42 0.526 . . . . 70.420000000000002 112.42 -171.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.67 80.18 3.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.07 0.462 . . . . 71.109999999999999 110.094 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp -76.04 161.34 28.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.454 0.645 . . . . 63.109999999999999 111.152 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 18.7 m-85 -131.14 148.68 52.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.082 -0.963 . . . . 64.219999999999999 109.537 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -117.05 162.43 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.155 -0.683 . . . . 74.329999999999998 109.155 176.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG21 HH11 ' A' ' 65' ' ' ARG . 71.1 t -95.4 137.76 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.35 -1.352 . . . . 71.299999999999997 107.35 172.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 HD11 ' A' ' 46' ' ' LEU . 33.4 m -134.57 164.71 33.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.109 0.481 . . . . 74.310000000000002 111.71 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.632 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 15.9 ptm180 -167.81 170.13 11.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.914 -1.039 . . . . 74.209999999999994 110.149 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.704 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -167.39 139.99 3.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.73 -0.213 . . . . 44.450000000000003 111.007 166.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 37.2 16.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.686 1.365 . . . . 73.120000000000005 114.686 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.806 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.8 pt-20 -112.31 -29.16 7.64 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.763 -0.585 . . . . 70.25 112.479 -172.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' NH2' ' A' ' 31' ' ' ARG . . . 74.62 7.69 79.97 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.599 -0.81 . . . . 21.199999999999999 111.666 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.806 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 6.7 tp60 -116.21 167.88 10.61 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.599 -0.889 . . . . 74.310000000000002 108.599 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -112.96 153.56 27.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.546 0.573 . . . . 73.099999999999994 112.546 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.407 ' O ' HG13 ' A' ' 29' ' ' VAL . 66.2 m -147.61 -179.33 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.999 -1.0 . . . . 73.510000000000005 109.478 172.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.9 m -123.54 163.48 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.382 . . . . 63.030000000000001 110.604 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -151.01 149.81 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 74.310000000000002 109.934 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.5 ttt -86.15 126.89 34.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 73.299999999999997 110.242 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.56 142.86 57.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.896 0.379 . . . . 70.439999999999998 110.949 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.66 -15.86 29.05 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.675 -0.693 . . . . 43.5 111.965 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.392 -0.225 . . . . 65.319999999999993 110.392 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -84.25 119.42 25.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.195 0.521 . . . . 72.319999999999993 110.485 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 52' ' ' THR . 33.9 mt -68.55 143.82 95.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.199 -0.91 . . . . 65.25 111.744 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 47.3 Cg_endo -75.29 154.21 40.99 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.451 2.1 . . . . 72.340000000000003 112.266 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.61 125.96 7.74 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.333 -0.848 . . . . 71.430000000000007 111.489 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.74 -35.0 4.83 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.972 -0.558 . . . . 71.010000000000005 112.177 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.704 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 16.8 m95 -77.19 157.27 30.99 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.629 0.252 . . . . 71.239999999999995 110.437 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 8.0 pt-20 -144.91 146.95 32.23 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.276 -0.42 . . . . 74.230000000000004 110.776 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.437 HG23 HD12 ' A' ' 46' ' ' LEU . 25.1 p -98.86 163.37 12.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.649 -0.705 . . . . 63.350000000000001 111.442 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -166.26 152.71 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 123.663 0.785 . . . . 74.209999999999994 110.306 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 100.88 -175.25 26.2 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.33 -0.85 . . . . 72.200000000000003 113.472 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -103.03 116.14 62.93 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.784 -1.191 . . . . 72.409999999999997 107.784 172.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 32.1 Cg_endo -60.18 124.85 16.07 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.961 1.774 . . . . 72.400000000000006 111.926 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.91 173.45 15.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.503 . . . . 55.439999999999998 109.86 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -55.63 153.71 7.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.402 0.144 . . . . 72.340000000000003 111.144 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HE3' HG21 ' A' ' 39' ' ' VAL . 23.7 tptm -44.05 -43.2 6.63 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.992 0.517 . . . . 75.310000000000002 111.054 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.99 -47.64 68.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.454 -0.794 . . . . 73.420000000000002 111.259 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.87 -32.07 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 72.450000000000003 110.51 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 39' ' ' VAL . 7.5 t -64.08 -48.75 74.97 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.808 -0.633 . . . . 63.149999999999999 110.58 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.0 pp -67.69 -34.83 77.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.882 0.372 . . . . 54.210000000000001 110.12 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.2 tt0 -58.86 -43.98 90.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.54 -0.755 . . . . 74.010000000000005 110.334 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 62.3 ttt-85 -56.94 -53.47 57.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.123 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.1 pt -71.04 -32.9 49.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.269 -0.423 . . . . 74.430000000000007 111.535 -174.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 33.2 mm-40 -65.65 -44.69 85.58 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.132 -0.322 . . . . 71.010000000000005 110.132 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.84 -1.9 6.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.052 0.39 . . . . 75.109999999999999 112.052 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.7 mt -103.59 -66.45 0.95 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.383 0.611 . . . . 70.129999999999995 111.222 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -85.61 -52.4 5.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 45.109999999999999 110.201 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -76.27 -11.05 59.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.757 -1.11 . . . . 55.350000000000001 111.57 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -43.15 -30.97 0.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 122.967 0.507 . . . . 73.310000000000002 111.732 -173.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 58.9 ttp -62.69 83.32 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.615 -0.72 . . . . 75.019999999999996 110.133 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.495 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.4 p -73.36 133.79 80.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.103 -0.953 . . . . 71.120000000000005 110.291 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 4.3 Cg_exo -70.97 -154.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.949 2.432 . . . . 72.129999999999995 112.613 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -20.15 15.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.292 -0.413 . . . . 60.32 111.946 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -57.52 -27.08 62.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.376 -0.375 . . . . 75.439999999999998 110.907 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.62 -36.05 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 72.150000000000006 111.068 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -68.02 -26.45 65.9 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.372 -0.376 . . . . 74.439999999999998 110.827 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.692 ' HG2' ' HA3' ' A' ' 89' ' ' GLY . 35.2 tt0 -67.85 -44.31 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.442 0.639 . . . . 73.109999999999999 109.395 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -71.02 -36.9 72.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.369 -0.832 . . . . 54.530000000000001 110.185 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.31 -23.69 62.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.484 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -73.15 83.11 1.32 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.022 -0.535 . . . . 64.540000000000006 109.936 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -93.26 78.3 4.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.277 0.56 . . . . 74.549999999999997 110.16 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -104.35 84.21 2.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.963 -0.562 . . . . 73.5 109.611 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m 62.87 9.46 3.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.004 -0.543 . . . . 53.329999999999998 110.776 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.8 146.11 5.43 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.297 -1.121 . . . . 74.420000000000002 110.297 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -94.75 164.05 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.874 2.383 . . . . 73.530000000000001 112.67 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.692 ' HA3' ' HG2' ' A' ' 80' ' ' GLU . . . -80.92 169.11 51.7 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.227 -0.749 . . . . 73.430000000000007 111.227 171.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 pt -122.46 103.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.096 0.474 . . . . 44.039999999999999 111.355 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -69.79 128.67 37.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.555 . . . . 74.510000000000005 110.887 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.39 14.35 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.321 -0.622 . . . . 74.099999999999994 109.321 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.7 -58.57 3.26 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 123.954 1.835 . . . . 75.120000000000005 110.632 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 72' ' ' ASP . 7.6 p -106.57 136.09 42.6 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 109.663 -3.426 . . . . 75.409999999999997 109.408 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.602 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 5.2 mpt_? . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.55 -0.75 . . . . 74.540000000000006 109.753 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.214 -0.291 . . . . 73.219999999999999 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.78 96.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.335 0.588 . . . . 73.439999999999998 109.571 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -77.08 93.15 3.83 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.583 -0.895 . . . . 72.239999999999995 108.583 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -60.0 97.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.734 -0.666 . . . . 53.229999999999997 111.277 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -135.31 96.55 3.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.765 -0.652 . . . . 64.019999999999996 109.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -161.15 159.76 29.39 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.34 -0.391 . . . . 74.209999999999994 110.992 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -122.52 120.07 32.76 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.827 -0.434 . . . . 52.520000000000003 109.827 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -176.41 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.547 0.689 . . . . 71.439999999999998 109.848 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 87.3 mmm -104.46 148.07 26.86 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.678 -0.692 . . . . 71.540000000000006 110.261 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.55 -106.43 1.74 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.136 -0.554 . . . . 73.319999999999993 112.634 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.6 m 60.49 79.23 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.53 0.681 . . . . 64.109999999999999 111.049 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HA ' HH21 ' A' ' 65' ' ' ARG . 4.2 mm? -80.29 -63.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 110.954 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' OE2' ' HB3' ' A' ' 12' ' ' LEU . 7.2 mp0 -109.46 165.03 11.96 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.897 -0.409 . . . . 52.229999999999997 109.897 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.13 101.23 1.74 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.014 0.435 . . . . 61.0 111.16 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -90.17 167.04 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 73.030000000000001 110.173 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.2 m 75.32 -24.48 0.22 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.932 0.716 . . . . 75.239999999999995 112.932 170.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -59.03 -38.26 78.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.832 0.348 . . . . 74.109999999999999 110.489 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.93 146.78 16.15 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 116.121 -0.491 . . . . 74.420000000000002 111.977 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.37 1.97 8.39 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.041 2.494 . . . . 73.409999999999997 112.577 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.9 146.53 16.31 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.097 -0.501 . . . . 44.340000000000003 112.183 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 58' ' ' THR . 34.6 t -165.54 59.34 0.11 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.314 0.578 . . . . 65.310000000000002 109.809 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -77.24 68.94 3.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.882 0.849 . . . . 73.349999999999994 110.453 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -110.69 0.17 17.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.865 -1.061 . . . . 74.420000000000002 110.056 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -161.48 175.52 12.06 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.949 -0.569 . . . . 70.420000000000002 109.507 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -68.25 178.8 1.78 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.094 0.473 . . . . 71.109999999999999 111.597 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.4 mp -85.06 148.75 26.0 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.226 0.536 . . . . 63.109999999999999 111.244 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 6.8 m-85 -127.83 162.12 27.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.309 -0.86 . . . . 64.219999999999999 110.637 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 m-85 -126.85 167.78 15.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 109.42 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.41 135.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 71.299999999999997 107.289 168.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 HG22 ' A' ' 52' ' ' THR . 33.4 m -139.94 169.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.867 0.303 . . . . 74.310000000000002 111.127 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -167.84 170.02 11.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.143 -0.481 . . . . 74.209999999999994 111.305 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -161.65 140.03 9.39 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.113 -0.494 . . . . 44.450000000000003 110.862 171.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.3 t30 46.07 8.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.055 1.131 . . . . 73.120000000000005 114.055 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ASN . 11.7 pt-20 -112.33 -32.09 6.62 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.786 -0.571 . . . . 70.25 112.073 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.88 -22.64 6.52 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 112.065 -0.414 . . . . 21.199999999999999 112.065 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -81.85 173.85 11.86 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.826 0.45 . . . . 74.310000000000002 109.961 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.587 ' HD2' ' HE1' ' A' ' 70' ' ' TRP . 14.7 m-85 -118.27 141.96 47.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 73.099999999999994 111.938 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 m -132.74 -179.35 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.79 -1.096 . . . . 73.510000000000005 109.246 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.35 160.35 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.704 0.287 . . . . 63.030000000000001 110.578 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 63.0 t-105 -148.13 151.25 35.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 74.310000000000002 109.9 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -91.37 129.28 37.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.289 -0.263 . . . . 73.299999999999997 110.289 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.38 150.87 25.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 70.439999999999998 110.609 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.26 16.47 Favored Glycine 0 N--CA 1.453 -0.177 0 N-CA-C 111.539 -0.624 . . . . 43.5 111.539 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 53.4 mtt-85 -88.19 110.11 20.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 110.416 -0.216 . . . . 65.319999999999993 110.416 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -71.33 130.01 40.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.067 0.461 . . . . 72.319999999999993 109.961 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD12 HG23 ' A' ' 52' ' ' THR . 40.4 mt -76.05 142.82 72.91 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.337 -0.847 . . . . 65.25 111.396 -176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 67.3 Cg_endo -75.82 156.25 39.35 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.579 2.186 . . . . 72.340000000000003 111.711 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.59 122.41 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.698 -0.683 . . . . 71.430000000000007 111.49 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.9 -32.21 5.75 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.061 -0.518 . . . . 71.010000000000005 112.434 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.502 ' HB3' HD13 ' A' ' 46' ' ' LEU . 31.2 m95 -80.19 146.25 31.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.851 0.325 . . . . 71.239999999999995 110.697 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.58 155.71 49.15 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.524 -0.307 . . . . 74.230000000000004 110.729 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 HD12 ' A' ' 46' ' ' LEU . 17.4 p -112.57 162.18 15.95 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.543 1.152 . . . . 63.350000000000001 111.483 -173.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG21 ' CE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -166.02 145.02 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.054 0.542 . . . . 74.209999999999994 111.009 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.13 -165.61 18.59 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.559 -0.746 . . . . 72.200000000000003 112.248 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -104.73 145.02 29.9 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.148 -0.686 . . . . 72.409999999999997 109.148 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.5 Cg_endo -67.3 105.31 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.051 1.167 . . . . 72.400000000000006 110.136 173.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.61 165.19 31.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.095 -0.957 . . . . 55.439999999999998 110.977 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 21' ' ' SER . 9.7 t -62.02 166.95 4.2 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.394 0.616 . . . . 72.340000000000003 112.487 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.651 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 58.9 tptt -46.34 -50.02 16.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.966 -1.016 . . . . 75.310000000000002 111.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.76 -39.24 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.951 -0.568 . . . . 73.420000000000002 111.303 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -73.7 -44.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.166 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 27.4 p -64.12 -45.15 89.85 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.002 -0.279 . . . . 63.149999999999999 111.25 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -68.15 -41.21 81.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 54.210000000000001 110.454 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.626 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.6 tt0 -63.2 -36.46 83.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 74.010000000000005 110.376 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.541 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 ttt180 -58.7 -53.73 55.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.878 0.37 . . . . 74.430000000000007 110.905 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.9 pt -72.78 -32.66 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 74.430000000000007 111.213 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 37.6 mm-40 -61.23 -44.62 96.97 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.193 -0.299 . . . . 71.010000000000005 110.193 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 83.8 mm-40 -73.09 0.93 10.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.93 0.395 . . . . 75.109999999999999 111.132 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 80.1 mt -103.62 -66.13 0.97 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 70.129999999999995 111.258 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.587 ' HE1' ' HD2' ' A' ' 37' ' ' TYR . 73.0 m95 -85.68 -45.69 11.44 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.979 -0.555 . . . . 45.109999999999999 111.027 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 m -81.71 -11.19 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.834 . . . . 55.350000000000001 110.901 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -43.26 -36.98 1.99 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.993 -0.548 . . . . 73.310000000000002 111.565 -172.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.9 tpt -59.52 89.44 0.01 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.637 -0.711 . . . . 75.019999999999996 109.95 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 p -91.55 127.78 49.18 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.68 -0.691 . . . . 71.120000000000005 110.356 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.8 -158.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.814 2.343 . . . . 72.129999999999995 112.081 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.05 -18.92 10.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.895 0.378 . . . . 60.32 111.268 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.6 p -61.76 -14.38 31.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.891 -0.595 . . . . 75.439999999999998 111.305 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 11.6 p -55.88 -37.26 47.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-O 121.062 0.458 . . . . 72.150000000000006 110.451 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -74.04 -49.37 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 74.439999999999998 110.582 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.16 -45.45 84.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.804 -0.634 . . . . 73.109999999999999 110.666 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -74.45 -14.1 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.293 -0.867 . . . . 54.530000000000001 111.306 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 14.8 tp -91.52 -72.55 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.844 0.354 . . . . 73.430000000000007 110.793 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -81.21 76.85 8.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.458 0.646 . . . . 64.540000000000006 110.123 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -56.74 -65.4 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.278 -0.874 . . . . 74.549999999999997 110.34 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.9 t60 76.2 -37.15 0.29 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.71 0.804 . . . . 73.5 111.655 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 p -71.66 -54.27 10.89 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.861 0.362 . . . . 53.329999999999998 110.762 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.74 -66.03 0.42 Allowed Glycine 0 C--O 1.235 0.199 0 C-N-CA 121.266 -0.492 . . . . 74.420000000000002 112.195 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 156.1 56.23 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.618 2.212 . . . . 73.530000000000001 112.505 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 93.34 0.11 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.812 -0.631 . . . . 73.430000000000007 112.7 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.7 pt -93.78 134.11 32.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.889 0.376 . . . . 44.039999999999999 110.903 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.65 152.1 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 74.510000000000005 111.87 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.34 162.95 27.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.237 0.541 . . . . 74.099999999999994 111.452 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.71 -157.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.106 -0.952 . . . . 75.120000000000005 108.916 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.15 135.53 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 123.23 0.332 . . . . 75.409999999999997 110.829 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.59 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 8.0 mpt_? . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.531 -0.747 . . . . 74.540000000000006 110.244 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 121.21 0.529 . . . . 73.219999999999999 110.167 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.93 113.31 0.14 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.762 -0.654 . . . . 73.439999999999998 110.927 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -119.79 136.65 54.37 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.649 -0.5 . . . . 72.239999999999995 109.649 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -131.13 92.51 3.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.899 0.381 . . . . 53.229999999999997 111.429 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -129.18 102.65 6.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.121 -0.49 . . . . 64.019999999999996 110.189 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 73' ' ' MET . 38.8 p-80 -165.97 150.51 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 74.209999999999994 109.799 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.677 ' HB3' ' HD1' ' A' ' 70' ' ' TRP . 21.8 p80 -166.09 129.59 2.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.846 0.355 . . . . 52.520000000000003 111.763 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -105.92 123.13 47.48 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.645 -0.872 . . . . 71.439999999999998 108.645 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 9' ' ' MET . 3.5 mpp? -90.81 110.42 21.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 71.540000000000006 111.631 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.55 150.01 18.34 Favored Glycine 0 C--O 1.237 0.326 0 N-CA-C 110.663 -0.975 . . . . 73.319999999999993 110.663 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -117.7 -78.78 0.58 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.202 0.501 . . . . 64.109999999999999 111.276 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.2 mt -112.1 106.24 14.82 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.339 -0.615 . . . . 73.430000000000007 109.339 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 173.65 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 52.229999999999997 110.842 -170.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.02 113.08 25.25 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.952 -0.567 . . . . 61.0 109.556 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 22.1 mt-30 -54.07 102.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.404 0.44 . . . . 73.030000000000001 111.623 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -65.99 -40.23 91.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.452 -0.573 . . . . 75.239999999999995 109.452 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -148.24 -167.38 2.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.353 -0.84 . . . . 74.109999999999999 108.789 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.21 -101.62 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.322 -0.711 . . . . 74.420000000000002 111.322 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.32 -163.74 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.726 2.284 . . . . 73.409999999999997 111.698 175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.64 146.76 5.31 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.104 -0.569 . . . . 44.340000000000003 111.926 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' MET . 17.4 t -74.72 121.0 21.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.526 -0.546 . . . . 65.310000000000002 109.526 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 21' ' ' SER . 61.8 mtt 72.84 11.02 5.4 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.798 -0.637 . . . . 73.349999999999994 110.997 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -94.33 -170.56 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.166 -1.42 . . . . 74.420000000000002 107.166 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.66 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 5.1 t70 -84.91 170.88 12.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.115 0.416 . . . . 70.420000000000002 110.489 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 58' ' ' THR . 8.3 mm-40 -77.72 171.84 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.903 -0.406 . . . . 71.109999999999999 109.903 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.44 138.43 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.918 0.866 . . . . 63.109999999999999 111.358 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.37 161.54 33.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.914 -1.494 . . . . 64.219999999999999 108.738 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -130.0 160.08 34.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.08 -0.964 . . . . 74.329999999999998 108.621 172.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 53' ' ' VAL . 55.8 t -90.32 120.89 39.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 107.564 -1.272 . . . . 71.299999999999997 107.564 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.76 160.51 32.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.192 0.52 . . . . 74.310000000000002 111.973 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 36' ' ' GLN . 17.2 ptt85 -169.53 170.16 8.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.777 -1.101 . . . . 74.209999999999994 110.216 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.608 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -145.03 139.49 27.48 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.516 -0.473 . . . . 44.450000000000003 110.505 169.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.0 t30 30.95 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.208 1.559 . . . . 73.120000000000005 115.208 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.0 pt-20 -112.49 -32.06 6.6 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.471 -0.768 . . . . 70.25 112.536 -172.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.94 -22.48 8.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.156 -0.545 . . . . 21.199999999999999 112.641 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.44 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 33.8 tt0 -80.01 158.65 26.48 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.952 -0.758 . . . . 74.310000000000002 108.952 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.05 140.61 46.58 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.771 0.656 . . . . 73.099999999999994 112.771 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m -134.1 -179.23 5.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.031 -0.986 . . . . 73.510000000000005 109.351 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.64 158.34 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.621 0.248 . . . . 63.030000000000001 110.694 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CE2' ' HG ' ' A' ' 46' ' ' LEU . 75.0 t90 -155.14 145.41 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.212 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.1 ttt -81.49 125.53 30.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.746 0.308 . . . . 73.299999999999997 111.279 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.06 142.12 47.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.027 -0.533 . . . . 70.439999999999998 110.494 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.47 -5.52 29.81 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 111.582 -0.607 . . . . 43.5 111.582 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -108.12 166.29 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.147 0.579 . . . . 65.319999999999993 109.45 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -97.19 115.07 26.91 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.116 -0.365 . . . . 72.319999999999993 110.565 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 mt -69.68 138.76 88.4 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 65.25 110.745 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 50' ' ' TRP . 19.2 Cg_endo -65.61 137.1 48.84 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 122.244 1.963 . . . . 72.340000000000003 111.75 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.11 124.9 4.14 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.47 -0.786 . . . . 71.430000000000007 111.509 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.6 -34.12 4.92 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.773 -0.649 . . . . 71.010000000000005 111.772 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 41.1 m95 -77.6 139.81 39.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.716 0.293 . . . . 71.239999999999995 110.723 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 13.0 pt-20 -126.7 156.22 41.44 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.59 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.2 p -104.39 153.19 21.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.555 -1.202 . . . . 63.350000000000001 111.085 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.37 161.73 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 123.419 0.688 . . . . 74.209999999999994 109.985 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.95 -159.4 24.51 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.399 -0.819 . . . . 72.200000000000003 111.96 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.76 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -109.9 137.48 20.48 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 109.269 -0.641 . . . . 72.409999999999997 109.269 176.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.645 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 57.0 Cg_endo -68.79 116.48 4.47 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.406 1.404 . . . . 72.400000000000006 110.431 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' O ' ' SG ' ' A' ' 62' ' ' CYS . . . -162.47 169.39 20.46 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.15 -0.477 . . . . 55.439999999999998 110.251 -169.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 24' ' ' ASP . 43.3 p -55.74 151.9 10.42 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.916 0.135 . . . . 72.340000000000003 111.035 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.13 -41.66 3.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.287 0.565 . . . . 75.310000000000002 110.147 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -56.66 -52.32 65.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.664 -1.153 . . . . 73.420000000000002 111.492 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.504 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 10.3 mm-40 -71.32 -41.8 69.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 72.450000000000003 110.754 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 57' ' ' ALA . 72.8 m -60.59 -45.95 92.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.395 -0.366 . . . . 63.149999999999999 111.167 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 95' ' ' ARG . 3.8 pp -68.09 -36.41 79.75 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.42 -0.585 . . . . 54.210000000000001 109.42 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -58.18 -31.58 67.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.428 -0.806 . . . . 74.010000000000005 110.318 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 34.1 ttt180 -65.83 -53.26 42.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.898 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 pt -73.35 -32.35 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 74.430000000000007 112.46 -171.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 95' ' ' ARG . 12.4 pt-20 -58.47 -32.69 69.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.042 0.448 . . . . 71.010000000000005 109.925 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 79.3 mm-40 -87.7 -9.38 54.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 111.379 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -103.74 -65.69 1.0 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.708 0.766 . . . . 70.129999999999995 111.619 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.677 ' HD1' ' HB3' ' A' ' 7' ' ' HIS . 29.1 t90 -85.39 -43.21 13.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.07 -0.968 . . . . 45.109999999999999 110.78 -175.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.13 -10.83 51.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.82 -0.627 . . . . 55.350000000000001 112.268 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 4.9 p-10 -40.74 -43.15 1.92 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.321 1.6 . . . . 73.310000000000002 115.321 -163.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.403 ' HB2' ' CE1' ' A' ' 6' ' ' HIS . 21.0 mtm -66.5 85.81 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.822 0.737 . . . . 75.019999999999996 110.582 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.98 142.06 72.19 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 114.49 -1.232 . . . . 71.120000000000005 111.015 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.67 -162.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.874 2.383 . . . . 72.129999999999995 111.923 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.18 -17.68 12.18 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.233 -0.439 . . . . 60.32 111.637 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.7 p -58.06 -17.23 16.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.096 -0.502 . . . . 75.439999999999998 111.412 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.5 p -58.82 -44.02 89.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.45 -0.341 . . . . 72.150000000000006 110.665 175.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -69.05 -28.37 66.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.304 -0.407 . . . . 74.439999999999998 110.122 -177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.05 -37.26 76.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 73.109999999999999 110.906 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -97.18 -5.59 36.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.632 -0.258 . . . . 54.530000000000001 111.665 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 36.7 mt -63.04 -18.57 63.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.634 0.254 . . . . 73.430000000000007 111.218 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.82 -44.58 96.57 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.913 0.387 . . . . 64.540000000000006 110.032 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -76.4 86.06 3.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 74.549999999999997 110.279 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -143.38 16.82 1.87 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.929 -0.578 . . . . 73.5 110.306 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 m -97.48 14.62 25.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.821 -0.627 . . . . 53.329999999999998 111.16 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 131.48 -72.47 0.48 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.523 -0.631 . . . . 74.420000000000002 111.523 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.04 52.77 3.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.89 2.393 . . . . 73.530000000000001 111.808 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.2 16.24 32.61 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.867 -0.606 . . . . 73.430000000000007 111.637 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.97 81.2 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 122.057 0.932 . . . . 44.039999999999999 110.639 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.1 160.19 32.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.502 -1.226 . . . . 74.510000000000005 109.605 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -76.54 177.5 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 74.099999999999994 110.658 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.93 -149.93 0.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 75.120000000000005 110.175 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.86 107.32 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.377 0.608 . . . . 75.409999999999997 111.221 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.682 ' HD3' ' H ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.319 -0.848 . . . . 74.540000000000006 108.743 171.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.522 0.201 . . . . 73.219999999999999 110.521 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.52 38.52 25.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.705 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -133.07 127.84 34.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.196 0.522 . . . . 72.239999999999995 110.971 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -140.54 115.36 9.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.615 -0.883 . . . . 53.229999999999997 108.615 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -84.68 -87.98 0.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.353 -0.24 . . . . 64.019999999999996 110.353 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -153.84 -175.65 5.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.384 -0.599 . . . . 74.209999999999994 109.384 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.93 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.738 -0.838 . . . . 52.520000000000003 108.738 171.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -101.61 154.18 19.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.118 -0.492 . . . . 71.439999999999998 110.646 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.4 ptp -150.83 150.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 71.540000000000006 109.733 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.65 7.64 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 123.428 0.455 . . . . 73.319999999999993 112.625 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.3 p -58.12 111.66 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 64.109999999999999 110.565 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.84 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 73.430000000000007 111.464 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -98.73 83.42 2.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.102 0.477 . . . . 52.229999999999997 111.236 -177.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.63 110.96 1.88 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.217 -0.66 . . . . 61.0 109.217 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 65.0 95.77 0.05 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 123.875 0.734 . . . . 73.030000000000001 109.738 -170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 16' ' ' THR . 7.8 t -83.93 91.25 7.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.866 0.841 . . . . 75.239999999999995 110.674 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -142.82 18.48 1.98 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.361 -0.836 . . . . 74.109999999999999 110.419 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.13 162.05 53.49 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.323 -0.711 . . . . 74.420000000000002 111.323 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 80.6 Cg_exo -46.87 112.0 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.792 2.328 . . . . 73.409999999999997 112.509 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.57 154.8 26.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 44.340000000000003 111.594 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 m -155.78 144.29 20.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.419 -0.215 . . . . 65.310000000000002 110.419 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 58.6 mtt -85.33 101.31 12.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.773 -0.454 . . . . 73.349999999999994 109.773 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -160.29 105.99 1.52 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.219 0.533 . . . . 74.420000000000002 111.484 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 44.37 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.336 -1.302 . . . . 70.420000000000002 113.568 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 58' ' ' THR . 10.8 pt-20 -84.23 140.39 31.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.777 0.322 . . . . 71.109999999999999 111.862 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.6 mp -119.04 138.42 52.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.308 -0.405 . . . . 63.109999999999999 110.289 176.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.06 158.15 39.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.505 0.722 . . . . 64.219999999999999 110.367 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.638 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 22.0 m-85 -113.03 169.54 8.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 74.329999999999998 109.118 166.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG11 HG21 ' A' ' 66' ' ' ILE . 56.5 t -95.01 125.22 47.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.825 -1.176 . . . . 71.299999999999997 107.825 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 HD11 ' A' ' 46' ' ' LEU . 27.4 m -125.95 160.86 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.258 0.551 . . . . 74.310000000000002 111.95 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 11.8 ptt180 -169.16 170.13 8.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.62 -1.173 . . . . 74.209999999999994 110.083 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -145.83 139.59 26.48 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 44.450000000000003 110.834 164.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 33.06 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.745 1.757 . . . . 73.120000000000005 115.745 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 11.9 pt-20 -112.59 -29.36 7.49 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.583 0.628 . . . . 70.25 111.917 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.28 -10.52 48.81 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.152 -0.547 . . . . 21.199999999999999 112.634 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.564 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 69.3 mt-30 -84.78 173.03 10.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.039 -0.726 . . . . 74.310000000000002 109.039 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.31 132.66 48.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.957 0.725 . . . . 73.099999999999994 112.957 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -131.69 -178.9 5.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.791 -1.095 . . . . 73.510000000000005 108.475 172.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' SG ' ' A' ' 62' ' ' CYS . 23.7 m -124.17 149.53 28.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.204 0.526 . . . . 63.030000000000001 111.322 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HB2' HG21 ' A' ' 30' ' ' VAL . 55.8 t-105 -148.83 143.4 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.755 . . . . 74.310000000000002 109.28 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.0 ttt -74.85 141.37 44.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.893 0.377 . . . . 73.299999999999997 111.311 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.55 147.04 44.31 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.828 -0.624 . . . . 70.439999999999998 110.374 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.79 4.83 67.05 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.392 -0.433 . . . . 43.5 112.304 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -121.81 112.35 18.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.88 -0.415 . . . . 65.319999999999993 109.88 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.9 m -57.98 123.0 14.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.583 -0.735 . . . . 72.319999999999993 111.469 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 15.9 mt -79.99 139.76 53.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.308 -0.86 . . . . 65.25 110.836 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.33 140.06 53.45 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.691 2.261 . . . . 72.340000000000003 111.632 172.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.82 126.19 15.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.96 -0.564 . . . . 71.430000000000007 110.384 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -29.54 7.06 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.11 -0.495 . . . . 71.010000000000005 112.295 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.618 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.6 m95 -75.5 155.05 36.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.028 0.414 . . . . 71.239999999999995 110.607 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.8 pt-20 -135.67 148.97 49.13 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 110.043 -0.355 . . . . 74.230000000000004 110.043 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.409 HG22 HG12 ' A' ' 30' ' ' VAL . 19.6 p -109.19 153.01 24.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.431 -0.804 . . . . 63.350000000000001 110.983 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.2 t -149.98 152.9 11.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 122.842 0.457 . . . . 74.209999999999994 110.476 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.73 -170.12 37.9 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.797 -0.638 . . . . 72.200000000000003 113.198 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 1.4 pm0 -108.43 143.71 28.03 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 109.102 -0.703 . . . . 72.409999999999997 109.102 173.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.638 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 36.8 Cg_endo -63.1 122.14 10.26 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.161 1.907 . . . . 72.400000000000006 112.678 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 157.35 42.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.453 -0.794 . . . . 55.439999999999998 109.604 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 11.1 t -56.32 156.7 5.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.61 0.243 . . . . 72.340000000000003 111.085 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -43.26 -50.18 6.56 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.663 -0.699 . . . . 75.310000000000002 111.635 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.39 -49.46 76.14 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.412 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -70.16 -35.1 73.77 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.093 0.473 . . . . 72.450000000000003 110.461 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.484 ' SG ' HG12 ' A' ' 39' ' ' VAL . 18.2 t -62.09 -51.71 66.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 63.149999999999999 110.048 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.7 pp -68.36 -33.43 74.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.016 -0.273 . . . . 54.210000000000001 110.347 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 67' ' ' GLU . 8.6 tt0 -62.45 -31.93 72.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.531 0.681 . . . . 74.010000000000005 110.635 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' HA ' ' HG2' ' A' ' 19' ' ' PRO . 35.9 ttm180 -62.35 -53.1 59.92 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.035 -0.529 . . . . 74.430000000000007 112.091 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.608 HG21 HG11 ' A' ' 29' ' ' VAL . 17.8 pt -72.96 -35.11 47.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.737 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 68' ' ' GLN . 4.2 pt-20 -57.78 -46.21 84.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.606 -0.438 . . . . 71.010000000000005 109.839 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.621 ' N ' ' HG3' ' A' ' 67' ' ' GLU . 86.0 mt-30 -74.15 -0.41 16.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.388 -0.369 . . . . 75.109999999999999 111.633 -173.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 93.8 mt -103.37 -68.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.552 -0.459 . . . . 70.129999999999995 112.139 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -87.34 -55.08 3.96 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.621 -0.718 . . . . 45.109999999999999 111.976 -176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 67' ' ' GLU . 2.9 p -81.81 -10.89 59.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.708 -1.133 . . . . 55.350000000000001 111.752 -171.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.1 t70 -41.85 -28.33 0.15 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.948 0.899 . . . . 73.310000000000002 113.043 -172.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 22.4 mmt -68.33 73.16 0.21 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.197 -0.668 . . . . 75.019999999999996 109.197 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 3.9 p -84.38 137.4 39.38 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.217 -0.901 . . . . 71.120000000000005 111.077 -175.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 11.4 Cg_exo -70.91 -157.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.024 2.482 . . . . 72.129999999999995 112.049 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.65 -16.47 10.72 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.866 0.365 . . . . 60.32 111.468 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 13.9 m -50.1 -33.17 17.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.717 -0.674 . . . . 75.439999999999998 111.583 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.15 -35.61 72.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.131 0.491 . . . . 72.150000000000006 110.623 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 79' ' ' ARG . 40.9 mmm-85 -73.62 -42.98 60.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.654 -0.703 . . . . 74.439999999999998 110.108 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.82 -28.7 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.327 -0.851 . . . . 73.109999999999999 111.116 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -63.38 -21.76 66.48 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.267 -0.424 . . . . 54.530000000000001 111.116 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.1 tp -95.15 9.17 40.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.165 0.507 . . . . 73.430000000000007 110.571 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.4 83.38 2.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.918 -0.771 . . . . 64.540000000000006 108.918 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 2.8 mp0 -69.03 78.82 0.33 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.675 0.62 . . . . 74.549999999999997 112.675 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.474 ' HB3' ' O ' ' A' ' 84' ' ' GLN . 5.3 p80 177.28 135.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.277 -0.638 . . . . 73.5 109.277 168.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 87.0 0.28 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.242 0.544 . . . . 53.329999999999998 110.663 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -92.64 147.16 18.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.687 -0.688 . . . . 74.420000000000002 111.583 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.44 106.51 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.937 2.425 . . . . 73.530000000000001 112.192 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.38 -56.19 0.43 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.689 -0.964 . . . . 73.430000000000007 110.689 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.7 mt 48.04 83.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.416 0.686 . . . . 44.039999999999999 112.156 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -133.25 125.37 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.557 -0.905 . . . . 74.510000000000005 108.557 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 77' ' ' SER . 74.7 m-85 -136.59 -171.19 2.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 111.819 0.303 . . . . 74.099999999999994 111.819 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.58 169.84 0.63 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.819 0.674 . . . . 75.120000000000005 112.819 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.9 p -107.49 152.08 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.338 -0.846 . . . . 75.409999999999997 110.436 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 67' ' ' GLU . 39.3 ptt85 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.435 -0.793 . . . . 74.540000000000006 110.015 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.15 -0.315 . . . . 73.219999999999999 110.15 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.06 64.59 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.198 0.523 . . . . 73.439999999999998 110.508 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -84.14 102.26 12.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.786 -0.643 . . . . 72.239999999999995 109.663 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -117.82 106.02 12.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.287 0.565 . . . . 53.229999999999997 111.268 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -106.26 3.46 27.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.551 0.691 . . . . 64.019999999999996 109.427 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -94.42 107.14 19.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.35 -0.841 . . . . 74.209999999999994 109.751 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -151.0 90.72 1.63 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 52.520000000000003 111.103 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -98.53 163.5 12.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.325 -0.62 . . . . 71.439999999999998 109.325 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 40.9 tpp -140.52 -79.03 0.29 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.411 -0.218 . . . . 71.540000000000006 110.411 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.29 -176.21 47.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.037 -0.601 . . . . 73.319999999999993 112.824 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -145.77 -73.52 0.23 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.063 0.459 . . . . 64.109999999999999 110.092 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.97 -167.04 1.38 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.109 -0.496 . . . . 73.430000000000007 110.133 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -178.24 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.993 0.425 . . . . 52.229999999999997 111.357 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -59.7 1.91 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.772 -0.825 . . . . 61.0 108.772 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -152.17 114.46 4.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.123 -0.944 . . . . 73.030000000000001 109.029 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -82.46 83.44 7.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.333 0.587 . . . . 75.239999999999995 110.294 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.16 130.78 45.29 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.428 -0.805 . . . . 74.109999999999999 111.066 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.92 -166.43 26.97 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.803 -0.919 . . . . 74.420000000000002 110.803 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.666 ' HB2' HE22 ' A' ' 60' ' ' GLN . 24.6 Cg_exo -62.86 99.49 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.16 1.907 . . . . 73.409999999999997 111.15 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.68 82.76 0.03 OUTLIER Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.88 -0.6 . . . . 44.340000000000003 113.301 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.654 ' HB2' HG21 ' A' ' 58' ' ' THR . 20.0 m -91.32 54.03 2.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.058 0.456 . . . . 65.310000000000002 110.661 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.2 mpt? -76.94 70.82 3.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.13 0.491 . . . . 73.349999999999994 110.705 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -113.27 -49.63 2.9 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.725 0.774 . . . . 74.420000000000002 109.948 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.52 179.46 5.0 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 114.608 -1.178 . . . . 70.420000000000002 111.009 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -67.06 150.93 48.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 71.109999999999999 111.061 -174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 56' ' ' PRO . 10.0 mp -69.17 151.56 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 63.109999999999999 110.97 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 33.8 m-85 -123.66 149.06 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.49 -0.777 . . . . 64.219999999999999 109.741 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -114.86 155.97 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 74.329999999999998 108.921 169.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.72 114.83 24.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 N-CA-C 107.86 -1.163 . . . . 71.299999999999997 107.86 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 40' ' ' TRP . 12.7 m -125.14 159.62 31.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 122.164 -0.335 . . . . 74.310000000000002 110.561 -170.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -162.0 162.11 28.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.351 -0.84 . . . . 74.209999999999994 110.722 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 p30 -152.05 139.69 19.75 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.269 -0.271 . . . . 44.450000000000003 110.269 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t30 46.63 4.63 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.993 1.109 . . . . 73.120000000000005 113.993 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.19 -32.43 6.54 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.656 -0.653 . . . . 70.25 112.095 -169.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.51 -22.68 3.16 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.352 -0.452 . . . . 21.199999999999999 112.617 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -75.51 173.96 10.29 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.727 -0.471 . . . . 74.310000000000002 109.727 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.49 136.01 53.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 73.099999999999994 112.172 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -135.86 -178.74 5.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.066 -0.97 . . . . 73.510000000000005 109.456 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG11 ' SG ' ' A' ' 62' ' ' CYS . 27.7 m -128.72 150.02 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.68 0.276 . . . . 63.030000000000001 111.069 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 30' ' ' VAL . 52.2 t-105 -149.45 141.48 23.88 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.851 -0.613 . . . . 74.310000000000002 109.736 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.6 mtt -65.45 134.24 53.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.1 0.476 . . . . 73.299999999999997 111.408 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.23 147.82 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.764 -0.653 . . . . 70.439999999999998 110.451 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.72 62.53 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.188 -0.765 . . . . 43.5 111.188 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -93.91 96.48 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.731 -0.84 . . . . 65.319999999999993 108.731 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m -55.57 116.52 2.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 112.113 -169.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.441 HD11 HG11 ' A' ' 30' ' ' VAL . 42.6 mt -74.4 139.64 75.22 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.729 -1.123 . . . . 65.25 110.055 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.22 160.48 20.31 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.636 2.224 . . . . 72.340000000000003 112.478 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.3 129.92 18.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.549 -0.75 . . . . 71.430000000000007 110.53 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.54 -33.29 5.31 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.35 -0.7 . . . . 71.010000000000005 111.35 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 43.2 m95 -88.72 148.08 24.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.508 0.194 . . . . 71.239999999999995 110.519 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 149.37 52.13 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 110.262 -0.273 . . . . 74.230000000000004 110.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 30' ' ' VAL . 34.8 p -111.53 148.3 33.5 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 124.376 1.048 . . . . 63.350000000000001 111.057 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -154.05 156.4 5.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.573 0.749 . . . . 74.209999999999994 109.878 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' O ' ' HE1' ' A' ' 28' ' ' PHE . . . 93.43 -158.58 23.7 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.406 -0.426 . . . . 72.200000000000003 113.483 169.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.89 131.68 21.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.611 . . . . 72.409999999999997 109.349 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HB2' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -70.08 109.08 2.28 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 121.623 1.549 . . . . 72.400000000000006 111.255 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.07 171.09 20.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.236 -0.893 . . . . 55.439999999999998 110.442 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.654 HG21 ' HB2' ' A' ' 21' ' ' SER . 9.9 t -58.28 166.19 1.75 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.254 0.55 . . . . 72.340000000000003 112.437 -175.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.683 ' HA ' ' SG ' ' A' ' 62' ' ' CYS . 32.1 tptt -49.82 -49.77 47.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.055 -0.975 . . . . 75.310000000000002 110.669 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.666 HE22 ' HB2' ' A' ' 19' ' ' PRO . 28.0 tt0 -54.42 -43.04 71.2 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.087 -0.96 . . . . 73.420000000000002 111.342 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -70.04 -48.45 57.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 72.450000000000003 110.746 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 9.1 p -62.93 -42.4 99.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.075 -0.511 . . . . 63.149999999999999 111.515 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.3 pp -67.93 -40.82 83.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.492 -0.483 . . . . 54.210000000000001 110.093 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.452 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.6 tt0 -60.19 -31.43 70.13 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.789 -0.641 . . . . 74.010000000000005 110.454 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 75.5 ttt-85 -73.86 -53.3 10.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.627 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 63' ' ' LEU . 39.3 pt -66.23 -32.8 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 112.228 0.455 . . . . 74.430000000000007 112.228 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.42 -32.85 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.606 0.241 . . . . 71.010000000000005 110.353 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.448 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 91.2 mt-30 -87.53 -1.63 58.07 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.073 -0.512 . . . . 75.109999999999999 111.349 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 85.9 mt -104.0 -66.72 0.94 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.272 0.558 . . . . 70.129999999999995 111.656 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -86.09 -55.14 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.391 -0.822 . . . . 45.109999999999999 111.163 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.507 HG22 HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -78.8 -10.99 59.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.205 -0.907 . . . . 55.350000000000001 111.311 -174.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB2' ' C ' ' A' ' 68' ' ' GLN . 33.4 t70 -41.76 -32.78 0.42 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.693 0.797 . . . . 73.310000000000002 112.981 -171.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.6 ttp -66.17 77.77 0.09 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.569 0.7 . . . . 75.019999999999996 110.207 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -85.3 132.07 46.26 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.028 -0.987 . . . . 71.120000000000005 110.456 -178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 Cg_exo -68.34 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.878 2.385 . . . . 72.129999999999995 112.518 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.95 -17.84 4.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.771 -0.65 . . . . 60.32 111.445 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m -50.96 -29.42 12.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.926 -0.579 . . . . 75.439999999999998 111.327 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.59 -35.88 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.452 -0.34 . . . . 72.150000000000006 110.868 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -55.03 -28.29 51.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.089 -0.505 . . . . 74.439999999999998 111.822 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.94 -39.63 83.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.01 0.433 . . . . 73.109999999999999 110.707 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.584 ' HE1' ' HA ' ' A' ' 91' ' ' ASP . 49.9 t-80 -94.69 -19.88 20.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 54.530000000000001 110.532 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.48 80.83 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.27 0.557 . . . . 73.430000000000007 109.889 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -85.93 139.38 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.362 -0.977 . . . . 64.540000000000006 108.362 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.83 101.55 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.808 -0.441 . . . . 74.549999999999997 109.808 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -124.31 112.35 16.88 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.265 0.555 . . . . 73.5 110.906 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.1 t -96.05 82.04 3.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.767 -0.651 . . . . 53.329999999999998 109.828 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.0 -176.61 22.44 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.721 -0.672 . . . . 74.420000000000002 111.793 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.07 148.05 93.92 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.939 2.426 . . . . 73.530000000000001 112.317 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.96 156.6 22.92 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.313 -0.715 . . . . 73.430000000000007 111.313 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.0 pt -72.8 89.61 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.614 0.721 . . . . 44.039999999999999 111.144 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.584 ' HA ' ' HE1' ' A' ' 81' ' ' HIS . 2.6 t0 -121.53 147.94 45.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.159 -0.928 . . . . 74.510000000000005 108.809 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -142.45 -175.72 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.104 0.478 . . . . 74.099999999999994 110.977 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.4 -149.77 0.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.753 . . . . 75.120000000000005 109.395 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 71' ' ' THR . 3.1 p -115.21 93.83 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.524 0.678 . . . . 75.409999999999997 111.663 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 N-CA-C 107.93 -1.137 . . . . 74.540000000000006 107.93 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.36 -0.237 . . . . 73.219999999999999 110.36 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.51 176.96 7.75 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.715 -0.221 . . . . 73.439999999999998 110.473 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m170 56.0 50.22 14.24 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.694 0.621 . . . . 72.239999999999995 111.957 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -74.84 83.62 2.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.045 0.45 . . . . 53.229999999999997 110.648 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 12.6 p-80 -63.58 107.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.63 -0.714 . . . . 64.019999999999996 109.543 172.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 84.5 m-70 68.53 167.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 110.021 -168.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -71.02 -68.64 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.543 -0.299 . . . . 52.520000000000003 110.629 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -159.37 174.02 15.36 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.155 -0.683 . . . . 71.439999999999998 109.155 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.2 ptp -92.92 -41.6 9.95 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.985 -0.376 . . . . 71.540000000000006 109.985 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.06 113.46 0.52 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.242 -0.504 . . . . 73.319999999999993 113.224 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 12' ' ' LEU . 20.1 m -154.76 177.85 10.79 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.109 -1.071 . . . . 64.109999999999999 108.109 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 11' ' ' THR . 36.8 tp -153.33 -73.54 0.13 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.429 0.559 . . . . 73.430000000000007 110.867 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HA ' HH11 ' A' ' 65' ' ' ARG . 4.6 mp0 -90.94 91.87 8.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.735 0.302 . . . . 52.229999999999997 110.384 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -157.48 102.94 1.92 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.953 -0.567 . . . . 61.0 109.843 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -62.81 -41.5 99.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.962 0.41 . . . . 73.030000000000001 110.897 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 54.93 26.44 7.91 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.316 -0.856 . . . . 75.239999999999995 110.051 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 21' ' ' SER . 55.8 tp60 -66.61 -44.17 82.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.021 -0.99 . . . . 74.109999999999999 110.469 -175.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.58 -125.87 7.51 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.493 -0.776 . . . . 74.420000000000002 111.209 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.25 140.75 15.72 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.991 2.46 . . . . 73.409999999999997 111.66 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.89 78.74 0.77 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 121.324 -0.465 . . . . 44.340000000000003 112.572 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 17' ' ' GLN . 27.1 m -74.81 114.23 13.02 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.071 -0.344 . . . . 65.310000000000002 110.071 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.3 tpt -74.34 109.02 7.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 73.349999999999994 110.546 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -96.81 113.35 24.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.893 -0.594 . . . . 74.420000000000002 110.195 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -156.31 -178.82 7.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.76 -0.83 . . . . 70.420000000000002 108.76 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.32 135.34 53.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.713 0.292 . . . . 71.109999999999999 110.492 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 56' ' ' PRO . 6.4 mp -85.14 143.47 28.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.413 0.625 . . . . 63.109999999999999 112.34 -172.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.625 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 6.3 m-85 -124.65 149.3 47.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.659 -1.155 . . . . 64.219999999999999 109.001 174.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.567 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -108.17 169.75 8.43 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.698 -0.482 . . . . 74.329999999999998 109.698 172.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 53' ' ' VAL . 51.0 t -99.0 137.53 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.412 -1.329 . . . . 71.299999999999997 107.412 172.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.62 161.91 29.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 118.405 0.548 . . . . 74.310000000000002 111.878 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -169.06 170.19 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.961 -1.018 . . . . 74.209999999999994 110.436 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 4.8 p30 -165.73 139.81 4.57 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.438 -0.208 . . . . 44.450000000000003 110.438 166.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.75 8.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.274 1.213 . . . . 73.120000000000005 114.274 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.8 pt-20 -112.08 -29.84 7.45 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.798 -0.564 . . . . 70.25 112.05 -169.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.66 -22.92 7.04 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.244 -0.503 . . . . 21.199999999999999 113.011 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.12 173.87 8.58 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.964 -0.384 . . . . 74.310000000000002 109.964 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -116.69 150.73 37.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.326 0.491 . . . . 73.099999999999994 112.326 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -144.47 -178.95 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.867 . . . . 73.510000000000005 109.453 168.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.55 165.41 16.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.784 0.326 . . . . 63.030000000000001 110.858 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.509 ' CZ2' ' HG3' ' A' ' 44' ' ' ARG . 35.0 t90 -151.72 132.2 13.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 74.310000000000002 110.692 -170.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.457 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 15.8 tpt -68.06 127.32 32.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.051 -0.522 . . . . 73.299999999999997 110.136 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.93 159.58 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 70.439999999999998 109.606 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.42 21.04 25.58 Favored Glycine 0 C--N 1.329 0.166 0 C-N-CA 121.022 -0.608 . . . . 43.5 112.004 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HG3' ' CZ2' ' A' ' 40' ' ' TRP . 4.8 ptm180 -148.28 179.11 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.654 -0.499 . . . . 65.319999999999993 109.654 175.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 m -109.47 154.0 23.26 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.559 -0.534 . . . . 72.319999999999993 109.559 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 47' ' ' PRO . 11.2 tp -104.22 129.19 25.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 65.25 110.193 -174.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 46' ' ' LEU . 83.9 Cg_exo -40.42 132.82 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.522 2.814 . . . . 72.340000000000003 113.217 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 128.29 20.53 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.728 -0.669 . . . . 71.430000000000007 111.192 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.86 -34.22 5.09 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.875 -0.89 . . . . 71.010000000000005 110.875 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.755 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 45.6 m95 -76.69 157.64 31.62 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 110.167 -0.308 . . . . 71.239999999999995 110.167 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.63 152.99 48.58 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 116.314 -0.403 . . . . 74.230000000000004 110.111 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -105.67 154.52 20.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.738 -1.119 . . . . 63.350000000000001 110.528 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -163.05 161.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.225 0 C-N-CA 123.334 0.654 . . . . 74.209999999999994 110.863 -174.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.464 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 92.44 -140.09 14.96 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.823 -1.08 . . . . 72.200000000000003 112.72 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 26.0 tt0 -140.26 133.96 15.27 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.308 -0.997 . . . . 72.409999999999997 108.308 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 70.0 Cg_endo -70.29 112.48 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.603 . . . . 72.400000000000006 111.073 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.448 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -142.63 174.41 10.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.591 -0.731 . . . . 55.439999999999998 110.692 -172.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -64.44 157.88 25.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.589 0.233 . . . . 72.340000000000003 110.603 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -44.38 -51.78 8.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.444 0.698 . . . . 75.310000000000002 111.654 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -55.38 -46.09 76.56 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.854 -0.612 . . . . 73.420000000000002 111.825 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.448 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 99.2 mt-30 -71.46 -32.17 67.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 72.450000000000003 111.126 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 71.8 m -68.68 -47.22 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 63.149999999999999 111.011 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' GLN . 3.8 pp -68.01 -36.13 79.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.924 0.393 . . . . 54.210000000000001 110.619 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 63' ' ' LEU . 25.5 tt0 -61.12 -43.55 98.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.532 . . . . 74.010000000000005 109.803 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.688 ' NH1' ' HB3' ' A' ' 55' ' ' GLU . 14.2 ttm180 -60.5 -53.45 57.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.38 -0.827 . . . . 74.430000000000007 111.924 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 19.5 pt -63.71 -32.48 57.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.779 0.324 . . . . 74.430000000000007 111.531 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 94' ' ' VAL . 8.6 mm-40 -64.31 -32.56 74.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.471 . . . . 71.010000000000005 110.612 175.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 72.4 mm-40 -86.35 7.94 23.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.055 0.455 . . . . 75.109999999999999 110.592 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 36.9 mt -103.53 -62.58 1.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.515 0.674 . . . . 70.129999999999995 110.537 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -85.83 -50.03 7.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.737 -1.12 . . . . 45.109999999999999 110.994 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -86.43 -10.52 54.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.739 -1.119 . . . . 55.350000000000001 112.176 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' HB3' ' C ' ' A' ' 68' ' ' GLN . 12.1 p-10 -41.83 -40.19 2.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.34 0.656 . . . . 73.310000000000002 112.726 -170.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.1 tpp -72.34 78.42 1.01 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.284 0.564 . . . . 75.019999999999996 109.612 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.9 133.27 48.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.12 -0.945 . . . . 71.120000000000005 110.906 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.91 -155.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.719 2.279 . . . . 72.129999999999995 111.536 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.79 -18.78 2.04 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.638 0.375 . . . . 60.32 111.959 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -57.99 -15.71 9.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.636 0.375 . . . . 75.439999999999998 111.502 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.01 -38.86 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.715 0.293 . . . . 72.150000000000006 110.657 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 84.2 mtt180 -68.99 -20.15 64.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.911 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 5.2 mm-40 -63.12 -33.58 75.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 73.109999999999999 110.334 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.477 ' HB3' HD22 ' A' ' 82' ' ' LEU . 12.9 t-80 -102.49 -33.93 9.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.256 -0.429 . . . . 54.530000000000001 110.765 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 2.6 mm? -120.06 103.75 9.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.516 -0.311 . . . . 73.430000000000007 110.88 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -96.13 149.88 21.13 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.512 -0.551 . . . . 64.540000000000006 109.512 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -60.41 -46.01 91.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.776 0.322 . . . . 74.549999999999997 111.072 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -93.37 148.32 22.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.456 -0.572 . . . . 73.5 109.456 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -57.2 122.88 13.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.939 0.4 . . . . 53.329999999999998 111.115 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.05 152.3 23.49 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.737 -0.665 . . . . 74.420000000000002 111.623 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.82 13.75 2.53 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.791 2.327 . . . . 73.530000000000001 112.712 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.42 72.27 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.430000000000007 112.202 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 pt -93.82 92.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.487 0.66 . . . . 44.039999999999999 110.557 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 80' ' ' GLU . 38.4 t70 -112.0 171.14 7.68 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.424 -0.807 . . . . 74.510000000000005 110.31 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -57.58 134.61 56.28 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.57 0.581 . . . . 74.099999999999994 112.57 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.49 -156.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.371 -0.832 . . . . 75.120000000000005 109.298 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 67' ' ' GLU . 6.7 p -70.87 121.3 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.625 -0.509 . . . . 75.409999999999997 109.625 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.862 1.265 . . . . 74.540000000000006 110.778 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.978 -0.379 . . . . 73.219999999999999 109.978 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.24 -52.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 73.439999999999998 110.22 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.9 p80 39.24 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.075 0.95 . . . . 72.239999999999995 112.806 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -151.43 41.01 0.7 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 53.229999999999997 110.148 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -65.58 78.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 64.019999999999996 110.848 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -151.81 40.8 0.66 Allowed 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.304 -0.628 . . . . 74.209999999999994 109.304 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -64.54 118.25 8.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.775 -0.648 . . . . 52.520000000000003 109.312 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -126.31 97.55 5.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.304 0.573 . . . . 71.439999999999998 111.333 -173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 tpt -111.86 -60.64 1.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.669 -1.234 . . . . 71.540000000000006 107.669 171.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.68 -87.85 0.01 OUTLIER Glycine 0 C--N 1.334 0.464 0 CA-C-N 114.916 -1.038 . . . . 73.319999999999993 114.364 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -44.37 -71.18 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.583 0.753 . . . . 64.109999999999999 112.916 -171.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HG ' ' H ' ' A' ' 13' ' ' GLU . 27.6 tp -170.48 176.43 4.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.565 -0.532 . . . . 73.430000000000007 109.565 -173.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.477 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 11.2 tp10 -56.31 142.66 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.445 0.466 . . . . 52.229999999999997 110.573 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.88 7.92 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 61.0 111.751 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -108.3 108.15 19.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.221 0.534 . . . . 73.030000000000001 110.911 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.7 t -116.94 11.37 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.585 -0.734 . . . . 75.239999999999995 109.781 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -106.05 91.82 3.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.617 -0.719 . . . . 74.109999999999999 109.913 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.44 124.9 3.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.194 -0.527 . . . . 74.420000000000002 111.955 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.19 150.75 60.05 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.463 2.109 . . . . 73.409999999999997 111.223 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.29 136.0 14.0 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.792 -0.718 . . . . 44.340000000000003 112.021 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' A' ' 24' ' ' ASP . 23.0 t -70.14 169.96 12.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.306 -0.628 . . . . 65.310000000000002 109.306 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.5 ptm -99.73 6.6 45.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.136 0.493 . . . . 73.349999999999994 111.112 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -150.84 -66.64 0.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.359 -0.837 . . . . 74.420000000000002 110.441 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 21' ' ' SER . 38.1 t70 -73.26 134.34 44.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.682 -0.69 . . . . 70.420000000000002 111.065 -175.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -73.97 -172.72 1.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.242 0.544 . . . . 71.109999999999999 111.518 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 56' ' ' PRO . 11.0 mp -85.2 142.23 29.59 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.585 . . . . 63.109999999999999 110.15 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 3.0 m-85 -125.18 148.62 48.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 64.219999999999999 110.055 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 56' ' ' PRO . 10.3 m-85 -109.68 157.67 18.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.176 -0.675 . . . . 74.329999999999998 109.176 168.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 37' ' ' TYR . 40.4 t -86.4 124.17 40.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.367 -1.346 . . . . 71.299999999999997 107.367 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 46' ' ' LEU . 19.3 m -125.54 162.52 28.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 122.103 -0.373 . . . . 74.310000000000002 111.054 -171.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.597 HH21 ' HA2' ' A' ' 35' ' ' GLY . 7.6 ptm180 -167.76 168.15 12.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.395 -0.366 . . . . 74.209999999999994 111.638 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -168.25 140.36 2.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.922 -0.581 . . . . 44.450000000000003 110.554 167.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.8 t30 45.89 13.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.029 0.932 . . . . 73.120000000000005 113.486 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 32' ' ' ASN . 9.8 pt-20 -112.43 -20.47 11.77 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.738 -0.601 . . . . 70.25 112.144 -172.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.597 ' HA2' HH21 ' A' ' 31' ' ' ARG . . . 75.52 -22.53 1.71 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.309 -0.472 . . . . 21.199999999999999 113.219 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 6.0 pt20 -103.42 173.96 6.08 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.778 0.431 . . . . 74.310000000000002 110.148 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.462 ' CD1' HG12 ' A' ' 29' ' ' VAL . 21.6 m-85 -108.74 158.13 17.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 73.099999999999994 112.471 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.5 m -141.73 -178.97 5.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.059 . . . . 73.510000000000005 108.646 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.757 HG21 ' HE3' ' A' ' 59' ' ' LYS . 20.6 m -127.79 152.34 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 118.237 0.472 . . . . 63.030000000000001 111.328 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -153.1 146.89 25.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.96 -0.564 . . . . 74.310000000000002 110.216 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 46.2 ttm -72.14 122.12 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.543 -0.299 . . . . 73.299999999999997 110.636 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.44 156.45 38.82 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 70.439999999999998 110.454 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.17 -31.81 8.22 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.302 -0.475 . . . . 43.5 112.145 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -106.6 130.34 54.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 65.319999999999993 110.216 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.5 m -66.0 159.37 25.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.22 0.534 . . . . 72.319999999999993 111.881 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 17.4 mt -107.3 155.5 39.33 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.228 -0.896 . . . . 65.25 111.227 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -55.85 152.36 36.13 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.172 2.581 . . . . 72.340000000000003 112.509 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.68 118.45 3.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.469 -0.787 . . . . 71.430000000000007 110.907 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.01 9.93 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 116.151 -0.477 . . . . 71.010000000000005 112.502 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.58 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 39.7 m95 -79.49 132.21 36.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.845 0.322 . . . . 71.239999999999995 111.037 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' ARG . 11.0 pt-20 -115.88 154.26 30.05 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.662 -177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 30' ' ' VAL . 40.1 p -112.77 146.22 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.439 1.087 . . . . 63.350000000000001 110.612 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 54' ' ' GLY . 17.3 t -154.86 156.12 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.606 0.363 . . . . 74.209999999999994 110.476 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 87.33 -179.83 48.13 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.121 -0.491 . . . . 72.200000000000003 113.958 169.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 29.9 tt0 -69.98 118.35 62.61 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 123.237 0.615 . . . . 72.409999999999997 111.062 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 35.6 Cg_endo -64.68 111.71 1.76 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.768 1.645 . . . . 72.400000000000006 110.786 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.84 179.41 6.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.939 -0.573 . . . . 55.439999999999998 110.465 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.0 t -55.68 157.8 3.91 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.976 0.417 . . . . 72.340000000000003 111.631 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.757 ' HE3' HG21 ' A' ' 39' ' ' VAL . 22.2 tptm -45.97 -45.02 15.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.456 -0.793 . . . . 75.310000000000002 111.145 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 8.8 tt0 -56.67 -43.18 80.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 73.420000000000002 111.13 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -69.25 -50.2 49.23 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.435 -0.348 . . . . 72.450000000000003 111.031 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.752 ' SG ' ' HA ' ' A' ' 59' ' ' LYS . 15.2 p -60.73 -43.53 97.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.342 -0.39 . . . . 63.149999999999999 111.13 -174.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.642 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 pp -67.78 -42.42 81.72 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.636 -0.425 . . . . 54.210000000000001 109.993 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' LEU . 31.7 tt0 -54.94 -40.7 70.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.111 0.482 . . . . 74.010000000000005 110.342 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.1 ttm-85 -58.37 -53.35 59.25 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.583 -0.735 . . . . 74.430000000000007 111.955 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 29' ' ' VAL . 17.4 pt -73.01 -34.63 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 116.507 -0.315 . . . . 74.430000000000007 111.797 -175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 10.0 mm-40 -61.59 -32.72 72.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 71.010000000000005 110.203 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -81.39 -8.42 59.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.272 -0.422 . . . . 75.109999999999999 111.722 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 94.8 mt -103.31 -67.03 0.9 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.886 0.374 . . . . 70.129999999999995 111.909 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -86.3 -52.9 5.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.511 0.672 . . . . 45.109999999999999 110.894 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 94' ' ' VAL . 1.5 m -70.55 -11.35 60.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.758 -1.11 . . . . 55.350000000000001 111.052 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 1.1 p-10 -42.16 -34.95 0.83 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.734 0.814 . . . . 73.310000000000002 113.093 -172.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -65.78 85.82 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.575 0.702 . . . . 75.019999999999996 111.651 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 7.4 p -106.57 130.56 22.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.565 -0.743 . . . . 71.120000000000005 110.19 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 74' ' ' VAL . 5.0 Cg_exo -73.42 -158.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.917 2.412 . . . . 72.129999999999995 112.151 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.96 -20.69 17.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 60.32 111.939 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.1 p -58.83 -16.35 16.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.155 -0.475 . . . . 75.439999999999998 111.794 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.17 -34.94 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.01 0.433 . . . . 72.150000000000006 110.682 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -66.94 -20.04 65.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.743 -0.662 . . . . 74.439999999999998 110.83 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -58.14 -35.87 72.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.097 -0.501 . . . . 73.109999999999999 110.158 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -97.45 -48.73 5.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.925 -0.58 . . . . 54.530000000000001 109.943 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 tt -94.95 95.15 8.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.783 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -67.16 146.88 53.78 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.847 -0.615 . . . . 64.540000000000006 111.013 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.92 87.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.941 -0.572 . . . . 74.549999999999997 111.32 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -126.68 146.71 50.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.923 -0.581 . . . . 73.5 109.514 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 p -83.05 88.53 6.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 53.329999999999998 110.364 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.98 169.05 29.09 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.694 -0.684 . . . . 74.420000000000002 111.74 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.28 176.29 2.74 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.974 2.449 . . . . 73.530000000000001 112.365 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.3 124.1 1.26 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.085 -0.579 . . . . 73.430000000000007 112.235 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.12 87.05 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.886 -0.783 . . . . 44.039999999999999 108.886 173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -127.53 179.09 5.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 74.510000000000005 109.886 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -118.29 -178.77 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.636 0.375 . . . . 74.099999999999994 110.04 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 72' ' ' ASP . . . -113.29 87.07 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 75.120000000000005 110.225 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 71' ' ' THR . 11.3 p 43.21 31.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.672 1.189 . . . . 75.409999999999997 113.855 176.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.531 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 114.764 -1.107 . . . . 74.540000000000006 110.316 171.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 110.429 -0.211 . . . . 73.219999999999999 110.429 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.25 105.32 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.654 0.596 . . . . 73.439999999999998 112.144 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 149.18 10.17 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.837 -0.619 . . . . 72.239999999999995 109.365 177.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -145.99 101.76 3.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.763 0.316 . . . . 53.229999999999997 110.233 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -102.99 145.45 29.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.126 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -94.9 -174.53 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.251 -0.648 . . . . 74.209999999999994 109.251 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -84.94 144.85 28.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.003 0.43 . . . . 52.520000000000003 110.975 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -151.5 137.3 18.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.415 -0.811 . . . . 71.439999999999998 109.229 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 80.9 mtp -65.09 -61.41 2.16 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.297 0.373 . . . . 71.540000000000006 110.632 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.66 51.06 12.46 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.908 -0.587 . . . . 73.319999999999993 112.922 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.4 p -80.07 -62.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.364 -0.606 . . . . 64.109999999999999 109.364 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.41 117.98 27.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 73.430000000000007 109.294 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 6.8 mm-40 -92.04 130.03 37.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.538 -0.542 . . . . 52.229999999999997 109.538 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.75 132.13 36.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.211 -0.292 . . . . 61.0 110.211 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -80.33 42.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 73.030000000000001 110.753 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -60.42 -26.32 66.62 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.804 -0.634 . . . . 75.239999999999995 110.352 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -88.83 -45.9 9.38 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.161 -0.681 . . . . 74.109999999999999 109.161 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.97 144.71 7.03 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.409 -0.814 . . . . 74.420000000000002 111.849 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HB3' ' HG2' ' A' ' 56' ' ' PRO . 85.2 Cg_endo -78.96 27.18 0.52 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.25 2.634 . . . . 73.409999999999997 112.401 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.55 -76.05 0.39 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.62 -0.592 . . . . 44.340000000000003 111.62 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.4 t -172.68 36.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 65.310000000000002 108.881 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.424 ' HA ' HD22 ' A' ' 26' ' ' LEU . 22.1 ptm 39.33 60.78 1.46 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.221 1.01 . . . . 73.349999999999994 110.418 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.64 -67.26 0.45 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.059 -1.428 . . . . 74.420000000000002 111.086 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -87.9 171.96 9.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.761 -0.654 . . . . 70.420000000000002 109.712 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.79 87.3 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.37 0.605 . . . . 71.109999999999999 110.19 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 56' ' ' PRO . 7.0 mp -71.29 163.11 28.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 63.109999999999999 111.107 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -126.39 148.5 49.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.977 -1.01 . . . . 64.219999999999999 109.288 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -111.99 153.31 26.99 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.378 -0.971 . . . . 74.329999999999998 108.378 174.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 53' ' ' VAL . 77.2 t -84.77 135.61 24.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.22 -1.77 . . . . 71.299999999999997 106.22 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 46' ' ' LEU . 21.6 m -136.46 165.12 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 121.483 -0.761 . . . . 74.310000000000002 111.644 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -166.01 164.32 18.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.793 -1.094 . . . . 74.209999999999994 110.282 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.657 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 3.4 p-10 -153.39 139.77 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 44.450000000000003 110.137 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 42.44 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.052 1.501 . . . . 73.120000000000005 115.052 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.4 pt-20 -112.53 -32.22 6.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.461 0.573 . . . . 70.25 111.832 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.01 -22.59 4.94 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.462 -0.399 . . . . 21.199999999999999 112.381 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -73.39 173.95 8.84 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -112.75 137.59 50.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.478 0.656 . . . . 73.099999999999994 112.41 -176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.7 m -137.27 -179.09 5.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.894 -1.048 . . . . 73.510000000000005 108.936 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG12 ' SG ' ' A' ' 62' ' ' CYS . 15.7 m -126.85 153.72 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.887 0.375 . . . . 63.030000000000001 111.125 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -144.19 156.08 44.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 74.310000000000002 109.259 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.8 ttt -82.59 121.3 26.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.017 -0.364 . . . . 73.299999999999997 110.017 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.34 157.81 34.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.985 0.421 . . . . 70.439999999999998 110.627 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -21.07 48.13 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.042 -0.823 . . . . 43.5 111.042 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 100.33 9.58 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.284 -0.636 . . . . 65.319999999999993 109.284 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -63.3 129.01 38.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.922 0.391 . . . . 72.319999999999993 110.422 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 2.7 mm? -58.72 145.19 78.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.635 -0.711 . . . . 65.25 112.418 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.99 144.12 99.5 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 123.007 2.472 . . . . 72.340000000000003 111.436 166.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.36 128.54 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 110.194 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.74 -29.75 7.02 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.551 -0.619 . . . . 71.010000000000005 111.551 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.657 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 36.0 m95 -86.69 170.9 11.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.068 -0.716 . . . . 71.239999999999995 109.068 172.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.83 146.57 28.03 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 120.937 0.399 . . . . 74.230000000000004 110.448 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.546 HG23 HD23 ' A' ' 46' ' ' LEU . 13.0 p -98.09 153.38 18.46 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.614 -1.176 . . . . 63.350000000000001 110.834 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -162.32 167.01 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 C-N-CA 124.266 1.026 . . . . 74.209999999999994 109.83 -175.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.499 ' HA2' ' HG3' ' A' ' 13' ' ' GLU . . . 83.44 179.46 52.32 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.171 -0.922 . . . . 72.200000000000003 111.412 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 47.6 tt0 -103.89 122.67 43.69 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.526 -1.286 . . . . 72.409999999999997 107.526 171.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.604 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 19.1 Cg_endo -55.72 124.9 17.42 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.119 . . . . 72.400000000000006 112.781 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB1' ' OE1' ' A' ' 61' ' ' GLN . . . -151.02 156.36 40.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 55.439999999999998 109.194 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -62.21 169.95 2.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.667 0.247 . . . . 72.340000000000003 111.667 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -43.39 -59.09 2.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.305 0.642 . . . . 75.310000000000002 112.289 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.25 -40.29 70.75 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.87 0.367 . . . . 73.420000000000002 111.456 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.461 ' OE1' ' HB1' ' A' ' 57' ' ' ALA . 96.4 mt-30 -74.8 -39.07 61.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 72.450000000000003 110.808 -176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' A' ' 39' ' ' VAL . 6.5 t -65.8 -51.05 62.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.637 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' GLN . 4.1 pp -62.73 -43.67 98.19 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.021 0.438 . . . . 54.210000000000001 110.067 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.7 tt0 -63.07 -35.8 81.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.022 -0.535 . . . . 74.010000000000005 110.529 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.622 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 16.0 ttt180 -61.87 -50.43 72.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 110.641 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.4 pt -74.15 -42.13 51.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.816 0.341 . . . . 74.430000000000007 111.63 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.94 -37.74 88.52 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.34 -0.391 . . . . 71.010000000000005 111.678 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.583 HE22 HG13 ' A' ' 94' ' ' VAL . 86.6 mm-40 -78.97 0.28 28.18 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 121.023 -0.271 . . . . 75.109999999999999 111.368 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 68.1 mt -103.92 -65.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.289 0.566 . . . . 70.129999999999995 111.141 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -85.45 -46.03 11.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.174 -0.921 . . . . 45.109999999999999 110.956 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -87.12 -11.17 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.561 -0.745 . . . . 55.350000000000001 112.545 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' HA ' HG21 ' A' ' 94' ' ' VAL . 4.4 p-10 -41.74 -40.51 2.03 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.413 0.894 . . . . 73.310000000000002 113.413 -166.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.2 mtm -66.68 84.28 0.11 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.614 0.721 . . . . 75.019999999999996 110.312 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.7 p -73.17 137.03 78.82 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.833 -1.076 . . . . 71.120000000000005 110.46 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' O ' HG12 ' A' ' 78' ' ' VAL . 16.6 Cg_exo -67.2 -165.98 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.924 2.416 . . . . 72.129999999999995 112.557 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 79' ' ' ARG . . . -54.74 -20.97 9.51 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.259 -0.428 . . . . 60.32 111.543 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 p -53.37 -24.54 12.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.84 -0.618 . . . . 75.439999999999998 111.542 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 7.5 p -64.23 -53.45 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.481 -0.327 . . . . 72.150000000000006 111.142 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.49 ' N ' HG13 ' A' ' 78' ' ' VAL . 14.4 ptp180 -65.62 -32.38 73.93 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 121.037 0.446 . . . . 74.439999999999998 110.057 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.94 -39.7 90.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 73.109999999999999 109.554 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 91' ' ' ASP . 5.9 t60 -72.5 -35.65 68.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 54.530000000000001 110.829 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 87.2 mt -57.16 -22.19 38.42 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.343 0.497 . . . . 73.430000000000007 112.343 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -60.95 -25.44 66.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.718 -0.219 . . . . 64.540000000000006 111.446 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.558 HE22 ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -117.41 156.47 27.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.681 0.277 . . . . 74.549999999999997 110.507 -178.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -159.09 23.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 73.5 110.656 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.9 t -74.4 174.99 8.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.263 -0.426 . . . . 53.329999999999998 110.769 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.39 -62.53 5.51 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.969 -0.559 . . . . 74.420000000000002 112.356 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.39 40.7 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.818 2.346 . . . . 73.530000000000001 112.273 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' HA3' HE22 ' A' ' 84' ' ' GLN . . . -85.37 51.51 4.51 Favored Glycine 0 C--O 1.236 0.246 0 C-N-CA 121.334 -0.46 . . . . 73.430000000000007 112.227 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -76.47 102.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 44.039999999999999 109.997 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 23.6 t70 -147.51 165.32 30.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.795 -0.639 . . . . 74.510000000000005 109.604 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -54.75 138.87 41.09 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.453 0.471 . . . . 74.099999999999994 111.97 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.34 167.97 17.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 75.120000000000005 109.051 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.583 HG13 HE22 ' A' ' 68' ' ' GLN . 3.0 p -72.73 105.24 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.198 0.523 . . . . 75.409999999999997 110.83 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-N 115.039 -0.982 . . . . 74.540000000000006 109.419 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.3 mpp? . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.238 -0.282 . . . . 73.219999999999999 110.238 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.14 -63.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.435 -0.348 . . . . 73.439999999999998 110.481 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 59.19 91.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.985 -0.552 . . . . 72.239999999999995 111.682 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -151.66 86.09 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.557 -0.535 . . . . 53.229999999999997 109.557 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -142.55 130.66 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 64.019999999999996 110.229 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 93.02 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.506 0.67 . . . . 74.209999999999994 110.32 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -74.2 99.15 3.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 52.520000000000003 111.115 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -73.6 73.93 1.48 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.175 0.512 . . . . 71.439999999999998 109.699 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 81.6 mtp -75.69 -79.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 71.540000000000006 111.002 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.32 107.18 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.619 -0.592 . . . . 73.319999999999993 111.619 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.3 m -157.8 154.09 27.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.475 -0.565 . . . . 64.109999999999999 109.475 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 64.3 mt -76.81 -140.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 119.22 -0.419 . . . . 73.430000000000007 110.764 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.577 ' HG3' ' HA2' ' A' ' 54' ' ' GLY . 5.7 mp0 -58.08 -0.44 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.155 1.169 . . . . 52.229999999999997 114.155 -163.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -69.47 136.26 51.27 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.008 -0.432 . . . . 61.0 111.178 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.651 ' NE2' ' HB ' ' A' ' 66' ' ' ILE . 21.6 pt20 -151.85 -162.63 1.56 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.429 -0.351 . . . . 73.030000000000001 110.921 -175.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.568 ' HB ' ' HG3' ' A' ' 36' ' ' GLN . 7.7 m -101.25 -51.4 3.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.095 -0.502 . . . . 75.239999999999995 110.025 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -174.18 143.38 0.89 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.06 112.16 1.26 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.969 -0.634 . . . . 74.420000000000002 112.858 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.4 153.95 21.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.615 2.21 . . . . 73.409999999999997 111.873 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.11 146.49 9.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.711 . . . . 44.340000000000003 112.458 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 m -92.81 171.84 8.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.718 0.407 . . . . 65.310000000000002 110.58 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.4 mtt -91.01 111.1 22.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.94 0.4 . . . . 73.349999999999994 111.018 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -129.99 -171.32 2.5 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.713 -0.676 . . . . 74.420000000000002 109.412 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.5 t70 -124.54 172.84 8.9 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.861 -0.422 . . . . 70.420000000000002 109.861 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' THR . 43.9 mt-10 73.99 164.53 0.28 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.483 0.713 . . . . 71.109999999999999 111.537 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.06 144.65 53.93 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.759 0.79 . . . . 63.109999999999999 112.182 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.75 149.05 47.62 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.327 -1.306 . . . . 64.219999999999999 108.885 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.765 ' CZ ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -108.58 165.07 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.384 -0.599 . . . . 74.329999999999998 109.384 173.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.582 HG11 HG21 ' A' ' 66' ' ' ILE . 36.5 t -102.26 114.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.94 -0.763 . . . . 71.299999999999997 108.94 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 52' ' ' THR . 17.3 m -125.74 165.32 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.59 0.234 . . . . 74.310000000000002 111.51 -169.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 21.3 ptt180 -169.25 170.36 8.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.032 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -149.36 139.79 22.42 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 120.773 -0.371 . . . . 44.450000000000003 110.727 168.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t30 33.31 20.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.531 1.533 . . . . 73.120000000000005 114.918 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' ASN . 13.2 pt-20 -112.41 -32.43 6.5 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.617 -0.677 . . . . 70.25 112.134 -174.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.95 19.93 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.317 -0.468 . . . . 21.199999999999999 112.751 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HG3' ' HB ' ' A' ' 16' ' ' THR . 25.6 mp0 -90.57 173.76 7.89 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.744 -0.835 . . . . 74.310000000000002 108.744 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.591 ' HD2' ' HB3' ' A' ' 15' ' ' GLN . 9.3 m-85 -117.43 171.72 7.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.934 0.873 . . . . 73.099999999999994 112.101 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -150.09 176.62 10.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.685 -1.598 . . . . 73.510000000000005 107.119 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' SG ' ' A' ' 62' ' ' CYS . 7.0 m -124.37 129.4 73.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.522 0.677 . . . . 63.030000000000001 111.186 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' HZ2' ' NH1' ' A' ' 44' ' ' ARG . 54.3 t-105 -119.05 135.96 54.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.806 -1.088 . . . . 74.310000000000002 109.292 -171.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.67 123.72 19.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.507 -0.183 . . . . 73.299999999999997 110.507 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.69 146.5 52.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.04 -0.356 . . . . 70.439999999999998 110.04 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.32 15.84 68.13 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.947 -0.644 . . . . 43.5 111.57 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HG2' HH11 ' A' ' 44' ' ' ARG . 34.8 ttt-85 -131.27 125.19 32.18 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.89 -0.782 . . . . 65.319999999999993 108.89 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.8 m -72.55 159.93 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 72.319999999999993 111.8 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.677 ' HG ' ' HB2' ' A' ' 50' ' ' TRP . 10.6 tp -119.49 135.66 24.2 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.459 -0.791 . . . . 65.25 109.5 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD2' HD12 ' A' ' 46' ' ' LEU . 55.7 Cg_endo -69.55 158.19 58.11 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.87 2.38 . . . . 72.340000000000003 113.665 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.08 129.12 26.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.911 -1.04 . . . . 71.430000000000007 110.788 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.62 -28.66 10.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.917 -0.583 . . . . 71.010000000000005 111.725 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.677 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 14.9 m95 -91.04 153.72 19.92 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.647 0.261 . . . . 71.239999999999995 110.502 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.76 138.87 53.88 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 110.36 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.586 ' HA ' HG12 ' A' ' 30' ' ' VAL . 7.3 p -100.81 131.31 46.76 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.585 -1.189 . . . . 63.350000000000001 109.616 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 54' ' ' GLY . 3.1 t -146.23 166.26 8.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 121.146 0.498 . . . . 74.209999999999994 110.317 -170.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' HA2' ' HG3' ' A' ' 13' ' ' GLU . . . 98.31 -141.09 15.39 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.647 -0.706 . . . . 72.200000000000003 114.231 167.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -136.53 119.41 11.96 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.385 -0.908 . . . . 72.409999999999997 108.788 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.765 ' HD3' ' CZ ' ' A' ' 28' ' ' PHE . 37.1 Cg_endo -63.05 115.8 3.18 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.648 1.565 . . . . 72.400000000000006 111.281 -176.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.38 155.09 35.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.608 -0.724 . . . . 55.439999999999998 109.554 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 10.0 t -55.88 153.76 8.12 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.744 -0.465 . . . . 72.340000000000003 109.744 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE3' HG23 ' A' ' 39' ' ' VAL . 24.6 tptm -43.14 -48.8 6.41 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.606 0.566 . . . . 75.310000000000002 111.848 -172.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -58.94 -51.08 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 73.420000000000002 111.03 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -69.42 -30.43 68.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.957 0.408 . . . . 72.450000000000003 110.406 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 39' ' ' VAL . 13.8 t -65.67 -52.41 51.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.776 -0.647 . . . . 63.149999999999999 110.175 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.815 HD13 ' HG2' ' A' ' 95' ' ' ARG . 4.0 pp -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.038 0.447 . . . . 54.210000000000001 110.387 176.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' LEU . 32.9 tt0 -62.83 -42.32 99.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 74.010000000000005 110.772 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.48 ' HD3' ' HG2' ' A' ' 13' ' ' GLU . 12.3 ttm-85 -57.26 -53.28 59.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 111.608 -174.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.651 ' HB ' ' NE2' ' A' ' 15' ' ' GLN . 13.1 pt -67.22 -34.71 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 111.531 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.849 ' HG3' ' HB2' ' A' ' 95' ' ' ARG . 14.0 mm-40 -66.23 -32.49 73.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 71.010000000000005 110.178 174.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 17.3 mm-40 -75.56 0.35 17.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.07 -0.514 . . . . 75.109999999999999 111.816 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 95.5 mt -103.81 -67.11 0.91 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.794 0.664 . . . . 70.129999999999995 112.794 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -86.04 -55.07 4.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.678 0.752 . . . . 45.109999999999999 110.579 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -11.48 60.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.392 -1.277 . . . . 55.350000000000001 110.915 -177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.46 -28.29 2.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.611 0.764 . . . . 73.310000000000002 112.799 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 86.4 mtp -68.76 74.36 0.27 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.282 0.563 . . . . 75.019999999999996 110.153 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.24 134.44 19.77 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.273 -0.876 . . . . 71.120000000000005 110.271 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -157.84 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.827 2.352 . . . . 72.129999999999995 111.662 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.59 -18.85 13.28 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.59 0.356 . . . . 60.32 111.405 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.3 p -53.82 -26.25 23.33 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.974 -0.557 . . . . 75.439999999999998 111.556 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.53 -36.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.195 0.521 . . . . 72.150000000000006 110.421 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 79' ' ' ARG . 17.7 mtp180 -73.84 -37.03 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.751 -0.659 . . . . 74.439999999999998 109.991 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.15 -25.83 67.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.762 -0.654 . . . . 73.109999999999999 110.632 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -70.25 -27.15 64.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.642 -0.708 . . . . 54.530000000000001 110.643 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.96 146.44 47.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.66 . . . . 73.430000000000007 110.82 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -79.27 136.53 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.693 -0.484 . . . . 64.540000000000006 109.693 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.02 -13.46 60.5 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.446 -0.343 . . . . 74.549999999999997 111.591 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -83.16 48.78 1.43 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.872 0.368 . . . . 73.5 111.012 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p 53.37 100.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.002 0.921 . . . . 53.329999999999998 112.274 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.59 179.68 46.15 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.411 -0.675 . . . . 74.420000000000002 111.411 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.04 -7.66 21.9 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.669 2.246 . . . . 73.530000000000001 112.379 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.49 -17.38 56.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-N 115.916 -0.583 . . . . 73.430000000000007 112.027 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.6 mt -75.43 134.63 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.572 0.349 . . . . 44.039999999999999 110.161 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -82.2 159.1 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.89 -0.411 . . . . 74.510000000000005 109.89 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -133.96 175.59 9.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 74.099999999999994 110.181 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.668 ' HB2' ' HG2' ' A' ' 68' ' ' GLN . . . -67.49 165.67 16.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.925 -0.579 . . . . 75.120000000000005 110.39 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 94' ' ' VAL . 11.7 p -88.86 22.09 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 122.883 1.325 . . . . 75.409999999999997 112.193 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.849 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 22.7 tpt180 . . . . . 0 C--N 1.297 -1.685 0 CA-C-N 113.626 -1.624 . . . . 74.540000000000006 109.272 168.139 . . . . . . . . 1 1 . 1 stop_ save_